<html xmlns:v="urn:schemas-microsoft-com:vml"
xmlns:o="urn:schemas-microsoft-com:office:office"
xmlns:w="urn:schemas-microsoft-com:office:word"
xmlns:dt="uuid:C2F41010-65B3-11d1-A29F-00AA00C14882"
xmlns:m="http://schemas.microsoft.com/office/2004/12/omml"
xmlns="http://www.w3.org/TR/REC-html40">

<head>
<meta http-equiv=Content-Type content="text/html; charset=utf-8">
<meta name=ProgId content=Word.Document>
<meta name=Generator content="Microsoft Word 15">
<meta name=Originator content="Microsoft Word 15">
<base href=NA>
<link rel=File-List
href="file:///F:/Documentos/artículo_revisión_consumo_2018_Daniel_Parra_archivos/filelist.xml">
<title>Medición de Consumo de Antimicrobianos como parte de Programas de Uso
Prudente de Antimi-crobianos en Hospitales Pediátricos</title>
<!--[if gte mso 9]><xml>
 <o:DocumentProperties>
  <o:Subject>Artículo</o:Subject>
  <o:Author>Daniel Parra</o:Author>
  <o:Keywords>consumo antimicrobianos; resistencia</o:Keywords>
  <o:Description>para publicación</o:Description>
  <o:Template>IOPP-WordTemplateLarge</o:Template>
  <o:LastAuthor>Daniel S. Parra G.</o:LastAuthor>
  <o:Revision>2</o:Revision>
  <o:TotalTime>312</o:TotalTime>
  <o:LastPrinted>2018-08-30T15:44:00Z</o:LastPrinted>
  <o:Created>2021-01-04T17:41:00Z</o:Created>
  <o:LastSaved>2021-01-04T17:41:00Z</o:LastSaved>
  <o:Pages>11</o:Pages>
  <o:Words>72414</o:Words>
  <o:Characters>398279</o:Characters>
  <o:Category>Ciencia;Consumo;Infectología</o:Category>
  <o:Company>Universidad Nacional de Colombia</o:Company>
  <o:Lines>Falta Revisión</o:Lines>
  <o:Lines>3318</o:Lines>
  <o:Paragraphs>939</o:Paragraphs>
  <o:CharactersWithSpaces>469754</o:CharactersWithSpaces>
  <o:Version>16.00</o:Version>
 </o:DocumentProperties>
 <o:CustomDocumentProperties>
  <o:Mendeley_x0020_Document_1 dt:dt="string">True</o:Mendeley_x0020_Document_1>
  <o:Mendeley_x0020_Unique_x0020_User_x0020_Id_1 dt:dt="string">e13d7812-2d7e-3a72-91d1-cfa8a42e4edb</o:Mendeley_x0020_Unique_x0020_User_x0020_Id_1>
  <o:Mendeley_x0020_Citation_x0020_Style_1 dt:dt="string">http://www.zotero.org/styles/vancouver</o:Mendeley_x0020_Citation_x0020_Style_1>
  <o:Mendeley_x0020_Recent_x0020_Style_x0020_Id_x0020_0_1 dt:dt="string">http://www.zotero.org/styles/american-political-science-association</o:Mendeley_x0020_Recent_x0020_Style_x0020_Id_x0020_0_1>
  <o:Mendeley_x0020_Recent_x0020_Style_x0020_Name_x0020_0_1 dt:dt="string">American Political Science Association</o:Mendeley_x0020_Recent_x0020_Style_x0020_Name_x0020_0_1>
  <o:Mendeley_x0020_Recent_x0020_Style_x0020_Id_x0020_1_1 dt:dt="string">http://www.zotero.org/styles/apa</o:Mendeley_x0020_Recent_x0020_Style_x0020_Id_x0020_1_1>
  <o:Mendeley_x0020_Recent_x0020_Style_x0020_Name_x0020_1_1 dt:dt="string">American Psychological Association 6th edition</o:Mendeley_x0020_Recent_x0020_Style_x0020_Name_x0020_1_1>
  <o:Mendeley_x0020_Recent_x0020_Style_x0020_Id_x0020_2_1 dt:dt="string">http://www.zotero.org/styles/american-sociological-association</o:Mendeley_x0020_Recent_x0020_Style_x0020_Id_x0020_2_1>
  <o:Mendeley_x0020_Recent_x0020_Style_x0020_Name_x0020_2_1 dt:dt="string">American Sociological Association</o:Mendeley_x0020_Recent_x0020_Style_x0020_Name_x0020_2_1>
  <o:Mendeley_x0020_Recent_x0020_Style_x0020_Id_x0020_3_1 dt:dt="string">http://www.zotero.org/styles/chicago-author-date</o:Mendeley_x0020_Recent_x0020_Style_x0020_Id_x0020_3_1>
  <o:Mendeley_x0020_Recent_x0020_Style_x0020_Name_x0020_3_1 dt:dt="string">Chicago Manual of Style 16th edition (author-date)</o:Mendeley_x0020_Recent_x0020_Style_x0020_Name_x0020_3_1>
  <o:Mendeley_x0020_Recent_x0020_Style_x0020_Id_x0020_4_1 dt:dt="string">http://www.zotero.org/styles/harvard-cite-them-right</o:Mendeley_x0020_Recent_x0020_Style_x0020_Id_x0020_4_1>
  <o:Mendeley_x0020_Recent_x0020_Style_x0020_Name_x0020_4_1 dt:dt="string">Cite Them Right 10th edition - Harvard</o:Mendeley_x0020_Recent_x0020_Style_x0020_Name_x0020_4_1>
  <o:Mendeley_x0020_Recent_x0020_Style_x0020_Id_x0020_5_1 dt:dt="string">http://www.zotero.org/styles/ieee</o:Mendeley_x0020_Recent_x0020_Style_x0020_Id_x0020_5_1>
  <o:Mendeley_x0020_Recent_x0020_Style_x0020_Name_x0020_5_1 dt:dt="string">IEEE</o:Mendeley_x0020_Recent_x0020_Style_x0020_Name_x0020_5_1>
  <o:Mendeley_x0020_Recent_x0020_Style_x0020_Id_x0020_6_1 dt:dt="string">http://www.zotero.org/styles/modern-humanities-research-association</o:Mendeley_x0020_Recent_x0020_Style_x0020_Id_x0020_6_1>
  <o:Mendeley_x0020_Recent_x0020_Style_x0020_Name_x0020_6_1 dt:dt="string">Modern Humanities Research Association 3rd edition (note with bibliography)</o:Mendeley_x0020_Recent_x0020_Style_x0020_Name_x0020_6_1>
  <o:Mendeley_x0020_Recent_x0020_Style_x0020_Id_x0020_7_1 dt:dt="string">http://www.zotero.org/styles/modern-language-association</o:Mendeley_x0020_Recent_x0020_Style_x0020_Id_x0020_7_1>
  <o:Mendeley_x0020_Recent_x0020_Style_x0020_Name_x0020_7_1 dt:dt="string">Modern Language Association 7th edition</o:Mendeley_x0020_Recent_x0020_Style_x0020_Name_x0020_7_1>
  <o:Mendeley_x0020_Recent_x0020_Style_x0020_Id_x0020_8_1 dt:dt="string">http://www.zotero.org/styles/nature</o:Mendeley_x0020_Recent_x0020_Style_x0020_Id_x0020_8_1>
  <o:Mendeley_x0020_Recent_x0020_Style_x0020_Name_x0020_8_1 dt:dt="string">Nature</o:Mendeley_x0020_Recent_x0020_Style_x0020_Name_x0020_8_1>
  <o:Mendeley_x0020_Recent_x0020_Style_x0020_Id_x0020_9_1 dt:dt="string">http://www.zotero.org/styles/vancouver</o:Mendeley_x0020_Recent_x0020_Style_x0020_Id_x0020_9_1>
  <o:Mendeley_x0020_Recent_x0020_Style_x0020_Name_x0020_9_1 dt:dt="string">Vancouver</o:Mendeley_x0020_Recent_x0020_Style_x0020_Name_x0020_9_1>
 </o:CustomDocumentProperties>
 <o:OfficeDocumentSettings>
  <o:RelyOnVML/>
  <o:AllowPNG/>
 </o:OfficeDocumentSettings>
</xml><![endif]-->
<link rel=dataStoreItem
href="file:///F:/Documentos/artículo_revisión_consumo_2018_Daniel_Parra_archivos/item0001.xml"
target="file:///F:\Documentos\artículo_revisión_consumo_2018_Daniel_Parra_archivos\props002.xml">
<link rel=themeData
href="file:///F:/Documentos/artículo_revisión_consumo_2018_Daniel_Parra_archivos/themedata.thmx">
<link rel=colorSchemeMapping
href="file:///F:/Documentos/artículo_revisión_consumo_2018_Daniel_Parra_archivos/colorschememapping.xml">
<!--[if gte mso 9]><xml>
 <w:WordDocument>
  <w:TrackMoves>false</w:TrackMoves>
  <w:TrackFormatting/>
  <w:AutoHyphenation/>
  <w:HyphenationZone>21</w:HyphenationZone>
  <w:PunctuationKerning/>
  <w:ValidateAgainstSchemas/>
  <w:SaveIfXMLInvalid>false</w:SaveIfXMLInvalid>
  <w:IgnoreMixedContent>false</w:IgnoreMixedContent>
  <w:AlwaysShowPlaceholderText>false</w:AlwaysShowPlaceholderText>
  <w:DoNotPromoteQF/>
  <w:LidThemeOther>EN-GB</w:LidThemeOther>
  <w:LidThemeAsian>X-NONE</w:LidThemeAsian>
  <w:LidThemeComplexScript>X-NONE</w:LidThemeComplexScript>
  <w:Compatibility>
   <w:BreakWrappedTables/>
   <w:SnapToGridInCell/>
   <w:WrapTextWithPunct/>
   <w:UseAsianBreakRules/>
   <w:DontGrowAutofit/>
   <w:SplitPgBreakAndParaMark/>
   <w:EnableOpenTypeKerning/>
   <w:DontFlipMirrorIndents/>
   <w:OverrideTableStyleHps/>
  </w:Compatibility>
  <m:mathPr>
   <m:mathFont m:val="Cambria Math"/>
   <m:brkBin m:val="before"/>
   <m:brkBinSub m:val="&#45;-"/>
   <m:smallFrac m:val="off"/>
   <m:dispDef/>
   <m:lMargin m:val="0"/>
   <m:rMargin m:val="0"/>
   <m:defJc m:val="centerGroup"/>
   <m:wrapIndent m:val="1440"/>
   <m:intLim m:val="subSup"/>
   <m:naryLim m:val="undOvr"/>
  </m:mathPr></w:WordDocument>
</xml><![endif]--><!--[if gte mso 9]><xml>
 <w:LatentStyles DefLockedState="false" DefUnhideWhenUsed="false"
  DefSemiHidden="false" DefQFormat="false" DefPriority="99"
  LatentStyleCount="371">
  <w:LsdException Locked="false" Priority="0" Name="Normal"/>
  <w:LsdException Locked="false" Priority="9" Name="heading 1"/>
  <w:LsdException Locked="false" Priority="9" SemiHidden="true"
   UnhideWhenUsed="true" Name="heading 2"/>
  <w:LsdException Locked="false" Priority="9" SemiHidden="true"
   UnhideWhenUsed="true" QFormat="true" Name="heading 3"/>
  <w:LsdException Locked="false" Priority="9" SemiHidden="true"
   UnhideWhenUsed="true" QFormat="true" Name="heading 4"/>
  <w:LsdException Locked="false" Priority="9" SemiHidden="true"
   UnhideWhenUsed="true" QFormat="true" Name="heading 5"/>
  <w:LsdException Locked="false" Priority="9" SemiHidden="true"
   UnhideWhenUsed="true" QFormat="true" Name="heading 6"/>
  <w:LsdException Locked="false" Priority="9" SemiHidden="true"
   UnhideWhenUsed="true" QFormat="true" Name="heading 7"/>
  <w:LsdException Locked="false" Priority="9" SemiHidden="true"
   UnhideWhenUsed="true" QFormat="true" Name="heading 8"/>
  <w:LsdException Locked="false" Priority="9" SemiHidden="true"
   UnhideWhenUsed="true" QFormat="true" Name="heading 9"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="index 1"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="index 2"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="index 3"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="index 4"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="index 5"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="index 6"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="index 7"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="index 8"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="index 9"/>
  <w:LsdException Locked="false" Priority="39" SemiHidden="true"
   UnhideWhenUsed="true" Name="toc 1"/>
  <w:LsdException Locked="false" Priority="39" SemiHidden="true"
   UnhideWhenUsed="true" Name="toc 2"/>
  <w:LsdException Locked="false" Priority="39" SemiHidden="true"
   UnhideWhenUsed="true" Name="toc 3"/>
  <w:LsdException Locked="false" Priority="39" SemiHidden="true"
   UnhideWhenUsed="true" Name="toc 4"/>
  <w:LsdException Locked="false" Priority="39" SemiHidden="true"
   UnhideWhenUsed="true" Name="toc 5"/>
  <w:LsdException Locked="false" Priority="39" SemiHidden="true"
   UnhideWhenUsed="true" Name="toc 6"/>
  <w:LsdException Locked="false" Priority="39" SemiHidden="true"
   UnhideWhenUsed="true" Name="toc 7"/>
  <w:LsdException Locked="false" Priority="39" SemiHidden="true"
   UnhideWhenUsed="true" Name="toc 8"/>
  <w:LsdException Locked="false" Priority="39" SemiHidden="true"
   UnhideWhenUsed="true" Name="toc 9"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Normal Indent"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="footnote text"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="annotation text"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="header"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="footer"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="index heading"/>
  <w:LsdException Locked="false" Priority="35" SemiHidden="true"
   UnhideWhenUsed="true" QFormat="true" Name="caption"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="table of figures"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="envelope address"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="envelope return"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="footnote reference"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="annotation reference"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="line number"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="page number"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="endnote reference"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="endnote text"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="table of authorities"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="macro"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="toa heading"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="List"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="List Bullet"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="List Number"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="List 2"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="List 3"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="List 4"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="List 5"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="List Bullet 2"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="List Bullet 3"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="List Bullet 4"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="List Bullet 5"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="List Number 2"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="List Number 3"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="List Number 4"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="List Number 5"/>
  <w:LsdException Locked="false" Priority="10" Name="Title"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Closing"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Signature"/>
  <w:LsdException Locked="false" Priority="1" SemiHidden="true"
   UnhideWhenUsed="true" Name="Default Paragraph Font"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Body Text"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Body Text Indent"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="List Continue"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="List Continue 2"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="List Continue 3"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="List Continue 4"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="List Continue 5"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Message Header"/>
  <w:LsdException Locked="false" Priority="11" Name="Subtitle"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Salutation"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Date"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Body Text First Indent"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Body Text First Indent 2"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Note Heading"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Body Text 2"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Body Text 3"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Body Text Indent 2"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Body Text Indent 3"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Block Text"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Hyperlink"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="FollowedHyperlink"/>
  <w:LsdException Locked="false" Priority="22" QFormat="true" Name="Strong"/>
  <w:LsdException Locked="false" Priority="20" QFormat="true" Name="Emphasis"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Document Map"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Plain Text"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="E-mail Signature"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="HTML Top of Form"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="HTML Bottom of Form"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Normal (Web)"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="HTML Acronym"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="HTML Address"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="HTML Cite"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="HTML Code"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="HTML Definition"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="HTML Keyboard"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="HTML Preformatted"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="HTML Sample"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="HTML Typewriter"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="HTML Variable"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Normal Table"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="annotation subject"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="No List"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Outline List 1"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Outline List 2"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Outline List 3"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table Simple 1"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table Simple 2"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table Simple 3"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table Classic 1"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table Classic 2"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table Classic 3"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table Classic 4"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table Colorful 1"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table Colorful 2"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table Colorful 3"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table Columns 1"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table Columns 2"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table Columns 3"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table Columns 4"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table Columns 5"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table Grid 1"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table Grid 2"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table Grid 3"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table Grid 4"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table Grid 5"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table Grid 6"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table Grid 7"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table Grid 8"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table List 1"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table List 2"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table List 3"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table List 4"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table List 5"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table List 6"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table List 7"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table List 8"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table 3D effects 1"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table 3D effects 2"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table 3D effects 3"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table Contemporary"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table Elegant"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table Professional"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table Subtle 1"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table Subtle 2"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table Web 1"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table Web 2"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table Web 3"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Balloon Text"/>
  <w:LsdException Locked="false" Priority="39" Name="Table Grid"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table Theme"/>
  <w:LsdException Locked="false" SemiHidden="true" Name="Placeholder Text"/>
  <w:LsdException Locked="false" Priority="1" Name="No Spacing"/>
  <w:LsdException Locked="false" Priority="60" Name="Light Shading"/>
  <w:LsdException Locked="false" Priority="61" Name="Light List"/>
  <w:LsdException Locked="false" Priority="62" Name="Light Grid"/>
  <w:LsdException Locked="false" Priority="63" Name="Medium Shading 1"/>
  <w:LsdException Locked="false" Priority="64" Name="Medium Shading 2"/>
  <w:LsdException Locked="false" Priority="65" Name="Medium List 1"/>
  <w:LsdException Locked="false" Priority="66" Name="Medium List 2"/>
  <w:LsdException Locked="false" Priority="67" Name="Medium Grid 1"/>
  <w:LsdException Locked="false" Priority="68" Name="Medium Grid 2"/>
  <w:LsdException Locked="false" Priority="69" Name="Medium Grid 3"/>
  <w:LsdException Locked="false" Priority="70" Name="Dark List"/>
  <w:LsdException Locked="false" Priority="71" Name="Colorful Shading"/>
  <w:LsdException Locked="false" Priority="72" Name="Colorful List"/>
  <w:LsdException Locked="false" Priority="73" Name="Colorful Grid"/>
  <w:LsdException Locked="false" Priority="60" Name="Light Shading Accent 1"/>
  <w:LsdException Locked="false" Priority="61" Name="Light List Accent 1"/>
  <w:LsdException Locked="false" Priority="62" Name="Light Grid Accent 1"/>
  <w:LsdException Locked="false" Priority="63" Name="Medium Shading 1 Accent 1"/>
  <w:LsdException Locked="false" Priority="64" Name="Medium Shading 2 Accent 1"/>
  <w:LsdException Locked="false" Priority="65" Name="Medium List 1 Accent 1"/>
  <w:LsdException Locked="false" SemiHidden="true" Name="Revision"/>
  <w:LsdException Locked="false" Priority="34" QFormat="true"
   Name="List Paragraph"/>
  <w:LsdException Locked="false" Priority="29" Name="Quote"/>
  <w:LsdException Locked="false" Priority="30" Name="Intense Quote"/>
  <w:LsdException Locked="false" Priority="66" Name="Medium List 2 Accent 1"/>
  <w:LsdException Locked="false" Priority="67" Name="Medium Grid 1 Accent 1"/>
  <w:LsdException Locked="false" Priority="68" Name="Medium Grid 2 Accent 1"/>
  <w:LsdException Locked="false" Priority="69" Name="Medium Grid 3 Accent 1"/>
  <w:LsdException Locked="false" Priority="70" Name="Dark List Accent 1"/>
  <w:LsdException Locked="false" Priority="71" Name="Colorful Shading Accent 1"/>
  <w:LsdException Locked="false" Priority="72" Name="Colorful List Accent 1"/>
  <w:LsdException Locked="false" Priority="73" Name="Colorful Grid Accent 1"/>
  <w:LsdException Locked="false" Priority="60" Name="Light Shading Accent 2"/>
  <w:LsdException Locked="false" Priority="61" Name="Light List Accent 2"/>
  <w:LsdException Locked="false" Priority="62" Name="Light Grid Accent 2"/>
  <w:LsdException Locked="false" Priority="63" Name="Medium Shading 1 Accent 2"/>
  <w:LsdException Locked="false" Priority="64" Name="Medium Shading 2 Accent 2"/>
  <w:LsdException Locked="false" Priority="65" Name="Medium List 1 Accent 2"/>
  <w:LsdException Locked="false" Priority="66" Name="Medium List 2 Accent 2"/>
  <w:LsdException Locked="false" Priority="67" Name="Medium Grid 1 Accent 2"/>
  <w:LsdException Locked="false" Priority="68" Name="Medium Grid 2 Accent 2"/>
  <w:LsdException Locked="false" Priority="69" Name="Medium Grid 3 Accent 2"/>
  <w:LsdException Locked="false" Priority="70" Name="Dark List Accent 2"/>
  <w:LsdException Locked="false" Priority="71" Name="Colorful Shading Accent 2"/>
  <w:LsdException Locked="false" Priority="72" Name="Colorful List Accent 2"/>
  <w:LsdException Locked="false" Priority="73" Name="Colorful Grid Accent 2"/>
  <w:LsdException Locked="false" Priority="60" Name="Light Shading Accent 3"/>
  <w:LsdException Locked="false" Priority="61" Name="Light List Accent 3"/>
  <w:LsdException Locked="false" Priority="62" Name="Light Grid Accent 3"/>
  <w:LsdException Locked="false" Priority="63" Name="Medium Shading 1 Accent 3"/>
  <w:LsdException Locked="false" Priority="64" Name="Medium Shading 2 Accent 3"/>
  <w:LsdException Locked="false" Priority="65" Name="Medium List 1 Accent 3"/>
  <w:LsdException Locked="false" Priority="66" Name="Medium List 2 Accent 3"/>
  <w:LsdException Locked="false" Priority="67" Name="Medium Grid 1 Accent 3"/>
  <w:LsdException Locked="false" Priority="68" Name="Medium Grid 2 Accent 3"/>
  <w:LsdException Locked="false" Priority="69" Name="Medium Grid 3 Accent 3"/>
  <w:LsdException Locked="false" Priority="70" Name="Dark List Accent 3"/>
  <w:LsdException Locked="false" Priority="71" Name="Colorful Shading Accent 3"/>
  <w:LsdException Locked="false" Priority="72" Name="Colorful List Accent 3"/>
  <w:LsdException Locked="false" Priority="73" Name="Colorful Grid Accent 3"/>
  <w:LsdException Locked="false" Priority="60" Name="Light Shading Accent 4"/>
  <w:LsdException Locked="false" Priority="61" Name="Light List Accent 4"/>
  <w:LsdException Locked="false" Priority="62" Name="Light Grid Accent 4"/>
  <w:LsdException Locked="false" Priority="63" Name="Medium Shading 1 Accent 4"/>
  <w:LsdException Locked="false" Priority="64" Name="Medium Shading 2 Accent 4"/>
  <w:LsdException Locked="false" Priority="65" Name="Medium List 1 Accent 4"/>
  <w:LsdException Locked="false" Priority="66" Name="Medium List 2 Accent 4"/>
  <w:LsdException Locked="false" Priority="67" Name="Medium Grid 1 Accent 4"/>
  <w:LsdException Locked="false" Priority="68" Name="Medium Grid 2 Accent 4"/>
  <w:LsdException Locked="false" Priority="69" Name="Medium Grid 3 Accent 4"/>
  <w:LsdException Locked="false" Priority="70" Name="Dark List Accent 4"/>
  <w:LsdException Locked="false" Priority="71" Name="Colorful Shading Accent 4"/>
  <w:LsdException Locked="false" Priority="72" Name="Colorful List Accent 4"/>
  <w:LsdException Locked="false" Priority="73" Name="Colorful Grid Accent 4"/>
  <w:LsdException Locked="false" Priority="60" Name="Light Shading Accent 5"/>
  <w:LsdException Locked="false" Priority="61" Name="Light List Accent 5"/>
  <w:LsdException Locked="false" Priority="62" Name="Light Grid Accent 5"/>
  <w:LsdException Locked="false" Priority="63" Name="Medium Shading 1 Accent 5"/>
  <w:LsdException Locked="false" Priority="64" Name="Medium Shading 2 Accent 5"/>
  <w:LsdException Locked="false" Priority="65" Name="Medium List 1 Accent 5"/>
  <w:LsdException Locked="false" Priority="66" Name="Medium List 2 Accent 5"/>
  <w:LsdException Locked="false" Priority="67" Name="Medium Grid 1 Accent 5"/>
  <w:LsdException Locked="false" Priority="68" Name="Medium Grid 2 Accent 5"/>
  <w:LsdException Locked="false" Priority="69" Name="Medium Grid 3 Accent 5"/>
  <w:LsdException Locked="false" Priority="70" Name="Dark List Accent 5"/>
  <w:LsdException Locked="false" Priority="71" Name="Colorful Shading Accent 5"/>
  <w:LsdException Locked="false" Priority="72" Name="Colorful List Accent 5"/>
  <w:LsdException Locked="false" Priority="73" Name="Colorful Grid Accent 5"/>
  <w:LsdException Locked="false" Priority="60" Name="Light Shading Accent 6"/>
  <w:LsdException Locked="false" Priority="61" Name="Light List Accent 6"/>
  <w:LsdException Locked="false" Priority="62" Name="Light Grid Accent 6"/>
  <w:LsdException Locked="false" Priority="63" Name="Medium Shading 1 Accent 6"/>
  <w:LsdException Locked="false" Priority="64" Name="Medium Shading 2 Accent 6"/>
  <w:LsdException Locked="false" Priority="65" Name="Medium List 1 Accent 6"/>
  <w:LsdException Locked="false" Priority="66" Name="Medium List 2 Accent 6"/>
  <w:LsdException Locked="false" Priority="67" Name="Medium Grid 1 Accent 6"/>
  <w:LsdException Locked="false" Priority="68" Name="Medium Grid 2 Accent 6"/>
  <w:LsdException Locked="false" Priority="69" Name="Medium Grid 3 Accent 6"/>
  <w:LsdException Locked="false" Priority="70" Name="Dark List Accent 6"/>
  <w:LsdException Locked="false" Priority="71" Name="Colorful Shading Accent 6"/>
  <w:LsdException Locked="false" Priority="72" Name="Colorful List Accent 6"/>
  <w:LsdException Locked="false" Priority="73" Name="Colorful Grid Accent 6"/>
  <w:LsdException Locked="false" Priority="19" Name="Subtle Emphasis"/>
  <w:LsdException Locked="false" Priority="21" Name="Intense Emphasis"/>
  <w:LsdException Locked="false" Priority="31" Name="Subtle Reference"/>
  <w:LsdException Locked="false" Priority="32" Name="Intense Reference"/>
  <w:LsdException Locked="false" Priority="33" QFormat="true" Name="Book Title"/>
  <w:LsdException Locked="false" Priority="37" SemiHidden="true"
   UnhideWhenUsed="true" Name="Bibliography"/>
  <w:LsdException Locked="false" Priority="39" SemiHidden="true"
   UnhideWhenUsed="true" QFormat="true" Name="TOC Heading"/>
  <w:LsdException Locked="false" Priority="41" Name="Plain Table 1"/>
  <w:LsdException Locked="false" Priority="42" Name="Plain Table 2"/>
  <w:LsdException Locked="false" Priority="43" Name="Plain Table 3"/>
  <w:LsdException Locked="false" Priority="44" Name="Plain Table 4"/>
  <w:LsdException Locked="false" Priority="45" Name="Plain Table 5"/>
  <w:LsdException Locked="false" Priority="40" Name="Grid Table Light"/>
  <w:LsdException Locked="false" Priority="46" Name="Grid Table 1 Light"/>
  <w:LsdException Locked="false" Priority="47" Name="Grid Table 2"/>
  <w:LsdException Locked="false" Priority="48" Name="Grid Table 3"/>
  <w:LsdException Locked="false" Priority="49" Name="Grid Table 4"/>
  <w:LsdException Locked="false" Priority="50" Name="Grid Table 5 Dark"/>
  <w:LsdException Locked="false" Priority="51" Name="Grid Table 6 Colorful"/>
  <w:LsdException Locked="false" Priority="52" Name="Grid Table 7 Colorful"/>
  <w:LsdException Locked="false" Priority="46"
   Name="Grid Table 1 Light Accent 1"/>
  <w:LsdException Locked="false" Priority="47" Name="Grid Table 2 Accent 1"/>
  <w:LsdException Locked="false" Priority="48" Name="Grid Table 3 Accent 1"/>
  <w:LsdException Locked="false" Priority="49" Name="Grid Table 4 Accent 1"/>
  <w:LsdException Locked="false" Priority="50" Name="Grid Table 5 Dark Accent 1"/>
  <w:LsdException Locked="false" Priority="51"
   Name="Grid Table 6 Colorful Accent 1"/>
  <w:LsdException Locked="false" Priority="52"
   Name="Grid Table 7 Colorful Accent 1"/>
  <w:LsdException Locked="false" Priority="46"
   Name="Grid Table 1 Light Accent 2"/>
  <w:LsdException Locked="false" Priority="47" Name="Grid Table 2 Accent 2"/>
  <w:LsdException Locked="false" Priority="48" Name="Grid Table 3 Accent 2"/>
  <w:LsdException Locked="false" Priority="49" Name="Grid Table 4 Accent 2"/>
  <w:LsdException Locked="false" Priority="50" Name="Grid Table 5 Dark Accent 2"/>
  <w:LsdException Locked="false" Priority="51"
   Name="Grid Table 6 Colorful Accent 2"/>
  <w:LsdException Locked="false" Priority="52"
   Name="Grid Table 7 Colorful Accent 2"/>
  <w:LsdException Locked="false" Priority="46"
   Name="Grid Table 1 Light Accent 3"/>
  <w:LsdException Locked="false" Priority="47" Name="Grid Table 2 Accent 3"/>
  <w:LsdException Locked="false" Priority="48" Name="Grid Table 3 Accent 3"/>
  <w:LsdException Locked="false" Priority="49" Name="Grid Table 4 Accent 3"/>
  <w:LsdException Locked="false" Priority="50" Name="Grid Table 5 Dark Accent 3"/>
  <w:LsdException Locked="false" Priority="51"
   Name="Grid Table 6 Colorful Accent 3"/>
  <w:LsdException Locked="false" Priority="52"
   Name="Grid Table 7 Colorful Accent 3"/>
  <w:LsdException Locked="false" Priority="46"
   Name="Grid Table 1 Light Accent 4"/>
  <w:LsdException Locked="false" Priority="47" Name="Grid Table 2 Accent 4"/>
  <w:LsdException Locked="false" Priority="48" Name="Grid Table 3 Accent 4"/>
  <w:LsdException Locked="false" Priority="49" Name="Grid Table 4 Accent 4"/>
  <w:LsdException Locked="false" Priority="50" Name="Grid Table 5 Dark Accent 4"/>
  <w:LsdException Locked="false" Priority="51"
   Name="Grid Table 6 Colorful Accent 4"/>
  <w:LsdException Locked="false" Priority="52"
   Name="Grid Table 7 Colorful Accent 4"/>
  <w:LsdException Locked="false" Priority="46"
   Name="Grid Table 1 Light Accent 5"/>
  <w:LsdException Locked="false" Priority="47" Name="Grid Table 2 Accent 5"/>
  <w:LsdException Locked="false" Priority="48" Name="Grid Table 3 Accent 5"/>
  <w:LsdException Locked="false" Priority="49" Name="Grid Table 4 Accent 5"/>
  <w:LsdException Locked="false" Priority="50" Name="Grid Table 5 Dark Accent 5"/>
  <w:LsdException Locked="false" Priority="51"
   Name="Grid Table 6 Colorful Accent 5"/>
  <w:LsdException Locked="false" Priority="52"
   Name="Grid Table 7 Colorful Accent 5"/>
  <w:LsdException Locked="false" Priority="46"
   Name="Grid Table 1 Light Accent 6"/>
  <w:LsdException Locked="false" Priority="47" Name="Grid Table 2 Accent 6"/>
  <w:LsdException Locked="false" Priority="48" Name="Grid Table 3 Accent 6"/>
  <w:LsdException Locked="false" Priority="49" Name="Grid Table 4 Accent 6"/>
  <w:LsdException Locked="false" Priority="50" Name="Grid Table 5 Dark Accent 6"/>
  <w:LsdException Locked="false" Priority="51"
   Name="Grid Table 6 Colorful Accent 6"/>
  <w:LsdException Locked="false" Priority="52"
   Name="Grid Table 7 Colorful Accent 6"/>
  <w:LsdException Locked="false" Priority="46" Name="List Table 1 Light"/>
  <w:LsdException Locked="false" Priority="47" Name="List Table 2"/>
  <w:LsdException Locked="false" Priority="48" Name="List Table 3"/>
  <w:LsdException Locked="false" Priority="49" Name="List Table 4"/>
  <w:LsdException Locked="false" Priority="50" Name="List Table 5 Dark"/>
  <w:LsdException Locked="false" Priority="51" Name="List Table 6 Colorful"/>
  <w:LsdException Locked="false" Priority="52" Name="List Table 7 Colorful"/>
  <w:LsdException Locked="false" Priority="46"
   Name="List Table 1 Light Accent 1"/>
  <w:LsdException Locked="false" Priority="47" Name="List Table 2 Accent 1"/>
  <w:LsdException Locked="false" Priority="48" Name="List Table 3 Accent 1"/>
  <w:LsdException Locked="false" Priority="49" Name="List Table 4 Accent 1"/>
  <w:LsdException Locked="false" Priority="50" Name="List Table 5 Dark Accent 1"/>
  <w:LsdException Locked="false" Priority="51"
   Name="List Table 6 Colorful Accent 1"/>
  <w:LsdException Locked="false" Priority="52"
   Name="List Table 7 Colorful Accent 1"/>
  <w:LsdException Locked="false" Priority="46"
   Name="List Table 1 Light Accent 2"/>
  <w:LsdException Locked="false" Priority="47" Name="List Table 2 Accent 2"/>
  <w:LsdException Locked="false" Priority="48" Name="List Table 3 Accent 2"/>
  <w:LsdException Locked="false" Priority="49" Name="List Table 4 Accent 2"/>
  <w:LsdException Locked="false" Priority="50" Name="List Table 5 Dark Accent 2"/>
  <w:LsdException Locked="false" Priority="51"
   Name="List Table 6 Colorful Accent 2"/>
  <w:LsdException Locked="false" Priority="52"
   Name="List Table 7 Colorful Accent 2"/>
  <w:LsdException Locked="false" Priority="46"
   Name="List Table 1 Light Accent 3"/>
  <w:LsdException Locked="false" Priority="47" Name="List Table 2 Accent 3"/>
  <w:LsdException Locked="false" Priority="48" Name="List Table 3 Accent 3"/>
  <w:LsdException Locked="false" Priority="49" Name="List Table 4 Accent 3"/>
  <w:LsdException Locked="false" Priority="50" Name="List Table 5 Dark Accent 3"/>
  <w:LsdException Locked="false" Priority="51"
   Name="List Table 6 Colorful Accent 3"/>
  <w:LsdException Locked="false" Priority="52"
   Name="List Table 7 Colorful Accent 3"/>
  <w:LsdException Locked="false" Priority="46"
   Name="List Table 1 Light Accent 4"/>
  <w:LsdException Locked="false" Priority="47" Name="List Table 2 Accent 4"/>
  <w:LsdException Locked="false" Priority="48" Name="List Table 3 Accent 4"/>
  <w:LsdException Locked="false" Priority="49" Name="List Table 4 Accent 4"/>
  <w:LsdException Locked="false" Priority="50" Name="List Table 5 Dark Accent 4"/>
  <w:LsdException Locked="false" Priority="51"
   Name="List Table 6 Colorful Accent 4"/>
  <w:LsdException Locked="false" Priority="52"
   Name="List Table 7 Colorful Accent 4"/>
  <w:LsdException Locked="false" Priority="46"
   Name="List Table 1 Light Accent 5"/>
  <w:LsdException Locked="false" Priority="47" Name="List Table 2 Accent 5"/>
  <w:LsdException Locked="false" Priority="48" Name="List Table 3 Accent 5"/>
  <w:LsdException Locked="false" Priority="49" Name="List Table 4 Accent 5"/>
  <w:LsdException Locked="false" Priority="50" Name="List Table 5 Dark Accent 5"/>
  <w:LsdException Locked="false" Priority="51"
   Name="List Table 6 Colorful Accent 5"/>
  <w:LsdException Locked="false" Priority="52"
   Name="List Table 7 Colorful Accent 5"/>
  <w:LsdException Locked="false" Priority="46"
   Name="List Table 1 Light Accent 6"/>
  <w:LsdException Locked="false" Priority="47" Name="List Table 2 Accent 6"/>
  <w:LsdException Locked="false" Priority="48" Name="List Table 3 Accent 6"/>
  <w:LsdException Locked="false" Priority="49" Name="List Table 4 Accent 6"/>
  <w:LsdException Locked="false" Priority="50" Name="List Table 5 Dark Accent 6"/>
  <w:LsdException Locked="false" Priority="51"
   Name="List Table 6 Colorful Accent 6"/>
  <w:LsdException Locked="false" Priority="52"
   Name="List Table 7 Colorful Accent 6"/>
 </w:LatentStyles>
</xml><![endif]-->
<style>
<!--
 /* Font Definitions */
 @font-face
	{font-family:Wingdings;
	panose-1:5 0 0 0 0 0 0 0 0 0;
	mso-font-charset:2;
	mso-generic-font-family:auto;
	mso-font-pitch:variable;
	mso-font-signature:0 268435456 0 0 -2147483648 0;}
@font-face
	{font-family:"Cambria Math";
	panose-1:0 0 0 0 0 0 0 0 0 0;
	mso-font-charset:1;
	mso-generic-font-family:roman;
	mso-font-pitch:variable;
	mso-font-signature:0 0 0 0 0 0;}
@font-face
	{font-family:Calibri;
	panose-1:2 15 5 2 2 2 4 3 2 4;
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:-536870145 1073786111 1 0 415 0;}
@font-face
	{font-family:Cambria;
	panose-1:2 4 5 3 5 4 6 3 2 4;
	mso-font-charset:0;
	mso-generic-font-family:roman;
	mso-font-pitch:variable;
	mso-font-signature:-536870145 1073743103 0 0 415 0;}
@font-face
	{font-family:Tahoma;
	panose-1:2 11 6 4 3 5 4 4 2 4;
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:-520081665 -1073717157 41 0 66047 0;}
@font-face
	{font-family:"Segoe UI";
	panose-1:2 11 5 2 4 2 4 2 2 3;
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:-520084737 -1073683329 41 0 479 0;}
 /* Style Definitions */
 p.MsoNormal, li.MsoNormal, div.MsoNormal
	{mso-style-unhide:no;
	mso-style-parent:"";
	margin-top:0mm;
	margin-right:0mm;
	margin-bottom:8.0pt;
	margin-left:0mm;
	line-height:107%;
	mso-pagination:widow-orphan;
	font-size:11.0pt;
	font-family:"Calibri",sans-serif;
	mso-ascii-font-family:Calibri;
	mso-ascii-theme-font:minor-latin;
	mso-fareast-font-family:Calibri;
	mso-fareast-theme-font:minor-latin;
	mso-hansi-font-family:Calibri;
	mso-hansi-theme-font:minor-latin;
	mso-bidi-font-family:"Times New Roman";
	mso-bidi-theme-font:minor-bidi;
	mso-ansi-language:EN-GB;
	mso-fareast-language:EN-US;}
h1
	{mso-style-priority:9;
	mso-style-unhide:no;
	mso-style-link:"Título 1 Car";
	mso-style-next:Normal;
	margin-top:12.0pt;
	margin-right:0mm;
	margin-bottom:0mm;
	margin-left:0mm;
	margin-bottom:.0001pt;
	line-height:107%;
	mso-pagination:widow-orphan lines-together;
	page-break-after:avoid;
	mso-outline-level:1;
	font-size:20.0pt;
	mso-bidi-font-size:16.0pt;
	font-family:"Arial",sans-serif;
	mso-font-kerning:16.0pt;
	mso-ansi-language:ES;
	mso-fareast-language:ES;}
h2
	{mso-style-noshow:yes;
	mso-style-priority:9;
	mso-style-link:"Título 2 Car";
	mso-style-next:Normal;
	margin-top:2.0pt;
	margin-right:0mm;
	margin-bottom:0mm;
	margin-left:0mm;
	margin-bottom:.0001pt;
	line-height:107%;
	mso-pagination:widow-orphan lines-together;
	page-break-after:avoid;
	mso-outline-level:2;
	font-size:16.0pt;
	mso-bidi-font-size:13.0pt;
	font-family:"Arial",sans-serif;
	mso-fareast-font-family:"Times New Roman";
	mso-bidi-font-family:"Times New Roman";
	mso-ansi-language:EN-GB;
	mso-fareast-language:EN-US;}
h3
	{mso-style-noshow:yes;
	mso-style-priority:9;
	mso-style-qformat:yes;
	mso-style-link:"Título 3 Car";
	mso-style-next:Normal;
	margin-top:2.0pt;
	margin-right:0mm;
	margin-bottom:0mm;
	margin-left:0mm;
	margin-bottom:.0001pt;
	line-height:107%;
	mso-pagination:widow-orphan lines-together;
	page-break-after:avoid;
	mso-outline-level:3;
	font-size:14.0pt;
	mso-bidi-font-size:11.0pt;
	font-family:"Arial",sans-serif;
	mso-fareast-font-family:"Times New Roman";
	mso-bidi-font-family:"Times New Roman";
	mso-ansi-language:EN-GB;
	mso-fareast-language:EN-US;}
h4
	{mso-style-noshow:yes;
	mso-style-priority:9;
	mso-style-qformat:yes;
	mso-style-link:"Título 4 Car";
	mso-style-next:Normal;
	margin-top:2.0pt;
	margin-right:0mm;
	margin-bottom:0mm;
	margin-left:0mm;
	margin-bottom:.0001pt;
	line-height:107%;
	mso-pagination:widow-orphan lines-together;
	page-break-after:avoid;
	mso-outline-level:4;
	font-size:12.0pt;
	font-family:"Arial",sans-serif;
	mso-bidi-font-family:"Times New Roman";
	mso-bidi-theme-font:minor-bidi;
	letter-spacing:.25pt;
	mso-ansi-language:EN-GB;
	mso-fareast-language:EN-US;}
h5
	{mso-style-noshow:yes;
	mso-style-priority:9;
	mso-style-qformat:yes;
	mso-style-link:"Título 5 Car";
	mso-style-next:Normal;
	margin-top:2.0pt;
	margin-right:0mm;
	margin-bottom:0mm;
	margin-left:0mm;
	margin-bottom:.0001pt;
	line-height:107%;
	mso-pagination:widow-orphan lines-together;
	page-break-after:avoid;
	mso-outline-level:5;
	font-size:12.0pt;
	font-family:"Arial",sans-serif;
	mso-bidi-font-family:"Times New Roman";
	mso-bidi-theme-font:minor-bidi;
	mso-ansi-language:EN-GB;
	mso-fareast-language:EN-US;
	font-weight:normal;
	font-style:italic;}
h6
	{mso-style-noshow:yes;
	mso-style-priority:9;
	mso-style-qformat:yes;
	mso-style-link:"Título 6 Car";
	mso-style-next:Normal;
	margin-top:2.0pt;
	margin-right:0mm;
	margin-bottom:0mm;
	margin-left:0mm;
	margin-bottom:.0001pt;
	line-height:107%;
	mso-pagination:widow-orphan lines-together;
	page-break-after:avoid;
	mso-outline-level:6;
	font-size:11.0pt;
	font-family:"Cambria",serif;
	mso-fareast-font-family:"Times New Roman";
	mso-bidi-font-family:"Times New Roman";
	color:#243F60;
	mso-ansi-language:EN-GB;
	mso-fareast-language:EN-US;
	font-weight:normal;
	font-style:italic;}
p.MsoHeading7, li.MsoHeading7, div.MsoHeading7
	{mso-style-noshow:yes;
	mso-style-priority:9;
	mso-style-qformat:yes;
	mso-style-link:"Título 7 Car";
	mso-style-next:Normal;
	margin-top:2.0pt;
	margin-right:0mm;
	margin-bottom:0mm;
	margin-left:0mm;
	margin-bottom:.0001pt;
	line-height:107%;
	mso-pagination:widow-orphan lines-together;
	page-break-after:avoid;
	mso-outline-level:7;
	font-size:11.0pt;
	font-family:"Cambria",serif;
	mso-fareast-font-family:"Times New Roman";
	mso-bidi-font-family:"Times New Roman";
	color:#404040;
	mso-ansi-language:EN-GB;
	mso-fareast-language:EN-US;
	font-style:italic;}
p.MsoHeading8, li.MsoHeading8, div.MsoHeading8
	{mso-style-noshow:yes;
	mso-style-priority:9;
	mso-style-qformat:yes;
	mso-style-link:"Título 8 Car";
	mso-style-next:Normal;
	margin-top:2.0pt;
	margin-right:0mm;
	margin-bottom:0mm;
	margin-left:0mm;
	margin-bottom:.0001pt;
	line-height:107%;
	mso-pagination:widow-orphan lines-together;
	page-break-after:avoid;
	mso-outline-level:8;
	font-size:10.0pt;
	font-family:"Cambria",serif;
	mso-fareast-font-family:"Times New Roman";
	mso-bidi-font-family:"Times New Roman";
	color:#404040;
	mso-ansi-language:EN-GB;
	mso-fareast-language:EN-US;}
p.MsoHeading9, li.MsoHeading9, div.MsoHeading9
	{mso-style-noshow:yes;
	mso-style-priority:9;
	mso-style-qformat:yes;
	mso-style-link:"Título 9 Car";
	mso-style-next:Normal;
	margin-top:2.0pt;
	margin-right:0mm;
	margin-bottom:0mm;
	margin-left:0mm;
	margin-bottom:.0001pt;
	line-height:107%;
	mso-pagination:widow-orphan lines-together;
	page-break-after:avoid;
	mso-outline-level:9;
	font-size:10.0pt;
	font-family:"Cambria",serif;
	mso-fareast-font-family:"Times New Roman";
	mso-bidi-font-family:"Times New Roman";
	color:#404040;
	mso-ansi-language:EN-GB;
	mso-fareast-language:EN-US;
	font-style:italic;}
p.MsoFootnoteText, li.MsoFootnoteText, div.MsoFootnoteText
	{mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-link:"Texto nota pie Car";
	margin:0mm;
	margin-bottom:.0001pt;
	mso-pagination:widow-orphan;
	font-size:10.0pt;
	font-family:"Calibri",sans-serif;
	mso-ascii-font-family:Calibri;
	mso-ascii-theme-font:minor-latin;
	mso-fareast-font-family:Calibri;
	mso-fareast-theme-font:minor-latin;
	mso-hansi-font-family:Calibri;
	mso-hansi-theme-font:minor-latin;
	mso-bidi-font-family:"Times New Roman";
	mso-bidi-theme-font:minor-bidi;
	mso-ansi-language:EN-GB;
	mso-fareast-language:EN-US;}
p.MsoHeader, li.MsoHeader, div.MsoHeader
	{mso-style-priority:99;
	mso-style-link:"Encabezado Car";
	margin:0mm;
	margin-bottom:.0001pt;
	mso-pagination:widow-orphan;
	tab-stops:center 225.65pt right 451.3pt;
	font-size:11.0pt;
	font-family:"Calibri",sans-serif;
	mso-ascii-font-family:Calibri;
	mso-ascii-theme-font:minor-latin;
	mso-fareast-font-family:Calibri;
	mso-fareast-theme-font:minor-latin;
	mso-hansi-font-family:Calibri;
	mso-hansi-theme-font:minor-latin;
	mso-bidi-font-family:"Times New Roman";
	mso-bidi-theme-font:minor-bidi;
	mso-ansi-language:EN-GB;
	mso-fareast-language:EN-US;}
p.MsoFooter, li.MsoFooter, div.MsoFooter
	{mso-style-priority:99;
	mso-style-link:"Pie de página Car";
	margin:0mm;
	margin-bottom:.0001pt;
	mso-pagination:widow-orphan;
	tab-stops:center 225.65pt right 451.3pt;
	font-size:11.0pt;
	font-family:"Calibri",sans-serif;
	mso-ascii-font-family:Calibri;
	mso-ascii-theme-font:minor-latin;
	mso-fareast-font-family:Calibri;
	mso-fareast-theme-font:minor-latin;
	mso-hansi-font-family:Calibri;
	mso-hansi-theme-font:minor-latin;
	mso-bidi-font-family:"Times New Roman";
	mso-bidi-theme-font:minor-bidi;
	mso-ansi-language:EN-GB;
	mso-fareast-language:EN-US;}
p.MsoCaption, li.MsoCaption, div.MsoCaption
	{mso-style-priority:35;
	mso-style-qformat:yes;
	mso-style-next:Normal;
	margin-top:0mm;
	margin-right:0mm;
	margin-bottom:10.0pt;
	margin-left:0mm;
	mso-pagination:widow-orphan;
	font-size:9.0pt;
	font-family:"Calibri",sans-serif;
	mso-ascii-font-family:Calibri;
	mso-ascii-theme-font:minor-latin;
	mso-fareast-font-family:Calibri;
	mso-fareast-theme-font:minor-latin;
	mso-hansi-font-family:Calibri;
	mso-hansi-theme-font:minor-latin;
	mso-bidi-font-family:"Times New Roman";
	mso-bidi-theme-font:minor-bidi;
	color:#44546A;
	mso-themecolor:text2;
	mso-ansi-language:EN-GB;
	mso-fareast-language:EN-US;
	font-style:italic;}
span.MsoFootnoteReference
	{mso-style-noshow:yes;
	mso-style-priority:99;
	vertical-align:super;}
span.MsoEndnoteReference
	{mso-style-noshow:yes;
	mso-style-priority:99;
	vertical-align:super;}
p.MsoEndnoteText, li.MsoEndnoteText, div.MsoEndnoteText
	{mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-link:"Texto nota al final Car";
	margin:0mm;
	margin-bottom:.0001pt;
	mso-pagination:widow-orphan;
	font-size:10.0pt;
	font-family:"Calibri",sans-serif;
	mso-ascii-font-family:Calibri;
	mso-ascii-theme-font:minor-latin;
	mso-fareast-font-family:Calibri;
	mso-fareast-theme-font:minor-latin;
	mso-hansi-font-family:Calibri;
	mso-hansi-theme-font:minor-latin;
	mso-bidi-font-family:"Times New Roman";
	mso-bidi-theme-font:minor-bidi;
	mso-ansi-language:EN-GB;
	mso-fareast-language:EN-US;}
p.MsoTitle, li.MsoTitle, div.MsoTitle
	{mso-style-priority:10;
	mso-style-unhide:no;
	mso-style-link:"Título Car";
	mso-style-next:Normal;
	margin:0mm;
	margin-bottom:.0001pt;
	mso-add-space:auto;
	mso-pagination:widow-orphan;
	font-size:24.0pt;
	mso-bidi-font-size:26.0pt;
	font-family:"Arial",sans-serif;
	mso-fareast-font-family:"Times New Roman";
	mso-bidi-font-family:"Times New Roman";
	letter-spacing:.25pt;
	mso-font-kerning:14.0pt;
	mso-ansi-language:EN-GB;
	mso-fareast-language:EN-US;
	font-weight:bold;
	mso-bidi-font-weight:normal;}
p.MsoTitleCxSpFirst, li.MsoTitleCxSpFirst, div.MsoTitleCxSpFirst
	{mso-style-priority:10;
	mso-style-unhide:no;
	mso-style-link:"Título Car";
	mso-style-next:Normal;
	mso-style-type:export-only;
	margin:0mm;
	margin-bottom:.0001pt;
	mso-add-space:auto;
	mso-pagination:widow-orphan;
	font-size:24.0pt;
	mso-bidi-font-size:26.0pt;
	font-family:"Arial",sans-serif;
	mso-fareast-font-family:"Times New Roman";
	mso-bidi-font-family:"Times New Roman";
	letter-spacing:.25pt;
	mso-font-kerning:14.0pt;
	mso-ansi-language:EN-GB;
	mso-fareast-language:EN-US;
	font-weight:bold;
	mso-bidi-font-weight:normal;}
p.MsoTitleCxSpMiddle, li.MsoTitleCxSpMiddle, div.MsoTitleCxSpMiddle
	{mso-style-priority:10;
	mso-style-unhide:no;
	mso-style-link:"Título Car";
	mso-style-next:Normal;
	mso-style-type:export-only;
	margin:0mm;
	margin-bottom:.0001pt;
	mso-add-space:auto;
	mso-pagination:widow-orphan;
	font-size:24.0pt;
	mso-bidi-font-size:26.0pt;
	font-family:"Arial",sans-serif;
	mso-fareast-font-family:"Times New Roman";
	mso-bidi-font-family:"Times New Roman";
	letter-spacing:.25pt;
	mso-font-kerning:14.0pt;
	mso-ansi-language:EN-GB;
	mso-fareast-language:EN-US;
	font-weight:bold;
	mso-bidi-font-weight:normal;}
p.MsoTitleCxSpLast, li.MsoTitleCxSpLast, div.MsoTitleCxSpLast
	{mso-style-priority:10;
	mso-style-unhide:no;
	mso-style-link:"Título Car";
	mso-style-next:Normal;
	mso-style-type:export-only;
	margin:0mm;
	margin-bottom:.0001pt;
	mso-add-space:auto;
	mso-pagination:widow-orphan;
	font-size:24.0pt;
	mso-bidi-font-size:26.0pt;
	font-family:"Arial",sans-serif;
	mso-fareast-font-family:"Times New Roman";
	mso-bidi-font-family:"Times New Roman";
	letter-spacing:.25pt;
	mso-font-kerning:14.0pt;
	mso-ansi-language:EN-GB;
	mso-fareast-language:EN-US;
	font-weight:bold;
	mso-bidi-font-weight:normal;}
p.MsoSubtitle, li.MsoSubtitle, div.MsoSubtitle
	{mso-style-priority:11;
	mso-style-unhide:no;
	mso-style-link:"Subtítulo Car";
	mso-style-next:Normal;
	margin-top:0mm;
	margin-right:0mm;
	margin-bottom:8.0pt;
	margin-left:0mm;
	line-height:107%;
	mso-pagination:widow-orphan;
	font-size:21.0pt;
	mso-bidi-font-size:12.0pt;
	font-family:"Arial",sans-serif;
	mso-fareast-font-family:"Times New Roman";
	mso-bidi-font-family:"Times New Roman";
	letter-spacing:.75pt;
	mso-ansi-language:EN-GB;
	mso-fareast-language:EN-US;
	font-weight:bold;
	mso-bidi-font-weight:normal;
	mso-bidi-font-style:italic;}
strong
	{mso-style-name:"Texto en negrita\,Texto de la tesis";
	mso-style-priority:22;
	mso-style-unhide:no;
	mso-style-qformat:yes;
	mso-ansi-font-size:12.0pt;
	font-family:"Arial",sans-serif;
	mso-ascii-font-family:Arial;
	mso-hansi-font-family:Arial;
	font-weight:normal;}
em
	{mso-style-priority:20;
	mso-style-unhide:no;
	mso-style-qformat:yes;
	font-family:"Arial",sans-serif;
	mso-ascii-font-family:Arial;
	mso-hansi-font-family:Arial;}
p.MsoAcetate, li.MsoAcetate, div.MsoAcetate
	{mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-link:"Texto de globo Car1";
	margin:0mm;
	margin-bottom:.0001pt;
	mso-pagination:widow-orphan;
	font-size:9.0pt;
	font-family:"Segoe UI",sans-serif;
	mso-fareast-font-family:Calibri;
	mso-fareast-theme-font:minor-latin;
	mso-ansi-language:EN-GB;
	mso-fareast-language:EN-US;}
p.MsoNoSpacing, li.MsoNoSpacing, div.MsoNoSpacing
	{mso-style-priority:1;
	mso-style-unhide:no;
	mso-style-parent:"";
	margin:0mm;
	margin-bottom:.0001pt;
	mso-pagination:widow-orphan;
	font-size:11.0pt;
	font-family:"Calibri",sans-serif;
	mso-ascii-font-family:Calibri;
	mso-ascii-theme-font:minor-latin;
	mso-fareast-font-family:Calibri;
	mso-fareast-theme-font:minor-latin;
	mso-hansi-font-family:Calibri;
	mso-hansi-theme-font:minor-latin;
	mso-bidi-font-family:"Times New Roman";
	mso-bidi-theme-font:minor-bidi;
	mso-ansi-language:EN-GB;
	mso-fareast-language:EN-US;}
p.MsoListParagraph, li.MsoListParagraph, div.MsoListParagraph
	{mso-style-priority:34;
	mso-style-unhide:no;
	mso-style-qformat:yes;
	mso-style-link:"Párrafo de lista Car";
	margin-top:0mm;
	margin-right:0mm;
	margin-bottom:8.0pt;
	margin-left:36.0pt;
	mso-add-space:auto;
	line-height:107%;
	mso-pagination:widow-orphan;
	font-size:11.0pt;
	font-family:"Calibri",sans-serif;
	mso-ascii-font-family:Calibri;
	mso-ascii-theme-font:minor-latin;
	mso-fareast-font-family:Calibri;
	mso-fareast-theme-font:minor-latin;
	mso-hansi-font-family:Calibri;
	mso-hansi-theme-font:minor-latin;
	mso-bidi-font-family:"Times New Roman";
	mso-bidi-theme-font:minor-bidi;
	mso-ansi-language:EN-GB;
	mso-fareast-language:EN-US;}
p.MsoListParagraphCxSpFirst, li.MsoListParagraphCxSpFirst, div.MsoListParagraphCxSpFirst
	{mso-style-priority:34;
	mso-style-unhide:no;
	mso-style-qformat:yes;
	mso-style-link:"Párrafo de lista Car";
	mso-style-type:export-only;
	margin-top:0mm;
	margin-right:0mm;
	margin-bottom:0mm;
	margin-left:36.0pt;
	margin-bottom:.0001pt;
	mso-add-space:auto;
	line-height:107%;
	mso-pagination:widow-orphan;
	font-size:11.0pt;
	font-family:"Calibri",sans-serif;
	mso-ascii-font-family:Calibri;
	mso-ascii-theme-font:minor-latin;
	mso-fareast-font-family:Calibri;
	mso-fareast-theme-font:minor-latin;
	mso-hansi-font-family:Calibri;
	mso-hansi-theme-font:minor-latin;
	mso-bidi-font-family:"Times New Roman";
	mso-bidi-theme-font:minor-bidi;
	mso-ansi-language:EN-GB;
	mso-fareast-language:EN-US;}
p.MsoListParagraphCxSpMiddle, li.MsoListParagraphCxSpMiddle, div.MsoListParagraphCxSpMiddle
	{mso-style-priority:34;
	mso-style-unhide:no;
	mso-style-qformat:yes;
	mso-style-link:"Párrafo de lista Car";
	mso-style-type:export-only;
	margin-top:0mm;
	margin-right:0mm;
	margin-bottom:0mm;
	margin-left:36.0pt;
	margin-bottom:.0001pt;
	mso-add-space:auto;
	line-height:107%;
	mso-pagination:widow-orphan;
	font-size:11.0pt;
	font-family:"Calibri",sans-serif;
	mso-ascii-font-family:Calibri;
	mso-ascii-theme-font:minor-latin;
	mso-fareast-font-family:Calibri;
	mso-fareast-theme-font:minor-latin;
	mso-hansi-font-family:Calibri;
	mso-hansi-theme-font:minor-latin;
	mso-bidi-font-family:"Times New Roman";
	mso-bidi-theme-font:minor-bidi;
	mso-ansi-language:EN-GB;
	mso-fareast-language:EN-US;}
p.MsoListParagraphCxSpLast, li.MsoListParagraphCxSpLast, div.MsoListParagraphCxSpLast
	{mso-style-priority:34;
	mso-style-unhide:no;
	mso-style-qformat:yes;
	mso-style-link:"Párrafo de lista Car";
	mso-style-type:export-only;
	margin-top:0mm;
	margin-right:0mm;
	margin-bottom:8.0pt;
	margin-left:36.0pt;
	mso-add-space:auto;
	line-height:107%;
	mso-pagination:widow-orphan;
	font-size:11.0pt;
	font-family:"Calibri",sans-serif;
	mso-ascii-font-family:Calibri;
	mso-ascii-theme-font:minor-latin;
	mso-fareast-font-family:Calibri;
	mso-fareast-theme-font:minor-latin;
	mso-hansi-font-family:Calibri;
	mso-hansi-theme-font:minor-latin;
	mso-bidi-font-family:"Times New Roman";
	mso-bidi-theme-font:minor-bidi;
	mso-ansi-language:EN-GB;
	mso-fareast-language:EN-US;}
p.MsoQuote, li.MsoQuote, div.MsoQuote
	{mso-style-priority:29;
	mso-style-unhide:no;
	mso-style-link:"Cita Car";
	mso-style-next:Normal;
	margin-top:10.0pt;
	margin-right:43.2pt;
	margin-bottom:8.0pt;
	margin-left:43.2pt;
	text-align:center;
	line-height:107%;
	mso-pagination:widow-orphan;
	font-size:11.0pt;
	font-family:"Arial",sans-serif;
	mso-fareast-font-family:Calibri;
	mso-fareast-theme-font:minor-latin;
	mso-bidi-font-family:"Times New Roman";
	mso-bidi-theme-font:minor-bidi;
	color:black;
	mso-ansi-language:EN-GB;
	mso-fareast-language:EN-US;
	font-style:italic;}
p.MsoIntenseQuote, li.MsoIntenseQuote, div.MsoIntenseQuote
	{mso-style-priority:30;
	mso-style-unhide:no;
	mso-style-link:"Cita destacada Car";
	mso-style-next:Normal;
	margin-top:18.0pt;
	margin-right:43.2pt;
	margin-bottom:18.0pt;
	margin-left:43.2pt;
	text-align:center;
	line-height:107%;
	mso-pagination:widow-orphan;
	border:none;
	mso-border-top-alt:solid #5B9BD5 .5pt;
	mso-border-top-themecolor:accent1;
	mso-border-bottom-alt:solid #5B9BD5 .5pt;
	mso-border-bottom-themecolor:accent1;
	padding:0mm;
	mso-padding-alt:10.0pt 0mm 10.0pt 0mm;
	font-size:11.0pt;
	font-family:"Arial",sans-serif;
	mso-fareast-font-family:Calibri;
	mso-fareast-theme-font:minor-latin;
	mso-bidi-font-family:"Times New Roman";
	mso-bidi-theme-font:minor-bidi;
	color:#4F81BD;
	mso-ansi-language:EN-GB;
	mso-fareast-language:EN-US;
	font-weight:bold;
	font-style:italic;}
span.MsoSubtleEmphasis
	{mso-style-priority:19;
	mso-style-unhide:no;
	color:#404040;
	mso-themecolor:text1;
	mso-themetint:191;
	font-style:italic;}
span.MsoIntenseEmphasis
	{mso-style-priority:21;
	mso-style-unhide:no;
	color:#5B9BD5;
	mso-themecolor:accent1;
	font-style:italic;}
span.MsoSubtleReference
	{mso-style-priority:31;
	mso-style-unhide:no;
	font-variant:small-caps;
	color:#5A5A5A;
	mso-themecolor:text1;
	mso-themetint:165;}
span.MsoIntenseReference
	{mso-style-priority:32;
	mso-style-unhide:no;
	font-variant:small-caps;
	color:#5B9BD5;
	mso-themecolor:accent1;
	letter-spacing:.25pt;
	font-weight:bold;}
span.MsoBookTitle
	{mso-style-priority:33;
	mso-style-unhide:no;
	mso-style-qformat:yes;
	font-family:"Arial",sans-serif;
	mso-ascii-font-family:Arial;
	mso-hansi-font-family:Arial;
	font-variant:small-caps;
	letter-spacing:.25pt;
	font-weight:bold;}
p.MsoTocHeading, li.MsoTocHeading, div.MsoTocHeading
	{mso-style-noshow:yes;
	mso-style-priority:39;
	mso-style-qformat:yes;
	mso-style-parent:"Título 1";
	mso-style-next:Normal;
	margin-top:12.0pt;
	margin-right:0mm;
	margin-bottom:0mm;
	margin-left:0mm;
	margin-bottom:.0001pt;
	line-height:107%;
	mso-pagination:widow-orphan lines-together;
	page-break-after:avoid;
	font-size:16.0pt;
	font-family:"Calibri Light",sans-serif;
	mso-ascii-font-family:"Calibri Light";
	mso-ascii-theme-font:major-latin;
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:major-fareast;
	mso-hansi-font-family:"Calibri Light";
	mso-hansi-theme-font:major-latin;
	mso-bidi-font-family:"Times New Roman";
	mso-bidi-theme-font:major-bidi;
	color:#2E74B5;
	mso-themecolor:accent1;
	mso-themeshade:191;
	mso-ansi-language:EN-GB;
	mso-fareast-language:EN-US;}
span.EncabezadoCar
	{mso-style-name:"Encabezado Car";
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-style-locked:yes;
	mso-style-link:Encabezado;}
span.PiedepginaCar
	{mso-style-name:"Pie de página Car";
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-style-locked:yes;
	mso-style-link:"Pie de página";}
p.IOPHeader, li.IOPHeader, div.IOPHeader
	{mso-style-name:IOPHeader;
	mso-style-unhide:no;
	mso-style-qformat:yes;
	mso-style-parent:Encabezado;
	mso-style-link:"IOPHeader Char";
	margin:0mm;
	margin-bottom:.0001pt;
	mso-pagination:widow-orphan;
	tab-stops:center 225.65pt right 451.3pt;
	border:none;
	mso-border-bottom-alt:solid windowtext .5pt;
	padding:0mm;
	mso-padding-alt:0mm 0mm 1.0pt 0mm;
	font-size:11.0pt;
	font-family:"Calibri",sans-serif;
	mso-ascii-font-family:Calibri;
	mso-ascii-theme-font:minor-latin;
	mso-fareast-font-family:Calibri;
	mso-fareast-theme-font:minor-latin;
	mso-hansi-font-family:Calibri;
	mso-hansi-theme-font:minor-latin;
	mso-bidi-font-family:"Times New Roman";
	mso-bidi-theme-font:minor-bidi;
	mso-ansi-language:EN-GB;
	mso-fareast-language:EN-US;}
p.IOPTitle, li.IOPTitle, div.IOPTitle
	{mso-style-name:IOPTitle;
	mso-style-unhide:no;
	mso-style-qformat:yes;
	mso-style-link:"IOPTitle Char";
	margin-top:0mm;
	margin-right:0mm;
	margin-bottom:26.0pt;
	margin-left:0mm;
	line-height:107%;
	mso-pagination:widow-orphan;
	font-size:24.0pt;
	font-family:"Calibri",sans-serif;
	mso-ascii-font-family:Calibri;
	mso-ascii-theme-font:minor-latin;
	mso-fareast-font-family:Calibri;
	mso-fareast-theme-font:minor-latin;
	mso-hansi-font-family:Calibri;
	mso-hansi-theme-font:minor-latin;
	mso-bidi-font-family:"Times New Roman";
	mso-bidi-theme-font:minor-bidi;
	mso-ansi-language:EN-GB;
	mso-fareast-language:EN-US;
	font-weight:bold;
	mso-bidi-font-weight:normal;}
span.IOPHeaderChar
	{mso-style-name:"IOPHeader Char";
	mso-style-unhide:no;
	mso-style-locked:yes;
	mso-style-parent:"Encabezado Car";
	mso-style-link:IOPHeader;}
p.IOPAuthor, li.IOPAuthor, div.IOPAuthor
	{mso-style-name:IOPAuthor;
	mso-style-unhide:no;
	mso-style-qformat:yes;
	mso-style-link:"IOPAuthor Char";
	margin-top:0mm;
	margin-right:127.6pt;
	margin-bottom:10.0pt;
	margin-left:0mm;
	line-height:107%;
	mso-pagination:widow-orphan;
	font-size:11.0pt;
	font-family:"Calibri",sans-serif;
	mso-ascii-font-family:Calibri;
	mso-ascii-theme-font:minor-latin;
	mso-fareast-font-family:Calibri;
	mso-fareast-theme-font:minor-latin;
	mso-hansi-font-family:Calibri;
	mso-hansi-theme-font:minor-latin;
	mso-bidi-font-family:"Times New Roman";
	mso-bidi-theme-font:minor-bidi;
	mso-ansi-language:EN-GB;
	mso-fareast-language:EN-US;
	font-weight:bold;
	mso-bidi-font-weight:normal;}
span.IOPTitleChar
	{mso-style-name:"IOPTitle Char";
	mso-style-unhide:no;
	mso-style-locked:yes;
	mso-style-link:IOPTitle;
	mso-ansi-font-size:24.0pt;
	mso-bidi-font-size:24.0pt;
	font-weight:bold;
	mso-bidi-font-weight:normal;}
p.IOPAff, li.IOPAff, div.IOPAff
	{mso-style-name:IOPAff;
	mso-style-unhide:no;
	mso-style-qformat:yes;
	mso-style-parent:IOPAuthor;
	mso-style-link:"IOPAff Char";
	margin-top:0mm;
	margin-right:127.6pt;
	margin-bottom:0mm;
	margin-left:0mm;
	margin-bottom:.0001pt;
	line-height:107%;
	mso-pagination:widow-orphan;
	font-size:9.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:Calibri;
	mso-fareast-theme-font:minor-latin;
	mso-ansi-language:EN-GB;
	mso-fareast-language:EN-US;}
span.IOPAuthorChar
	{mso-style-name:"IOPAuthor Char";
	mso-style-unhide:no;
	mso-style-locked:yes;
	mso-style-link:IOPAuthor;
	font-weight:bold;
	mso-bidi-font-weight:normal;}
p.IOPH1, li.IOPH1, div.IOPH1
	{mso-style-name:IOPH1;
	mso-style-unhide:no;
	mso-style-qformat:yes;
	mso-style-parent:IOPAff;
	mso-style-link:"IOPH1 Char";
	margin-top:10.0pt;
	margin-right:0mm;
	margin-bottom:6.0pt;
	margin-left:0mm;
	line-height:107%;
	mso-pagination:widow-orphan;
	font-size:11.0pt;
	mso-bidi-font-size:9.0pt;
	font-family:"Calibri",sans-serif;
	mso-ascii-font-family:Calibri;
	mso-ascii-theme-font:minor-latin;
	mso-fareast-font-family:Calibri;
	mso-fareast-theme-font:minor-latin;
	mso-hansi-font-family:Calibri;
	mso-hansi-theme-font:minor-latin;
	mso-bidi-font-family:"Times New Roman";
	mso-ansi-language:EN-GB;
	mso-fareast-language:EN-US;
	font-weight:bold;
	mso-bidi-font-weight:normal;}
span.IOPAffChar
	{mso-style-name:"IOPAff Char";
	mso-style-unhide:no;
	mso-style-locked:yes;
	mso-style-parent:"IOPAuthor Char";
	mso-style-link:IOPAff;
	mso-ansi-font-size:9.0pt;
	mso-bidi-font-size:9.0pt;
	font-family:"Times New Roman",serif;
	mso-ascii-font-family:"Times New Roman";
	mso-hansi-font-family:"Times New Roman";
	mso-bidi-font-family:"Times New Roman";
	font-weight:normal;}
p.IOPAbsText, li.IOPAbsText, div.IOPAbsText
	{mso-style-name:IOPAbsText;
	mso-style-unhide:no;
	mso-style-qformat:yes;
	mso-style-link:"IOPAbsText Char";
	margin-top:0mm;
	margin-right:127.6pt;
	margin-bottom:0mm;
	margin-left:0mm;
	margin-bottom:.0001pt;
	line-height:107%;
	mso-pagination:widow-orphan;
	font-size:10.0pt;
	mso-bidi-font-size:11.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:Calibri;
	mso-fareast-theme-font:minor-latin;
	mso-bidi-font-family:"Times New Roman";
	mso-bidi-theme-font:minor-bidi;
	mso-ansi-language:EN-GB;
	mso-fareast-language:EN-US;}
span.IOPH1Char
	{mso-style-name:"IOPH1 Char";
	mso-style-unhide:no;
	mso-style-locked:yes;
	mso-style-parent:"IOPAff Char";
	mso-style-link:IOPH1;
	mso-ansi-font-size:9.0pt;
	mso-bidi-font-size:9.0pt;
	font-family:"Times New Roman",serif;
	mso-ascii-font-family:"Times New Roman";
	mso-hansi-font-family:"Times New Roman";
	mso-bidi-font-family:"Times New Roman";
	font-weight:bold;
	mso-bidi-font-weight:normal;}
p.IOPKwd, li.IOPKwd, div.IOPKwd
	{mso-style-name:IOPKwd;
	mso-style-unhide:no;
	mso-style-qformat:yes;
	mso-style-parent:IOPAbsText;
	mso-style-link:"IOPKwd Char";
	margin-top:12.0pt;
	margin-right:0mm;
	margin-bottom:12.0pt;
	margin-left:0mm;
	line-height:107%;
	mso-pagination:widow-orphan;
	border:none;
	mso-border-bottom-alt:solid windowtext .5pt;
	padding:0mm;
	mso-padding-alt:0mm 0mm 1.0pt 0mm;
	font-size:10.0pt;
	mso-bidi-font-size:11.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:Calibri;
	mso-fareast-theme-font:minor-latin;
	mso-bidi-font-family:"Times New Roman";
	mso-bidi-theme-font:minor-bidi;
	mso-ansi-language:EN-GB;
	mso-fareast-language:EN-US;}
span.IOPAbsTextChar
	{mso-style-name:"IOPAbsText Char";
	mso-style-unhide:no;
	mso-style-locked:yes;
	mso-style-link:IOPAbsText;
	mso-ansi-font-size:10.0pt;
	font-family:"Times New Roman",serif;
	mso-ascii-font-family:"Times New Roman";
	mso-hansi-font-family:"Times New Roman";}
p.IOPText, li.IOPText, div.IOPText
	{mso-style-name:IOPText;
	mso-style-unhide:no;
	mso-style-qformat:yes;
	mso-style-parent:IOPAbsText;
	mso-style-link:"IOPText Char";
	margin:0mm;
	margin-bottom:.0001pt;
	text-align:justify;
	text-indent:11.35pt;
	line-height:107%;
	mso-pagination:widow-orphan;
	font-size:10.0pt;
	mso-bidi-font-size:11.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:Calibri;
	mso-fareast-theme-font:minor-latin;
	mso-bidi-font-family:"Times New Roman";
	mso-bidi-theme-font:minor-bidi;
	mso-ansi-language:EN-GB;
	mso-fareast-language:EN-US;}
span.IOPKwdChar
	{mso-style-name:"IOPKwd Char";
	mso-style-unhide:no;
	mso-style-locked:yes;
	mso-style-parent:"IOPAbsText Char";
	mso-style-link:IOPKwd;
	mso-ansi-font-size:10.0pt;
	font-family:"Times New Roman",serif;
	mso-ascii-font-family:"Times New Roman";
	mso-hansi-font-family:"Times New Roman";}
span.IOPTextChar
	{mso-style-name:"IOPText Char";
	mso-style-unhide:no;
	mso-style-locked:yes;
	mso-style-parent:"IOPAbsText Char";
	mso-style-link:IOPText;
	mso-ansi-font-size:10.0pt;
	font-family:"Times New Roman",serif;
	mso-ascii-font-family:"Times New Roman";
	mso-hansi-font-family:"Times New Roman";}
p.IOPH2, li.IOPH2, div.IOPH2
	{mso-style-name:IOPH2;
	mso-style-unhide:no;
	mso-style-qformat:yes;
	mso-style-parent:IOPH1;
	mso-style-link:"IOPH2 Char";
	margin-top:10.0pt;
	margin-right:0mm;
	margin-bottom:6.0pt;
	margin-left:0mm;
	line-height:107%;
	mso-pagination:widow-orphan;
	font-size:11.0pt;
	mso-bidi-font-size:9.0pt;
	font-family:"Calibri",sans-serif;
	mso-ascii-font-family:Calibri;
	mso-ascii-theme-font:minor-latin;
	mso-fareast-font-family:Calibri;
	mso-fareast-theme-font:minor-latin;
	mso-hansi-font-family:Calibri;
	mso-hansi-theme-font:minor-latin;
	mso-bidi-font-family:"Times New Roman";
	mso-ansi-language:EN-GB;
	mso-fareast-language:EN-US;
	font-style:italic;
	mso-bidi-font-style:normal;}
p.IOPH3, li.IOPH3, div.IOPH3
	{mso-style-name:IOPH3;
	mso-style-unhide:no;
	mso-style-qformat:yes;
	mso-style-parent:IOPH2;
	mso-style-link:"IOPH3 Char";
	margin-top:10.0pt;
	margin-right:0mm;
	margin-bottom:0mm;
	margin-left:0mm;
	margin-bottom:.0001pt;
	line-height:107%;
	mso-pagination:widow-orphan;
	font-size:11.0pt;
	mso-bidi-font-size:9.0pt;
	font-family:"Calibri",sans-serif;
	mso-ascii-font-family:Calibri;
	mso-ascii-theme-font:minor-latin;
	mso-fareast-font-family:Calibri;
	mso-fareast-theme-font:minor-latin;
	mso-hansi-font-family:Calibri;
	mso-hansi-theme-font:minor-latin;
	mso-bidi-font-family:"Times New Roman";
	mso-ansi-language:EN-GB;
	mso-fareast-language:EN-US;
	font-style:italic;
	mso-bidi-font-style:normal;}
span.IOPH2Char
	{mso-style-name:"IOPH2 Char";
	mso-style-unhide:no;
	mso-style-locked:yes;
	mso-style-parent:"IOPH1 Char";
	mso-style-link:IOPH2;
	mso-ansi-font-size:9.0pt;
	mso-bidi-font-size:9.0pt;
	font-family:"Times New Roman",serif;
	mso-ascii-font-family:"Times New Roman";
	mso-hansi-font-family:"Times New Roman";
	mso-bidi-font-family:"Times New Roman";
	font-weight:normal;
	font-style:italic;
	mso-bidi-font-style:normal;}
p.IOPrefs, li.IOPrefs, div.IOPrefs
	{mso-style-name:IOPrefs;
	mso-style-unhide:no;
	mso-style-parent:"";
	mso-style-link:"IOPrefs Char";
	margin-top:0mm;
	margin-right:0mm;
	margin-bottom:0mm;
	margin-left:14.2pt;
	margin-bottom:.0001pt;
	text-indent:-14.2pt;
	line-height:107%;
	mso-pagination:widow-orphan;
	font-size:9.0pt;
	mso-bidi-font-size:11.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:Calibri;
	mso-fareast-theme-font:minor-latin;
	mso-bidi-font-family:"Times New Roman";
	mso-bidi-theme-font:minor-bidi;
	mso-ansi-language:EN-GB;
	mso-fareast-language:EN-US;
	mso-no-proof:yes;}
span.IOPH3Char
	{mso-style-name:"IOPH3 Char";
	mso-style-unhide:no;
	mso-style-locked:yes;
	mso-style-parent:"IOPH2 Char";
	mso-style-link:IOPH3;
	mso-ansi-font-size:9.0pt;
	mso-bidi-font-size:9.0pt;
	font-family:"Times New Roman",serif;
	mso-ascii-font-family:"Times New Roman";
	mso-hansi-font-family:"Times New Roman";
	mso-bidi-font-family:"Times New Roman";
	font-weight:normal;
	font-style:italic;
	mso-bidi-font-style:normal;}
p.IOPRefs0, li.IOPRefs0, div.IOPRefs0
	{mso-style-name:IOPRefs;
	mso-style-unhide:no;
	mso-style-qformat:yes;
	mso-style-parent:IOPrefs;
	mso-style-link:"IOPRefs Char";
	margin-top:0mm;
	margin-right:0mm;
	margin-bottom:0mm;
	margin-left:14.2pt;
	margin-bottom:.0001pt;
	text-indent:-14.2pt;
	line-height:107%;
	mso-pagination:widow-orphan;
	mso-list:l3 level1 lfo2;
	tab-stops:list 14.2pt;
	font-size:9.0pt;
	mso-bidi-font-size:11.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:Calibri;
	mso-fareast-theme-font:minor-latin;
	mso-bidi-font-family:"Times New Roman";
	mso-bidi-theme-font:minor-bidi;
	mso-ansi-language:EN-GB;
	mso-fareast-language:EN-US;
	mso-no-proof:yes;}
span.IOPrefsChar
	{mso-style-name:"IOPrefs Char";
	mso-style-unhide:no;
	mso-style-locked:yes;
	mso-style-link:IOPrefs;
	mso-ansi-font-size:9.0pt;
	font-family:"Times New Roman",serif;
	mso-ascii-font-family:"Times New Roman";
	mso-hansi-font-family:"Times New Roman";
	mso-no-proof:yes;}
span.IOPRefsChar0
	{mso-style-name:"IOPRefs Char";
	mso-style-unhide:no;
	mso-style-locked:yes;
	mso-style-parent:"IOPrefs Char";
	mso-style-link:IOPRefs;
	mso-ansi-font-size:9.0pt;
	font-family:"Times New Roman",serif;
	mso-ascii-font-family:"Times New Roman";
	mso-hansi-font-family:"Times New Roman";
	mso-no-proof:yes;}
span.TextonotapieCar
	{mso-style-name:"Texto nota pie Car";
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-style-locked:yes;
	mso-style-link:"Texto nota pie";
	mso-ansi-font-size:10.0pt;
	mso-bidi-font-size:10.0pt;}
span.TextonotaalfinalCar
	{mso-style-name:"Texto nota al final Car";
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-style-locked:yes;
	mso-style-link:"Texto nota al final";
	mso-ansi-font-size:10.0pt;
	mso-bidi-font-size:10.0pt;}
p.TtuloPrimerNivel1, li.TtuloPrimerNivel1, div.TtuloPrimerNivel1
	{mso-style-name:"Título Primer Nivel1";
	mso-style-update:auto;
	mso-style-priority:9;
	mso-style-unhide:no;
	mso-style-qformat:yes;
	mso-style-next:Normal;
	margin-top:100.0pt;
	margin-right:0mm;
	margin-bottom:24.0pt;
	margin-left:36.0pt;
	text-indent:-18.0pt;
	mso-pagination:widow-orphan;
	page-break-after:avoid;
	mso-outline-level:1;
	mso-list:l6 level1 lfo12;
	font-size:20.0pt;
	mso-bidi-font-size:16.0pt;
	font-family:"Arial",sans-serif;
	mso-fareast-font-family:Calibri;
	mso-fareast-theme-font:minor-latin;
	mso-font-kerning:16.0pt;
	mso-ansi-language:ES;
	mso-fareast-language:ES;
	font-weight:bold;}
p.TtuloSegundonivel1, li.TtuloSegundonivel1, div.TtuloSegundonivel1
	{mso-style-name:"Título Segundo nivel1";
	mso-style-priority:9;
	mso-style-qformat:yes;
	mso-style-next:Normal;
	margin-top:20.0pt;
	margin-right:0mm;
	margin-bottom:10.0pt;
	margin-left:72.0pt;
	text-indent:-18.0pt;
	mso-pagination:widow-orphan lines-together;
	page-break-after:avoid;
	mso-outline-level:2;
	mso-list:l6 level2 lfo12;
	font-size:16.0pt;
	mso-bidi-font-size:13.0pt;
	font-family:"Arial",sans-serif;
	mso-fareast-font-family:"Times New Roman";
	mso-bidi-font-family:"Times New Roman";
	mso-fareast-language:EN-US;
	font-weight:bold;}
p.TtuloTercernivel1, li.TtuloTercernivel1, div.TtuloTercernivel1
	{mso-style-name:"Título Tercer nivel1";
	mso-style-noshow:yes;
	mso-style-priority:9;
	mso-style-qformat:yes;
	mso-style-next:Normal;
	margin-top:20.0pt;
	margin-right:0mm;
	margin-bottom:10.0pt;
	margin-left:108.0pt;
	text-indent:-18.0pt;
	mso-pagination:widow-orphan lines-together;
	page-break-after:avoid;
	mso-outline-level:3;
	mso-list:l6 level3 lfo12;
	font-size:14.0pt;
	mso-bidi-font-size:11.0pt;
	font-family:"Arial",sans-serif;
	mso-fareast-font-family:"Times New Roman";
	mso-bidi-font-family:"Times New Roman";
	mso-fareast-language:EN-US;
	font-weight:bold;}
p.Ttulo41, li.Ttulo41, div.Ttulo41
	{mso-style-name:"Título 41";
	mso-style-noshow:yes;
	mso-style-priority:9;
	mso-style-next:Normal;
	margin:0mm;
	margin-bottom:.0001pt;
	line-height:112%;
	mso-pagination:widow-orphan;
	mso-outline-level:4;
	font-size:12.0pt;
	font-family:"Arial",sans-serif;
	mso-fareast-font-family:Calibri;
	mso-fareast-theme-font:minor-latin;
	mso-bidi-font-family:"Times New Roman";
	mso-bidi-theme-font:minor-bidi;
	letter-spacing:.25pt;
	mso-fareast-language:EN-US;
	font-weight:bold;}
p.Ttulo51, li.Ttulo51, div.Ttulo51
	{mso-style-name:"Título 51";
	mso-style-noshow:yes;
	mso-style-priority:9;
	mso-style-next:Normal;
	margin-top:0mm;
	margin-right:0mm;
	margin-bottom:0mm;
	margin-left:180.0pt;
	margin-bottom:.0001pt;
	text-indent:-18.0pt;
	line-height:112%;
	mso-pagination:widow-orphan;
	mso-outline-level:5;
	mso-list:l6 level5 lfo12;
	font-size:12.0pt;
	font-family:"Arial",sans-serif;
	mso-fareast-font-family:Calibri;
	mso-fareast-theme-font:minor-latin;
	mso-bidi-font-family:"Times New Roman";
	mso-bidi-theme-font:minor-bidi;
	mso-fareast-language:EN-US;
	font-style:italic;}
p.Ttulo61, li.Ttulo61, div.Ttulo61
	{mso-style-name:"Título 61";
	mso-style-noshow:yes;
	mso-style-priority:9;
	mso-style-qformat:yes;
	mso-style-next:Normal;
	margin-top:10.0pt;
	margin-right:0mm;
	margin-bottom:0mm;
	margin-left:216.0pt;
	margin-bottom:.0001pt;
	text-indent:-18.0pt;
	line-height:115%;
	mso-pagination:widow-orphan lines-together;
	page-break-after:avoid;
	mso-outline-level:6;
	mso-list:l6 level6 lfo12;
	font-size:11.0pt;
	font-family:"Cambria",serif;
	mso-fareast-font-family:"Times New Roman";
	mso-bidi-font-family:"Times New Roman";
	color:#243F60;
	mso-fareast-language:EN-US;
	font-style:italic;}
p.Ttulo71, li.Ttulo71, div.Ttulo71
	{mso-style-name:"Título 71";
	mso-style-noshow:yes;
	mso-style-priority:9;
	mso-style-qformat:yes;
	mso-style-next:Normal;
	margin-top:10.0pt;
	margin-right:0mm;
	margin-bottom:0mm;
	margin-left:252.0pt;
	margin-bottom:.0001pt;
	text-indent:-18.0pt;
	line-height:115%;
	mso-pagination:widow-orphan lines-together;
	page-break-after:avoid;
	mso-outline-level:7;
	mso-list:l6 level7 lfo12;
	font-size:11.0pt;
	font-family:"Cambria",serif;
	mso-fareast-font-family:"Times New Roman";
	mso-bidi-font-family:"Times New Roman";
	color:#404040;
	mso-fareast-language:EN-US;
	font-style:italic;}
p.Ttulo81, li.Ttulo81, div.Ttulo81
	{mso-style-name:"Título 81";
	mso-style-noshow:yes;
	mso-style-priority:9;
	mso-style-qformat:yes;
	mso-style-next:Normal;
	margin-top:10.0pt;
	margin-right:0mm;
	margin-bottom:0mm;
	margin-left:288.0pt;
	margin-bottom:.0001pt;
	text-indent:-18.0pt;
	line-height:115%;
	mso-pagination:widow-orphan lines-together;
	page-break-after:avoid;
	mso-outline-level:8;
	mso-list:l6 level8 lfo12;
	font-size:10.0pt;
	font-family:"Cambria",serif;
	mso-fareast-font-family:"Times New Roman";
	mso-bidi-font-family:"Times New Roman";
	color:#404040;
	mso-fareast-language:EN-US;}
p.Ttulo91, li.Ttulo91, div.Ttulo91
	{mso-style-name:"Título 91";
	mso-style-noshow:yes;
	mso-style-priority:9;
	mso-style-qformat:yes;
	mso-style-next:Normal;
	margin-top:10.0pt;
	margin-right:0mm;
	margin-bottom:0mm;
	margin-left:178.45pt;
	margin-bottom:.0001pt;
	text-indent:-79.2pt;
	line-height:115%;
	mso-pagination:widow-orphan lines-together;
	page-break-after:avoid;
	mso-outline-level:9;
	mso-list:l1 level9 lfo8;
	font-size:10.0pt;
	font-family:"Cambria",serif;
	mso-fareast-font-family:"Times New Roman";
	mso-bidi-font-family:"Times New Roman";
	color:#404040;
	mso-fareast-language:EN-US;
	font-style:italic;}
span.Ttulo1Car
	{mso-style-name:"Título 1 Car";
	mso-style-priority:9;
	mso-style-unhide:no;
	mso-style-locked:yes;
	mso-style-link:"Título 1";
	mso-ansi-font-size:20.0pt;
	mso-bidi-font-size:16.0pt;
	font-family:"Arial",sans-serif;
	mso-ascii-font-family:Arial;
	mso-hansi-font-family:Arial;
	mso-bidi-font-family:Arial;
	mso-font-kerning:16.0pt;
	mso-ansi-language:ES;
	mso-fareast-language:ES;
	font-weight:bold;}
span.Ttulo2Car
	{mso-style-name:"Título 2 Car";
	mso-style-priority:9;
	mso-style-unhide:no;
	mso-style-locked:yes;
	mso-style-link:"Título 2";
	mso-ansi-font-size:16.0pt;
	mso-bidi-font-size:13.0pt;
	font-family:"Arial",sans-serif;
	mso-ascii-font-family:Arial;
	mso-fareast-font-family:"Times New Roman";
	mso-hansi-font-family:Arial;
	mso-bidi-font-family:"Times New Roman";
	font-weight:bold;}
span.Ttulo3Car
	{mso-style-name:"Título 3 Car";
	mso-style-noshow:yes;
	mso-style-priority:9;
	mso-style-unhide:no;
	mso-style-locked:yes;
	mso-style-link:"Título 3";
	mso-ansi-font-size:14.0pt;
	font-family:"Arial",sans-serif;
	mso-ascii-font-family:Arial;
	mso-fareast-font-family:"Times New Roman";
	mso-hansi-font-family:Arial;
	mso-bidi-font-family:"Times New Roman";
	font-weight:bold;}
span.Ttulo4Car
	{mso-style-name:"Título 4 Car";
	mso-style-noshow:yes;
	mso-style-priority:9;
	mso-style-unhide:no;
	mso-style-locked:yes;
	mso-style-link:"Título 4";
	mso-ansi-font-size:12.0pt;
	mso-bidi-font-size:12.0pt;
	font-family:"Arial",sans-serif;
	mso-ascii-font-family:Arial;
	mso-hansi-font-family:Arial;
	letter-spacing:.25pt;
	font-weight:bold;}
span.Ttulo5Car
	{mso-style-name:"Título 5 Car";
	mso-style-noshow:yes;
	mso-style-priority:9;
	mso-style-unhide:no;
	mso-style-locked:yes;
	mso-style-link:"Título 5";
	mso-ansi-font-size:12.0pt;
	mso-bidi-font-size:12.0pt;
	font-family:"Arial",sans-serif;
	mso-ascii-font-family:Arial;
	mso-hansi-font-family:Arial;
	font-style:italic;}
span.Ttulo6Car
	{mso-style-name:"Título 6 Car";
	mso-style-noshow:yes;
	mso-style-priority:9;
	mso-style-unhide:no;
	mso-style-locked:yes;
	mso-style-link:"Título 6";
	font-family:"Cambria",serif;
	mso-ascii-font-family:Cambria;
	mso-fareast-font-family:"Times New Roman";
	mso-hansi-font-family:Cambria;
	mso-bidi-font-family:"Times New Roman";
	color:#243F60;
	font-style:italic;}
span.Ttulo7Car
	{mso-style-name:"Título 7 Car";
	mso-style-noshow:yes;
	mso-style-priority:9;
	mso-style-unhide:no;
	mso-style-locked:yes;
	mso-style-link:"Título 7";
	font-family:"Cambria",serif;
	mso-ascii-font-family:Cambria;
	mso-fareast-font-family:"Times New Roman";
	mso-hansi-font-family:Cambria;
	mso-bidi-font-family:"Times New Roman";
	color:#404040;
	font-style:italic;}
span.Ttulo8Car
	{mso-style-name:"Título 8 Car";
	mso-style-noshow:yes;
	mso-style-priority:9;
	mso-style-unhide:no;
	mso-style-locked:yes;
	mso-style-link:"Título 8";
	mso-ansi-font-size:10.0pt;
	mso-bidi-font-size:10.0pt;
	font-family:"Cambria",serif;
	mso-ascii-font-family:Cambria;
	mso-fareast-font-family:"Times New Roman";
	mso-hansi-font-family:Cambria;
	mso-bidi-font-family:"Times New Roman";
	color:#404040;}
span.Ttulo9Car
	{mso-style-name:"Título 9 Car";
	mso-style-noshow:yes;
	mso-style-priority:9;
	mso-style-unhide:no;
	mso-style-locked:yes;
	mso-style-link:"Título 9";
	mso-ansi-font-size:10.0pt;
	mso-bidi-font-size:10.0pt;
	font-family:"Cambria",serif;
	mso-ascii-font-family:Cambria;
	mso-fareast-font-family:"Times New Roman";
	mso-hansi-font-family:Cambria;
	mso-bidi-font-family:"Times New Roman";
	color:#404040;
	font-style:italic;}
p.Ttulo1, li.Ttulo1, div.Ttulo1
	{mso-style-name:Título1;
	mso-style-priority:10;
	mso-style-unhide:no;
	mso-style-qformat:yes;
	mso-style-next:Normal;
	margin-top:24.0pt;
	margin-right:0mm;
	margin-bottom:15.0pt;
	margin-left:0mm;
	mso-add-space:auto;
	text-align:center;
	mso-pagination:widow-orphan;
	font-size:24.0pt;
	mso-bidi-font-size:26.0pt;
	font-family:"Arial",sans-serif;
	mso-fareast-font-family:"Times New Roman";
	mso-bidi-font-family:"Times New Roman";
	letter-spacing:.25pt;
	mso-font-kerning:14.0pt;
	mso-fareast-language:EN-US;
	font-weight:bold;
	mso-bidi-font-weight:normal;}
p.Ttulo1CxSpFirst, li.Ttulo1CxSpFirst, div.Ttulo1CxSpFirst
	{mso-style-name:Título1CxSpFirst;
	mso-style-priority:10;
	mso-style-unhide:no;
	mso-style-qformat:yes;
	mso-style-next:Normal;
	mso-style-type:export-only;
	margin-top:24.0pt;
	margin-right:0mm;
	margin-bottom:0mm;
	margin-left:0mm;
	margin-bottom:.0001pt;
	mso-add-space:auto;
	text-align:center;
	mso-pagination:widow-orphan;
	font-size:24.0pt;
	mso-bidi-font-size:26.0pt;
	font-family:"Arial",sans-serif;
	mso-fareast-font-family:"Times New Roman";
	mso-bidi-font-family:"Times New Roman";
	letter-spacing:.25pt;
	mso-font-kerning:14.0pt;
	mso-fareast-language:EN-US;
	font-weight:bold;
	mso-bidi-font-weight:normal;}
p.Ttulo1CxSpMiddle, li.Ttulo1CxSpMiddle, div.Ttulo1CxSpMiddle
	{mso-style-name:Título1CxSpMiddle;
	mso-style-priority:10;
	mso-style-unhide:no;
	mso-style-qformat:yes;
	mso-style-next:Normal;
	mso-style-type:export-only;
	margin:0mm;
	margin-bottom:.0001pt;
	mso-add-space:auto;
	text-align:center;
	mso-pagination:widow-orphan;
	font-size:24.0pt;
	mso-bidi-font-size:26.0pt;
	font-family:"Arial",sans-serif;
	mso-fareast-font-family:"Times New Roman";
	mso-bidi-font-family:"Times New Roman";
	letter-spacing:.25pt;
	mso-font-kerning:14.0pt;
	mso-fareast-language:EN-US;
	font-weight:bold;
	mso-bidi-font-weight:normal;}
p.Ttulo1CxSpLast, li.Ttulo1CxSpLast, div.Ttulo1CxSpLast
	{mso-style-name:Título1CxSpLast;
	mso-style-priority:10;
	mso-style-unhide:no;
	mso-style-qformat:yes;
	mso-style-next:Normal;
	mso-style-type:export-only;
	margin-top:0mm;
	margin-right:0mm;
	margin-bottom:15.0pt;
	margin-left:0mm;
	mso-add-space:auto;
	text-align:center;
	mso-pagination:widow-orphan;
	font-size:24.0pt;
	mso-bidi-font-size:26.0pt;
	font-family:"Arial",sans-serif;
	mso-fareast-font-family:"Times New Roman";
	mso-bidi-font-family:"Times New Roman";
	letter-spacing:.25pt;
	mso-font-kerning:14.0pt;
	mso-fareast-language:EN-US;
	font-weight:bold;
	mso-bidi-font-weight:normal;}
span.TtuloCar
	{mso-style-name:"Título Car";
	mso-style-priority:10;
	mso-style-unhide:no;
	mso-style-locked:yes;
	mso-style-link:Título;
	mso-ansi-font-size:24.0pt;
	mso-bidi-font-size:26.0pt;
	font-family:"Arial",sans-serif;
	mso-ascii-font-family:Arial;
	mso-fareast-font-family:"Times New Roman";
	mso-hansi-font-family:Arial;
	mso-bidi-font-family:"Times New Roman";
	letter-spacing:.25pt;
	mso-font-kerning:14.0pt;
	font-weight:bold;
	mso-bidi-font-weight:normal;}
p.TtuloAnexos1, li.TtuloAnexos1, div.TtuloAnexos1
	{mso-style-name:"Título Anexos1";
	mso-style-priority:11;
	mso-style-unhide:no;
	mso-style-qformat:yes;
	mso-style-next:Normal;
	margin-top:100.0pt;
	margin-right:0mm;
	margin-bottom:24.0pt;
	margin-left:35.7pt;
	text-indent:-17.85pt;
	mso-pagination:widow-orphan;
	mso-list:l7 level1 lfo9;
	tab-stops:list 14.2pt;
	font-size:21.0pt;
	mso-bidi-font-size:12.0pt;
	font-family:"Arial",sans-serif;
	mso-fareast-font-family:"Times New Roman";
	mso-bidi-font-family:"Times New Roman";
	letter-spacing:.75pt;
	mso-fareast-language:EN-US;
	font-weight:bold;
	mso-bidi-font-weight:normal;
	mso-bidi-font-style:italic;}
span.SubttuloCar
	{mso-style-name:"Subtítulo Car";
	mso-style-priority:11;
	mso-style-unhide:no;
	mso-style-locked:yes;
	mso-style-link:Subtítulo;
	mso-ansi-font-size:21.0pt;
	mso-bidi-font-size:12.0pt;
	font-family:"Arial",sans-serif;
	mso-ascii-font-family:Arial;
	mso-fareast-font-family:"Times New Roman";
	mso-hansi-font-family:Arial;
	mso-bidi-font-family:"Times New Roman";
	letter-spacing:.75pt;
	font-weight:bold;
	mso-bidi-font-weight:normal;
	mso-bidi-font-style:italic;}
p.Sinespaciado1, li.Sinespaciado1, div.Sinespaciado1
	{mso-style-name:"Sin espaciado1";
	mso-style-priority:1;
	mso-style-unhide:no;
	mso-style-qformat:yes;
	mso-style-parent:"";
	mso-style-link:"Sin espaciado Car";
	mso-style-next:"Sin espaciado";
	margin:0mm;
	margin-bottom:.0001pt;
	mso-pagination:widow-orphan;
	font-size:11.0pt;
	font-family:"Arial",sans-serif;
	mso-fareast-font-family:Calibri;
	mso-fareast-theme-font:minor-latin;
	mso-bidi-font-family:"Times New Roman";
	mso-bidi-theme-font:minor-bidi;
	mso-fareast-language:EN-US;}
p.Cita1, li.Cita1, div.Cita1
	{mso-style-name:Cita1;
	mso-style-priority:29;
	mso-style-unhide:no;
	mso-style-qformat:yes;
	mso-style-next:Normal;
	margin-top:0mm;
	margin-right:0mm;
	margin-bottom:10.0pt;
	margin-left:0mm;
	line-height:115%;
	mso-pagination:widow-orphan;
	font-size:11.0pt;
	font-family:"Arial",sans-serif;
	mso-fareast-font-family:Calibri;
	mso-fareast-theme-font:minor-latin;
	mso-bidi-font-family:"Times New Roman";
	mso-bidi-theme-font:minor-bidi;
	color:black;
	mso-fareast-language:EN-US;
	font-style:italic;}
span.CitaCar
	{mso-style-name:"Cita Car";
	mso-style-priority:29;
	mso-style-unhide:no;
	mso-style-locked:yes;
	mso-style-link:Cita;
	font-family:"Arial",sans-serif;
	mso-ascii-font-family:Arial;
	mso-hansi-font-family:Arial;
	color:black;
	font-style:italic;}
p.Citadestacada1, li.Citadestacada1, div.Citadestacada1
	{mso-style-name:"Cita destacada1";
	mso-style-priority:30;
	mso-style-unhide:no;
	mso-style-qformat:yes;
	mso-style-next:Normal;
	margin-top:10.0pt;
	margin-right:46.8pt;
	margin-bottom:14.0pt;
	margin-left:46.8pt;
	line-height:115%;
	mso-pagination:widow-orphan;
	border:none;
	mso-border-bottom-alt:solid #4F81BD .5pt;
	padding:0mm;
	mso-padding-alt:0mm 0mm 4.0pt 0mm;
	font-size:11.0pt;
	font-family:"Arial",sans-serif;
	mso-fareast-font-family:Calibri;
	mso-fareast-theme-font:minor-latin;
	mso-bidi-font-family:"Times New Roman";
	mso-bidi-theme-font:minor-bidi;
	color:#4F81BD;
	mso-fareast-language:EN-US;
	font-weight:bold;
	font-style:italic;}
span.CitadestacadaCar
	{mso-style-name:"Cita destacada Car";
	mso-style-priority:30;
	mso-style-unhide:no;
	mso-style-locked:yes;
	mso-style-link:"Cita destacada";
	font-family:"Arial",sans-serif;
	mso-ascii-font-family:Arial;
	mso-hansi-font-family:Arial;
	color:#4F81BD;
	font-weight:bold;
	font-style:italic;}
span.nfasissutil1
	{mso-style-name:"Énfasis sutil1";
	mso-style-priority:19;
	mso-style-unhide:no;
	mso-style-qformat:yes;
	font-family:"Arial",sans-serif;
	mso-ascii-font-family:Arial;
	mso-hansi-font-family:Arial;
	color:gray;
	font-style:italic;}
span.nfasisintenso1
	{mso-style-name:"Énfasis intenso1";
	mso-style-priority:21;
	mso-style-unhide:no;
	mso-style-qformat:yes;
	font-family:"Arial",sans-serif;
	mso-ascii-font-family:Arial;
	mso-hansi-font-family:Arial;
	color:#4F81BD;
	font-weight:bold;
	font-style:italic;}
span.Referenciasutil1
	{mso-style-name:"Referencia sutil1";
	mso-style-priority:31;
	mso-style-unhide:no;
	mso-style-qformat:yes;
	font-variant:small-caps;
	color:#C0504D;
	text-decoration:underline;
	text-underline:single;}
span.Referenciaintensa1
	{mso-style-name:"Referencia intensa1";
	mso-style-priority:32;
	mso-style-unhide:no;
	mso-style-qformat:yes;
	mso-style-parent:"";
	font-variant:small-caps;
	color:#C0504D;
	letter-spacing:.25pt;
	font-weight:bold;
	text-decoration:underline;
	text-underline:single;}
p.TtuloTDC1, li.TtuloTDC1, div.TtuloTDC1
	{mso-style-name:"Título TDC1";
	mso-style-noshow:yes;
	mso-style-priority:39;
	mso-style-qformat:yes;
	mso-style-link:"Título TDC Car";
	mso-style-next:Normal;
	margin:0mm;
	margin-bottom:.0001pt;
	mso-pagination:widow-orphan lines-together;
	font-size:11.0pt;
	mso-bidi-font-size:14.0pt;
	font-family:"Arial",sans-serif;
	mso-fareast-font-family:"Times New Roman";
	mso-bidi-font-family:"Times New Roman";
	mso-fareast-language:EN-US;}
span.SinespaciadoCar
	{mso-style-name:"Sin espaciado Car";
	mso-style-priority:1;
	mso-style-unhide:no;
	mso-style-locked:yes;
	mso-style-link:"Sin espaciado1";
	font-family:"Arial",sans-serif;
	mso-ascii-font-family:Arial;
	mso-hansi-font-family:Arial;}
p.Textodeglobo1, li.Textodeglobo1, div.Textodeglobo1
	{mso-style-name:"Texto de globo1";
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-link:"Texto de globo Car";
	mso-style-next:"Texto de globo";
	margin-top:0mm;
	margin-right:0mm;
	margin-bottom:10.0pt;
	margin-left:0mm;
	line-height:115%;
	mso-pagination:widow-orphan;
	font-size:8.0pt;
	font-family:"Tahoma",sans-serif;
	mso-fareast-font-family:Calibri;
	mso-fareast-theme-font:minor-latin;
	mso-ansi-language:EN-GB;
	mso-fareast-language:EN-US;}
span.TextodegloboCar
	{mso-style-name:"Texto de globo Car";
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-style-locked:yes;
	mso-style-link:"Texto de globo1";
	mso-ansi-font-size:8.0pt;
	mso-bidi-font-size:8.0pt;
	font-family:"Tahoma",sans-serif;
	mso-ascii-font-family:Tahoma;
	mso-hansi-font-family:Tahoma;
	mso-bidi-font-family:Tahoma;}
p.Bibliografa1, li.Bibliografa1, div.Bibliografa1
	{mso-style-name:Bibliografía1;
	mso-style-priority:37;
	mso-style-next:Normal;
	margin-top:0mm;
	margin-right:0mm;
	margin-bottom:10.0pt;
	margin-left:0mm;
	line-height:115%;
	mso-pagination:widow-orphan;
	font-size:11.0pt;
	font-family:"Arial",sans-serif;
	mso-fareast-font-family:Calibri;
	mso-fareast-theme-font:minor-latin;
	mso-bidi-font-family:"Times New Roman";
	mso-bidi-theme-font:minor-bidi;
	mso-fareast-language:EN-US;}
p.Ttulospreliminares, li.Ttulospreliminares, div.Ttulospreliminares
	{mso-style-name:"Títulos preliminares";
	mso-style-unhide:no;
	mso-style-qformat:yes;
	mso-style-parent:"Título TDC";
	mso-style-link:"Títulos preliminares Car";
	margin-top:12.0pt;
	margin-right:0mm;
	margin-bottom:0mm;
	margin-left:0mm;
	margin-bottom:.0001pt;
	line-height:107%;
	mso-pagination:widow-orphan lines-together;
	page-break-after:avoid;
	font-size:16.0pt;
	font-family:"Calibri Light",sans-serif;
	mso-ascii-font-family:"Calibri Light";
	mso-ascii-theme-font:major-latin;
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:major-fareast;
	mso-hansi-font-family:"Calibri Light";
	mso-hansi-theme-font:major-latin;
	mso-bidi-font-family:"Times New Roman";
	mso-bidi-theme-font:major-bidi;
	color:#2E74B5;
	mso-themecolor:accent1;
	mso-themeshade:191;
	mso-ansi-language:EN-GB;
	mso-fareast-language:EN-US;}
span.TtulospreliminaresCar
	{mso-style-name:"Títulos preliminares Car";
	mso-style-unhide:no;
	mso-style-locked:yes;
	mso-style-parent:"Título TDC Car";
	mso-style-link:"Títulos preliminares";
	mso-ansi-font-size:16.0pt;
	mso-bidi-font-size:16.0pt;
	font-family:"Calibri Light",sans-serif;
	mso-ascii-font-family:"Calibri Light";
	mso-ascii-theme-font:major-latin;
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:major-fareast;
	mso-hansi-font-family:"Calibri Light";
	mso-hansi-theme-font:major-latin;
	mso-bidi-font-family:"Times New Roman";
	mso-bidi-theme-font:major-bidi;
	color:#2E74B5;
	mso-themecolor:accent1;
	mso-themeshade:191;}
p.Ttulospreliminares2, li.Ttulospreliminares2, div.Ttulospreliminares2
	{mso-style-name:"Títulos preliminares 2";
	mso-style-unhide:no;
	mso-style-qformat:yes;
	mso-style-link:"Títulos preliminares 2 Car";
	margin-top:100.0pt;
	margin-right:0mm;
	margin-bottom:10.0pt;
	margin-left:0mm;
	mso-pagination:widow-orphan;
	font-size:20.0pt;
	mso-bidi-font-size:11.0pt;
	font-family:"Arial",sans-serif;
	mso-fareast-font-family:Calibri;
	mso-fareast-theme-font:minor-latin;
	mso-bidi-font-family:"Times New Roman";
	mso-bidi-theme-font:minor-bidi;
	mso-fareast-language:EN-US;
	font-weight:bold;
	mso-bidi-font-weight:normal;}
span.Ttulospreliminares2Car
	{mso-style-name:"Títulos preliminares 2 Car";
	mso-style-unhide:no;
	mso-style-locked:yes;
	mso-style-link:"Títulos preliminares 2";
	mso-ansi-font-size:20.0pt;
	font-family:"Arial",sans-serif;
	mso-ascii-font-family:Arial;
	mso-hansi-font-family:Arial;
	mso-ansi-language:ES-CO;
	font-weight:bold;
	mso-bidi-font-weight:normal;}
p.EstiloUniversidadNacionalEntregaDocumentos, li.EstiloUniversidadNacionalEntregaDocumentos, div.EstiloUniversidadNacionalEntregaDocumentos
	{mso-style-name:"Estilo Universidad Nacional Entrega Documentos";
	mso-style-unhide:no;
	mso-style-qformat:yes;
	mso-style-parent:"Párrafo de lista";
	mso-style-link:"Estilo Universidad Nacional Entrega Documentos Car";
	margin-top:0mm;
	margin-right:0mm;
	margin-bottom:8.0pt;
	margin-left:36.0pt;
	mso-add-space:auto;
	line-height:107%;
	mso-pagination:widow-orphan;
	font-size:11.0pt;
	mso-bidi-font-size:12.0pt;
	font-family:"Arial",sans-serif;
	mso-fareast-font-family:Calibri;
	mso-fareast-theme-font:minor-latin;
	mso-bidi-font-family:"Times New Roman";
	mso-bidi-theme-font:minor-bidi;
	mso-ansi-language:ES;
	mso-fareast-language:ES;}
p.EstiloUniversidadNacionalEntregaDocumentosCxSpFirst, li.EstiloUniversidadNacionalEntregaDocumentosCxSpFirst, div.EstiloUniversidadNacionalEntregaDocumentosCxSpFirst
	{mso-style-name:"Estilo Universidad Nacional Entrega DocumentosCxSpFirst";
	mso-style-unhide:no;
	mso-style-qformat:yes;
	mso-style-parent:"Párrafo de lista";
	mso-style-link:"Estilo Universidad Nacional Entrega Documentos Car";
	mso-style-type:export-only;
	margin-top:0mm;
	margin-right:0mm;
	margin-bottom:0mm;
	margin-left:36.0pt;
	margin-bottom:.0001pt;
	mso-add-space:auto;
	line-height:107%;
	mso-pagination:widow-orphan;
	font-size:11.0pt;
	mso-bidi-font-size:12.0pt;
	font-family:"Arial",sans-serif;
	mso-fareast-font-family:Calibri;
	mso-fareast-theme-font:minor-latin;
	mso-bidi-font-family:"Times New Roman";
	mso-bidi-theme-font:minor-bidi;
	mso-ansi-language:ES;
	mso-fareast-language:ES;}
p.EstiloUniversidadNacionalEntregaDocumentosCxSpMiddle, li.EstiloUniversidadNacionalEntregaDocumentosCxSpMiddle, div.EstiloUniversidadNacionalEntregaDocumentosCxSpMiddle
	{mso-style-name:"Estilo Universidad Nacional Entrega DocumentosCxSpMiddle";
	mso-style-unhide:no;
	mso-style-qformat:yes;
	mso-style-parent:"Párrafo de lista";
	mso-style-link:"Estilo Universidad Nacional Entrega Documentos Car";
	mso-style-type:export-only;
	margin-top:0mm;
	margin-right:0mm;
	margin-bottom:0mm;
	margin-left:36.0pt;
	margin-bottom:.0001pt;
	mso-add-space:auto;
	line-height:107%;
	mso-pagination:widow-orphan;
	font-size:11.0pt;
	mso-bidi-font-size:12.0pt;
	font-family:"Arial",sans-serif;
	mso-fareast-font-family:Calibri;
	mso-fareast-theme-font:minor-latin;
	mso-bidi-font-family:"Times New Roman";
	mso-bidi-theme-font:minor-bidi;
	mso-ansi-language:ES;
	mso-fareast-language:ES;}
p.EstiloUniversidadNacionalEntregaDocumentosCxSpLast, li.EstiloUniversidadNacionalEntregaDocumentosCxSpLast, div.EstiloUniversidadNacionalEntregaDocumentosCxSpLast
	{mso-style-name:"Estilo Universidad Nacional Entrega DocumentosCxSpLast";
	mso-style-unhide:no;
	mso-style-qformat:yes;
	mso-style-parent:"Párrafo de lista";
	mso-style-link:"Estilo Universidad Nacional Entrega Documentos Car";
	mso-style-type:export-only;
	margin-top:0mm;
	margin-right:0mm;
	margin-bottom:8.0pt;
	margin-left:36.0pt;
	mso-add-space:auto;
	line-height:107%;
	mso-pagination:widow-orphan;
	font-size:11.0pt;
	mso-bidi-font-size:12.0pt;
	font-family:"Arial",sans-serif;
	mso-fareast-font-family:Calibri;
	mso-fareast-theme-font:minor-latin;
	mso-bidi-font-family:"Times New Roman";
	mso-bidi-theme-font:minor-bidi;
	mso-ansi-language:ES;
	mso-fareast-language:ES;}
span.EstiloUniversidadNacionalEntregaDocumentosCar
	{mso-style-name:"Estilo Universidad Nacional Entrega Documentos Car";
	mso-style-unhide:no;
	mso-style-locked:yes;
	mso-style-parent:"Párrafo de lista Car";
	mso-style-link:"Estilo Universidad Nacional Entrega Documentos";}
p.UNMaestra, li.UNMaestra, div.UNMaestra
	{mso-style-name:"UN Maestríaç";
	mso-style-unhide:no;
	mso-style-qformat:yes;
	mso-style-parent:"Estilo Universidad Nacional Entrega Documentos";
	mso-style-link:"UN Maestríaç Car";
	margin:0mm;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:150%;
	mso-pagination:widow-orphan;
	font-size:11.0pt;
	mso-bidi-font-size:12.0pt;
	font-family:"Arial",sans-serif;
	mso-fareast-font-family:"Times New Roman";
	mso-bidi-font-family:"Times New Roman";
	mso-bidi-theme-font:minor-bidi;
	mso-ansi-language:ES;
	mso-fareast-language:ES;
	font-weight:bold;
	mso-bidi-font-weight:normal;}
span.UNMaestraCar
	{mso-style-name:"UN Maestríaç Car";
	mso-style-unhide:no;
	mso-style-locked:yes;
	mso-style-parent:"Estilo Universidad Nacional Entrega Documentos Car";
	mso-style-link:"UN Maestríaç";
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:"Times New Roman";
	font-weight:bold;
	mso-bidi-font-weight:normal;}
p.TDC11, li.TDC11, div.TDC11
	{mso-style-name:"TDC 11";
	mso-style-update:auto;
	mso-style-noshow:yes;
	mso-style-priority:39;
	mso-style-qformat:yes;
	mso-style-next:Normal;
	margin-top:10.0pt;
	margin-right:0mm;
	margin-bottom:0mm;
	margin-left:0mm;
	margin-bottom:.0001pt;
	text-align:right;
	mso-pagination:widow-orphan;
	tab-stops:22.0pt right dotted 439.45pt;
	font-size:11.0pt;
	mso-bidi-font-size:12.0pt;
	font-family:"Arial",sans-serif;
	mso-fareast-font-family:"Times New Roman";
	mso-ansi-language:ES;
	mso-fareast-language:EN-US;
	font-weight:bold;
	mso-bidi-font-weight:normal;
	mso-no-proof:yes;}
p.TDC21, li.TDC21, div.TDC21
	{mso-style-name:"TDC 21";
	mso-style-update:auto;
	mso-style-noshow:yes;
	mso-style-priority:39;
	mso-style-qformat:yes;
	mso-style-next:Normal;
	margin-top:0mm;
	margin-right:0mm;
	margin-bottom:0mm;
	margin-left:11.05pt;
	margin-bottom:.0001pt;
	mso-pagination:widow-orphan;
	font-size:11.0pt;
	font-family:"Arial",sans-serif;
	mso-fareast-font-family:"Times New Roman";
	mso-bidi-font-family:"Times New Roman";
	mso-bidi-theme-font:minor-bidi;
	mso-ansi-language:ES;
	mso-fareast-language:EN-US;}
p.TDC31, li.TDC31, div.TDC31
	{mso-style-name:"TDC 31";
	mso-style-update:auto;
	mso-style-noshow:yes;
	mso-style-priority:39;
	mso-style-qformat:yes;
	mso-style-next:Normal;
	margin-top:0mm;
	margin-right:0mm;
	margin-bottom:0mm;
	margin-left:22.1pt;
	margin-bottom:.0001pt;
	mso-pagination:widow-orphan;
	tab-stops:55.0pt right dotted 439.45pt;
	font-size:11.0pt;
	font-family:"Arial",sans-serif;
	mso-fareast-font-family:"Times New Roman";
	mso-bidi-font-family:"Times New Roman";
	mso-bidi-theme-font:minor-bidi;
	mso-ansi-language:ES;
	mso-fareast-language:EN-US;
	mso-no-proof:yes;}
span.PrrafodelistaCar
	{mso-style-name:"Párrafo de lista Car";
	mso-style-priority:34;
	mso-style-unhide:no;
	mso-style-locked:yes;
	mso-style-link:"Párrafo de lista";}
span.TtuloTDCCar
	{mso-style-name:"Título TDC Car";
	mso-style-noshow:yes;
	mso-style-priority:39;
	mso-style-unhide:no;
	mso-style-locked:yes;
	mso-style-link:"Título TDC1";
	mso-bidi-font-size:14.0pt;
	font-family:"Arial",sans-serif;
	mso-ascii-font-family:Arial;
	mso-fareast-font-family:"Times New Roman";
	mso-hansi-font-family:Arial;
	mso-bidi-font-family:"Times New Roman";}
span.Ttulo1Car1
	{mso-style-name:"Título 1 Car1";
	mso-style-priority:9;
	mso-style-unhide:no;
	mso-ansi-font-size:16.0pt;
	mso-bidi-font-size:16.0pt;
	font-family:"Calibri Light",sans-serif;
	mso-ascii-font-family:"Calibri Light";
	mso-ascii-theme-font:major-latin;
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:major-fareast;
	mso-hansi-font-family:"Calibri Light";
	mso-hansi-theme-font:major-latin;
	mso-bidi-font-family:"Times New Roman";
	mso-bidi-theme-font:major-bidi;
	color:#2E74B5;
	mso-themecolor:accent1;
	mso-themeshade:191;}
span.Ttulo2Car1
	{mso-style-name:"Título 2 Car1";
	mso-style-noshow:yes;
	mso-style-priority:9;
	mso-style-unhide:no;
	mso-ansi-font-size:13.0pt;
	mso-bidi-font-size:13.0pt;
	font-family:"Calibri Light",sans-serif;
	mso-ascii-font-family:"Calibri Light";
	mso-ascii-theme-font:major-latin;
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:major-fareast;
	mso-hansi-font-family:"Calibri Light";
	mso-hansi-theme-font:major-latin;
	mso-bidi-font-family:"Times New Roman";
	mso-bidi-theme-font:major-bidi;
	color:#2E74B5;
	mso-themecolor:accent1;
	mso-themeshade:191;}
span.Ttulo3Car1
	{mso-style-name:"Título 3 Car1";
	mso-style-noshow:yes;
	mso-style-priority:9;
	mso-style-unhide:no;
	mso-ansi-font-size:12.0pt;
	mso-bidi-font-size:12.0pt;
	font-family:"Calibri Light",sans-serif;
	mso-ascii-font-family:"Calibri Light";
	mso-ascii-theme-font:major-latin;
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:major-fareast;
	mso-hansi-font-family:"Calibri Light";
	mso-hansi-theme-font:major-latin;
	mso-bidi-font-family:"Times New Roman";
	mso-bidi-theme-font:major-bidi;
	color:#1F4D78;
	mso-themecolor:accent1;
	mso-themeshade:127;}
span.Ttulo4Car1
	{mso-style-name:"Título 4 Car1";
	mso-style-noshow:yes;
	mso-style-priority:9;
	mso-style-unhide:no;
	font-family:"Calibri Light",sans-serif;
	mso-ascii-font-family:"Calibri Light";
	mso-ascii-theme-font:major-latin;
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:major-fareast;
	mso-hansi-font-family:"Calibri Light";
	mso-hansi-theme-font:major-latin;
	mso-bidi-font-family:"Times New Roman";
	mso-bidi-theme-font:major-bidi;
	color:#2E74B5;
	mso-themecolor:accent1;
	mso-themeshade:191;
	font-style:italic;}
span.Ttulo5Car1
	{mso-style-name:"Título 5 Car1";
	mso-style-noshow:yes;
	mso-style-priority:9;
	mso-style-unhide:no;
	font-family:"Calibri Light",sans-serif;
	mso-ascii-font-family:"Calibri Light";
	mso-ascii-theme-font:major-latin;
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:major-fareast;
	mso-hansi-font-family:"Calibri Light";
	mso-hansi-theme-font:major-latin;
	mso-bidi-font-family:"Times New Roman";
	mso-bidi-theme-font:major-bidi;
	color:#2E74B5;
	mso-themecolor:accent1;
	mso-themeshade:191;}
span.Ttulo6Car1
	{mso-style-name:"Título 6 Car1";
	mso-style-noshow:yes;
	mso-style-priority:9;
	mso-style-unhide:no;
	font-family:"Calibri Light",sans-serif;
	mso-ascii-font-family:"Calibri Light";
	mso-ascii-theme-font:major-latin;
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:major-fareast;
	mso-hansi-font-family:"Calibri Light";
	mso-hansi-theme-font:major-latin;
	mso-bidi-font-family:"Times New Roman";
	mso-bidi-theme-font:major-bidi;
	color:#1F4D78;
	mso-themecolor:accent1;
	mso-themeshade:127;}
span.Ttulo7Car1
	{mso-style-name:"Título 7 Car1";
	mso-style-noshow:yes;
	mso-style-priority:9;
	mso-style-unhide:no;
	font-family:"Calibri Light",sans-serif;
	mso-ascii-font-family:"Calibri Light";
	mso-ascii-theme-font:major-latin;
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:major-fareast;
	mso-hansi-font-family:"Calibri Light";
	mso-hansi-theme-font:major-latin;
	mso-bidi-font-family:"Times New Roman";
	mso-bidi-theme-font:major-bidi;
	color:#1F4D78;
	mso-themecolor:accent1;
	mso-themeshade:127;
	font-style:italic;}
span.Ttulo8Car1
	{mso-style-name:"Título 8 Car1";
	mso-style-noshow:yes;
	mso-style-priority:9;
	mso-style-unhide:no;
	mso-ansi-font-size:10.5pt;
	mso-bidi-font-size:10.5pt;
	font-family:"Calibri Light",sans-serif;
	mso-ascii-font-family:"Calibri Light";
	mso-ascii-theme-font:major-latin;
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:major-fareast;
	mso-hansi-font-family:"Calibri Light";
	mso-hansi-theme-font:major-latin;
	mso-bidi-font-family:"Times New Roman";
	mso-bidi-theme-font:major-bidi;
	color:#272727;
	mso-themecolor:text1;
	mso-themetint:216;}
span.Ttulo9Car1
	{mso-style-name:"Título 9 Car1";
	mso-style-noshow:yes;
	mso-style-priority:9;
	mso-style-unhide:no;
	mso-ansi-font-size:10.5pt;
	mso-bidi-font-size:10.5pt;
	font-family:"Calibri Light",sans-serif;
	mso-ascii-font-family:"Calibri Light";
	mso-ascii-theme-font:major-latin;
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:major-fareast;
	mso-hansi-font-family:"Calibri Light";
	mso-hansi-theme-font:major-latin;
	mso-bidi-font-family:"Times New Roman";
	mso-bidi-theme-font:major-bidi;
	color:#272727;
	mso-themecolor:text1;
	mso-themetint:216;
	font-style:italic;}
span.TtuloCar1
	{mso-style-name:"Título Car1";
	mso-style-priority:10;
	mso-style-unhide:no;
	mso-ansi-font-size:28.0pt;
	mso-bidi-font-size:28.0pt;
	font-family:"Calibri Light",sans-serif;
	mso-ascii-font-family:"Calibri Light";
	mso-ascii-theme-font:major-latin;
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:major-fareast;
	mso-hansi-font-family:"Calibri Light";
	mso-hansi-theme-font:major-latin;
	mso-bidi-font-family:"Times New Roman";
	mso-bidi-theme-font:major-bidi;
	letter-spacing:-.5pt;
	mso-font-kerning:14.0pt;}
span.SubttuloCar1
	{mso-style-name:"Subtítulo Car1";
	mso-style-priority:11;
	mso-style-unhide:no;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;
	color:#5A5A5A;
	mso-themecolor:text1;
	mso-themetint:165;
	letter-spacing:.75pt;}
span.CitaCar1
	{mso-style-name:"Cita Car1";
	mso-style-priority:29;
	mso-style-unhide:no;
	color:#404040;
	mso-themecolor:text1;
	mso-themetint:191;
	font-style:italic;}
span.CitadestacadaCar1
	{mso-style-name:"Cita destacada Car1";
	mso-style-priority:30;
	mso-style-unhide:no;
	color:#5B9BD5;
	mso-themecolor:accent1;
	font-style:italic;}
span.TextodegloboCar1
	{mso-style-name:"Texto de globo Car1";
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-style-locked:yes;
	mso-style-link:"Texto de globo";
	mso-ansi-font-size:9.0pt;
	mso-bidi-font-size:9.0pt;
	font-family:"Segoe UI",sans-serif;
	mso-ascii-font-family:"Segoe UI";
	mso-hansi-font-family:"Segoe UI";
	mso-bidi-font-family:"Segoe UI";}
.MsoChpDefault
	{mso-style-type:export-only;
	mso-default-props:yes;
	font-family:"Calibri",sans-serif;
	mso-ascii-font-family:Calibri;
	mso-ascii-theme-font:minor-latin;
	mso-fareast-font-family:Calibri;
	mso-fareast-theme-font:minor-latin;
	mso-hansi-font-family:Calibri;
	mso-hansi-theme-font:minor-latin;
	mso-bidi-font-family:"Times New Roman";
	mso-bidi-theme-font:minor-bidi;
	mso-ansi-language:EN-GB;
	mso-fareast-language:EN-US;}
.MsoPapDefault
	{mso-style-type:export-only;
	margin-bottom:8.0pt;
	line-height:107%;}
 /* Page Definitions */
 @page
	{mso-footnote-separator:url("file:///F:/Documentos/artículo_revisión_consumo_2018_Daniel_Parra_archivos/header.htm") fs;
	mso-footnote-continuation-separator:url("file:///F:/Documentos/artículo_revisión_consumo_2018_Daniel_Parra_archivos/header.htm") fcs;
	mso-endnote-separator:url("file:///F:/Documentos/artículo_revisión_consumo_2018_Daniel_Parra_archivos/header.htm") es;
	mso-endnote-continuation-separator:url("file:///F:/Documentos/artículo_revisión_consumo_2018_Daniel_Parra_archivos/header.htm") ecs;}
@page WordSection1
	{size:595.3pt 841.9pt;
	margin:104.9pt 45.35pt 73.7pt 45.35pt;
	mso-header-margin:35.45pt;
	mso-footer-margin:35.45pt;
	mso-header:url("file:///F:/Documentos/artículo_revisión_consumo_2018_Daniel_Parra_archivos/header.htm") h1;
	mso-footer:url("file:///F:/Documentos/artículo_revisión_consumo_2018_Daniel_Parra_archivos/header.htm") f1;
	mso-paper-source:0;}
div.WordSection1
	{page:WordSection1;}
@page WordSection2
	{size:595.3pt 841.9pt;
	margin:70.9pt 45.35pt 102.05pt 45.35pt;
	mso-header-margin:35.45pt;
	mso-footer-margin:35.45pt;
	mso-columns:2 even 11.35pt;
	mso-title-page:yes;
	mso-header:url("file:///F:/Documentos/artículo_revisión_consumo_2018_Daniel_Parra_archivos/header.htm") h2;
	mso-footer:url("file:///F:/Documentos/artículo_revisión_consumo_2018_Daniel_Parra_archivos/header.htm") f2;
	mso-paper-source:0;}
div.WordSection2
	{page:WordSection2;}
@page WordSection3
	{size:595.3pt 841.9pt;
	margin:70.9pt 45.35pt 102.05pt 45.35pt;
	mso-header-margin:35.45pt;
	mso-footer-margin:35.45pt;
	mso-title-page:yes;
	mso-header:url("file:///F:/Documentos/artículo_revisión_consumo_2018_Daniel_Parra_archivos/header.htm") h2;
	mso-footer:url("file:///F:/Documentos/artículo_revisión_consumo_2018_Daniel_Parra_archivos/header.htm") f2;
	mso-paper-source:0;}
div.WordSection3
	{page:WordSection3;}
@page WordSection4
	{size:595.3pt 841.9pt;
	margin:70.9pt 45.35pt 102.05pt 45.35pt;
	mso-header-margin:35.45pt;
	mso-footer-margin:35.45pt;
	mso-columns:2 even 11.35pt;
	mso-title-page:yes;
	mso-header:url("file:///F:/Documentos/artículo_revisión_consumo_2018_Daniel_Parra_archivos/header.htm") h2;
	mso-footer:url("file:///F:/Documentos/artículo_revisión_consumo_2018_Daniel_Parra_archivos/header.htm") f2;
	mso-paper-source:0;}
div.WordSection4
	{page:WordSection4;}
 /* List Definitions */
 @list l0
	{mso-list-id:161627407;
	mso-list-type:hybrid;
	mso-list-template-ids:1515735388 604635141 604635139 604635141 604635137 604635139 604635141 604635137 604635139 604635141;}
@list l0:level1
	{mso-level-number-format:bullet;
	mso-level-text:;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Wingdings;}
@list l0:level2
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:"Courier New";}
@list l0:level3
	{mso-level-number-format:bullet;
	mso-level-text:;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Wingdings;}
@list l0:level4
	{mso-level-number-format:bullet;
	mso-level-text:;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Symbol;}
@list l0:level5
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:"Courier New";}
@list l0:level6
	{mso-level-number-format:bullet;
	mso-level-text:;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Wingdings;}
@list l0:level7
	{mso-level-number-format:bullet;
	mso-level-text:;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Symbol;}
@list l0:level8
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:"Courier New";}
@list l0:level9
	{mso-level-number-format:bullet;
	mso-level-text:;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Wingdings;}
@list l1
	{mso-list-id:316300910;
	mso-list-type:hybrid;
	mso-list-template-ids:-1220885568 604635137 604635139 604635141 604635137 604635139 604635141 604635137 604635139 604635141;}
@list l1:level1
	{mso-level-number-format:bullet;
	mso-level-text:;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Symbol;}
@list l1:level2
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:"Courier New";}
@list l1:level3
	{mso-level-number-format:bullet;
	mso-level-text:;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Wingdings;}
@list l1:level4
	{mso-level-number-format:bullet;
	mso-level-text:;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Symbol;}
@list l1:level5
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:"Courier New";}
@list l1:level6
	{mso-level-number-format:bullet;
	mso-level-text:;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Wingdings;}
@list l1:level7
	{mso-level-number-format:bullet;
	mso-level-text:;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Symbol;}
@list l1:level8
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:"Courier New";}
@list l1:level9
	{mso-level-number-format:bullet;
	mso-level-style-link:"Título 91";
	mso-level-text:;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Wingdings;}
@list l2
	{mso-list-id:564922862;
	mso-list-type:hybrid;
	mso-list-template-ids:1557987102 604635141 604635139 604635141 604635137 604635139 604635141 604635137 604635139 604635141;}
@list l2:level1
	{mso-level-number-format:bullet;
	mso-level-text:;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Wingdings;}
@list l2:level2
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:"Courier New";}
@list l2:level3
	{mso-level-number-format:bullet;
	mso-level-text:;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Wingdings;}
@list l2:level4
	{mso-level-number-format:bullet;
	mso-level-text:;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Symbol;}
@list l2:level5
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:"Courier New";}
@list l2:level6
	{mso-level-number-format:bullet;
	mso-level-text:;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Wingdings;}
@list l2:level7
	{mso-level-number-format:bullet;
	mso-level-text:;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Symbol;}
@list l2:level8
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:"Courier New";}
@list l2:level9
	{mso-level-number-format:bullet;
	mso-level-text:;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Wingdings;}
@list l3
	{mso-list-id:634795312;
	mso-list-type:hybrid;
	mso-list-template-ids:766521004 -103493074 134807577 134807579 134807567 134807577 134807579 134807567 134807577 134807579;}
@list l3:level1
	{mso-level-style-link:IOPRefs;
	mso-level-text:"\[%1\]";
	mso-level-tab-stop:14.2pt;
	mso-level-number-position:left;
	margin-left:14.2pt;
	text-indent:-14.2pt;}
@list l3:level2
	{mso-level-number-format:alpha-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;}
@list l3:level3
	{mso-level-number-format:roman-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:right;
	text-indent:-9.0pt;}
@list l3:level4
	{mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;}
@list l3:level5
	{mso-level-number-format:alpha-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;}
@list l3:level6
	{mso-level-number-format:roman-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:right;
	text-indent:-9.0pt;}
@list l3:level7
	{mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;}
@list l3:level8
	{mso-level-number-format:alpha-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;}
@list l3:level9
	{mso-level-number-format:roman-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:right;
	text-indent:-9.0pt;}
@list l4
	{mso-list-id:650401779;
	mso-list-type:hybrid;
	mso-list-template-ids:-969881504 604635141 604635139 604635141 604635137 604635139 604635141 604635137 604635139 604635141;}
@list l4:level1
	{mso-level-number-format:bullet;
	mso-level-text:;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Wingdings;}
@list l4:level2
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:"Courier New";}
@list l4:level3
	{mso-level-number-format:bullet;
	mso-level-text:;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Wingdings;}
@list l4:level4
	{mso-level-number-format:bullet;
	mso-level-text:;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Symbol;}
@list l4:level5
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:"Courier New";}
@list l4:level6
	{mso-level-number-format:bullet;
	mso-level-text:;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Wingdings;}
@list l4:level7
	{mso-level-number-format:bullet;
	mso-level-text:;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Symbol;}
@list l4:level8
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:"Courier New";}
@list l4:level9
	{mso-level-number-format:bullet;
	mso-level-text:;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Wingdings;}
@list l5
	{mso-list-id:1125001199;
	mso-list-type:hybrid;
	mso-list-template-ids:-333041332 1137229688 604635161 604635163 604635151 604635161 604635163 604635151 604635161 604635163;}
@list l5:level1
	{mso-level-number-format:alpha-upper;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:35.85pt;
	text-indent:-18.0pt;
	mso-ansi-font-weight:bold;}
@list l5:level2
	{mso-level-number-format:alpha-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;}
@list l5:level3
	{mso-level-number-format:roman-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:right;
	text-indent:-9.0pt;}
@list l5:level4
	{mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;}
@list l5:level5
	{mso-level-number-format:alpha-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;}
@list l5:level6
	{mso-level-number-format:roman-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:right;
	text-indent:-9.0pt;}
@list l5:level7
	{mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;}
@list l5:level8
	{mso-level-number-format:alpha-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;}
@list l5:level9
	{mso-level-number-format:roman-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:right;
	text-indent:-9.0pt;}
@list l6
	{mso-list-id:1284578383;
	mso-list-template-ids:-348869108;}
@list l6:level1
	{mso-level-style-link:"Título Primer Nivel1";
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:117.25pt;
	text-indent:-18.0pt;}
@list l6:level2
	{mso-level-style-link:"Título Segundo nivel1";
	mso-level-text:"%1\.%2";
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:78.45pt;
	text-indent:-28.8pt;
	mso-ansi-font-weight:bold;}
@list l6:level3
	{mso-level-style-link:"Título Tercer nivel1";
	mso-level-text:"%1\.%2\.%3";
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:36.0pt;
	text-indent:-36.0pt;
	mso-ansi-font-weight:bold;}
@list l6:level4
	{mso-level-text:"%1\.%2\.%3\.%4";
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:142.45pt;
	text-indent:-43.2pt;
	mso-ansi-font-weight:bold;}
@list l6:level5
	{mso-level-style-link:"Título 51";
	mso-level-text:"%1\.%2\.%3\.%4\.%5";
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:149.65pt;
	text-indent:-50.4pt;
	mso-ansi-font-weight:bold;}
@list l6:level6
	{mso-level-style-link:"Título 61";
	mso-level-text:"%1\.%2\.%3\.%4\.%5\.%6";
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:156.85pt;
	text-indent:-57.6pt;
	mso-ansi-font-weight:bold;}
@list l6:level7
	{mso-level-style-link:"Título 71";
	mso-level-text:"%1\.%2\.%3\.%4\.%5\.%6\.%7";
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:164.05pt;
	text-indent:-64.8pt;
	mso-ansi-font-weight:bold;}
@list l6:level8
	{mso-level-style-link:"Título 81";
	mso-level-text:"%1\.%2\.%3\.%4\.%5\.%6\.%7\.%8";
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:171.25pt;
	text-indent:-72.0pt;
	mso-ansi-font-weight:bold;}
@list l6:level9
	{mso-level-text:"%1\.%2\.%3\.%4\.%5\.%6\.%7\.%8\.%9";
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:178.45pt;
	text-indent:-79.2pt;
	mso-ansi-font-weight:bold;}
@list l7
	{mso-list-id:1353802205;
	mso-list-type:hybrid;
	mso-list-template-ids:1535003650 604635137 604635139 604635141 604635137 604635139 604635141 604635137 604635139 604635141;}
@list l7:level1
	{mso-level-number-format:bullet;
	mso-level-style-link:"Título Anexos1";
	mso-level-text:;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Symbol;}
@list l7:level2
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:"Courier New";}
@list l7:level3
	{mso-level-number-format:bullet;
	mso-level-text:;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Wingdings;}
@list l7:level4
	{mso-level-number-format:bullet;
	mso-level-text:;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Symbol;}
@list l7:level5
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:"Courier New";}
@list l7:level6
	{mso-level-number-format:bullet;
	mso-level-text:;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Wingdings;}
@list l7:level7
	{mso-level-number-format:bullet;
	mso-level-text:;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Symbol;}
@list l7:level8
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:"Courier New";}
@list l7:level9
	{mso-level-number-format:bullet;
	mso-level-text:;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Wingdings;}
@list l8
	{mso-list-id:1362127789;
	mso-list-type:hybrid;
	mso-list-template-ids:-519004662 604635141 604635139 604635141 604635137 604635139 604635141 604635137 604635139 604635141;}
@list l8:level1
	{mso-level-number-format:bullet;
	mso-level-text:;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Wingdings;}
@list l8:level2
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:"Courier New";}
@list l8:level3
	{mso-level-number-format:bullet;
	mso-level-text:;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Wingdings;}
@list l8:level4
	{mso-level-number-format:bullet;
	mso-level-text:;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Symbol;}
@list l8:level5
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:"Courier New";}
@list l8:level6
	{mso-level-number-format:bullet;
	mso-level-text:;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Wingdings;}
@list l8:level7
	{mso-level-number-format:bullet;
	mso-level-text:;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Symbol;}
@list l8:level8
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:"Courier New";}
@list l8:level9
	{mso-level-number-format:bullet;
	mso-level-text:;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Wingdings;}
@list l9
	{mso-list-id:1398626829;
	mso-list-type:hybrid;
	mso-list-template-ids:-1438205126 604635151 604635161 604635163 604635151 604635161 604635163 604635151 604635161 604635163;}
@list l9:level1
	{mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;}
@list l9:level2
	{mso-level-number-format:alpha-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;}
@list l9:level3
	{mso-level-number-format:roman-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:right;
	text-indent:-9.0pt;}
@list l9:level4
	{mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;}
@list l9:level5
	{mso-level-number-format:alpha-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;}
@list l9:level6
	{mso-level-number-format:roman-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:right;
	text-indent:-9.0pt;}
@list l9:level7
	{mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;}
@list l9:level8
	{mso-level-number-format:alpha-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;}
@list l9:level9
	{mso-level-number-format:roman-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:right;
	text-indent:-9.0pt;}
@list l10
	{mso-list-id:1402021038;
	mso-list-type:hybrid;
	mso-list-template-ids:-1438205126 604635151 604635161 604635163 604635151 604635161 604635163 604635151 604635161 604635163;}
@list l10:level1
	{mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;}
@list l10:level2
	{mso-level-number-format:alpha-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;}
@list l10:level3
	{mso-level-number-format:roman-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:right;
	text-indent:-9.0pt;}
@list l10:level4
	{mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;}
@list l10:level5
	{mso-level-number-format:alpha-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;}
@list l10:level6
	{mso-level-number-format:roman-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:right;
	text-indent:-9.0pt;}
@list l10:level7
	{mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;}
@list l10:level8
	{mso-level-number-format:alpha-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;}
@list l10:level9
	{mso-level-number-format:roman-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:right;
	text-indent:-9.0pt;}
@list l11
	{mso-list-id:1493719912;
	mso-list-type:hybrid;
	mso-list-template-ids:-303369776 604635141 604635139 604635141 604635137 604635139 604635141 604635137 604635139 604635141;}
@list l11:level1
	{mso-level-number-format:bullet;
	mso-level-text:;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Wingdings;}
@list l11:level2
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:"Courier New";}
@list l11:level3
	{mso-level-number-format:bullet;
	mso-level-text:;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Wingdings;}
@list l11:level4
	{mso-level-number-format:bullet;
	mso-level-text:;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Symbol;}
@list l11:level5
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:"Courier New";}
@list l11:level6
	{mso-level-number-format:bullet;
	mso-level-text:;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Wingdings;}
@list l11:level7
	{mso-level-number-format:bullet;
	mso-level-text:;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Symbol;}
@list l11:level8
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:"Courier New";}
@list l11:level9
	{mso-level-number-format:bullet;
	mso-level-text:;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Wingdings;}
@list l12
	{mso-list-id:1877425698;
	mso-list-type:hybrid;
	mso-list-template-ids:-1994781814 950674886 134807577 134807579 134807567 134807577 134807579 134807567 134807577 134807579;}
@list l12:level1
	{mso-level-text:"\[%1\]";
	mso-level-tab-stop:14.2pt;
	mso-level-number-position:left;
	margin-left:14.2pt;
	text-indent:3.8pt;}
@list l12:level2
	{mso-level-number-format:alpha-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;}
@list l12:level3
	{mso-level-number-format:roman-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:right;
	text-indent:-9.0pt;}
@list l12:level4
	{mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;}
@list l12:level5
	{mso-level-number-format:alpha-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;}
@list l12:level6
	{mso-level-number-format:roman-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:right;
	text-indent:-9.0pt;}
@list l12:level7
	{mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;}
@list l12:level8
	{mso-level-number-format:alpha-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;}
@list l12:level9
	{mso-level-number-format:roman-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:right;
	text-indent:-9.0pt;}
@list l13
	{mso-list-id:1972663904;
	mso-list-type:hybrid;
	mso-list-template-ids:920687038 604635141 604635139 604635141 604635137 604635139 604635141 604635137 604635139 604635141;}
@list l13:level1
	{mso-level-number-format:bullet;
	mso-level-text:;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Wingdings;}
@list l13:level2
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:"Courier New";}
@list l13:level3
	{mso-level-number-format:bullet;
	mso-level-text:;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Wingdings;}
@list l13:level4
	{mso-level-number-format:bullet;
	mso-level-text:;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Symbol;}
@list l13:level5
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:"Courier New";}
@list l13:level6
	{mso-level-number-format:bullet;
	mso-level-text:;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Wingdings;}
@list l13:level7
	{mso-level-number-format:bullet;
	mso-level-text:;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Symbol;}
@list l13:level8
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:"Courier New";}
@list l13:level9
	{mso-level-number-format:bullet;
	mso-level-text:;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Wingdings;}
ol
	{margin-bottom:0mm;}
ul
	{margin-bottom:0mm;}
-->
</style>
<!--[if gte mso 10]>
<style>
 /* Style Definitions */
 table.MsoNormalTable
	{mso-style-name:"Tabla normal";
	mso-tstyle-rowband-size:0;
	mso-tstyle-colband-size:0;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-parent:"";
	mso-padding-alt:0mm 5.4pt 0mm 5.4pt;
	mso-para-margin-top:0mm;
	mso-para-margin-right:0mm;
	mso-para-margin-bottom:8.0pt;
	mso-para-margin-left:0mm;
	line-height:107%;
	mso-pagination:widow-orphan;
	font-size:11.0pt;
	font-family:"Calibri",sans-serif;
	mso-ascii-font-family:Calibri;
	mso-ascii-theme-font:minor-latin;
	mso-hansi-font-family:Calibri;
	mso-hansi-theme-font:minor-latin;
	mso-ansi-language:EN-GB;
	mso-fareast-language:EN-US;}
table.MsoTableGrid
	{mso-style-name:"Tabla con cuadrícula";
	mso-tstyle-rowband-size:0;
	mso-tstyle-colband-size:0;
	mso-style-priority:39;
	mso-style-unhide:no;
	border:solid windowtext 1.0pt;
	mso-border-alt:solid windowtext .5pt;
	mso-padding-alt:0mm 5.4pt 0mm 5.4pt;
	mso-border-insideh:.5pt solid windowtext;
	mso-border-insidev:.5pt solid windowtext;
	mso-para-margin:0mm;
	mso-para-margin-bottom:.0001pt;
	mso-pagination:widow-orphan;
	font-size:11.0pt;
	font-family:"Calibri",sans-serif;
	mso-ascii-font-family:Calibri;
	mso-ascii-theme-font:minor-latin;
	mso-hansi-font-family:Calibri;
	mso-hansi-theme-font:minor-latin;
	mso-ansi-language:EN-GB;
	mso-fareast-language:EN-US;}
table.Tablaconcuadrcula1
	{mso-style-name:"Tabla con cuadrícula1";
	mso-tstyle-rowband-size:0;
	mso-tstyle-colband-size:0;
	mso-style-priority:59;
	mso-style-unhide:no;
	border:solid windowtext 1.0pt;
	mso-border-alt:solid windowtext .5pt;
	mso-padding-alt:0mm 5.4pt 0mm 5.4pt;
	mso-border-insideh:.5pt solid windowtext;
	mso-border-insidev:.5pt solid windowtext;
	mso-para-margin-top:0mm;
	mso-para-margin-right:0mm;
	mso-para-margin-bottom:10.0pt;
	mso-para-margin-left:0mm;
	line-height:115%;
	mso-pagination:widow-orphan;
	font-size:11.0pt;
	font-family:"Calibri",sans-serif;
	mso-ascii-font-family:Calibri;
	mso-ascii-theme-font:minor-latin;
	mso-hansi-font-family:Calibri;
	mso-hansi-theme-font:minor-latin;
	mso-fareast-language:EN-US;}
table.CuadrculaPersonal
	{mso-style-name:"Cuadrícula Personal";
	mso-tstyle-rowband-size:1;
	mso-tstyle-colband-size:1;
	mso-style-priority:62;
	mso-style-unhide:no;
	border:solid black 1.0pt;
	mso-padding-alt:0mm 5.4pt 0mm 5.4pt;
	mso-border-insideh:1.0pt solid black;
	mso-border-insidev:1.0pt solid black;
	mso-tstyle-shading:#F2F2F2;
	mso-para-margin-top:0mm;
	mso-para-margin-right:0mm;
	mso-para-margin-bottom:10.0pt;
	mso-para-margin-left:0mm;
	line-height:115%;
	mso-pagination:widow-orphan;
	font-size:10.0pt;
	font-family:"Calibri",sans-serif;
	mso-fareast-font-family:Calibri;}
table.CuadrculaPersonalFirstRow
	{mso-style-name:"Cuadrícula Personal";
	mso-table-condition:first-row;
	mso-style-priority:62;
	mso-style-unhide:no;
	mso-tstyle-shading:#F2F2F2;
	mso-tstyle-border-top:1.0pt solid black;
	mso-tstyle-border-left:1.0pt solid black;
	mso-tstyle-border-bottom:1.0pt solid black;
	mso-tstyle-border-right:1.0pt solid black;
	mso-tstyle-border-insideh:cell-none;
	mso-tstyle-border-insidev:1.0pt solid black;
	mso-para-margin-top:0mm;
	mso-para-margin-bottom:0mm;
	mso-para-margin-bottom:.0001pt;
	line-height:normal;
	font-family:"Calibri",sans-serif;
	mso-ascii-font-family:Calibri;
	mso-hansi-font-family:Calibri;
	mso-bidi-font-family:"Times New Roman";
	mso-ansi-font-weight:bold;
	mso-bidi-font-weight:bold;}
table.CuadrculaPersonalLastRow
	{mso-style-name:"Cuadrícula Personal";
	mso-table-condition:last-row;
	mso-style-priority:62;
	mso-style-unhide:no;
	mso-tstyle-shading:#F2F2F2;
	mso-tstyle-border-top:1.0pt solid black;
	mso-tstyle-border-left:1.0pt solid black;
	mso-tstyle-border-bottom:1.0pt solid black;
	mso-tstyle-border-right:1.0pt solid black;
	mso-tstyle-border-insideh:cell-none;
	mso-tstyle-border-insidev:1.0pt solid black;
	mso-para-margin-top:0mm;
	mso-para-margin-bottom:0mm;
	mso-para-margin-bottom:.0001pt;
	line-height:normal;
	font-family:"Calibri",sans-serif;
	mso-ascii-font-family:Calibri;
	mso-fareast-font-family:"Times New Roman";
	mso-hansi-font-family:Calibri;
	mso-bidi-font-family:"Times New Roman";
	mso-ansi-font-weight:normal;
	mso-bidi-font-weight:bold;}
table.CuadrculaPersonalFirstCol
	{mso-style-name:"Cuadrícula Personal";
	mso-table-condition:first-column;
	mso-style-priority:62;
	mso-style-unhide:no;
	font-family:"Calibri",sans-serif;
	mso-ascii-font-family:Calibri;
	mso-fareast-font-family:"Times New Roman";
	mso-hansi-font-family:Calibri;
	mso-bidi-font-family:"Times New Roman";
	mso-ansi-font-weight:normal;
	mso-bidi-font-weight:bold;}
table.CuadrculaPersonalLastCol
	{mso-style-name:"Cuadrícula Personal";
	mso-table-condition:last-column;
	mso-style-priority:62;
	mso-style-unhide:no;
	mso-tstyle-border-top:1.0pt solid black;
	mso-tstyle-border-left:1.0pt solid black;
	mso-tstyle-border-bottom:1.0pt solid black;
	mso-tstyle-border-right:1.0pt solid black;
	font-family:"Calibri",sans-serif;
	mso-ascii-font-family:Calibri;
	mso-fareast-font-family:"Times New Roman";
	mso-hansi-font-family:Calibri;
	mso-bidi-font-family:"Times New Roman";
	mso-ansi-font-weight:normal;
	mso-bidi-font-weight:bold;}
table.CuadrculaPersonalOddColumn
	{mso-style-name:"Cuadrícula Personal";
	mso-table-condition:odd-column;
	mso-style-priority:62;
	mso-style-unhide:no;
	mso-tstyle-shading:#F2F2F2;}
table.CuadrculaPersonalEvenColumn
	{mso-style-name:"Cuadrícula Personal";
	mso-table-condition:even-column;
	mso-style-priority:62;
	mso-style-unhide:no;
	mso-tstyle-shading:#F2F2F2;}
table.CuadrculaPersonalOddRow
	{mso-style-name:"Cuadrícula Personal";
	mso-table-condition:odd-row;
	mso-style-priority:62;
	mso-style-unhide:no;
	mso-tstyle-shading:white;}
table.CuadrculaPersonalEvenRow
	{mso-style-name:"Cuadrícula Personal";
	mso-table-condition:even-row;
	mso-style-priority:62;
	mso-style-unhide:no;
	mso-tstyle-border-top:1.0pt solid black;
	mso-tstyle-border-left:1.0pt solid black;
	mso-tstyle-border-bottom:1.0pt solid black;
	mso-tstyle-border-right:1.0pt solid black;
	mso-tstyle-border-insidev:1.0pt solid black;}
</style>
<![endif]--><!--[if gte mso 9]><xml>
 <o:shapedefaults v:ext="edit" spidmax="2049"/>
</xml><![endif]--><!--[if gte mso 9]><xml>
 <o:shapelayout v:ext="edit">
  <o:idmap v:ext="edit" data="1"/>
 </o:shapelayout></xml><![endif]-->
</head>

<body lang=ES-CO style='tab-interval:36.0pt'>

<div class=WordSection1>

<p class=IOPTitle><span style='mso-ansi-language:ES-CO'>Medición de Consumo de Antimicrobianos
como parte de Programas de Uso Prudente de Antimicrobianos en Hospitales
Pediátricos<o:p></o:p></span></p>

<p class=IOPAuthor><span style='mso-ansi-language:ES-CO'>Parra Daniel S.<sup>1</sup><o:p></o:p></span></p>

<p class=IOPAff><sup><span style='mso-ansi-language:ES-CO'>1 </span></sup><span
style='mso-ansi-language:ES-CO'>Departamento de Farmacia, Universidad Nacional
de Colombia, Bogotá, Colombia<o:p></o:p></span></p>

<p class=IOPAff><span style='mso-ansi-language:ES-CO'><o:p>&nbsp;</o:p></span></p>

<p class=IOPAff><span style='mso-ansi-language:ES-CO'>E-mail:
dsparrag@unal.edu.co <o:p></o:p></span></p>

<p class=IOPAff><span style='mso-ansi-language:ES-CO'><o:p>&nbsp;</o:p></span></p>

<p class=IOPAff><span style='mso-ansi-language:ES-CO'>Recibido 09/07/2017<o:p></o:p></span></p>

<p class=IOPAff><span style='mso-ansi-language:ES-CO'>Aceptado para publicación
25/08/2018<o:p></o:p></span></p>

<p class=IOPAff><span style='mso-ansi-language:ES-CO'>Publicado 25/08/2018<o:p></o:p></span></p>

<p class=IOPH1><span style='mso-ansi-language:ES-CO'>Resumen<o:p></o:p></span></p>

<p class=IOPAbsText><span style='mso-ansi-language:ES-CO;mso-no-proof:yes'>Se
elaboró una revisión narrativa sobre indicadores de consumo de antimicrobianos
haciendo<o:p></o:p></span></p>

<p class=IOPAbsText><span style='mso-ansi-language:ES-CO;mso-no-proof:yes'>un énfasis
especial en estudios en pacientes pediátricos. Lo anterior con el fin de<o:p></o:p></span></p>

<p class=IOPAbsText><span style='mso-ansi-language:ES-CO;mso-no-proof:yes'>conocer
el mejor indicador a utilizar en un hospital pediátrico con el fin de vigilar
su uso de<o:p></o:p></span></p>

<p class=IOPAbsText><span style='mso-ansi-language:ES-CO;mso-no-proof:yes'>manera
más eficiente. Se encuentra en la literatura una gran cantidad de indicadores
disponibles previamente desarrollados. En una gran parte de estudios en niños
se ha reportado<o:p></o:p></span></p>

<p class=IOPAbsText><span style='mso-ansi-language:ES-CO;mso-no-proof:yes'>este
parámetro por medio de indicadores de duración. Se ha propuesto que el mejor<o:p></o:p></span></p>

<p class=IOPAbsText><span style='mso-ansi-language:ES-CO;mso-no-proof:yes'>indicador
para consumo de antimicrobianos es días de terapia frente al uso de dosis
diarias<o:p></o:p></span></p>

<p class=IOPAbsText><span lang=EN-US style='mso-ansi-language:EN-US;mso-no-proof:
yes'>definidas.<o:p></o:p></span></p>

<p class=IOPH1><span lang=EN-US style='mso-ansi-language:EN-US'>Abstract <o:p></o:p></span></p>

<p class=IOPAbsText><span lang=EN-US style='mso-ansi-language:EN-US;mso-no-proof:
yes'>A narrative review, about antimicrobial consumption indicators, was
developed with special<o:p></o:p></span></p>

<p class=IOPAbsText><span lang=EN-US style='mso-ansi-language:EN-US;mso-no-proof:
yes'>emphasis on studies of pediatric patients. In order to know the best
indicator of consumption<o:p></o:p></span></p>

<p class=IOPAbsText><span lang=EN-US style='mso-ansi-language:EN-US;mso-no-proof:
yes'>in a pediatric hospital, in order to monitor its use more efficiently. In
the literature, we<o:p></o:p></span></p>

<p class=IOPAbsText><span lang=EN-US style='mso-ansi-language:EN-US;mso-no-proof:
yes'>found a large number of indicators available. In part of studies in
children, this parameter<o:p></o:p></span></p>

<p class=IOPAbsText><span lang=EN-US style='mso-ansi-language:EN-US;mso-no-proof:
yes'>has been reported by means of duration indicators. It has been proposed
that the best<o:p></o:p></span></p>

<p class=IOPAbsText><span lang=EN-US style='mso-ansi-language:EN-US;mso-no-proof:
yes'>indicator for antimicrobial consumption in the days of therapy versus the
use of defined<o:p></o:p></span></p>

<p class=IOPAbsText><span style='mso-ansi-language:ES-CO;mso-no-proof:yes'>daily
doses.<o:p></o:p></span></p>

<div style='mso-element:para-border-div;border:none;border-bottom:solid windowtext 1.0pt;
mso-border-bottom-alt:solid windowtext .5pt;padding:0mm 0mm 1.0pt 0mm'>

<p class=IOPKwd><b style='mso-bidi-font-weight:normal'><span style='mso-ansi-language:
ES-CO'>Palabras clave</span></b><span style='mso-ansi-language:ES-CO'>: antibacterianos,
utilización de medicamentos, pediatría<o:p></o:p></span></p>

<p class=IOPKwd><span style='mso-ansi-language:ES-CO'><o:p>&nbsp;</o:p></span></p>

</div>

</div>

<span style='font-size:10.0pt;mso-bidi-font-size:11.0pt;line-height:107%;
font-family:"Times New Roman",serif;mso-fareast-font-family:Calibri;mso-fareast-theme-font:
minor-latin;mso-bidi-theme-font:minor-bidi;mso-ansi-language:ES-CO;mso-fareast-language:
EN-US;mso-bidi-language:AR-SA'><br clear=all style='page-break-before:auto;
mso-break-type:section-break'>
</span>

<div class=WordSection2>

<p class=IOPH1><span style='mso-ansi-language:ES-CO'>1. Introducción<o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0mm;margin-bottom:.0001pt;text-align:
justify;text-indent:11.35pt;tab-stops:191.4pt'><span lang=ES style='font-size:
10.0pt;line-height:107%;font-family:"Times New Roman",serif;mso-fareast-font-family:
Calibri;mso-ansi-language:ES'>El mundo se enfrenta a una crisis por la
resistencia bacteriana, debido a la mayor incidencia de enfermedades
infecciosas que afectan a la población humana que son intratables por los
agentes antimicrobianos disponibles </span><!--[if supportFields]><span
lang=ES style='font-size:10.0pt;line-height:107%;font-family:"Times New Roman",serif;
mso-fareast-font-family:Calibri;mso-ansi-language:ES'><span style='mso-element:
field-begin;mso-field-lock:yes'></span>ADDIN CSL_CITATION
{&quot;citationItems&quot;:[{&quot;id&quot;:&quot;ITEM-1&quot;,&quot;itemData&quot;:{&quot;DOI&quot;:&quot;10.3389/fpubh.2014.00145&quot;,&quot;ISBN&quot;:&quot;2296-2565&quot;,&quot;ISSN&quot;:&quot;2296-2565&quot;,&quot;PMID&quot;:&quot;25279369&quot;,&quot;abstract&quot;:&quot;The
Antimicrobial Resistance (AMR) crisis is the increasing global incidence of
infectious diseases affecting the human population, which are untreatable with
any known antimicrobial agent. This crisis will have a devastating cost on
human society as both debilitating and lethal diseases increase in frequency
and scope. Three major factors determine this crisis: 1/ The increasing
frequency of AMR phenotypes amongst microbes is an evolutionary response to the
widespread use of antimicrobials. 2/ The large and globally connected human
population allows pathogens in any environment access to all of humanity. 3/
The extensive and often unnecessary use of antimicrobials by humanity provides
the strong selective pressure that is driving the evolutionary response in the
microbial world. Of these factors, the size of the human population is least
amenable to rapid change. In contrast the remaining two factors may be
affected, so offering a means of managing the crisis: The rate at which AMR, as
well as virulence factors evolve in microbial world may be slowed by reducing
the applied selective pressure. This may be accomplished by radically reducing
the global use of current and prospective antimicrobials. Current management
measures to legislate the use of antimicrobials and to educate the healthcare
world in the issues, while useful, have not comprehensively addressed the
problem of achieving an overall reduction in the human use of antimicrobials.
We propose that in addition to current measures and increased research into new
antimicrobials and diagnostics, a comprehensive education programme will be
required to change the public paradigm of antimicrobial usage from that of a
first line treatment to that of a last resort when all other therapeutic
options have failed.&quot;,&quot;author&quot;:[{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Michael&quot;,&quot;given&quot;:&quot;Carolyn
Anne&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Dominey-Howes&quot;,&quot;given&quot;:&quot;Dale&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Labbate&quot;,&quot;given&quot;:&quot;Maurizio&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;}],&quot;container-title&quot;:&quot;Frontiers
in Public
Health&quot;,&quot;id&quot;:&quot;ITEM-1&quot;,&quot;issue&quot;:&quot;September&quot;,&quot;issued&quot;:{&quot;date-parts&quot;:[[&quot;2014&quot;]]},&quot;page&quot;:&quot;145&quot;,&quot;title&quot;:&quot;The
Antimicrobial Resistance Crisis: Causes, Consequences, and
Management&quot;,&quot;type&quot;:&quot;article-journal&quot;,&quot;volume&quot;:&quot;2&quot;},&quot;uris&quot;:[&quot;http://www.mendeley.com/documents/?uuid=6d83cde8-5be0-4d4c-baa4-0c44096ba887&quot;]}],&quot;mendeley&quot;:{&quot;formattedCitation&quot;:&quot;(1)&quot;,&quot;plainTextFormattedCitation&quot;:&quot;(1)&quot;,&quot;previouslyFormattedCitation&quot;:&quot;(1)&quot;},&quot;properties&quot;:{&quot;noteIndex&quot;:0},&quot;schema&quot;:&quot;https://github.com/citation-style-language/schema/raw/master/csl-citation.json&quot;}<span
style='mso-element:field-separator'></span></span><![endif]--><span lang=ES
style='font-size:10.0pt;line-height:107%;font-family:"Times New Roman",serif;
mso-fareast-font-family:Calibri;mso-ansi-language:ES'><span style='mso-no-proof:
yes'>(1)</span></span><!--[if supportFields]><span lang=ES style='font-size:
10.0pt;line-height:107%;font-family:"Times New Roman",serif;mso-fareast-font-family:
Calibri;mso-ansi-language:ES'><span style='mso-element:field-end'></span></span><![endif]--><span
lang=ES style='font-size:10.0pt;line-height:107%;font-family:"Times New Roman",serif;
mso-fareast-font-family:Calibri;mso-ansi-language:ES'>. Las consecuencias de
una era post-antibiótica tendrán fuertes impactos en la sociedad en términos de
vidas humanas, enfermedad y recursos gastados. Con el fin de manejar el
problema los gobiernos del mundo han desarrollado una serie de políticas que
tienen como objetivo buscar nuevas terapias o mejorar la utilización de los
antimicrobianos disponibles </span><!--[if supportFields]><span lang=ES
style='font-size:10.0pt;line-height:107%;font-family:"Times New Roman",serif;
mso-fareast-font-family:Calibri;mso-ansi-language:ES'><span style='mso-element:
field-begin;mso-field-lock:yes'></span>ADDIN CSL_CITATION
{&quot;citationItems&quot;:[{&quot;id&quot;:&quot;ITEM-1&quot;,&quot;itemData&quot;:{&quot;ISBN&quot;:&quot;9789295044609&quot;,&quot;ISSN&quot;:&quot;1098-6596&quot;,&quot;PMID&quot;:&quot;25246403&quot;,&quot;abstract&quot;:&quot;The
information in this report, or on which this report is based, has been obtained
from sources that the authors believe to be reliable and accurate. However, it
has not been independently verified and no representation or warranty, express
or implied, is made as to the accuracy or completeness of any information
obtained from third parties. In addition, the statements in this report may
provide current expectations of future events based on certain assumptions and
include any statement that does not directly relate to a historical fact or a
current fact. These statements involve known and unknown risks, uncertainties
and other factors which are not exhaustive. The companies contributing to this
report operate in a continually changing environment and new risks emerge
continually. Readers are cautioned not to place undue reliance on these statements.
The companies contributing to this report undertake no obligation to publicly
revise or update any statements, whether as a result of new information, future
events or otherwise and they shall in no event be liable for any loss or damage
arising in connection with the use of the information in this
report.&quot;,&quot;author&quot;:[{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;World
Economic Forum
(WEF)&quot;,&quot;given&quot;:&quot;&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;}],&quot;container-title&quot;:&quot;World
Economic Forum&quot;,&quot;id&quot;:&quot;ITEM-1&quot;,&quot;issued&quot;:{&quot;date-parts&quot;:[[&quot;2013&quot;]]},&quot;number-of-pages&quot;:&quot;80&quot;,&quot;title&quot;:&quot;Global
Risks Report 2013 Eighth
Edition&quot;,&quot;type&quot;:&quot;book&quot;},&quot;uris&quot;:[&quot;http://www.mendeley.com/documents/?uuid=74303c46-93e7-42a5-ae02-f94732474c1e&quot;]},{&quot;id&quot;:&quot;ITEM-2&quot;,&quot;itemData&quot;:{&quot;DOI&quot;:&quot;10.3389/fpubh.2014.00145&quot;,&quot;ISBN&quot;:&quot;2296-2565&quot;,&quot;ISSN&quot;:&quot;2296-2565&quot;,&quot;PMID&quot;:&quot;25279369&quot;,&quot;abstract&quot;:&quot;The
Antimicrobial Resistance (AMR) crisis is the increasing global incidence of
infectious diseases affecting the human population, which are untreatable with
any known antimicrobial agent. This crisis will have a devastating cost on
human society as both debilitating and lethal diseases increase in frequency
and scope. Three major factors determine this crisis: 1/ The increasing
frequency of AMR phenotypes amongst microbes is an evolutionary response to the
widespread use of antimicrobials. 2/ The large and globally connected human
population allows pathogens in any environment access to all of humanity. 3/
The extensive and often unnecessary use of antimicrobials by humanity provides
the strong selective pressure that is driving the evolutionary response in the
microbial world. Of these factors, the size of the human population is least
amenable to rapid change. In contrast the remaining two factors may be
affected, so offering a means of managing the crisis: The rate at which AMR, as
well as virulence factors evolve in microbial world may be slowed by reducing
the applied selective pressure. This may be accomplished by radically reducing
the global use of current and prospective antimicrobials. Current management
measures to legislate the use of antimicrobials and to educate the healthcare
world in the issues, while useful, have not comprehensively addressed the
problem of achieving an overall reduction in the human use of antimicrobials.
We propose that in addition to current measures and increased research into new
antimicrobials and diagnostics, a comprehensive education programme will be
required to change the public paradigm of antimicrobial usage from that of a
first line treatment to that of a last resort when all other therapeutic
options have
failed.&quot;,&quot;author&quot;:[{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Michael&quot;,&quot;given&quot;:&quot;Carolyn
Anne&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Dominey-Howes&quot;,&quot;given&quot;:&quot;Dale&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Labbate&quot;,&quot;given&quot;:&quot;Maurizio&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;}],&quot;container-title&quot;:&quot;Frontiers
in Public Health&quot;,&quot;id&quot;:&quot;ITEM-2&quot;,&quot;issue&quot;:&quot;September&quot;,&quot;issued&quot;:{&quot;date-parts&quot;:[[&quot;2014&quot;]]},&quot;page&quot;:&quot;145&quot;,&quot;title&quot;:&quot;The
Antimicrobial Resistance Crisis: Causes, Consequences, and
Management&quot;,&quot;type&quot;:&quot;article-journal&quot;,&quot;volume&quot;:&quot;2&quot;},&quot;uris&quot;:[&quot;http://www.mendeley.com/documents/?uuid=6d83cde8-5be0-4d4c-baa4-0c44096ba887&quot;]}],&quot;mendeley&quot;:{&quot;formattedCitation&quot;:&quot;(1,2)&quot;,&quot;plainTextFormattedCitation&quot;:&quot;(1,2)&quot;,&quot;previouslyFormattedCitation&quot;:&quot;(1,2)&quot;},&quot;properties&quot;:{&quot;noteIndex&quot;:0},&quot;schema&quot;:&quot;https://github.com/citation-style-language/schema/raw/master/csl-citation.json&quot;}<span
style='mso-element:field-separator'></span></span><![endif]--><span lang=ES
style='font-size:10.0pt;line-height:107%;font-family:"Times New Roman",serif;
mso-fareast-font-family:Calibri;mso-ansi-language:ES'><span style='mso-no-proof:
yes'>(1,2)</span></span><!--[if supportFields]><span lang=ES style='font-size:
10.0pt;line-height:107%;font-family:"Times New Roman",serif;mso-fareast-font-family:
Calibri;mso-ansi-language:ES'><span style='mso-element:field-end'></span></span><![endif]--><span
lang=ES style='font-size:10.0pt;line-height:107%;font-family:"Times New Roman",serif;
mso-fareast-font-family:Calibri;mso-ansi-language:ES'>.<o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0mm;margin-bottom:.0001pt;text-align:
justify;text-indent:11.35pt;tab-stops:191.4pt'><span lang=ES style='font-size:
10.0pt;line-height:107%;font-family:"Times New Roman",serif;mso-fareast-font-family:
Calibri;mso-ansi-language:ES'><o:p>&nbsp;</o:p></span></p>

<p class=MsoNormal style='margin-bottom:0mm;margin-bottom:.0001pt;text-align:
justify;text-indent:11.35pt;tab-stops:191.4pt'><span lang=ES style='font-size:
10.0pt;line-height:107%;font-family:"Times New Roman",serif;mso-fareast-font-family:
Calibri;mso-ansi-language:ES'>La intensidad en el uso de antibióticos se ha
identificado como un factor clave para la selección de resistencia </span><!--[if supportFields]><span
lang=ES style='font-size:10.0pt;line-height:107%;font-family:"Times New Roman",serif;
mso-fareast-font-family:Calibri;mso-ansi-language:ES'><span style='mso-element:
field-begin;mso-field-lock:yes'></span>ADDIN CSL_CITATION {&quot;citationItems&quot;:[{&quot;id&quot;:&quot;ITEM-1&quot;,&quot;itemData&quot;:{&quot;DOI&quot;:&quot;10.1007/s11908-999-0039-x&quot;,&quot;ISBN&quot;:&quot;1523-3847
(Print)\\r1523-3847&quot;,&quot;ISSN&quot;:&quot;1534-3146&quot;,&quot;PMID&quot;:&quot;11095806&quot;,&quot;abstract&quot;:&quot;Evidence
linking antimicrobial use with resistance is compelling on the local, national,
and international levels. That resistance levels can be influenced by changing
patterns of use also seems clear. We must now determine how, as a global
society, to best use the resource of antimicrobials and how to protect novel
compounds that are just now becoming available from emerging resistance. We
must act not only within the arena of human use but also on use in animals and
for
crops.&quot;,&quot;author&quot;:[{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Shlaes&quot;,&quot;given&quot;:&quot;D
M&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;}],&quot;container-title&quot;:&quot;Current
infectious disease
reports&quot;,&quot;id&quot;:&quot;ITEM-1&quot;,&quot;issue&quot;:&quot;4&quot;,&quot;issued&quot;:{&quot;date-parts&quot;:[[&quot;1999&quot;]]},&quot;page&quot;:&quot;334-337&quot;,&quot;title&quot;:&quot;Role
of Antimicrobial Stewardship in Prevention and Control of Antibiotic
Resistance.&quot;,&quot;type&quot;:&quot;article-journal&quot;,&quot;volume&quot;:&quot;1&quot;},&quot;uris&quot;:[&quot;http://www.mendeley.com/documents/?uuid=7c7dc36d-d361-42e9-967a-869cb0b6ce4a&quot;,&quot;http://www.mendeley.com/documents/?uuid=bd42774a-60af-4abc-8442-41bfa2ba18a7&quot;]}],&quot;mendeley&quot;:{&quot;formattedCitation&quot;:&quot;(3)&quot;,&quot;plainTextFormattedCitation&quot;:&quot;(3)&quot;,&quot;previouslyFormattedCitation&quot;:&quot;(3)&quot;},&quot;properties&quot;:{&quot;noteIndex&quot;:0},&quot;schema&quot;:&quot;https://github.com/citation-style-language/schema/raw/master/csl-citation.json&quot;}<span
style='mso-element:field-separator'></span></span><![endif]--><span lang=ES
style='font-size:10.0pt;line-height:107%;font-family:"Times New Roman",serif;
mso-fareast-font-family:Calibri;mso-ansi-language:ES'><span style='mso-no-proof:
yes'>(3)</span></span><!--[if supportFields]><span lang=ES style='font-size:
10.0pt;line-height:107%;font-family:"Times New Roman",serif;mso-fareast-font-family:
Calibri;mso-ansi-language:ES'><span style='mso-element:field-end'></span></span><![endif]--><span
lang=ES style='font-size:10.0pt;line-height:107%;font-family:"Times New Roman",serif;
mso-fareast-font-family:Calibri;mso-ansi-language:ES'>. La alta prevalencia de
resistencia en patógenos nosocomiales hace necesario mejorar el uso de
antimicrobianos en hospitales </span><!--[if supportFields]><span lang=ES
style='font-size:10.0pt;line-height:107%;font-family:"Times New Roman",serif;
mso-fareast-font-family:Calibri;mso-ansi-language:ES'><span style='mso-element:
field-begin;mso-field-lock:yes'></span>ADDIN CSL_CITATION
{&quot;citationItems&quot;:[{&quot;id&quot;:&quot;ITEM-1&quot;,&quot;itemData&quot;:{&quot;DOI&quot;:&quot;10.1378/chest.119.2&quot;,&quot;ISBN&quot;:&quot;0012-3692
(Print) 0012-3692 (Linking)&quot;,&quot;ISSN&quot;:&quot;00123692&quot;,&quot;PMID&quot;:&quot;11171776&quot;,&quot;abstract&quot;:&quot;Multiple
surveillance studies have demonstrated that resistance among prevalent
pathogens is increasing at an alarming rate, leading to greater patient
morbidity and mortality from nosocomial infections. Among Gram-positive
organisms, the most important resistant pathogens are methicillin-
(oxacillin-)resistant Staphylococcus aureus, beta-lactam-resistant and
multidrug-resistant pneumococci, and vancomycin-resistant enterococci.
Important causes of Gram-negative resistance include extended-spectrum
beta-lactamases (ESBLs) in Klebsiella pneumoniae, Escherichia coli, and Proteus
mirabilis, high-level third-generation cephalosporin (Amp C) beta-lactamase
resistance among Enterobacter species and Citrobacter freundii, and
multidrug-resistance genes observed in Pseudomonas aeruginosa, Acinetobacter,
and Stenotrophomonas maltophilia. In selecting an empiric treatment for a
nosocomial infection, one should consider the prevalent resistance patterns.
Antimicrobials used for the treatment of nosocomial infections should be
effective against any likely resistant pathogens and should not further promote
the development of resistance. Recent data suggest that because of ESBLs and
high-level amp C beta-lactamase resistances, use of third-generation
cephalosporins may be ineffective in many patients with nosocomial infections.
In addition, use of these agents may allow overgrowth of inherently resistant
enterococci. The role of fluoroquinolones in the empiric treatment of
nosocomial infections is also being limited by new resistance patterns and increasing
resistance levels. Available antimicrobials with good activity against many
resistant pathogens include the carbapenems, piperacillin/tazobactam, and
cefepime. In addition, several new agents with good activity against
Gram-positive organisms are in development or have been recently released.
Appropriate antimicrobial selection, surveillance systems, and effective
infection-control procedures are key partners in limiting
antimicrobial-resistant pathogen occurrence and
spread.&quot;,&quot;author&quot;:[{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Jones&quot;,&quot;given&quot;:&quot;R.
N.&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;}],&quot;container-title&quot;:&quot;Chest&quot;,&quot;id&quot;:&quot;ITEM-1&quot;,&quot;issue&quot;:&quot;2
SUPPL.&quot;,&quot;issued&quot;:{&quot;date-parts&quot;:[[&quot;2001&quot;]]},&quot;page&quot;:&quot;397S-404S&quot;,&quot;publisher&quot;:&quot;The
American College of Chest Physicians&quot;,&quot;title&quot;:&quot;Resistance
patterns among nosocomial pathogens: Trends over the past few
years&quot;,&quot;type&quot;:&quot;article-journal&quot;,&quot;volume&quot;:&quot;119&quot;},&quot;uris&quot;:[&quot;http://www.mendeley.com/documents/?uuid=5d597f57-ace4-4152-9f24-eedf745f8899&quot;]}],&quot;mendeley&quot;:{&quot;formattedCitation&quot;:&quot;(4)&quot;,&quot;plainTextFormattedCitation&quot;:&quot;(4)&quot;,&quot;previouslyFormattedCitation&quot;:&quot;(4)&quot;},&quot;properties&quot;:{&quot;noteIndex&quot;:0},&quot;schema&quot;:&quot;https://github.com/citation-style-language/schema/raw/master/csl-citation.json&quot;}<span
style='mso-element:field-separator'></span></span><![endif]--><span lang=ES
style='font-size:10.0pt;line-height:107%;font-family:"Times New Roman",serif;
mso-fareast-font-family:Calibri;mso-ansi-language:ES'><span style='mso-no-proof:
yes'>(4)</span></span><!--[if supportFields]><span lang=ES style='font-size:
10.0pt;line-height:107%;font-family:"Times New Roman",serif;mso-fareast-font-family:
Calibri;mso-ansi-language:ES'><span style='mso-element:field-end'></span></span><![endif]--><span
lang=ES style='font-size:10.0pt;line-height:107%;font-family:"Times New Roman",serif;
mso-fareast-font-family:Calibri;mso-ansi-language:ES'>. Esta perspectiva
impulsó el nacimiento de los programas de uso prudente de antimicrobianos en
hospitales. Estos programas que inicialmente se enfocaban en la prevención y
control de la resistencia </span><!--[if supportFields]><span lang=ES
style='font-size:10.0pt;line-height:107%;font-family:"Times New Roman",serif;
mso-fareast-font-family:Calibri;mso-ansi-language:ES'><span style='mso-element:
field-begin;mso-field-lock:yes'></span>ADDIN CSL_CITATION
{&quot;citationItems&quot;:[{&quot;id&quot;:&quot;ITEM-1&quot;,&quot;itemData&quot;:{&quot;abstract&quot;:&quot;Antimicrobial
resistance among some hospital organisms has increased to a stage where it can
no longer be tolerated. The need for preventive and corrective measures is
urgent. There is an association between the use of antimicrobial agents and
resistance that is likely causal. Alterations in antimicrobial usage have been
shown to affect antimicrobial resistance rates, particularly with use of
aminoglycosides. Efforts to improve antimicrobial use through educational
efforts alone have been largely ineffective, even when coupled with quality
management or clinical guideline aspects. Thus, further work is urgently needed
to determine the impact of antimicrobial-use controls. Additional large-scale,
well controlled trials of antimicrobial-use regulation employing sophisticated
epidemiologic methods, molecular biological organism typing, and precise
resistance mechanism analysis will be required to determine the best methods to
prevent and control this problem and ensure our optimal antimicrobial-use
\&quot;stewardship\&quot;; Consideration of the long-term effects of
antimicrobial selection, dosage, and duration of treatment on resistance
development should be a part of every antimicrobial treatment
decision.&quot;,&quot;author&quot;:[{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;McGowan&quot;,&quot;given&quot;:&quot;JE&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Gerding&quot;,&quot;given&quot;:&quot;DN&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;}],&quot;container-title&quot;:&quot;New
horizons (Baltimore,
Md.)&quot;,&quot;id&quot;:&quot;ITEM-1&quot;,&quot;issue&quot;:&quot;3&quot;,&quot;issued&quot;:{&quot;date-parts&quot;:[[&quot;1996&quot;]]},&quot;page&quot;:&quot;370-376&quot;,&quot;title&quot;:&quot;Does
antibiotic restriction prevent
resistance?&quot;,&quot;type&quot;:&quot;article-journal&quot;,&quot;volume&quot;:&quot;4&quot;},&quot;uris&quot;:[&quot;http://www.mendeley.com/documents/?uuid=f2dff63d-8f1d-471d-9fdd-c84d9392fdaf&quot;,&quot;http://www.mendeley.com/documents/?uuid=84bbced7-c910-41ab-b5a1-aadbb78121c7&quot;]},{&quot;id&quot;:&quot;ITEM-2&quot;,&quot;itemData&quot;:{&quot;DOI&quot;:&quot;10.1086/647610&quot;,&quot;ISBN&quot;:&quot;1058-4838&quot;,&quot;ISSN&quot;:&quot;1058-4838&quot;,&quot;PMID&quot;:&quot;9314444&quot;,&quot;abstract&quot;:&quot;Antimicrobial
resistance results in increased morbidity, mortality, and costs of health care,
Prevention of the emergence of resistance and the dissemination of resistant
microorganisms will reduce these adverse effects and their attendant costs.
Appropriate antimicrobial stewardship that includes optimal selection, dose,
and duration of treatment, as well as control of antibiotic use, will prevent
or slow the emergence of resistance among microorganisms. A comprehensively
applied infection control program will interdict the dissemination of resistant
strains.&quot;,&quot;author&quot;:[{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Shlaes&quot;,&quot;given&quot;:&quot;D
M&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Gerding&quot;,&quot;given&quot;:&quot;D
N&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;John&quot;,&quot;given&quot;:&quot;J
F&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Craig&quot;,&quot;given&quot;:&quot;W
A&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Bornstein&quot;,&quot;given&quot;:&quot;D
L&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Duncan&quot;,&quot;given&quot;:&quot;R
A&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Eckman&quot;,&quot;given&quot;:&quot;M
R&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Farrer&quot;,&quot;given&quot;:&quot;W
E&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Greene&quot;,&quot;given&quot;:&quot;W
H&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Lorian&quot;,&quot;given&quot;:&quot;V&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Levy&quot;,&quot;given&quot;:&quot;S&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;McGowan&quot;,&quot;given&quot;:&quot;J
E&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Paul&quot;,&quot;given&quot;:&quot;S
M&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Ruskin&quot;,&quot;given&quot;:&quot;J&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Tenover&quot;,&quot;given&quot;:&quot;F
C&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Watanakunakorn&quot;,&quot;given&quot;:&quot;C&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;}],&quot;container-title&quot;:&quot;Clinical
infectious
diseases&quot;,&quot;id&quot;:&quot;ITEM-2&quot;,&quot;issue&quot;:&quot;3&quot;,&quot;issued&quot;:{&quot;date-parts&quot;:[[&quot;1997&quot;]]},&quot;page&quot;:&quot;584-599&quot;,&quot;title&quot;:&quot;Society
for Healthcare Epidemiology of America and Infectious Diseases Society of
America Joint Committee on the Prevention of Antimicrobial Resistance:
Guidelines for the prevention of antimicrobial resistance in
hospitals&quot;,&quot;type&quot;:&quot;article-journal&quot;,&quot;volume&quot;:&quot;25&quot;},&quot;uris&quot;:[&quot;http://www.mendeley.com/documents/?uuid=71962e32-abab-4f47-ba68-18b07b5537a1&quot;,&quot;http://www.mendeley.com/documents/?uuid=93c5cd32-4c42-4a1c-82e8-b12f270769fb&quot;]}],&quot;mendeley&quot;:{&quot;formattedCitation&quot;:&quot;(5,6)&quot;,&quot;plainTextFormattedCitation&quot;:&quot;(5,6)&quot;,&quot;previouslyFormattedCitation&quot;:&quot;(5,6)&quot;},&quot;properties&quot;:{&quot;noteIndex&quot;:0},&quot;schema&quot;:&quot;https://github.com/citation-style-language/schema/raw/master/csl-citation.json&quot;}<span
style='mso-element:field-separator'></span></span><![endif]--><span lang=ES
style='font-size:10.0pt;line-height:107%;font-family:"Times New Roman",serif;
mso-fareast-font-family:Calibri;mso-ansi-language:ES'><span style='mso-no-proof:
yes'>(5,6)</span></span><!--[if supportFields]><span lang=ES style='font-size:
10.0pt;line-height:107%;font-family:"Times New Roman",serif;mso-fareast-font-family:
Calibri;mso-ansi-language:ES'><span style='mso-element:field-end'></span></span><![endif]--><span
lang=ES style='font-size:10.0pt;line-height:107%;font-family:"Times New Roman",serif;
mso-fareast-font-family:Calibri;mso-ansi-language:ES'>, en la actualidad
ofrecen un manejo de los desenlaces negativos asociados al uso de
antimicrobianos </span><!--[if supportFields]><span lang=ES style='font-size:
10.0pt;line-height:107%;font-family:"Times New Roman",serif;mso-fareast-font-family:
Calibri;mso-ansi-language:ES'><span style='mso-element:field-begin;mso-field-lock:
yes'></span>ADDIN CSL_CITATION
{&quot;citationItems&quot;:[{&quot;id&quot;:&quot;ITEM-1&quot;,&quot;itemData&quot;:{&quot;DOI&quot;:&quot;10.1097/IPC.0b013e318068b1c0&quot;,&quot;ISBN&quot;:&quot;1058-4838&quot;,&quot;ISSN&quot;:&quot;1056-9103&quot;,&quot;PMID&quot;:&quot;19046053&quot;,&quot;abstract&quot;:&quot;This
document presents guidelines for developing institutional programs to enhance
antimicrobial stewardship, an activity that includes appropriate selection,
dosing, route, and duration of antimicrobial therapy. The multifaceted nature
of antimicrobial stewardship has led to collaborative review and support of
these recommendations by the following organizations: American Academy of
Pediatrics, American Society of Health-System Pharmacists, Infectious Diseases
Society for Obstetrics and Gynecology, Pediatric Infectious Diseases Society,
Society for Hospital Medicine, and Society of Infectious Diseases Pharmacists.
The primary goal of antimicrobial stewardship is to optimize clinical outcomes
while minimizing unintended consequences of antimicrobial use, including
toxicity, the selection of pathogenic organisms (such as Clostridium
difficile), and the emergence of resistance. Thus, the appropriate use of
antimicrobials is an essential part of patient safety and deserves careful
oversight and guidance. Given the association between antimicrobial use and the
selection of resistant pathogens, the frequency of inappropriate antimicrobial
use is often used as a surrogate marker for the avoidable impact on
antimicrobial resistance. The combination of effective antimicrobial
stewardship with a comprehensive infection control program has been shown to
limit the emergence and transmission of antimicrobial-resistant bacteria. A
secondary goal of antimicrobial stewardship is to reduce health care costs
without adversely impacting quality of care. These guidelines focus on the
development of effective hospital-based stewardship programs and do not include
specific outpatient recommendations. Although judicious use of antimicrobials
is important in outpatient clinics and long-term care facilities, there are
very few data regarding effective interventions, and it is unclear which
interventions are most responsible for improvement in these settings. The
population targeted by these guidelines includes all patients in acute care
hospitals. Most of the evidence supporting the recommendations in these
guidelines is derived from studies of interventions to improve antimicrobial
use for hospitalized adults. Many of these studies have focused on adults in
intensive care units. Only a handful of studies have focused on hospitalized
newborns, children, and adolescents. Few studies have included substantial
populations of severely immunocompromised patients, such as patients
u…&quot;,&quot;author&quot;:[{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Dellit&quot;,&quot;given&quot;:&quot;Timothy
H&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Owens&quot;,&quot;given&quot;:&quot;Robert
C&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;MacGowan&quot;,&quot;given&quot;:&quot;John
E&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Hooton&quot;,&quot;given&quot;:&quot;Thomas
M&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Gerding&quot;,&quot;given&quot;:&quot;Dale
N&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Weinstein&quot;,&quot;given&quot;:&quot;Robert
A&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Burke&quot;,&quot;given&quot;:&quot;John
P&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Huskins&quot;,&quot;given&quot;:&quot;W.
Charles&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Paterson&quot;,&quot;given&quot;:&quot;David
L&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Fishman&quot;,&quot;given&quot;:&quot;&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;}],&quot;container-title&quot;:&quot;Clinical
infectious
diseases&quot;,&quot;id&quot;:&quot;ITEM-1&quot;,&quot;issue&quot;:&quot;1&quot;,&quot;issued&quot;:{&quot;date-parts&quot;:[[&quot;2007&quot;]]},&quot;page&quot;:&quot;159-77&quot;,&quot;title&quot;:&quot;Infectious
Diseases Society of America and Society for Healthcare Epidemiology of America
Guidelines for developing an institutional program to enhance antimicrobial
stewardship.&quot;,&quot;type&quot;:&quot;article-journal&quot;,&quot;volume&quot;:&quot;44&quot;},&quot;uris&quot;:[&quot;http://www.mendeley.com/documents/?uuid=7a3025d0-2045-40c0-a529-f6a71ba24063&quot;,&quot;http://www.mendeley.com/documents/?uuid=286f3c38-92ab-473c-bc79-97700c993c02&quot;]},{&quot;id&quot;:&quot;ITEM-2&quot;,&quot;itemData&quot;:{&quot;DOI&quot;:&quot;10.1093/cid/ciw217&quot;,&quot;ISBN&quot;:&quot;1058-4838&quot;,&quot;ISSN&quot;:&quot;15376591&quot;,&quot;PMID&quot;:&quot;27080992&quot;,&quot;abstract&quot;:&quot;Evidence-based
guidelines for implementation and measurement of antibiotic stewardship
interventions in inpatient populations including long-term care were prepared
by a multidisciplinary expert panel of the Infectious Diseases Society of
America and the Society for Healthcare Epidemiology of America. The panel
included clinicians and investigators representing internal medicine, emergency
medicine, microbiology, critical care, surgery, epidemiology, pharmacy, and
adult and pediatric infectious diseases specialties. These recommendations
address the best approaches for antibiotic stewardship programs to influence
the optimal use of antibiotics.&quot;,&quot;author&quot;:[{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Barlam&quot;,&quot;given&quot;:&quot;Tamar
F.&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Cosgrove&quot;,&quot;given&quot;:&quot;Sara
E.&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Abbo&quot;,&quot;given&quot;:&quot;Lilian
M.&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Macdougall&quot;,&quot;given&quot;:&quot;Conan&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Schuetz&quot;,&quot;given&quot;:&quot;Audrey
N.&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Septimus&quot;,&quot;given&quot;:&quot;Edward
J.&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Srinivasan&quot;,&quot;given&quot;:&quot;Arjun&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Dellit&quot;,&quot;given&quot;:&quot;Timothy
H.&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Falck-Ytter&quot;,&quot;given&quot;:&quot;Yngve
T.&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Fishman&quot;,&quot;given&quot;:&quot;Neil
O.&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Hamilton&quot;,&quot;given&quot;:&quot;Cindy
W.&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Jenkins&quot;,&quot;given&quot;:&quot;Timothy
C.&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Lipsett&quot;,&quot;given&quot;:&quot;Pamela
A.&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Malani&quot;,&quot;given&quot;:&quot;Preeti
N.&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;May&quot;,&quot;given&quot;:&quot;Larissa
S.&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Moran&quot;,&quot;given&quot;:&quot;Gregory
J.&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Neuhauser&quot;,&quot;given&quot;:&quot;Melinda
M.&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Newland&quot;,&quot;given&quot;:&quot;Jason
G.&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Ohl&quot;,&quot;given&quot;:&quot;Christopher
A.&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Samore&quot;,&quot;given&quot;:&quot;Matthew
H.&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Seo&quot;,&quot;given&quot;:&quot;Susan
K.&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Trivedi&quot;,&quot;given&quot;:&quot;Kavita
K.&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;}],&quot;container-title&quot;:&quot;Clinical
Infectious
Diseases&quot;,&quot;id&quot;:&quot;ITEM-2&quot;,&quot;issue&quot;:&quot;10&quot;,&quot;issued&quot;:{&quot;date-parts&quot;:[[&quot;2016&quot;]]},&quot;page&quot;:&quot;1197-1202&quot;,&quot;title&quot;:&quot;Executive
summary: Implementing an antibiotic stewardship program: Guidelines by the
infectious diseases society of America and the society for healthcare
epidemiology of America&quot;,&quot;type&quot;:&quot;article-journal&quot;,&quot;volume&quot;:&quot;62&quot;},&quot;uris&quot;:[&quot;http://www.mendeley.com/documents/?uuid=16106433-58f0-458c-9dea-0455a3026bbe&quot;]}],&quot;mendeley&quot;:{&quot;formattedCitation&quot;:&quot;(7,8)&quot;,&quot;plainTextFormattedCitation&quot;:&quot;(7,8)&quot;,&quot;previouslyFormattedCitation&quot;:&quot;(7,8)&quot;},&quot;properties&quot;:{&quot;noteIndex&quot;:0},&quot;schema&quot;:&quot;https://github.com/citation-style-language/schema/raw/master/csl-citation.json&quot;}<span
style='mso-element:field-separator'></span></span><![endif]--><span lang=ES
style='font-size:10.0pt;line-height:107%;font-family:"Times New Roman",serif;
mso-fareast-font-family:Calibri;mso-ansi-language:ES'><span style='mso-no-proof:
yes'>(7,8)</span></span><!--[if supportFields]><span lang=ES style='font-size:
10.0pt;line-height:107%;font-family:"Times New Roman",serif;mso-fareast-font-family:
Calibri;mso-ansi-language:ES'><span style='mso-element:field-end'></span></span><![endif]--><span
lang=ES style='font-size:10.0pt;line-height:107%;font-family:"Times New Roman",serif;
mso-fareast-font-family:Calibri;mso-ansi-language:ES'>. En la actualidad los
programas de uso prudente de antimicrobianos, también conocidos como </span><span
style='font-size:10.0pt;line-height:107%;font-family:"Times New Roman",serif;
mso-fareast-font-family:Calibri;mso-ansi-language:ES-CO'>antimicrobial
stewardship programs</span><span lang=ES style='font-size:10.0pt;line-height:
107%;font-family:"Times New Roman",serif;mso-fareast-font-family:Calibri;
mso-ansi-language:ES'> (ASP) constituyen esfuerzos para optimizar el uso de
antimicrobianos con la intención de mejorar los resultados clínicos de
pacientes con infecciones, minimizar los eventos adversos y garantizar la
utilización de tratamientos costo/efectivos </span><!--[if supportFields]><span
lang=ES style='font-size:10.0pt;line-height:107%;font-family:"Times New Roman",serif;
mso-fareast-font-family:Calibri;mso-ansi-language:ES'><span style='mso-element:
field-begin;mso-field-lock:yes'></span>ADDIN CSL_CITATION
{&quot;citationItems&quot;:[{&quot;id&quot;:&quot;ITEM-1&quot;,&quot;itemData&quot;:{&quot;DOI&quot;:&quot;10.1016/j.farma.2011.10.001&quot;,&quot;ISBN&quot;:&quot;0213-005X&quot;,&quot;ISSN&quot;:&quot;11306343&quot;,&quot;PMID&quot;:&quot;22137161&quot;,&quot;abstract&quot;:&quot;The
antimicrobial agents are unique drugs for several reasons. First, their
efficacy is higher than other drugs in terms of reduction of morbidity and
mortality. Also, antibiotics are the only group of drugs associated with
ecological effects, because their administration may contribute to the
emergence and spread of microbial resistance. Finally, they are used by almost
all medical specialties. Appropriate use of antimicrobials is very complex
because of the important advances in the management of infectious diseases and
the spread of antibiotic resistance. Thus, the implementation of programs for
optimizing the use of antibiotics in hospitals (called PROA in this document)
is necessary. This consensus document defines the objectives of the PROA
(namely, to improve the clinical results of patients with infections, to
minimise the adverse events associated to the use of antimicrobials including
the emergence and spread of antibiotic resistance, and to ensure the use of the
most cost-efficacious treatments), and provides recommendations for the
implementation of these programs in Spanish hospitals. The key aspects of the
recommendations are as follows. Multidisciplinary antibiotic teams should be
formed, under the auspices of the Infection Committees. The PROA need to be
considered as part of institutional programs and the strategic objectives of
the hospital. The PROA should include specific objectives based on measurable
indicators, and activities aimed at improving the use of antimicrobials, mainly
through educational activities and interventions based more on training
activities directed to prescribers than just on restrictive measures. ?? 2011
SEFH. Publicado por Elsevier Espa??a, S.L. Todos los derechos
reservados.&quot;,&quot;author&quot;:[{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Rodríguez-Baño&quot;,&quot;given&quot;:&quot;J.&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Paño-Pardo&quot;,&quot;given&quot;:&quot;J.
R.&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Alvarez-Rocha&quot;,&quot;given&quot;:&quot;L.&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Asensio&quot;,&quot;given&quot;:&quot;Ángel&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Calbo&quot;,&quot;given&quot;:&quot;E.&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Cercenado&quot;,&quot;given&quot;:&quot;E.&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Cisneros&quot;,&quot;given&quot;:&quot;J.
M.&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Cobo&quot;,&quot;given&quot;:&quot;J.&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Delgado&quot;,&quot;given&quot;:&quot;O.&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Garnacho-Montero&quot;,&quot;given&quot;:&quot;J.&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Grau&quot;,&quot;given&quot;:&quot;S.&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Horcajada&quot;,&quot;given&quot;:&quot;J.
P.&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Hornero&quot;,&quot;given&quot;:&quot;A.&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Murillas-Angoiti&quot;,&quot;given&quot;:&quot;J.&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Oliver&quot;,&quot;given&quot;:&quot;A.&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Padilla&quot;,&quot;given&quot;:&quot;B.&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Pasquau&quot;,&quot;given&quot;:&quot;J.&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Pujol&quot;,&quot;given&quot;:&quot;M.&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Ruiz-Garbajosa&quot;,&quot;given&quot;:&quot;P.&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;San
Juan&quot;,&quot;given&quot;:&quot;R.&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Sierra&quot;,&quot;given&quot;:&quot;R.&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;}],&quot;container-title&quot;:&quot;Farmacia
Hospitalaria&quot;,&quot;id&quot;:&quot;ITEM-1&quot;,&quot;issue&quot;:&quot;1&quot;,&quot;issued&quot;:{&quot;date-parts&quot;:[[&quot;2012&quot;]]},&quot;title&quot;:&quot;Programas
de optimización de uso de antimicrobianos (PROA) en hospitales españoles: documento
de consenso GEIH-SEIMC, SEFH y
SEMPSPH&quot;,&quot;type&quot;:&quot;article-journal&quot;,&quot;volume&quot;:&quot;36&quot;},&quot;uris&quot;:[&quot;http://www.mendeley.com/documents/?uuid=2062501e-4089-4809-94fa-a88c440072bf&quot;]}],&quot;mendeley&quot;:{&quot;formattedCitation&quot;:&quot;(9)&quot;,&quot;plainTextFormattedCitation&quot;:&quot;(9)&quot;,&quot;previouslyFormattedCitation&quot;:&quot;(9)&quot;},&quot;properties&quot;:{&quot;noteIndex&quot;:0},&quot;schema&quot;:&quot;https://github.com/citation-style-language/schema/raw/master/csl-citation.json&quot;}<span
style='mso-element:field-separator'></span></span><![endif]--><span lang=ES
style='font-size:10.0pt;line-height:107%;font-family:"Times New Roman",serif;
mso-fareast-font-family:Calibri;mso-ansi-language:ES'><span style='mso-no-proof:
yes'>(9)</span></span><!--[if supportFields]><span lang=ES style='font-size:
10.0pt;line-height:107%;font-family:"Times New Roman",serif;mso-fareast-font-family:
Calibri;mso-ansi-language:ES'><span style='mso-element:field-end'></span></span><![endif]--><span
lang=ES style='font-size:10.0pt;line-height:107%;font-family:"Times New Roman",serif;
mso-fareast-font-family:Calibri;mso-ansi-language:ES'>. <o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0mm;margin-bottom:.0001pt;text-align:
justify;text-indent:11.35pt;tab-stops:191.4pt'><span lang=ES style='font-size:
10.0pt;line-height:107%;font-family:"Times New Roman",serif;mso-fareast-font-family:
Calibri;mso-ansi-language:ES'><o:p>&nbsp;</o:p></span></p>

<p class=MsoNormal style='margin-bottom:0mm;margin-bottom:.0001pt;text-align:
justify;text-indent:11.35pt;tab-stops:191.4pt'><span lang=ES style='font-size:
10.0pt;line-height:107%;font-family:"Times New Roman",serif;mso-fareast-font-family:
Calibri;mso-ansi-language:ES'>El impacto de intervenciones provenientes de un
ASP debe ser evaluado puesto que se pueden tener algunas con efectos
redundantes, así como desfavorables </span><!--[if supportFields]><span
lang=ES style='font-size:10.0pt;line-height:107%;font-family:"Times New Roman",serif;
mso-fareast-font-family:Calibri;mso-ansi-language:ES'><span style='mso-element:
field-begin;mso-field-lock:yes'></span>ADDIN CSL_CITATION {&quot;citationItems&quot;:[{&quot;id&quot;:&quot;ITEM-1&quot;,&quot;itemData&quot;:{&quot;DOI&quot;:&quot;10.1080/14787210.2016.1178064&quot;,&quot;ISBN&quot;:&quot;1478-7210&quot;,&quot;ISSN&quot;:&quot;1744-8336
(Electronic)&quot;,&quot;PMID&quot;:&quot;27077229&quot;,&quot;abstract&quot;:&quot;Antimicrobial
Stewardship Programs (ASPs) are being implemented worldwide to optimize
antimicrobial therapy, and thereby improve patient safety and quality of care.
Additionally, this should counteract resistance development. It is, however,
vital that correct and timely diagnostics are performed in parallel, and that
an institution runs a well-organized infection prevention program. Currently,
there is no clear consensus on which interventions an ASP should comprise.
Indeed this depends on the institution, the region, and the patient population
that is served. Different interventions will lead to different effects.
Therefore, adequate evaluations, both clinically and financially, are crucial.
Here, we provide a general overview of, and perspective on different
intervention strategies and methods to evaluate these ASP programs, covering
before mentioned topics. This should lead to a more consistent approach in
evaluating these programs, making it easier to compare different interventions
and studies with each other and ultimately improve infection and patient
management.&quot;,&quot;author&quot;:[{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Dik&quot;,&quot;given&quot;:&quot;Jan-Willem
H.&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Hendrix&quot;,&quot;given&quot;:&quot;Ron&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Poelman&quot;,&quot;given&quot;:&quot;Randy&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Niesters&quot;,&quot;given&quot;:&quot;Hubert
G.&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Postma&quot;,&quot;given&quot;:&quot;Maarten
J.&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Sinha&quot;,&quot;given&quot;:&quot;Bhanu&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Friedrich&quot;,&quot;given&quot;:&quot;Alexander
W.&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;}],&quot;container-title&quot;:&quot;Expert
Review of Anti-Infective
Therapy&quot;,&quot;id&quot;:&quot;ITEM-1&quot;,&quot;issue&quot;:&quot;6&quot;,&quot;issued&quot;:{&quot;date-parts&quot;:[[&quot;2016&quot;]]},&quot;page&quot;:&quot;569-575&quot;,&quot;title&quot;:&quot;Measuring
the impact of antimicrobial stewardship programs&quot;,&quot;type&quot;:&quot;article-journal&quot;,&quot;volume&quot;:&quot;14&quot;},&quot;uris&quot;:[&quot;http://www.mendeley.com/documents/?uuid=64b39fec-edc7-41c8-a72f-1933c7de4ac7&quot;]}],&quot;mendeley&quot;:{&quot;formattedCitation&quot;:&quot;(10)&quot;,&quot;plainTextFormattedCitation&quot;:&quot;(10)&quot;,&quot;previouslyFormattedCitation&quot;:&quot;(10)&quot;},&quot;properties&quot;:{&quot;noteIndex&quot;:0},&quot;schema&quot;:&quot;https://github.com/citation-style-language/schema/raw/master/csl-citation.json&quot;}<span
style='mso-element:field-separator'></span></span><![endif]--><span lang=ES
style='font-size:10.0pt;line-height:107%;font-family:"Times New Roman",serif;
mso-fareast-font-family:Calibri;mso-ansi-language:ES'><span style='mso-no-proof:
yes'>(10)</span></span><!--[if supportFields]><span lang=ES style='font-size:
10.0pt;line-height:107%;font-family:"Times New Roman",serif;mso-fareast-font-family:
Calibri;mso-ansi-language:ES'><span style='mso-element:field-end'></span></span><![endif]--><span
lang=ES style='font-size:10.0pt;line-height:107%;font-family:"Times New Roman",serif;
mso-fareast-font-family:Calibri;mso-ansi-language:ES'>. La utilización excesiva
de antimicrobianos se ha relacionado con mayor posibilidad de presentación de
resultados negativos o indeseables asociados. El consumo de antimicrobianos se
ha utilizado ampliamente con el fin de medir el impacto de intervenciones. Sin
embargo, existen diversas formas de medir la misma con falta de estandarización
al respecto. En ciertas poblaciones especiales como pacientes pediátricos se
podrían tener sesgos importantes con el uso de algunos indicadores. La presente
revisión narrativa tiene como objetivo presentar diversas medidas de consumo de
antimicrobianos y realizar una comparación del desempeño de las mismas. <o:p></o:p></span></p>

<p class=IOPH1><span style='mso-ansi-language:ES-CO'>2. Medición de Consumo de
Antimicrobianos<o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0mm;margin-bottom:.0001pt;text-align:
justify;text-indent:11.35pt;line-height:105%'><span lang=ES style='font-size:
10.0pt;line-height:105%;font-family:"Times New Roman",serif;mso-fareast-font-family:
Calibri;mso-ansi-language:ES'>La evaluación de programas de uso seguro se hace
a través de indicadores de procesos y de resultados </span><!--[if supportFields]><span
lang=ES style='font-size:10.0pt;line-height:105%;font-family:"Times New Roman",serif;
mso-fareast-font-family:Calibri;mso-ansi-language:ES'><span style='mso-element:
field-begin;mso-field-lock:yes'></span>ADDIN CSL_CITATION {&quot;citationItems&quot;:[{&quot;id&quot;:&quot;ITEM-1&quot;,&quot;itemData&quot;:{&quot;DOI&quot;:&quot;10.1001/jama.260.12.1743&quot;,&quot;ISBN&quot;:&quot;0098-7484&quot;,&quot;ISSN&quot;:&quot;00987484&quot;,&quot;PMID&quot;:&quot;3045356&quot;,&quot;abstract&quot;:&quot;Before
assessment can begin we must decide how quality is to be defined and that
depends on whether one assesses only the performance of practitioners or also
the contributions of patients and of the health care system; on how broadly
health and responsibility for health are defined; on whether the maximally
effective or optimally effective care is sought; and on whether individual or
social preferences define the optimum. We also need detailed information about
the causal linkages among the structural attributes of the settings in which
care occurs, the processes of care, and the outcomes of care. Specifying the components
or outcomes of care to be sampled, formulating the appropriate criteria and
standards, and obtaining the necessary information are the steps that follow.
Though we know much about assessing quality, much remains to be
known.&quot;,&quot;author&quot;:[{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Donabedian&quot;,&quot;given&quot;:&quot;Avedis&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;}],&quot;container-title&quot;:&quot;JAMA
: the journal of the American Medical
Association&quot;,&quot;id&quot;:&quot;ITEM-1&quot;,&quot;issue&quot;:&quot;12&quot;,&quot;issued&quot;:{&quot;date-parts&quot;:[[&quot;1997&quot;]]},&quot;page&quot;:&quot;1743-1748&quot;,&quot;title&quot;:&quot;The
quality of care. How can it be
assessed?&quot;,&quot;type&quot;:&quot;article-journal&quot;,&quot;volume&quot;:&quot;260&quot;},&quot;uris&quot;:[&quot;http://www.mendeley.com/documents/?uuid=4f8b4b9f-c433-4c02-af7e-efda3454cc40&quot;,&quot;http://www.mendeley.com/documents/?uuid=f8209350-92f7-424e-81f5-c9ae034bf675&quot;]},{&quot;id&quot;:&quot;ITEM-2&quot;,&quot;itemData&quot;:{&quot;DOI&quot;:&quot;10.1097/IPC.0b013e318068b1c0&quot;,&quot;ISBN&quot;:&quot;1058-4838&quot;,&quot;ISSN&quot;:&quot;1056-9103&quot;,&quot;PMID&quot;:&quot;19046053&quot;,&quot;abstract&quot;:&quot;This
document presents guidelines for developing institutional programs to enhance
antimicrobial stewardship, an activity that includes appropriate selection,
dosing, route, and duration of antimicrobial therapy. The multifaceted nature
of antimicrobial stewardship has led to collaborative review and support of
these recommendations by the following organizations: American Academy of
Pediatrics, American Society of Health-System Pharmacists, Infectious Diseases
Society for Obstetrics and Gynecology, Pediatric Infectious Diseases Society,
Society for Hospital Medicine, and Society of Infectious Diseases Pharmacists.
The primary goal of antimicrobial stewardship is to optimize clinical outcomes
while minimizing unintended consequences of antimicrobial use, including
toxicity, the selection of pathogenic organisms (such as Clostridium
difficile), and the emergence of resistance. Thus, the appropriate use of
antimicrobials is an essential part of patient safety and deserves careful
oversight and guidance. Given the association between antimicrobial use and the
selection of resistant pathogens, the frequency of inappropriate antimicrobial
use is often used as a surrogate marker for the avoidable impact on
antimicrobial resistance. The combination of effective antimicrobial
stewardship with a comprehensive infection control program has been shown to
limit the emergence and transmission of antimicrobial-resistant bacteria. A
secondary goal of antimicrobial stewardship is to reduce health care costs
without adversely impacting quality of care. These guidelines focus on the
development of effective hospital-based stewardship programs and do not include
specific outpatient recommendations. Although judicious use of antimicrobials
is important in outpatient clinics and long-term care facilities, there are
very few data regarding effective interventions, and it is unclear which
interventions are most responsible for improvement in these settings. The
population targeted by these guidelines includes all patients in acute care
hospitals. Most of the evidence supporting the recommendations in these
guidelines is derived from studies of interventions to improve antimicrobial
use for hospitalized adults. Many of these studies have focused on adults in
intensive care units. Only a handful of studies have focused on hospitalized
newborns, children, and adolescents. Few studies have included substantial
populations of severely immunocompromised patients, such as patients
u…&quot;,&quot;author&quot;:[{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Dellit&quot;,&quot;given&quot;:&quot;Timothy
H&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Owens&quot;,&quot;given&quot;:&quot;Robert
C&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;MacGowan&quot;,&quot;given&quot;:&quot;John
E&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Hooton&quot;,&quot;given&quot;:&quot;Thomas
M&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Gerding&quot;,&quot;given&quot;:&quot;Dale
N&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Weinstein&quot;,&quot;given&quot;:&quot;Robert
A&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Burke&quot;,&quot;given&quot;:&quot;John
P&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Huskins&quot;,&quot;given&quot;:&quot;W.
Charles&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Paterson&quot;,&quot;given&quot;:&quot;David
L&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Fishman&quot;,&quot;given&quot;:&quot;&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;}],&quot;container-title&quot;:&quot;Clinical
infectious
diseases&quot;,&quot;id&quot;:&quot;ITEM-2&quot;,&quot;issue&quot;:&quot;1&quot;,&quot;issued&quot;:{&quot;date-parts&quot;:[[&quot;2007&quot;]]},&quot;page&quot;:&quot;159-77&quot;,&quot;title&quot;:&quot;Infectious
Diseases Society of America and Society for Healthcare Epidemiology of America
Guidelines for developing an institutional program to enhance antimicrobial
stewardship.&quot;,&quot;type&quot;:&quot;article-journal&quot;,&quot;volume&quot;:&quot;44&quot;},&quot;uris&quot;:[&quot;http://www.mendeley.com/documents/?uuid=286f3c38-92ab-473c-bc79-97700c993c02&quot;,&quot;http://www.mendeley.com/documents/?uuid=7a3025d0-2045-40c0-a529-f6a71ba24063&quot;]}],&quot;mendeley&quot;:{&quot;formattedCitation&quot;:&quot;(7,11)&quot;,&quot;plainTextFormattedCitation&quot;:&quot;(7,11)&quot;,&quot;previouslyFormattedCitation&quot;:&quot;(7,11)&quot;},&quot;properties&quot;:{&quot;noteIndex&quot;:0},&quot;schema&quot;:&quot;https://github.com/citation-style-language/schema/raw/master/csl-citation.json&quot;}<span
style='mso-element:field-separator'></span></span><![endif]--><span lang=ES
style='font-size:10.0pt;line-height:105%;font-family:"Times New Roman",serif;
mso-fareast-font-family:Calibri;mso-ansi-language:ES'><span style='mso-no-proof:
yes'>(7,11)</span></span><!--[if supportFields]><span lang=ES style='font-size:
10.0pt;line-height:105%;font-family:"Times New Roman",serif;mso-fareast-font-family:
Calibri;mso-ansi-language:ES'><span style='mso-element:field-end'></span></span><![endif]--><span
lang=ES style='font-size:10.0pt;line-height:105%;font-family:"Times New Roman",serif;
mso-fareast-font-family:Calibri;mso-ansi-language:ES'>. Los indicadores de
resultado se relacionan con el mejoramiento del estado de los pacientes, el
cual es un objetivo central en la atención en salud </span><!--[if supportFields]><span
lang=ES style='font-size:10.0pt;line-height:105%;font-family:"Times New Roman",serif;
mso-fareast-font-family:Calibri;mso-ansi-language:ES'><span style='mso-element:
field-begin;mso-field-lock:yes'></span>ADDIN CSL_CITATION
{&quot;citationItems&quot;:[{&quot;id&quot;:&quot;ITEM-1&quot;,&quot;itemData&quot;:{&quot;DOI&quot;:&quot;10.1016/j.idc.2014.01.006&quot;,&quot;ISBN&quot;:&quot;1557-9824;
0891-5520&quot;,&quot;ISSN&quot;:&quot;15579824&quot;,&quot;PMID&quot;:&quot;24857388&quot;,&quot;abstract&quot;:&quot;Measurement
of antimicrobial use before and after an intervention and the associated
outcomes are key activities of antimicrobial stewardship programs. In the
United States, the recommended metric for aggregate antibiotic use is days of
therapy/1000 patient-days. Clinical outcomes, including response to therapy and
bacterial resistance, are critical measures but are more difficult to document
than economic outcomes. Interhospital benchmarking of risk adjusted
antimicrobial use is possible, although several obstacles remain before it can
have an impact on patient care. Many challenges for stewardship programs
remain, but the methods and science to support their efforts are rapidly
evolving. ?? 2014 Elsevier
Inc.&quot;,&quot;author&quot;:[{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Ibrahim&quot;,&quot;given&quot;:&quot;Omar
M.&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Polk&quot;,&quot;given&quot;:&quot;Ron
E.&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;}],&quot;container-title&quot;:&quot;Infectious
Disease Clinics of North
America&quot;,&quot;id&quot;:&quot;ITEM-1&quot;,&quot;issue&quot;:&quot;2&quot;,&quot;issued&quot;:{&quot;date-parts&quot;:[[&quot;2014&quot;]]},&quot;page&quot;:&quot;195-214&quot;,&quot;publisher&quot;:&quot;Elsevier
Inc&quot;,&quot;title&quot;:&quot;Antimicrobial use metrics and benchmarking to
improve stewardship outcomes: Methodology, opportunities, and
challenges&quot;,&quot;type&quot;:&quot;article-journal&quot;,&quot;volume&quot;:&quot;28&quot;},&quot;uris&quot;:[&quot;http://www.mendeley.com/documents/?uuid=b5137c9a-a901-4403-ae77-72cac1becba4&quot;]}],&quot;mendeley&quot;:{&quot;formattedCitation&quot;:&quot;(12)&quot;,&quot;plainTextFormattedCitation&quot;:&quot;(12)&quot;,&quot;previouslyFormattedCitation&quot;:&quot;(12)&quot;},&quot;properties&quot;:{&quot;noteIndex&quot;:0},&quot;schema&quot;:&quot;https://github.com/citation-style-language/schema/raw/master/csl-citation.json&quot;}<span
style='mso-element:field-separator'></span></span><![endif]--><span lang=ES
style='font-size:10.0pt;line-height:105%;font-family:"Times New Roman",serif;
mso-fareast-font-family:Calibri;mso-ansi-language:ES'><span style='mso-no-proof:
yes'>(12)</span></span><!--[if supportFields]><span lang=ES style='font-size:
10.0pt;line-height:105%;font-family:"Times New Roman",serif;mso-fareast-font-family:
Calibri;mso-ansi-language:ES'><span style='mso-element:field-end'></span></span><![endif]--><span
lang=ES style='font-size:10.0pt;line-height:105%;font-family:"Times New Roman",serif;
mso-fareast-font-family:Calibri;mso-ansi-language:ES'>. Por tal se consideran
como indicadores primarios p. ej. eventos adversos a medicamentos, resistencia
bacteriana e infecciones por <i style='mso-bidi-font-style:normal'>C. difficile</i>.
Los indicadores de proceso como consumo de antibióticos y costos, se utilizan
como marcadores subrogados de los resultados en salud y suelen ser más fáciles
de medir que los indicadores de resultados. <o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0mm;margin-bottom:.0001pt;text-align:
justify;text-indent:11.35pt;line-height:105%'><span lang=ES style='font-size:
10.0pt;line-height:105%;font-family:"Times New Roman",serif;mso-fareast-font-family:
Calibri;mso-ansi-language:ES'><o:p>&nbsp;</o:p></span></p>

<p class=MsoNormal style='margin-bottom:0mm;margin-bottom:.0001pt;text-align:
justify;text-indent:11.35pt;line-height:105%'><span lang=ES style='font-size:
10.0pt;line-height:105%;font-family:"Times New Roman",serif;mso-fareast-font-family:
Calibri;mso-ansi-language:ES'>Los ASP deben hacer medición del consumo de
antimicrobianos, estratificado por antibiótico complementado con un análisis
con consumo total, por unidad y por servicio </span><!--[if supportFields]><span
lang=ES style='font-size:10.0pt;line-height:105%;font-family:"Times New Roman",serif;
mso-fareast-font-family:Calibri;mso-ansi-language:ES'><span style='mso-element:
field-begin;mso-field-lock:yes'></span>ADDIN CSL_CITATION
{&quot;citationItems&quot;:[{&quot;id&quot;:&quot;ITEM-1&quot;,&quot;itemData&quot;:{&quot;DOI&quot;:&quot;10.1093/cid/ciw217&quot;,&quot;ISBN&quot;:&quot;1058-4838&quot;,&quot;ISSN&quot;:&quot;15376591&quot;,&quot;PMID&quot;:&quot;27080992&quot;,&quot;abstract&quot;:&quot;Evidence-based
guidelines for implementation and measurement of antibiotic stewardship
interventions in inpatient populations including long-term care were prepared
by a multidisciplinary expert panel of the Infectious Diseases Society of
America and the Society for Healthcare Epidemiology of America. The panel
included clinicians and investigators representing internal medicine, emergency
medicine, microbiology, critical care, surgery, epidemiology, pharmacy, and
adult and pediatric infectious diseases specialties. These recommendations
address the best approaches for antibiotic stewardship programs to influence
the optimal use of antibiotics.&quot;,&quot;author&quot;:[{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Barlam&quot;,&quot;given&quot;:&quot;Tamar
F.&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Cosgrove&quot;,&quot;given&quot;:&quot;Sara
E.&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Abbo&quot;,&quot;given&quot;:&quot;Lilian
M.&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Macdougall&quot;,&quot;given&quot;:&quot;Conan&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Schuetz&quot;,&quot;given&quot;:&quot;Audrey
N.&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Septimus&quot;,&quot;given&quot;:&quot;Edward
J.&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Srinivasan&quot;,&quot;given&quot;:&quot;Arjun&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Dellit&quot;,&quot;given&quot;:&quot;Timothy
H.&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Falck-Ytter&quot;,&quot;given&quot;:&quot;Yngve
T.&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Fishman&quot;,&quot;given&quot;:&quot;Neil
O.&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Hamilton&quot;,&quot;given&quot;:&quot;Cindy
W.&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Jenkins&quot;,&quot;given&quot;:&quot;Timothy
C.&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Lipsett&quot;,&quot;given&quot;:&quot;Pamela
A.&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Malani&quot;,&quot;given&quot;:&quot;Preeti
N.&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;May&quot;,&quot;given&quot;:&quot;Larissa
S.&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Moran&quot;,&quot;given&quot;:&quot;Gregory
J.&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Neuhauser&quot;,&quot;given&quot;:&quot;Melinda
M.&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Newland&quot;,&quot;given&quot;:&quot;Jason
G.&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Ohl&quot;,&quot;given&quot;:&quot;Christopher
A.&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Samore&quot;,&quot;given&quot;:&quot;Matthew
H.&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Seo&quot;,&quot;given&quot;:&quot;Susan
K.&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Trivedi&quot;,&quot;given&quot;:&quot;Kavita
K.&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;}],&quot;container-title&quot;:&quot;Clinical
Infectious
Diseases&quot;,&quot;id&quot;:&quot;ITEM-1&quot;,&quot;issue&quot;:&quot;10&quot;,&quot;issued&quot;:{&quot;date-parts&quot;:[[&quot;2016&quot;]]},&quot;page&quot;:&quot;1197-1202&quot;,&quot;title&quot;:&quot;Executive
summary: Implementing an antibiotic stewardship program: Guidelines by the
infectious diseases society of America and the society for healthcare
epidemiology of America&quot;,&quot;type&quot;:&quot;article-journal&quot;,&quot;volume&quot;:&quot;62&quot;},&quot;uris&quot;:[&quot;http://www.mendeley.com/documents/?uuid=16106433-58f0-458c-9dea-0455a3026bbe&quot;]},{&quot;id&quot;:&quot;ITEM-2&quot;,&quot;itemData&quot;:{&quot;DOI&quot;:&quot;10.1097/IPC.0b013e318068b1c0&quot;,&quot;ISBN&quot;:&quot;1058-4838&quot;,&quot;ISSN&quot;:&quot;1056-9103&quot;,&quot;PMID&quot;:&quot;19046053&quot;,&quot;abstract&quot;:&quot;This
document presents guidelines for developing institutional programs to enhance
antimicrobial stewardship, an activity that includes appropriate selection,
dosing, route, and duration of antimicrobial therapy. The multifaceted nature
of antimicrobial stewardship has led to collaborative review and support of
these recommendations by the following organizations: American Academy of
Pediatrics, American Society of Health-System Pharmacists, Infectious Diseases
Society for Obstetrics and Gynecology, Pediatric Infectious Diseases Society,
Society for Hospital Medicine, and Society of Infectious Diseases Pharmacists.
The primary goal of antimicrobial stewardship is to optimize clinical outcomes
while minimizing unintended consequences of antimicrobial use, including
toxicity, the selection of pathogenic organisms (such as Clostridium
difficile), and the emergence of resistance. Thus, the appropriate use of
antimicrobials is an essential part of patient safety and deserves careful
oversight and guidance. Given the association between antimicrobial use and the
selection of resistant pathogens, the frequency of inappropriate antimicrobial
use is often used as a surrogate marker for the avoidable impact on
antimicrobial resistance. The combination of effective antimicrobial
stewardship with a comprehensive infection control program has been shown to
limit the emergence and transmission of antimicrobial-resistant bacteria. A
secondary goal of antimicrobial stewardship is to reduce health care costs
without adversely impacting quality of care. These guidelines focus on the
development of effective hospital-based stewardship programs and do not include
specific outpatient recommendations. Although judicious use of antimicrobials
is important in outpatient clinics and long-term care facilities, there are
very few data regarding effective interventions, and it is unclear which
interventions are most responsible for improvement in these settings. The
population targeted by these guidelines includes all patients in acute care
hospitals. Most of the evidence supporting the recommendations in these
guidelines is derived from studies of interventions to improve antimicrobial
use for hospitalized adults. Many of these studies have focused on adults in
intensive care units. Only a handful of studies have focused on hospitalized newborns,
children, and adolescents. Few studies have included substantial populations of
severely immunocompromised patients, such as patients
u…&quot;,&quot;author&quot;:[{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Dellit&quot;,&quot;given&quot;:&quot;Timothy
H&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Owens&quot;,&quot;given&quot;:&quot;Robert
C&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;MacGowan&quot;,&quot;given&quot;:&quot;John
E&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Hooton&quot;,&quot;given&quot;:&quot;Thomas
M&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Gerding&quot;,&quot;given&quot;:&quot;Dale
N&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Weinstein&quot;,&quot;given&quot;:&quot;Robert
A&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Burke&quot;,&quot;given&quot;:&quot;John
P&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Huskins&quot;,&quot;given&quot;:&quot;W.
Charles&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Paterson&quot;,&quot;given&quot;:&quot;David
L&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Fishman&quot;,&quot;given&quot;:&quot;&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;}],&quot;container-title&quot;:&quot;Clinical
infectious diseases&quot;,&quot;id&quot;:&quot;ITEM-2&quot;,&quot;issue&quot;:&quot;1&quot;,&quot;issued&quot;:{&quot;date-parts&quot;:[[&quot;2007&quot;]]},&quot;page&quot;:&quot;159-77&quot;,&quot;title&quot;:&quot;Infectious
Diseases Society of America and Society for Healthcare Epidemiology of America
Guidelines for developing an institutional program to enhance antimicrobial
stewardship.&quot;,&quot;type&quot;:&quot;article-journal&quot;,&quot;volume&quot;:&quot;44&quot;},&quot;uris&quot;:[&quot;http://www.mendeley.com/documents/?uuid=286f3c38-92ab-473c-bc79-97700c993c02&quot;,&quot;http://www.mendeley.com/documents/?uuid=7a3025d0-2045-40c0-a529-f6a71ba24063&quot;,&quot;http://www.mendeley.com/documents/?uuid=9d413de4-3874-4e2b-8774-2b12ac1c82ef&quot;]}],&quot;mendeley&quot;:{&quot;formattedCitation&quot;:&quot;(7,8)&quot;,&quot;plainTextFormattedCitation&quot;:&quot;(7,8)&quot;,&quot;previouslyFormattedCitation&quot;:&quot;(7,8)&quot;},&quot;properties&quot;:{&quot;noteIndex&quot;:0},&quot;schema&quot;:&quot;https://github.com/citation-style-language/schema/raw/master/csl-citation.json&quot;}<span
style='mso-element:field-separator'></span></span><![endif]--><span lang=ES
style='font-size:10.0pt;line-height:105%;font-family:"Times New Roman",serif;
mso-fareast-font-family:Calibri;mso-ansi-language:ES'><span style='mso-no-proof:
yes'>(7,8)</span></span><!--[if supportFields]><span lang=ES style='font-size:
10.0pt;line-height:105%;font-family:"Times New Roman",serif;mso-fareast-font-family:
Calibri;mso-ansi-language:ES'><span style='mso-element:field-end'></span></span><![endif]--><span
lang=ES style='font-size:10.0pt;line-height:105%;font-family:"Times New Roman",serif;
mso-fareast-font-family:Calibri;mso-ansi-language:ES'>. Más aún, se debe hacer
seguimiento de las tendencias de consumo con el fin de estandarizar y conocer
valores de referencia internos. Así como hacer benchmarking o comparación
estandarizada entre instituciones con el fin de hacer mejoramiento de la
calidad </span><!--[if supportFields]><span lang=ES style='font-size:10.0pt;
line-height:105%;font-family:"Times New Roman",serif;mso-fareast-font-family:
Calibri;mso-ansi-language:ES'><span style='mso-element:field-begin;mso-field-lock:
yes'></span>ADDIN CSL_CITATION
{&quot;citationItems&quot;:[{&quot;id&quot;:&quot;ITEM-1&quot;,&quot;itemData&quot;:{&quot;abstract&quot;:&quot;Three
major trends in antibiotic use in US hospitals have emerged over the last few
years: antibiotics as quality metrics, persistent use of different measures of
antibiotic consumption and the emergence of antibiotic stewardship programs.
Compared with Europe, where approaches are heterogeneous but generally
consistent, the USA currently lacks the infrastructure to monitor antibiotic
resistance and antibiotic consumption locally. Both have implemented
programmatic strategies for prudent antibiotic use. The USA appears to have
implemented processes more systematically to measure the quality of antibiotic
use.&quot;,&quot;author&quot;:[{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Jacob&quot;,&quot;given&quot;:&quot;J
T&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Gaynes&quot;,&quot;given&quot;:&quot;RP&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;}],&quot;container-title&quot;:&quot;Expert
Review of Anti-infective Therapy&quot;,&quot;id&quot;:&quot;ITEM-1&quot;,&quot;issue&quot;:&quot;8&quot;,&quot;issued&quot;:{&quot;date-parts&quot;:[[&quot;2010&quot;]]},&quot;page&quot;:&quot;893-902&quot;,&quot;title&quot;:&quot;Emerging
trends in antibiotic use in US hospitals: quality, quantification and
stewardship&quot;,&quot;type&quot;:&quot;article-journal&quot;,&quot;volume&quot;:&quot;8&quot;},&quot;uris&quot;:[&quot;http://www.mendeley.com/documents/?uuid=e3592e4a-9766-47be-a9d6-3c8792716d6f&quot;,&quot;http://www.mendeley.com/documents/?uuid=67b411c4-1309-4ba8-a3d3-e6c41e656b01&quot;]}],&quot;mendeley&quot;:{&quot;formattedCitation&quot;:&quot;(13)&quot;,&quot;plainTextFormattedCitation&quot;:&quot;(13)&quot;,&quot;previouslyFormattedCitation&quot;:&quot;(13)&quot;},&quot;properties&quot;:{&quot;noteIndex&quot;:0},&quot;schema&quot;:&quot;https://github.com/citation-style-language/schema/raw/master/csl-citation.json&quot;}<span
style='mso-element:field-separator'></span></span><![endif]--><span lang=ES
style='font-size:10.0pt;line-height:105%;font-family:"Times New Roman",serif;
mso-fareast-font-family:Calibri;mso-ansi-language:ES'><span style='mso-no-proof:
yes'>(13)</span></span><!--[if supportFields]><span lang=ES style='font-size:
10.0pt;line-height:105%;font-family:"Times New Roman",serif;mso-fareast-font-family:
Calibri;mso-ansi-language:ES'><span style='mso-element:field-end'></span></span><![endif]--><span
lang=ES style='font-size:10.0pt;line-height:105%;font-family:"Times New Roman",serif;
mso-fareast-font-family:Calibri;mso-ansi-language:ES'>. Lo anterior teniendo en
cuenta las limitaciones en las comparaciones y la necesidad potencial de
ajustes de riesgo </span><!--[if supportFields]><span lang=ES style='font-size:
10.0pt;line-height:105%;font-family:"Times New Roman",serif;mso-fareast-font-family:
Calibri;mso-ansi-language:ES'><span style='mso-element:field-begin;mso-field-lock:
yes'></span>ADDIN CSL_CITATION
{&quot;citationItems&quot;:[{&quot;id&quot;:&quot;ITEM-1&quot;,&quot;itemData&quot;:{&quot;DOI&quot;:&quot;10.1097/IPC.0b013e318068b1c0&quot;,&quot;ISBN&quot;:&quot;1058-4838&quot;,&quot;ISSN&quot;:&quot;1056-9103&quot;,&quot;PMID&quot;:&quot;19046053&quot;,&quot;abstract&quot;:&quot;This
document presents guidelines for developing institutional programs to enhance
antimicrobial stewardship, an activity that includes appropriate selection,
dosing, route, and duration of antimicrobial therapy. The multifaceted nature
of antimicrobial stewardship has led to collaborative review and support of
these recommendations by the following organizations: American Academy of
Pediatrics, American Society of Health-System Pharmacists, Infectious Diseases
Society for Obstetrics and Gynecology, Pediatric Infectious Diseases Society,
Society for Hospital Medicine, and Society of Infectious Diseases Pharmacists.
The primary goal of antimicrobial stewardship is to optimize clinical outcomes
while minimizing unintended consequences of antimicrobial use, including
toxicity, the selection of pathogenic organisms (such as Clostridium
difficile), and the emergence of resistance. Thus, the appropriate use of
antimicrobials is an essential part of patient safety and deserves careful
oversight and guidance. Given the association between antimicrobial use and the
selection of resistant pathogens, the frequency of inappropriate antimicrobial
use is often used as a surrogate marker for the avoidable impact on
antimicrobial resistance. The combination of effective antimicrobial
stewardship with a comprehensive infection control program has been shown to
limit the emergence and transmission of antimicrobial-resistant bacteria. A
secondary goal of antimicrobial stewardship is to reduce health care costs
without adversely impacting quality of care. These guidelines focus on the
development of effective hospital-based stewardship programs and do not include
specific outpatient recommendations. Although judicious use of antimicrobials
is important in outpatient clinics and long-term care facilities, there are
very few data regarding effective interventions, and it is unclear which
interventions are most responsible for improvement in these settings. The
population targeted by these guidelines includes all patients in acute care
hospitals. Most of the evidence supporting the recommendations in these
guidelines is derived from studies of interventions to improve antimicrobial
use for hospitalized adults. Many of these studies have focused on adults in
intensive care units. Only a handful of studies have focused on hospitalized
newborns, children, and adolescents. Few studies have included substantial
populations of severely immunocompromised patients, such as patients
u…&quot;,&quot;author&quot;:[{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Dellit&quot;,&quot;given&quot;:&quot;Timothy
H&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Owens&quot;,&quot;given&quot;:&quot;Robert
C&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;MacGowan&quot;,&quot;given&quot;:&quot;John
E&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Hooton&quot;,&quot;given&quot;:&quot;Thomas
M&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Gerding&quot;,&quot;given&quot;:&quot;Dale
N&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Weinstein&quot;,&quot;given&quot;:&quot;Robert
A&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Burke&quot;,&quot;given&quot;:&quot;John
P&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Huskins&quot;,&quot;given&quot;:&quot;W.
Charles&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Paterson&quot;,&quot;given&quot;:&quot;David
L&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Fishman&quot;,&quot;given&quot;:&quot;&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;}],&quot;container-title&quot;:&quot;Clinical
infectious
diseases&quot;,&quot;id&quot;:&quot;ITEM-1&quot;,&quot;issue&quot;:&quot;1&quot;,&quot;issued&quot;:{&quot;date-parts&quot;:[[&quot;2007&quot;]]},&quot;page&quot;:&quot;159-77&quot;,&quot;title&quot;:&quot;Infectious
Diseases Society of America and Society for Healthcare Epidemiology of America
Guidelines for developing an institutional program to enhance antimicrobial
stewardship.&quot;,&quot;type&quot;:&quot;article-journal&quot;,&quot;volume&quot;:&quot;44&quot;},&quot;uris&quot;:[&quot;http://www.mendeley.com/documents/?uuid=286f3c38-92ab-473c-bc79-97700c993c02&quot;,&quot;http://www.mendeley.com/documents/?uuid=7a3025d0-2045-40c0-a529-f6a71ba24063&quot;]}],&quot;mendeley&quot;:{&quot;formattedCitation&quot;:&quot;(7)&quot;,&quot;plainTextFormattedCitation&quot;:&quot;(7)&quot;,&quot;previouslyFormattedCitation&quot;:&quot;(7)&quot;},&quot;properties&quot;:{&quot;noteIndex&quot;:0},&quot;schema&quot;:&quot;https://github.com/citation-style-language/schema/raw/master/csl-citation.json&quot;}<span
style='mso-element:field-separator'></span></span><![endif]--><span lang=ES
style='font-size:10.0pt;line-height:105%;font-family:"Times New Roman",serif;
mso-fareast-font-family:Calibri;mso-ansi-language:ES'><span style='mso-no-proof:
yes'>(7)</span></span><!--[if supportFields]><span lang=ES style='font-size:
10.0pt;line-height:105%;font-family:"Times New Roman",serif;mso-fareast-font-family:
Calibri;mso-ansi-language:ES'><span style='mso-element:field-end'></span></span><![endif]--><span
lang=ES style='font-size:10.0pt;line-height:105%;font-family:"Times New Roman",serif;
mso-fareast-font-family:Calibri;mso-ansi-language:ES'>.<o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0mm;margin-bottom:.0001pt;text-align:
justify;text-indent:11.35pt;line-height:105%'><span lang=ES style='font-size:
10.0pt;line-height:105%;font-family:"Times New Roman",serif;mso-fareast-font-family:
Calibri;mso-ansi-language:ES'><o:p>&nbsp;</o:p></span></p>

<p class=MsoNormal style='margin-bottom:0mm;margin-bottom:.0001pt;text-align:
justify;text-indent:11.35pt;line-height:105%'><span lang=ES style='font-size:
10.0pt;line-height:105%;font-family:"Times New Roman",serif;mso-fareast-font-family:
Calibri;mso-ansi-language:ES'>Los indicadores actúan como punto de partida para
el mejoramiento continuo y se establecen como estímulos para el cambio </span><!--[if supportFields]><span
lang=ES style='font-size:10.0pt;line-height:105%;font-family:"Times New Roman",serif;
mso-fareast-font-family:Calibri;mso-ansi-language:ES'><span style='mso-element:
field-begin;mso-field-lock:yes'></span>ADDIN CSL_CITATION
{&quot;citationItems&quot;:[{&quot;id&quot;:&quot;ITEM-1&quot;,&quot;itemData&quot;:{&quot;DOI&quot;:&quot;10.1093/jac/dkh362&quot;,&quot;ISSN&quot;:&quot;03057453&quot;,&quot;PMID&quot;:&quot;15269192&quot;,&quot;abstract&quot;:&quot;OBJECTIVES:
To compare the recognized defined daily dose per 100 bed-days (DDD/100
bed-days) measure with the defined daily dose per finished consultant episode
(DDD/FCE) in a group of hospitals with a variety of medicines management strategies.
To compare antibiotic usage using the above indicators in hospitals with and
without electronic prescribing systems.\\n\\nMETHODS: Twelve hospitals were
used in the study. Nine hospitals were selected and split into three cohorts
(three high-scoring, three medium-scoring and three low-scoring) by their 2001
medicines management self-assessment scores (MMAS). An additional cohort of
three electronic prescribing hospitals was included for comparison. MMAS were
compared to antibiotic management scores (AMS) developed from a questionnaire
relating specifically to control of antibiotics. FCEs and occupied bed-days
were obtained from published statistics and statistical analyses of the DDD/100
bed-days and DDD/FCE were carried out using SPSS.\\n\\nRESULTS: The DDD/100 bed-days
varied from 81.33 to 189.37 whilst the DDD/FCE varied from 2.88 to 7.43. The
two indicators showed a high degree of correlation with r=0.74. MMAS were from
9 to 22 (possible range 0-23) and the AMS from 2 to 13 (possible range 0-22).
The two scores showed a high degree of correlation with r=0.74. No correlation
was established between either indicator and either score.\\n\\nCONCLUSIONS:
The WHO indicator for medicines utilization, DDD/100 bed-days, exhibited the
same level of conformity as that exhibited from the use of the DDD/FCE
indicating that the DDD/FCE is a useful additional indicator for identifying
hospitals which require further study. The MMAS can be assumed to be an
accurate guide to antibiotic medicines management controls. No relationship has
been found between a high degree of medicines management control and the
quantity of antibiotic
prescribed.&quot;,&quot;author&quot;:[{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Curtis&quot;,&quot;given&quot;:&quot;Chris&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Marriott&quot;,&quot;given&quot;:&quot;John&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Langley&quot;,&quot;given&quot;:&quot;Chris&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;}],&quot;container-title&quot;:&quot;Journal
of Antimicrobial
Chemotherapy&quot;,&quot;id&quot;:&quot;ITEM-1&quot;,&quot;issue&quot;:&quot;2&quot;,&quot;issued&quot;:{&quot;date-parts&quot;:[[&quot;2004&quot;]]},&quot;page&quot;:&quot;529-533&quot;,&quot;title&quot;:&quot;Development
of a prescribing indicator for objective quantification of antibiotic usage in
secondary
care&quot;,&quot;type&quot;:&quot;article-journal&quot;,&quot;volume&quot;:&quot;54&quot;},&quot;uris&quot;:[&quot;http://www.mendeley.com/documents/?uuid=56ade435-5272-484d-a755-449440685d4b&quot;]}],&quot;mendeley&quot;:{&quot;formattedCitation&quot;:&quot;(14)&quot;,&quot;plainTextFormattedCitation&quot;:&quot;(14)&quot;,&quot;previouslyFormattedCitation&quot;:&quot;(14)&quot;},&quot;properties&quot;:{&quot;noteIndex&quot;:0},&quot;schema&quot;:&quot;https://github.com/citation-style-language/schema/raw/master/csl-citation.json&quot;}<span
style='mso-element:field-separator'></span></span><![endif]--><span lang=ES
style='font-size:10.0pt;line-height:105%;font-family:"Times New Roman",serif;
mso-fareast-font-family:Calibri;mso-ansi-language:ES'><span style='mso-no-proof:
yes'>(14)</span></span><!--[if supportFields]><span lang=ES style='font-size:
10.0pt;line-height:105%;font-family:"Times New Roman",serif;mso-fareast-font-family:
Calibri;mso-ansi-language:ES'><span style='mso-element:field-end'></span></span><![endif]--><span
lang=ES style='font-size:10.0pt;line-height:105%;font-family:"Times New Roman",serif;
mso-fareast-font-family:Calibri;mso-ansi-language:ES'>. Las comparaciones
interhospitalarias, por medio de benchmarking, permiten la definición de
valores de referencia de consumo de antimicrobianos que deben ser tenidos en
cuenta entre instituciones similares. En la realización benchmarking con datos
de consumo se tienen dificultades por el uso de diversos métodos de medición,
así como la falta de </span><span style='font-size:10.0pt;line-height:105%;
font-family:"Times New Roman",serif;mso-fareast-font-family:Calibri;mso-ansi-language:
ES-CO'>provisión de información metodológica esencial </span><!--[if supportFields]><span
lang=ES style='font-size:10.0pt;line-height:105%;font-family:"Times New Roman",serif;
mso-fareast-font-family:Calibri;mso-ansi-language:ES'><span style='mso-element:
field-begin;mso-field-lock:yes'></span>ADDIN CSL_CITATION
{&quot;citationItems&quot;:[{&quot;id&quot;:&quot;ITEM-1&quot;,&quot;itemData&quot;:{&quot;DOI&quot;:&quot;10.1007/s15010-008-7462-z&quot;,&quot;ISBN&quot;:&quot;03008126&quot;,&quot;ISSN&quot;:&quot;03008126&quot;,&quot;PMID&quot;:&quot;19011740&quot;,&quot;abstract&quot;:&quot;Reports
on antibiotic use often lack complete definitions of the units of measurement,
hampering the comparison of data between hospitals or hospital units. To
compare methods of measures of in-hospital antimicrobial use, we determined
aggregate in-hospital consumption data at a tertiary care university hospital
using variations of nominators and denominators. Means of defined daily doses
(DDD) of individual antimicrobials per 100 bed-days and per 100 admissions at
each hospital and intensive care unit (ICU) were calculated. Furthermore, a
literature review was performed for benchmarking purposes. Antibiotic use in
different hospital units ranged from 0.105 to 323.37 DDD/100 bed-days and from
4.23 to 6737.92 DDD/100 admissions, respectively. Including the day of
discharge in the denominator 'bed-days' underestimated antibiotic use in
various hospital wards by up to 27.7 DDD/100 bed-days (26.0%). Equating
'numbers of patients admitted to the hospital' and 'numbers of admissions' on a
hospital level resulted in a difference of 192.6 DDD/100 admissions (64%)
because patients transferred between hospital units accounted for multiple admissions.
Likewise, reporting antimicrobial (Anatomical Therapeutic Chemical [ATC] group
'J') instead of antibiotic (ATC group 'J01') use led to a difference of 16.5
DDD/100 bed-days (19.3%). The literature review revealed underreporting of
complete definitions of antibiotic use measurements. Data on in-hospital
antimicrobial use vary widely not only due to different antibiotic policies at
different institutions but also due to different methods of measures. Adherence
to the standard of reporting the methods of measurement is warranted for
benchmarking and promotion of rational antimicrobial
use.&quot;,&quot;author&quot;:[{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Kuster&quot;,&quot;given&quot;:&quot;S.
P.&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Ruef&quot;,&quot;given&quot;:&quot;C.&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Ledergerber&quot;,&quot;given&quot;:&quot;B.&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Hintermann&quot;,&quot;given&quot;:&quot;A.&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Deplazes&quot;,&quot;given&quot;:&quot;C.&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Neuber&quot;,&quot;given&quot;:&quot;L.&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Weber&quot;,&quot;given&quot;:&quot;R.&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;}],&quot;container-title&quot;:&quot;Infection&quot;,&quot;id&quot;:&quot;ITEM-1&quot;,&quot;issue&quot;:&quot;6&quot;,&quot;issued&quot;:{&quot;date-parts&quot;:[[&quot;2008&quot;]]},&quot;page&quot;:&quot;549-559&quot;,&quot;title&quot;:&quot;Quantitative
antibiotic use in hospitals: Comparison of measurements, literature review, and
recommendations for a standard of
reporting&quot;,&quot;type&quot;:&quot;article-journal&quot;,&quot;volume&quot;:&quot;36&quot;},&quot;uris&quot;:[&quot;http://www.mendeley.com/documents/?uuid=09d6d835-3880-4f79-83b5-6e020c660ddc&quot;]}],&quot;mendeley&quot;:{&quot;formattedCitation&quot;:&quot;(15)&quot;,&quot;plainTextFormattedCitation&quot;:&quot;(15)&quot;,&quot;previouslyFormattedCitation&quot;:&quot;(15)&quot;},&quot;properties&quot;:{&quot;noteIndex&quot;:0},&quot;schema&quot;:&quot;https://github.com/citation-style-language/schema/raw/master/csl-citation.json&quot;}<span
style='mso-element:field-separator'></span></span><![endif]--><span lang=ES
style='font-size:10.0pt;line-height:105%;font-family:"Times New Roman",serif;
mso-fareast-font-family:Calibri;mso-ansi-language:ES'><span style='mso-no-proof:
yes'>(15)</span></span><!--[if supportFields]><span lang=ES style='font-size:
10.0pt;line-height:105%;font-family:"Times New Roman",serif;mso-fareast-font-family:
Calibri;mso-ansi-language:ES'><span style='mso-element:field-end'></span></span><![endif]--><span
lang=ES style='font-size:10.0pt;line-height:105%;font-family:"Times New Roman",serif;
mso-fareast-font-family:Calibri;mso-ansi-language:ES'>. La obtención de valores
de referencia es importante porque permite participar a </span><span
style='font-size:10.0pt;line-height:105%;font-family:"Times New Roman",serif;
mso-fareast-font-family:Calibri;mso-ansi-language:ES-CO'>a través del
mejoramiento de la calidad en la disminución de costos y la mejora de los
resultados en salud </span><!--[if supportFields]><span style='font-size:10.0pt;
line-height:105%;font-family:"Times New Roman",serif;mso-fareast-font-family:
Calibri;mso-ansi-language:ES-CO'><span style='mso-element:field-begin;
mso-field-lock:yes'></span>ADDIN CSL_CITATION
{&quot;citationItems&quot;:[{&quot;id&quot;:&quot;ITEM-1&quot;,&quot;itemData&quot;:{&quot;DOI&quot;:&quot;10.1086/673982&quot;,&quot;ISBN&quot;:&quot;1559-6834;
0899-823X&quot;,&quot;ISSN&quot;:&quot;0899-823X&quot;,&quot;PMID&quot;:&quot;24225609&quot;,&quot;abstract&quot;:&quot;OBJECTIVE:
Antimicrobial stewardship programs (ASPs) are recommended to optimize
antimicrobial use for hospitalized patients. Although mechanisms for the
implementation of ASPs have been described, data-driven approaches to
prioritize specific conditions and antimicrobials for intervention have not
been established. We aimed to develop a strategy for identifying high-impact
targets for antimicrobial stewardship efforts. DESIGn: Retrospective
cross-sectional study.\\n\\nSETTING AND PATIENTS: Children admitted to 32
freestanding children's hospitals in the United States in 2010.\\n\\nMETHODS:
We identified the conditions with the largest proportional contribution to the
total days of antibiotic therapy prescribed to all hospitalized children. For
the 4 highest-using conditions, we examined variability between hospitals in
antibiotic selection patterns for use of either first- or second-line therapies
depending on the condition. Antibiotic use was determined using standardized
probability of exposure to selected agents and standardized days of therapy per
1,000 patient-days, adjusting for patient demographics and severity of
illness.\\n\\nRESULTS: In 2010, 524,364 children received 2,082,929 days of
antibiotic therapy. Surgical patients received 43% of all antibiotics. The 4
highest-using conditions-pneumonia, appendicitis, cystic fibrosis, and skin and
soft-tissue infection-represent 1% of all conditions yet accounted for more
than 10% of all antibiotic use. Wide variability in antibiotic use occurred for
3 of these 4 conditions.\\n\\nCONCLUSIONS: Antibiotic use in children's
hospitals varied broadly across institutions when examining diagnoses
individually and adjusting for severity of illness. Identifying conditions with
both frequent and variable antimicrobial use informs the prioritization of
high-impact targets for future antimicrobial stewardship
interventions.&quot;,&quot;author&quot;:[{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Gerber&quot;,&quot;given&quot;:&quot;Jeffrey
S.&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Kronman&quot;,&quot;given&quot;:&quot;Matthew
P.&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Ross&quot;,&quot;given&quot;:&quot;Rachael
K.&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Hersh&quot;,&quot;given&quot;:&quot;Adam
L.&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Newland&quot;,&quot;given&quot;:&quot;Jason
G.&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Metjian&quot;,&quot;given&quot;:&quot;Talene
A.&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Zaoutis&quot;,&quot;given&quot;:&quot;Theoklis
E.&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;}],&quot;container-title&quot;:&quot;Infection
Control and Hospital
Epidemiology&quot;,&quot;id&quot;:&quot;ITEM-1&quot;,&quot;issue&quot;:&quot;12&quot;,&quot;issued&quot;:{&quot;date-parts&quot;:[[&quot;2013&quot;]]},&quot;page&quot;:&quot;1252-1258&quot;,&quot;title&quot;:&quot;Identifying
Targets for Antimicrobial Stewardship in Children's
Hospitals&quot;,&quot;type&quot;:&quot;article-journal&quot;,&quot;volume&quot;:&quot;34&quot;},&quot;uris&quot;:[&quot;http://www.mendeley.com/documents/?uuid=663df377-b354-4d74-8734-d3005cc2c3a3&quot;]}],&quot;mendeley&quot;:{&quot;formattedCitation&quot;:&quot;(16)&quot;,&quot;plainTextFormattedCitation&quot;:&quot;(16)&quot;,&quot;previouslyFormattedCitation&quot;:&quot;(16)&quot;},&quot;properties&quot;:{&quot;noteIndex&quot;:0},&quot;schema&quot;:&quot;https://github.com/citation-style-language/schema/raw/master/csl-citation.json&quot;}<span
style='mso-element:field-separator'></span></span><![endif]--><span
style='font-size:10.0pt;line-height:105%;font-family:"Times New Roman",serif;
mso-fareast-font-family:Calibri;mso-ansi-language:ES-CO'><span
style='mso-no-proof:yes'>(16)</span></span><!--[if supportFields]><span
style='font-size:10.0pt;line-height:105%;font-family:"Times New Roman",serif;
mso-fareast-font-family:Calibri;mso-ansi-language:ES-CO'><span
style='mso-element:field-end'></span></span><![endif]--><span style='font-size:
10.0pt;line-height:105%;font-family:"Times New Roman",serif;mso-fareast-font-family:
Calibri;mso-ansi-language:ES-CO'>.<span style='background:aqua;mso-highlight:
aqua'><o:p></o:p></span></span></p>

<p class=IOPH1><span style='mso-ansi-language:ES-CO'>3. Relación entre consumo
y eventos adversos relacionados a la utilización de antimicrobianos<o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0mm;margin-bottom:.0001pt;text-align:
justify;text-indent:11.35pt;line-height:105%'><span lang=ES style='font-size:
10.0pt;line-height:105%;font-family:"Times New Roman",serif;mso-fareast-font-family:
Calibri;mso-ansi-language:ES'>Existe evidencia sobre la relación entre la
intensidad del consumo de antimicrobianos y la probabilidad de presentación de
desenlaces negativos relacionados a su uso. Entre estos desenlaces se cuenta al
daño colateral </span><!--[if supportFields]><span lang=ES style='font-size:
10.0pt;line-height:105%;font-family:"Times New Roman",serif;mso-fareast-font-family:
Calibri;mso-ansi-language:ES'><span style='mso-element:field-begin;mso-field-lock:
yes'></span>ADDIN CSL_CITATION {&quot;citationItems&quot;:[{&quot;id&quot;:&quot;ITEM-1&quot;,&quot;itemData&quot;:{&quot;DOI&quot;:&quot;10.1093/cid/cir301&quot;,&quot;ISBN&quot;:&quot;1058-4838&quot;,&quot;ISSN&quot;:&quot;10584838&quot;,&quot;PMID&quot;:&quot;21653301&quot;,&quot;abstract&quot;:&quot;Clostridium
difficile infection (CDI) is a major cause of hospital-acquired diarrhea and is
most commonly associated with changes in normal intestinal flora caused by
administration of antibiotics. Few studies have examined the risk of CDI
associated with total dose, duration, or number of antibiotics while taking
into account the complex changes in exposures over time.&quot;,&quot;author&quot;:[{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Stevens&quot;,&quot;given&quot;:&quot;Vanessa&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Dumyati&quot;,&quot;given&quot;:&quot;Ghinwa&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Fine&quot;,&quot;given&quot;:&quot;Lynn
S.&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Fisher&quot;,&quot;given&quot;:&quot;Susan
G.&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Wijngaarden&quot;,&quot;given&quot;:&quot;Edwin&quot;,&quot;non-dropping-particle&quot;:&quot;Van&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;}],&quot;container-title&quot;:&quot;Clinical
Infectious Diseases&quot;,&quot;id&quot;:&quot;ITEM-1&quot;,&quot;issue&quot;:&quot;1&quot;,&quot;issued&quot;:{&quot;date-parts&quot;:[[&quot;2011&quot;]]},&quot;page&quot;:&quot;42-48&quot;,&quot;title&quot;:&quot;Cumulative
antibiotic exposures over time and the risk of clostridium difficile
infection&quot;,&quot;type&quot;:&quot;article-journal&quot;,&quot;volume&quot;:&quot;53&quot;},&quot;uris&quot;:[&quot;http://www.mendeley.com/documents/?uuid=391d1011-0c60-4337-bbd3-690194dae8c6&quot;]},{&quot;id&quot;:&quot;ITEM-2&quot;,&quot;itemData&quot;:{&quot;DOI&quot;:&quot;10.1086/382690&quot;,&quot;ISBN&quot;:&quot;1537-6591
(Electronic)\\r1058-4838
(Linking)&quot;,&quot;ISSN&quot;:&quot;1058-4838&quot;,&quot;PMID&quot;:&quot;15127367&quot;,&quot;abstract&quot;:&quot;\&quot;Collateral
damage\&quot; is a term used to refer to ecological adverse effects of
antibiotic therapy; namely, the selection of drug-resistant organisms and the
unwanted development of colonization or infection with multidrug-resistant
organisms. The risk of such damage can be assessed for different antibiotic
classes by a variety of epidemiologic studies. Cephalosporin use has been
linked to subsequent infection with vancomycin-resistant enterococci,
extended-spectrum beta-lactamase-producing Klebsiella pneumoniae,
beta-lactam-resistant Acinetobacter species, and Clostridium difficile.
Quinolone use has been linked to infection with methicillin-resistant
Staphylococcus aureus and with increasing quinolone resistance in gram-negative
bacilli, such as Pseudomonas aeruginosa. Neither third-generation
cephalosporins nor quinolones appear suitable for sustained use in hospitals as
\&quot;workhorse\&quot; antibiotic therapy&quot;,&quot;author&quot;:[{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Paterson&quot;,&quot;given&quot;:&quot;D.
L.&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;}],&quot;container-title&quot;:&quot;Clinical
Infectious
Diseases&quot;,&quot;id&quot;:&quot;ITEM-2&quot;,&quot;issue&quot;:&quot;Supplement
4&quot;,&quot;issued&quot;:{&quot;date-parts&quot;:[[&quot;2004&quot;]]},&quot;page&quot;:&quot;S341-S345&quot;,&quot;title&quot;:&quot;\&quot;Collateral
Damage\&quot; from Cephalosporin or Quinolone Antibiotic
Therapy&quot;,&quot;type&quot;:&quot;article-journal&quot;,&quot;volume&quot;:&quot;38&quot;},&quot;uris&quot;:[&quot;http://www.mendeley.com/documents/?uuid=b0e7f145-fea8-4f68-8163-a4a6ebcbc267&quot;]}],&quot;mendeley&quot;:{&quot;formattedCitation&quot;:&quot;(17,18)&quot;,&quot;plainTextFormattedCitation&quot;:&quot;(17,18)&quot;,&quot;previouslyFormattedCitation&quot;:&quot;(17,18)&quot;},&quot;properties&quot;:{&quot;noteIndex&quot;:0},&quot;schema&quot;:&quot;https://github.com/citation-style-language/schema/raw/master/csl-citation.json&quot;}<span
style='mso-element:field-separator'></span></span><![endif]--><span lang=ES
style='font-size:10.0pt;line-height:105%;font-family:"Times New Roman",serif;
mso-fareast-font-family:Calibri;mso-ansi-language:ES'><span style='mso-no-proof:
yes'>(17,18)</span></span><!--[if supportFields]><span lang=ES
style='font-size:10.0pt;line-height:105%;font-family:"Times New Roman",serif;
mso-fareast-font-family:Calibri;mso-ansi-language:ES'><span style='mso-element:
field-end'></span></span><![endif]--><span lang=ES style='font-size:10.0pt;
line-height:105%;font-family:"Times New Roman",serif;mso-fareast-font-family:
Calibri;mso-ansi-language:ES'> generación y persistencia de resistencia </span><!--[if supportFields]><span
lang=ES style='font-size:10.0pt;line-height:105%;font-family:"Times New Roman",serif;
mso-fareast-font-family:Calibri;mso-ansi-language:ES'><span style='mso-element:
field-begin;mso-field-lock:yes'></span>ADDIN CSL_CITATION
{&quot;citationItems&quot;:[{&quot;id&quot;:&quot;ITEM-1&quot;,&quot;itemData&quot;:{&quot;author&quot;:[{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Harbarth&quot;,&quot;given&quot;:&quot;Stephan&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Harris&quot;,&quot;given&quot;:&quot;Anthony
D&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Carmeli&quot;,&quot;given&quot;:&quot;Yehuda&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Samore&quot;,&quot;given&quot;:&quot;Matthew
H&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;}],&quot;container-title&quot;:&quot;Clinical
infectious
diseases&quot;,&quot;id&quot;:&quot;ITEM-1&quot;,&quot;issued&quot;:{&quot;date-parts&quot;:[[&quot;2001&quot;]]},&quot;page&quot;:&quot;1462-168&quot;,&quot;title&quot;:&quot;Parallel
Analysis of Individual and Aggregated Data on Antibiotic Exposure and
Resistance in Gram-Negative
Bacilli&quot;,&quot;type&quot;:&quot;article-journal&quot;,&quot;volume&quot;:&quot;33&quot;},&quot;uris&quot;:[&quot;http://www.mendeley.com/documents/?uuid=4d065c2b-2a0e-42b9-afb9-97685e6fdb92&quot;]},{&quot;id&quot;:&quot;ITEM-2&quot;,&quot;itemData&quot;:{&quot;DOI&quot;:&quot;10.1093/jac/dkh510&quot;,&quot;ISSN&quot;:&quot;03057453&quot;,&quot;PMID&quot;:&quot;15574472&quot;,&quot;abstract&quot;:&quot;OBJECTIVES:
To compare rates of in vitro fluoroquinolone resistance of bacterial isolates
obtained from inpatients of two haematology-oncology services with high and low
fluoroquinolone consumption. METHODS: Two hospitals with consistently high (A)
and low (B) fluoroquinolone use in their haematology-oncology services between
the years 1999 and 2002 were identified in a hospital antibiotic use
surveillance project. Rates of in vitro resistance to fluoroquinolones in
inpatients of the services were determined for Escherichia coli and
coagulase-negative staphylococcal bloodstream isolates, and also for
Pseudomonas aeruginosa and Staphylococcus aureus isolates from any site.
RESULTS: Fluoroquinolone resistance of E. coli was significantly higher in
hospital A than in hospital B, but there was no such correlation between
fluoroquinolone use and resistance rates for P. aeruginosa and staphylococci.
CONCLUSION: The impact of antibiotic consumption on the prevalence of
resistance may differ widely between different pathogens. Interventions using
ecological analyses of the relationship between hospital antibiotic use and
resistance need to consider pathogen-specific dynamics in the emergence and
control of bacterial resistance.&quot;,&quot;author&quot;:[{&quot;dropping-particle&quot;:&quot;V.&quot;,&quot;family&quot;:&quot;Kern&quot;,&quot;given&quot;:&quot;Winfried&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Steib-Bauert&quot;,&quot;given&quot;:&quot;Michaela&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;With&quot;,&quot;given&quot;:&quot;Katja&quot;,&quot;non-dropping-particle&quot;:&quot;de&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Reuter&quot;,&quot;given&quot;:&quot;Stefan&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Bertz&quot;,&quot;given&quot;:&quot;Hartmut&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Frank&quot;,&quot;given&quot;:&quot;Uwe&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Baum&quot;,&quot;given&quot;:&quot;Heike&quot;,&quot;non-dropping-particle&quot;:&quot;von&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;}],&quot;container-title&quot;:&quot;Journal
of Antimicrobial
Chemotherapy&quot;,&quot;id&quot;:&quot;ITEM-2&quot;,&quot;issue&quot;:&quot;1&quot;,&quot;issued&quot;:{&quot;date-parts&quot;:[[&quot;2005&quot;]]},&quot;page&quot;:&quot;57-60&quot;,&quot;title&quot;:&quot;Fluoroquinolone
consumption and resistance in haematology-oncology patients: Ecological
analysis in two university hospitals
1999-2002&quot;,&quot;type&quot;:&quot;article-journal&quot;,&quot;volume&quot;:&quot;55&quot;},&quot;uris&quot;:[&quot;http://www.mendeley.com/documents/?uuid=eef49272-7dc3-4b9b-888b-74f55d84ade4&quot;]}],&quot;mendeley&quot;:{&quot;formattedCitation&quot;:&quot;(19,20)&quot;,&quot;plainTextFormattedCitation&quot;:&quot;(19,20)&quot;,&quot;previouslyFormattedCitation&quot;:&quot;(19,20)&quot;},&quot;properties&quot;:{&quot;noteIndex&quot;:0},&quot;schema&quot;:&quot;https://github.com/citation-style-language/schema/raw/master/csl-citation.json&quot;}<span
style='mso-element:field-separator'></span></span><![endif]--><span lang=ES
style='font-size:10.0pt;line-height:105%;font-family:"Times New Roman",serif;
mso-fareast-font-family:Calibri;mso-ansi-language:ES'><span style='mso-no-proof:
yes'>(19,20)</span></span><!--[if supportFields]><span lang=ES
style='font-size:10.0pt;line-height:105%;font-family:"Times New Roman",serif;
mso-fareast-font-family:Calibri;mso-ansi-language:ES'><span style='mso-element:
field-end'></span></span><![endif]--><span lang=ES style='font-size:10.0pt;
line-height:105%;font-family:"Times New Roman",serif;mso-fareast-font-family:
Calibri;mso-ansi-language:ES'>. El daño colateral es un término que engloba a
los efectos adversos ecológicos de la terapia antimicrobiana como la selección
de organismos resistentes y el desarrollo de colonización o infección por
organismos multirresistentes </span><!--[if supportFields]><span lang=ES
style='font-size:10.0pt;line-height:105%;font-family:"Times New Roman",serif;
mso-fareast-font-family:Calibri;mso-ansi-language:ES'><span style='mso-element:
field-begin;mso-field-lock:yes'></span>ADDIN CSL_CITATION
{&quot;citationItems&quot;:[{&quot;id&quot;:&quot;ITEM-1&quot;,&quot;itemData&quot;:{&quot;DOI&quot;:&quot;10.1086/382690&quot;,&quot;ISBN&quot;:&quot;1537-6591
(Electronic)\\r1058-4838
(Linking)&quot;,&quot;ISSN&quot;:&quot;1058-4838&quot;,&quot;PMID&quot;:&quot;15127367&quot;,&quot;abstract&quot;:&quot;\&quot;Collateral
damage\&quot; is a term used to refer to ecological adverse effects of
antibiotic therapy; namely, the selection of drug-resistant organisms and the
unwanted development of colonization or infection with multidrug-resistant
organisms. The risk of such damage can be assessed for different antibiotic
classes by a variety of epidemiologic studies. Cephalosporin use has been
linked to subsequent infection with vancomycin-resistant enterococci,
extended-spectrum beta-lactamase-producing Klebsiella pneumoniae,
beta-lactam-resistant Acinetobacter species, and Clostridium difficile.
Quinolone use has been linked to infection with methicillin-resistant
Staphylococcus aureus and with increasing quinolone resistance in gram-negative
bacilli, such as Pseudomonas aeruginosa. Neither third-generation
cephalosporins nor quinolones appear suitable for sustained use in hospitals as
\&quot;workhorse\&quot; antibiotic therapy&quot;,&quot;author&quot;:[{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Paterson&quot;,&quot;given&quot;:&quot;D.
L.&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;}],&quot;container-title&quot;:&quot;Clinical
Infectious
Diseases&quot;,&quot;id&quot;:&quot;ITEM-1&quot;,&quot;issue&quot;:&quot;Supplement
4&quot;,&quot;issued&quot;:{&quot;date-parts&quot;:[[&quot;2004&quot;]]},&quot;page&quot;:&quot;S341-S345&quot;,&quot;title&quot;:&quot;\&quot;Collateral
Damage\&quot; from Cephalosporin or Quinolone Antibiotic
Therapy&quot;,&quot;type&quot;:&quot;article-journal&quot;,&quot;volume&quot;:&quot;38&quot;},&quot;uris&quot;:[&quot;http://www.mendeley.com/documents/?uuid=b0e7f145-fea8-4f68-8163-a4a6ebcbc267&quot;]}],&quot;mendeley&quot;:{&quot;formattedCitation&quot;:&quot;(18)&quot;,&quot;plainTextFormattedCitation&quot;:&quot;(18)&quot;,&quot;previouslyFormattedCitation&quot;:&quot;(18)&quot;},&quot;properties&quot;:{&quot;noteIndex&quot;:0},&quot;schema&quot;:&quot;https://github.com/citation-style-language/schema/raw/master/csl-citation.json&quot;}<span
style='mso-element:field-separator'></span></span><![endif]--><span lang=ES
style='font-size:10.0pt;line-height:105%;font-family:"Times New Roman",serif;
mso-fareast-font-family:Calibri;mso-ansi-language:ES'><span style='mso-no-proof:
yes'>(18)</span></span><!--[if supportFields]><span lang=ES style='font-size:
10.0pt;line-height:105%;font-family:"Times New Roman",serif;mso-fareast-font-family:
Calibri;mso-ansi-language:ES'><span style='mso-element:field-end'></span></span><![endif]--><span
lang=ES style='font-size:10.0pt;line-height:105%;font-family:"Times New Roman",serif;
mso-fareast-font-family:Calibri;mso-ansi-language:ES'>. <o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0mm;margin-bottom:.0001pt;text-align:
justify;text-indent:11.35pt;line-height:105%'><span lang=ES style='font-size:
10.0pt;line-height:105%;font-family:"Times New Roman",serif;mso-fareast-font-family:
Calibri;mso-ansi-language:ES'><o:p>&nbsp;</o:p></span></p>

<p class=MsoNormal style='margin-bottom:0mm;margin-bottom:.0001pt;text-align:
justify;text-indent:11.35pt;line-height:105%'><span lang=ES style='font-size:
10.0pt;line-height:105%;font-family:"Times New Roman",serif;mso-fareast-font-family:
Calibri;mso-ansi-language:ES'>Se ha identificado el consumo de quinolonas y
cefalosporinas de tercera generación como factores de riesgo modificables para
infecciones por <i style='mso-bidi-font-style:normal'>Clostridium difficile</i>
(CDI) </span><!--[if supportFields]><span lang=ES style='font-size:10.0pt;
line-height:105%;font-family:"Times New Roman",serif;mso-fareast-font-family:
Calibri;mso-ansi-language:ES'><span style='mso-element:field-begin;mso-field-lock:
yes'></span>ADDIN CSL_CITATION
{&quot;citationItems&quot;:[{&quot;id&quot;:&quot;ITEM-1&quot;,&quot;itemData&quot;:{&quot;DOI&quot;:&quot;CLM3077
[pii] 10.1111/j.1469-0691.2009.03077.x&quot;,&quot;ISBN&quot;:&quot;1469-0691
(Electronic)\\r1198-743X (Linking)&quot;,&quot;ISSN&quot;:&quot;1469-0691
(Electronic) 1198-743X
(Linking)&quot;,&quot;PMID&quot;:&quot;19832710&quot;,&quot;abstract&quot;:&quot;Clin
Microbiol Infect 2010; 16: 1297-1302 Abstract Strategies to reduce rates of
Clostridium difficile infection (CDI) generally recommend isolation or
cohorting of active cases and the reduced use of cephalosporin and quinolone
antibiotics. Data supporting these recommendations come predominantly from the
setting of epidemic disease caused by ribotype 027 strains. We introduced an
initiative involving a restrictive antibiotic policy and a CDI-cohort ward at
an acute, 820-bed teaching hospital where ribotype 027 strains account for only
one quarter of all CDI cases. Antibiotic use and monthly CDI cases in the 12
months before and the 15 months after the initiative were compared using an
interrupted time series analysis and segmented regression analysis. The
initiative resulted in a reduced level of cephalosporin and quinolone use
(22.0% and 38.7%, respectively, both p &lt;0.001) and changes in the trends of
antibiotic use such that cephalosporin use decreased by an additional 62.1
defined daily doses (DDD) per month (p &lt;0.001) and antipseudomonal
penicillin use increased by 20.7 DDD per month (p = 0.011). There were no
significant changes in doxycycline or carbapenem use. Although the number of
CDI cases each month was falling before the intervention, there was a
significant increase in the rate of reduction after the intervention from 3% to
8% per month (0.92, 95% CI 0.86-0.99, p = 0.03). During the study period, there
was no change in the proportion of cases having their onset in the community,
nor in the proportion of ribotype 027 cases. CDI cohorting and restriction of
cephalosporin and quinolone use are effective in reducing CDI cases in a
setting where ribotype 027 is endemic. AD -) Department of Microbiology and
Infection, Brighton and Sussex University Hospitals NHS Trust, Brighton,
UK.&quot;,&quot;author&quot;:[{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Price&quot;,&quot;given&quot;:&quot;J.&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Cheek&quot;,&quot;given&quot;:&quot;E.&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Lippett&quot;,&quot;given&quot;:&quot;S.&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;}],&quot;container-title&quot;:&quot;Clinical
Microbiology and
Infection&quot;,&quot;id&quot;:&quot;ITEM-1&quot;,&quot;issue&quot;:&quot;8&quot;,&quot;issued&quot;:{&quot;date-parts&quot;:[[&quot;2010&quot;]]},&quot;page&quot;:&quot;1297-302&quot;,&quot;title&quot;:&quot;Impact
of an intervention to control Clostridium difficile infection on hospital and
community-onset disease; an interrupted time series
analysis&quot;,&quot;type&quot;:&quot;article-journal&quot;,&quot;volume&quot;:&quot;16&quot;},&quot;uris&quot;:[&quot;http://www.mendeley.com/documents/?uuid=27c2762f-b977-4036-853e-81fe80fd147d&quot;]}],&quot;mendeley&quot;:{&quot;formattedCitation&quot;:&quot;(21)&quot;,&quot;plainTextFormattedCitation&quot;:&quot;(21)&quot;,&quot;previouslyFormattedCitation&quot;:&quot;(21)&quot;},&quot;properties&quot;:{&quot;noteIndex&quot;:0},&quot;schema&quot;:&quot;https://github.com/citation-style-language/schema/raw/master/csl-citation.json&quot;}<span
style='mso-element:field-separator'></span></span><![endif]--><span lang=ES
style='font-size:10.0pt;line-height:105%;font-family:"Times New Roman",serif;
mso-fareast-font-family:Calibri;mso-ansi-language:ES'><span style='mso-no-proof:
yes'>(21)</span></span><!--[if supportFields]><span lang=ES style='font-size:
10.0pt;line-height:105%;font-family:"Times New Roman",serif;mso-fareast-font-family:
Calibri;mso-ansi-language:ES'><span style='mso-element:field-end'></span></span><![endif]--><span
lang=ES style='font-size:10.0pt;line-height:105%;font-family:"Times New Roman",serif;
mso-fareast-font-family:Calibri;mso-ansi-language:ES'>. Un estudio de cohorte
retrospectivo encontró un riesgo mayor de adquirir CDI relacionado al número y
días de exposición a antibióticos. El cociente de riesgo (95% CR) para CDI fue
1.9-5.0 para pacientes con 8-18 DOTs y 4.6-13.4 para pacientes con &gt;18 DOTs </span><!--[if supportFields]><span
lang=ES style='font-size:10.0pt;line-height:105%;font-family:"Times New Roman",serif;
mso-fareast-font-family:Calibri;mso-ansi-language:ES'><span style='mso-element:
field-begin;mso-field-lock:yes'></span>ADDIN CSL_CITATION
{&quot;citationItems&quot;:[{&quot;id&quot;:&quot;ITEM-1&quot;,&quot;itemData&quot;:{&quot;DOI&quot;:&quot;10.1093/cid/cir301&quot;,&quot;ISBN&quot;:&quot;1058-4838&quot;,&quot;ISSN&quot;:&quot;10584838&quot;,&quot;PMID&quot;:&quot;21653301&quot;,&quot;abstract&quot;:&quot;Clostridium
difficile infection (CDI) is a major cause of hospital-acquired diarrhea and is
most commonly associated with changes in normal intestinal flora caused by
administration of antibiotics. Few studies have examined the risk of CDI
associated with total dose, duration, or number of antibiotics while taking
into account the complex changes in exposures over
time.&quot;,&quot;author&quot;:[{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Stevens&quot;,&quot;given&quot;:&quot;Vanessa&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Dumyati&quot;,&quot;given&quot;:&quot;Ghinwa&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Fine&quot;,&quot;given&quot;:&quot;Lynn
S.&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Fisher&quot;,&quot;given&quot;:&quot;Susan
G.&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Wijngaarden&quot;,&quot;given&quot;:&quot;Edwin&quot;,&quot;non-dropping-particle&quot;:&quot;Van&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;}],&quot;container-title&quot;:&quot;Clinical
Infectious
Diseases&quot;,&quot;id&quot;:&quot;ITEM-1&quot;,&quot;issue&quot;:&quot;1&quot;,&quot;issued&quot;:{&quot;date-parts&quot;:[[&quot;2011&quot;]]},&quot;page&quot;:&quot;42-48&quot;,&quot;title&quot;:&quot;Cumulative
antibiotic exposures over time and the risk of clostridium difficile
infection&quot;,&quot;type&quot;:&quot;article-journal&quot;,&quot;volume&quot;:&quot;53&quot;},&quot;uris&quot;:[&quot;http://www.mendeley.com/documents/?uuid=391d1011-0c60-4337-bbd3-690194dae8c6&quot;]}],&quot;mendeley&quot;:{&quot;formattedCitation&quot;:&quot;(17)&quot;,&quot;plainTextFormattedCitation&quot;:&quot;(17)&quot;,&quot;previouslyFormattedCitation&quot;:&quot;(17)&quot;},&quot;properties&quot;:{&quot;noteIndex&quot;:0},&quot;schema&quot;:&quot;https://github.com/citation-style-language/schema/raw/master/csl-citation.json&quot;}<span
style='mso-element:field-separator'></span></span><![endif]--><span lang=ES
style='font-size:10.0pt;line-height:105%;font-family:"Times New Roman",serif;
mso-fareast-font-family:Calibri;mso-ansi-language:ES'><span style='mso-no-proof:
yes'>(17)</span></span><!--[if supportFields]><span lang=ES style='font-size:
10.0pt;line-height:105%;font-family:"Times New Roman",serif;mso-fareast-font-family:
Calibri;mso-ansi-language:ES'><span style='mso-element:field-end'></span></span><![endif]--><span
lang=ES style='font-size:10.0pt;line-height:105%;font-family:"Times New Roman",serif;
mso-fareast-font-family:Calibri;mso-ansi-language:ES'>.<o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0mm;margin-bottom:.0001pt;text-align:
justify;text-indent:11.35pt;line-height:105%'><span lang=ES style='font-size:
10.0pt;line-height:105%;font-family:"Times New Roman",serif;mso-fareast-font-family:
Calibri;mso-ansi-language:ES'><o:p>&nbsp;</o:p></span></p>

<p class=MsoNormal style='margin-bottom:0mm;margin-bottom:.0001pt;text-align:
justify;text-indent:11.35pt;line-height:105%'><span lang=ES style='font-size:
10.0pt;line-height:105%;font-family:"Times New Roman",serif;mso-fareast-font-family:
Calibri;mso-ansi-language:ES'>Una intervención que redujo el uso de
cefalosporinas (22.0%) y quinolonas (38.7%) en conjunto con una intervención de
aislamiento, permitieron la reducción de la tasa de CDI de 1.30 a 0.69 casos
por 1000 días-paciente </span><!--[if supportFields]><span lang=ES
style='font-size:10.0pt;line-height:105%;font-family:"Times New Roman",serif;
mso-fareast-font-family:Calibri;mso-ansi-language:ES'><span style='mso-element:
field-begin;mso-field-lock:yes'></span>ADDIN CSL_CITATION
{&quot;citationItems&quot;:[{&quot;id&quot;:&quot;ITEM-1&quot;,&quot;itemData&quot;:{&quot;DOI&quot;:&quot;CLM3077
[pii] 10.1111/j.1469-0691.2009.03077.x&quot;,&quot;ISBN&quot;:&quot;1469-0691
(Electronic)\\r1198-743X (Linking)&quot;,&quot;ISSN&quot;:&quot;1469-0691
(Electronic) 1198-743X
(Linking)&quot;,&quot;PMID&quot;:&quot;19832710&quot;,&quot;abstract&quot;:&quot;Clin
Microbiol Infect 2010; 16: 1297-1302 Abstract Strategies to reduce rates of
Clostridium difficile infection (CDI) generally recommend isolation or
cohorting of active cases and the reduced use of cephalosporin and quinolone
antibiotics. Data supporting these recommendations come predominantly from the
setting of epidemic disease caused by ribotype 027 strains. We introduced an
initiative involving a restrictive antibiotic policy and a CDI-cohort ward at
an acute, 820-bed teaching hospital where ribotype 027 strains account for only
one quarter of all CDI cases. Antibiotic use and monthly CDI cases in the 12
months before and the 15 months after the initiative were compared using an
interrupted time series analysis and segmented regression analysis. The
initiative resulted in a reduced level of cephalosporin and quinolone use
(22.0% and 38.7%, respectively, both p &lt;0.001) and changes in the trends of
antibiotic use such that cephalosporin use decreased by an additional 62.1
defined daily doses (DDD) per month (p &lt;0.001) and antipseudomonal
penicillin use increased by 20.7 DDD per month (p = 0.011). There were no
significant changes in doxycycline or carbapenem use. Although the number of
CDI cases each month was falling before the intervention, there was a
significant increase in the rate of reduction after the intervention from 3% to
8% per month (0.92, 95% CI 0.86-0.99, p = 0.03). During the study period, there
was no change in the proportion of cases having their onset in the community,
nor in the proportion of ribotype 027 cases. CDI cohorting and restriction of
cephalosporin and quinolone use are effective in reducing CDI cases in a
setting where ribotype 027 is endemic. AD -) Department of Microbiology and
Infection, Brighton and Sussex University Hospitals NHS Trust, Brighton,
UK.&quot;,&quot;author&quot;:[{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Price&quot;,&quot;given&quot;:&quot;J.&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Cheek&quot;,&quot;given&quot;:&quot;E.&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Lippett&quot;,&quot;given&quot;:&quot;S.&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;}],&quot;container-title&quot;:&quot;Clinical
Microbiology and
Infection&quot;,&quot;id&quot;:&quot;ITEM-1&quot;,&quot;issue&quot;:&quot;8&quot;,&quot;issued&quot;:{&quot;date-parts&quot;:[[&quot;2010&quot;]]},&quot;page&quot;:&quot;1297-302&quot;,&quot;title&quot;:&quot;Impact
of an intervention to control Clostridium difficile infection on hospital and
community-onset disease; an interrupted time series
analysis&quot;,&quot;type&quot;:&quot;article-journal&quot;,&quot;volume&quot;:&quot;16&quot;},&quot;uris&quot;:[&quot;http://www.mendeley.com/documents/?uuid=27c2762f-b977-4036-853e-81fe80fd147d&quot;]}],&quot;mendeley&quot;:{&quot;formattedCitation&quot;:&quot;(21)&quot;,&quot;plainTextFormattedCitation&quot;:&quot;(21)&quot;,&quot;previouslyFormattedCitation&quot;:&quot;(21)&quot;},&quot;properties&quot;:{&quot;noteIndex&quot;:0},&quot;schema&quot;:&quot;https://github.com/citation-style-language/schema/raw/master/csl-citation.json&quot;}<span
style='mso-element:field-separator'></span></span><![endif]--><span lang=ES
style='font-size:10.0pt;line-height:105%;font-family:"Times New Roman",serif;
mso-fareast-font-family:Calibri;mso-ansi-language:ES'><span style='mso-no-proof:
yes'>(21)</span></span><!--[if supportFields]><span lang=ES style='font-size:
10.0pt;line-height:105%;font-family:"Times New Roman",serif;mso-fareast-font-family:
Calibri;mso-ansi-language:ES'><span style='mso-element:field-end'></span></span><![endif]--><span
lang=ES style='font-size:10.0pt;line-height:105%;font-family:"Times New Roman",serif;
mso-fareast-font-family:Calibri;mso-ansi-language:ES'>. Un análisis de serie de
tiempo encontró que la disminución en el consumo de quinolonas por 5 DDD/100 PD
estuvo asociada a un RR de 0.24-0.46 en riesgo de infección por CDI tras la
intervención. Con una disminución adicional con RR de 0.20-0.78 en riesgo tras
una intervención que disminuyó el consumo por 2 DDD/100 PD </span><!--[if supportFields]><span
lang=ES style='font-size:10.0pt;line-height:105%;font-family:"Times New Roman",serif;
mso-fareast-font-family:Calibri;mso-ansi-language:ES'><span style='mso-element:
field-begin;mso-field-lock:yes'></span>ADDIN CSL_CITATION
{&quot;citationItems&quot;:[{&quot;id&quot;:&quot;ITEM-1&quot;,&quot;itemData&quot;:{&quot;DOI&quot;:&quot;10.1016/j.jhin.2015.05.013&quot;,&quot;ISBN&quot;:&quot;0195-6701\\r1532-2939&quot;,&quot;ISSN&quot;:&quot;15322939&quot;,&quot;PMID&quot;:&quot;26169793&quot;,&quot;abstract&quot;:&quot;Background:
Antimicrobial stewardship is a key component in the reduction of
healthcare-associated infections, particularly Clostridium difficile infection
(CDI). We successfully restricted the use of cephalosporins and, subsequently,
fluoroquinolones. From an endemically high level of &gt;280 cases per year in
2007-08, the number of CDIs reduced to 72 cases in 2011-12. Aim: To describe
the implementation and impact of fluoroquinolone restriction on CDI. Methods:
This was an interrupted time-series analysis pre and post fluoroquinolone
restriction for 60 months based on a Poisson distribution model. Findings: In
June 2008, fluoroquinolone consumption halved to about 5 defined daily doses
(DDD) per 100 occupied bed-days (OBD). This was followed by a significant fall
in CDI number [rate ratio (RR): 0.332; 95% confidence interval (CI):
0.240-0.460] which remained low over the subsequent months. Subsequently,
fluoroquinolone consumption was further reduced to about 2 DDD/100 OBD in June
2010 accompanied by further reduction in CDI rate (RR: 0.394; 95% CI:
0.199-0.781). In a univariate Poisson model the CDI rate was associated with
fluoroquinolone usage (RR: 1.086; 95% CI: 1.077-1.094). Conclusion: We conclude
that in an environment where cephalosporin usage is already low, the reduction
in fluoroquinolone usage was associated with an immediate, large, and
significant reduction in CDI cases.&quot;,&quot;author&quot;:[{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Sarma&quot;,&quot;given&quot;:&quot;J.
B.&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Marshall&quot;,&quot;given&quot;:&quot;B.&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Cleeve&quot;,&quot;given&quot;:&quot;V.&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Tate&quot;,&quot;given&quot;:&quot;D.&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Oswald&quot;,&quot;given&quot;:&quot;T.&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Woolfrey&quot;,&quot;given&quot;:&quot;S.&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;}],&quot;container-title&quot;:&quot;Journal
of Hospital
Infection&quot;,&quot;id&quot;:&quot;ITEM-1&quot;,&quot;issue&quot;:&quot;1&quot;,&quot;issued&quot;:{&quot;date-parts&quot;:[[&quot;2015&quot;]]},&quot;page&quot;:&quot;74-80&quot;,&quot;publisher&quot;:&quot;Elsevier
Ltd&quot;,&quot;title&quot;:&quot;Effects of fluoroquinolone restriction (from
2007 to 2012) on Clostridium difficile infections: Interrupted time-series
analysis&quot;,&quot;type&quot;:&quot;article-journal&quot;,&quot;volume&quot;:&quot;91&quot;},&quot;uris&quot;:[&quot;http://www.mendeley.com/documents/?uuid=d0b91444-2a65-448f-9ea8-d213514b8c75&quot;]}],&quot;mendeley&quot;:{&quot;formattedCitation&quot;:&quot;(22)&quot;,&quot;plainTextFormattedCitation&quot;:&quot;(22)&quot;,&quot;previouslyFormattedCitation&quot;:&quot;(22)&quot;},&quot;properties&quot;:{&quot;noteIndex&quot;:0},&quot;schema&quot;:&quot;https://github.com/citation-style-language/schema/raw/master/csl-citation.json&quot;}<span
style='mso-element:field-separator'></span></span><![endif]--><span lang=ES
style='font-size:10.0pt;line-height:105%;font-family:"Times New Roman",serif;
mso-fareast-font-family:Calibri;mso-ansi-language:ES'><span style='mso-no-proof:
yes'>(22)</span></span><!--[if supportFields]><span lang=ES style='font-size:
10.0pt;line-height:105%;font-family:"Times New Roman",serif;mso-fareast-font-family:
Calibri;mso-ansi-language:ES'><span style='mso-element:field-end'></span></span><![endif]--><span
lang=ES style='font-size:10.0pt;line-height:105%;font-family:"Times New Roman",serif;
mso-fareast-font-family:Calibri;mso-ansi-language:ES'>. El control adecuado de
CDI depende de factores como control de brotes, adecuada limpieza, aislamiento
efectivo y uso prudente de antibióticos </span><!--[if supportFields]><span
lang=ES style='font-size:10.0pt;line-height:105%;font-family:"Times New Roman",serif;
mso-fareast-font-family:Calibri;mso-ansi-language:ES'><span style='mso-element:
field-begin;mso-field-lock:yes'></span>ADDIN CSL_CITATION
{&quot;citationItems&quot;:[{&quot;id&quot;:&quot;ITEM-1&quot;,&quot;itemData&quot;:{&quot;DOI&quot;:&quot;10.1086/677828&quot;,&quot;ISSN&quot;:&quot;0899823X&quot;,&quot;author&quot;:[{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Ostrowsky&quot;,&quot;given&quot;:&quot;B.&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Ruiz&quot;,&quot;given&quot;:&quot;R.&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Brown&quot;,&quot;given&quot;:&quot;S.&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Chung&quot;,&quot;given&quot;:&quot;P.&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Koppelman&quot;,&quot;given&quot;:&quot;E.&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Deusen
Lukas&quot;,&quot;given&quot;:&quot;C.&quot;,&quot;non-dropping-particle&quot;:&quot;van&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Guo&quot;,&quot;given&quot;:&quot;Y.&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Jalon&quot;,&quot;given&quot;:&quot;H.&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Sumer&quot;,&quot;given&quot;:&quot;Z.&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Araujo&quot;,&quot;given&quot;:&quot;C.&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Sirtalan&quot;,&quot;given&quot;:&quot;I.&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Brown&quot;,&quot;given&quot;:&quot;C.&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Riska&quot;,&quot;given&quot;:&quot;P.&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Currie&quot;,&quot;given&quot;:&quot;B.&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;}],&quot;container-title&quot;:&quot;Infection
Control and Hospital
Epidemiology&quot;,&quot;id&quot;:&quot;ITEM-1&quot;,&quot;issue&quot;:&quot;S3&quot;,&quot;issued&quot;:{&quot;date-parts&quot;:[[&quot;2014&quot;]]},&quot;page&quot;:&quot;S86-S95&quot;,&quot;title&quot;:&quot;Lessons
Learned from Implementing &lt;i&gt;Clostridium difficile&lt;/i&gt; –Focused
Antibiotic Stewardship Interventions&quot;,&quot;type&quot;:&quot;article-journal&quot;,&quot;volume&quot;:&quot;35&quot;},&quot;uris&quot;:[&quot;http://www.mendeley.com/documents/?uuid=1e45861a-1e34-4393-9b1f-6888f965649d&quot;]}],&quot;mendeley&quot;:{&quot;formattedCitation&quot;:&quot;(23)&quot;,&quot;plainTextFormattedCitation&quot;:&quot;(23)&quot;,&quot;previouslyFormattedCitation&quot;:&quot;(23)&quot;},&quot;properties&quot;:{&quot;noteIndex&quot;:0},&quot;schema&quot;:&quot;https://github.com/citation-style-language/schema/raw/master/csl-citation.json&quot;}<span
style='mso-element:field-separator'></span></span><![endif]--><span lang=ES
style='font-size:10.0pt;line-height:105%;font-family:"Times New Roman",serif;
mso-fareast-font-family:Calibri;mso-ansi-language:ES'><span style='mso-no-proof:
yes'>(23)</span></span><!--[if supportFields]><span lang=ES style='font-size:
10.0pt;line-height:105%;font-family:"Times New Roman",serif;mso-fareast-font-family:
Calibri;mso-ansi-language:ES'><span style='mso-element:field-end'></span></span><![endif]--><span
lang=ES style='font-size:10.0pt;line-height:105%;font-family:"Times New Roman",serif;
mso-fareast-font-family:Calibri;mso-ansi-language:ES'>.<o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0mm;margin-bottom:.0001pt;text-align:
justify;text-indent:11.35pt;line-height:105%'><span lang=ES style='font-size:
10.0pt;line-height:105%;font-family:"Times New Roman",serif;mso-fareast-font-family:
Calibri;mso-ansi-language:ES'><o:p>&nbsp;</o:p></span></p>

<p class=MsoNormal style='margin-bottom:0mm;margin-bottom:.0001pt;text-align:
justify;text-indent:11.35pt;line-height:105%'><span lang=ES style='font-size:
10.0pt;line-height:105%;font-family:"Times New Roman",serif;mso-fareast-font-family:
Calibri;mso-ansi-language:ES'>La intensidad en el consumo de antibióticos es
identificada como un factor clave para la selección y mantenimiento de la
resistencia en microorganismos </span><!--[if supportFields]><span lang=ES
style='font-size:10.0pt;line-height:105%;font-family:"Times New Roman",serif;
mso-fareast-font-family:Calibri;mso-ansi-language:ES'><span style='mso-element:
field-begin;mso-field-lock:yes'></span>ADDIN CSL_CITATION
{&quot;citationItems&quot;:[{&quot;id&quot;:&quot;ITEM-1&quot;,&quot;itemData&quot;:{&quot;DOI&quot;:&quot;10.1007/s11908-999-0039-x&quot;,&quot;ISBN&quot;:&quot;1523-3847
(Print)\\r1523-3847&quot;,&quot;ISSN&quot;:&quot;1534-3146&quot;,&quot;PMID&quot;:&quot;11095806&quot;,&quot;abstract&quot;:&quot;Evidence
linking antimicrobial use with resistance is compelling on the local, national,
and international levels. That resistance levels can be influenced by changing
patterns of use also seems clear. We must now determine how, as a global
society, to best use the resource of antimicrobials and how to protect novel
compounds that are just now becoming available from emerging resistance. We
must act not only within the arena of human use but also on use in animals and
for
crops.&quot;,&quot;author&quot;:[{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Shlaes&quot;,&quot;given&quot;:&quot;D
M&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;}],&quot;container-title&quot;:&quot;Current
infectious disease reports&quot;,&quot;id&quot;:&quot;ITEM-1&quot;,&quot;issue&quot;:&quot;4&quot;,&quot;issued&quot;:{&quot;date-parts&quot;:[[&quot;1999&quot;]]},&quot;page&quot;:&quot;334-337&quot;,&quot;title&quot;:&quot;Role
of Antimicrobial Stewardship in Prevention and Control of Antibiotic
Resistance.&quot;,&quot;type&quot;:&quot;article-journal&quot;,&quot;volume&quot;:&quot;1&quot;},&quot;uris&quot;:[&quot;http://www.mendeley.com/documents/?uuid=bd42774a-60af-4abc-8442-41bfa2ba18a7&quot;,&quot;http://www.mendeley.com/documents/?uuid=7c7dc36d-d361-42e9-967a-869cb0b6ce4a&quot;]}],&quot;mendeley&quot;:{&quot;formattedCitation&quot;:&quot;(3)&quot;,&quot;plainTextFormattedCitation&quot;:&quot;(3)&quot;,&quot;previouslyFormattedCitation&quot;:&quot;(3)&quot;},&quot;properties&quot;:{&quot;noteIndex&quot;:0},&quot;schema&quot;:&quot;https://github.com/citation-style-language/schema/raw/master/csl-citation.json&quot;}<span
style='mso-element:field-separator'></span></span><![endif]--><span lang=ES
style='font-size:10.0pt;line-height:105%;font-family:"Times New Roman",serif;
mso-fareast-font-family:Calibri;mso-ansi-language:ES'><span style='mso-no-proof:
yes'>(3)</span></span><!--[if supportFields]><span lang=ES style='font-size:
10.0pt;line-height:105%;font-family:"Times New Roman",serif;mso-fareast-font-family:
Calibri;mso-ansi-language:ES'><span style='mso-element:field-end'></span></span><![endif]--><span
lang=ES style='font-size:10.0pt;line-height:105%;font-family:"Times New Roman",serif;
mso-fareast-font-family:Calibri;mso-ansi-language:ES'>. Entre
Enterobacteriaceae se ha encontrado relación entre el consumo de
antimicrobianos como aminoglucósidos </span><!--[if supportFields]><span
lang=ES style='font-size:10.0pt;line-height:105%;font-family:"Times New Roman",serif;
mso-fareast-font-family:Calibri;mso-ansi-language:ES'><span style='mso-element:
field-begin;mso-field-lock:yes'></span>ADDIN CSL_CITATION
{&quot;citationItems&quot;:[{&quot;id&quot;:&quot;ITEM-1&quot;,&quot;itemData&quot;:{&quot;DOI&quot;:&quot;10.7860/JCDR/2015/11029.5537&quot;,&quot;ISSN&quot;:&quot;0973709X&quot;,&quot;PMID&quot;:&quot;25859453&quot;,&quot;abstract&quot;:&quot;INTRODUCTION:
Gram negative organisms are one of the major causes of nosocomial diseases.
Development of resistance to antibiotics by these organisms increases their
risk in clinical treatment of patients. It also affects morbidity and mortality
hence needs to be monitored and controlled.\\n\\nAIM: The aim of the present
study was to analyse the correlation between consumption of parenteral antibiotics
and the rates of antimicrobial resistance among the Escherichia coli and
Klebsiella pneumoniae isolates collected during Dec 2010 - Jun 2013 from JIPMER
hospital.\\n\\nMATERIALS AND METHODS: Consumption data of parenteral
antibiotics in J01 category of Anatomical Therapeutic Chemical (ATC) in JIPMER
was obtained and expressed in Defined Daily Doses (DDD) per 1000 inhabitants.
Valid consumption and resistance data during the period Dec 2010 to Jun 2013
were obtained at 6 month intervals and were correlated to draw a relationship
between antimicrobial consumption and its impact on drug resistance for
Escherichia coli and Klebsiella pneumoniae.\\n\\nRESULTS: Escherichia coli
isolates showed high resistance for increased use of gentamycin and ciprofloxacin.
Increase in antibiotic consumption increases the resistance for Escherichia
coli except for amikacin. Among the Klebsiella isolates, meropenem and
gentamycin showed high correlations followed by ceftazidime, amikacin,
ceftriaxone and ciprofloxacin.\\n\\nCONCLUSION: In summary, a statistically
significant association was noticed between consumption of the studied
antimicrobials and resistance of Escherichia coli isolates, except for amikacin
and ceftazidime. In the case of Klebsiella pneumoniae, there was a
statistically significant association between the resistance rates and
consumption of gentamycin, ceftazidime and meropenem. Further, a linear
relationship was noted between antimicrobial consumption and resistant isolates
of Escherichia coli and Klebsiella pneumoniae, except for Escherichia coli
resistance to
amikacin.&quot;,&quot;author&quot;:[{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Joseph&quot;,&quot;given&quot;:&quot;Noyal
Mariya&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Bhanupriya&quot;,&quot;given&quot;:&quot;B.&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Shewade&quot;,&quot;given&quot;:&quot;Deepak
Gopal&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Harish&quot;,&quot;given&quot;:&quot;Belgode
Narasimha&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;}],&quot;container-title&quot;:&quot;Journal
of Clinical and Diagnostic
Research&quot;,&quot;id&quot;:&quot;ITEM-1&quot;,&quot;issue&quot;:&quot;2&quot;,&quot;issued&quot;:{&quot;date-parts&quot;:[[&quot;2015&quot;]]},&quot;page&quot;:&quot;DC08-DC12&quot;,&quot;title&quot;:&quot;Relationship
between antimicrobial consumption and the incidence of antimicrobial resistance
in Escherichia coli and Klebsiella pneumoniae
isolates&quot;,&quot;type&quot;:&quot;article-journal&quot;,&quot;volume&quot;:&quot;9&quot;},&quot;uris&quot;:[&quot;http://www.mendeley.com/documents/?uuid=1a2667ee-8b6b-472e-9184-4324718e4e94&quot;]},{&quot;id&quot;:&quot;ITEM-2&quot;,&quot;itemData&quot;:{&quot;DOI&quot;:&quot;10.1186/1756-0500-7-454&quot;,&quot;ISSN&quot;:&quot;1756-0500&quot;,&quot;PMID&quot;:&quot;25027417&quot;,&quot;abstract&quot;:&quot;BACKGROUND:
Increasing bacterial resistance to antibiotics is one of the most serious
problems in current medicine. An important factor contributing to the growing
prevalence of multiresistant bacteria is application of antibiotics. This study
aimed at analyzing the development of resistance of Enterobacteriaceae to
selected beta-lactam, fluoroquinolone and aminoglycoside antibiotics in the
University Hospital Olomouc and assessing the effect of selection pressure of
these antibiotics.\\n\\nMETHODS: For the period between 1 January 2000 and 31
December 2011, resistance of Klebsiella pneumoniae, Escherichia coli,
Enterobacter cloacae and Proteus mirabilis to third- and fourth-generation
cephalosporins, meropenem, piperacillin/tazobactam, fluoroquinolones and
aminoglycosides was retrospectively studied. For the assessment of selection
pressure of antibiotics, a parameter of defined daily dose in absolute annual
consumption (DDDatb) based on the ATC/DDD classification and in relative annual
consumption (RDDDatb) as the number of defined daily doses per 100 bed-days was
used. The relationship between frequency of strains resistant to a particular
antibiotic and antibiotic consumption was assessed by linear regression
analysis using Spearman's correlation. The level of statistical significance
was set at p &lt; 0.05.\\n\\nRESULTS: A total of 113,027 isolates from the
Enterobacteriaceae family were analyzed. There was a significant effect of
selection pressure of the primary antibiotic in the following cases:
piperacillin/tazobactam in Klebsiella pneumoniae, gentamicin in Klebsiella
pneumoniae and Escherichia coli and amikacin in Escherichia coli and
Enterobacter cloacae. Also, there was significant correlation between
resistance to ceftazidime and consumption of piperacillin/tazobactam in
Klebsiella pneumoniae and Escherichia coli. No relationship was found between
consumption of third- and fourth-generation cephalosporins and resistance to
ceftazidime or between fluoroquinolone consumption and resistance to
ciprofloxacin.\\n\\nCONCLUSION: The study showed the effects of both direct and
indirect selection pressure on increasing resistance to gentamicin, amikacin,
piperacillin/tazobactam and ceftazidime. Given the fact that no correlation was
found between resistance to fluoroquinolones and consumption of either primary
or secondary antibiotics, we assume that the increasing resistance to
fluoroquinolones is probably due to circulation of resistance genes in the
bacte…&quot;,&quot;author&quot;:[{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Sedláková&quot;,&quot;given&quot;:&quot;Miroslava
Htoutou&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Urbánek&quot;,&quot;given&quot;:&quot;Karel&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Vojtová&quot;,&quot;given&quot;:&quot;Vladimíra&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Suchánková&quot;,&quot;given&quot;:&quot;Hana&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Imwensi&quot;,&quot;given&quot;:&quot;Peter&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Kolář&quot;,&quot;given&quot;:&quot;Milan&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;}],&quot;container-title&quot;:&quot;BMC
research
notes&quot;,&quot;id&quot;:&quot;ITEM-2&quot;,&quot;issued&quot;:{&quot;date-parts&quot;:[[&quot;2014&quot;]]},&quot;page&quot;:&quot;454&quot;,&quot;title&quot;:&quot;Antibiotic
consumption and its influence on the resistance in
Enterobacteriaceae.&quot;,&quot;type&quot;:&quot;article-journal&quot;,&quot;volume&quot;:&quot;7&quot;},&quot;uris&quot;:[&quot;http://www.mendeley.com/documents/?uuid=d140b723-2e2e-476d-aea0-17fa921efb40&quot;]}],&quot;mendeley&quot;:{&quot;formattedCitation&quot;:&quot;(24,25)&quot;,&quot;plainTextFormattedCitation&quot;:&quot;(24,25)&quot;,&quot;previouslyFormattedCitation&quot;:&quot;(24,25)&quot;},&quot;properties&quot;:{&quot;noteIndex&quot;:0},&quot;schema&quot;:&quot;https://github.com/citation-style-language/schema/raw/master/csl-citation.json&quot;}<span
style='mso-element:field-separator'></span></span><![endif]--><span lang=ES
style='font-size:10.0pt;line-height:105%;font-family:"Times New Roman",serif;
mso-fareast-font-family:Calibri;mso-ansi-language:ES'><span style='mso-no-proof:
yes'>(24,25)</span></span><!--[if supportFields]><span lang=ES
style='font-size:10.0pt;line-height:105%;font-family:"Times New Roman",serif;
mso-fareast-font-family:Calibri;mso-ansi-language:ES'><span style='mso-element:
field-end'></span></span><![endif]--><span lang=ES style='font-size:10.0pt;
line-height:105%;font-family:"Times New Roman",serif;mso-fareast-font-family:
Calibri;mso-ansi-language:ES'>, ceftriaxona </span><!--[if supportFields]><span
lang=ES style='font-size:10.0pt;line-height:105%;font-family:"Times New Roman",serif;
mso-fareast-font-family:Calibri;mso-ansi-language:ES'><span style='mso-element:
field-begin;mso-field-lock:yes'></span>ADDIN CSL_CITATION
{&quot;citationItems&quot;:[{&quot;id&quot;:&quot;ITEM-1&quot;,&quot;itemData&quot;:{&quot;DOI&quot;:&quot;10.7860/JCDR/2015/11029.5537&quot;,&quot;ISSN&quot;:&quot;0973709X&quot;,&quot;PMID&quot;:&quot;25859453&quot;,&quot;abstract&quot;:&quot;INTRODUCTION:
Gram negative organisms are one of the major causes of nosocomial diseases.
Development of resistance to antibiotics by these organisms increases their
risk in clinical treatment of patients. It also affects morbidity and mortality
hence needs to be monitored and controlled.\\n\\nAIM: The aim of the present
study was to analyse the correlation between consumption of parenteral
antibiotics and the rates of antimicrobial resistance among the Escherichia
coli and Klebsiella pneumoniae isolates collected during Dec 2010 - Jun 2013
from JIPMER hospital.\\n\\nMATERIALS AND METHODS: Consumption data of
parenteral antibiotics in J01 category of Anatomical Therapeutic Chemical (ATC)
in JIPMER was obtained and expressed in Defined Daily Doses (DDD) per 1000
inhabitants. Valid consumption and resistance data during the period Dec 2010
to Jun 2013 were obtained at 6 month intervals and were correlated to draw a
relationship between antimicrobial consumption and its impact on drug
resistance for Escherichia coli and Klebsiella pneumoniae.\\n\\nRESULTS:
Escherichia coli isolates showed high resistance for increased use of
gentamycin and ciprofloxacin. Increase in antibiotic consumption increases the
resistance for Escherichia coli except for amikacin. Among the Klebsiella isolates,
meropenem and gentamycin showed high correlations followed by ceftazidime,
amikacin, ceftriaxone and ciprofloxacin.\\n\\nCONCLUSION: In summary, a
statistically significant association was noticed between consumption of the
studied antimicrobials and resistance of Escherichia coli isolates, except for
amikacin and ceftazidime. In the case of Klebsiella pneumoniae, there was a
statistically significant association between the resistance rates and
consumption of gentamycin, ceftazidime and meropenem. Further, a linear
relationship was noted between antimicrobial consumption and resistant isolates
of Escherichia coli and Klebsiella pneumoniae, except for Escherichia coli
resistance to
amikacin.&quot;,&quot;author&quot;:[{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Joseph&quot;,&quot;given&quot;:&quot;Noyal
Mariya&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Bhanupriya&quot;,&quot;given&quot;:&quot;B.&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Shewade&quot;,&quot;given&quot;:&quot;Deepak
Gopal&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Harish&quot;,&quot;given&quot;:&quot;Belgode
Narasimha&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;}],&quot;container-title&quot;:&quot;Journal
of Clinical and Diagnostic Research&quot;,&quot;id&quot;:&quot;ITEM-1&quot;,&quot;issue&quot;:&quot;2&quot;,&quot;issued&quot;:{&quot;date-parts&quot;:[[&quot;2015&quot;]]},&quot;page&quot;:&quot;DC08-DC12&quot;,&quot;title&quot;:&quot;Relationship
between antimicrobial consumption and the incidence of antimicrobial resistance
in Escherichia coli and Klebsiella pneumoniae
isolates&quot;,&quot;type&quot;:&quot;article-journal&quot;,&quot;volume&quot;:&quot;9&quot;},&quot;uris&quot;:[&quot;http://www.mendeley.com/documents/?uuid=1a2667ee-8b6b-472e-9184-4324718e4e94&quot;]}],&quot;mendeley&quot;:{&quot;formattedCitation&quot;:&quot;(24)&quot;,&quot;plainTextFormattedCitation&quot;:&quot;(24)&quot;,&quot;previouslyFormattedCitation&quot;:&quot;(24)&quot;},&quot;properties&quot;:{&quot;noteIndex&quot;:0},&quot;schema&quot;:&quot;https://github.com/citation-style-language/schema/raw/master/csl-citation.json&quot;}<span
style='mso-element:field-separator'></span></span><![endif]--><span lang=ES
style='font-size:10.0pt;line-height:105%;font-family:"Times New Roman",serif;
mso-fareast-font-family:Calibri;mso-ansi-language:ES'><span style='mso-no-proof:
yes'>(24)</span></span><!--[if supportFields]><span lang=ES style='font-size:
10.0pt;line-height:105%;font-family:"Times New Roman",serif;mso-fareast-font-family:
Calibri;mso-ansi-language:ES'><span style='mso-element:field-end'></span></span><![endif]--><span
lang=ES style='font-size:10.0pt;line-height:105%;font-family:"Times New Roman",serif;
mso-fareast-font-family:Calibri;mso-ansi-language:ES'> y meropenem </span><!--[if supportFields]><span
lang=ES style='font-size:10.0pt;line-height:105%;font-family:"Times New Roman",serif;
mso-fareast-font-family:Calibri;mso-ansi-language:ES'><span style='mso-element:
field-begin;mso-field-lock:yes'></span>ADDIN CSL_CITATION {&quot;citationItems&quot;:[{&quot;id&quot;:&quot;ITEM-1&quot;,&quot;itemData&quot;:{&quot;DOI&quot;:&quot;10.7860/JCDR/2015/11029.5537&quot;,&quot;ISSN&quot;:&quot;0973709X&quot;,&quot;PMID&quot;:&quot;25859453&quot;,&quot;abstract&quot;:&quot;INTRODUCTION:
Gram negative organisms are one of the major causes of nosocomial diseases.
Development of resistance to antibiotics by these organisms increases their
risk in clinical treatment of patients. It also affects morbidity and mortality
hence needs to be monitored and controlled.\\n\\nAIM: The aim of the present
study was to analyse the correlation between consumption of parenteral
antibiotics and the rates of antimicrobial resistance among the Escherichia
coli and Klebsiella pneumoniae isolates collected during Dec 2010 - Jun 2013
from JIPMER hospital.\\n\\nMATERIALS AND METHODS: Consumption data of
parenteral antibiotics in J01 category of Anatomical Therapeutic Chemical (ATC)
in JIPMER was obtained and expressed in Defined Daily Doses (DDD) per 1000
inhabitants. Valid consumption and resistance data during the period Dec 2010
to Jun 2013 were obtained at 6 month intervals and were correlated to draw a
relationship between antimicrobial consumption and its impact on drug
resistance for Escherichia coli and Klebsiella pneumoniae.\\n\\nRESULTS:
Escherichia coli isolates showed high resistance for increased use of gentamycin
and ciprofloxacin. Increase in antibiotic consumption increases the resistance
for Escherichia coli except for amikacin. Among the Klebsiella isolates,
meropenem and gentamycin showed high correlations followed by ceftazidime,
amikacin, ceftriaxone and ciprofloxacin.\\n\\nCONCLUSION: In summary, a
statistically significant association was noticed between consumption of the
studied antimicrobials and resistance of Escherichia coli isolates, except for
amikacin and ceftazidime. In the case of Klebsiella pneumoniae, there was a
statistically significant association between the resistance rates and
consumption of gentamycin, ceftazidime and meropenem. Further, a linear
relationship was noted between antimicrobial consumption and resistant isolates
of Escherichia coli and Klebsiella pneumoniae, except for Escherichia coli
resistance to
amikacin.&quot;,&quot;author&quot;:[{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Joseph&quot;,&quot;given&quot;:&quot;Noyal
Mariya&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Bhanupriya&quot;,&quot;given&quot;:&quot;B.&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Shewade&quot;,&quot;given&quot;:&quot;Deepak
Gopal&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Harish&quot;,&quot;given&quot;:&quot;Belgode
Narasimha&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;}],&quot;container-title&quot;:&quot;Journal
of Clinical and Diagnostic Research&quot;,&quot;id&quot;:&quot;ITEM-1&quot;,&quot;issue&quot;:&quot;2&quot;,&quot;issued&quot;:{&quot;date-parts&quot;:[[&quot;2015&quot;]]},&quot;page&quot;:&quot;DC08-DC12&quot;,&quot;title&quot;:&quot;Relationship
between antimicrobial consumption and the incidence of antimicrobial resistance
in Escherichia coli and Klebsiella pneumoniae
isolates&quot;,&quot;type&quot;:&quot;article-journal&quot;,&quot;volume&quot;:&quot;9&quot;},&quot;uris&quot;:[&quot;http://www.mendeley.com/documents/?uuid=1a2667ee-8b6b-472e-9184-4324718e4e94&quot;]}],&quot;mendeley&quot;:{&quot;formattedCitation&quot;:&quot;(24)&quot;,&quot;plainTextFormattedCitation&quot;:&quot;(24)&quot;,&quot;previouslyFormattedCitation&quot;:&quot;(24)&quot;},&quot;properties&quot;:{&quot;noteIndex&quot;:0},&quot;schema&quot;:&quot;https://github.com/citation-style-language/schema/raw/master/csl-citation.json&quot;}<span
style='mso-element:field-separator'></span></span><![endif]--><span lang=ES
style='font-size:10.0pt;line-height:105%;font-family:"Times New Roman",serif;
mso-fareast-font-family:Calibri;mso-ansi-language:ES'><span style='mso-no-proof:
yes'>(24)</span></span><!--[if supportFields]><span lang=ES style='font-size:
10.0pt;line-height:105%;font-family:"Times New Roman",serif;mso-fareast-font-family:
Calibri;mso-ansi-language:ES'><span style='mso-element:field-end'></span></span><![endif]--><span
lang=ES style='font-size:10.0pt;line-height:105%;font-family:"Times New Roman",serif;
mso-fareast-font-family:Calibri;mso-ansi-language:ES'> con mayor resistencia en
<i style='mso-bidi-font-style:normal'>E. coli</i>. En la resistencia de <i
style='mso-bidi-font-style:normal'>K. pneumoniae</i> se han involucrado a
piperacilina y gentamicina, así mismo a la resistencia de <i style='mso-bidi-font-style:
normal'>E. cloacae</i> con el consumo de amikacina </span><!--[if supportFields]><span
lang=ES style='font-size:10.0pt;line-height:105%;font-family:"Times New Roman",serif;
mso-fareast-font-family:Calibri;mso-ansi-language:ES'><span style='mso-element:
field-begin;mso-field-lock:yes'></span>ADDIN CSL_CITATION
{&quot;citationItems&quot;:[{&quot;id&quot;:&quot;ITEM-1&quot;,&quot;itemData&quot;:{&quot;DOI&quot;:&quot;10.1186/1756-0500-7-454&quot;,&quot;ISSN&quot;:&quot;1756-0500&quot;,&quot;PMID&quot;:&quot;25027417&quot;,&quot;abstract&quot;:&quot;BACKGROUND:
Increasing bacterial resistance to antibiotics is one of the most serious
problems in current medicine. An important factor contributing to the growing
prevalence of multiresistant bacteria is application of antibiotics. This study
aimed at analyzing the development of resistance of Enterobacteriaceae to
selected beta-lactam, fluoroquinolone and aminoglycoside antibiotics in the
University Hospital Olomouc and assessing the effect of selection pressure of
these antibiotics.\\n\\nMETHODS: For the period between 1 January 2000 and 31
December 2011, resistance of Klebsiella pneumoniae, Escherichia coli,
Enterobacter cloacae and Proteus mirabilis to third- and fourth-generation
cephalosporins, meropenem, piperacillin/tazobactam, fluoroquinolones and
aminoglycosides was retrospectively studied. For the assessment of selection
pressure of antibiotics, a parameter of defined daily dose in absolute annual
consumption (DDDatb) based on the ATC/DDD classification and in relative annual
consumption (RDDDatb) as the number of defined daily doses per 100 bed-days was
used. The relationship between frequency of strains resistant to a particular
antibiotic and antibiotic consumption was assessed by linear regression
analysis using Spearman's correlation. The level of statistical significance
was set at p &lt; 0.05.\\n\\nRESULTS: A total of 113,027 isolates from the
Enterobacteriaceae family were analyzed. There was a significant effect of
selection pressure of the primary antibiotic in the following cases:
piperacillin/tazobactam in Klebsiella pneumoniae, gentamicin in Klebsiella
pneumoniae and Escherichia coli and amikacin in Escherichia coli and
Enterobacter cloacae. Also, there was significant correlation between
resistance to ceftazidime and consumption of piperacillin/tazobactam in
Klebsiella pneumoniae and Escherichia coli. No relationship was found between
consumption of third- and fourth-generation cephalosporins and resistance to
ceftazidime or between fluoroquinolone consumption and resistance to
ciprofloxacin.\\n\\nCONCLUSION: The study showed the effects of both direct and
indirect selection pressure on increasing resistance to gentamicin, amikacin,
piperacillin/tazobactam and ceftazidime. Given the fact that no correlation was
found between resistance to fluoroquinolones and consumption of either primary
or secondary antibiotics, we assume that the increasing resistance to
fluoroquinolones is probably due to circulation of resistance genes in the
bacte…&quot;,&quot;author&quot;:[{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Sedláková&quot;,&quot;given&quot;:&quot;Miroslava
Htoutou&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Urbánek&quot;,&quot;given&quot;:&quot;Karel&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Vojtová&quot;,&quot;given&quot;:&quot;Vladimíra&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Suchánková&quot;,&quot;given&quot;:&quot;Hana&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Imwensi&quot;,&quot;given&quot;:&quot;Peter&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Kolář&quot;,&quot;given&quot;:&quot;Milan&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;}],&quot;container-title&quot;:&quot;BMC
research
notes&quot;,&quot;id&quot;:&quot;ITEM-1&quot;,&quot;issued&quot;:{&quot;date-parts&quot;:[[&quot;2014&quot;]]},&quot;page&quot;:&quot;454&quot;,&quot;title&quot;:&quot;Antibiotic
consumption and its influence on the resistance in
Enterobacteriaceae.&quot;,&quot;type&quot;:&quot;article-journal&quot;,&quot;volume&quot;:&quot;7&quot;},&quot;uris&quot;:[&quot;http://www.mendeley.com/documents/?uuid=d140b723-2e2e-476d-aea0-17fa921efb40&quot;]}],&quot;mendeley&quot;:{&quot;formattedCitation&quot;:&quot;(25)&quot;,&quot;plainTextFormattedCitation&quot;:&quot;(25)&quot;,&quot;previouslyFormattedCitation&quot;:&quot;(25)&quot;},&quot;properties&quot;:{&quot;noteIndex&quot;:0},&quot;schema&quot;:&quot;https://github.com/citation-style-language/schema/raw/master/csl-citation.json&quot;}<span
style='mso-element:field-separator'></span></span><![endif]--><span lang=ES
style='font-size:10.0pt;line-height:105%;font-family:"Times New Roman",serif;
mso-fareast-font-family:Calibri;mso-ansi-language:ES'><span style='mso-no-proof:
yes'>(25)</span></span><!--[if supportFields]><span lang=ES style='font-size:
10.0pt;line-height:105%;font-family:"Times New Roman",serif;mso-fareast-font-family:
Calibri;mso-ansi-language:ES'><span style='mso-element:field-end'></span></span><![endif]--><span
lang=ES style='font-size:10.0pt;line-height:105%;font-family:"Times New Roman",serif;
mso-fareast-font-family:Calibri;mso-ansi-language:ES'>. En el caso de <i
style='mso-bidi-font-style:normal'>P. aeruginosa</i> se han involucrado las
tasas de consumo a la resistencia en el caso de gentamicina, ceftazidima y
meropenem </span><!--[if supportFields]><span lang=ES style='font-size:10.0pt;
line-height:105%;font-family:"Times New Roman",serif;mso-fareast-font-family:
Calibri;mso-ansi-language:ES'><span style='mso-element:field-begin;mso-field-lock:
yes'></span>ADDIN CSL_CITATION
{&quot;citationItems&quot;:[{&quot;id&quot;:&quot;ITEM-1&quot;,&quot;itemData&quot;:{&quot;DOI&quot;:&quot;10.7860/JCDR/2015/11029.5537&quot;,&quot;ISSN&quot;:&quot;0973709X&quot;,&quot;PMID&quot;:&quot;25859453&quot;,&quot;abstract&quot;:&quot;INTRODUCTION:
Gram negative organisms are one of the major causes of nosocomial diseases.
Development of resistance to antibiotics by these organisms increases their
risk in clinical treatment of patients. It also affects morbidity and mortality
hence needs to be monitored and controlled.\\n\\nAIM: The aim of the present
study was to analyse the correlation between consumption of parenteral
antibiotics and the rates of antimicrobial resistance among the Escherichia
coli and Klebsiella pneumoniae isolates collected during Dec 2010 - Jun 2013
from JIPMER hospital.\\n\\nMATERIALS AND METHODS: Consumption data of
parenteral antibiotics in J01 category of Anatomical Therapeutic Chemical (ATC)
in JIPMER was obtained and expressed in Defined Daily Doses (DDD) per 1000
inhabitants. Valid consumption and resistance data during the period Dec 2010
to Jun 2013 were obtained at 6 month intervals and were correlated to draw a
relationship between antimicrobial consumption and its impact on drug
resistance for Escherichia coli and Klebsiella pneumoniae.\\n\\nRESULTS:
Escherichia coli isolates showed high resistance for increased use of
gentamycin and ciprofloxacin. Increase in antibiotic consumption increases the
resistance for Escherichia coli except for amikacin. Among the Klebsiella
isolates, meropenem and gentamycin showed high correlations followed by
ceftazidime, amikacin, ceftriaxone and ciprofloxacin.\\n\\nCONCLUSION: In
summary, a statistically significant association was noticed between
consumption of the studied antimicrobials and resistance of Escherichia coli
isolates, except for amikacin and ceftazidime. In the case of Klebsiella
pneumoniae, there was a statistically significant association between the
resistance rates and consumption of gentamycin, ceftazidime and meropenem.
Further, a linear relationship was noted between antimicrobial consumption and
resistant isolates of Escherichia coli and Klebsiella pneumoniae, except for
Escherichia coli resistance to
amikacin.&quot;,&quot;author&quot;:[{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Joseph&quot;,&quot;given&quot;:&quot;Noyal
Mariya&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Bhanupriya&quot;,&quot;given&quot;:&quot;B.&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Shewade&quot;,&quot;given&quot;:&quot;Deepak
Gopal&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Harish&quot;,&quot;given&quot;:&quot;Belgode
Narasimha&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;}],&quot;container-title&quot;:&quot;Journal
of Clinical and Diagnostic
Research&quot;,&quot;id&quot;:&quot;ITEM-1&quot;,&quot;issue&quot;:&quot;2&quot;,&quot;issued&quot;:{&quot;date-parts&quot;:[[&quot;2015&quot;]]},&quot;page&quot;:&quot;DC08-DC12&quot;,&quot;title&quot;:&quot;Relationship
between antimicrobial consumption and the incidence of antimicrobial resistance
in Escherichia coli and Klebsiella pneumoniae
isolates&quot;,&quot;type&quot;:&quot;article-journal&quot;,&quot;volume&quot;:&quot;9&quot;},&quot;uris&quot;:[&quot;http://www.mendeley.com/documents/?uuid=1a2667ee-8b6b-472e-9184-4324718e4e94&quot;]}],&quot;mendeley&quot;:{&quot;formattedCitation&quot;:&quot;(24)&quot;,&quot;plainTextFormattedCitation&quot;:&quot;(24)&quot;,&quot;previouslyFormattedCitation&quot;:&quot;(24)&quot;},&quot;properties&quot;:{&quot;noteIndex&quot;:0},&quot;schema&quot;:&quot;https://github.com/citation-style-language/schema/raw/master/csl-citation.json&quot;}<span
style='mso-element:field-separator'></span></span><![endif]--><span lang=ES
style='font-size:10.0pt;line-height:105%;font-family:"Times New Roman",serif;
mso-fareast-font-family:Calibri;mso-ansi-language:ES'><span style='mso-no-proof:
yes'>(24)</span></span><!--[if supportFields]><span lang=ES style='font-size:
10.0pt;line-height:105%;font-family:"Times New Roman",serif;mso-fareast-font-family:
Calibri;mso-ansi-language:ES'><span style='mso-element:field-end'></span></span><![endif]--><span
lang=ES style='font-size:10.0pt;line-height:105%;font-family:"Times New Roman",serif;
mso-fareast-font-family:Calibri;mso-ansi-language:ES'>. Con respecto a las
fluoroquinolonas en varios estudios se ha demostrado la relación </span><!--[if supportFields]><span
lang=ES style='font-size:10.0pt;line-height:105%;font-family:"Times New Roman",serif;
mso-fareast-font-family:Calibri;mso-ansi-language:ES'><span style='mso-element:
field-begin;mso-field-lock:yes'></span>ADDIN CSL_CITATION
{&quot;citationItems&quot;:[{&quot;id&quot;:&quot;ITEM-1&quot;,&quot;itemData&quot;:{&quot;DOI&quot;:&quot;10.1093/jac/dkh510&quot;,&quot;ISSN&quot;:&quot;03057453&quot;,&quot;PMID&quot;:&quot;15574472&quot;,&quot;abstract&quot;:&quot;OBJECTIVES:
To compare rates of in vitro fluoroquinolone resistance of bacterial isolates
obtained from inpatients of two haematology-oncology services with high and low
fluoroquinolone consumption. METHODS: Two hospitals with consistently high (A)
and low (B) fluoroquinolone use in their haematology-oncology services between
the years 1999 and 2002 were identified in a hospital antibiotic use
surveillance project. Rates of in vitro resistance to fluoroquinolones in
inpatients of the services were determined for Escherichia coli and
coagulase-negative staphylococcal bloodstream isolates, and also for Pseudomonas
aeruginosa and Staphylococcus aureus isolates from any site. RESULTS:
Fluoroquinolone resistance of E. coli was significantly higher in hospital A
than in hospital B, but there was no such correlation between fluoroquinolone
use and resistance rates for P. aeruginosa and staphylococci. CONCLUSION: The
impact of antibiotic consumption on the prevalence of resistance may differ
widely between different pathogens. Interventions using ecological analyses of
the relationship between hospital antibiotic use and resistance need to
consider pathogen-specific dynamics in the emergence and control of bacterial
resistance.&quot;,&quot;author&quot;:[{&quot;dropping-particle&quot;:&quot;V.&quot;,&quot;family&quot;:&quot;Kern&quot;,&quot;given&quot;:&quot;Winfried&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Steib-Bauert&quot;,&quot;given&quot;:&quot;Michaela&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;With&quot;,&quot;given&quot;:&quot;Katja&quot;,&quot;non-dropping-particle&quot;:&quot;de&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Reuter&quot;,&quot;given&quot;:&quot;Stefan&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Bertz&quot;,&quot;given&quot;:&quot;Hartmut&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Frank&quot;,&quot;given&quot;:&quot;Uwe&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Baum&quot;,&quot;given&quot;:&quot;Heike&quot;,&quot;non-dropping-particle&quot;:&quot;von&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;}],&quot;container-title&quot;:&quot;Journal
of Antimicrobial Chemotherapy&quot;,&quot;id&quot;:&quot;ITEM-1&quot;,&quot;issue&quot;:&quot;1&quot;,&quot;issued&quot;:{&quot;date-parts&quot;:[[&quot;2005&quot;]]},&quot;page&quot;:&quot;57-60&quot;,&quot;title&quot;:&quot;Fluoroquinolone
consumption and resistance in haematology-oncology patients: Ecological
analysis in two university hospitals
1999-2002&quot;,&quot;type&quot;:&quot;article-journal&quot;,&quot;volume&quot;:&quot;55&quot;},&quot;uris&quot;:[&quot;http://www.mendeley.com/documents/?uuid=eef49272-7dc3-4b9b-888b-74f55d84ade4&quot;]},{&quot;id&quot;:&quot;ITEM-2&quot;,&quot;itemData&quot;:{&quot;DOI&quot;:&quot;10.7860/JCDR/2015/11029.5537&quot;,&quot;ISSN&quot;:&quot;0973709X&quot;,&quot;PMID&quot;:&quot;25859453&quot;,&quot;abstract&quot;:&quot;INTRODUCTION:
Gram negative organisms are one of the major causes of nosocomial diseases.
Development of resistance to antibiotics by these organisms increases their
risk in clinical treatment of patients. It also affects morbidity and mortality
hence needs to be monitored and controlled.\\n\\nAIM: The aim of the present
study was to analyse the correlation between consumption of parenteral
antibiotics and the rates of antimicrobial resistance among the Escherichia
coli and Klebsiella pneumoniae isolates collected during Dec 2010 - Jun 2013
from JIPMER hospital.\\n\\nMATERIALS AND METHODS: Consumption data of
parenteral antibiotics in J01 category of Anatomical Therapeutic Chemical (ATC)
in JIPMER was obtained and expressed in Defined Daily Doses (DDD) per 1000
inhabitants. Valid consumption and resistance data during the period Dec 2010
to Jun 2013 were obtained at 6 month intervals and were correlated to draw a
relationship between antimicrobial consumption and its impact on drug
resistance for Escherichia coli and Klebsiella pneumoniae.\\n\\nRESULTS:
Escherichia coli isolates showed high resistance for increased use of
gentamycin and ciprofloxacin. Increase in antibiotic consumption increases the
resistance for Escherichia coli except for amikacin. Among the Klebsiella
isolates, meropenem and gentamycin showed high correlations followed by
ceftazidime, amikacin, ceftriaxone and ciprofloxacin.\\n\\nCONCLUSION: In
summary, a statistically significant association was noticed between
consumption of the studied antimicrobials and resistance of Escherichia coli
isolates, except for amikacin and ceftazidime. In the case of Klebsiella
pneumoniae, there was a statistically significant association between the
resistance rates and consumption of gentamycin, ceftazidime and meropenem.
Further, a linear relationship was noted between antimicrobial consumption and
resistant isolates of Escherichia coli and Klebsiella pneumoniae, except for
Escherichia coli resistance to
amikacin.&quot;,&quot;author&quot;:[{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Joseph&quot;,&quot;given&quot;:&quot;Noyal
Mariya&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Bhanupriya&quot;,&quot;given&quot;:&quot;B.&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Shewade&quot;,&quot;given&quot;:&quot;Deepak
Gopal&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Harish&quot;,&quot;given&quot;:&quot;Belgode
Narasimha&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;}],&quot;container-title&quot;:&quot;Journal
of Clinical and Diagnostic
Research&quot;,&quot;id&quot;:&quot;ITEM-2&quot;,&quot;issue&quot;:&quot;2&quot;,&quot;issued&quot;:{&quot;date-parts&quot;:[[&quot;2015&quot;]]},&quot;page&quot;:&quot;DC08-DC12&quot;,&quot;title&quot;:&quot;Relationship
between antimicrobial consumption and the incidence of antimicrobial resistance
in Escherichia coli and Klebsiella pneumoniae isolates&quot;,&quot;type&quot;:&quot;article-journal&quot;,&quot;volume&quot;:&quot;9&quot;},&quot;uris&quot;:[&quot;http://www.mendeley.com/documents/?uuid=1a2667ee-8b6b-472e-9184-4324718e4e94&quot;]}],&quot;mendeley&quot;:{&quot;formattedCitation&quot;:&quot;(20,24)&quot;,&quot;plainTextFormattedCitation&quot;:&quot;(20,24)&quot;,&quot;previouslyFormattedCitation&quot;:&quot;(20,24)&quot;},&quot;properties&quot;:{&quot;noteIndex&quot;:0},&quot;schema&quot;:&quot;https://github.com/citation-style-language/schema/raw/master/csl-citation.json&quot;}<span
style='mso-element:field-separator'></span></span><![endif]--><span lang=ES
style='font-size:10.0pt;line-height:105%;font-family:"Times New Roman",serif;
mso-fareast-font-family:Calibri;mso-ansi-language:ES'><span style='mso-no-proof:
yes'>(20,24)</span></span><!--[if supportFields]><span lang=ES
style='font-size:10.0pt;line-height:105%;font-family:"Times New Roman",serif;
mso-fareast-font-family:Calibri;mso-ansi-language:ES'><span style='mso-element:
field-end'></span></span><![endif]--><span lang=ES style='font-size:10.0pt;
line-height:105%;font-family:"Times New Roman",serif;mso-fareast-font-family:
Calibri;mso-ansi-language:ES'>, pero en otros se ha encontrado que se alcanzado
un umbral en el cual la transferencia horizontal de determinantes de
resistencia es tan alta, que su propagación es independiente del consumo </span><!--[if supportFields]><span
lang=ES style='font-size:10.0pt;line-height:105%;font-family:"Times New Roman",serif;
mso-fareast-font-family:Calibri;mso-ansi-language:ES'><span style='mso-element:
field-begin;mso-field-lock:yes'></span>ADDIN CSL_CITATION
{&quot;citationItems&quot;:[{&quot;id&quot;:&quot;ITEM-1&quot;,&quot;itemData&quot;:{&quot;DOI&quot;:&quot;10.1186/1756-0500-7-454&quot;,&quot;ISSN&quot;:&quot;1756-0500&quot;,&quot;PMID&quot;:&quot;25027417&quot;,&quot;abstract&quot;:&quot;BACKGROUND:
Increasing bacterial resistance to antibiotics is one of the most serious
problems in current medicine. An important factor contributing to the growing
prevalence of multiresistant bacteria is application of antibiotics. This study
aimed at analyzing the development of resistance of Enterobacteriaceae to
selected beta-lactam, fluoroquinolone and aminoglycoside antibiotics in the
University Hospital Olomouc and assessing the effect of selection pressure of
these antibiotics.\\n\\nMETHODS: For the period between 1 January 2000 and 31
December 2011, resistance of Klebsiella pneumoniae, Escherichia coli,
Enterobacter cloacae and Proteus mirabilis to third- and fourth-generation
cephalosporins, meropenem, piperacillin/tazobactam, fluoroquinolones and
aminoglycosides was retrospectively studied. For the assessment of selection
pressure of antibiotics, a parameter of defined daily dose in absolute annual
consumption (DDDatb) based on the ATC/DDD classification and in relative annual
consumption (RDDDatb) as the number of defined daily doses per 100 bed-days was
used. The relationship between frequency of strains resistant to a particular
antibiotic and antibiotic consumption was assessed by linear regression
analysis using Spearman's correlation. The level of statistical significance
was set at p &lt; 0.05.\\n\\nRESULTS: A total of 113,027 isolates from the Enterobacteriaceae
family were analyzed. There was a significant effect of selection pressure of
the primary antibiotic in the following cases: piperacillin/tazobactam in
Klebsiella pneumoniae, gentamicin in Klebsiella pneumoniae and Escherichia coli
and amikacin in Escherichia coli and Enterobacter cloacae. Also, there was
significant correlation between resistance to ceftazidime and consumption of
piperacillin/tazobactam in Klebsiella pneumoniae and Escherichia coli. No
relationship was found between consumption of third- and fourth-generation
cephalosporins and resistance to ceftazidime or between fluoroquinolone
consumption and resistance to ciprofloxacin.\\n\\nCONCLUSION: The study showed
the effects of both direct and indirect selection pressure on increasing
resistance to gentamicin, amikacin, piperacillin/tazobactam and ceftazidime.
Given the fact that no correlation was found between resistance to
fluoroquinolones and consumption of either primary or secondary antibiotics, we
assume that the increasing resistance to fluoroquinolones is probably due to
circulation of resistance genes in the
bacte…&quot;,&quot;author&quot;:[{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Sedláková&quot;,&quot;given&quot;:&quot;Miroslava
Htoutou&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Urbánek&quot;,&quot;given&quot;:&quot;Karel&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Vojtová&quot;,&quot;given&quot;:&quot;Vladimíra&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Suchánková&quot;,&quot;given&quot;:&quot;Hana&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Imwensi&quot;,&quot;given&quot;:&quot;Peter&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Kolář&quot;,&quot;given&quot;:&quot;Milan&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;}],&quot;container-title&quot;:&quot;BMC
research notes&quot;,&quot;id&quot;:&quot;ITEM-1&quot;,&quot;issued&quot;:{&quot;date-parts&quot;:[[&quot;2014&quot;]]},&quot;page&quot;:&quot;454&quot;,&quot;title&quot;:&quot;Antibiotic
consumption and its influence on the resistance in Enterobacteriaceae.&quot;,&quot;type&quot;:&quot;article-journal&quot;,&quot;volume&quot;:&quot;7&quot;},&quot;uris&quot;:[&quot;http://www.mendeley.com/documents/?uuid=d140b723-2e2e-476d-aea0-17fa921efb40&quot;]}],&quot;mendeley&quot;:{&quot;formattedCitation&quot;:&quot;(25)&quot;,&quot;plainTextFormattedCitation&quot;:&quot;(25)&quot;,&quot;previouslyFormattedCitation&quot;:&quot;(25)&quot;},&quot;properties&quot;:{&quot;noteIndex&quot;:0},&quot;schema&quot;:&quot;https://github.com/citation-style-language/schema/raw/master/csl-citation.json&quot;}<span
style='mso-element:field-separator'></span></span><![endif]--><span lang=ES
style='font-size:10.0pt;line-height:105%;font-family:"Times New Roman",serif;
mso-fareast-font-family:Calibri;mso-ansi-language:ES'><span style='mso-no-proof:
yes'>(25)</span></span><!--[if supportFields]><span lang=ES style='font-size:
10.0pt;line-height:105%;font-family:"Times New Roman",serif;mso-fareast-font-family:
Calibri;mso-ansi-language:ES'><span style='mso-element:field-end'></span></span><![endif]--><span
lang=ES style='font-size:10.0pt;line-height:105%;font-family:"Times New Roman",serif;
mso-fareast-font-family:Calibri;mso-ansi-language:ES'>. <o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0mm;margin-bottom:.0001pt;text-align:
justify;text-indent:11.35pt;line-height:105%'><span lang=ES style='font-size:
10.0pt;line-height:105%;font-family:"Times New Roman",serif;mso-fareast-font-family:
Calibri;mso-ansi-language:ES'><o:p>&nbsp;</o:p></span></p>

<p class=MsoNormal style='margin-bottom:0mm;margin-bottom:.0001pt;text-align:
justify;text-indent:11.35pt;line-height:105%'><span lang=ES style='font-size:
10.0pt;line-height:105%;font-family:"Times New Roman",serif;mso-fareast-font-family:
Calibri;mso-ansi-language:ES'>En el caso de <i style='mso-bidi-font-style:normal'>Staphylococcus
aureus</i> se ha encontrado una relación positiva entre el consumo de
combinaciones con β-lactámicos y resistencia a meticilina, quinolonas y
aminoglucósidos, consumo de carbapenémicos y resistencia a quinolonas </span><!--[if supportFields]><span
lang=ES style='font-size:10.0pt;line-height:105%;font-family:"Times New Roman",serif;
mso-fareast-font-family:Calibri;mso-ansi-language:ES'><span style='mso-element:
field-begin;mso-field-lock:yes'></span>ADDIN CSL_CITATION
{&quot;citationItems&quot;:[{&quot;id&quot;:&quot;ITEM-1&quot;,&quot;itemData&quot;:{&quot;DOI&quot;:&quot;10.1089/1076629041310019&quot;,&quot;ISBN&quot;:&quot;1076-6294
(Print)&quot;,&quot;ISSN&quot;:&quot;1076-6294&quot;,&quot;PMID&quot;:&quot;15256033&quot;,&quot;abstract&quot;:&quot;Antibiotic
consumption during 1996 was measured in 15 large hospitals from 14 countries
and 3000 consecutive Staphylococcus aureus samples were collected, allowing
calculation of local resistance rates and typing of isolates. Antibiotic
consumption data were converted to defined daily doses (DDD), and similar
antibiotics were grouped if they belonged to the same therapeutic subgroup.
Variations in hospital size were corrected by using DDD per 1000 bed-days. The
total antibiotic consumption in the 15 hospitals varied between 296 DDD/1000
bed-days and 1108 DDD/1000 bed-days. Differences in the usage of therapeutical
subgroups of antimicrobials varied significantly between hospitals. A positive
correlation was found between S. aureus resistance to methicillin (MRSA) and
consumption of beta-lactam combinations, between resistance to quinolones and
consumption of beta-lactam combinations and carbapenems and resistance to
aminoglycosides and consumption of beta-lactam combinations. The consumption of
beta-lactamase-sensitive antibiotics was negatively correlated to resistance to
methicillin, quinolones, and aminoglycosides. Usage of the different
antimicrobial therapeutical subgroups was also correlated. Consumption of
beta-lactamase-sensitive antibiotics (penicillin) was positively correlated to
consumption of beta-lactamase-resistant penicillins and negatively correlated
to consumption of carbapenems, quinolones, and glycopeptides, whereas
consumption of cephalosporins was positively correlated to consumption of
aminoglycosides, quinolones, and glycopeptides. In this study of hospitals with
MRSA prevalence of between 0% and 63%, significant correlations were found
between resistance and consumption of antimicrobials. These findings support the
importance of antimicrobial consumption on resistance. An accompanying paper
addresses the issue of antibiotic resistance and clonality of
isolates&quot;,&quot;author&quot;:[{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Westh&quot;,&quot;given&quot;:&quot;H&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Zinn&quot;,&quot;given&quot;:&quot;C
S&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Rosdahl&quot;,&quot;given&quot;:&quot;V
T&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;}],&quot;container-title&quot;:&quot;Microb
Drug
Resist&quot;,&quot;id&quot;:&quot;ITEM-1&quot;,&quot;issue&quot;:&quot;1076-6294
(Print)&quot;,&quot;issued&quot;:{&quot;date-parts&quot;:[[&quot;2004&quot;]]},&quot;page&quot;:&quot;169-176&quot;,&quot;title&quot;:&quot;An
international multicenter study of antimicrobial consumption and resistance in
Staphylococcus aureus isolates from 15 hospitals in 14
countries&quot;,&quot;type&quot;:&quot;article-journal&quot;,&quot;volume&quot;:&quot;10&quot;},&quot;uris&quot;:[&quot;http://www.mendeley.com/documents/?uuid=70274d2c-6304-46d3-8be4-0a4d4190aa12&quot;]}],&quot;mendeley&quot;:{&quot;formattedCitation&quot;:&quot;(26)&quot;,&quot;plainTextFormattedCitation&quot;:&quot;(26)&quot;,&quot;previouslyFormattedCitation&quot;:&quot;(26)&quot;},&quot;properties&quot;:{&quot;noteIndex&quot;:0},&quot;schema&quot;:&quot;https://github.com/citation-style-language/schema/raw/master/csl-citation.json&quot;}<span
style='mso-element:field-separator'></span></span><![endif]--><span lang=ES
style='font-size:10.0pt;line-height:105%;font-family:"Times New Roman",serif;
mso-fareast-font-family:Calibri;mso-ansi-language:ES'><span style='mso-no-proof:
yes'>(26)</span></span><!--[if supportFields]><span lang=ES style='font-size:
10.0pt;line-height:105%;font-family:"Times New Roman",serif;mso-fareast-font-family:
Calibri;mso-ansi-language:ES'><span style='mso-element:field-end'></span></span><![endif]--><span
lang=ES style='font-size:10.0pt;line-height:105%;font-family:"Times New Roman",serif;
mso-fareast-font-family:Calibri;mso-ansi-language:ES'>. Sin embargo en algunos
estudios no ha sido tan fácil demostrar la relación entre resistencia por parte
de cocos Gram-positivos y el consumo de antibióticos </span><!--[if supportFields]><span
lang=ES style='font-size:10.0pt;line-height:105%;font-family:"Times New Roman",serif;
mso-fareast-font-family:Calibri;mso-ansi-language:ES'><span style='mso-element:
field-begin;mso-field-lock:yes'></span>ADDIN CSL_CITATION
{&quot;citationItems&quot;:[{&quot;id&quot;:&quot;ITEM-1&quot;,&quot;itemData&quot;:{&quot;DOI&quot;:&quot;10.1093/jac/dkh510&quot;,&quot;ISSN&quot;:&quot;03057453&quot;,&quot;PMID&quot;:&quot;15574472&quot;,&quot;abstract&quot;:&quot;OBJECTIVES:
To compare rates of in vitro fluoroquinolone resistance of bacterial isolates
obtained from inpatients of two haematology-oncology services with high and low
fluoroquinolone consumption. METHODS: Two hospitals with consistently high (A)
and low (B) fluoroquinolone use in their haematology-oncology services between
the years 1999 and 2002 were identified in a hospital antibiotic use
surveillance project. Rates of in vitro resistance to fluoroquinolones in
inpatients of the services were determined for Escherichia coli and
coagulase-negative staphylococcal bloodstream isolates, and also for
Pseudomonas aeruginosa and Staphylococcus aureus isolates from any site.
RESULTS: Fluoroquinolone resistance of E. coli was significantly higher in
hospital A than in hospital B, but there was no such correlation between
fluoroquinolone use and resistance rates for P. aeruginosa and staphylococci.
CONCLUSION: The impact of antibiotic consumption on the prevalence of
resistance may differ widely between different pathogens. Interventions using
ecological analyses of the relationship between hospital antibiotic use and
resistance need to consider pathogen-specific dynamics in the emergence and
control of bacterial
resistance.&quot;,&quot;author&quot;:[{&quot;dropping-particle&quot;:&quot;V.&quot;,&quot;family&quot;:&quot;Kern&quot;,&quot;given&quot;:&quot;Winfried&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Steib-Bauert&quot;,&quot;given&quot;:&quot;Michaela&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;With&quot;,&quot;given&quot;:&quot;Katja&quot;,&quot;non-dropping-particle&quot;:&quot;de&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Reuter&quot;,&quot;given&quot;:&quot;Stefan&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Bertz&quot;,&quot;given&quot;:&quot;Hartmut&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Frank&quot;,&quot;given&quot;:&quot;Uwe&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Baum&quot;,&quot;given&quot;:&quot;Heike&quot;,&quot;non-dropping-particle&quot;:&quot;von&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;}],&quot;container-title&quot;:&quot;Journal
of Antimicrobial
Chemotherapy&quot;,&quot;id&quot;:&quot;ITEM-1&quot;,&quot;issue&quot;:&quot;1&quot;,&quot;issued&quot;:{&quot;date-parts&quot;:[[&quot;2005&quot;]]},&quot;page&quot;:&quot;57-60&quot;,&quot;title&quot;:&quot;Fluoroquinolone
consumption and resistance in haematology-oncology patients: Ecological
analysis in two university hospitals 1999-2002&quot;,&quot;type&quot;:&quot;article-journal&quot;,&quot;volume&quot;:&quot;55&quot;},&quot;uris&quot;:[&quot;http://www.mendeley.com/documents/?uuid=eef49272-7dc3-4b9b-888b-74f55d84ade4&quot;]}],&quot;mendeley&quot;:{&quot;formattedCitation&quot;:&quot;(20)&quot;,&quot;plainTextFormattedCitation&quot;:&quot;(20)&quot;,&quot;previouslyFormattedCitation&quot;:&quot;(20)&quot;},&quot;properties&quot;:{&quot;noteIndex&quot;:0},&quot;schema&quot;:&quot;https://github.com/citation-style-language/schema/raw/master/csl-citation.json&quot;}<span
style='mso-element:field-separator'></span></span><![endif]--><span lang=ES
style='font-size:10.0pt;line-height:105%;font-family:"Times New Roman",serif;
mso-fareast-font-family:Calibri;mso-ansi-language:ES'><span style='mso-no-proof:
yes'>(20)</span></span><!--[if supportFields]><span lang=ES style='font-size:
10.0pt;line-height:105%;font-family:"Times New Roman",serif;mso-fareast-font-family:
Calibri;mso-ansi-language:ES'><span style='mso-element:field-end'></span></span><![endif]--><span
lang=ES style='font-size:10.0pt;line-height:105%;font-family:"Times New Roman",serif;
mso-fareast-font-family:Calibri;mso-ansi-language:ES'>. En ocasiones la
relación entre consumo de antimicrobianos y resistencia no es tan clara debido
a sesgos ecológicos. Por ende se deben realizar análisis de datos a nivel de
paciente con el fin de elucidar mejor la relación entre ambos factores </span><!--[if supportFields]><span
lang=ES style='font-size:10.0pt;line-height:105%;font-family:"Times New Roman",serif;
mso-fareast-font-family:Calibri;mso-ansi-language:ES'><span style='mso-element:
field-begin;mso-field-lock:yes'></span>ADDIN CSL_CITATION
{&quot;citationItems&quot;:[{&quot;id&quot;:&quot;ITEM-1&quot;,&quot;itemData&quot;:{&quot;author&quot;:[{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Harbarth&quot;,&quot;given&quot;:&quot;Stephan&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Harris&quot;,&quot;given&quot;:&quot;Anthony
D&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Carmeli&quot;,&quot;given&quot;:&quot;Yehuda&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Samore&quot;,&quot;given&quot;:&quot;Matthew
H&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;}],&quot;container-title&quot;:&quot;Clinical
infectious
diseases&quot;,&quot;id&quot;:&quot;ITEM-1&quot;,&quot;issued&quot;:{&quot;date-parts&quot;:[[&quot;2001&quot;]]},&quot;page&quot;:&quot;1462-168&quot;,&quot;title&quot;:&quot;Parallel
Analysis of Individual and Aggregated Data on Antibiotic Exposure and
Resistance in Gram-Negative
Bacilli&quot;,&quot;type&quot;:&quot;article-journal&quot;,&quot;volume&quot;:&quot;33&quot;},&quot;uris&quot;:[&quot;http://www.mendeley.com/documents/?uuid=4d065c2b-2a0e-42b9-afb9-97685e6fdb92&quot;]}],&quot;mendeley&quot;:{&quot;formattedCitation&quot;:&quot;(19)&quot;,&quot;plainTextFormattedCitation&quot;:&quot;(19)&quot;,&quot;previouslyFormattedCitation&quot;:&quot;(19)&quot;},&quot;properties&quot;:{&quot;noteIndex&quot;:0},&quot;schema&quot;:&quot;https://github.com/citation-style-language/schema/raw/master/csl-citation.json&quot;}<span
style='mso-element:field-separator'></span></span><![endif]--><span lang=ES
style='font-size:10.0pt;line-height:105%;font-family:"Times New Roman",serif;
mso-fareast-font-family:Calibri;mso-ansi-language:ES'><span style='mso-no-proof:
yes'>(19)</span></span><!--[if supportFields]><span lang=ES style='font-size:
10.0pt;line-height:105%;font-family:"Times New Roman",serif;mso-fareast-font-family:
Calibri;mso-ansi-language:ES'><span style='mso-element:field-end'></span></span><![endif]--><span
lang=ES style='font-size:10.0pt;line-height:105%;font-family:"Times New Roman",serif;
mso-fareast-font-family:Calibri;mso-ansi-language:ES'>.<o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0mm;margin-bottom:.0001pt;text-align:
justify;text-indent:11.35pt;line-height:105%'><span lang=ES style='font-size:
10.0pt;line-height:105%;font-family:"Times New Roman",serif;mso-fareast-font-family:
Calibri;mso-ansi-language:ES'><o:p>&nbsp;</o:p></span></p>

<p class=MsoNormal style='margin-bottom:0mm;margin-bottom:.0001pt;text-align:
justify;text-indent:11.35pt;line-height:105%'><span lang=ES style='font-size:
10.0pt;line-height:105%;font-family:"Times New Roman",serif;mso-fareast-font-family:
Calibri;mso-ansi-language:ES'>La relación entre la intensidad del uso de
antimicrobianos y la probabilidad de reacciones adversas a medicamentos no ha
podido ser establecida de una manera clara. Sin embargo el reporte de las
mismas e implementación de estrategias para reducir su incidencia son
importantes con el fin de cumplir con los objetivos clínicos de un ASP </span><!--[if supportFields]><span
lang=ES style='font-size:10.0pt;line-height:105%;font-family:"Times New Roman",serif;
mso-fareast-font-family:Calibri;mso-ansi-language:ES'><span style='mso-element:
field-begin;mso-field-lock:yes'></span>ADDIN CSL_CITATION
{&quot;citationItems&quot;:[{&quot;id&quot;:&quot;ITEM-1&quot;,&quot;itemData&quot;:{&quot;DOI&quot;:&quot;10.1002/phar.1524&quot;,&quot;ISBN&quot;:&quot;1875-9114&quot;,&quot;ISSN&quot;:&quot;18759114&quot;,&quot;PMID&quot;:&quot;25615401&quot;,&quot;abstract&quot;:&quot;Antimicrobial
stewardship is an activity that optimizes patient care through selection of the
most appropriate antimicrobial therapy. Antimicrobial stewardship programs
strive to enhance patient care and reduce preventable consequences of
antimicrobial use. They are also vital in monitoring for the development of
adverse events occurring as a result of antimicrobial therapy, although literature
reviews of this activity are scarce. Although randomized controlled trials are
considered the gold standard to study the efficacy of a medication, these
trials are not designed to test safety end points and often are only able to
identify the most commonly occurring and acute adverse events. In addition,
prior to a drug going to market, it is difficult to detect rare adverse events
because the associated costs are economically untenable given the limited
pipeline of novel agents. These limitations in some ways may be resolved with
the use of postmarketing surveillance and spontaneous reporting systems such as
the United States Food and Drug Administration Adverse Event Reporting System.
The focus of this commentary is to highlight the importance of adverse event
reporting by antimicrobial stewardship programs to spontaneous reporting
systems as a means to improve patient
care.&quot;,&quot;author&quot;:[{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Hoffmann&quot;,&quot;given&quot;:&quot;Charles&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Khadem&quot;,&quot;given&quot;:&quot;Tina&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Schweighardt&quot;,&quot;given&quot;:&quot;Anne&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Brown&quot;,&quot;given&quot;:&quot;Jack&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;}],&quot;container-title&quot;:&quot;Pharmacotherapy&quot;,&quot;id&quot;:&quot;ITEM-1&quot;,&quot;issue&quot;:&quot;1&quot;,&quot;issued&quot;:{&quot;date-parts&quot;:[[&quot;2015&quot;]]},&quot;page&quot;:&quot;59-63&quot;,&quot;title&quot;:&quot;New
thoughts on the \&quot;forgotten\&quot; aspect of Antimicrobial stewardship:
Adverse event
reporting&quot;,&quot;type&quot;:&quot;article-journal&quot;,&quot;volume&quot;:&quot;35&quot;},&quot;uris&quot;:[&quot;http://www.mendeley.com/documents/?uuid=331e09b7-d409-4730-9b06-e18cd34b037e&quot;]}],&quot;mendeley&quot;:{&quot;formattedCitation&quot;:&quot;(27)&quot;,&quot;plainTextFormattedCitation&quot;:&quot;(27)&quot;,&quot;previouslyFormattedCitation&quot;:&quot;(27)&quot;},&quot;properties&quot;:{&quot;noteIndex&quot;:0},&quot;schema&quot;:&quot;https://github.com/citation-style-language/schema/raw/master/csl-citation.json&quot;}<span
style='mso-element:field-separator'></span></span><![endif]--><span lang=ES
style='font-size:10.0pt;line-height:105%;font-family:"Times New Roman",serif;
mso-fareast-font-family:Calibri;mso-ansi-language:ES'><span style='mso-no-proof:
yes'>(27)</span></span><!--[if supportFields]><span lang=ES style='font-size:
10.0pt;line-height:105%;font-family:"Times New Roman",serif;mso-fareast-font-family:
Calibri;mso-ansi-language:ES'><span style='mso-element:field-end'></span></span><![endif]--><span
lang=ES style='font-size:10.0pt;line-height:105%;font-family:"Times New Roman",serif;
mso-fareast-font-family:Calibri;mso-ansi-language:ES'>. Se puede utilizar
medidas de consumo en el análisis de eventos adversos con el fin de identificar
el riesgo desproporcionado asociado con antimicrobianos de menor prescripción </span><!--[if supportFields]><span
lang=ES style='font-size:10.0pt;line-height:105%;font-family:"Times New Roman",serif;
mso-fareast-font-family:Calibri;mso-ansi-language:ES'><span style='mso-element:
field-begin;mso-field-lock:yes'></span>ADDIN CSL_CITATION
{&quot;citationItems&quot;:[{&quot;id&quot;:&quot;ITEM-1&quot;,&quot;itemData&quot;:{&quot;DOI&quot;:&quot;10.1007/s11096-013-9805-9&quot;,&quot;ISBN&quot;:&quot;2210-7711
(Electronic)&quot;,&quot;ISSN&quot;:&quot;22107703&quot;,&quot;PMID&quot;:&quot;23794077&quot;,&quot;abstract&quot;:&quot;Background
Medication incidents (MIs) account for 11.3 % of all reported patient-safety
incidents in England and Wales. Approximately one-third of inpatients are
pre-scribed an antibiotic at some point during their hospital stay. The WHO has
identified incident reporting as one solution to reduce the recurrence of
adverse incidents. Objectives The aim of this study was to determine the number
and nature of reported antibiotic-associated MIs occurring in inpatients and to
use defined daily doses (DDDs) to calculate the incident rate for the
antibiotics most commonly associated with MIs at each hospital. Setting Two UK
acute NHS teaching hospitals. Methods Retrospective quantitative analysis was
performed on antibiotic-associated MIs reported to the risk management system
over a 2-year period. Quality-assurance measures were undertaken before
analysis. The study was approved by the clinical audit departments at both
hospitals. Drug con-sumption data from each hospital were used to calculate the
DDD for each antibiotic. Main outcome measures The num-ber of
antibiotic-related MIs reported and the incident rate for the 10 antibiotics
most commonly associated with MIs at each hospital. Results Healthcare staff
submitted 6,756 reports, of which 885 (13.1 %) included antibiotics. This
resulted in a total of 959 MIs. Most MIs occurred during prescribing (42.4 %, n
= 407) and administration (40.0 %, n = 384) stages. Most common types of MIs
were omission/delay (26.3 %, n = 252), and dose/frequency (17.9 %, n = 172).
Penicillins (34.5 %, n = 331) and aminoglycosides (16.6 %, n = 159) were the
most frequently reported groups with co-amoxiclav (16.8 %, n = 161) and
gentamicin (14.1 %, n = 135) the most frequently reported drugs. Using DDDs to
assess the incident rate showed that cefotaxime (105.4/10,000 DDDs), gentamicin
(25.7/10,000 DDDs) and vancomycin (23.7/10,000 DDDs) had the highest rates.
Conclusions This study highlights that detailed analysis of data from reports
is essential in understanding MIs and developing strategies to prevent their
recurrence. Using DDDs in the analysis of MIs allowed determination of an
incident rate providing more useful information than the absolute numbers
alone. It also highlighted the disproportionate risk associated with less
commonly prescribed antibiotics not identified using MI reporting rates
alone.&quot;,&quot;author&quot;:[{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Hamad&quot;,&quot;given&quot;:&quot;Anas&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Cavell&quot;,&quot;given&quot;:&quot;Gillian&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Wade&quot;,&quot;given&quot;:&quot;Paul&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Hinton&quot;,&quot;given&quot;:&quot;James&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Whittlesea&quot;,&quot;given&quot;:&quot;Cate&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;}],&quot;container-title&quot;:&quot;International
Journal of Clinical Pharmacy&quot;,&quot;id&quot;:&quot;ITEM-1&quot;,&quot;issue&quot;:&quot;5&quot;,&quot;issued&quot;:{&quot;date-parts&quot;:[[&quot;2013&quot;]]},&quot;page&quot;:&quot;772-779&quot;,&quot;title&quot;:&quot;Risk
of medication safety incidents with antibiotic use measured by defined daily
doses&quot;,&quot;type&quot;:&quot;article-journal&quot;,&quot;volume&quot;:&quot;35&quot;},&quot;uris&quot;:[&quot;http://www.mendeley.com/documents/?uuid=7e09abb2-526f-4ab3-b250-d953cdee560f&quot;]}],&quot;mendeley&quot;:{&quot;formattedCitation&quot;:&quot;(28)&quot;,&quot;plainTextFormattedCitation&quot;:&quot;(28)&quot;,&quot;previouslyFormattedCitation&quot;:&quot;(28)&quot;},&quot;properties&quot;:{&quot;noteIndex&quot;:0},&quot;schema&quot;:&quot;https://github.com/citation-style-language/schema/raw/master/csl-citation.json&quot;}<span
style='mso-element:field-separator'></span></span><![endif]--><span lang=ES
style='font-size:10.0pt;line-height:105%;font-family:"Times New Roman",serif;
mso-fareast-font-family:Calibri;mso-ansi-language:ES'><span style='mso-no-proof:
yes'>(28)</span></span><!--[if supportFields]><span lang=ES style='font-size:
10.0pt;line-height:105%;font-family:"Times New Roman",serif;mso-fareast-font-family:
Calibri;mso-ansi-language:ES'><span style='mso-element:field-end'></span></span><![endif]--><span
lang=ES style='font-size:10.0pt;line-height:105%;font-family:"Times New Roman",serif;
mso-fareast-font-family:Calibri;mso-ansi-language:ES'>.<o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0mm;margin-bottom:.0001pt;text-align:
justify;text-indent:11.35pt;line-height:105%'><span lang=ES style='font-size:
10.0pt;line-height:105%;font-family:"Times New Roman",serif;mso-fareast-font-family:
Calibri;mso-ansi-language:ES'><o:p>&nbsp;</o:p></span></p>

<p class=MsoNormal style='margin-bottom:0mm;margin-bottom:.0001pt;text-align:
justify;text-indent:11.35pt;line-height:105%'><span lang=ES style='font-size:
10.0pt;line-height:105%;font-family:"Times New Roman",serif;mso-fareast-font-family:
Calibri;mso-ansi-language:ES'>En la medición de consumo de antibióticos se
tiene un fuerte interés en el impacto ecológico a diferencia de la medición de
consumo de otros medicamentos (antihipertensivos, antidepresivos, etc.) en los
que importan más los efectos adversos sobre el organismo humano </span><!--[if supportFields]><span
lang=ES style='font-size:10.0pt;line-height:105%;font-family:"Times New Roman",serif;
mso-fareast-font-family:Calibri;mso-ansi-language:ES'><span style='mso-element:
field-begin;mso-field-lock:yes'></span>ADDIN CSL_CITATION
{&quot;citationItems&quot;:[{&quot;id&quot;:&quot;ITEM-1&quot;,&quot;itemData&quot;:{&quot;DOI&quot;:&quot;10.1093/jac/dkp399&quot;,&quot;ISBN&quot;:&quot;4419156562&quot;,&quot;ISSN&quot;:&quot;03057453&quot;,&quot;PMID&quot;:&quot;19884120&quot;,&quot;abstract&quot;:&quot;Background
Measurement of prescribing is an important component of antimicrobial
stewardship. The standard unit of measurement in hospitals is defined daily
doses denominated by bed days (e.g. DDDs per 1000 bed days) but alternatives
have not been evaluated in depth.Methods Electronically prescribed doses of
systemic antibacterials administered in this trust during 2008 were analysed in
order to generate 10 indices of antimicrobial use for each of 14 departments.
These indices were five measurements of consumption (DDDs, agent days, courses,
antibiotic days and treatment periods) each denominated by two measurements of
activity [bed days and finished consultant episodes (FCEs)].Results The 10
indices cluster into four groups within which they correlate well but between
which correlation is poor. These four groups comprise a volume-related
measurement of consumption (DDDs, agent days, antibiotic days) and an
exposure-related measurement of consumption (courses, treatment periods), each
denominated by either bed occupancy (bed days) or patient throughput
(FCEs).Conclusions Indices within these four groups seem to provide different
and complementary information. Restricting measurement of antimicrobial use to
a single metric such as DDDs per 1000 bed days may be insufficient. It is not
known which (if any) of these indices are the best predictors of
antimicrobial-related risks such as resistance pressure or Clostridium
difficile
infection.&quot;,&quot;author&quot;:[{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Berrington&quot;,&quot;given&quot;:&quot;Andrew&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;}],&quot;container-title&quot;:&quot;Journal
of Antimicrobial
Chemotherapy&quot;,&quot;id&quot;:&quot;ITEM-1&quot;,&quot;issue&quot;:&quot;1&quot;,&quot;issued&quot;:{&quot;date-parts&quot;:[[&quot;2009&quot;]]},&quot;page&quot;:&quot;163-168&quot;,&quot;title&quot;:&quot;Antimicrobial
prescribing in hospitals: Be careful what you
measure&quot;,&quot;type&quot;:&quot;article-journal&quot;,&quot;volume&quot;:&quot;65&quot;},&quot;uris&quot;:[&quot;http://www.mendeley.com/documents/?uuid=e845ab0f-2b9f-4fb4-82db-4266f5332f47&quot;]}],&quot;mendeley&quot;:{&quot;formattedCitation&quot;:&quot;(29)&quot;,&quot;plainTextFormattedCitation&quot;:&quot;(29)&quot;,&quot;previouslyFormattedCitation&quot;:&quot;(29)&quot;},&quot;properties&quot;:{&quot;noteIndex&quot;:0},&quot;schema&quot;:&quot;https://github.com/citation-style-language/schema/raw/master/csl-citation.json&quot;}<span
style='mso-element:field-separator'></span></span><![endif]--><span lang=ES
style='font-size:10.0pt;line-height:105%;font-family:"Times New Roman",serif;
mso-fareast-font-family:Calibri;mso-ansi-language:ES'><span style='mso-no-proof:
yes'>(29)</span></span><!--[if supportFields]><span lang=ES style='font-size:
10.0pt;line-height:105%;font-family:"Times New Roman",serif;mso-fareast-font-family:
Calibri;mso-ansi-language:ES'><span style='mso-element:field-end'></span></span><![endif]--><span
lang=ES style='font-size:10.0pt;line-height:105%;font-family:"Times New Roman",serif;
mso-fareast-font-family:Calibri;mso-ansi-language:ES'>. Por tanto la dosis
acumulada puede no ser el mejor predictor del riesgo en el consumo de
antibióticos y quizás los regímenes o la intensidad del uso sean mejores
indicadores de consumo en este tipo de medicamentos </span><!--[if supportFields]><span
lang=ES style='font-size:10.0pt;line-height:105%;font-family:"Times New Roman",serif;
mso-fareast-font-family:Calibri;mso-ansi-language:ES'><span style='mso-element:
field-begin;mso-field-lock:yes'></span>ADDIN CSL_CITATION
{&quot;citationItems&quot;:[{&quot;id&quot;:&quot;ITEM-1&quot;,&quot;itemData&quot;:{&quot;DOI&quot;:&quot;10.1093/jac/dkp399&quot;,&quot;ISBN&quot;:&quot;4419156562&quot;,&quot;ISSN&quot;:&quot;03057453&quot;,&quot;PMID&quot;:&quot;19884120&quot;,&quot;abstract&quot;:&quot;Background
Measurement of prescribing is an important component of antimicrobial
stewardship. The standard unit of measurement in hospitals is defined daily
doses denominated by bed days (e.g. DDDs per 1000 bed days) but alternatives
have not been evaluated in depth.Methods Electronically prescribed doses of
systemic antibacterials administered in this trust during 2008 were analysed in
order to generate 10 indices of antimicrobial use for each of 14 departments.
These indices were five measurements of consumption (DDDs, agent days, courses,
antibiotic days and treatment periods) each denominated by two measurements of
activity [bed days and finished consultant episodes (FCEs)].Results The 10
indices cluster into four groups within which they correlate well but between
which correlation is poor. These four groups comprise a volume-related
measurement of consumption (DDDs, agent days, antibiotic days) and an
exposure-related measurement of consumption (courses, treatment periods), each
denominated by either bed occupancy (bed days) or patient throughput
(FCEs).Conclusions Indices within these four groups seem to provide different
and complementary information. Restricting measurement of antimicrobial use to
a single metric such as DDDs per 1000 bed days may be insufficient. It is not
known which (if any) of these indices are the best predictors of
antimicrobial-related risks such as resistance pressure or Clostridium
difficile
infection.&quot;,&quot;author&quot;:[{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Berrington&quot;,&quot;given&quot;:&quot;Andrew&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;}],&quot;container-title&quot;:&quot;Journal
of Antimicrobial
Chemotherapy&quot;,&quot;id&quot;:&quot;ITEM-1&quot;,&quot;issue&quot;:&quot;1&quot;,&quot;issued&quot;:{&quot;date-parts&quot;:[[&quot;2009&quot;]]},&quot;page&quot;:&quot;163-168&quot;,&quot;title&quot;:&quot;Antimicrobial
prescribing in hospitals: Be careful what you
measure&quot;,&quot;type&quot;:&quot;article-journal&quot;,&quot;volume&quot;:&quot;65&quot;},&quot;uris&quot;:[&quot;http://www.mendeley.com/documents/?uuid=e845ab0f-2b9f-4fb4-82db-4266f5332f47&quot;]}],&quot;mendeley&quot;:{&quot;formattedCitation&quot;:&quot;(29)&quot;,&quot;plainTextFormattedCitation&quot;:&quot;(29)&quot;,&quot;previouslyFormattedCitation&quot;:&quot;(29)&quot;},&quot;properties&quot;:{&quot;noteIndex&quot;:0},&quot;schema&quot;:&quot;https://github.com/citation-style-language/schema/raw/master/csl-citation.json&quot;}<span
style='mso-element:field-separator'></span></span><![endif]--><span lang=ES
style='font-size:10.0pt;line-height:105%;font-family:"Times New Roman",serif;
mso-fareast-font-family:Calibri;mso-ansi-language:ES'><span style='mso-no-proof:
yes'>(29)</span></span><!--[if supportFields]><span lang=ES style='font-size:
10.0pt;line-height:105%;font-family:"Times New Roman",serif;mso-fareast-font-family:
Calibri;mso-ansi-language:ES'><span style='mso-element:field-end'></span></span><![endif]--><span
lang=ES style='font-size:10.0pt;line-height:105%;font-family:"Times New Roman",serif;
mso-fareast-font-family:Calibri;mso-ansi-language:ES'>. Por ejemplo, e<span
style='color:black'>l uso de DDD/ 100PD como un predictor de presión ecológica
es conveniente pero arbitrario puesto que no siempre los riesgos derivados del
uso de antibióticos están linealmente relacionados a dosis acumuladas.</span><span
style='color:#C00000'> </span><o:p></o:p></span></p>

<p class=IOPH1><span style='mso-ansi-language:ES-CO'>4. Indicadores de consumo<o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0mm;margin-bottom:.0001pt;text-align:
justify;text-indent:11.35pt;line-height:105%'><span lang=ES style='font-size:
10.0pt;line-height:105%;font-family:"Times New Roman",serif;mso-fareast-font-family:
Calibri;mso-ansi-language:ES'>El consumo se refiere a la medida agregada o
ponderada de la cantidad de antimicrobianos que son consumidos a nivel de
pacientes, unidades, servicios o instituciones </span><!--[if supportFields]><span
lang=ES style='font-size:10.0pt;line-height:105%;font-family:"Times New Roman",serif;
mso-fareast-font-family:Calibri;mso-ansi-language:ES'><span style='mso-element:
field-begin;mso-field-lock:yes'></span>ADDIN CSL_CITATION {&quot;citationItems&quot;:[{&quot;id&quot;:&quot;ITEM-1&quot;,&quot;itemData&quot;:{&quot;DOI&quot;:&quot;10.1007/s40506-014-0015-3&quot;,&quot;ISBN&quot;:&quot;4050601400&quot;,&quot;ISSN&quot;:&quot;1534-6250&quot;,&quot;PMID&quot;:&quot;25999798&quot;,&quot;abstract&quot;:&quot;Antimicrobial
stewardship is a new field that struggles to find the right balance between
meaningful and useful metrics to study the impact of antimicrobial stewardship
programs (ASPs). ASP metrics primarily measure antimicrobial use, although
microbiological resistance and clinical outcomes are also important measures of
the impact an ASP has on a hospital and its patient population. Antimicrobial
measures looking at consumption are the most commonly used measures, and are
focused on defined daily doses, days of therapy, and costs, usually
standardized per 1,000 patient-days. Each measure provides slightly different
information, with their own upsides and downfalls. Point prevalence measurement
of antimicrobial use is an increasingly used approach to understanding
consumption that does not entirely rely on sophisticated electronic information
systems, and is also replicable. Appropriateness measures hold appeal and
promise, but have not been developed to the degree that makes them useful and
widely applicable. The primary reason why antimicrobial stewardship is
necessary is the growth of antimicrobial resistance. Accordingly, antimicrobial
resistance is an important metric of the impact of an ASP. The most common
approach to measuring resistance for ASP purposes is to report rates of common
or important community- or nosocomial-acquired antimicrobial-resistant organisms,
such as methicillin-resistant Staphylococcus aureus and Clostridium difficile.
Such an approach is dependent on detection methods, community rates of
resistance, and co-interventions, and therefore may not be the most accurate or
reflective measure of antimicrobial stewardship interventions. Development of
an index to reflect the net burden of resistance holds theoretical promise, but
has yet to be realized. Finally, programs must consider patient outcome
measures. Mortality is the most objective and reliable method, but has several
drawbacks. Disease- or organism-specific mortality, or cure, are increasingly
used
metrics.&quot;,&quot;author&quot;:[{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Morris&quot;,&quot;given&quot;:&quot;Andrew
M.&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;}],&quot;container-title&quot;:&quot;Current
Treatment Options in Infectious
Diseases&quot;,&quot;id&quot;:&quot;ITEM-1&quot;,&quot;issue&quot;:&quot;2&quot;,&quot;issued&quot;:{&quot;date-parts&quot;:[[&quot;2014&quot;]]},&quot;page&quot;:&quot;101-112&quot;,&quot;title&quot;:&quot;Antimicrobial
Stewardship Programs: Appropriate Measures and Metrics to Study their
Impact&quot;,&quot;type&quot;:&quot;article-journal&quot;,&quot;volume&quot;:&quot;6&quot;},&quot;uris&quot;:[&quot;http://www.mendeley.com/documents/?uuid=de07aac5-dd0b-42f5-8af0-a19b7b7157b1&quot;]}],&quot;mendeley&quot;:{&quot;formattedCitation&quot;:&quot;(30)&quot;,&quot;plainTextFormattedCitation&quot;:&quot;(30)&quot;,&quot;previouslyFormattedCitation&quot;:&quot;(30)&quot;},&quot;properties&quot;:{&quot;noteIndex&quot;:0},&quot;schema&quot;:&quot;https://github.com/citation-style-language/schema/raw/master/csl-citation.json&quot;}<span
style='mso-element:field-separator'></span></span><![endif]--><span lang=ES
style='font-size:10.0pt;line-height:105%;font-family:"Times New Roman",serif;
mso-fareast-font-family:Calibri;mso-ansi-language:ES'><span style='mso-no-proof:
yes'>(30)</span></span><!--[if supportFields]><span lang=ES style='font-size:
10.0pt;line-height:105%;font-family:"Times New Roman",serif;mso-fareast-font-family:
Calibri;mso-ansi-language:ES'><span style='mso-element:field-end'></span></span><![endif]--><span
lang=ES style='font-size:10.0pt;line-height:105%;font-family:"Times New Roman",serif;
mso-fareast-font-family:Calibri;mso-ansi-language:ES'>. Esta medida suele ser
expresada en forma de tasa ajustada, el numerador es la exposición acumulada en
cuanto a utilización de antibióticos dentro de una población. Por otra parte el
denominador tiene una medida de la cantidad de individuos potencialmente
expuestos a los antimicrobianos en un periodo de tiempo determinado </span><!--[if supportFields]><span
lang=ES style='font-size:10.0pt;line-height:105%;font-family:"Times New Roman",serif;
mso-fareast-font-family:Calibri;mso-ansi-language:ES'><span style='mso-element:
field-begin;mso-field-lock:yes'></span>ADDIN CSL_CITATION
{&quot;citationItems&quot;:[{&quot;id&quot;:&quot;ITEM-1&quot;,&quot;itemData&quot;:{&quot;DOI&quot;:&quot;10.1007/s15010-008-7462-z&quot;,&quot;ISBN&quot;:&quot;1180-2332
(Print)\r1180-2332
(Linking)&quot;,&quot;ISSN&quot;:&quot;1180-2332&quot;,&quot;PMID&quot;:&quot;18159441&quot;,&quot;abstract&quot;:&quot;Despite
the global public health importance of resistance of microorganisms to the
effects of antibiotics, and the direct relationship of consumption to
resistance, little information is available concerning levels of consumption in
Canadian hospitals and out-patient settings. The present paper provides
practical advice on the use of administrative pharmacy data to address this
need. Focus is made on the use of the Anatomical Therapeutic Chemical
classification and Defined Daily Dose system. Examples of consumption data from
Canadian community and hospital settings, with comparisons to international
data, are used to incite interest and to propose uses of this information. It
is hoped that all persons responsible for policy decisions regarding licensing,
reimbursement, prescribing guidelines, formulary controls or any other
structure pertaining to antimicrobial use become conversant with the concepts
of population antibiotic consumption and that this paper provides them with the
impetus and direction to begin accurately measuring and comparing antibiotic
use in their
jurisdictions.&quot;,&quot;author&quot;:[{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Hutchinson&quot;,&quot;given&quot;:&quot;James
M&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Patrick&quot;,&quot;given&quot;:&quot;David
M&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Marra&quot;,&quot;given&quot;:&quot;Fawziah&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Ng&quot;,&quot;given&quot;:&quot;Helen&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Bowie&quot;,&quot;given&quot;:&quot;William
R&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Heule&quot;,&quot;given&quot;:&quot;Laurie&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Muscat&quot;,&quot;given&quot;:&quot;Mark&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Monnet&quot;,&quot;given&quot;:&quot;Dominique
L&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;}],&quot;container-title&quot;:&quot;The
Canadian journal of infectious
diseases&quot;,&quot;id&quot;:&quot;ITEM-1&quot;,&quot;issue&quot;:&quot;1&quot;,&quot;issued&quot;:{&quot;date-parts&quot;:[[&quot;2004&quot;]]},&quot;page&quot;:&quot;29-35&quot;,&quot;title&quot;:&quot;Measurement
of antibiotic consumption: A practical guide to the use of the Anatomical
Thgerapeutic Chemical classification and Definied Daily Dose system methodology
in Canada.&quot;,&quot;type&quot;:&quot;article-journal&quot;,&quot;volume&quot;:&quot;15&quot;},&quot;uris&quot;:[&quot;http://www.mendeley.com/documents/?uuid=7649f9f8-f5f7-4a70-8fa5-04fa4e411c7a&quot;]},{&quot;id&quot;:&quot;ITEM-2&quot;,&quot;itemData&quot;:{&quot;ISBN&quot;:&quot;8280820396&quot;,&quot;author&quot;:[{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;World
Health
Organization&quot;,&quot;given&quot;:&quot;&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;}],&quot;id&quot;:&quot;ITEM-2&quot;,&quot;issued&quot;:{&quot;date-parts&quot;:[[&quot;2003&quot;]]},&quot;number-of-pages&quot;:&quot;1-84&quot;,&quot;publisher&quot;:&quot;World
Health Organization&quot;,&quot;publisher-place&quot;:&quot;Oslo&quot;,&quot;title&quot;:&quot;Introduction
to Drug Utilization
Research&quot;,&quot;type&quot;:&quot;book&quot;},&quot;uris&quot;:[&quot;http://www.mendeley.com/documents/?uuid=bb6fa8e5-b29a-4307-9f24-0ab56ed75043&quot;,&quot;http://www.mendeley.com/documents/?uuid=19a02bb5-5741-46c4-85ee-9ff8127f3490&quot;]}],&quot;mendeley&quot;:{&quot;formattedCitation&quot;:&quot;(31,32)&quot;,&quot;plainTextFormattedCitation&quot;:&quot;(31,32)&quot;,&quot;previouslyFormattedCitation&quot;:&quot;(31,32)&quot;},&quot;properties&quot;:{&quot;noteIndex&quot;:0},&quot;schema&quot;:&quot;https://github.com/citation-style-language/schema/raw/master/csl-citation.json&quot;}<span
style='mso-element:field-separator'></span></span><![endif]--><span lang=ES
style='font-size:10.0pt;line-height:105%;font-family:"Times New Roman",serif;
mso-fareast-font-family:Calibri;mso-ansi-language:ES'><span style='mso-no-proof:
yes'>(31,32)</span></span><!--[if supportFields]><span lang=ES
style='font-size:10.0pt;line-height:105%;font-family:"Times New Roman",serif;
mso-fareast-font-family:Calibri;mso-ansi-language:ES'><span style='mso-element:
field-end'></span></span><![endif]--><span lang=ES style='font-size:10.0pt;
line-height:105%;font-family:"Times New Roman",serif;mso-fareast-font-family:
Calibri;mso-ansi-language:ES'>. En una revisión de estudios sobre medición de
consumo de antimicrobianos se encontraron 26 medidas de consumo distintas producto
de la combinación de 13 tipos de numeradores con 5 tipos de denominadores </span><!--[if supportFields]><span
lang=ES style='font-size:10.0pt;line-height:105%;font-family:"Times New Roman",serif;
mso-fareast-font-family:Calibri;mso-ansi-language:ES'><span style='mso-element:
field-begin;mso-field-lock:yes'></span>ADDIN CSL_CITATION
{&quot;citationItems&quot;:[{&quot;id&quot;:&quot;ITEM-1&quot;,&quot;itemData&quot;:{&quot;DOI&quot;:&quot;10.1093/jac/dku003&quot;,&quot;ISBN&quot;:&quot;1460-2091
(Electronic)\r0305-7453 (Linking)&quot;,&quot;ISSN&quot;:&quot;14602091&quot;,&quot;PMID&quot;:&quot;24481320&quot;,&quot;abstract&quot;:&quot;Objectives
The optimal measure to use for surveillance of antimicrobial usage in hospital
settings, especially when including paediatric populations, is unknown. This
systematic review of literature aims to list, define and compare existing measures
of antimicrobial use that have been applied in settings that included
paediatric inpatients, to complement surveillance of resistance.\\nMethods We
identified cohort studies and repeated point-prevalence studies presenting data
on antimicrobial use in populations of inpatients or validations/comparisons of
antimicrobial measures through a systematic search of literature using MEDLINE,
EMBASE, CINAHL and LILACS (1975–2011) and citation tracking. Study populations
needed to include hospitalized paediatric patients. Two reviewers independently
extracted data on study characteristics and results.\\nResults Overall, 3878
records were screened and 79 studies met selection criteria. Twenty-six
distinct measures were found, the most frequently used being defined daily
doses (DDD)/patient-days and exposed patients/patients. Only two studies
compared different measures quantitatively, showing (i) a positive correlation
between proportion of exposed patients and antimicrobial-days/patient-days and
(ii) a strong correlation between doses/patient-days and
agent-days/patient-days (r = 0.98), with doses/patient-days correlating more
with resistance rates (r = 0.80 versus 0.55).\\nConclusions The measure of
antimicrobial use that best predicts antimicrobial resistance prevalence and
rates, for surveillance purposes, has still not been identified; additional
evidence on this topic is a
necessity.&quot;,&quot;author&quot;:[{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Fortin&quot;,&quot;given&quot;:&quot;??&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Fontela&quot;,&quot;given&quot;:&quot;P.
S.&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Manges&quot;,&quot;given&quot;:&quot;A.
R.&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Platt&quot;,&quot;given&quot;:&quot;R.
W.&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Buckeridge&quot;,&quot;given&quot;:&quot;D.
L.&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Quach&quot;,&quot;given&quot;:&quot;C.&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;}],&quot;container-title&quot;:&quot;Journal
of Antimicrobial Chemotherapy&quot;,&quot;id&quot;:&quot;ITEM-1&quot;,&quot;issue&quot;:&quot;6&quot;,&quot;issued&quot;:{&quot;date-parts&quot;:[[&quot;2014&quot;]]},&quot;page&quot;:&quot;1447-1456&quot;,&quot;title&quot;:&quot;Measuring
antimicrobial use in hospitalized patients: A systematic review of available
measures applicable to
paediatrics&quot;,&quot;type&quot;:&quot;article-journal&quot;,&quot;volume&quot;:&quot;69&quot;},&quot;uris&quot;:[&quot;http://www.mendeley.com/documents/?uuid=78f22e19-8fdc-4837-af8a-62643303c1b8&quot;]}],&quot;mendeley&quot;:{&quot;formattedCitation&quot;:&quot;(33)&quot;,&quot;plainTextFormattedCitation&quot;:&quot;(33)&quot;,&quot;previouslyFormattedCitation&quot;:&quot;(33)&quot;},&quot;properties&quot;:{&quot;noteIndex&quot;:0},&quot;schema&quot;:&quot;https://github.com/citation-style-language/schema/raw/master/csl-citation.json&quot;}<span
style='mso-element:field-separator'></span></span><![endif]--><span lang=ES
style='font-size:10.0pt;line-height:105%;font-family:"Times New Roman",serif;
mso-fareast-font-family:Calibri;mso-ansi-language:ES'><span style='mso-no-proof:
yes'>(33)</span></span><!--[if supportFields]><span lang=ES style='font-size:
10.0pt;line-height:105%;font-family:"Times New Roman",serif;mso-fareast-font-family:
Calibri;mso-ansi-language:ES'><span style='mso-element:field-end'></span></span><![endif]--><span
lang=ES style='font-size:10.0pt;line-height:105%;font-family:"Times New Roman",serif;
mso-fareast-font-family:Calibri;mso-ansi-language:ES'>. Entre los numeradores
más utilizados se tienen dosis diarias definidas y días de terapia con
denominadores como pacientes-día y número de admisiones.<o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0mm;margin-bottom:.0001pt;text-align:
justify;text-indent:11.35pt;line-height:105%'><span lang=ES style='font-size:
10.0pt;line-height:105%;font-family:"Times New Roman",serif;mso-fareast-font-family:
Calibri;mso-ansi-language:ES'><o:p>&nbsp;</o:p></span></p>

<p class=MsoNormal style='margin-bottom:0mm;margin-bottom:.0001pt;text-align:
justify;text-indent:11.35pt;line-height:105%'><span lang=ES style='font-size:
10.0pt;line-height:105%;font-family:"Times New Roman",serif;mso-fareast-font-family:
Calibri;mso-ansi-language:ES'>Con el fin de mejorar la precisión de las
comparaciones interhospitalarias las medidas de consumo de antibióticos en
hospitales deben cumplir ciertos requisitos. Entre estos incluir información
sobre el volumen de antibióticos utilizados, número de pacientes con un
antibiótico y proporción de pacientes tratados con antibióticos </span><!--[if supportFields]><span
lang=ES style='font-size:10.0pt;line-height:105%;font-family:"Times New Roman",serif;
mso-fareast-font-family:Calibri;mso-ansi-language:ES'><span style='mso-element:
field-begin;mso-field-lock:yes'></span>ADDIN CSL_CITATION
{&quot;citationItems&quot;:[{&quot;id&quot;:&quot;ITEM-1&quot;,&quot;itemData&quot;:{&quot;DOI&quot;:&quot;10.1177/1757177410363357&quot;,&quot;ISBN&quot;:&quot;17571774&quot;,&quot;ISSN&quot;:&quot;ISSN
1757-1774&quot;,&quot;abstract&quot;:&quot;Increasing rates of antibiotic
resistance have been related to increased rates of antibiotic prescribing. This
paper describes the use of indicators to measure and compare antibiotic use and
enable hospitals to benchmark their practice. The Defined Daily Dose measure
may be combined with a number of denominators that quantify patient activity in
order to correct for workload variations between hospitals. This may be
combined with data from mandatory surveillance schemes for various infections
to inform prescribing
practice.\\n&quot;,&quot;author&quot;:[{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Curtis&quot;,&quot;given&quot;:&quot;C
E&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;}],&quot;container-title&quot;:&quot;Journal
of Infection
Prevention&quot;,&quot;id&quot;:&quot;ITEM-1&quot;,&quot;issue&quot;:&quot;4&quot;,&quot;issued&quot;:{&quot;date-parts&quot;:[[&quot;2010&quot;]]},&quot;page&quot;:&quot;124-126&quot;,&quot;title&quot;:&quot;Indicators
for the monitoring of antibiotic
use.&quot;,&quot;type&quot;:&quot;article-journal&quot;,&quot;volume&quot;:&quot;11&quot;},&quot;uris&quot;:[&quot;http://www.mendeley.com/documents/?uuid=88cd6823-507b-47bc-9ae7-4f25bf584caa&quot;]}],&quot;mendeley&quot;:{&quot;formattedCitation&quot;:&quot;(34)&quot;,&quot;plainTextFormattedCitation&quot;:&quot;(34)&quot;,&quot;previouslyFormattedCitation&quot;:&quot;(34)&quot;},&quot;properties&quot;:{&quot;noteIndex&quot;:0},&quot;schema&quot;:&quot;https://github.com/citation-style-language/schema/raw/master/csl-citation.json&quot;}<span
style='mso-element:field-separator'></span></span><![endif]--><span lang=ES
style='font-size:10.0pt;line-height:105%;font-family:"Times New Roman",serif;
mso-fareast-font-family:Calibri;mso-ansi-language:ES'><span style='mso-no-proof:
yes'>(34)</span></span><!--[if supportFields]><span lang=ES style='font-size:
10.0pt;line-height:105%;font-family:"Times New Roman",serif;mso-fareast-font-family:
Calibri;mso-ansi-language:ES'><span style='mso-element:field-end'></span></span><![endif]--><span
lang=ES style='font-size:10.0pt;line-height:105%;font-family:"Times New Roman",serif;
mso-fareast-font-family:Calibri;mso-ansi-language:ES'>. De manera ideal, se
deben medir las cantidades de medicamento administradas y no la cantidad
ordenada, dispensada, facturada o comprada, puesto que el punto de interés es
lo que el paciente recibe </span><!--[if supportFields]><span lang=ES
style='font-size:10.0pt;line-height:105%;font-family:"Times New Roman",serif;
mso-fareast-font-family:Calibri;mso-ansi-language:ES'><span style='mso-element:
field-begin;mso-field-lock:yes'></span>ADDIN CSL_CITATION
{&quot;citationItems&quot;:[{&quot;id&quot;:&quot;ITEM-1&quot;,&quot;itemData&quot;:{&quot;abstract&quot;:&quot;Three
major trends in antibiotic use in US hospitals have emerged over the last few
years: antibiotics as quality metrics, persistent use of different measures of
antibiotic consumption and the emergence of antibiotic stewardship programs.
Compared with Europe, where approaches are heterogeneous but generally
consistent, the USA currently lacks the infrastructure to monitor antibiotic
resistance and antibiotic consumption locally. Both have implemented
programmatic strategies for prudent antibiotic use. The USA appears to have
implemented processes more systematically to measure the quality of antibiotic
use.&quot;,&quot;author&quot;:[{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Jacob&quot;,&quot;given&quot;:&quot;J
T&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Gaynes&quot;,&quot;given&quot;:&quot;RP&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;}],&quot;container-title&quot;:&quot;Expert
Review of Anti-infective
Therapy&quot;,&quot;id&quot;:&quot;ITEM-1&quot;,&quot;issue&quot;:&quot;8&quot;,&quot;issued&quot;:{&quot;date-parts&quot;:[[&quot;2010&quot;]]},&quot;page&quot;:&quot;893-902&quot;,&quot;title&quot;:&quot;Emerging
trends in antibiotic use in US hospitals: quality, quantification and
stewardship&quot;,&quot;type&quot;:&quot;article-journal&quot;,&quot;volume&quot;:&quot;8&quot;},&quot;uris&quot;:[&quot;http://www.mendeley.com/documents/?uuid=67b411c4-1309-4ba8-a3d3-e6c41e656b01&quot;,&quot;http://www.mendeley.com/documents/?uuid=e3592e4a-9766-47be-a9d6-3c8792716d6f&quot;]}],&quot;mendeley&quot;:{&quot;formattedCitation&quot;:&quot;(13)&quot;,&quot;plainTextFormattedCitation&quot;:&quot;(13)&quot;,&quot;previouslyFormattedCitation&quot;:&quot;(13)&quot;},&quot;properties&quot;:{&quot;noteIndex&quot;:0},&quot;schema&quot;:&quot;https://github.com/citation-style-language/schema/raw/master/csl-citation.json&quot;}<span
style='mso-element:field-separator'></span></span><![endif]--><span lang=ES
style='font-size:10.0pt;line-height:105%;font-family:"Times New Roman",serif;
mso-fareast-font-family:Calibri;mso-ansi-language:ES'><span style='mso-no-proof:
yes'>(13)</span></span><!--[if supportFields]><span lang=ES style='font-size:
10.0pt;line-height:105%;font-family:"Times New Roman",serif;mso-fareast-font-family:
Calibri;mso-ansi-language:ES'><span style='mso-element:field-end'></span></span><![endif]--><span
lang=ES style='font-size:10.0pt;line-height:105%;font-family:"Times New Roman",serif;
mso-fareast-font-family:Calibri;mso-ansi-language:ES'>.<o:p></o:p></span></p>

<p class=IOPH1><span style='mso-ansi-language:ES-CO'>5. Medidas de consumo
acumulativo (numeradores)<o:p></o:p></span></p>

<p class=MsoNormal style='margin-top:10.0pt;margin-right:0mm;margin-bottom:
6.0pt;margin-left:0mm'><i style='mso-bidi-font-style:normal'><span
style='mso-bidi-font-size:9.0pt;line-height:107%;mso-bidi-font-family:"Times New Roman";
mso-ansi-language:ES-CO'>5.1 Dosis diaria definida<o:p></o:p></span></i></p>

<p class=MsoNormal style='margin-bottom:0mm;margin-bottom:.0001pt;text-align:
justify;text-indent:11.35pt;line-height:105%'><span lang=ES style='font-size:
10.0pt;line-height:105%;font-family:"Times New Roman",serif;mso-fareast-font-family:
Calibri;mso-ansi-language:ES'>La dosis diaria definida (DDD) se considera como
la dosis de mantenimiento promedio diaria para un medicamento usado en su
indicación principal en adultos </span><!--[if supportFields]><span lang=ES
style='font-size:10.0pt;line-height:105%;font-family:"Times New Roman",serif;
mso-fareast-font-family:Calibri;mso-ansi-language:ES'><span style='mso-element:
field-begin;mso-field-lock:yes'></span>ADDIN CSL_CITATION
{&quot;citationItems&quot;:[{&quot;id&quot;:&quot;ITEM-1&quot;,&quot;itemData&quot;:{&quot;DOI&quot;:&quot;10.1017/CBO9781107415324.004&quot;,&quot;ISBN&quot;:&quot;9788578110796&quot;,&quot;ISSN&quot;:&quot;1098-6596&quot;,&quot;PMID&quot;:&quot;25246403&quot;,&quot;abstract&quot;:&quot;Predicting
the binding mode of flexible polypeptides to proteins is an important task that
falls outside the domain of applicability of most small molecule and
protein−protein docking tools. Here, we test the small molecule flexible ligand
docking program Glide on a set of 19 non-α-helical peptides and systematically
improve pose prediction accuracy by enhancing Glide sampling for flexible
polypeptides. In addition, scoring of the poses was improved by post-processing
with physics-based implicit solvent MM- GBSA calculations. Using the best RMSD
among the top 10 scoring poses as a metric, the success rate (RMSD ≤ 2.0 Å for
the interface backbone atoms) increased from 21% with default Glide SP settings
to 58% with the enhanced peptide sampling and scoring protocol in the case of
redocking to the native protein structure. This approaches the accuracy of the
recently developed Rosetta FlexPepDock method (63% success for these 19
peptides) while being over 100 times faster. Cross-docking was performed for a
subset of cases where an unbound receptor structure was available, and in that
case, 40% of peptides were docked successfully. We analyze the results and find
that the optimized polypeptide protocol is most accurate for extended peptides
of limited size and number of formal charges, defining a domain of
applicability for this
approach.&quot;,&quot;author&quot;:[{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;WHO
Collaborating Centre for Drug Statistics
Methodology&quot;,&quot;given&quot;:&quot;&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;}],&quot;edition&quot;:&quot;19th
editi&quot;,&quot;id&quot;:&quot;ITEM-1&quot;,&quot;issued&quot;:{&quot;date-parts&quot;:[[&quot;2015&quot;]]},&quot;number-of-pages&quot;:&quot;1-292&quot;,&quot;publisher-place&quot;:&quot;Oslo&quot;,&quot;title&quot;:&quot;Guidelines
for ATC classification and DDD assignment
2016&quot;,&quot;type&quot;:&quot;book&quot;,&quot;volume&quot;:&quot;1&quot;},&quot;uris&quot;:[&quot;http://www.mendeley.com/documents/?uuid=001564eb-56fd-499a-9134-a2c1fbce8156&quot;,&quot;http://www.mendeley.com/documents/?uuid=683f6900-7570-468d-88cb-4dc0ea280eb9&quot;]},{&quot;id&quot;:&quot;ITEM-2&quot;,&quot;itemData&quot;:{&quot;ISBN&quot;:&quot;8280820396&quot;,&quot;author&quot;:[{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;World
Health
Organization&quot;,&quot;given&quot;:&quot;&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;}],&quot;id&quot;:&quot;ITEM-2&quot;,&quot;issued&quot;:{&quot;date-parts&quot;:[[&quot;2003&quot;]]},&quot;number-of-pages&quot;:&quot;1-84&quot;,&quot;publisher&quot;:&quot;World
Health
Organization&quot;,&quot;publisher-place&quot;:&quot;Oslo&quot;,&quot;title&quot;:&quot;Introduction
to Drug Utilization
Research&quot;,&quot;type&quot;:&quot;book&quot;},&quot;uris&quot;:[&quot;http://www.mendeley.com/documents/?uuid=19a02bb5-5741-46c4-85ee-9ff8127f3490&quot;,&quot;http://www.mendeley.com/documents/?uuid=bb6fa8e5-b29a-4307-9f24-0ab56ed75043&quot;]}],&quot;mendeley&quot;:{&quot;formattedCitation&quot;:&quot;(32,35)&quot;,&quot;plainTextFormattedCitation&quot;:&quot;(32,35)&quot;,&quot;previouslyFormattedCitation&quot;:&quot;(32,35)&quot;},&quot;properties&quot;:{&quot;noteIndex&quot;:0},&quot;schema&quot;:&quot;https://github.com/citation-style-language/schema/raw/master/csl-citation.json&quot;}<span
style='mso-element:field-separator'></span></span><![endif]--><span lang=ES
style='font-size:10.0pt;line-height:105%;font-family:"Times New Roman",serif;
mso-fareast-font-family:Calibri;mso-ansi-language:ES'><span style='mso-no-proof:
yes'>(32,35)</span></span><!--[if supportFields]><span lang=ES
style='font-size:10.0pt;line-height:105%;font-family:"Times New Roman",serif;
mso-fareast-font-family:Calibri;mso-ansi-language:ES'><span style='mso-element:
field-end'></span></span><![endif]--><span lang=ES style='font-size:10.0pt;
line-height:105%;font-family:"Times New Roman",serif;mso-fareast-font-family:
Calibri;mso-ansi-language:ES'>. La DDD tiene como objetivo estandarizar la
medida de consumo de medicamentos inicialmente expresada en unidades de peso
como gramos o miligramos. Por ejemplo, si un paciente ha consumido 30.000
gramos de ampicilina intravenosa en un mes y se considera una DDD de 2.000
gramos para la vía intravenosa, el consumo se puede expresar como 15 DDDs por
mes. <o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0mm;margin-bottom:.0001pt;text-align:
justify;text-indent:11.35pt;line-height:105%'><span lang=ES style='font-size:
10.0pt;line-height:105%;font-family:"Times New Roman",serif;mso-fareast-font-family:
Calibri;mso-ansi-language:ES'><o:p>&nbsp;</o:p></span></p>

<p class=MsoNormal style='margin-bottom:0mm;margin-bottom:.0001pt;text-align:
justify;text-indent:11.35pt;line-height:105%'><span lang=ES style='font-size:
10.0pt;line-height:105%;font-family:"Times New Roman",serif;mso-fareast-font-family:
Calibri;mso-ansi-language:ES'>Esta medida de consumo es definida para cada
medicamento y vía de administración por la Organización Mundial de la Salud
(OMS). Las DDDs hacen parte del sistema de clasificación Anatómico, Terapéutico
y Químico (ATC). El ATC es un sistema que permite la clasificación de los
medicamentos, de acuerdo al órgano o sistema en el cual estos actúan junto a
sus propiedades terapéuticas, farmacológicas y/o químicas. Los medicamentos son
clasificados en grupos dentro de cinco niveles diferentes. En el ATC existen catorce
grupos principales (primer nivel), con subgrupos farmacológicos y terapéuticos
(segundo nivel). Los niveles tercero y cuarto son subgrupos químicos,
farmacológicos y terapéuticos, existe además un quinto nivel que es específico
para cada fármaco </span><!--[if supportFields]><span lang=ES style='font-size:
10.0pt;line-height:105%;font-family:"Times New Roman",serif;mso-fareast-font-family:
Calibri;mso-ansi-language:ES'><span style='mso-element:field-begin;mso-field-lock:
yes'></span>ADDIN CSL_CITATION
{&quot;citationItems&quot;:[{&quot;id&quot;:&quot;ITEM-1&quot;,&quot;itemData&quot;:{&quot;DOI&quot;:&quot;10.1017/CBO9781107415324.004&quot;,&quot;ISBN&quot;:&quot;9788578110796&quot;,&quot;ISSN&quot;:&quot;1098-6596&quot;,&quot;PMID&quot;:&quot;25246403&quot;,&quot;abstract&quot;:&quot;Predicting
the binding mode of flexible polypeptides to proteins is an important task that
falls outside the domain of applicability of most small molecule and
protein−protein docking tools. Here, we test the small molecule flexible ligand
docking program Glide on a set of 19 non-α-helical peptides and systematically
improve pose prediction accuracy by enhancing Glide sampling for flexible
polypeptides. In addition, scoring of the poses was improved by post-processing
with physics-based implicit solvent MM- GBSA calculations. Using the best RMSD
among the top 10 scoring poses as a metric, the success rate (RMSD ≤ 2.0 Å for
the interface backbone atoms) increased from 21% with default Glide SP settings
to 58% with the enhanced peptide sampling and scoring protocol in the case of
redocking to the native protein structure. This approaches the accuracy of the
recently developed Rosetta FlexPepDock method (63% success for these 19
peptides) while being over 100 times faster. Cross-docking was performed for a
subset of cases where an unbound receptor structure was available, and in that
case, 40% of peptides were docked successfully. We analyze the results and find
that the optimized polypeptide protocol is most accurate for extended peptides
of limited size and number of formal charges, defining a domain of
applicability for this approach.&quot;,&quot;author&quot;:[{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;WHO
Collaborating Centre for Drug Statistics
Methodology&quot;,&quot;given&quot;:&quot;&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;}],&quot;edition&quot;:&quot;19th
editi&quot;,&quot;id&quot;:&quot;ITEM-1&quot;,&quot;issued&quot;:{&quot;date-parts&quot;:[[&quot;2015&quot;]]},&quot;number-of-pages&quot;:&quot;1-292&quot;,&quot;publisher-place&quot;:&quot;Oslo&quot;,&quot;title&quot;:&quot;Guidelines
for ATC classification and DDD assignment
2016&quot;,&quot;type&quot;:&quot;book&quot;,&quot;volume&quot;:&quot;1&quot;},&quot;uris&quot;:[&quot;http://www.mendeley.com/documents/?uuid=683f6900-7570-468d-88cb-4dc0ea280eb9&quot;,&quot;http://www.mendeley.com/documents/?uuid=001564eb-56fd-499a-9134-a2c1fbce8156&quot;]}],&quot;mendeley&quot;:{&quot;formattedCitation&quot;:&quot;(35)&quot;,&quot;plainTextFormattedCitation&quot;:&quot;(35)&quot;,&quot;previouslyFormattedCitation&quot;:&quot;(35)&quot;},&quot;properties&quot;:{&quot;noteIndex&quot;:0},&quot;schema&quot;:&quot;https://github.com/citation-style-language/schema/raw/master/csl-citation.json&quot;}<span
style='mso-element:field-separator'></span></span><![endif]--><span lang=ES
style='font-size:10.0pt;line-height:105%;font-family:"Times New Roman",serif;
mso-fareast-font-family:Calibri;mso-ansi-language:ES'><span style='mso-no-proof:
yes'>(35)</span></span><!--[if supportFields]><span lang=ES style='font-size:
10.0pt;line-height:105%;font-family:"Times New Roman",serif;mso-fareast-font-family:
Calibri;mso-ansi-language:ES'><span style='mso-element:field-end'></span></span><![endif]--><span
lang=ES style='font-size:10.0pt;line-height:105%;font-family:"Times New Roman",serif;
mso-fareast-font-family:Calibri;mso-ansi-language:ES'>.<o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0mm;margin-bottom:.0001pt;text-align:
justify;text-indent:11.35pt;line-height:105%'><span lang=ES style='font-size:
10.0pt;line-height:105%;font-family:"Times New Roman",serif;mso-fareast-font-family:
Calibri;mso-ansi-language:ES'><o:p>&nbsp;</o:p></span></p>

<p class=MsoNormal style='margin-bottom:0mm;margin-bottom:.0001pt;text-align:
justify;text-indent:11.35pt;line-height:105%'><span lang=ES style='font-size:
10.0pt;line-height:105%;font-family:"Times New Roman",serif;mso-fareast-font-family:
Calibri;mso-ansi-language:ES'>El principio básico del sistema ATC/DDD, es
asignar una dosis diaria definida para cada medicamento y ruta de
administración, definidos por un código ATC en el quinto nivel de la
clasificación. </span><span style='font-size:10.0pt;line-height:105%;
font-family:"Times New Roman",serif;mso-fareast-font-family:Calibri;mso-ansi-language:
ES-CO'>Las dosis diarias definidas son asignadas para cada medicamento, a
través de un consenso proveniente de un grupo de expertos nombrados por la OMS.
</span><span lang=ES style='font-size:10.0pt;line-height:105%;font-family:"Times New Roman",serif;
mso-fareast-font-family:Calibri;mso-ansi-language:ES'>El sistema ATC/DDD es
coordinado en Europa por el Centro Colaborador de la OMS en Metodología
Estadística de los Medicamentos, </span><span style='font-size:10.0pt;
line-height:105%;font-family:"Times New Roman",serif;mso-fareast-font-family:
Calibri;mso-ansi-language:ES-CO'>establecido en Oslo en 1982. Las solicitudes
de inclusión o </span><span lang=ES style='font-size:10.0pt;line-height:105%;
font-family:"Times New Roman",serif;mso-fareast-font-family:Calibri;mso-ansi-language:
ES'>modificación de códigos ATC/DDD son elaboradas por usuarios del sistema
para el Centro Colaborador. <o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0mm;margin-bottom:.0001pt;text-align:
justify;text-indent:11.35pt;line-height:105%'><span lang=ES style='font-size:
10.0pt;line-height:105%;font-family:"Times New Roman",serif;mso-fareast-font-family:
Calibri;mso-ansi-language:ES'><o:p>&nbsp;</o:p></span></p>

<p class=MsoNormal style='margin-bottom:0mm;margin-bottom:.0001pt;text-align:
justify;text-indent:11.35pt;line-height:105%'><span lang=ES style='font-size:
10.0pt;line-height:105%;font-family:"Times New Roman",serif;mso-fareast-font-family:
Calibri;mso-ansi-language:ES'>Las solicitudes son enviadas por </span><span
style='font-size:10.0pt;line-height:105%;font-family:"Times New Roman",serif;
mso-fareast-font-family:Calibri;mso-ansi-language:ES-CO'>el Centro Colaborador </span><span
lang=ES style='font-size:10.0pt;line-height:105%;font-family:"Times New Roman",serif;
mso-fareast-font-family:Calibri;mso-ansi-language:ES'>al principal regulador
del ATC/DDD que es el </span><span style='font-size:10.0pt;line-height:105%;
font-family:"Times New Roman",serif;mso-fareast-font-family:Calibri;mso-ansi-language:
ES-CO'>Grupo Internacional de Trabajo de la OMS en Metodología Estadística de
los Medicamentos establecido en 1996</span><span style='font-size:10.0pt;
line-height:105%;font-family:"Times New Roman",serif;mso-fareast-font-family:
Calibri;mso-ansi-language:ES'> </span><!--[if supportFields]><span lang=ES
style='font-size:10.0pt;line-height:105%;font-family:"Times New Roman",serif;
mso-fareast-font-family:Calibri;mso-ansi-language:ES'><span style='mso-element:
field-begin;mso-field-lock:yes'></span>ADDIN CSL_CITATION
{&quot;citationItems&quot;:[{&quot;id&quot;:&quot;ITEM-1&quot;,&quot;itemData&quot;:{&quot;DOI&quot;:&quot;10.1086/511649&quot;,&quot;ISSN&quot;:&quot;1058-4838,
1537-6591&quot;,&quot;PMID&quot;:&quot;17278057&quot;,&quot;author&quot;:[{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Monnet&quot;,&quot;given&quot;:&quot;Dominique
L&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;}],&quot;container-title&quot;:&quot;Clinical
Infectious
Diseases&quot;,&quot;id&quot;:&quot;ITEM-1&quot;,&quot;issue&quot;:&quot;5&quot;,&quot;issued&quot;:{&quot;date-parts&quot;:[[&quot;2007&quot;]]},&quot;page&quot;:&quot;671-673&quot;,&quot;title&quot;:&quot;Measuring
Antimicrobial Use: The Way
Forward&quot;,&quot;type&quot;:&quot;article-journal&quot;,&quot;volume&quot;:&quot;44&quot;},&quot;uris&quot;:[&quot;http://www.mendeley.com/documents/?uuid=eb9aff9e-d334-4dc1-bf55-70ba542df143&quot;,&quot;http://www.mendeley.com/documents/?uuid=c9da7220-ab0d-44b1-b38a-3d3901247135&quot;]}],&quot;mendeley&quot;:{&quot;formattedCitation&quot;:&quot;(36)&quot;,&quot;plainTextFormattedCitation&quot;:&quot;(36)&quot;,&quot;previouslyFormattedCitation&quot;:&quot;(36)&quot;},&quot;properties&quot;:{&quot;noteIndex&quot;:0},&quot;schema&quot;:&quot;https://github.com/citation-style-language/schema/raw/master/csl-citation.json&quot;}<span
style='mso-element:field-separator'></span></span><![endif]--><span lang=ES
style='font-size:10.0pt;line-height:105%;font-family:"Times New Roman",serif;
mso-fareast-font-family:Calibri;mso-ansi-language:ES'><span style='mso-no-proof:
yes'>(36)</span></span><!--[if supportFields]><span lang=ES style='font-size:
10.0pt;line-height:105%;font-family:"Times New Roman",serif;mso-fareast-font-family:
Calibri;mso-ansi-language:ES'><span style='mso-element:field-end'></span></span><![endif]--><span
style='font-size:10.0pt;line-height:105%;font-family:"Times New Roman",serif;
mso-fareast-font-family:Calibri;mso-ansi-language:ES-CO'>. Al provenir de
recomendación de expertos se considera a las DDDs como unidades de medida, más
que herramientas para ajustar las diferencias observadas entre la dosis
utilizadas por varios individuos </span><!--[if supportFields]><span
style='font-size:10.0pt;line-height:105%;font-family:"Times New Roman",serif;
mso-fareast-font-family:Calibri;mso-ansi-language:ES-CO'><span
style='mso-element:field-begin;mso-field-lock:yes'></span>ADDIN CSL_CITATION
{&quot;citationItems&quot;:[{&quot;id&quot;:&quot;ITEM-1&quot;,&quot;itemData&quot;:{&quot;DOI&quot;:&quot;10.1086/511649&quot;,&quot;ISSN&quot;:&quot;1058-4838,
1537-6591&quot;,&quot;PMID&quot;:&quot;17278057&quot;,&quot;author&quot;:[{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Monnet&quot;,&quot;given&quot;:&quot;Dominique
L&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;}],&quot;container-title&quot;:&quot;Clinical
Infectious Diseases&quot;,&quot;id&quot;:&quot;ITEM-1&quot;,&quot;issue&quot;:&quot;5&quot;,&quot;issued&quot;:{&quot;date-parts&quot;:[[&quot;2007&quot;]]},&quot;page&quot;:&quot;671-673&quot;,&quot;title&quot;:&quot;Measuring
Antimicrobial Use: The Way
Forward&quot;,&quot;type&quot;:&quot;article-journal&quot;,&quot;volume&quot;:&quot;44&quot;},&quot;uris&quot;:[&quot;http://www.mendeley.com/documents/?uuid=c9da7220-ab0d-44b1-b38a-3d3901247135&quot;,&quot;http://www.mendeley.com/documents/?uuid=eb9aff9e-d334-4dc1-bf55-70ba542df143&quot;]}],&quot;mendeley&quot;:{&quot;formattedCitation&quot;:&quot;(36)&quot;,&quot;plainTextFormattedCitation&quot;:&quot;(36)&quot;,&quot;previouslyFormattedCitation&quot;:&quot;(36)&quot;},&quot;properties&quot;:{&quot;noteIndex&quot;:0},&quot;schema&quot;:&quot;https://github.com/citation-style-language/schema/raw/master/csl-citation.json&quot;}<span
style='mso-element:field-separator'></span></span><![endif]--><span
style='font-size:10.0pt;line-height:105%;font-family:"Times New Roman",serif;
mso-fareast-font-family:Calibri;mso-ansi-language:ES-CO'><span
style='mso-no-proof:yes'>(36)</span></span><!--[if supportFields]><span
style='font-size:10.0pt;line-height:105%;font-family:"Times New Roman",serif;
mso-fareast-font-family:Calibri;mso-ansi-language:ES-CO'><span
style='mso-element:field-end'></span></span><![endif]--><span style='font-size:
10.0pt;line-height:105%;font-family:"Times New Roman",serif;mso-fareast-font-family:
Calibri;mso-ansi-language:ES-CO'>. Así mismo no es infrecuente que la DDD
difiera de la dosis que normalmente es prescrita y/o recomendada en un
individuo en la práctica clínica </span><!--[if supportFields]><span
style='font-size:10.0pt;line-height:105%;font-family:"Times New Roman",serif;
mso-fareast-font-family:Calibri;mso-ansi-language:ES-CO'><span
style='mso-element:field-begin;mso-field-lock:yes'></span>ADDIN CSL_CITATION {&quot;citationItems&quot;:[{&quot;id&quot;:&quot;ITEM-1&quot;,&quot;itemData&quot;:{&quot;DOI&quot;:&quot;10.1177/1757177410363357&quot;,&quot;ISBN&quot;:&quot;17571774&quot;,&quot;ISSN&quot;:&quot;ISSN
1757-1774&quot;,&quot;abstract&quot;:&quot;Increasing rates of antibiotic
resistance have been related to increased rates of antibiotic prescribing. This
paper describes the use of indicators to measure and compare antibiotic use and
enable hospitals to benchmark their practice. The Defined Daily Dose measure
may be combined with a number of denominators that quantify patient activity in
order to correct for workload variations between hospitals. This may be
combined with data from mandatory surveillance schemes for various infections
to inform prescribing
practice.\\n&quot;,&quot;author&quot;:[{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Curtis&quot;,&quot;given&quot;:&quot;C
E&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;}],&quot;container-title&quot;:&quot;Journal
of Infection
Prevention&quot;,&quot;id&quot;:&quot;ITEM-1&quot;,&quot;issue&quot;:&quot;4&quot;,&quot;issued&quot;:{&quot;date-parts&quot;:[[&quot;2010&quot;]]},&quot;page&quot;:&quot;124-126&quot;,&quot;title&quot;:&quot;Indicators
for the monitoring of antibiotic
use.&quot;,&quot;type&quot;:&quot;article-journal&quot;,&quot;volume&quot;:&quot;11&quot;},&quot;uris&quot;:[&quot;http://www.mendeley.com/documents/?uuid=88cd6823-507b-47bc-9ae7-4f25bf584caa&quot;]}],&quot;mendeley&quot;:{&quot;formattedCitation&quot;:&quot;(34)&quot;,&quot;plainTextFormattedCitation&quot;:&quot;(34)&quot;,&quot;previouslyFormattedCitation&quot;:&quot;(34)&quot;},&quot;properties&quot;:{&quot;noteIndex&quot;:0},&quot;schema&quot;:&quot;https://github.com/citation-style-language/schema/raw/master/csl-citation.json&quot;}<span
style='mso-element:field-separator'></span></span><![endif]--><span
style='font-size:10.0pt;line-height:105%;font-family:"Times New Roman",serif;
mso-fareast-font-family:Calibri;mso-ansi-language:ES-CO'><span
style='mso-no-proof:yes'>(34)</span></span><!--[if supportFields]><span
style='font-size:10.0pt;line-height:105%;font-family:"Times New Roman",serif;
mso-fareast-font-family:Calibri;mso-ansi-language:ES-CO'><span
style='mso-element:field-end'></span></span><![endif]--><span style='font-size:
10.0pt;line-height:105%;font-family:"Times New Roman",serif;mso-fareast-font-family:
Calibri;mso-ansi-language:ES-CO'>.<o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0mm;margin-bottom:.0001pt;text-align:
justify;text-indent:11.35pt;line-height:105%'><span style='font-size:10.0pt;
line-height:105%;font-family:"Times New Roman",serif;mso-fareast-font-family:
Calibri;mso-ansi-language:ES-CO'><o:p>&nbsp;</o:p></span></p>

<p class=MsoNormal style='margin-bottom:0mm;margin-bottom:.0001pt;text-align:
justify;text-indent:11.35pt;line-height:105%'><span style='font-size:10.0pt;
line-height:105%;font-family:"Times New Roman",serif;mso-fareast-font-family:
Calibri;mso-ansi-language:ES-CO'>El sistema de DDDs no puede ser aplicado para
la medición de consumo de antimicrobianos en la población pediátrica. Lo
anterior es debido a que en niños la dosis es ajustada de acuerdo a la edad,
peso corporal y talla entre otros factores. La variabilidad en las dosis
utilizadas es tan amplia, que pierde sentido definir una dosis para todos los
pacientes. En adición muchos medicamentos no tienen indicaciones aprobadas en
niños y las recomendaciones de dosis no tienen evidencia suficiente, por la
falta de estudios clínicos que evalúen eficacia y seguridad </span><!--[if supportFields]><span
style='font-size:10.0pt;line-height:105%;font-family:"Times New Roman",serif;
mso-fareast-font-family:Calibri;mso-ansi-language:ES-CO'><span
style='mso-element:field-begin;mso-field-lock:yes'></span>ADDIN CSL_CITATION
{&quot;citationItems&quot;:[{&quot;id&quot;:&quot;ITEM-1&quot;,&quot;itemData&quot;:{&quot;DOI&quot;:&quot;10.1111/bcp.12305&quot;,&quot;ISBN&quot;:&quot;01406736&quot;,&quot;ISSN&quot;:&quot;13652125&quot;,&quot;PMID&quot;:&quot;24325152&quot;,&quot;abstract&quot;:&quot;The
imperative to undertake randomised trials in children arises from extraordinary
advances in basic biomedical sciences, needing a matching commitment to
translational research if child health is to reap the benefits from this new knowledge.
Unfortunately, many prescribed treatments for children have not been adequately
tested in children, sometimes resulting in harmful treatments being given and
beneficial treatments being withheld. Government, industry, funding agencies,
and clinicians are responsible for research priorities being adult-focused
because of the greater burden of disease in adults, coupled with financial and
marketing considerations. This bias has meant that the equal rights of children
to participate in trials has not always been recognised. This is changing,
however, as the need for clinical trials in children has been increasingly
recognised by the scientific community and broader public, leading to new
legislation in some countries making trials of interventions mandatory in
children as well as adults before drug approval is given. Trials in children
are more challenging than those in adults. The pool of eligible children
entering trials is often small because many conditions are uncommon in
children, and the threshold for gaining consent is often higher and more
complex because parents have to make decisions about trial participation on
behalf of their child. Uncertain about what is best, despite supporting the
notion of trials in principle, parents and paediatricians generally opt for the
new intervention or for standard care rather than trial participation. In this
review, we explore issues relating to trial participation for children and
suggest some strategies for improving the conduct of clinical trials involving
children.&quot;,&quot;author&quot;:[{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Joseph&quot;,&quot;given&quot;:&quot;Pathma
D.&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Craig&quot;,&quot;given&quot;:&quot;Jonathan
C.&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Caldwell&quot;,&quot;given&quot;:&quot;Patrina
H
Y&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;}],&quot;container-title&quot;:&quot;British
Journal of Clinical
Pharmacology&quot;,&quot;id&quot;:&quot;ITEM-1&quot;,&quot;issue&quot;:&quot;3&quot;,&quot;issued&quot;:{&quot;date-parts&quot;:[[&quot;2015&quot;]]},&quot;page&quot;:&quot;357-369&quot;,&quot;title&quot;:&quot;Clinical
trials in
children&quot;,&quot;type&quot;:&quot;article-journal&quot;,&quot;volume&quot;:&quot;79&quot;},&quot;uris&quot;:[&quot;http://www.mendeley.com/documents/?uuid=d0835ffe-f1a1-43af-ac07-86347418f594&quot;]}],&quot;mendeley&quot;:{&quot;formattedCitation&quot;:&quot;(37)&quot;,&quot;plainTextFormattedCitation&quot;:&quot;(37)&quot;,&quot;previouslyFormattedCitation&quot;:&quot;(37)&quot;},&quot;properties&quot;:{&quot;noteIndex&quot;:0},&quot;schema&quot;:&quot;https://github.com/citation-style-language/schema/raw/master/csl-citation.json&quot;}<span
style='mso-element:field-separator'></span></span><![endif]--><span
style='font-size:10.0pt;line-height:105%;font-family:"Times New Roman",serif;
mso-fareast-font-family:Calibri;mso-ansi-language:ES-CO'><span
style='mso-no-proof:yes'>(37)</span></span><!--[if supportFields]><span
style='font-size:10.0pt;line-height:105%;font-family:"Times New Roman",serif;
mso-fareast-font-family:Calibri;mso-ansi-language:ES-CO'><span
style='mso-element:field-end'></span></span><![endif]--><span style='font-size:
10.0pt;line-height:105%;font-family:"Times New Roman",serif;mso-fareast-font-family:
Calibri;mso-ansi-language:ES-CO'>. El Grupo Internacional de Trabajo de la OMS
en Metodología Estadística de los Medicamentos ha concluido que es imposible
asignar DDDs en estos pacientes. Por tanto la investigación en problemas de
utilización de medicamentos en este grupo se debe realizar utilizando formas de
medición con sistemas diferentes </span><!--[if supportFields]><span
style='font-size:10.0pt;line-height:105%;font-family:"Times New Roman",serif;
mso-fareast-font-family:Calibri;mso-ansi-language:ES-CO'><span
style='mso-element:field-begin;mso-field-lock:yes'></span>ADDIN CSL_CITATION
{&quot;citationItems&quot;:[{&quot;id&quot;:&quot;ITEM-1&quot;,&quot;itemData&quot;:{&quot;DOI&quot;:&quot;10.1017/CBO9781107415324.004&quot;,&quot;ISBN&quot;:&quot;9788578110796&quot;,&quot;ISSN&quot;:&quot;1098-6596&quot;,&quot;PMID&quot;:&quot;25246403&quot;,&quot;abstract&quot;:&quot;Predicting
the binding mode of flexible polypeptides to proteins is an important task that
falls outside the domain of applicability of most small molecule and
protein−protein docking tools. Here, we test the small molecule flexible ligand
docking program Glide on a set of 19 non-α-helical peptides and systematically
improve pose prediction accuracy by enhancing Glide sampling for flexible
polypeptides. In addition, scoring of the poses was improved by post-processing
with physics-based implicit solvent MM- GBSA calculations. Using the best RMSD
among the top 10 scoring poses as a metric, the success rate (RMSD ≤ 2.0 Å for
the interface backbone atoms) increased from 21% with default Glide SP settings
to 58% with the enhanced peptide sampling and scoring protocol in the case of
redocking to the native protein structure. This approaches the accuracy of the
recently developed Rosetta FlexPepDock method (63% success for these 19
peptides) while being over 100 times faster. Cross-docking was performed for a
subset of cases where an unbound receptor structure was available, and in that
case, 40% of peptides were docked successfully. We analyze the results and find
that the optimized polypeptide protocol is most accurate for extended peptides
of limited size and number of formal charges, defining a domain of
applicability for this approach.&quot;,&quot;author&quot;:[{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;WHO
Collaborating Centre for Drug Statistics
Methodology&quot;,&quot;given&quot;:&quot;&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;}],&quot;edition&quot;:&quot;19th
editi&quot;,&quot;id&quot;:&quot;ITEM-1&quot;,&quot;issued&quot;:{&quot;date-parts&quot;:[[&quot;2015&quot;]]},&quot;number-of-pages&quot;:&quot;1-292&quot;,&quot;publisher-place&quot;:&quot;Oslo&quot;,&quot;title&quot;:&quot;Guidelines
for ATC classification and DDD assignment
2016&quot;,&quot;type&quot;:&quot;book&quot;,&quot;volume&quot;:&quot;1&quot;},&quot;uris&quot;:[&quot;http://www.mendeley.com/documents/?uuid=683f6900-7570-468d-88cb-4dc0ea280eb9&quot;,&quot;http://www.mendeley.com/documents/?uuid=001564eb-56fd-499a-9134-a2c1fbce8156&quot;]}],&quot;mendeley&quot;:{&quot;formattedCitation&quot;:&quot;(35)&quot;,&quot;plainTextFormattedCitation&quot;:&quot;(35)&quot;,&quot;previouslyFormattedCitation&quot;:&quot;(35)&quot;},&quot;properties&quot;:{&quot;noteIndex&quot;:0},&quot;schema&quot;:&quot;https://github.com/citation-style-language/schema/raw/master/csl-citation.json&quot;}<span
style='mso-element:field-separator'></span></span><![endif]--><span
style='font-size:10.0pt;line-height:105%;font-family:"Times New Roman",serif;
mso-fareast-font-family:Calibri;mso-ansi-language:ES-CO'><span
style='mso-no-proof:yes'>(35)</span></span><!--[if supportFields]><span
style='font-size:10.0pt;line-height:105%;font-family:"Times New Roman",serif;
mso-fareast-font-family:Calibri;mso-ansi-language:ES-CO'><span
style='mso-element:field-end'></span></span><![endif]--><span style='font-size:
10.0pt;line-height:105%;font-family:"Times New Roman",serif;mso-fareast-font-family:
Calibri;mso-ansi-language:ES-CO'>.<o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0mm;margin-bottom:.0001pt;text-align:
justify;text-indent:11.35pt;line-height:105%'><span style='font-size:10.0pt;
line-height:105%;font-family:"Times New Roman",serif;mso-fareast-font-family:
Calibri;mso-ansi-language:ES-CO'><o:p>&nbsp;</o:p></span></p>

<p class=MsoNormal style='margin-bottom:0mm;margin-bottom:.0001pt;text-align:
justify;text-indent:11.35pt;line-height:105%'><span style='font-size:10.0pt;
line-height:105%;font-family:"Times New Roman",serif;mso-fareast-font-family:
Calibri;mso-ansi-language:ES-CO'>La variación del peso corporal en niños es
amplia siendo el peso promedio a la edad de 1 mes de 4.2 kg y el peso promedio
a los 18 años es 60kg. Por otra parte, en neonatos la variación es menor con un
valor de peso promedio de 2.1 ± 1.0 kg. En estos pacientes debido a la menor
variación se han propuesto modificaciones a la DDD como la dosis diaria
definida neonatal (nDDD) propuestas de acuerdo a literatura </span><!--[if supportFields]><span
style='font-size:10.0pt;line-height:105%;font-family:"Times New Roman",serif;
mso-fareast-font-family:Calibri;mso-ansi-language:ES-CO'><span
style='mso-element:field-begin;mso-field-lock:yes'></span>ADDIN CSL_CITATION
{&quot;citationItems&quot;:[{&quot;id&quot;:&quot;ITEM-1&quot;,&quot;itemData&quot;:{&quot;DOI&quot;:&quot;10.1007/s10096-010-0990-3&quot;,&quot;ISBN&quot;:&quot;1435-4373
(Electronic)\\n0934-9723
(Linking)&quot;,&quot;ISSN&quot;:&quot;09349723&quot;,&quot;PMID&quot;:&quot;20556467&quot;,&quot;abstract&quot;:&quot;The
defined daily dose (DDD) as defined by the World Health Organization (WHO) has
been the most frequently used unit of measurement to measure antibiotic use.
However, measuring antibiotic use in paediatrics is a problem as the WHO DDD
methodology is not applicable in children (aged &gt;1 month) due to the large
variation in body weight within this population. Based on the narrow range of
body weights in the neonatal population, we therefore aimed to develop a set of
neonatal DDDs for antibiotics. Eight well-respected (inter)national sources for
dosage recommendations of antibiotics in children and neonates were consulted
for the assumed maintenance dose of the ten most frequently used antibiotics in
neonatal intensive care units in its main indication for neonates. A set of
neonatal DDDs for ten commonly used antibiotics in neonates based on an assumed
neonatal weight of 2 kg was proposed. Primarily in children DDDs are not
applicable to quantify antibiotic use since there is large variation in body
weight. In the neonatal population, however, based on its narrow range of body
weights and when access to patient level data is not available, neonatal DDDs
can be used as a unit of measurement.[PUBLICATION
ABSTRACT]]]]]&gt;&lt;![CDATA[&gt;&lt;/val&gt;&quot;,&quot;author&quot;:[{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Liem&quot;,&quot;given&quot;:&quot;T.
B.Y.&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Heerdink&quot;,&quot;given&quot;:&quot;E.
R.&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Egberts&quot;,&quot;given&quot;:&quot;A.
C.G.&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Rademaker&quot;,&quot;given&quot;:&quot;C.
M.A.&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;}],&quot;container-title&quot;:&quot;European
Journal of Clinical Microbiology and Infectious
Diseases&quot;,&quot;id&quot;:&quot;ITEM-1&quot;,&quot;issue&quot;:&quot;10&quot;,&quot;issued&quot;:{&quot;date-parts&quot;:[[&quot;2010&quot;]]},&quot;page&quot;:&quot;1301-1303&quot;,&quot;title&quot;:&quot;Quantifying
antibiotic use in paediatrics: A proposal for neonatal
DDDs&quot;,&quot;type&quot;:&quot;article-journal&quot;,&quot;volume&quot;:&quot;29&quot;},&quot;uris&quot;:[&quot;http://www.mendeley.com/documents/?uuid=5127d144-c713-436f-ba9f-2e3dbe4b0f4e&quot;]}],&quot;mendeley&quot;:{&quot;formattedCitation&quot;:&quot;(38)&quot;,&quot;plainTextFormattedCitation&quot;:&quot;(38)&quot;,&quot;previouslyFormattedCitation&quot;:&quot;(38)&quot;},&quot;properties&quot;:{&quot;noteIndex&quot;:0},&quot;schema&quot;:&quot;https://github.com/citation-style-language/schema/raw/master/csl-citation.json&quot;}<span
style='mso-element:field-separator'></span></span><![endif]--><span
style='font-size:10.0pt;line-height:105%;font-family:"Times New Roman",serif;
mso-fareast-font-family:Calibri;mso-ansi-language:ES-CO'><span
style='mso-no-proof:yes'>(38)</span></span><!--[if supportFields]><span
style='font-size:10.0pt;line-height:105%;font-family:"Times New Roman",serif;
mso-fareast-font-family:Calibri;mso-ansi-language:ES-CO'><span
style='mso-element:field-end'></span></span><![endif]--><span style='font-size:
10.0pt;line-height:105%;font-family:"Times New Roman",serif;mso-fareast-font-family:
Calibri;mso-ansi-language:ES-CO'>.<o:p></o:p></span></p>

<p class=MsoNormal style='margin-top:10.0pt;margin-right:0mm;margin-bottom:
6.0pt;margin-left:0mm'><i style='mso-bidi-font-style:normal'><span
style='mso-bidi-font-size:9.0pt;line-height:107%;mso-bidi-font-family:"Times New Roman";
mso-ansi-language:ES-CO'>5.2 Dosis diaria prescrita<o:p></o:p></span></i></p>

<p class=MsoNormal style='margin-bottom:0mm;margin-bottom:.0001pt;text-align:
justify;text-indent:11.35pt;line-height:105%'><span lang=ES style='font-size:
10.0pt;line-height:105%;font-family:"Times New Roman",serif;mso-fareast-font-family:
Calibri;mso-ansi-language:ES'>La dosis diaria prescrita (DDP) es el promedio de
las dosis recibidas en una muestra de pacientes (adultos) con función renal
normal en la práctica clínica </span><!--[if supportFields]><span lang=ES
style='font-size:10.0pt;line-height:105%;font-family:"Times New Roman",serif;
mso-fareast-font-family:Calibri;mso-ansi-language:ES'><span style='mso-element:
field-begin;mso-field-lock:yes'></span>ADDIN CSL_CITATION
{&quot;citationItems&quot;:[{&quot;id&quot;:&quot;ITEM-1&quot;,&quot;itemData&quot;:{&quot;DOI&quot;:&quot;10.1177/1757177410363357&quot;,&quot;ISBN&quot;:&quot;17571774&quot;,&quot;ISSN&quot;:&quot;ISSN
1757-1774&quot;,&quot;abstract&quot;:&quot;Increasing rates of antibiotic
resistance have been related to increased rates of antibiotic prescribing. This
paper describes the use of indicators to measure and compare antibiotic use and
enable hospitals to benchmark their practice. The Defined Daily Dose measure
may be combined with a number of denominators that quantify patient activity in
order to correct for workload variations between hospitals. This may be
combined with data from mandatory surveillance schemes for various infections
to inform prescribing
practice.\\n&quot;,&quot;author&quot;:[{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Curtis&quot;,&quot;given&quot;:&quot;C
E&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;}],&quot;container-title&quot;:&quot;Journal
of Infection Prevention&quot;,&quot;id&quot;:&quot;ITEM-1&quot;,&quot;issue&quot;:&quot;4&quot;,&quot;issued&quot;:{&quot;date-parts&quot;:[[&quot;2010&quot;]]},&quot;page&quot;:&quot;124-126&quot;,&quot;title&quot;:&quot;Indicators
for the monitoring of antibiotic use.&quot;,&quot;type&quot;:&quot;article-journal&quot;,&quot;volume&quot;:&quot;11&quot;},&quot;uris&quot;:[&quot;http://www.mendeley.com/documents/?uuid=88cd6823-507b-47bc-9ae7-4f25bf584caa&quot;]}],&quot;mendeley&quot;:{&quot;formattedCitation&quot;:&quot;(34)&quot;,&quot;plainTextFormattedCitation&quot;:&quot;(34)&quot;,&quot;previouslyFormattedCitation&quot;:&quot;(34)&quot;},&quot;properties&quot;:{&quot;noteIndex&quot;:0},&quot;schema&quot;:&quot;https://github.com/citation-style-language/schema/raw/master/csl-citation.json&quot;}<span
style='mso-element:field-separator'></span></span><![endif]--><span lang=ES
style='font-size:10.0pt;line-height:105%;font-family:"Times New Roman",serif;
mso-fareast-font-family:Calibri;mso-ansi-language:ES'><span style='mso-no-proof:
yes'>(34)</span></span><!--[if supportFields]><span lang=ES style='font-size:
10.0pt;line-height:105%;font-family:"Times New Roman",serif;mso-fareast-font-family:
Calibri;mso-ansi-language:ES'><span style='mso-element:field-end'></span></span><![endif]--><span
lang=ES style='font-size:10.0pt;line-height:105%;font-family:"Times New Roman",serif;
mso-fareast-font-family:Calibri;mso-ansi-language:ES'>. La DDP se calcula para
la población de interés, por lo cual es más representativa de la dosis
utilizada en la práctica para un paciente. La DDP se puede definir de acuerdo
al diagnóstico infeccioso, por ejemplo el meropenem podría tener una DDP de
1.5g para infecciones en piel, 3g para infecciones intrabdominales y 6g para
meningitis </span><!--[if supportFields]><span lang=ES style='font-size:10.0pt;
line-height:105%;font-family:"Times New Roman",serif;mso-fareast-font-family:
Calibri;mso-ansi-language:ES'><span style='mso-element:field-begin;mso-field-lock:
yes'></span>ADDIN CSL_CITATION
{&quot;citationItems&quot;:[{&quot;id&quot;:&quot;ITEM-1&quot;,&quot;itemData&quot;:{&quot;abstract&quot;:&quot;These
highlights do not include all the information needed to use MERREM I.V. safely
and effectively. See full prescribing information for MERREM
I.V.&quot;,&quot;author&quot;:[{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;AstraZeneca&quot;,&quot;given&quot;:&quot;&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;}],&quot;id&quot;:&quot;ITEM-1&quot;,&quot;issued&quot;:{&quot;date-parts&quot;:[[&quot;2016&quot;]]},&quot;page&quot;:&quot;1-24&quot;,&quot;title&quot;:&quot;Merrem
Highlights of Prescribing
Information&quot;,&quot;type&quot;:&quot;article-journal&quot;},&quot;uris&quot;:[&quot;http://www.mendeley.com/documents/?uuid=b5d8e8b3-5621-4026-955f-0c07204a1a36&quot;]}],&quot;mendeley&quot;:{&quot;formattedCitation&quot;:&quot;(39)&quot;,&quot;plainTextFormattedCitation&quot;:&quot;(39)&quot;,&quot;previouslyFormattedCitation&quot;:&quot;(39)&quot;},&quot;properties&quot;:{&quot;noteIndex&quot;:0},&quot;schema&quot;:&quot;https://github.com/citation-style-language/schema/raw/master/csl-citation.json&quot;}<span
style='mso-element:field-separator'></span></span><![endif]--><span lang=ES
style='font-size:10.0pt;line-height:105%;font-family:"Times New Roman",serif;
mso-fareast-font-family:Calibri;mso-ansi-language:ES'><span style='mso-no-proof:
yes'>(39)</span></span><!--[if supportFields]><span lang=ES style='font-size:
10.0pt;line-height:105%;font-family:"Times New Roman",serif;mso-fareast-font-family:
Calibri;mso-ansi-language:ES'><span style='mso-element:field-end'></span></span><![endif]--><span
lang=ES style='font-size:10.0pt;line-height:105%;font-family:"Times New Roman",serif;
mso-fareast-font-family:Calibri;mso-ansi-language:ES'>. <o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0mm;margin-bottom:.0001pt;text-align:
justify;text-indent:11.35pt;line-height:105%'><span lang=ES style='font-size:
10.0pt;line-height:105%;font-family:"Times New Roman",serif;mso-fareast-font-family:
Calibri;mso-ansi-language:ES'><o:p>&nbsp;</o:p></span></p>

<p class=MsoNormal style='margin-bottom:0mm;margin-bottom:.0001pt;text-align:
justify;text-indent:11.35pt;line-height:105%'><span lang=ES style='font-size:
10.0pt;line-height:105%;font-family:"Times New Roman",serif;mso-fareast-font-family:
Calibri;mso-ansi-language:ES'>La DDP presenta limitaciones cuando se intenta
hacer comparaciones entre hospitales, regiones o países. Estas limitaciones
parten de su variabilidad de acuerdo a las tradiciones terapéuticas nacionales
y la severidad de las condiciones tratadas, entre otros factores. Por lo
anterior, una DDP debería ser acompañada de una descripción
farmacoepidemiológica de la muestra de pacientes que fue utilizada en su
definición </span><!--[if supportFields]><span lang=ES style='font-size:10.0pt;
line-height:105%;font-family:"Times New Roman",serif;mso-fareast-font-family:
Calibri;mso-ansi-language:ES'><span style='mso-element:field-begin;mso-field-lock:
yes'></span>ADDIN CSL_CITATION
{&quot;citationItems&quot;:[{&quot;id&quot;:&quot;ITEM-1&quot;,&quot;itemData&quot;:{&quot;ISBN&quot;:&quot;8280820396&quot;,&quot;author&quot;:[{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;World
Health Organization&quot;,&quot;given&quot;:&quot;&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;}],&quot;id&quot;:&quot;ITEM-1&quot;,&quot;issued&quot;:{&quot;date-parts&quot;:[[&quot;2003&quot;]]},&quot;number-of-pages&quot;:&quot;1-84&quot;,&quot;publisher&quot;:&quot;World
Health Organization&quot;,&quot;publisher-place&quot;:&quot;Oslo&quot;,&quot;title&quot;:&quot;Introduction
to Drug Utilization
Research&quot;,&quot;type&quot;:&quot;book&quot;},&quot;uris&quot;:[&quot;http://www.mendeley.com/documents/?uuid=19a02bb5-5741-46c4-85ee-9ff8127f3490&quot;,&quot;http://www.mendeley.com/documents/?uuid=bb6fa8e5-b29a-4307-9f24-0ab56ed75043&quot;]}],&quot;mendeley&quot;:{&quot;formattedCitation&quot;:&quot;(32)&quot;,&quot;plainTextFormattedCitation&quot;:&quot;(32)&quot;,&quot;previouslyFormattedCitation&quot;:&quot;(32)&quot;},&quot;properties&quot;:{&quot;noteIndex&quot;:0},&quot;schema&quot;:&quot;https://github.com/citation-style-language/schema/raw/master/csl-citation.json&quot;}<span
style='mso-element:field-separator'></span></span><![endif]--><span lang=ES
style='font-size:10.0pt;line-height:105%;font-family:"Times New Roman",serif;
mso-fareast-font-family:Calibri;mso-ansi-language:ES'><span style='mso-no-proof:
yes'>(32)</span></span><!--[if supportFields]><span lang=ES style='font-size:
10.0pt;line-height:105%;font-family:"Times New Roman",serif;mso-fareast-font-family:
Calibri;mso-ansi-language:ES'><span style='mso-element:field-end'></span></span><![endif]--><span
lang=ES style='font-size:10.0pt;line-height:105%;font-family:"Times New Roman",serif;
mso-fareast-font-family:Calibri;mso-ansi-language:ES'>. En algunas
instituciones se han utilizado dosis diarias definidas internamente con el fin
de reflejar mejor su propio uso </span><!--[if supportFields]><span lang=ES
style='font-size:10.0pt;line-height:105%;font-family:"Times New Roman",serif;
mso-fareast-font-family:Calibri;mso-ansi-language:ES'><span style='mso-element:
field-begin;mso-field-lock:yes'></span>ADDIN CSL_CITATION
{&quot;citationItems&quot;:[{&quot;id&quot;:&quot;ITEM-1&quot;,&quot;itemData&quot;:{&quot;abstract&quot;:&quot;Three
major trends in antibiotic use in US hospitals have emerged over the last few
years: antibiotics as quality metrics, persistent use of different measures of
antibiotic consumption and the emergence of antibiotic stewardship programs.
Compared with Europe, where approaches are heterogeneous but generally
consistent, the USA currently lacks the infrastructure to monitor antibiotic
resistance and antibiotic consumption locally. Both have implemented
programmatic strategies for prudent antibiotic use. The USA appears to have
implemented processes more systematically to measure the quality of antibiotic
use.&quot;,&quot;author&quot;:[{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Jacob&quot;,&quot;given&quot;:&quot;J
T&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Gaynes&quot;,&quot;given&quot;:&quot;RP&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;}],&quot;container-title&quot;:&quot;Expert
Review of Anti-infective
Therapy&quot;,&quot;id&quot;:&quot;ITEM-1&quot;,&quot;issue&quot;:&quot;8&quot;,&quot;issued&quot;:{&quot;date-parts&quot;:[[&quot;2010&quot;]]},&quot;page&quot;:&quot;893-902&quot;,&quot;title&quot;:&quot;Emerging
trends in antibiotic use in US hospitals: quality, quantification and
stewardship&quot;,&quot;type&quot;:&quot;article-journal&quot;,&quot;volume&quot;:&quot;8&quot;},&quot;uris&quot;:[&quot;http://www.mendeley.com/documents/?uuid=67b411c4-1309-4ba8-a3d3-e6c41e656b01&quot;,&quot;http://www.mendeley.com/documents/?uuid=e3592e4a-9766-47be-a9d6-3c8792716d6f&quot;]}],&quot;mendeley&quot;:{&quot;formattedCitation&quot;:&quot;(13)&quot;,&quot;plainTextFormattedCitation&quot;:&quot;(13)&quot;,&quot;previouslyFormattedCitation&quot;:&quot;(13)&quot;},&quot;properties&quot;:{&quot;noteIndex&quot;:0},&quot;schema&quot;:&quot;https://github.com/citation-style-language/schema/raw/master/csl-citation.json&quot;}<span
style='mso-element:field-separator'></span></span><![endif]--><span lang=ES
style='font-size:10.0pt;line-height:105%;font-family:"Times New Roman",serif;
mso-fareast-font-family:Calibri;mso-ansi-language:ES'><span style='mso-no-proof:
yes'>(13)</span></span><!--[if supportFields]><span lang=ES style='font-size:
10.0pt;line-height:105%;font-family:"Times New Roman",serif;mso-fareast-font-family:
Calibri;mso-ansi-language:ES'><span style='mso-element:field-end'></span></span><![endif]--><span
lang=ES style='font-size:10.0pt;line-height:105%;font-family:"Times New Roman",serif;
mso-fareast-font-family:Calibri;mso-ansi-language:ES'>. Lo anterior puede
generar sesgos durante la realización de comparaciones interhospitalarias por
lo cual se debe preferir la denominación de DDP en estos casos.<o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0mm;margin-bottom:.0001pt;text-align:
justify;text-indent:11.35pt;line-height:105%'><span lang=ES style='font-size:
10.0pt;line-height:105%;font-family:"Times New Roman",serif;mso-fareast-font-family:
Calibri;mso-ansi-language:ES'><o:p>&nbsp;</o:p></span></p>

<p class=MsoNormal style='margin-bottom:0mm;margin-bottom:.0001pt;text-align:
justify;text-indent:11.35pt;line-height:105%'><span lang=ES style='font-size:
10.0pt;line-height:105%;font-family:"Times New Roman",serif;mso-fareast-font-family:
Calibri;mso-ansi-language:ES'>La DDP no representa una medida de consumo
aceptable para medicamentos que se dosifican de acuerdo al peso como
vancomicina o aminoglucósidos </span><!--[if supportFields]><span lang=ES
style='font-size:10.0pt;line-height:105%;font-family:"Times New Roman",serif;
mso-fareast-font-family:Calibri;mso-ansi-language:ES'><span style='mso-element:
field-begin;mso-field-lock:yes'></span>ADDIN CSL_CITATION
{&quot;citationItems&quot;:[{&quot;id&quot;:&quot;ITEM-1&quot;,&quot;itemData&quot;:{&quot;DOI&quot;:&quot;10.1023/B:PHAR.0000018595.78732.1c&quot;,&quot;ISBN&quot;:&quot;0928-1231&quot;,&quot;ISSN&quot;:&quot;09281231&quot;,&quot;PMID&quot;:&quot;15085943&quot;,&quot;abstract&quot;:&quot;BACKGROUND:
For several years now, the French national recommendations have been trying to
set up a surveillance system in hospitals to link data on antibiotic resistance
and data on the use of antibiotics, particularly for certain
'micro-organism/antibiotic' pairs. The indicators recommended in the lastest
newsletter of the Direction Générale de la Santé (French Public Health
Department) for monitoring the consumption of antibiotics were the number of
days of treatment or the number of defined daily doses (DDD), both (in)directly
related to the number of days of hospitalisation and/or the number of patients
hospitalised.OBJECTIVE: The aim of this study was to compare the actual number
of days of treatment, which is an observed indicator, with two indicators
calculated on the basis of the DDD and the DPD (daily prescribed dose), both in
terms of feasibility of collection and the relevance of the information
generated. MATERIALS AND METHODS: For several hospital care units, the 'length
of exposure' to a given antibiotic was determined by four different indicators:
two actual observed indicators [the patient's medical file (reference) and the
named-patient based, computerised dispensing system from the central pharmacy]
and two derived calculated indicators [obtained by dividing the number of grams
prescribed by the DDD or by the DPD]. RESULTS: The average incidence density of
antibiotic treatment (length of exposure per 1000 days of hospitalisation)
obtained by the calculated indicators was higher than that obtained with the
observed reference (+52% for the DDD and +33% for the DPD) but lower than that
obtained with the second observed indicator (computerised system) (-10%). The
differences were large and random (high variability depending on the hospital
department, the antibiotic and the administration route; variations in both
directions: actual length of treatment longer or shorter than the calculated
length of treatment). CONCLUSION: The question which indicator should be chosen
is inconclusive for the evaluation of the selection pressure exerted by an
antibiotic. The two indicators proposed in the newsletter (observed indicator
and calculated indicator) seem to be complementary for use in a regional or
national network to monitor resistance and consumption of antibiotics. Each
hospital should validate the indicators and define for itself which indicator
is most appropriate for estimating the actual length of antibiotic exposure.
This may imply diff…&quot;,&quot;author&quot;:[{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Mandy&quot;,&quot;given&quot;:&quot;Bruno&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Koutny&quot;,&quot;given&quot;:&quot;Estelle&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Cornette&quot;,&quot;given&quot;:&quot;Christian&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Woronoff-Lemsi&quot;,&quot;given&quot;:&quot;Marie
Christine&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Talon&quot;,&quot;given&quot;:&quot;Daniel&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;}],&quot;container-title&quot;:&quot;Pharmacy
World and Science&quot;,&quot;id&quot;:&quot;ITEM-1&quot;,&quot;issue&quot;:&quot;2&quot;,&quot;issued&quot;:{&quot;date-parts&quot;:[[&quot;2004&quot;]]},&quot;page&quot;:&quot;90-95&quot;,&quot;title&quot;:&quot;Methodological
validation of monitoring indicators of antibiotics use in
hospitals&quot;,&quot;type&quot;:&quot;article-journal&quot;,&quot;volume&quot;:&quot;26&quot;},&quot;uris&quot;:[&quot;http://www.mendeley.com/documents/?uuid=3e97ffab-bc6e-4997-bc6f-23f6a502face&quot;]}],&quot;mendeley&quot;:{&quot;formattedCitation&quot;:&quot;(40)&quot;,&quot;plainTextFormattedCitation&quot;:&quot;(40)&quot;,&quot;previouslyFormattedCitation&quot;:&quot;(40)&quot;},&quot;properties&quot;:{&quot;noteIndex&quot;:0},&quot;schema&quot;:&quot;https://github.com/citation-style-language/schema/raw/master/csl-citation.json&quot;}<span
style='mso-element:field-separator'></span></span><![endif]--><span lang=ES
style='font-size:10.0pt;line-height:105%;font-family:"Times New Roman",serif;
mso-fareast-font-family:Calibri;mso-ansi-language:ES'><span style='mso-no-proof:
yes'>(40)</span></span><!--[if supportFields]><span lang=ES style='font-size:
10.0pt;line-height:105%;font-family:"Times New Roman",serif;mso-fareast-font-family:
Calibri;mso-ansi-language:ES'><span style='mso-element:field-end'></span></span><![endif]--><span
lang=ES style='font-size:10.0pt;line-height:105%;font-family:"Times New Roman",serif;
mso-fareast-font-family:Calibri;mso-ansi-language:ES'>. Lo mismo ocurre en
individuos que reciben antimicrobianos de acuerdo a su peso o superficie de
área corporal (por ejemplo pacientes pediátricos o con insuficiencia renal) </span><!--[if supportFields]><span
lang=ES style='font-size:10.0pt;line-height:105%;font-family:"Times New Roman",serif;
mso-fareast-font-family:Calibri;mso-ansi-language:ES'><span style='mso-element:
field-begin;mso-field-lock:yes'></span>ADDIN CSL_CITATION
{&quot;citationItems&quot;:[{&quot;id&quot;:&quot;ITEM-1&quot;,&quot;itemData&quot;:{&quot;DOI&quot;:&quot;10.1023/B:PHAR.0000018595.78732.1c&quot;,&quot;ISBN&quot;:&quot;0928-1231&quot;,&quot;ISSN&quot;:&quot;09281231&quot;,&quot;PMID&quot;:&quot;15085943&quot;,&quot;abstract&quot;:&quot;BACKGROUND:
For several years now, the French national recommendations have been trying to
set up a surveillance system in hospitals to link data on antibiotic resistance
and data on the use of antibiotics, particularly for certain
'micro-organism/antibiotic' pairs. The indicators recommended in the lastest
newsletter of the Direction Générale de la Santé (French Public Health
Department) for monitoring the consumption of antibiotics were the number of
days of treatment or the number of defined daily doses (DDD), both (in)directly
related to the number of days of hospitalisation and/or the number of patients
hospitalised.OBJECTIVE: The aim of this study was to compare the actual number
of days of treatment, which is an observed indicator, with two indicators
calculated on the basis of the DDD and the DPD (daily prescribed dose), both in
terms of feasibility of collection and the relevance of the information
generated. MATERIALS AND METHODS: For several hospital care units, the 'length
of exposure' to a given antibiotic was determined by four different indicators:
two actual observed indicators [the patient's medical file (reference) and the
named-patient based, computerised dispensing system from the central pharmacy]
and two derived calculated indicators [obtained by dividing the number of grams
prescribed by the DDD or by the DPD]. RESULTS: The average incidence density of
antibiotic treatment (length of exposure per 1000 days of hospitalisation)
obtained by the calculated indicators was higher than that obtained with the
observed reference (+52% for the DDD and +33% for the DPD) but lower than that
obtained with the second observed indicator (computerised system) (-10%). The
differences were large and random (high variability depending on the hospital
department, the antibiotic and the administration route; variations in both
directions: actual length of treatment longer or shorter than the calculated
length of treatment). CONCLUSION: The question which indicator should be chosen
is inconclusive for the evaluation of the selection pressure exerted by an
antibiotic. The two indicators proposed in the newsletter (observed indicator
and calculated indicator) seem to be complementary for use in a regional or
national network to monitor resistance and consumption of antibiotics. Each
hospital should validate the indicators and define for itself which indicator
is most appropriate for estimating the actual length of antibiotic exposure.
This may imply diff…&quot;,&quot;author&quot;:[{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Mandy&quot;,&quot;given&quot;:&quot;Bruno&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Koutny&quot;,&quot;given&quot;:&quot;Estelle&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Cornette&quot;,&quot;given&quot;:&quot;Christian&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Woronoff-Lemsi&quot;,&quot;given&quot;:&quot;Marie
Christine&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Talon&quot;,&quot;given&quot;:&quot;Daniel&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;}],&quot;container-title&quot;:&quot;Pharmacy
World and
Science&quot;,&quot;id&quot;:&quot;ITEM-1&quot;,&quot;issue&quot;:&quot;2&quot;,&quot;issued&quot;:{&quot;date-parts&quot;:[[&quot;2004&quot;]]},&quot;page&quot;:&quot;90-95&quot;,&quot;title&quot;:&quot;Methodological
validation of monitoring indicators of antibiotics use in
hospitals&quot;,&quot;type&quot;:&quot;article-journal&quot;,&quot;volume&quot;:&quot;26&quot;},&quot;uris&quot;:[&quot;http://www.mendeley.com/documents/?uuid=3e97ffab-bc6e-4997-bc6f-23f6a502face&quot;]}],&quot;mendeley&quot;:{&quot;formattedCitation&quot;:&quot;(40)&quot;,&quot;plainTextFormattedCitation&quot;:&quot;(40)&quot;,&quot;previouslyFormattedCitation&quot;:&quot;(40)&quot;},&quot;properties&quot;:{&quot;noteIndex&quot;:0},&quot;schema&quot;:&quot;https://github.com/citation-style-language/schema/raw/master/csl-citation.json&quot;}<span
style='mso-element:field-separator'></span></span><![endif]--><span lang=ES
style='font-size:10.0pt;line-height:105%;font-family:"Times New Roman",serif;
mso-fareast-font-family:Calibri;mso-ansi-language:ES'><span style='mso-no-proof:
yes'>(40)</span></span><!--[if supportFields]><span lang=ES style='font-size:
10.0pt;line-height:105%;font-family:"Times New Roman",serif;mso-fareast-font-family:
Calibri;mso-ansi-language:ES'><span style='mso-element:field-end'></span></span><![endif]--><span
lang=ES style='font-size:10.0pt;line-height:105%;font-family:"Times New Roman",serif;
mso-fareast-font-family:Calibri;mso-ansi-language:ES'>.<o:p></o:p></span></p>

<p class=MsoNormal style='margin-top:10.0pt;margin-right:0mm;margin-bottom:
6.0pt;margin-left:0mm'><i style='mso-bidi-font-style:normal'><span
style='mso-bidi-font-size:9.0pt;line-height:107%;mso-bidi-font-family:"Times New Roman";
mso-ansi-language:ES-CO'>5.3 Dosis diaria recomendada<o:p></o:p></span></i></p>

<p class=MsoNormal style='margin-bottom:10.0pt;text-align:justify;line-height:
115%'><span style='font-size:10.0pt;line-height:115%;font-family:"Times New Roman",serif;
mso-fareast-font-family:Calibri;mso-ansi-language:ES-CO'>La recomendación de
dosis diarias recomendadas (DDR) parte de un consenso de expertos diferente a
la OMS que es la que cobija al sistema ATC/DDD. Esta dosis podría ser la
recomendada por una guía de práctica clínica local o nacional para una
indicación de tratamiento específica </span><!--[if supportFields]><span
style='font-size:10.0pt;line-height:115%;font-family:"Times New Roman",serif;
mso-fareast-font-family:Calibri;mso-ansi-language:ES-CO'><span
style='mso-element:field-begin;mso-field-lock:yes'></span>ADDIN CSL_CITATION
{&quot;citationItems&quot;:[{&quot;id&quot;:&quot;ITEM-1&quot;,&quot;itemData&quot;:{&quot;DOI&quot;:&quot;10.1007/s15010-008-8138-4&quot;,&quot;ISBN&quot;:&quot;0300-8126&quot;,&quot;ISSN&quot;:&quot;03008126&quot;,&quot;PMID&quot;:&quot;19277464&quot;,&quot;abstract&quot;:&quot;BACKGROUND:
Hospital antibiotic use is usually measured by calculating the volume as the
number of daily doses defined by the World Health Organization/Anatomical
Therapeutic Chemical (WHO/ATC) index (DDDs) divided by a denominator indicating
clinical activity, such as the number of occupied bed days. Previous studies have
found discrepancies between DDDs, daily doses as recommended in practice
guidelines (recommended daily doses, RDDs), and truly prescribed daily doses
(PDDs). Very few studies have quantified these discrepancies. METHODS: A point
prevalence survey was carried out in defined acute care service areas of a
large German state university hospital. Of the 941 adult inpatients present on
the day of the survey for whom adequate information was available, 267 (28%)
had 471 prescriptions for antimicrobial drugs on that specific day. A check for
any additional antimicrobial drug prescriptions for these 267 patients during
the six days immediately preceding the survey day yielded a total of 2,304
PDDs, of which 1,754 were antibacterial agents. The latter antibacterial drug
PDDs constituted the basis for analysis. The proportion of PDDs different from
RDDs and from DDDs was evaluated, and the deviations were calculated. RDD dose
definitions corresponded to the local practice guideline recommendations of
antibiotic therapy for adult hospitalized patients with normal renal
function.\\n\\nRESULTS: Of the 1,754 PDDs, 625 were matching DDD dose
definitions (36%), and 1,024 (58%) were matching RDD dose definitions (p &lt;
0.01). Corresponding values for patients with impaired renal function
(creatinine clearance &lt; 50 ml/min) were 36% and 42%, respectively. Large DDD
discrepancies (&lt; 50% of prescribed doses matching DDD definitions) were
noted for beta-lactams and macrolides, while large RDD discrepancies were
observed for aminoglycosides. Compared with PDDs, the use of DDDs as the
measurement of hospital antibiotic use overestimated antibiotic use volumes by
32%, while the use of RDD led to a slight underestimation (-9%).CONCLUSION: The
use of DDDs as currently defined by WHO/ATC for measuring hospital antibiotic
consumption may be associated with a substantial overestimation of antibiotic
use density, while using practice guideline-derived RDDs may yield more valid
antibiotic exposure estimates that would be helpful in cross-sectional and
longitudinal analyses of antibiotic
consumption.&quot;,&quot;author&quot;:[{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;With&quot;,&quot;given&quot;:&quot;K.&quot;,&quot;non-dropping-particle&quot;:&quot;De&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Bestehorn&quot;,&quot;given&quot;:&quot;H.&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Steib-Bauert&quot;,&quot;given&quot;:&quot;M.&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;V.&quot;,&quot;family&quot;:&quot;Kern&quot;,&quot;given&quot;:&quot;W.&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;}],&quot;container-title&quot;:&quot;Infection&quot;,&quot;id&quot;:&quot;ITEM-1&quot;,&quot;issue&quot;:&quot;4&quot;,&quot;issued&quot;:{&quot;date-parts&quot;:[[&quot;2009&quot;]]},&quot;page&quot;:&quot;349-352&quot;,&quot;title&quot;:&quot;Comparison
of defined versus recommended versus prescribed daily doses for measuring
hospital antibiotic consumption&quot;,&quot;type&quot;:&quot;article-journal&quot;,&quot;volume&quot;:&quot;37&quot;},&quot;uris&quot;:[&quot;http://www.mendeley.com/documents/?uuid=57fcb398-1a6f-40d5-aaa1-0babbf0b8893&quot;]}],&quot;mendeley&quot;:{&quot;formattedCitation&quot;:&quot;(41)&quot;,&quot;plainTextFormattedCitation&quot;:&quot;(41)&quot;,&quot;previouslyFormattedCitation&quot;:&quot;(41)&quot;},&quot;properties&quot;:{&quot;noteIndex&quot;:0},&quot;schema&quot;:&quot;https://github.com/citation-style-language/schema/raw/master/csl-citation.json&quot;}<span
style='mso-element:field-separator'></span></span><![endif]--><span
style='font-size:10.0pt;line-height:115%;font-family:"Times New Roman",serif;
mso-fareast-font-family:Calibri;mso-ansi-language:ES-CO'><span
style='mso-no-proof:yes'>(41)</span></span><!--[if supportFields]><span
style='font-size:10.0pt;line-height:115%;font-family:"Times New Roman",serif;
mso-fareast-font-family:Calibri;mso-ansi-language:ES-CO'><span
style='mso-element:field-end'></span></span><![endif]--><span style='font-size:
10.0pt;line-height:115%;font-family:"Times New Roman",serif;mso-fareast-font-family:
Calibri;mso-ansi-language:ES-CO'>.<o:p></o:p></span></p>

<p class=MsoNormal style='margin-top:10.0pt;margin-right:0mm;margin-bottom:
6.0pt;margin-left:0mm'><i style='mso-bidi-font-style:normal'><span
style='mso-bidi-font-size:9.0pt;line-height:107%;mso-bidi-font-family:"Times New Roman";
mso-ansi-language:ES-CO'>5.4 Días de terapia con antimicrobianos<o:p></o:p></span></i></p>

<p class=MsoNormal style='margin-bottom:0mm;margin-bottom:.0001pt;text-align:
justify;text-indent:11.35pt;line-height:105%'><span style='font-size:10.0pt;
line-height:105%;font-family:"Times New Roman",serif;mso-fareast-font-family:
Calibri;mso-ansi-language:ES-CO'>Los días de terapia (DOTs, Days Of Therapy) </span><span
lang=ES style='font-size:10.0pt;line-height:105%;font-family:"Times New Roman",serif;
mso-fareast-font-family:Calibri;mso-ansi-language:ES'>constituyen una medida de
consumo alternativa a DDR y DDD para antimicrobianos. Se define 1 DOT como
cualquier dosis de antimicrobiano recibida durante un periodo de 24 horas
(empezando a una hora definida) </span><!--[if supportFields]><span lang=ES
style='font-size:10.0pt;line-height:105%;font-family:"Times New Roman",serif;
mso-fareast-font-family:Calibri;mso-ansi-language:ES'><span style='mso-element:
field-begin;mso-field-lock:yes'></span>ADDIN CSL_CITATION {&quot;citationItems&quot;:[{&quot;id&quot;:&quot;ITEM-1&quot;,&quot;itemData&quot;:{&quot;DOI&quot;:&quot;10.1093/cid/cir672&quot;,&quot;ISBN&quot;:&quot;10584838&quot;,&quot;ISSN&quot;:&quot;10584838&quot;,&quot;PMID&quot;:&quot;74640963&quot;,&quot;abstract&quot;:&quot;Background.
Antimicrobial stewardship programs are advised to measure and risk-adjust
antimicrobial use to facilitate interhospital comparisons, a process called
benchmarking. The purpose of this investigation was to evaluate a new
benchmarking strategy for antibacterials. Methods. Hospital-wide adult
antibacterial drug use in 2009 was measured as days of therapy (DOT) and length
of therapy (LOT) from billing records in 70 US academic medical centers (AMCs).
Patients were assigned to 1 of 35 clinical service lines (CSL) based on their
Medicare Severity Diagnosis Related Group. Expected (E) use was determined by
indirect standardization and compared with observed (O) use. Results. Of 1 791
180 discharged adults, 63.7% received antibacterial drugs; the range by CSL was
14.3% (psychiatry) to 99.7% (lung transplant). Mean ± SD hospital-wide use was
839 ± 106 DOTs (range, 594-1109) and 536 ± 53.0 LOT (range, 427-684) per 1000
patient-days. The ventilator support CSL had the most DOT per discharge,
39.4±9.4 days; the LOT was 21.5±4.5 days. The hospital-wide O/E ratio range was
0.7-1.45; in 5 AMCs the ratio exceeded the 90% confidence interval (CI) and was
below the 90% CI in 6. Variability in use was explained by the proportion of
treated patients within each CSL and mean LOT and DOT per discharge.
Conclusions. Adult antibacterial drug use was benchmarked to expected use
adjusted for patient mix, and outlier hospitals were identified. Differences
between expected and observed use reflect usage patterns that were benchmarked
and are targets for evaluation and intervention. [ABSTRACT FROM
AUTHOR]]]]]&gt;&lt;![CDATA[&gt;&amp;#xD;&lt;![CDATA[Copyright of Clinical
Infectious Diseases is the property of Infectious Diseases Society of America
and its content may not be copied or emailed to multiple sites or posted to a
listserv without the copyright holder's express written permission. However,
users may print, download, or email articles for individual use. This abstract
may be abridged. No warranty is given about the accuracy of the copy. Users
should refer to the original published version of the material for the full
abstract. (Copyright applies to all Abstracts.)&quot;,&quot;author&quot;:[{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Polk&quot;,&quot;given&quot;:&quot;Ron
E.&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Hohmann&quot;,&quot;given&quot;:&quot;Samuel
F.&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Medvedev&quot;,&quot;given&quot;:&quot;Sofia&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Ibrahim&quot;,&quot;given&quot;:&quot;Omar&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;}],&quot;container-title&quot;:&quot;Clinical
Infectious
Diseases&quot;,&quot;id&quot;:&quot;ITEM-1&quot;,&quot;issue&quot;:&quot;11&quot;,&quot;issued&quot;:{&quot;date-parts&quot;:[[&quot;2011&quot;]]},&quot;page&quot;:&quot;1100-1110&quot;,&quot;title&quot;:&quot;Benchmarking
risk-adjusted adult antibacterial drug use in 70 US academic medical center
hospitals&quot;,&quot;type&quot;:&quot;article-journal&quot;,&quot;volume&quot;:&quot;53&quot;},&quot;uris&quot;:[&quot;http://www.mendeley.com/documents/?uuid=5b334094-ff76-44ef-9105-1634ae1f6951&quot;]}],&quot;mendeley&quot;:{&quot;formattedCitation&quot;:&quot;(42)&quot;,&quot;plainTextFormattedCitation&quot;:&quot;(42)&quot;,&quot;previouslyFormattedCitation&quot;:&quot;(42)&quot;},&quot;properties&quot;:{&quot;noteIndex&quot;:0},&quot;schema&quot;:&quot;https://github.com/citation-style-language/schema/raw/master/csl-citation.json&quot;}<span
style='mso-element:field-separator'></span></span><![endif]--><span lang=ES
style='font-size:10.0pt;line-height:105%;font-family:"Times New Roman",serif;
mso-fareast-font-family:Calibri;mso-ansi-language:ES'><span style='mso-no-proof:
yes'>(42)</span></span><!--[if supportFields]><span lang=ES style='font-size:
10.0pt;line-height:105%;font-family:"Times New Roman",serif;mso-fareast-font-family:
Calibri;mso-ansi-language:ES'><span style='mso-element:field-end'></span></span><![endif]--><span
lang=ES style='font-size:10.0pt;line-height:105%;font-family:"Times New Roman",serif;
mso-fareast-font-family:Calibri;mso-ansi-language:ES'>. Cada antimicrobiano
administrado a un paciente, se suma en el conteo de días de terapia para
obtener un consumo acumulado. Por ejemplo, si un paciente recibe tratamiento
con ceftriaxona y vancomicina por 3 días con vancomicina por 4 días
adicionales, se tiene un consumo acumulado de 10 DOTs.<o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0mm;margin-bottom:.0001pt;text-align:
justify;text-indent:11.35pt;line-height:105%'><span lang=ES style='font-size:
10.0pt;line-height:105%;font-family:"Times New Roman",serif;mso-fareast-font-family:
Calibri;mso-ansi-language:ES'><o:p>&nbsp;</o:p></span></p>

<p class=MsoNormal style='margin-bottom:0mm;margin-bottom:.0001pt;text-align:
justify;text-indent:11.35pt;line-height:105%'><span lang=ES style='font-size:
10.0pt;line-height:105%;font-family:"Times New Roman",serif;mso-fareast-font-family:
Calibri;mso-ansi-language:ES'>Los DOTs se relacionan directamente con la
duración de la exposición por un paciente a un antimicrobiano. Esta medida no
depende de la dosis utilizada por el paciente por lo cual se prefiere en
poblaciones en las cuales se hace dosificación basada en peso o área corporal.
Entre los cuales se tienen a pacientes pediátricos y pacientes con función
renal disminuida </span><!--[if supportFields]><span lang=ES style='font-size:
10.0pt;line-height:105%;font-family:"Times New Roman",serif;mso-fareast-font-family:
Calibri;mso-ansi-language:ES'><span style='mso-element:field-begin;mso-field-lock:
yes'></span>ADDIN CSL_CITATION {&quot;citationItems&quot;:[{&quot;id&quot;:&quot;ITEM-1&quot;,&quot;itemData&quot;:{&quot;DOI&quot;:&quot;10.1086/344753&quot;,&quot;ISSN&quot;:&quot;1537-6591&quot;,&quot;PMID&quot;:&quot;12471568&quot;,&quot;abstract&quot;:&quot;The
defined daily dose, a popular measurement of antimicrobial use, may
underestimate the use of antimicrobials that are dose-adjusted in patients with
renal insufficiency. To evaluate the effect of renal dysfunction on these
measures, we performed a retrospective cohort study that involved patients
receiving ceftriaxone, levofloxacin, or vancomycin, with use of defined daily
doses and 2 methods based on therapy duration--stop-start days (i.e., entire
therapy duration) and transaction days (i.e., unique therapeutic days). The
vancomycin use rate for patients with renal insufficiency was 36% lower than
that of patients with normal renal function for defined daily doses, and it was
23% lower for transaction days; for levofloxacin, there was a 27% rate
reduction for the defined daily dose. No significant reduction was noted when
the stop-start day method was used. Compared with the defined daily dose
method, measures of therapy duration are less affected by renal function and
may improve comparisons between
populations.&quot;,&quot;author&quot;:[{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Zagorski&quot;,&quot;given&quot;:&quot;B
M&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Trick&quot;,&quot;given&quot;:&quot;W
E&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Schwartz&quot;,&quot;given&quot;:&quot;D
N&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Wisniewski&quot;,&quot;given&quot;:&quot;M
F&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Hershow&quot;,&quot;given&quot;:&quot;R
C&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Fridkin&quot;,&quot;given&quot;:&quot;S
K&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Weinstein&quot;,&quot;given&quot;:&quot;R
a&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;}],&quot;container-title&quot;:&quot;Clinical
Infectious Diseases&quot;,&quot;id&quot;:&quot;ITEM-1&quot;,&quot;issue&quot;:&quot;12&quot;,&quot;issued&quot;:{&quot;date-parts&quot;:[[&quot;2002&quot;]]},&quot;page&quot;:&quot;1491-7&quot;,&quot;title&quot;:&quot;The
effect of renal dysfunction on antimicrobial use
measurements.&quot;,&quot;type&quot;:&quot;article-journal&quot;,&quot;volume&quot;:&quot;35&quot;},&quot;uris&quot;:[&quot;http://www.mendeley.com/documents/?uuid=f92142ad-ac18-4df9-b187-e43988032dfb&quot;]}],&quot;mendeley&quot;:{&quot;formattedCitation&quot;:&quot;(43)&quot;,&quot;plainTextFormattedCitation&quot;:&quot;(43)&quot;,&quot;previouslyFormattedCitation&quot;:&quot;(43)&quot;},&quot;properties&quot;:{&quot;noteIndex&quot;:0},&quot;schema&quot;:&quot;https://github.com/citation-style-language/schema/raw/master/csl-citation.json&quot;}<span
style='mso-element:field-separator'></span></span><![endif]--><span lang=ES
style='font-size:10.0pt;line-height:105%;font-family:"Times New Roman",serif;
mso-fareast-font-family:Calibri;mso-ansi-language:ES'><span style='mso-no-proof:
yes'>(43)</span></span><!--[if supportFields]><span lang=ES style='font-size:
10.0pt;line-height:105%;font-family:"Times New Roman",serif;mso-fareast-font-family:
Calibri;mso-ansi-language:ES'><span style='mso-element:field-end'></span></span><![endif]--><span
lang=ES style='font-size:10.0pt;line-height:105%;font-family:"Times New Roman",serif;
mso-fareast-font-family:Calibri;mso-ansi-language:ES'>. Los DOTs son buenos
predictores del impacto ecológico, al medir la intensidad de uso y no la dosis
acumulada </span><!--[if supportFields]><span lang=ES style='font-size:10.0pt;
line-height:105%;font-family:"Times New Roman",serif;mso-fareast-font-family:
Calibri;mso-ansi-language:ES'><span style='mso-element:field-begin;mso-field-lock:
yes'></span>ADDIN CSL_CITATION
{&quot;citationItems&quot;:[{&quot;id&quot;:&quot;ITEM-1&quot;,&quot;itemData&quot;:{&quot;DOI&quot;:&quot;10.1093/jac/dkp399&quot;,&quot;ISBN&quot;:&quot;4419156562&quot;,&quot;ISSN&quot;:&quot;03057453&quot;,&quot;PMID&quot;:&quot;19884120&quot;,&quot;abstract&quot;:&quot;Background
Measurement of prescribing is an important component of antimicrobial
stewardship. The standard unit of measurement in hospitals is defined daily
doses denominated by bed days (e.g. DDDs per 1000 bed days) but alternatives
have not been evaluated in depth.Methods Electronically prescribed doses of
systemic antibacterials administered in this trust during 2008 were analysed in
order to generate 10 indices of antimicrobial use for each of 14 departments.
These indices were five measurements of consumption (DDDs, agent days, courses,
antibiotic days and treatment periods) each denominated by two measurements of
activity [bed days and finished consultant episodes (FCEs)].Results The 10
indices cluster into four groups within which they correlate well but between
which correlation is poor. These four groups comprise a volume-related
measurement of consumption (DDDs, agent days, antibiotic days) and an
exposure-related measurement of consumption (courses, treatment periods), each
denominated by either bed occupancy (bed days) or patient throughput
(FCEs).Conclusions Indices within these four groups seem to provide different
and complementary information. Restricting measurement of antimicrobial use to
a single metric such as DDDs per 1000 bed days may be insufficient. It is not
known which (if any) of these indices are the best predictors of
antimicrobial-related risks such as resistance pressure or Clostridium
difficile infection.&quot;,&quot;author&quot;:[{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Berrington&quot;,&quot;given&quot;:&quot;Andrew&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;}],&quot;container-title&quot;:&quot;Journal
of Antimicrobial
Chemotherapy&quot;,&quot;id&quot;:&quot;ITEM-1&quot;,&quot;issue&quot;:&quot;1&quot;,&quot;issued&quot;:{&quot;date-parts&quot;:[[&quot;2009&quot;]]},&quot;page&quot;:&quot;163-168&quot;,&quot;title&quot;:&quot;Antimicrobial
prescribing in hospitals: Be careful what you
measure&quot;,&quot;type&quot;:&quot;article-journal&quot;,&quot;volume&quot;:&quot;65&quot;},&quot;uris&quot;:[&quot;http://www.mendeley.com/documents/?uuid=e845ab0f-2b9f-4fb4-82db-4266f5332f47&quot;]}],&quot;mendeley&quot;:{&quot;formattedCitation&quot;:&quot;(29)&quot;,&quot;plainTextFormattedCitation&quot;:&quot;(29)&quot;,&quot;previouslyFormattedCitation&quot;:&quot;(29)&quot;},&quot;properties&quot;:{&quot;noteIndex&quot;:0},&quot;schema&quot;:&quot;https://github.com/citation-style-language/schema/raw/master/csl-citation.json&quot;}<span
style='mso-element:field-separator'></span></span><![endif]--><span lang=ES
style='font-size:10.0pt;line-height:105%;font-family:"Times New Roman",serif;
mso-fareast-font-family:Calibri;mso-ansi-language:ES'><span style='mso-no-proof:
yes'>(29)</span></span><!--[if supportFields]><span lang=ES style='font-size:
10.0pt;line-height:105%;font-family:"Times New Roman",serif;mso-fareast-font-family:
Calibri;mso-ansi-language:ES'><span style='mso-element:field-end'></span></span><![endif]--><span
lang=ES style='font-size:10.0pt;line-height:105%;font-family:"Times New Roman",serif;
mso-fareast-font-family:Calibri;mso-ansi-language:ES'>. Por lo anterior, esta
unidad de consumo se considera adecuada para la evaluar el consumo de
antimicrobianos y podría ser superior a DDD, RDD y PDD en este fin.<o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0mm;margin-bottom:.0001pt;text-align:
justify;text-indent:11.35pt;line-height:105%'><span lang=ES style='font-size:
10.0pt;line-height:105%;font-family:"Times New Roman",serif;mso-fareast-font-family:
Calibri;mso-ansi-language:ES'><o:p>&nbsp;</o:p></span></p>

<p class=MsoNormal style='margin-bottom:0mm;margin-bottom:.0001pt;text-align:
justify;text-indent:11.35pt;line-height:105%'><span lang=ES style='font-size:
10.0pt;line-height:105%;font-family:"Times New Roman",serif;mso-fareast-font-family:
Calibri;mso-ansi-language:ES'>Un factor que limita la amplia utilización de
este indicador es la falta de información de consumo de antimicrobianos a nivel
paciente en varias instituciones </span><!--[if supportFields]><span lang=ES
style='font-size:10.0pt;line-height:105%;font-family:"Times New Roman",serif;
mso-fareast-font-family:Calibri;mso-ansi-language:ES'><span style='mso-element:
field-begin;mso-field-lock:yes'></span>ADDIN CSL_CITATION
{&quot;citationItems&quot;:[{&quot;id&quot;:&quot;ITEM-1&quot;,&quot;itemData&quot;:{&quot;DOI&quot;:&quot;10.1128/CMR.00001-13&quot;,&quot;ISBN&quot;:&quot;0893-8512&quot;,&quot;ISSN&quot;:&quot;08938512&quot;,&quot;PMID&quot;:&quot;23554418&quot;,&quot;abstract&quot;:&quot;Bacterial
resistance to antibiotics is a growing clinical problem and public health
threat. Antibiotic use is a known risk factor for the emergence of antibiotic
resistance, but demonstrating the causal link between antibiotic use and
resistance is challenging. This review describes different study designs for
assessing the association between antibiotic use and resistance and discusses
strengths and limitations of each. Approaches to measuring antibiotic use and
antibiotic resistance are presented. Important methodological issues such as
confounding, establishing temporality, and control group selection are
examined.&quot;,&quot;author&quot;:[{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Schechner&quot;,&quot;given&quot;:&quot;Vered&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Temkin&quot;,&quot;given&quot;:&quot;Elizabeth&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Harbarth&quot;,&quot;given&quot;:&quot;Stephan&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Carmeli&quot;,&quot;given&quot;:&quot;Yehuda&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Schwaber&quot;,&quot;given&quot;:&quot;Mitchell
J.&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;}],&quot;container-title&quot;:&quot;Clinical
Microbiology Reviews&quot;,&quot;id&quot;:&quot;ITEM-1&quot;,&quot;issue&quot;:&quot;2&quot;,&quot;issued&quot;:{&quot;date-parts&quot;:[[&quot;2013&quot;]]},&quot;page&quot;:&quot;289-307&quot;,&quot;title&quot;:&quot;Epidemiological
interpretation of studies examining the effect of antibiotic usage on
resistance&quot;,&quot;type&quot;:&quot;article-journal&quot;,&quot;volume&quot;:&quot;26&quot;},&quot;uris&quot;:[&quot;http://www.mendeley.com/documents/?uuid=845f3dca-569c-4aae-88b5-f77b80bf3bc9&quot;]}],&quot;mendeley&quot;:{&quot;formattedCitation&quot;:&quot;(44)&quot;,&quot;plainTextFormattedCitation&quot;:&quot;(44)&quot;,&quot;previouslyFormattedCitation&quot;:&quot;(44)&quot;},&quot;properties&quot;:{&quot;noteIndex&quot;:0},&quot;schema&quot;:&quot;https://github.com/citation-style-language/schema/raw/master/csl-citation.json&quot;}<span
style='mso-element:field-separator'></span></span><![endif]--><span lang=ES
style='font-size:10.0pt;line-height:105%;font-family:"Times New Roman",serif;
mso-fareast-font-family:Calibri;mso-ansi-language:ES'><span style='mso-no-proof:
yes'>(44)</span></span><!--[if supportFields]><span lang=ES style='font-size:
10.0pt;line-height:105%;font-family:"Times New Roman",serif;mso-fareast-font-family:
Calibri;mso-ansi-language:ES'><span style='mso-element:field-end'></span></span><![endif]--><span
lang=ES style='font-size:10.0pt;line-height:105%;font-family:"Times New Roman",serif;
mso-fareast-font-family:Calibri;mso-ansi-language:ES'>. En las mismas la
obtención de datos de consumo a través de DOTs tiene que hacerse de manera
manual lo que es propenso a errores e intensivo en cuanto al gasto en recursos
y tiempo. Los resultados de consumo a través de DDDs y DOTs se correlacionan
frecuentemente aunque existen excepciones </span><!--[if supportFields]><span
lang=ES style='font-size:10.0pt;line-height:105%;font-family:"Times New Roman",serif;
mso-fareast-font-family:Calibri;mso-ansi-language:ES'><span style='mso-element:
field-begin;mso-field-lock:yes'></span>ADDIN CSL_CITATION
{&quot;citationItems&quot;:[{&quot;id&quot;:&quot;ITEM-1&quot;,&quot;itemData&quot;:{&quot;DOI&quot;:&quot;10.1586/eri.11.153&quot;,&quot;ISBN&quot;:&quot;1744-8336;
1478-7210&quot;,&quot;ISSN&quot;:&quot;1478-7210&quot;,&quot;PMID&quot;:&quot;22149615&quot;,&quot;abstract&quot;:&quot;The
judicious use of antibiotics is an important strategy to preserving efficacy in
the treatment of infectious diseases. Infectious disease practitioners are
poised to provide patient-specific recommendations for appropriate agents and
to optimize dosage and duration of therapy. Antimicrobial stewardship programs
(involving pharmacists, physicians and other healthcare providers) are increasing
in number as antibiotic resistance increases with a disproportionately small
number of new agents being developed. Two strategies for antimicrobial
stewardship are currently endorsed by national organizations and include
preauthorization/formulary restriction and prospective audit with feedback. As
it is important for programs to choose appropriate clinical and financial
outcomes goals in order to assure sustainability, we review these strategies
and discuss the impact of each on clinical outcomes and
costs.&quot;,&quot;author&quot;:[{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Griffith&quot;,&quot;given&quot;:&quot;Milena&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Postelnick&quot;,&quot;given&quot;:&quot;Michael&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Scheetz&quot;,&quot;given&quot;:&quot;Marc&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;}],&quot;container-title&quot;:&quot;Expert
Review of Anti-infective
Therapy&quot;,&quot;id&quot;:&quot;ITEM-1&quot;,&quot;issue&quot;:&quot;1&quot;,&quot;issued&quot;:{&quot;date-parts&quot;:[[&quot;2012&quot;]]},&quot;page&quot;:&quot;63-73&quot;,&quot;title&quot;:&quot;Antimicrobial
stewardship programs: methods of operation and suggested
outcomes&quot;,&quot;type&quot;:&quot;article-journal&quot;,&quot;volume&quot;:&quot;10&quot;},&quot;uris&quot;:[&quot;http://www.mendeley.com/documents/?uuid=9b006cd5-7f69-441a-b300-b3e6fae44d0e&quot;]}],&quot;mendeley&quot;:{&quot;formattedCitation&quot;:&quot;(45)&quot;,&quot;plainTextFormattedCitation&quot;:&quot;(45)&quot;,&quot;previouslyFormattedCitation&quot;:&quot;(45)&quot;},&quot;properties&quot;:{&quot;noteIndex&quot;:0},&quot;schema&quot;:&quot;https://github.com/citation-style-language/schema/raw/master/csl-citation.json&quot;}<span
style='mso-element:field-separator'></span></span><![endif]--><span lang=ES
style='font-size:10.0pt;line-height:105%;font-family:"Times New Roman",serif;
mso-fareast-font-family:Calibri;mso-ansi-language:ES'><span style='mso-no-proof:
yes'>(45)</span></span><!--[if supportFields]><span lang=ES style='font-size:
10.0pt;line-height:105%;font-family:"Times New Roman",serif;mso-fareast-font-family:
Calibri;mso-ansi-language:ES'><span style='mso-element:field-end'></span></span><![endif]--><span
lang=ES style='font-size:10.0pt;line-height:105%;font-family:"Times New Roman",serif;
mso-fareast-font-family:Calibri;mso-ansi-language:ES'>. En el caso de
comparaciones interhospitalarias se requiere un entendimiento adecuado del
método para obtener los estimados de DOT con el fin de evitar sesgos </span><!--[if supportFields]><span
lang=ES style='font-size:10.0pt;line-height:105%;font-family:"Times New Roman",serif;
mso-fareast-font-family:Calibri;mso-ansi-language:ES'><span style='mso-element:
field-begin;mso-field-lock:yes'></span>ADDIN CSL_CITATION
{&quot;citationItems&quot;:[{&quot;id&quot;:&quot;ITEM-1&quot;,&quot;itemData&quot;:{&quot;abstract&quot;:&quot;Three
major trends in antibiotic use in US hospitals have emerged over the last few
years: antibiotics as quality metrics, persistent use of different measures of
antibiotic consumption and the emergence of antibiotic stewardship programs.
Compared with Europe, where approaches are heterogeneous but generally consistent,
the USA currently lacks the infrastructure to monitor antibiotic resistance and
antibiotic consumption locally. Both have implemented programmatic strategies
for prudent antibiotic use. The USA appears to have implemented processes more
systematically to measure the quality of antibiotic
use.&quot;,&quot;author&quot;:[{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Jacob&quot;,&quot;given&quot;:&quot;J
T&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Gaynes&quot;,&quot;given&quot;:&quot;RP&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;}],&quot;container-title&quot;:&quot;Expert
Review of Anti-infective
Therapy&quot;,&quot;id&quot;:&quot;ITEM-1&quot;,&quot;issue&quot;:&quot;8&quot;,&quot;issued&quot;:{&quot;date-parts&quot;:[[&quot;2010&quot;]]},&quot;page&quot;:&quot;893-902&quot;,&quot;title&quot;:&quot;Emerging
trends in antibiotic use in US hospitals: quality, quantification and stewardship&quot;,&quot;type&quot;:&quot;article-journal&quot;,&quot;volume&quot;:&quot;8&quot;},&quot;uris&quot;:[&quot;http://www.mendeley.com/documents/?uuid=67b411c4-1309-4ba8-a3d3-e6c41e656b01&quot;,&quot;http://www.mendeley.com/documents/?uuid=e3592e4a-9766-47be-a9d6-3c8792716d6f&quot;]}],&quot;mendeley&quot;:{&quot;formattedCitation&quot;:&quot;(13)&quot;,&quot;plainTextFormattedCitation&quot;:&quot;(13)&quot;,&quot;previouslyFormattedCitation&quot;:&quot;(13)&quot;},&quot;properties&quot;:{&quot;noteIndex&quot;:0},&quot;schema&quot;:&quot;https://github.com/citation-style-language/schema/raw/master/csl-citation.json&quot;}<span
style='mso-element:field-separator'></span></span><![endif]--><span lang=ES
style='font-size:10.0pt;line-height:105%;font-family:"Times New Roman",serif;
mso-fareast-font-family:Calibri;mso-ansi-language:ES'><span style='mso-no-proof:
yes'>(13)</span></span><!--[if supportFields]><span lang=ES style='font-size:
10.0pt;line-height:105%;font-family:"Times New Roman",serif;mso-fareast-font-family:
Calibri;mso-ansi-language:ES'><span style='mso-element:field-end'></span></span><![endif]--><span
lang=ES style='font-size:10.0pt;line-height:105%;font-family:"Times New Roman",serif;
mso-fareast-font-family:Calibri;mso-ansi-language:ES'>. Pese a estas
limitaciones la guía vigente de IDSA/SHEA para la implementación de ASPs
sugiere monitorizar el consumo de antimicrobianos mediante DOTs en lugar de
DDDs </span><!--[if supportFields]><span lang=ES style='font-size:10.0pt;
line-height:105%;font-family:"Times New Roman",serif;mso-fareast-font-family:
Calibri;mso-ansi-language:ES'><span style='mso-element:field-begin;mso-field-lock:
yes'></span>ADDIN CSL_CITATION
{&quot;citationItems&quot;:[{&quot;id&quot;:&quot;ITEM-1&quot;,&quot;itemData&quot;:{&quot;DOI&quot;:&quot;10.1093/cid/ciw217&quot;,&quot;ISBN&quot;:&quot;1058-4838&quot;,&quot;ISSN&quot;:&quot;15376591&quot;,&quot;PMID&quot;:&quot;27080992&quot;,&quot;abstract&quot;:&quot;Evidence-based
guidelines for implementation and measurement of antibiotic stewardship
interventions in inpatient populations including long-term care were prepared
by a multidisciplinary expert panel of the Infectious Diseases Society of America
and the Society for Healthcare Epidemiology of America. The panel included
clinicians and investigators representing internal medicine, emergency
medicine, microbiology, critical care, surgery, epidemiology, pharmacy, and
adult and pediatric infectious diseases specialties. These recommendations
address the best approaches for antibiotic stewardship programs to influence
the optimal use of
antibiotics.&quot;,&quot;author&quot;:[{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Barlam&quot;,&quot;given&quot;:&quot;Tamar
F.&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Cosgrove&quot;,&quot;given&quot;:&quot;Sara
E.&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Abbo&quot;,&quot;given&quot;:&quot;Lilian
M.&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Macdougall&quot;,&quot;given&quot;:&quot;Conan&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Schuetz&quot;,&quot;given&quot;:&quot;Audrey
N.&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Septimus&quot;,&quot;given&quot;:&quot;Edward
J.&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Srinivasan&quot;,&quot;given&quot;:&quot;Arjun&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Dellit&quot;,&quot;given&quot;:&quot;Timothy
H.&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Falck-Ytter&quot;,&quot;given&quot;:&quot;Yngve
T.&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Fishman&quot;,&quot;given&quot;:&quot;Neil
O.&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Hamilton&quot;,&quot;given&quot;:&quot;Cindy
W.&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Jenkins&quot;,&quot;given&quot;:&quot;Timothy
C.&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Lipsett&quot;,&quot;given&quot;:&quot;Pamela
A.&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Malani&quot;,&quot;given&quot;:&quot;Preeti
N.&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;May&quot;,&quot;given&quot;:&quot;Larissa
S.&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Moran&quot;,&quot;given&quot;:&quot;Gregory
J.&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Neuhauser&quot;,&quot;given&quot;:&quot;Melinda
M.&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Newland&quot;,&quot;given&quot;:&quot;Jason
G.&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Ohl&quot;,&quot;given&quot;:&quot;Christopher
A.&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Samore&quot;,&quot;given&quot;:&quot;Matthew
H.&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Seo&quot;,&quot;given&quot;:&quot;Susan
K.&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Trivedi&quot;,&quot;given&quot;:&quot;Kavita
K.&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;}],&quot;container-title&quot;:&quot;Clinical
Infectious
Diseases&quot;,&quot;id&quot;:&quot;ITEM-1&quot;,&quot;issue&quot;:&quot;10&quot;,&quot;issued&quot;:{&quot;date-parts&quot;:[[&quot;2016&quot;]]},&quot;page&quot;:&quot;1197-1202&quot;,&quot;title&quot;:&quot;Executive
summary: Implementing an antibiotic stewardship program: Guidelines by the
infectious diseases society of America and the society for healthcare
epidemiology of
America&quot;,&quot;type&quot;:&quot;article-journal&quot;,&quot;volume&quot;:&quot;62&quot;},&quot;uris&quot;:[&quot;http://www.mendeley.com/documents/?uuid=16106433-58f0-458c-9dea-0455a3026bbe&quot;]}],&quot;mendeley&quot;:{&quot;formattedCitation&quot;:&quot;(8)&quot;,&quot;plainTextFormattedCitation&quot;:&quot;(8)&quot;,&quot;previouslyFormattedCitation&quot;:&quot;(8)&quot;},&quot;properties&quot;:{&quot;noteIndex&quot;:0},&quot;schema&quot;:&quot;https://github.com/citation-style-language/schema/raw/master/csl-citation.json&quot;}<span
style='mso-element:field-separator'></span></span><![endif]--><span lang=ES
style='font-size:10.0pt;line-height:105%;font-family:"Times New Roman",serif;
mso-fareast-font-family:Calibri;mso-ansi-language:ES'><span style='mso-no-proof:
yes'>(8)</span></span><!--[if supportFields]><span lang=ES style='font-size:
10.0pt;line-height:105%;font-family:"Times New Roman",serif;mso-fareast-font-family:
Calibri;mso-ansi-language:ES'><span style='mso-element:field-end'></span></span><![endif]--><span
lang=ES style='font-size:10.0pt;line-height:105%;font-family:"Times New Roman",serif;
mso-fareast-font-family:Calibri;mso-ansi-language:ES'>.<o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0mm;margin-bottom:.0001pt;text-align:
justify;text-indent:11.35pt;line-height:105%'><span lang=ES style='font-size:
10.0pt;line-height:105%;font-family:"Times New Roman",serif;mso-fareast-font-family:
Calibri;mso-ansi-language:ES'><o:p>&nbsp;</o:p></span></p>

<p class=MsoNormal style='margin-bottom:0mm;margin-bottom:.0001pt;text-align:
justify;text-indent:11.35pt;line-height:105%'><span lang=ES style='font-size:
10.0pt;line-height:105%;font-family:"Times New Roman",serif;mso-fareast-font-family:
Calibri;mso-ansi-language:ES'>Un método de medición de consumo relacionado a
DOTs es la duración de terapia (</span><span style='font-size:10.0pt;
line-height:105%;font-family:"Times New Roman",serif;mso-fareast-font-family:
Calibri;mso-ansi-language:ES-CO'>LOTs, Length Of Therapy</span><span lang=ES
style='font-size:10.0pt;line-height:105%;font-family:"Times New Roman",serif;
mso-fareast-font-family:Calibri;mso-ansi-language:ES'>). El LOT es la suma de
días durante los cuales se administra al menos un antibiótico a un paciente, en
este no se tienen en cuenta el número y tipos de antibióticos que se reciben </span><!--[if supportFields]><span
lang=ES style='font-size:10.0pt;line-height:105%;font-family:"Times New Roman",serif;
mso-fareast-font-family:Calibri;mso-ansi-language:ES'><span style='mso-element:
field-begin;mso-field-lock:yes'></span>ADDIN CSL_CITATION
{&quot;citationItems&quot;:[{&quot;id&quot;:&quot;ITEM-1&quot;,&quot;itemData&quot;:{&quot;DOI&quot;:&quot;10.1093/cid/cir672&quot;,&quot;ISBN&quot;:&quot;10584838&quot;,&quot;ISSN&quot;:&quot;10584838&quot;,&quot;PMID&quot;:&quot;74640963&quot;,&quot;abstract&quot;:&quot;Background.
Antimicrobial stewardship programs are advised to measure and risk-adjust
antimicrobial use to facilitate interhospital comparisons, a process called
benchmarking. The purpose of this investigation was to evaluate a new
benchmarking strategy for antibacterials. Methods. Hospital-wide adult
antibacterial drug use in 2009 was measured as days of therapy (DOT) and length
of therapy (LOT) from billing records in 70 US academic medical centers (AMCs).
Patients were assigned to 1 of 35 clinical service lines (CSL) based on their
Medicare Severity Diagnosis Related Group. Expected (E) use was determined by
indirect standardization and compared with observed (O) use. Results. Of 1 791
180 discharged adults, 63.7% received antibacterial drugs; the range by CSL was
14.3% (psychiatry) to 99.7% (lung transplant). Mean ± SD hospital-wide use was
839 ± 106 DOTs (range, 594-1109) and 536 ± 53.0 LOT (range, 427-684) per 1000
patient-days. The ventilator support CSL had the most DOT per discharge,
39.4±9.4 days; the LOT was 21.5±4.5 days. The hospital-wide O/E ratio range was
0.7-1.45; in 5 AMCs the ratio exceeded the 90% confidence interval (CI) and was
below the 90% CI in 6. Variability in use was explained by the proportion of
treated patients within each CSL and mean LOT and DOT per discharge.
Conclusions. Adult antibacterial drug use was benchmarked to expected use
adjusted for patient mix, and outlier hospitals were identified. Differences
between expected and observed use reflect usage patterns that were benchmarked
and are targets for evaluation and intervention. [ABSTRACT FROM
AUTHOR]]]]]&gt;&lt;![CDATA[&gt;&amp;#xD;&lt;![CDATA[Copyright of Clinical
Infectious Diseases is the property of Infectious Diseases Society of America
and its content may not be copied or emailed to multiple sites or posted to a
listserv without the copyright holder's express written permission. However,
users may print, download, or email articles for individual use. This abstract
may be abridged. No warranty is given about the accuracy of the copy. Users
should refer to the original published version of the material for the full
abstract. (Copyright applies to all
Abstracts.)&quot;,&quot;author&quot;:[{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Polk&quot;,&quot;given&quot;:&quot;Ron
E.&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Hohmann&quot;,&quot;given&quot;:&quot;Samuel
F.&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Medvedev&quot;,&quot;given&quot;:&quot;Sofia&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Ibrahim&quot;,&quot;given&quot;:&quot;Omar&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;}],&quot;container-title&quot;:&quot;Clinical
Infectious
Diseases&quot;,&quot;id&quot;:&quot;ITEM-1&quot;,&quot;issue&quot;:&quot;11&quot;,&quot;issued&quot;:{&quot;date-parts&quot;:[[&quot;2011&quot;]]},&quot;page&quot;:&quot;1100-1110&quot;,&quot;title&quot;:&quot;Benchmarking
risk-adjusted adult antibacterial drug use in 70 US academic medical center
hospitals&quot;,&quot;type&quot;:&quot;article-journal&quot;,&quot;volume&quot;:&quot;53&quot;},&quot;uris&quot;:[&quot;http://www.mendeley.com/documents/?uuid=5b334094-ff76-44ef-9105-1634ae1f6951&quot;]}],&quot;mendeley&quot;:{&quot;formattedCitation&quot;:&quot;(42)&quot;,&quot;plainTextFormattedCitation&quot;:&quot;(42)&quot;,&quot;previouslyFormattedCitation&quot;:&quot;(42)&quot;},&quot;properties&quot;:{&quot;noteIndex&quot;:0},&quot;schema&quot;:&quot;https://github.com/citation-style-language/schema/raw/master/csl-citation.json&quot;}<span
style='mso-element:field-separator'></span></span><![endif]--><span lang=ES
style='font-size:10.0pt;line-height:105%;font-family:"Times New Roman",serif;
mso-fareast-font-family:Calibri;mso-ansi-language:ES'><span style='mso-no-proof:
yes'>(42)</span></span><!--[if supportFields]><span lang=ES style='font-size:
10.0pt;line-height:105%;font-family:"Times New Roman",serif;mso-fareast-font-family:
Calibri;mso-ansi-language:ES'><span style='mso-element:field-end'></span></span><![endif]--><span
lang=ES style='font-size:10.0pt;line-height:105%;font-family:"Times New Roman",serif;
mso-fareast-font-family:Calibri;mso-ansi-language:ES'>. Por ejemplo, si un
paciente recibe tratamiento con ceftriaxona y vancomicina por 3 días con
vancomicina por 4 días adicionales, se cuentan 7 LOTs. La obtención de LOTs
permite obtener información adicional, la magnitud del ratio DOT/LOT refleja la
frecuencia de utilización de combinaciones de antibióticos frente a monoterapia
</span><!--[if supportFields]><span lang=ES style='font-size:10.0pt;line-height:
105%;font-family:"Times New Roman",serif;mso-fareast-font-family:Calibri;
mso-ansi-language:ES'><span style='mso-element:field-begin;mso-field-lock:yes'></span>ADDIN
CSL_CITATION
{&quot;citationItems&quot;:[{&quot;id&quot;:&quot;ITEM-1&quot;,&quot;itemData&quot;:{&quot;DOI&quot;:&quot;10.1093/cid/cir672&quot;,&quot;ISBN&quot;:&quot;10584838&quot;,&quot;ISSN&quot;:&quot;10584838&quot;,&quot;PMID&quot;:&quot;74640963&quot;,&quot;abstract&quot;:&quot;Background.
Antimicrobial stewardship programs are advised to measure and risk-adjust
antimicrobial use to facilitate interhospital comparisons, a process called
benchmarking. The purpose of this investigation was to evaluate a new
benchmarking strategy for antibacterials. Methods. Hospital-wide adult
antibacterial drug use in 2009 was measured as days of therapy (DOT) and length
of therapy (LOT) from billing records in 70 US academic medical centers (AMCs).
Patients were assigned to 1 of 35 clinical service lines (CSL) based on their
Medicare Severity Diagnosis Related Group. Expected (E) use was determined by
indirect standardization and compared with observed (O) use. Results. Of 1 791
180 discharged adults, 63.7% received antibacterial drugs; the range by CSL was
14.3% (psychiatry) to 99.7% (lung transplant). Mean ± SD hospital-wide use was
839 ± 106 DOTs (range, 594-1109) and 536 ± 53.0 LOT (range, 427-684) per 1000
patient-days. The ventilator support CSL had the most DOT per discharge,
39.4±9.4 days; the LOT was 21.5±4.5 days. The hospital-wide O/E ratio range was
0.7-1.45; in 5 AMCs the ratio exceeded the 90% confidence interval (CI) and was
below the 90% CI in 6. Variability in use was explained by the proportion of
treated patients within each CSL and mean LOT and DOT per discharge.
Conclusions. Adult antibacterial drug use was benchmarked to expected use
adjusted for patient mix, and outlier hospitals were identified. Differences
between expected and observed use reflect usage patterns that were benchmarked
and are targets for evaluation and intervention. [ABSTRACT FROM
AUTHOR]]]]]&gt;&lt;![CDATA[&gt;&amp;#xD;&lt;![CDATA[Copyright of Clinical
Infectious Diseases is the property of Infectious Diseases Society of America
and its content may not be copied or emailed to multiple sites or posted to a
listserv without the copyright holder's express written permission. However,
users may print, download, or email articles for individual use. This abstract
may be abridged. No warranty is given about the accuracy of the copy. Users
should refer to the original published version of the material for the full
abstract. (Copyright applies to all
Abstracts.)&quot;,&quot;author&quot;:[{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Polk&quot;,&quot;given&quot;:&quot;Ron
E.&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Hohmann&quot;,&quot;given&quot;:&quot;Samuel
F.&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Medvedev&quot;,&quot;given&quot;:&quot;Sofia&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Ibrahim&quot;,&quot;given&quot;:&quot;Omar&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;}],&quot;container-title&quot;:&quot;Clinical
Infectious
Diseases&quot;,&quot;id&quot;:&quot;ITEM-1&quot;,&quot;issue&quot;:&quot;11&quot;,&quot;issued&quot;:{&quot;date-parts&quot;:[[&quot;2011&quot;]]},&quot;page&quot;:&quot;1100-1110&quot;,&quot;title&quot;:&quot;Benchmarking
risk-adjusted adult antibacterial drug use in 70 US academic medical center
hospitals&quot;,&quot;type&quot;:&quot;article-journal&quot;,&quot;volume&quot;:&quot;53&quot;},&quot;uris&quot;:[&quot;http://www.mendeley.com/documents/?uuid=5b334094-ff76-44ef-9105-1634ae1f6951&quot;]}],&quot;mendeley&quot;:{&quot;formattedCitation&quot;:&quot;(42)&quot;,&quot;plainTextFormattedCitation&quot;:&quot;(42)&quot;,&quot;previouslyFormattedCitation&quot;:&quot;(42)&quot;},&quot;properties&quot;:{&quot;noteIndex&quot;:0},&quot;schema&quot;:&quot;https://github.com/citation-style-language/schema/raw/master/csl-citation.json&quot;}<span
style='mso-element:field-separator'></span></span><![endif]--><span lang=ES
style='font-size:10.0pt;line-height:105%;font-family:"Times New Roman",serif;
mso-fareast-font-family:Calibri;mso-ansi-language:ES'><span style='mso-no-proof:
yes'>(42)</span></span><!--[if supportFields]><span lang=ES style='font-size:
10.0pt;line-height:105%;font-family:"Times New Roman",serif;mso-fareast-font-family:
Calibri;mso-ansi-language:ES'><span style='mso-element:field-end'></span></span><![endif]--><span
lang=ES style='font-size:10.0pt;line-height:105%;font-family:"Times New Roman",serif;
mso-fareast-font-family:Calibri;mso-ansi-language:ES'>. <o:p></o:p></span></p>

<p class=MsoNormal style='margin-top:10.0pt;margin-right:0mm;margin-bottom:
6.0pt;margin-left:0mm'><i style='mso-bidi-font-style:normal'><span
style='mso-bidi-font-size:9.0pt;line-height:107%;mso-bidi-font-family:"Times New Roman";
mso-ansi-language:ES-CO'>5.5 Otras medidas de consumo de antibióticos<o:p></o:p></span></i></p>

<p class=MsoNormal style='margin-bottom:0mm;margin-bottom:.0001pt;text-align:
justify;text-indent:11.35pt;line-height:105%'><span lang=ES style='font-size:
10.0pt;line-height:105%;font-family:"Times New Roman",serif;mso-fareast-font-family:
Calibri;color:black;mso-ansi-language:ES'>Los cursos de tratamiento se definen
como cualquier periodo durante el cual el mismo agente es administrado al mismo
paciente en días consecutivos, mientras los periodos de tratamiento son el
periodo de días consecutivos en los cual se administró al menos un antibiótico
a un paciente </span><!--[if supportFields]><span lang=ES style='font-size:
10.0pt;line-height:105%;font-family:"Times New Roman",serif;mso-fareast-font-family:
Calibri;color:black;mso-ansi-language:ES'><span style='mso-element:field-begin;
mso-field-lock:yes'></span>ADDIN CSL_CITATION {&quot;citationItems&quot;:[{&quot;id&quot;:&quot;ITEM-1&quot;,&quot;itemData&quot;:{&quot;DOI&quot;:&quot;10.1093/jac/dkp399&quot;,&quot;ISBN&quot;:&quot;4419156562&quot;,&quot;ISSN&quot;:&quot;03057453&quot;,&quot;PMID&quot;:&quot;19884120&quot;,&quot;abstract&quot;:&quot;Background
Measurement of prescribing is an important component of antimicrobial
stewardship. The standard unit of measurement in hospitals is defined daily
doses denominated by bed days (e.g. DDDs per 1000 bed days) but alternatives
have not been evaluated in depth.Methods Electronically prescribed doses of
systemic antibacterials administered in this trust during 2008 were analysed in
order to generate 10 indices of antimicrobial use for each of 14 departments.
These indices were five measurements of consumption (DDDs, agent days, courses,
antibiotic days and treatment periods) each denominated by two measurements of
activity [bed days and finished consultant episodes (FCEs)].Results The 10
indices cluster into four groups within which they correlate well but between
which correlation is poor. These four groups comprise a volume-related
measurement of consumption (DDDs, agent days, antibiotic days) and an
exposure-related measurement of consumption (courses, treatment periods), each
denominated by either bed occupancy (bed days) or patient throughput
(FCEs).Conclusions Indices within these four groups seem to provide different
and complementary information. Restricting measurement of antimicrobial use to
a single metric such as DDDs per 1000 bed days may be insufficient. It is not
known which (if any) of these indices are the best predictors of
antimicrobial-related risks such as resistance pressure or Clostridium
difficile
infection.&quot;,&quot;author&quot;:[{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Berrington&quot;,&quot;given&quot;:&quot;Andrew&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;}],&quot;container-title&quot;:&quot;Journal
of Antimicrobial Chemotherapy&quot;,&quot;id&quot;:&quot;ITEM-1&quot;,&quot;issue&quot;:&quot;1&quot;,&quot;issued&quot;:{&quot;date-parts&quot;:[[&quot;2009&quot;]]},&quot;page&quot;:&quot;163-168&quot;,&quot;title&quot;:&quot;Antimicrobial
prescribing in hospitals: Be careful what you
measure&quot;,&quot;type&quot;:&quot;article-journal&quot;,&quot;volume&quot;:&quot;65&quot;},&quot;uris&quot;:[&quot;http://www.mendeley.com/documents/?uuid=e845ab0f-2b9f-4fb4-82db-4266f5332f47&quot;]}],&quot;mendeley&quot;:{&quot;formattedCitation&quot;:&quot;(29)&quot;,&quot;plainTextFormattedCitation&quot;:&quot;(29)&quot;,&quot;previouslyFormattedCitation&quot;:&quot;(29)&quot;},&quot;properties&quot;:{&quot;noteIndex&quot;:0},&quot;schema&quot;:&quot;https://github.com/citation-style-language/schema/raw/master/csl-citation.json&quot;}<span
style='mso-element:field-separator'></span></span><![endif]--><span lang=ES
style='font-size:10.0pt;line-height:105%;font-family:"Times New Roman",serif;
mso-fareast-font-family:Calibri;color:black;mso-ansi-language:ES'><span
style='mso-no-proof:yes'>(29)</span></span><!--[if supportFields]><span
lang=ES style='font-size:10.0pt;line-height:105%;font-family:"Times New Roman",serif;
mso-fareast-font-family:Calibri;color:black;mso-ansi-language:ES'><span
style='mso-element:field-end'></span></span><![endif]--><span lang=ES
style='font-size:10.0pt;line-height:105%;font-family:"Times New Roman",serif;
mso-fareast-font-family:Calibri;color:black;mso-ansi-language:ES'>. </span><span
lang=ES style='font-size:10.0pt;line-height:105%;font-family:"Times New Roman",serif;
mso-fareast-font-family:Calibri;mso-ansi-language:ES'>Por ejemplo, si un
paciente recibe tratamiento con ceftriaxona y vancomicina por 3 días con
vancomicina por 4 días adicionales se cuentan dos cursos de tratamiento y un
periodo de tratamiento. <o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0mm;margin-bottom:.0001pt;text-align:
justify;text-indent:11.35pt;line-height:105%'><span lang=ES style='font-size:
10.0pt;line-height:105%;font-family:"Times New Roman",serif;mso-fareast-font-family:
Calibri;mso-ansi-language:ES'><o:p>&nbsp;</o:p></span></p>

<p class=MsoNormal style='margin-bottom:0mm;margin-bottom:.0001pt;text-align:
justify;text-indent:11.35pt;line-height:105%'><span lang=ES style='font-size:
10.0pt;line-height:105%;font-family:"Times New Roman",serif;mso-fareast-font-family:
Calibri;mso-ansi-language:ES'>Los días libres de antimicrobiano se enfoca en sí
el paciente recibe o no antimicrobianos, y puede tener ciertas ventaja sobre
DOTs pero es una medida con uso poco extendido en ASPs </span><!--[if supportFields]><span
lang=ES style='font-size:10.0pt;line-height:105%;font-family:"Times New Roman",serif;
mso-fareast-font-family:Calibri;mso-ansi-language:ES'><span style='mso-element:
field-begin;mso-field-lock:yes'></span>ADDIN CSL_CITATION
{&quot;citationItems&quot;:[{&quot;id&quot;:&quot;ITEM-1&quot;,&quot;itemData&quot;:{&quot;DOI&quot;:&quot;10.1007/s40506-014-0015-3&quot;,&quot;ISBN&quot;:&quot;4050601400&quot;,&quot;ISSN&quot;:&quot;1534-6250&quot;,&quot;PMID&quot;:&quot;25999798&quot;,&quot;abstract&quot;:&quot;Antimicrobial
stewardship is a new field that struggles to find the right balance between
meaningful and useful metrics to study the impact of antimicrobial stewardship
programs (ASPs). ASP metrics primarily measure antimicrobial use, although
microbiological resistance and clinical outcomes are also important measures of
the impact an ASP has on a hospital and its patient population. Antimicrobial
measures looking at consumption are the most commonly used measures, and are
focused on defined daily doses, days of therapy, and costs, usually
standardized per 1,000 patient-days. Each measure provides slightly different
information, with their own upsides and downfalls. Point prevalence measurement
of antimicrobial use is an increasingly used approach to understanding
consumption that does not entirely rely on sophisticated electronic information
systems, and is also replicable. Appropriateness measures hold appeal and
promise, but have not been developed to the degree that makes them useful and
widely applicable. The primary reason why antimicrobial stewardship is
necessary is the growth of antimicrobial resistance. Accordingly, antimicrobial
resistance is an important metric of the impact of an ASP. The most common
approach to measuring resistance for ASP purposes is to report rates of common
or important community- or nosocomial-acquired antimicrobial-resistant
organisms, such as methicillin-resistant Staphylococcus aureus and Clostridium
difficile. Such an approach is dependent on detection methods, community rates
of resistance, and co-interventions, and therefore may not be the most accurate
or reflective measure of antimicrobial stewardship interventions. Development
of an index to reflect the net burden of resistance holds theoretical promise,
but has yet to be realized. Finally, programs must consider patient outcome
measures. Mortality is the most objective and reliable method, but has several
drawbacks. Disease- or organism-specific mortality, or cure, are increasingly
used
metrics.&quot;,&quot;author&quot;:[{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Morris&quot;,&quot;given&quot;:&quot;Andrew
M.&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;}],&quot;container-title&quot;:&quot;Current
Treatment Options in Infectious
Diseases&quot;,&quot;id&quot;:&quot;ITEM-1&quot;,&quot;issue&quot;:&quot;2&quot;,&quot;issued&quot;:{&quot;date-parts&quot;:[[&quot;2014&quot;]]},&quot;page&quot;:&quot;101-112&quot;,&quot;title&quot;:&quot;Antimicrobial
Stewardship Programs: Appropriate Measures and Metrics to Study their
Impact&quot;,&quot;type&quot;:&quot;article-journal&quot;,&quot;volume&quot;:&quot;6&quot;},&quot;uris&quot;:[&quot;http://www.mendeley.com/documents/?uuid=de07aac5-dd0b-42f5-8af0-a19b7b7157b1&quot;]}],&quot;mendeley&quot;:{&quot;formattedCitation&quot;:&quot;(30)&quot;,&quot;plainTextFormattedCitation&quot;:&quot;(30)&quot;,&quot;previouslyFormattedCitation&quot;:&quot;(30)&quot;},&quot;properties&quot;:{&quot;noteIndex&quot;:0},&quot;schema&quot;:&quot;https://github.com/citation-style-language/schema/raw/master/csl-citation.json&quot;}<span
style='mso-element:field-separator'></span></span><![endif]--><span lang=ES
style='font-size:10.0pt;line-height:105%;font-family:"Times New Roman",serif;
mso-fareast-font-family:Calibri;mso-ansi-language:ES'><span style='mso-no-proof:
yes'>(30)</span></span><!--[if supportFields]><span lang=ES style='font-size:
10.0pt;line-height:105%;font-family:"Times New Roman",serif;mso-fareast-font-family:
Calibri;mso-ansi-language:ES'><span style='mso-element:field-end'></span></span><![endif]--><span
lang=ES style='font-size:10.0pt;line-height:105%;font-family:"Times New Roman",serif;
mso-fareast-font-family:Calibri;mso-ansi-language:ES'>. En adición se ha
reportado la utilización de gramos totales de medicamento utilizados como
medida de consumo </span><!--[if supportFields]><span lang=ES style='font-size:
10.0pt;line-height:105%;font-family:"Times New Roman",serif;mso-fareast-font-family:
Calibri;mso-ansi-language:ES'><span style='mso-element:field-begin;mso-field-lock:
yes'></span>ADDIN CSL_CITATION {&quot;citationItems&quot;:[{&quot;id&quot;:&quot;ITEM-1&quot;,&quot;itemData&quot;:{&quot;DOI&quot;:&quot;10.1007/s40506-014-0015-3&quot;,&quot;ISBN&quot;:&quot;4050601400&quot;,&quot;ISSN&quot;:&quot;1534-6250&quot;,&quot;PMID&quot;:&quot;25999798&quot;,&quot;abstract&quot;:&quot;Antimicrobial
stewardship is a new field that struggles to find the right balance between
meaningful and useful metrics to study the impact of antimicrobial stewardship
programs (ASPs). ASP metrics primarily measure antimicrobial use, although
microbiological resistance and clinical outcomes are also important measures of
the impact an ASP has on a hospital and its patient population. Antimicrobial
measures looking at consumption are the most commonly used measures, and are
focused on defined daily doses, days of therapy, and costs, usually
standardized per 1,000 patient-days. Each measure provides slightly different
information, with their own upsides and downfalls. Point prevalence measurement
of antimicrobial use is an increasingly used approach to understanding
consumption that does not entirely rely on sophisticated electronic information
systems, and is also replicable. Appropriateness measures hold appeal and
promise, but have not been developed to the degree that makes them useful and
widely applicable. The primary reason why antimicrobial stewardship is
necessary is the growth of antimicrobial resistance. Accordingly, antimicrobial
resistance is an important metric of the impact of an ASP. The most common
approach to measuring resistance for ASP purposes is to report rates of common
or important community- or nosocomial-acquired antimicrobial-resistant organisms,
such as methicillin-resistant Staphylococcus aureus and Clostridium difficile.
Such an approach is dependent on detection methods, community rates of
resistance, and co-interventions, and therefore may not be the most accurate or
reflective measure of antimicrobial stewardship interventions. Development of
an index to reflect the net burden of resistance holds theoretical promise, but
has yet to be realized. Finally, programs must consider patient outcome
measures. Mortality is the most objective and reliable method, but has several
drawbacks. Disease- or organism-specific mortality, or cure, are increasingly
used
metrics.&quot;,&quot;author&quot;:[{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Morris&quot;,&quot;given&quot;:&quot;Andrew
M.&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;}],&quot;container-title&quot;:&quot;Current
Treatment Options in Infectious
Diseases&quot;,&quot;id&quot;:&quot;ITEM-1&quot;,&quot;issue&quot;:&quot;2&quot;,&quot;issued&quot;:{&quot;date-parts&quot;:[[&quot;2014&quot;]]},&quot;page&quot;:&quot;101-112&quot;,&quot;title&quot;:&quot;Antimicrobial
Stewardship Programs: Appropriate Measures and Metrics to Study their
Impact&quot;,&quot;type&quot;:&quot;article-journal&quot;,&quot;volume&quot;:&quot;6&quot;},&quot;uris&quot;:[&quot;http://www.mendeley.com/documents/?uuid=de07aac5-dd0b-42f5-8af0-a19b7b7157b1&quot;]}],&quot;mendeley&quot;:{&quot;formattedCitation&quot;:&quot;(30)&quot;,&quot;plainTextFormattedCitation&quot;:&quot;(30)&quot;,&quot;previouslyFormattedCitation&quot;:&quot;(30)&quot;},&quot;properties&quot;:{&quot;noteIndex&quot;:0},&quot;schema&quot;:&quot;https://github.com/citation-style-language/schema/raw/master/csl-citation.json&quot;}<span
style='mso-element:field-separator'></span></span><![endif]--><span lang=ES
style='font-size:10.0pt;line-height:105%;font-family:"Times New Roman",serif;
mso-fareast-font-family:Calibri;mso-ansi-language:ES'><span style='mso-no-proof:
yes'>(30)</span></span><!--[if supportFields]><span lang=ES style='font-size:
10.0pt;line-height:105%;font-family:"Times New Roman",serif;mso-fareast-font-family:
Calibri;mso-ansi-language:ES'><span style='mso-element:field-end'></span></span><![endif]--><span
lang=ES style='font-size:10.0pt;line-height:105%;font-family:"Times New Roman",serif;
mso-fareast-font-family:Calibri;mso-ansi-language:ES'>. Por último, se puede
considerar al costo como una medida de consumo y su </span><span
style='font-size:10.0pt;line-height:105%;font-family:"Times New Roman",serif;
mso-fareast-font-family:Calibri;mso-ansi-language:ES-CO'>seguimiento es
importante para justificar la continuación del soporte administrativo </span><!--[if supportFields]><span
style='font-size:10.0pt;line-height:105%;font-family:"Times New Roman",serif;
mso-fareast-font-family:Calibri;mso-ansi-language:ES-CO'><span
style='mso-element:field-begin;mso-field-lock:yes'></span>ADDIN CSL_CITATION
{&quot;citationItems&quot;:[{&quot;id&quot;:&quot;ITEM-1&quot;,&quot;itemData&quot;:{&quot;DOI&quot;:&quot;10.1093/cid/ciw217&quot;,&quot;ISBN&quot;:&quot;1058-4838&quot;,&quot;ISSN&quot;:&quot;15376591&quot;,&quot;PMID&quot;:&quot;27080992&quot;,&quot;abstract&quot;:&quot;Evidence-based
guidelines for implementation and measurement of antibiotic stewardship
interventions in inpatient populations including long-term care were prepared
by a multidisciplinary expert panel of the Infectious Diseases Society of
America and the Society for Healthcare Epidemiology of America. The panel
included clinicians and investigators representing internal medicine, emergency
medicine, microbiology, critical care, surgery, epidemiology, pharmacy, and
adult and pediatric infectious diseases specialties. These recommendations
address the best approaches for antibiotic stewardship programs to influence
the optimal use of
antibiotics.&quot;,&quot;author&quot;:[{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Barlam&quot;,&quot;given&quot;:&quot;Tamar
F.&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Cosgrove&quot;,&quot;given&quot;:&quot;Sara
E.&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Abbo&quot;,&quot;given&quot;:&quot;Lilian
M.&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Macdougall&quot;,&quot;given&quot;:&quot;Conan&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Schuetz&quot;,&quot;given&quot;:&quot;Audrey
N.&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Septimus&quot;,&quot;given&quot;:&quot;Edward
J.&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Srinivasan&quot;,&quot;given&quot;:&quot;Arjun&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Dellit&quot;,&quot;given&quot;:&quot;Timothy
H.&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Falck-Ytter&quot;,&quot;given&quot;:&quot;Yngve
T.&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Fishman&quot;,&quot;given&quot;:&quot;Neil
O.&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Hamilton&quot;,&quot;given&quot;:&quot;Cindy
W.&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Jenkins&quot;,&quot;given&quot;:&quot;Timothy
C.&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Lipsett&quot;,&quot;given&quot;:&quot;Pamela
A.&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Malani&quot;,&quot;given&quot;:&quot;Preeti
N.&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;May&quot;,&quot;given&quot;:&quot;Larissa
S.&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Moran&quot;,&quot;given&quot;:&quot;Gregory
J.&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Neuhauser&quot;,&quot;given&quot;:&quot;Melinda
M.&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Newland&quot;,&quot;given&quot;:&quot;Jason
G.&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Ohl&quot;,&quot;given&quot;:&quot;Christopher
A.&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Samore&quot;,&quot;given&quot;:&quot;Matthew
H.&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Seo&quot;,&quot;given&quot;:&quot;Susan
K.&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Trivedi&quot;,&quot;given&quot;:&quot;Kavita
K.&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;}],&quot;container-title&quot;:&quot;Clinical
Infectious Diseases&quot;,&quot;id&quot;:&quot;ITEM-1&quot;,&quot;issue&quot;:&quot;10&quot;,&quot;issued&quot;:{&quot;date-parts&quot;:[[&quot;2016&quot;]]},&quot;page&quot;:&quot;1197-1202&quot;,&quot;title&quot;:&quot;Executive
summary: Implementing an antibiotic stewardship program: Guidelines by the
infectious diseases society of America and the society for healthcare
epidemiology of America&quot;,&quot;type&quot;:&quot;article-journal&quot;,&quot;volume&quot;:&quot;62&quot;},&quot;uris&quot;:[&quot;http://www.mendeley.com/documents/?uuid=16106433-58f0-458c-9dea-0455a3026bbe&quot;]}],&quot;mendeley&quot;:{&quot;formattedCitation&quot;:&quot;(8)&quot;,&quot;plainTextFormattedCitation&quot;:&quot;(8)&quot;,&quot;previouslyFormattedCitation&quot;:&quot;(8)&quot;},&quot;properties&quot;:{&quot;noteIndex&quot;:0},&quot;schema&quot;:&quot;https://github.com/citation-style-language/schema/raw/master/csl-citation.json&quot;}<span
style='mso-element:field-separator'></span></span><![endif]--><span
style='font-size:10.0pt;line-height:105%;font-family:"Times New Roman",serif;
mso-fareast-font-family:Calibri;mso-ansi-language:ES-CO'><span
style='mso-no-proof:yes'>(8)</span></span><!--[if supportFields]><span
style='font-size:10.0pt;line-height:105%;font-family:"Times New Roman",serif;
mso-fareast-font-family:Calibri;mso-ansi-language:ES-CO'><span
style='mso-element:field-end'></span></span><![endif]--><span style='font-size:
10.0pt;line-height:105%;font-family:"Times New Roman",serif;mso-fareast-font-family:
Calibri;mso-ansi-language:ES-CO'>. <span style='color:red'><o:p></o:p></span></span></p>

<p class=IOPH1><span style='mso-ansi-language:ES-CO'>6. Denominadores en el
Consumo de Antibióticos<o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0mm;margin-bottom:.0001pt;text-align:
justify;text-indent:11.35pt'><span lang=ES style='font-size:10.0pt;line-height:
107%;font-family:"Times New Roman",serif;mso-fareast-font-family:Calibri;
mso-ansi-language:ES'>El uso de un denominador permite estandarizar la medida
de exposición a las variaciones en la ocupación del hospital </span><!--[if supportFields]><span
lang=ES style='font-size:10.0pt;line-height:107%;font-family:"Times New Roman",serif;
mso-fareast-font-family:Calibri;mso-ansi-language:ES'><span style='mso-element:
field-begin;mso-field-lock:yes'></span>ADDIN CSL_CITATION
{&quot;citationItems&quot;:[{&quot;id&quot;:&quot;ITEM-1&quot;,&quot;itemData&quot;:{&quot;DOI&quot;:&quot;10.1177/1757177410363357&quot;,&quot;ISBN&quot;:&quot;17571774&quot;,&quot;ISSN&quot;:&quot;ISSN
1757-1774&quot;,&quot;abstract&quot;:&quot;Increasing rates of antibiotic
resistance have been related to increased rates of antibiotic prescribing. This
paper describes the use of indicators to measure and compare antibiotic use and
enable hospitals to benchmark their practice. The Defined Daily Dose measure
may be combined with a number of denominators that quantify patient activity in
order to correct for workload variations between hospitals. This may be
combined with data from mandatory surveillance schemes for various infections to
inform prescribing
practice.\\n&quot;,&quot;author&quot;:[{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Curtis&quot;,&quot;given&quot;:&quot;C
E&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;}],&quot;container-title&quot;:&quot;Journal
of Infection
Prevention&quot;,&quot;id&quot;:&quot;ITEM-1&quot;,&quot;issue&quot;:&quot;4&quot;,&quot;issued&quot;:{&quot;date-parts&quot;:[[&quot;2010&quot;]]},&quot;page&quot;:&quot;124-126&quot;,&quot;title&quot;:&quot;Indicators
for the monitoring of antibiotic
use.&quot;,&quot;type&quot;:&quot;article-journal&quot;,&quot;volume&quot;:&quot;11&quot;},&quot;uris&quot;:[&quot;http://www.mendeley.com/documents/?uuid=88cd6823-507b-47bc-9ae7-4f25bf584caa&quot;]}],&quot;mendeley&quot;:{&quot;formattedCitation&quot;:&quot;(34)&quot;,&quot;plainTextFormattedCitation&quot;:&quot;(34)&quot;,&quot;previouslyFormattedCitation&quot;:&quot;(34)&quot;},&quot;properties&quot;:{&quot;noteIndex&quot;:0},&quot;schema&quot;:&quot;https://github.com/citation-style-language/schema/raw/master/csl-citation.json&quot;}<span
style='mso-element:field-separator'></span></span><![endif]--><span lang=ES
style='font-size:10.0pt;line-height:107%;font-family:"Times New Roman",serif;
mso-fareast-font-family:Calibri;mso-ansi-language:ES'><span style='mso-no-proof:
yes'>(34)</span></span><!--[if supportFields]><span lang=ES style='font-size:
10.0pt;line-height:107%;font-family:"Times New Roman",serif;mso-fareast-font-family:
Calibri;mso-ansi-language:ES'><span style='mso-element:field-end'></span></span><![endif]--><span
lang=ES style='font-size:10.0pt;line-height:107%;font-family:"Times New Roman",serif;
mso-fareast-font-family:Calibri;mso-ansi-language:ES'>. Un denominador adecuado
se relaciona con la presión de selección ejercida por un antibiótico </span><!--[if supportFields]><span
lang=ES style='font-size:10.0pt;line-height:107%;font-family:"Times New Roman",serif;
mso-fareast-font-family:Calibri;mso-ansi-language:ES'><span style='mso-element:
field-begin;mso-field-lock:yes'></span>ADDIN CSL_CITATION
{&quot;citationItems&quot;:[{&quot;id&quot;:&quot;ITEM-1&quot;,&quot;itemData&quot;:{&quot;DOI&quot;:&quot;10.1023/B:PHAR.0000018595.78732.1c&quot;,&quot;ISBN&quot;:&quot;0928-1231&quot;,&quot;ISSN&quot;:&quot;09281231&quot;,&quot;PMID&quot;:&quot;15085943&quot;,&quot;abstract&quot;:&quot;BACKGROUND:
For several years now, the French national recommendations have been trying to
set up a surveillance system in hospitals to link data on antibiotic resistance
and data on the use of antibiotics, particularly for certain
'micro-organism/antibiotic' pairs. The indicators recommended in the lastest
newsletter of the Direction Générale de la Santé (French Public Health
Department) for monitoring the consumption of antibiotics were the number of
days of treatment or the number of defined daily doses (DDD), both (in)directly
related to the number of days of hospitalisation and/or the number of patients
hospitalised.OBJECTIVE: The aim of this study was to compare the actual number
of days of treatment, which is an observed indicator, with two indicators
calculated on the basis of the DDD and the DPD (daily prescribed dose), both in
terms of feasibility of collection and the relevance of the information
generated. MATERIALS AND METHODS: For several hospital care units, the 'length
of exposure' to a given antibiotic was determined by four different indicators:
two actual observed indicators [the patient's medical file (reference) and the
named-patient based, computerised dispensing system from the central pharmacy]
and two derived calculated indicators [obtained by dividing the number of grams
prescribed by the DDD or by the DPD]. RESULTS: The average incidence density of
antibiotic treatment (length of exposure per 1000 days of hospitalisation)
obtained by the calculated indicators was higher than that obtained with the
observed reference (+52% for the DDD and +33% for the DPD) but lower than that
obtained with the second observed indicator (computerised system) (-10%). The
differences were large and random (high variability depending on the hospital
department, the antibiotic and the administration route; variations in both
directions: actual length of treatment longer or shorter than the calculated
length of treatment). CONCLUSION: The question which indicator should be chosen
is inconclusive for the evaluation of the selection pressure exerted by an
antibiotic. The two indicators proposed in the newsletter (observed indicator
and calculated indicator) seem to be complementary for use in a regional or
national network to monitor resistance and consumption of antibiotics. Each
hospital should validate the indicators and define for itself which indicator
is most appropriate for estimating the actual length of antibiotic exposure.
This may imply
diff…&quot;,&quot;author&quot;:[{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Mandy&quot;,&quot;given&quot;:&quot;Bruno&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Koutny&quot;,&quot;given&quot;:&quot;Estelle&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Cornette&quot;,&quot;given&quot;:&quot;Christian&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Woronoff-Lemsi&quot;,&quot;given&quot;:&quot;Marie
Christine&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Talon&quot;,&quot;given&quot;:&quot;Daniel&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;}],&quot;container-title&quot;:&quot;Pharmacy
World and
Science&quot;,&quot;id&quot;:&quot;ITEM-1&quot;,&quot;issue&quot;:&quot;2&quot;,&quot;issued&quot;:{&quot;date-parts&quot;:[[&quot;2004&quot;]]},&quot;page&quot;:&quot;90-95&quot;,&quot;title&quot;:&quot;Methodological
validation of monitoring indicators of antibiotics use in
hospitals&quot;,&quot;type&quot;:&quot;article-journal&quot;,&quot;volume&quot;:&quot;26&quot;},&quot;uris&quot;:[&quot;http://www.mendeley.com/documents/?uuid=3e97ffab-bc6e-4997-bc6f-23f6a502face&quot;]}],&quot;mendeley&quot;:{&quot;formattedCitation&quot;:&quot;(40)&quot;,&quot;plainTextFormattedCitation&quot;:&quot;(40)&quot;,&quot;previouslyFormattedCitation&quot;:&quot;(40)&quot;},&quot;properties&quot;:{&quot;noteIndex&quot;:0},&quot;schema&quot;:&quot;https://github.com/citation-style-language/schema/raw/master/csl-citation.json&quot;}<span
style='mso-element:field-separator'></span></span><![endif]--><span lang=ES
style='font-size:10.0pt;line-height:107%;font-family:"Times New Roman",serif;
mso-fareast-font-family:Calibri;mso-ansi-language:ES'><span style='mso-no-proof:
yes'>(40)</span></span><!--[if supportFields]><span lang=ES style='font-size:
10.0pt;line-height:107%;font-family:"Times New Roman",serif;mso-fareast-font-family:
Calibri;mso-ansi-language:ES'><span style='mso-element:field-end'></span></span><![endif]--><span
lang=ES style='font-size:10.0pt;line-height:107%;font-family:"Times New Roman",serif;
mso-fareast-font-family:Calibri;mso-ansi-language:ES'>.<o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0mm;margin-bottom:.0001pt;text-align:
justify;text-indent:11.35pt'><span lang=ES style='font-size:10.0pt;line-height:
107%;font-family:"Times New Roman",serif;mso-fareast-font-family:Calibri;
mso-ansi-language:ES'><o:p>&nbsp;</o:p></span></p>

<p class=MsoNormal style='margin-bottom:0mm;margin-bottom:.0001pt;text-align:
justify;text-indent:11.35pt'><span lang=ES style='font-size:10.0pt;line-height:
107%;font-family:"Times New Roman",serif;mso-fareast-font-family:Calibri;
mso-ansi-language:ES'>Los días paciente (PD, </span><span style='font-size:
10.0pt;line-height:107%;font-family:"Times New Roman",serif;mso-fareast-font-family:
Calibri;mso-ansi-language:ES-CO'>patient-days</span><span lang=ES
style='font-size:10.0pt;line-height:107%;font-family:"Times New Roman",serif;
mso-fareast-font-family:Calibri;mso-ansi-language:ES'>) son el número total de
días que los pacientes estuvieron en hospitalización </span><!--[if supportFields]><span
lang=ES style='font-size:10.0pt;line-height:107%;font-family:"Times New Roman",serif;
mso-fareast-font-family:Calibri;mso-ansi-language:ES'><span style='mso-element:
field-begin;mso-field-lock:yes'></span>ADDIN CSL_CITATION
{&quot;citationItems&quot;:[{&quot;id&quot;:&quot;ITEM-1&quot;,&quot;itemData&quot;:{&quot;DOI&quot;:&quot;10.1177/003335490712200205&quot;,&quot;ISBN&quot;:&quot;0033-3549
(Print)\\r0033-3549
(Linking)&quot;,&quot;ISSN&quot;:&quot;0033-3549&quot;,&quot;PMID&quot;:&quot;17357358&quot;,&quot;abstract&quot;:&quot;OBJECTIVE:
The purpose of this study was to provide a national estimate of the number of
healthcare-associated infections (HAI) and deaths in United States hospitals.
METHODS: No single source of nationally representative data on HAIs is
currently available. The authors used a multi-step approach and three data
sources. The main source of data was the National Nosocomial Infections
Surveillance (NNIS) system, data from 1990-2002, conducted by the Centers for
Disease Control and Prevention. Data from the National Hospital Discharge
Survey (for 2002) and the American Hospital Association Survey (for 2000) were
used to supplement NNIS data. The percentage of patients with an HAI whose
death was determined to be caused or associated with the HAI from NNIS data was
used to estimate the number of deaths. RESULTS: In 2002, the estimated number
of HAIs in U.S. hospitals, adjusted to include federal facilities, was
approximately 1.7 million: 33,269 HAIs among newborns in high-risk nurseries,
19,059 among newborns in well-baby nurseries, 417,946 among adults and children
in ICUs, and 1,266,851 among adults and children outside of ICUs. The estimated
deaths associated with HAIs in U.S. hospitals were 98,987: of these, 35,967
were for pneumonia, 30,665 for bloodstream infections, 13,088 for urinary tract
infections, 8,205 for surgical site infections, and 11,062 for infections of
other sites. CONCLUSION: HAIs in hospitals are a significant cause of morbidity
and mortality in the United States. The method described for estimating the
number of HAIs makes the best use of existing data at the national
level.&quot;,&quot;author&quot;:[{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Klevens&quot;,&quot;given&quot;:&quot;R.
Monina&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Edwards&quot;,&quot;given&quot;:&quot;Jonathan
R.&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Richards&quot;,&quot;given&quot;:&quot;Chesley
L.&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Horan&quot;,&quot;given&quot;:&quot;Teresa
C.&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Gaynes&quot;,&quot;given&quot;:&quot;Robert
P.&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Pollock&quot;,&quot;given&quot;:&quot;Daniel
A.&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Cardo&quot;,&quot;given&quot;:&quot;Denise
M.&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;}],&quot;container-title&quot;:&quot;Public
Health Reports&quot;,&quot;id&quot;:&quot;ITEM-1&quot;,&quot;issue&quot;:&quot;2&quot;,&quot;issued&quot;:{&quot;date-parts&quot;:[[&quot;2007&quot;]]},&quot;page&quot;:&quot;160-166&quot;,&quot;title&quot;:&quot;Estimating
Health Care-Associated Infections and Deaths in U.S. Hospitals,
2002&quot;,&quot;type&quot;:&quot;article-journal&quot;,&quot;volume&quot;:&quot;122&quot;},&quot;uris&quot;:[&quot;http://www.mendeley.com/documents/?uuid=ea22ff4c-a296-4f40-b917-b8e320cd3133&quot;]}],&quot;mendeley&quot;:{&quot;formattedCitation&quot;:&quot;(46)&quot;,&quot;plainTextFormattedCitation&quot;:&quot;(46)&quot;,&quot;previouslyFormattedCitation&quot;:&quot;(46)&quot;},&quot;properties&quot;:{&quot;noteIndex&quot;:0},&quot;schema&quot;:&quot;https://github.com/citation-style-language/schema/raw/master/csl-citation.json&quot;}<span
style='mso-element:field-separator'></span></span><![endif]--><span lang=ES
style='font-size:10.0pt;line-height:107%;font-family:"Times New Roman",serif;
mso-fareast-font-family:Calibri;mso-ansi-language:ES'><span style='mso-no-proof:
yes'>(46)</span></span><!--[if supportFields]><span lang=ES style='font-size:
10.0pt;line-height:107%;font-family:"Times New Roman",serif;mso-fareast-font-family:
Calibri;mso-ansi-language:ES'><span style='mso-element:field-end'></span></span><![endif]--><span
lang=ES style='font-size:10.0pt;line-height:107%;font-family:"Times New Roman",serif;
mso-fareast-font-family:Calibri;mso-ansi-language:ES'>. En los días de
hospitalización la persona es confinada a una cama y permanece durante al menos
una noche en el hospital. Los PD se pueden calcular multiplicando en número
total de camas en los servicios por el porcentaje de ocupación y por el número
de días en el mes. El porcentaje de ocupación se obtiene dividiendo el número
de días-cama ocupados sobre el número de días cama disponible en un periodo de
tiempo </span><!--[if supportFields]><span lang=ES style='font-size:10.0pt;
line-height:107%;font-family:"Times New Roman",serif;mso-fareast-font-family:
Calibri;mso-ansi-language:ES'><span style='mso-element:field-begin;mso-field-lock:
yes'></span>ADDIN CSL_CITATION
{&quot;citationItems&quot;:[{&quot;id&quot;:&quot;ITEM-1&quot;,&quot;itemData&quot;:{&quot;ISBN&quot;:&quot;0717-3652&quot;,&quot;author&quot;:[{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Retamal&quot;,&quot;given&quot;:&quot;Mirza&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;}],&quot;container-title&quot;:&quot;Revista
Chilena de Salud
Pública&quot;,&quot;id&quot;:&quot;ITEM-1&quot;,&quot;issue&quot;:&quot;3&quot;,&quot;issued&quot;:{&quot;date-parts&quot;:[[&quot;2009&quot;]]},&quot;page&quot;:&quot;169-174&quot;,&quot;title&quot;:&quot;Autogestión
hospitalaria en
cifras&quot;,&quot;type&quot;:&quot;article-journal&quot;,&quot;volume&quot;:&quot;13&quot;},&quot;uris&quot;:[&quot;http://www.mendeley.com/documents/?uuid=d85e8d76-0d9b-4fe9-828b-a84993d6aab1&quot;]}],&quot;mendeley&quot;:{&quot;formattedCitation&quot;:&quot;(47)&quot;,&quot;plainTextFormattedCitation&quot;:&quot;(47)&quot;,&quot;previouslyFormattedCitation&quot;:&quot;(47)&quot;},&quot;properties&quot;:{&quot;noteIndex&quot;:0},&quot;schema&quot;:&quot;https://github.com/citation-style-language/schema/raw/master/csl-citation.json&quot;}<span
style='mso-element:field-separator'></span></span><![endif]--><span lang=ES
style='font-size:10.0pt;line-height:107%;font-family:"Times New Roman",serif;
mso-fareast-font-family:Calibri;mso-ansi-language:ES'><span style='mso-no-proof:
yes'>(47)</span></span><!--[if supportFields]><span lang=ES style='font-size:
10.0pt;line-height:107%;font-family:"Times New Roman",serif;mso-fareast-font-family:
Calibri;mso-ansi-language:ES'><span style='mso-element:field-end'></span></span><![endif]--><span
lang=ES style='font-size:10.0pt;line-height:107%;font-family:"Times New Roman",serif;
mso-fareast-font-family:Calibri;mso-ansi-language:ES'>. De manera alternativa
se pueden calcular multiplicando el número de pacientes admitidos y el promedio
LOS </span><!--[if supportFields]><span lang=ES style='font-size:10.0pt;
line-height:107%;font-family:"Times New Roman",serif;mso-fareast-font-family:
Calibri;mso-ansi-language:ES'><span style='mso-element:field-begin;mso-field-lock:
yes'></span>ADDIN CSL_CITATION
{&quot;citationItems&quot;:[{&quot;id&quot;:&quot;ITEM-1&quot;,&quot;itemData&quot;:{&quot;DOI&quot;:&quot;10.1093/jac/dki093&quot;,&quot;ISBN&quot;:&quot;0305-7453&quot;,&quot;ISSN&quot;:&quot;03057453&quot;,&quot;PMID&quot;:&quot;15814603&quot;,&quot;abstract&quot;:&quot;OBJECTIVES:
The number of defined daily doses (DDD) per 100 patient days is often used as
an indicator for the selection pressure exerted by antibiotics in the hospital
setting. However, this unit of measurement does not fully describe the
selection pressure and is sensitive to changes in hospital resource indicators.
Additional information is required to facilitate interpretation of this
indicator. The number of DDD per 100 admissions could be a valuable additional
tool. The aim of this study is to investigate the importance of units of
measurement in quantifying antibiotic use data with regards to antibiotic
resistance risks. PATIENTS AND METHODS: Trends in antibiotic use in acute care
Dutch hospitals between 1997-2001 were studied. Antibiotic use was expressed in
DDD per 100 patient days and in DDD per 100 admissions. RESULTS: From 1997 to
2001, total systemic antibiotic use significantly increased from 47.2 to 54.7
DDD per 100 patient days, whereas expressed in DDD per 100 admissions it
remained constant. Some individual antibiotics increases in DDD per 100 patient
days were not accompanied by increases in DDD per 100 admissions and vice
versa. The mean number of total DDD per hospital decreased (not significantly)
between 1997 and 2001. The mean number of patient days, admissions and length
of stay decreased significantly. CONCLUSIONS: Knowledge of variation in
resource indicators and additional expression of the data in DDD per 100
admissions is imperative for a meaningful understanding of observed trends in
antibiotic use expressed in DDD per 100 patient days. Further research is
needed to determine the correlation between different measures of antibiotic
use and the level of antibiotic resistance.&quot;,&quot;author&quot;:[{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Filius&quot;,&quot;given&quot;:&quot;P.
M
G&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Liem&quot;,&quot;given&quot;:&quot;T.
B
Y&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Linden&quot;,&quot;given&quot;:&quot;P.
D.&quot;,&quot;non-dropping-particle&quot;:&quot;van
der&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Janknegt&quot;,&quot;given&quot;:&quot;R.&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Natsch&quot;,&quot;given&quot;:&quot;S.&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Vulto&quot;,&quot;given&quot;:&quot;A.
G.&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Verbrugh&quot;,&quot;given&quot;:&quot;H.
A.&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;}],&quot;container-title&quot;:&quot;Journal
of Antimicrobial
Chemotherapy&quot;,&quot;id&quot;:&quot;ITEM-1&quot;,&quot;issue&quot;:&quot;5&quot;,&quot;issued&quot;:{&quot;date-parts&quot;:[[&quot;2005&quot;]]},&quot;page&quot;:&quot;805-808&quot;,&quot;title&quot;:&quot;An
additional measure for quantifying antibiotic use in
hospitals&quot;,&quot;type&quot;:&quot;article-journal&quot;,&quot;volume&quot;:&quot;55&quot;},&quot;uris&quot;:[&quot;http://www.mendeley.com/documents/?uuid=d7898d35-3f88-46a1-ad2f-1edddd4a793d&quot;]}],&quot;mendeley&quot;:{&quot;formattedCitation&quot;:&quot;(48)&quot;,&quot;plainTextFormattedCitation&quot;:&quot;(48)&quot;,&quot;previouslyFormattedCitation&quot;:&quot;(48)&quot;},&quot;properties&quot;:{&quot;noteIndex&quot;:0},&quot;schema&quot;:&quot;https://github.com/citation-style-language/schema/raw/master/csl-citation.json&quot;}<span
style='mso-element:field-separator'></span></span><![endif]--><span lang=ES
style='font-size:10.0pt;line-height:107%;font-family:"Times New Roman",serif;
mso-fareast-font-family:Calibri;mso-ansi-language:ES'><span style='mso-no-proof:
yes'>(48)</span></span><!--[if supportFields]><span lang=ES style='font-size:
10.0pt;line-height:107%;font-family:"Times New Roman",serif;mso-fareast-font-family:
Calibri;mso-ansi-language:ES'><span style='mso-element:field-end'></span></span><![endif]--><span
lang=ES style='font-size:10.0pt;line-height:107%;font-family:"Times New Roman",serif;
mso-fareast-font-family:Calibri;mso-ansi-language:ES'>. La duración o días de
estancia (LOS), describe la duración de un episodio de hospitalización, este se
puede calcular al substraer el día de admisión del día de egreso.<o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0mm;margin-bottom:.0001pt;text-align:
justify;text-indent:11.35pt'><span lang=ES style='font-size:10.0pt;line-height:
107%;font-family:"Times New Roman",serif;mso-fareast-font-family:Calibri;
mso-ansi-language:ES'><o:p>&nbsp;</o:p></span></p>

<p class=MsoNormal style='margin-bottom:0mm;margin-bottom:.0001pt;text-align:
justify;text-indent:11.35pt'><span lang=ES style='font-size:10.0pt;line-height:
107%;font-family:"Times New Roman",serif;mso-fareast-font-family:Calibri;
mso-ansi-language:ES'>El uso de PD como denominador tiene limitaciones puesto
que su magnitud se ve alterada por las variaciones en el tipo de pacientes
presentes en una institución (severidad y diagnósticos), número de admisiones
y/o promedio de LOS </span><!--[if supportFields]><span lang=ES
style='font-size:10.0pt;line-height:107%;font-family:"Times New Roman",serif;
mso-fareast-font-family:Calibri;mso-ansi-language:ES'><span style='mso-element:
field-begin;mso-field-lock:yes'></span>ADDIN CSL_CITATION
{&quot;citationItems&quot;:[{&quot;id&quot;:&quot;ITEM-1&quot;,&quot;itemData&quot;:{&quot;DOI&quot;:&quot;10.1177/1757177410363357&quot;,&quot;ISBN&quot;:&quot;17571774&quot;,&quot;ISSN&quot;:&quot;ISSN
1757-1774&quot;,&quot;abstract&quot;:&quot;Increasing rates of antibiotic
resistance have been related to increased rates of antibiotic prescribing. This
paper describes the use of indicators to measure and compare antibiotic use and
enable hospitals to benchmark their practice. The Defined Daily Dose measure
may be combined with a number of denominators that quantify patient activity in
order to correct for workload variations between hospitals. This may be
combined with data from mandatory surveillance schemes for various infections
to inform prescribing
practice.\\n&quot;,&quot;author&quot;:[{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Curtis&quot;,&quot;given&quot;:&quot;C
E&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;}],&quot;container-title&quot;:&quot;Journal
of Infection Prevention&quot;,&quot;id&quot;:&quot;ITEM-1&quot;,&quot;issue&quot;:&quot;4&quot;,&quot;issued&quot;:{&quot;date-parts&quot;:[[&quot;2010&quot;]]},&quot;page&quot;:&quot;124-126&quot;,&quot;title&quot;:&quot;Indicators
for the monitoring of antibiotic use.&quot;,&quot;type&quot;:&quot;article-journal&quot;,&quot;volume&quot;:&quot;11&quot;},&quot;uris&quot;:[&quot;http://www.mendeley.com/documents/?uuid=88cd6823-507b-47bc-9ae7-4f25bf584caa&quot;]}],&quot;mendeley&quot;:{&quot;formattedCitation&quot;:&quot;(34)&quot;,&quot;plainTextFormattedCitation&quot;:&quot;(34)&quot;,&quot;previouslyFormattedCitation&quot;:&quot;(34)&quot;},&quot;properties&quot;:{&quot;noteIndex&quot;:0},&quot;schema&quot;:&quot;https://github.com/citation-style-language/schema/raw/master/csl-citation.json&quot;}<span
style='mso-element:field-separator'></span></span><![endif]--><span lang=ES
style='font-size:10.0pt;line-height:107%;font-family:"Times New Roman",serif;
mso-fareast-font-family:Calibri;mso-ansi-language:ES'><span style='mso-no-proof:
yes'>(34)</span></span><!--[if supportFields]><span lang=ES style='font-size:
10.0pt;line-height:107%;font-family:"Times New Roman",serif;mso-fareast-font-family:
Calibri;mso-ansi-language:ES'><span style='mso-element:field-end'></span></span><![endif]--><span
lang=ES style='font-size:10.0pt;line-height:107%;font-family:"Times New Roman",serif;
mso-fareast-font-family:Calibri;mso-ansi-language:ES'>. Los PD en la medición
del consumo de pacientes en servicios ambulatorios no suele ser fiable ya que
la inclusión de este tipo de pacientes puede sobrestimar el consumo. El aporte
de pacientes ambulatorios en PD es nulo en el cálculo, puesto que se admiten y
se les da egreso el mismo día.<o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0mm;margin-bottom:.0001pt;text-align:
justify;text-indent:11.35pt'><span lang=ES style='font-size:10.0pt;line-height:
107%;font-family:"Times New Roman",serif;mso-fareast-font-family:Calibri;
mso-ansi-language:ES'><o:p>&nbsp;</o:p></span></p>

<p class=MsoNormal style='margin-bottom:0mm;margin-bottom:.0001pt;text-align:
justify;text-indent:11.35pt'><span lang=ES style='font-size:10.0pt;line-height:
107%;font-family:"Times New Roman",serif;mso-fareast-font-family:Calibri;
mso-ansi-language:ES'>El número de episodios de consultante finalizados (FCE, </span><span
style='font-size:10.0pt;line-height:107%;font-family:"Times New Roman",serif;
mso-fareast-font-family:Calibri;mso-ansi-language:ES-CO'>Finished Consultant
Episodes</span><span lang=ES style='font-size:10.0pt;line-height:107%;
font-family:"Times New Roman",serif;mso-fareast-font-family:Calibri;mso-ansi-language:
ES'>) es la suma de las veces que un paciente es admitido a un servicio por un
facultativo en una institución </span><!--[if supportFields]><span lang=ES
style='font-size:10.0pt;line-height:107%;font-family:"Times New Roman",serif;
mso-fareast-font-family:Calibri;mso-ansi-language:ES'><span style='mso-element:
field-begin;mso-field-lock:yes'></span>ADDIN CSL_CITATION
{&quot;citationItems&quot;:[{&quot;id&quot;:&quot;ITEM-1&quot;,&quot;itemData&quot;:{&quot;DOI&quot;:&quot;10.1093/jac/dkh362&quot;,&quot;ISSN&quot;:&quot;03057453&quot;,&quot;PMID&quot;:&quot;15269192&quot;,&quot;abstract&quot;:&quot;OBJECTIVES:
To compare the recognized defined daily dose per 100 bed-days (DDD/100
bed-days) measure with the defined daily dose per finished consultant episode
(DDD/FCE) in a group of hospitals with a variety of medicines management
strategies. To compare antibiotic usage using the above indicators in hospitals
with and without electronic prescribing systems.\\n\\nMETHODS: Twelve hospitals
were used in the study. Nine hospitals were selected and split into three
cohorts (three high-scoring, three medium-scoring and three low-scoring) by
their 2001 medicines management self-assessment scores (MMAS). An additional
cohort of three electronic prescribing hospitals was included for comparison.
MMAS were compared to antibiotic management scores (AMS) developed from a questionnaire
relating specifically to control of antibiotics. FCEs and occupied bed-days
were obtained from published statistics and statistical analyses of the DDD/100
bed-days and DDD/FCE were carried out using SPSS.\\n\\nRESULTS: The DDD/100
bed-days varied from 81.33 to 189.37 whilst the DDD/FCE varied from 2.88 to
7.43. The two indicators showed a high degree of correlation with r=0.74. MMAS
were from 9 to 22 (possible range 0-23) and the AMS from 2 to 13 (possible
range 0-22). The two scores showed a high degree of correlation with r=0.74. No
correlation was established between either indicator and either
score.\\n\\nCONCLUSIONS: The WHO indicator for medicines utilization, DDD/100
bed-days, exhibited the same level of conformity as that exhibited from the use
of the DDD/FCE indicating that the DDD/FCE is a useful additional indicator for
identifying hospitals which require further study. The MMAS can be assumed to
be an accurate guide to antibiotic medicines management controls. No
relationship has been found between a high degree of medicines management
control and the quantity of antibiotic
prescribed.&quot;,&quot;author&quot;:[{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Curtis&quot;,&quot;given&quot;:&quot;Chris&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Marriott&quot;,&quot;given&quot;:&quot;John&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Langley&quot;,&quot;given&quot;:&quot;Chris&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;}],&quot;container-title&quot;:&quot;Journal
of Antimicrobial Chemotherapy&quot;,&quot;id&quot;:&quot;ITEM-1&quot;,&quot;issue&quot;:&quot;2&quot;,&quot;issued&quot;:{&quot;date-parts&quot;:[[&quot;2004&quot;]]},&quot;page&quot;:&quot;529-533&quot;,&quot;title&quot;:&quot;Development
of a prescribing indicator for objective quantification of antibiotic usage in
secondary
care&quot;,&quot;type&quot;:&quot;article-journal&quot;,&quot;volume&quot;:&quot;54&quot;},&quot;uris&quot;:[&quot;http://www.mendeley.com/documents/?uuid=56ade435-5272-484d-a755-449440685d4b&quot;]}],&quot;mendeley&quot;:{&quot;formattedCitation&quot;:&quot;(14)&quot;,&quot;plainTextFormattedCitation&quot;:&quot;(14)&quot;,&quot;previouslyFormattedCitation&quot;:&quot;(14)&quot;},&quot;properties&quot;:{&quot;noteIndex&quot;:0},&quot;schema&quot;:&quot;https://github.com/citation-style-language/schema/raw/master/csl-citation.json&quot;}<span
style='mso-element:field-separator'></span></span><![endif]--><span lang=ES
style='font-size:10.0pt;line-height:107%;font-family:"Times New Roman",serif;
mso-fareast-font-family:Calibri;mso-ansi-language:ES'><span style='mso-no-proof:
yes'>(14)</span></span><!--[if supportFields]><span lang=ES style='font-size:
10.0pt;line-height:107%;font-family:"Times New Roman",serif;mso-fareast-font-family:
Calibri;mso-ansi-language:ES'><span style='mso-element:field-end'></span></span><![endif]--><span
lang=ES style='font-size:10.0pt;line-height:107%;font-family:"Times New Roman",serif;
mso-fareast-font-family:Calibri;mso-ansi-language:ES'>. El número de admisiones
suele ser menor que el número de FCE en un hospital, porque cada vez que un
paciente se traslada entre servicios del hospital se adiciona un FCE </span><!--[if supportFields]><span
lang=ES style='font-size:10.0pt;line-height:107%;font-family:"Times New Roman",serif;
mso-fareast-font-family:Calibri;mso-ansi-language:ES'><span style='mso-element:
field-begin;mso-field-lock:yes'></span>ADDIN CSL_CITATION {&quot;citationItems&quot;:[{&quot;id&quot;:&quot;ITEM-1&quot;,&quot;itemData&quot;:{&quot;DOI&quot;:&quot;10.1093/jac/dkp399&quot;,&quot;ISBN&quot;:&quot;4419156562&quot;,&quot;ISSN&quot;:&quot;03057453&quot;,&quot;PMID&quot;:&quot;19884120&quot;,&quot;abstract&quot;:&quot;Background
Measurement of prescribing is an important component of antimicrobial
stewardship. The standard unit of measurement in hospitals is defined daily
doses denominated by bed days (e.g. DDDs per 1000 bed days) but alternatives
have not been evaluated in depth.Methods Electronically prescribed doses of
systemic antibacterials administered in this trust during 2008 were analysed in
order to generate 10 indices of antimicrobial use for each of 14 departments.
These indices were five measurements of consumption (DDDs, agent days, courses,
antibiotic days and treatment periods) each denominated by two measurements of activity
[bed days and finished consultant episodes (FCEs)].Results The 10 indices
cluster into four groups within which they correlate well but between which
correlation is poor. These four groups comprise a volume-related measurement of
consumption (DDDs, agent days, antibiotic days) and an exposure-related
measurement of consumption (courses, treatment periods), each denominated by
either bed occupancy (bed days) or patient throughput (FCEs).Conclusions
Indices within these four groups seem to provide different and complementary
information. Restricting measurement of antimicrobial use to a single metric
such as DDDs per 1000 bed days may be insufficient. It is not known which (if
any) of these indices are the best predictors of antimicrobial-related risks such
as resistance pressure or Clostridium difficile
infection.&quot;,&quot;author&quot;:[{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Berrington&quot;,&quot;given&quot;:&quot;Andrew&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;}],&quot;container-title&quot;:&quot;Journal
of Antimicrobial Chemotherapy&quot;,&quot;id&quot;:&quot;ITEM-1&quot;,&quot;issue&quot;:&quot;1&quot;,&quot;issued&quot;:{&quot;date-parts&quot;:[[&quot;2009&quot;]]},&quot;page&quot;:&quot;163-168&quot;,&quot;title&quot;:&quot;Antimicrobial
prescribing in hospitals: Be careful what you measure&quot;,&quot;type&quot;:&quot;article-journal&quot;,&quot;volume&quot;:&quot;65&quot;},&quot;uris&quot;:[&quot;http://www.mendeley.com/documents/?uuid=e845ab0f-2b9f-4fb4-82db-4266f5332f47&quot;]}],&quot;mendeley&quot;:{&quot;formattedCitation&quot;:&quot;(29)&quot;,&quot;plainTextFormattedCitation&quot;:&quot;(29)&quot;,&quot;previouslyFormattedCitation&quot;:&quot;(29)&quot;},&quot;properties&quot;:{&quot;noteIndex&quot;:0},&quot;schema&quot;:&quot;https://github.com/citation-style-language/schema/raw/master/csl-citation.json&quot;}<span
style='mso-element:field-separator'></span></span><![endif]--><span lang=ES
style='font-size:10.0pt;line-height:107%;font-family:"Times New Roman",serif;
mso-fareast-font-family:Calibri;mso-ansi-language:ES'><span style='mso-no-proof:
yes'>(29)</span></span><!--[if supportFields]><span lang=ES style='font-size:
10.0pt;line-height:107%;font-family:"Times New Roman",serif;mso-fareast-font-family:
Calibri;mso-ansi-language:ES'><span style='mso-element:field-end'></span></span><![endif]--><span
lang=ES style='font-size:10.0pt;line-height:107%;font-family:"Times New Roman",serif;
mso-fareast-font-family:Calibri;mso-ansi-language:ES'>. En el cálculo de FCEs
se debe tener en cuenta que el día de admisión y egreso cuentan como uno. </span><span
style='font-size:10.0pt;line-height:107%;font-family:"Times New Roman",serif;
mso-fareast-font-family:Calibri;mso-ansi-language:ES-CO'>El uso del número de
FCE es sensible a cambios en el consumo y tiene la ventaja de tener en cuenta
las diferencias en la complejidad (case-mix) de las instituciones </span><!--[if supportFields]><span
style='font-size:10.0pt;line-height:107%;font-family:"Times New Roman",serif;
mso-fareast-font-family:Calibri;mso-ansi-language:ES-CO'><span
style='mso-element:field-begin;mso-field-lock:yes'></span>ADDIN CSL_CITATION
{&quot;citationItems&quot;:[{&quot;id&quot;:&quot;ITEM-1&quot;,&quot;itemData&quot;:{&quot;DOI&quot;:&quot;10.1007/s11096-007-9147-6&quot;,&quot;ISBN&quot;:&quot;0928-1231&quot;,&quot;ISSN&quot;:&quot;09281231&quot;,&quot;PMID&quot;:&quot;17682836&quot;,&quot;abstract&quot;:&quot;To
investigate whether Defined Daily Dose/Finished Consultant Episode (DDD/FCE)
ratio is sensitive to changes in prescribing patterns and could be used as a
prescribing indicator in
hospitals.&quot;,&quot;author&quot;:[{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Fitzpatrick&quot;,&quot;given&quot;:&quot;Raymond
W.&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Edwards&quot;,&quot;given&quot;:&quot;C.
M
C&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;}],&quot;container-title&quot;:&quot;Pharmacy
World and
Science&quot;,&quot;id&quot;:&quot;ITEM-1&quot;,&quot;issue&quot;:&quot;1&quot;,&quot;issued&quot;:{&quot;date-parts&quot;:[[&quot;2008&quot;]]},&quot;page&quot;:&quot;73-78&quot;,&quot;title&quot;:&quot;Evaluation
of a tool to benchmark hospital antibiotic prescribing in the United
Kingdom&quot;,&quot;type&quot;:&quot;article-journal&quot;,&quot;volume&quot;:&quot;30&quot;},&quot;uris&quot;:[&quot;http://www.mendeley.com/documents/?uuid=3e85af05-d49a-4f2c-aad6-d8704059c877&quot;]}],&quot;mendeley&quot;:{&quot;formattedCitation&quot;:&quot;(49)&quot;,&quot;plainTextFormattedCitation&quot;:&quot;(49)&quot;,&quot;previouslyFormattedCitation&quot;:&quot;(49)&quot;},&quot;properties&quot;:{&quot;noteIndex&quot;:0},&quot;schema&quot;:&quot;https://github.com/citation-style-language/schema/raw/master/csl-citation.json&quot;}<span
style='mso-element:field-separator'></span></span><![endif]--><span
style='font-size:10.0pt;line-height:107%;font-family:"Times New Roman",serif;
mso-fareast-font-family:Calibri;mso-ansi-language:ES-CO'><span
style='mso-no-proof:yes'>(49)</span></span><!--[if supportFields]><span
style='font-size:10.0pt;line-height:107%;font-family:"Times New Roman",serif;
mso-fareast-font-family:Calibri;mso-ansi-language:ES-CO'><span
style='mso-element:field-end'></span></span><![endif]--><span style='font-size:
10.0pt;line-height:107%;font-family:"Times New Roman",serif;mso-fareast-font-family:
Calibri;mso-ansi-language:ES-CO'>. <o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0mm;margin-bottom:.0001pt;text-align:
justify;text-indent:11.35pt'><span style='font-size:10.0pt;line-height:107%;
font-family:"Times New Roman",serif;mso-fareast-font-family:Calibri;mso-ansi-language:
ES-CO'><o:p>&nbsp;</o:p></span></p>

<p class=MsoNormal style='margin-bottom:0mm;margin-bottom:.0001pt;text-align:
justify;text-indent:11.35pt'><span lang=ES style='font-size:10.0pt;line-height:
107%;font-family:"Times New Roman",serif;mso-fareast-font-family:Calibri;
mso-ansi-language:ES'>En estudios de consumo de antibióticos en Reino Unido a
nivel nación se han realizado mediciones a través del indicador número de
prescripciones por STAR-PU </span><!--[if supportFields]><span lang=ES
style='font-size:10.0pt;line-height:107%;font-family:"Times New Roman",serif;
mso-fareast-font-family:Calibri;mso-ansi-language:ES'><span style='mso-element:
field-begin;mso-field-lock:yes'></span>ADDIN CSL_CITATION
{&quot;citationItems&quot;:[{&quot;id&quot;:&quot;ITEM-1&quot;,&quot;itemData&quot;:{&quot;DOI&quot;:&quot;10.1093/jac/dkl511&quot;,&quot;ISBN&quot;:&quot;0305-7453&quot;,&quot;ISSN&quot;:&quot;03057453&quot;,&quot;PMID&quot;:&quot;17283035&quot;,&quot;abstract&quot;:&quot;BACKGROUND:
Antimicrobial drug resistance is a significant cause of avoidable morbidity and
mortality. Inappropriate prescribing of antimicrobials is acknowledged as a key
determinant of this phenomenon. Many approaches are advocated for reducing this
inappropriate prescribing, including regulatory, professional and educational
interventions. Mass media campaigns are often suggested as a useful tool in
managing public expectations, but the evidence to support this is weak, as no
controlled studies of such campaigns exist. Evaluating such campaigns is
problematic, and uncontrolled observations are misleading. We report here the
first controlled study of such an intervention in the use of antimicrobials.
METHODS: Two sequential mass media campaigns, providing information on the
appropriate use of antimicrobials, were conducted during early 2004 and 2005 in
the North East of England. These messages were articulated in the campaign by
the cartoon character 'Moxy Malone'. The campaigns were supported by printed
materials, and in parts of this area, with professional education and
prescribing support. A retrospective controlled before-after study was
conducted, examining the effects on observed prescribing of antimicrobials for
the populations covered by these two cycles of mass media campaigns. These
populations were controlled with matched populations in the North of England.
The primary outcome examined was prescribing rates (items) for all microbial
agents for these populations, corrected for population structure (STAR-PU). A
repeated measures analysis of variance (ANOVA) was used to analyse factors that
had a possible effect on the prescribing of antibacterial drugs. This was
supported by a survey of primary care organizations (PCOs) of all interventions
undertaken around antimicrobial use in the intervention and comparison
populations. RESULTS: In this retrospective study, there was incomplete
reporting of adjuvant interventions undertaken by the PCOs intervention and
comparison areas, so isolating the intervention, and attributing cause and
effect is difficult. In this pragmatic evaluation the campaign was found to
significantly reduce the volume of antibacterial drugs during the winter months
of the intervention years. There were 21.7 fewer items prescribed per 1000
population (P &lt; 0.0005), for the intervention populations over these winter
months, equivalent to a 5.8% absolute reduction in prescribing. CONCLUSIONS:
Mass media campaigns have a role in…&quot;,&quot;author&quot;:[{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Lambert&quot;,&quot;given&quot;:&quot;M.
F.&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Masters&quot;,&quot;given&quot;:&quot;G.
A.&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Brent&quot;,&quot;given&quot;:&quot;S.
L.&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;}],&quot;container-title&quot;:&quot;Journal
of Antimicrobial
Chemotherapy&quot;,&quot;id&quot;:&quot;ITEM-1&quot;,&quot;issue&quot;:&quot;3&quot;,&quot;issued&quot;:{&quot;date-parts&quot;:[[&quot;2007&quot;]]},&quot;page&quot;:&quot;537-543&quot;,&quot;title&quot;:&quot;Can
mass media campaigns change antimicrobial prescribing? A regional evaluation
study&quot;,&quot;type&quot;:&quot;article-journal&quot;,&quot;volume&quot;:&quot;59&quot;},&quot;uris&quot;:[&quot;http://www.mendeley.com/documents/?uuid=16ddacc4-32c3-4976-8e15-3e734652728d&quot;]},{&quot;id&quot;:&quot;ITEM-2&quot;,&quot;itemData&quot;:{&quot;DOI&quot;:&quot;10.3399/bjgp09X472593&quot;,&quot;ISBN&quot;:&quot;0960-1643&quot;,&quot;ISSN&quot;:&quot;09601643&quot;,&quot;PMID&quot;:&quot;19843411&quot;,&quot;abstract&quot;:&quot;BACKGROUND:
Substantial variation in antibiotic prescribing rates between general practices
persists, but remains unexplained at national level.\\n\\nAIM: To establish the
degree of variation in antibiotic prescribing between practices in England and
identify the characteristics of practices that prescribe higher volumes of
antibiotics.\\n\\nDESIGN OF STUDY: Cross-sectional study.\\n\\nSETTING: 8057
general practices in England.\\n\\nMETHOD: A dataset was constructed containing
data on standardised antibiotic prescribing volumes, practice characteristics,
patient morbidity, ethnicity, social deprivation, and Quality and Outcomes
Framework achievement (2004-2005). Data were analysed using multiple regression
modelling.\\n\\nRESULTS: There was a twofold difference in standardised
antibiotic prescribing volumes between practices in the 10th and 90th centiles
of the sample (0.48 versus 0.95 antibiotic prescriptions per antibiotic STAR-PU
[Specific Therapeutic group Age-sex weightings-Related Prescribing Unit]). A
regression model containing nine variables explained 17.2% of the variance in
antibiotic prescribing. Practice location in the north of England was the
strongest predictor of high antibiotic prescribing. Practices serving
populations with greater morbidity and a higher proportion of white patients
prescribed more antibiotics, as did practices with shorter appointments,
non-training practices, and practices with higher proportions of GPs who were
male, &gt;45 years of age, and qualified outside the UK.\\n\\nCONCLUSION:
Practice and practice population characteristics explained about one-sixth of
the variation in antibiotic prescribing nationally. Consultation-level and
qualitative studies are needed to help further explain these findings and
improve our understanding of this
variation.&quot;,&quot;author&quot;:[{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Wang&quot;,&quot;given&quot;:&quot;Kay
Yee&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Seed&quot;,&quot;given&quot;:&quot;Paul&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Schofield&quot;,&quot;given&quot;:&quot;Peter&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Ibrahim&quot;,&quot;given&quot;:&quot;Saima&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Ashworth&quot;,&quot;given&quot;:&quot;Mark&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;}],&quot;container-title&quot;:&quot;British
Journal of General Practice&quot;,&quot;id&quot;:&quot;ITEM-2&quot;,&quot;issue&quot;:&quot;567&quot;,&quot;issued&quot;:{&quot;date-parts&quot;:[[&quot;2009&quot;]]},&quot;page&quot;:&quot;724-727&quot;,&quot;title&quot;:&quot;Which
practices are high antibiotic prescribers? A cross-sectional
analysis&quot;,&quot;type&quot;:&quot;article-journal&quot;,&quot;volume&quot;:&quot;59&quot;},&quot;uris&quot;:[&quot;http://www.mendeley.com/documents/?uuid=a647e859-fcef-4463-9352-f37e816cbb4a&quot;]}],&quot;mendeley&quot;:{&quot;formattedCitation&quot;:&quot;(50,51)&quot;,&quot;plainTextFormattedCitation&quot;:&quot;(50,51)&quot;,&quot;previouslyFormattedCitation&quot;:&quot;(50,51)&quot;},&quot;properties&quot;:{&quot;noteIndex&quot;:0},&quot;schema&quot;:&quot;https://github.com/citation-style-language/schema/raw/master/csl-citation.json&quot;}<span
style='mso-element:field-separator'></span></span><![endif]--><span lang=ES
style='font-size:10.0pt;line-height:107%;font-family:"Times New Roman",serif;
mso-fareast-font-family:Calibri;mso-ansi-language:ES'><span style='mso-no-proof:
yes'>(50,51)</span></span><!--[if supportFields]><span lang=ES
style='font-size:10.0pt;line-height:107%;font-family:"Times New Roman",serif;
mso-fareast-font-family:Calibri;mso-ansi-language:ES'><span style='mso-element:
field-end'></span></span><![endif]--><span lang=ES style='font-size:10.0pt;
line-height:107%;font-family:"Times New Roman",serif;mso-fareast-font-family:
Calibri;mso-ansi-language:ES'>. </span><span style='font-size:10.0pt;
line-height:107%;font-family:"Times New Roman",serif;mso-fareast-font-family:
Calibri;mso-ansi-language:ES-CO'>El STAR-PU (specific therapeutic group age-sex
related prescribing unit) es una unidad de prescripción estandarizada que tiene
en cuenta la variabilidad socio-económica y demográfica de una región </span><!--[if supportFields]><span
style='font-size:10.0pt;line-height:107%;font-family:"Times New Roman",serif;
mso-fareast-font-family:Calibri;mso-ansi-language:ES-CO'><span
style='mso-element:field-begin;mso-field-lock:yes'></span>ADDIN CSL_CITATION
{&quot;citationItems&quot;:[{&quot;id&quot;:&quot;ITEM-1&quot;,&quot;itemData&quot;:{&quot;DOI&quot;:&quot;10.1136/bmj.311.7011.991&quot;,&quot;ISBN&quot;:&quot;0959-8138&quot;,&quot;ISSN&quot;:&quot;0959-8138&quot;,&quot;PMID&quot;:&quot;7580642&quot;,&quot;abstract&quot;:&quot;OBJECTIVES:
To derive cost comparators for prescribing by English general practitioners in
eight specific therapeutic groups, based on age-sex related weightings, and to
confirm, from a new dataset, earlier age-sex weightings for overall prescribing
(ASTRO-PUs). DESIGN: Calculations based on one year's prescribing data from
selected practices using AAH Meditel software, held on MediPlus by
Intercontinental Medical Statistics (IMS, UK and Ireland), and research
practices using VAMP software, held on the General Practice Research Database.
SETTING: 112 English practices with 739,672 patients and 510 British practices with
3,126,570 patients. MAIN OUTCOME MEASURES: Cost based weightings for 18 age-sex
groups and for temporary residents for eight leading specific therapeutic
groups and for prescribing overall. RESULTS: The two datasets were similar in
age distribution and in the way that prescription numbers were distributed by
age-sex band in each therapeutic group. The cost based weightings for specific
therapeutic groups showed great variation in the use of these groups for
patients in different age-sex groups. When these weightings were applied to the
prescribing of practices in two family health services authorities they
differed in their power to predict prescribing costs: for cardiovascular and
gastrointestinal drugs predictive power was particularly high; for drugs for
infections it was particularly low, since these are widely used at all ages and
for both sexes. Cost based weightings for overall prescribing derived from the
IMS data were similar to those of the ASTRO-PU system even though they were
derived by different methods from different datasets. CONCLUSIONS: The
weightings (STAR-PUs) offer a sound basis for cost comparisons at the
therapeutic group level. Cost-based weightings for overall prescribing derived
from the IMS data were reassuringly similar to those of the existing ASTRO-PU
system.&quot;,&quot;author&quot;:[{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Lloyd&quot;,&quot;given&quot;:&quot;D
C&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Harris&quot;,&quot;given&quot;:&quot;C
M&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Roberts&quot;,&quot;given&quot;:&quot;D
J&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;}],&quot;container-title&quot;:&quot;British
medical
journal&quot;,&quot;id&quot;:&quot;ITEM-1&quot;,&quot;issue&quot;:&quot;7011&quot;,&quot;issued&quot;:{&quot;date-parts&quot;:[[&quot;1995&quot;]]},&quot;page&quot;:&quot;991-4&quot;,&quot;title&quot;:&quot;Specific
therapeutic group age-sex related prescribing units (STAR-PUs): weightings for
analysing general practices' prescribing in
England.&quot;,&quot;type&quot;:&quot;article-journal&quot;,&quot;volume&quot;:&quot;311&quot;},&quot;uris&quot;:[&quot;http://www.mendeley.com/documents/?uuid=82114766-dc39-4ccb-aa6e-fe63b6cdd58f&quot;]}],&quot;mendeley&quot;:{&quot;formattedCitation&quot;:&quot;(52)&quot;,&quot;plainTextFormattedCitation&quot;:&quot;(52)&quot;,&quot;previouslyFormattedCitation&quot;:&quot;(52)&quot;},&quot;properties&quot;:{&quot;noteIndex&quot;:0},&quot;schema&quot;:&quot;https://github.com/citation-style-language/schema/raw/master/csl-citation.json&quot;}<span
style='mso-element:field-separator'></span></span><![endif]--><span
style='font-size:10.0pt;line-height:107%;font-family:"Times New Roman",serif;
mso-fareast-font-family:Calibri;mso-ansi-language:ES-CO'><span
style='mso-no-proof:yes'>(52)</span></span><!--[if supportFields]><span
style='font-size:10.0pt;line-height:107%;font-family:"Times New Roman",serif;
mso-fareast-font-family:Calibri;mso-ansi-language:ES-CO'><span
style='mso-element:field-end'></span></span><![endif]--><span style='font-size:
10.0pt;line-height:107%;font-family:"Times New Roman",serif;mso-fareast-font-family:
Calibri;mso-ansi-language:ES-CO'>. STAR-PU se considera robusto para mediciones
de consumo de antimicrobianos, a diferencia del número de prescripciones/ítems
que no mide la exposición a la que se ve sometido un paciente </span><!--[if supportFields]><span
style='font-size:10.0pt;line-height:107%;font-family:"Times New Roman",serif;
mso-fareast-font-family:Calibri;mso-ansi-language:ES-CO'><span
style='mso-element:field-begin;mso-field-lock:yes'></span>ADDIN CSL_CITATION {&quot;citationItems&quot;:[{&quot;id&quot;:&quot;ITEM-1&quot;,&quot;itemData&quot;:{&quot;DOI&quot;:&quot;10.1093/jac/dkp399&quot;,&quot;ISBN&quot;:&quot;4419156562&quot;,&quot;ISSN&quot;:&quot;03057453&quot;,&quot;PMID&quot;:&quot;19884120&quot;,&quot;abstract&quot;:&quot;Background
Measurement of prescribing is an important component of antimicrobial
stewardship. The standard unit of measurement in hospitals is defined daily
doses denominated by bed days (e.g. DDDs per 1000 bed days) but alternatives
have not been evaluated in depth.Methods Electronically prescribed doses of
systemic antibacterials administered in this trust during 2008 were analysed in
order to generate 10 indices of antimicrobial use for each of 14 departments.
These indices were five measurements of consumption (DDDs, agent days, courses,
antibiotic days and treatment periods) each denominated by two measurements of
activity [bed days and finished consultant episodes (FCEs)].Results The 10
indices cluster into four groups within which they correlate well but between
which correlation is poor. These four groups comprise a volume-related
measurement of consumption (DDDs, agent days, antibiotic days) and an
exposure-related measurement of consumption (courses, treatment periods), each
denominated by either bed occupancy (bed days) or patient throughput
(FCEs).Conclusions Indices within these four groups seem to provide different
and complementary information. Restricting measurement of antimicrobial use to
a single metric such as DDDs per 1000 bed days may be insufficient. It is not
known which (if any) of these indices are the best predictors of
antimicrobial-related risks such as resistance pressure or Clostridium
difficile
infection.&quot;,&quot;author&quot;:[{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Berrington&quot;,&quot;given&quot;:&quot;Andrew&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;}],&quot;container-title&quot;:&quot;Journal
of Antimicrobial Chemotherapy&quot;,&quot;id&quot;:&quot;ITEM-1&quot;,&quot;issue&quot;:&quot;1&quot;,&quot;issued&quot;:{&quot;date-parts&quot;:[[&quot;2009&quot;]]},&quot;page&quot;:&quot;163-168&quot;,&quot;title&quot;:&quot;Antimicrobial
prescribing in hospitals: Be careful what you
measure&quot;,&quot;type&quot;:&quot;article-journal&quot;,&quot;volume&quot;:&quot;65&quot;},&quot;uris&quot;:[&quot;http://www.mendeley.com/documents/?uuid=e845ab0f-2b9f-4fb4-82db-4266f5332f47&quot;]}],&quot;mendeley&quot;:{&quot;formattedCitation&quot;:&quot;(29)&quot;,&quot;plainTextFormattedCitation&quot;:&quot;(29)&quot;,&quot;previouslyFormattedCitation&quot;:&quot;(29)&quot;},&quot;properties&quot;:{&quot;noteIndex&quot;:0},&quot;schema&quot;:&quot;https://github.com/citation-style-language/schema/raw/master/csl-citation.json&quot;}<span
style='mso-element:field-separator'></span></span><![endif]--><span
style='font-size:10.0pt;line-height:107%;font-family:"Times New Roman",serif;
mso-fareast-font-family:Calibri;mso-ansi-language:ES-CO'><span
style='mso-no-proof:yes'>(29)</span></span><!--[if supportFields]><span
style='font-size:10.0pt;line-height:107%;font-family:"Times New Roman",serif;
mso-fareast-font-family:Calibri;mso-ansi-language:ES-CO'><span
style='mso-element:field-end'></span></span><![endif]--><span style='font-size:
10.0pt;line-height:107%;font-family:"Times New Roman",serif;mso-fareast-font-family:
Calibri;mso-ansi-language:ES-CO'>. Su uso no se encuentra muy extendido en la
actualidad y por lo general no es recomendable.</span><span lang=ES
style='font-size:10.0pt;line-height:107%;font-family:"Times New Roman",serif;
mso-fareast-font-family:Calibri;mso-ansi-language:ES'><o:p></o:p></span></p>

<p class=IOPH1><span style='mso-ansi-language:ES-CO'>7. Comparación entre
medidas de consumo de antimicrobianos<o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0mm;margin-bottom:.0001pt;text-align:
justify;text-indent:11.35pt'><span lang=ES style='font-size:10.0pt;line-height:
107%;font-family:"Times New Roman",serif;mso-fareast-font-family:Calibri;
mso-ansi-language:ES'>Las diferentes medidas de consumo se pueden agrupar en
categorías de acuerdo a la correlación que existe entre ellas. Un estudio
realizado con antibióticos prescritos en un hospital de 950 camas mos<span
style='color:black'>tró la correlación entre 10 tipos de medidas de consumo de
antibióticos </span></span><!--[if supportFields]><span lang=ES
style='font-size:10.0pt;line-height:107%;font-family:"Times New Roman",serif;
mso-fareast-font-family:Calibri;color:black;mso-ansi-language:ES'><span
style='mso-element:field-begin;mso-field-lock:yes'></span>ADDIN CSL_CITATION
{&quot;citationItems&quot;:[{&quot;id&quot;:&quot;ITEM-1&quot;,&quot;itemData&quot;:{&quot;DOI&quot;:&quot;10.1093/jac/dkp399&quot;,&quot;ISBN&quot;:&quot;4419156562&quot;,&quot;ISSN&quot;:&quot;03057453&quot;,&quot;PMID&quot;:&quot;19884120&quot;,&quot;abstract&quot;:&quot;Background
Measurement of prescribing is an important component of antimicrobial stewardship.
The standard unit of measurement in hospitals is defined daily doses denominated
by bed days (e.g. DDDs per 1000 bed days) but alternatives have not been
evaluated in depth.Methods Electronically prescribed doses of systemic
antibacterials administered in this trust during 2008 were analysed in order to
generate 10 indices of antimicrobial use for each of 14 departments. These
indices were five measurements of consumption (DDDs, agent days, courses,
antibiotic days and treatment periods) each denominated by two measurements of
activity [bed days and finished consultant episodes (FCEs)].Results The 10
indices cluster into four groups within which they correlate well but between
which correlation is poor. These four groups comprise a volume-related
measurement of consumption (DDDs, agent days, antibiotic days) and an
exposure-related measurement of consumption (courses, treatment periods), each
denominated by either bed occupancy (bed days) or patient throughput
(FCEs).Conclusions Indices within these four groups seem to provide different
and complementary information. Restricting measurement of antimicrobial use to
a single metric such as DDDs per 1000 bed days may be insufficient. It is not
known which (if any) of these indices are the best predictors of
antimicrobial-related risks such as resistance pressure or Clostridium
difficile infection.&quot;,&quot;author&quot;:[{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Berrington&quot;,&quot;given&quot;:&quot;Andrew&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;}],&quot;container-title&quot;:&quot;Journal
of Antimicrobial
Chemotherapy&quot;,&quot;id&quot;:&quot;ITEM-1&quot;,&quot;issue&quot;:&quot;1&quot;,&quot;issued&quot;:{&quot;date-parts&quot;:[[&quot;2009&quot;]]},&quot;page&quot;:&quot;163-168&quot;,&quot;title&quot;:&quot;Antimicrobial
prescribing in hospitals: Be careful what you
measure&quot;,&quot;type&quot;:&quot;article-journal&quot;,&quot;volume&quot;:&quot;65&quot;},&quot;uris&quot;:[&quot;http://www.mendeley.com/documents/?uuid=e845ab0f-2b9f-4fb4-82db-4266f5332f47&quot;]}],&quot;mendeley&quot;:{&quot;formattedCitation&quot;:&quot;(29)&quot;,&quot;plainTextFormattedCitation&quot;:&quot;(29)&quot;,&quot;previouslyFormattedCitation&quot;:&quot;(29)&quot;},&quot;properties&quot;:{&quot;noteIndex&quot;:0},&quot;schema&quot;:&quot;https://github.com/citation-style-language/schema/raw/master/csl-citation.json&quot;}<span
style='mso-element:field-separator'></span></span><![endif]--><span lang=ES
style='font-size:10.0pt;line-height:107%;font-family:"Times New Roman",serif;
mso-fareast-font-family:Calibri;color:black;mso-ansi-language:ES'><span
style='mso-no-proof:yes'>(29)</span></span><!--[if supportFields]><span
lang=ES style='font-size:10.0pt;line-height:107%;font-family:"Times New Roman",serif;
mso-fareast-font-family:Calibri;color:black;mso-ansi-language:ES'><span
style='mso-element:field-end'></span></span><![endif]--><span lang=ES
style='font-size:10.0pt;line-height:107%;font-family:"Times New Roman",serif;
mso-fareast-font-family:Calibri;color:black;mso-ansi-language:ES'>. Estas
medidas resultaban de la combinación entre 5 tipos de numerador (DDDs, DOTs,
LOTs, cursos de tratamiento y periodos de tratamiento) con 2 tipos de
denominador (1000PD y FCEs). Se encontraron varias agrupaciones (con alta
correlación) que miden atributos diferentes: 1) </span><span style='font-size:
10.0pt;line-height:107%;font-family:"Times New Roman",serif;mso-fareast-font-family:
Calibri;color:black;mso-ansi-language:ES-CO'>DDDs, DOTs, LOTs por 1000PD, 2)
DDDs, DOTs, LOTs por 1000 FCEs, 3) cursos y </span><span lang=ES
style='font-size:10.0pt;line-height:107%;font-family:"Times New Roman",serif;
mso-fareast-font-family:Calibri;color:black;mso-ansi-language:ES'>periodos de
trata</span><span style='font-size:10.0pt;line-height:107%;font-family:"Times New Roman",serif;
mso-fareast-font-family:Calibri;color:black;mso-ansi-language:ES-CO'>miento por
1000PD y 4) </span><span lang=ES style='font-size:10.0pt;line-height:107%;
font-family:"Times New Roman",serif;mso-fareast-font-family:Calibri;color:black;
mso-ansi-language:ES'>cursos y periodos de tratamiento </span><span
style='font-size:10.0pt;line-height:107%;font-family:"Times New Roman",serif;
mso-fareast-font-family:Calibri;color:black;mso-ansi-language:ES-CO'>por 1000
FCEs. </span><span lang=ES style='font-size:10.0pt;line-height:107%;font-family:
"Times New Roman",serif;mso-fareast-font-family:Calibri;color:black;mso-ansi-language:
ES'><o:p></o:p></span></p>

<p class=MsoNormal style='margin-top:10.0pt;margin-right:0mm;margin-bottom:
6.0pt;margin-left:0mm'><i style='mso-bidi-font-style:normal'><span
style='mso-bidi-font-size:9.0pt;line-height:107%;mso-bidi-font-family:"Times New Roman";
mso-ansi-language:ES-CO'>7.1 Comparación entre numeradores<o:p></o:p></span></i></p>

<p class=MsoNormal style='margin-bottom:0mm;margin-bottom:.0001pt;text-align:
justify;text-indent:11.35pt'><span lang=ES style='font-size:10.0pt;line-height:
107%;font-family:"Times New Roman",serif;mso-fareast-font-family:Calibri;
mso-ansi-language:ES'>Las DDDs tienden a sobrestimar el consumo respecto a
indicadores de referencia como PDDs </span><!--[if supportFields]><span
lang=ES style='font-size:10.0pt;line-height:107%;font-family:"Times New Roman",serif;
mso-fareast-font-family:Calibri;mso-ansi-language:ES'><span style='mso-element:
field-begin;mso-field-lock:yes'></span>ADDIN CSL_CITATION
{&quot;citationItems&quot;:[{&quot;id&quot;:&quot;ITEM-1&quot;,&quot;itemData&quot;:{&quot;DOI&quot;:&quot;10.1007/s15010-006-5085-9&quot;,&quot;ISSN&quot;:&quot;03008126&quot;,&quot;PMID&quot;:&quot;16703299&quot;,&quot;abstract&quot;:&quot;BACKGROUND:
Hospital antibiotic use can be measured by calculating daily doses as defined
by the WHO/ATC index (DDD) divided by the number of patient or occupied bed
days. We wondered whether changes in antibiotic use density over time at a
university hospital using this data format are similar in order of magnitude
when compared with a different, alternative dose definition and the number of
admissions rather than the number of patient days as denominator. METHODS: Data
obtained from the hospital pharmacy for the medical and surgical services of a
1,000-bed university hospital for the period 1992 through 2003 were expressed
both in daily doses per 100 patient days and daily doses per admission. A PDD
dose definition (prescribed daily doses), defining doses that reflect the
usually prescribed dose in adult hospitalized patients with normal renal
function was compared with the WHO/ATC 2001 DDD dose definitions. The percent
changes using the different data formats between two 3-year averages (1992-1994
and 2001-2003) were calculated. RESULTS AND CONCLUSION: The DDD/100 patient
days data format overestimated antibiotic use density changes in this hospital
both in medicine (81% vs 48%) as well as in surgery (69% vs 39%) when compared
with PDD/100 patient days. Due to changes in the number of admissions and
length of stay over the years, the percent change between the two periods
expressed in doses per 100 patient days in addition differed substantially from
that estimated by using the DDD per admission or PDD per admission data format.
Studies evaluating the evolution of hospital antibiotic use need to address the
limitations and adequacy of the different data
formats.&quot;,&quot;author&quot;:[{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;With&quot;,&quot;given&quot;:&quot;K.&quot;,&quot;non-dropping-particle&quot;:&quot;De&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Maier&quot;,&quot;given&quot;:&quot;L.&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Steib-Bauert&quot;,&quot;given&quot;:&quot;M.&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Kern&quot;,&quot;given&quot;:&quot;P.&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;V.&quot;,&quot;family&quot;:&quot;Kern&quot;,&quot;given&quot;:&quot;W.&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;}],&quot;container-title&quot;:&quot;Infection&quot;,&quot;id&quot;:&quot;ITEM-1&quot;,&quot;issue&quot;:&quot;2&quot;,&quot;issued&quot;:{&quot;date-parts&quot;:[[&quot;2006&quot;]]},&quot;page&quot;:&quot;91-94&quot;,&quot;title&quot;:&quot;Trends
in antibiotic use at a University Hospital: Defined or prescribed daily doses?
Patient days or admissions as
denominator?&quot;,&quot;type&quot;:&quot;article-journal&quot;,&quot;volume&quot;:&quot;34&quot;},&quot;uris&quot;:[&quot;http://www.mendeley.com/documents/?uuid=d0a23bba-8474-405e-bf30-f999ad11ce60&quot;]},{&quot;id&quot;:&quot;ITEM-2&quot;,&quot;itemData&quot;:{&quot;DOI&quot;:&quot;10.1111/j.1365-2125.2006.02605.x&quot;,&quot;ISBN&quot;:&quot;0306-5251&quot;,&quot;ISSN&quot;:&quot;03065251&quot;,&quot;PMID&quot;:&quot;16669851&quot;,&quot;abstract&quot;:&quot;AIMS:
The defined daily doses (DDD) defined by the WHO are widely used as an indicator
to measure antibiotic use in the hospital setting. However, discrepancies exist
between countries in terms of antibiotic dosage. The aim of the present study
was to compare, for each antibacterial agent available at our university
hospital, the prescribed daily doses (PDD) with the DDD.\\n\\nMETHODS: Data
were extracted from the pharmacy computer system. Antibiotic use was expressed
in DDD per 1000 patient days. We also calculated the ratio of number of
DDD:number of treatment-days and estimated the average PDD for each antibiotic
and route of administration.\\n\\nRESULTS: The average PDD did not correspond
to the DDD for many classes of antibiotics. If fluoroquinolones and
cephalosporins were prescribed at a dosage close to the DDD, other antimicrobial
classes such as penicillins, aminoglycosides or macrolides were not. Overall,
the number of DDD overestimated the number of treatment days by 40%. For the
most consumed antibiotic at our hospital, i.e. oral amoxicillin-clavulanic
acid, the PDD was three times the DDD.\\n\\nCONCLUSIONS: Our study shows that,
except for the fluoroquinolones and the cephalosporins, the number of DDD did
not correctly reflect the number of antibiotic treatment days at our hospital.
This does not invalidate the systematic approach of the WHO and hospitals
should use the DDDs to make national and international comparisons of their
antibiotic use. However, each hospital should define and validate its own
indicators to describe the local exposures to antibiotics and to study the relationship
with
resistance.&quot;,&quot;author&quot;:[{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Muller&quot;,&quot;given&quot;:&quot;Arno&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Monnet&quot;,&quot;given&quot;:&quot;Dominique
L.&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Talon&quot;,&quot;given&quot;:&quot;Daniel&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Hénon&quot;,&quot;given&quot;:&quot;Thierry&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Bertrand&quot;,&quot;given&quot;:&quot;Xavier&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;}],&quot;container-title&quot;:&quot;British
Journal of Clinical
Pharmacology&quot;,&quot;id&quot;:&quot;ITEM-2&quot;,&quot;issue&quot;:&quot;5&quot;,&quot;issued&quot;:{&quot;date-parts&quot;:[[&quot;2006&quot;]]},&quot;page&quot;:&quot;585-591&quot;,&quot;title&quot;:&quot;Discrepancies
between prescribed daily doses and WHO defined daily doses of antibacterials at
a university
hospital&quot;,&quot;type&quot;:&quot;article-journal&quot;,&quot;volume&quot;:&quot;61&quot;},&quot;uris&quot;:[&quot;http://www.mendeley.com/documents/?uuid=77e84106-dcfd-46ca-aeee-f819c2ebf883&quot;]},{&quot;id&quot;:&quot;ITEM-3&quot;,&quot;itemData&quot;:{&quot;DOI&quot;:&quot;10.1007/s15010-008-8138-4&quot;,&quot;ISBN&quot;:&quot;0300-8126&quot;,&quot;ISSN&quot;:&quot;03008126&quot;,&quot;PMID&quot;:&quot;19277464&quot;,&quot;abstract&quot;:&quot;BACKGROUND:
Hospital antibiotic use is usually measured by calculating the volume as the
number of daily doses defined by the World Health Organization/Anatomical
Therapeutic Chemical (WHO/ATC) index (DDDs) divided by a denominator indicating
clinical activity, such as the number of occupied bed days. Previous studies
have found discrepancies between DDDs, daily doses as recommended in practice
guidelines (recommended daily doses, RDDs), and truly prescribed daily doses
(PDDs). Very few studies have quantified these discrepancies. METHODS: A point
prevalence survey was carried out in defined acute care service areas of a
large German state university hospital. Of the 941 adult inpatients present on
the day of the survey for whom adequate information was available, 267 (28%)
had 471 prescriptions for antimicrobial drugs on that specific day. A check for
any additional antimicrobial drug prescriptions for these 267 patients during
the six days immediately preceding the survey day yielded a total of 2,304
PDDs, of which 1,754 were antibacterial agents. The latter antibacterial drug
PDDs constituted the basis for analysis. The proportion of PDDs different from
RDDs and from DDDs was evaluated, and the deviations were calculated. RDD dose
definitions corresponded to the local practice guideline recommendations of
antibiotic therapy for adult hospitalized patients with normal renal
function.\\n\\nRESULTS: Of the 1,754 PDDs, 625 were matching DDD dose
definitions (36%), and 1,024 (58%) were matching RDD dose definitions (p &lt;
0.01). Corresponding values for patients with impaired renal function
(creatinine clearance &lt; 50 ml/min) were 36% and 42%, respectively. Large DDD
discrepancies (&lt; 50% of prescribed doses matching DDD definitions) were
noted for beta-lactams and macrolides, while large RDD discrepancies were
observed for aminoglycosides. Compared with PDDs, the use of DDDs as the
measurement of hospital antibiotic use overestimated antibiotic use volumes by
32%, while the use of RDD led to a slight underestimation (-9%).CONCLUSION: The
use of DDDs as currently defined by WHO/ATC for measuring hospital antibiotic
consumption may be associated with a substantial overestimation of antibiotic
use density, while using practice guideline-derived RDDs may yield more valid
antibiotic exposure estimates that would be helpful in cross-sectional and
longitudinal analyses of antibiotic consumption.&quot;,&quot;author&quot;:[{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;With&quot;,&quot;given&quot;:&quot;K.&quot;,&quot;non-dropping-particle&quot;:&quot;De&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Bestehorn&quot;,&quot;given&quot;:&quot;H.&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Steib-Bauert&quot;,&quot;given&quot;:&quot;M.&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;V.&quot;,&quot;family&quot;:&quot;Kern&quot;,&quot;given&quot;:&quot;W.&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;}],&quot;container-title&quot;:&quot;Infection&quot;,&quot;id&quot;:&quot;ITEM-3&quot;,&quot;issue&quot;:&quot;4&quot;,&quot;issued&quot;:{&quot;date-parts&quot;:[[&quot;2009&quot;]]},&quot;page&quot;:&quot;349-352&quot;,&quot;title&quot;:&quot;Comparison
of defined versus recommended versus prescribed daily doses for measuring
hospital antibiotic
consumption&quot;,&quot;type&quot;:&quot;article-journal&quot;,&quot;volume&quot;:&quot;37&quot;},&quot;uris&quot;:[&quot;http://www.mendeley.com/documents/?uuid=57fcb398-1a6f-40d5-aaa1-0babbf0b8893&quot;]}],&quot;mendeley&quot;:{&quot;formattedCitation&quot;:&quot;(41,53,54)&quot;,&quot;plainTextFormattedCitation&quot;:&quot;(41,53,54)&quot;,&quot;previouslyFormattedCitation&quot;:&quot;(41,53,54)&quot;},&quot;properties&quot;:{&quot;noteIndex&quot;:0},&quot;schema&quot;:&quot;https://github.com/citation-style-language/schema/raw/master/csl-citation.json&quot;}<span
style='mso-element:field-separator'></span></span><![endif]--><span lang=ES
style='font-size:10.0pt;line-height:107%;font-family:"Times New Roman",serif;
mso-fareast-font-family:Calibri;mso-ansi-language:ES'><span style='mso-no-proof:
yes'>(41,53,54)</span></span><!--[if supportFields]><span lang=ES
style='font-size:10.0pt;line-height:107%;font-family:"Times New Roman",serif;
mso-fareast-font-family:Calibri;mso-ansi-language:ES'><span style='mso-element:
field-end'></span></span><![endif]--><span lang=ES style='font-size:10.0pt;
line-height:107%;font-family:"Times New Roman",serif;mso-fareast-font-family:
Calibri;mso-ansi-language:ES'>. El indicador RDD por otra parte tiende a
subestimar el consumo </span><!--[if supportFields]><span lang=ES
style='font-size:10.0pt;line-height:107%;font-family:"Times New Roman",serif;
mso-fareast-font-family:Calibri;mso-ansi-language:ES'><span style='mso-element:
field-begin;mso-field-lock:yes'></span>ADDIN CSL_CITATION {&quot;citationItems&quot;:[{&quot;id&quot;:&quot;ITEM-1&quot;,&quot;itemData&quot;:{&quot;DOI&quot;:&quot;10.1007/s15010-008-8138-4&quot;,&quot;ISBN&quot;:&quot;0300-8126&quot;,&quot;ISSN&quot;:&quot;03008126&quot;,&quot;PMID&quot;:&quot;19277464&quot;,&quot;abstract&quot;:&quot;BACKGROUND:
Hospital antibiotic use is usually measured by calculating the volume as the
number of daily doses defined by the World Health Organization/Anatomical
Therapeutic Chemical (WHO/ATC) index (DDDs) divided by a denominator indicating
clinical activity, such as the number of occupied bed days. Previous studies
have found discrepancies between DDDs, daily doses as recommended in practice
guidelines (recommended daily doses, RDDs), and truly prescribed daily doses
(PDDs). Very few studies have quantified these discrepancies. METHODS: A point
prevalence survey was carried out in defined acute care service areas of a
large German state university hospital. Of the 941 adult inpatients present on
the day of the survey for whom adequate information was available, 267 (28%)
had 471 prescriptions for antimicrobial drugs on that specific day. A check for
any additional antimicrobial drug prescriptions for these 267 patients during
the six days immediately preceding the survey day yielded a total of 2,304
PDDs, of which 1,754 were antibacterial agents. The latter antibacterial drug
PDDs constituted the basis for analysis. The proportion of PDDs different from
RDDs and from DDDs was evaluated, and the deviations were calculated. RDD dose
definitions corresponded to the local practice guideline recommendations of
antibiotic therapy for adult hospitalized patients with normal renal
function.\\n\\nRESULTS: Of the 1,754 PDDs, 625 were matching DDD dose
definitions (36%), and 1,024 (58%) were matching RDD dose definitions (p &lt;
0.01). Corresponding values for patients with impaired renal function
(creatinine clearance &lt; 50 ml/min) were 36% and 42%, respectively. Large DDD
discrepancies (&lt; 50% of prescribed doses matching DDD definitions) were
noted for beta-lactams and macrolides, while large RDD discrepancies were
observed for aminoglycosides. Compared with PDDs, the use of DDDs as the
measurement of hospital antibiotic use overestimated antibiotic use volumes by
32%, while the use of RDD led to a slight underestimation (-9%).CONCLUSION: The
use of DDDs as currently defined by WHO/ATC for measuring hospital antibiotic
consumption may be associated with a substantial overestimation of antibiotic
use density, while using practice guideline-derived RDDs may yield more valid
antibiotic exposure estimates that would be helpful in cross-sectional and
longitudinal analyses of antibiotic consumption.&quot;,&quot;author&quot;:[{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;With&quot;,&quot;given&quot;:&quot;K.&quot;,&quot;non-dropping-particle&quot;:&quot;De&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Bestehorn&quot;,&quot;given&quot;:&quot;H.&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Steib-Bauert&quot;,&quot;given&quot;:&quot;M.&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;V.&quot;,&quot;family&quot;:&quot;Kern&quot;,&quot;given&quot;:&quot;W.&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;}],&quot;container-title&quot;:&quot;Infection&quot;,&quot;id&quot;:&quot;ITEM-1&quot;,&quot;issue&quot;:&quot;4&quot;,&quot;issued&quot;:{&quot;date-parts&quot;:[[&quot;2009&quot;]]},&quot;page&quot;:&quot;349-352&quot;,&quot;title&quot;:&quot;Comparison
of defined versus recommended versus prescribed daily doses for measuring
hospital antibiotic
consumption&quot;,&quot;type&quot;:&quot;article-journal&quot;,&quot;volume&quot;:&quot;37&quot;},&quot;uris&quot;:[&quot;http://www.mendeley.com/documents/?uuid=57fcb398-1a6f-40d5-aaa1-0babbf0b8893&quot;]}],&quot;mendeley&quot;:{&quot;formattedCitation&quot;:&quot;(41)&quot;,&quot;plainTextFormattedCitation&quot;:&quot;(41)&quot;,&quot;previouslyFormattedCitation&quot;:&quot;(41)&quot;},&quot;properties&quot;:{&quot;noteIndex&quot;:0},&quot;schema&quot;:&quot;https://github.com/citation-style-language/schema/raw/master/csl-citation.json&quot;}<span
style='mso-element:field-separator'></span></span><![endif]--><span lang=ES
style='font-size:10.0pt;line-height:107%;font-family:"Times New Roman",serif;
mso-fareast-font-family:Calibri;mso-ansi-language:ES'><span style='mso-no-proof:
yes'>(41)</span></span><!--[if supportFields]><span lang=ES style='font-size:
10.0pt;line-height:107%;font-family:"Times New Roman",serif;mso-fareast-font-family:
Calibri;mso-ansi-language:ES'><span style='mso-element:field-end'></span></span><![endif]--><span
lang=ES style='font-size:10.0pt;line-height:107%;font-family:"Times New Roman",serif;
mso-fareast-font-family:Calibri;mso-ansi-language:ES'>. Un estudio comparó
DDDs/100PD con PDDs/100PD, mientras examinaba las tendencias de consumo durante
varios años </span><!--[if supportFields]><span lang=ES style='font-size:10.0pt;
line-height:107%;font-family:"Times New Roman",serif;mso-fareast-font-family:
Calibri;mso-ansi-language:ES'><span style='mso-element:field-begin;mso-field-lock:
yes'></span>ADDIN CSL_CITATION
{&quot;citationItems&quot;:[{&quot;id&quot;:&quot;ITEM-1&quot;,&quot;itemData&quot;:{&quot;DOI&quot;:&quot;10.1007/s15010-006-5085-9&quot;,&quot;ISSN&quot;:&quot;03008126&quot;,&quot;PMID&quot;:&quot;16703299&quot;,&quot;abstract&quot;:&quot;BACKGROUND:
Hospital antibiotic use can be measured by calculating daily doses as defined
by the WHO/ATC index (DDD) divided by the number of patient or occupied bed
days. We wondered whether changes in antibiotic use density over time at a
university hospital using this data format are similar in order of magnitude
when compared with a different, alternative dose definition and the number of
admissions rather than the number of patient days as denominator. METHODS: Data
obtained from the hospital pharmacy for the medical and surgical services of a
1,000-bed university hospital for the period 1992 through 2003 were expressed
both in daily doses per 100 patient days and daily doses per admission. A PDD
dose definition (prescribed daily doses), defining doses that reflect the
usually prescribed dose in adult hospitalized patients with normal renal
function was compared with the WHO/ATC 2001 DDD dose definitions. The percent
changes using the different data formats between two 3-year averages (1992-1994
and 2001-2003) were calculated. RESULTS AND CONCLUSION: The DDD/100 patient
days data format overestimated antibiotic use density changes in this hospital
both in medicine (81% vs 48%) as well as in surgery (69% vs 39%) when compared
with PDD/100 patient days. Due to changes in the number of admissions and
length of stay over the years, the percent change between the two periods
expressed in doses per 100 patient days in addition differed substantially from
that estimated by using the DDD per admission or PDD per admission data format.
Studies evaluating the evolution of hospital antibiotic use need to address the
limitations and adequacy of the different data formats.&quot;,&quot;author&quot;:[{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;With&quot;,&quot;given&quot;:&quot;K.&quot;,&quot;non-dropping-particle&quot;:&quot;De&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Maier&quot;,&quot;given&quot;:&quot;L.&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Steib-Bauert&quot;,&quot;given&quot;:&quot;M.&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Kern&quot;,&quot;given&quot;:&quot;P.&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;V.&quot;,&quot;family&quot;:&quot;Kern&quot;,&quot;given&quot;:&quot;W.&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;}],&quot;container-title&quot;:&quot;Infection&quot;,&quot;id&quot;:&quot;ITEM-1&quot;,&quot;issue&quot;:&quot;2&quot;,&quot;issued&quot;:{&quot;date-parts&quot;:[[&quot;2006&quot;]]},&quot;page&quot;:&quot;91-94&quot;,&quot;title&quot;:&quot;Trends
in antibiotic use at a University Hospital: Defined or prescribed daily doses?
Patient days or admissions as
denominator?&quot;,&quot;type&quot;:&quot;article-journal&quot;,&quot;volume&quot;:&quot;34&quot;},&quot;uris&quot;:[&quot;http://www.mendeley.com/documents/?uuid=d0a23bba-8474-405e-bf30-f999ad11ce60&quot;]}],&quot;mendeley&quot;:{&quot;formattedCitation&quot;:&quot;(53)&quot;,&quot;plainTextFormattedCitation&quot;:&quot;(53)&quot;,&quot;previouslyFormattedCitation&quot;:&quot;(53)&quot;},&quot;properties&quot;:{&quot;noteIndex&quot;:0},&quot;schema&quot;:&quot;https://github.com/citation-style-language/schema/raw/master/csl-citation.json&quot;}<span
style='mso-element:field-separator'></span></span><![endif]--><span lang=ES
style='font-size:10.0pt;line-height:107%;font-family:"Times New Roman",serif;
mso-fareast-font-family:Calibri;mso-ansi-language:ES'><span style='mso-no-proof:
yes'>(53)</span></span><!--[if supportFields]><span lang=ES style='font-size:
10.0pt;line-height:107%;font-family:"Times New Roman",serif;mso-fareast-font-family:
Calibri;mso-ansi-language:ES'><span style='mso-element:field-end'></span></span><![endif]--><span
lang=ES style='font-size:10.0pt;line-height:107%;font-family:"Times New Roman",serif;
mso-fareast-font-family:Calibri;mso-ansi-language:ES'>. Se obtuvo el promedio
de utilización en dos periodos de tres años entre 1992-2003, y la variación en
el consumo promedio de un periodo a otro se expresó como porcentaje. El cambio
en utilización en DDDs/100PD fue +81% y +69% para servicios de medicina interna
y cirugía. Cuando se utilizó el indicador PDDs/100PD, el aumento en el consumo
observado fue menor con +48% y +38%, para los mismos servicios. Las DDDs
tienden a sobrestimar el consumo puesto que las dosis definidas en la mayor
parte de antibióticos sistémicos son menores a las utilizadas en la práctica </span><!--[if supportFields]><span
lang=ES style='font-size:10.0pt;line-height:107%;font-family:"Times New Roman",serif;
mso-fareast-font-family:Calibri;mso-ansi-language:ES'><span style='mso-element:
field-begin;mso-field-lock:yes'></span>ADDIN CSL_CITATION
{&quot;citationItems&quot;:[{&quot;id&quot;:&quot;ITEM-1&quot;,&quot;itemData&quot;:{&quot;DOI&quot;:&quot;10.1007/s15010-006-5085-9&quot;,&quot;ISSN&quot;:&quot;03008126&quot;,&quot;PMID&quot;:&quot;16703299&quot;,&quot;abstract&quot;:&quot;BACKGROUND:
Hospital antibiotic use can be measured by calculating daily doses as defined
by the WHO/ATC index (DDD) divided by the number of patient or occupied bed
days. We wondered whether changes in antibiotic use density over time at a
university hospital using this data format are similar in order of magnitude
when compared with a different, alternative dose definition and the number of
admissions rather than the number of patient days as denominator. METHODS: Data
obtained from the hospital pharmacy for the medical and surgical services of a
1,000-bed university hospital for the period 1992 through 2003 were expressed
both in daily doses per 100 patient days and daily doses per admission. A PDD
dose definition (prescribed daily doses), defining doses that reflect the
usually prescribed dose in adult hospitalized patients with normal renal
function was compared with the WHO/ATC 2001 DDD dose definitions. The percent
changes using the different data formats between two 3-year averages (1992-1994
and 2001-2003) were calculated. RESULTS AND CONCLUSION: The DDD/100 patient
days data format overestimated antibiotic use density changes in this hospital
both in medicine (81% vs 48%) as well as in surgery (69% vs 39%) when compared
with PDD/100 patient days. Due to changes in the number of admissions and
length of stay over the years, the percent change between the two periods
expressed in doses per 100 patient days in addition differed substantially from
that estimated by using the DDD per admission or PDD per admission data format.
Studies evaluating the evolution of hospital antibiotic use need to address the
limitations and adequacy of the different data formats.&quot;,&quot;author&quot;:[{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;With&quot;,&quot;given&quot;:&quot;K.&quot;,&quot;non-dropping-particle&quot;:&quot;De&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Maier&quot;,&quot;given&quot;:&quot;L.&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Steib-Bauert&quot;,&quot;given&quot;:&quot;M.&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Kern&quot;,&quot;given&quot;:&quot;P.&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;V.&quot;,&quot;family&quot;:&quot;Kern&quot;,&quot;given&quot;:&quot;W.&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;}],&quot;container-title&quot;:&quot;Infection&quot;,&quot;id&quot;:&quot;ITEM-1&quot;,&quot;issue&quot;:&quot;2&quot;,&quot;issued&quot;:{&quot;date-parts&quot;:[[&quot;2006&quot;]]},&quot;page&quot;:&quot;91-94&quot;,&quot;title&quot;:&quot;Trends
in antibiotic use at a University Hospital: Defined or prescribed daily doses?
Patient days or admissions as
denominator?&quot;,&quot;type&quot;:&quot;article-journal&quot;,&quot;volume&quot;:&quot;34&quot;},&quot;uris&quot;:[&quot;http://www.mendeley.com/documents/?uuid=d0a23bba-8474-405e-bf30-f999ad11ce60&quot;]}],&quot;mendeley&quot;:{&quot;formattedCitation&quot;:&quot;(53)&quot;,&quot;plainTextFormattedCitation&quot;:&quot;(53)&quot;,&quot;previouslyFormattedCitation&quot;:&quot;(53)&quot;},&quot;properties&quot;:{&quot;noteIndex&quot;:0},&quot;schema&quot;:&quot;https://github.com/citation-style-language/schema/raw/master/csl-citation.json&quot;}<span
style='mso-element:field-separator'></span></span><![endif]--><span lang=ES
style='font-size:10.0pt;line-height:107%;font-family:"Times New Roman",serif;
mso-fareast-font-family:Calibri;mso-ansi-language:ES'><span style='mso-no-proof:
yes'>(53)</span></span><!--[if supportFields]><span lang=ES style='font-size:
10.0pt;line-height:107%;font-family:"Times New Roman",serif;mso-fareast-font-family:
Calibri;mso-ansi-language:ES'><span style='mso-element:field-end'></span></span><![endif]--><span
lang=ES style='font-size:10.0pt;line-height:107%;font-family:"Times New Roman",serif;
mso-fareast-font-family:Calibri;mso-ansi-language:ES'>.<o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0mm;margin-bottom:.0001pt;text-align:
justify;text-indent:11.35pt'><span lang=ES style='font-size:10.0pt;line-height:
107%;font-family:"Times New Roman",serif;mso-fareast-font-family:Calibri;
mso-ansi-language:ES'><o:p>&nbsp;</o:p></span></p>

<p class=MsoNormal style='margin-bottom:0mm;margin-bottom:.0001pt;text-align:
justify;text-indent:11.35pt'><span style='font-size:10.0pt;line-height:107%;
font-family:"Times New Roman",serif;mso-fareast-font-family:Calibri;mso-ansi-language:
ES-CO'>En un hospital universitario de adultos se llevó a cabo una encuesta con
el fin de hacer comparación entre DDDs, PDDs y RDDs </span><!--[if supportFields]><span
style='font-size:10.0pt;line-height:107%;font-family:"Times New Roman",serif;
mso-fareast-font-family:Calibri;mso-ansi-language:ES-CO'><span
style='mso-element:field-begin;mso-field-lock:yes'></span>ADDIN CSL_CITATION
{&quot;citationItems&quot;:[{&quot;id&quot;:&quot;ITEM-1&quot;,&quot;itemData&quot;:{&quot;DOI&quot;:&quot;10.1007/s15010-008-8138-4&quot;,&quot;ISBN&quot;:&quot;0300-8126&quot;,&quot;ISSN&quot;:&quot;03008126&quot;,&quot;PMID&quot;:&quot;19277464&quot;,&quot;abstract&quot;:&quot;BACKGROUND:
Hospital antibiotic use is usually measured by calculating the volume as the
number of daily doses defined by the World Health Organization/Anatomical
Therapeutic Chemical (WHO/ATC) index (DDDs) divided by a denominator indicating
clinical activity, such as the number of occupied bed days. Previous studies
have found discrepancies between DDDs, daily doses as recommended in practice
guidelines (recommended daily doses, RDDs), and truly prescribed daily doses
(PDDs). Very few studies have quantified these discrepancies. METHODS: A point
prevalence survey was carried out in defined acute care service areas of a
large German state university hospital. Of the 941 adult inpatients present on
the day of the survey for whom adequate information was available, 267 (28%)
had 471 prescriptions for antimicrobial drugs on that specific day. A check for
any additional antimicrobial drug prescriptions for these 267 patients during
the six days immediately preceding the survey day yielded a total of 2,304
PDDs, of which 1,754 were antibacterial agents. The latter antibacterial drug
PDDs constituted the basis for analysis. The proportion of PDDs different from
RDDs and from DDDs was evaluated, and the deviations were calculated. RDD dose
definitions corresponded to the local practice guideline recommendations of
antibiotic therapy for adult hospitalized patients with normal renal
function.\\n\\nRESULTS: Of the 1,754 PDDs, 625 were matching DDD dose
definitions (36%), and 1,024 (58%) were matching RDD dose definitions (p &lt;
0.01). Corresponding values for patients with impaired renal function
(creatinine clearance &lt; 50 ml/min) were 36% and 42%, respectively. Large DDD
discrepancies (&lt; 50% of prescribed doses matching DDD definitions) were
noted for beta-lactams and macrolides, while large RDD discrepancies were
observed for aminoglycosides. Compared with PDDs, the use of DDDs as the
measurement of hospital antibiotic use overestimated antibiotic use volumes by
32%, while the use of RDD led to a slight underestimation (-9%).CONCLUSION: The
use of DDDs as currently defined by WHO/ATC for measuring hospital antibiotic
consumption may be associated with a substantial overestimation of antibiotic
use density, while using practice guideline-derived RDDs may yield more valid
antibiotic exposure estimates that would be helpful in cross-sectional and
longitudinal analyses of antibiotic
consumption.&quot;,&quot;author&quot;:[{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;With&quot;,&quot;given&quot;:&quot;K.&quot;,&quot;non-dropping-particle&quot;:&quot;De&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Bestehorn&quot;,&quot;given&quot;:&quot;H.&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Steib-Bauert&quot;,&quot;given&quot;:&quot;M.&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;V.&quot;,&quot;family&quot;:&quot;Kern&quot;,&quot;given&quot;:&quot;W.&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;}],&quot;container-title&quot;:&quot;Infection&quot;,&quot;id&quot;:&quot;ITEM-1&quot;,&quot;issue&quot;:&quot;4&quot;,&quot;issued&quot;:{&quot;date-parts&quot;:[[&quot;2009&quot;]]},&quot;page&quot;:&quot;349-352&quot;,&quot;title&quot;:&quot;Comparison
of defined versus recommended versus prescribed daily doses for measuring
hospital antibiotic
consumption&quot;,&quot;type&quot;:&quot;article-journal&quot;,&quot;volume&quot;:&quot;37&quot;},&quot;uris&quot;:[&quot;http://www.mendeley.com/documents/?uuid=57fcb398-1a6f-40d5-aaa1-0babbf0b8893&quot;]}],&quot;mendeley&quot;:{&quot;formattedCitation&quot;:&quot;(41)&quot;,&quot;plainTextFormattedCitation&quot;:&quot;(41)&quot;,&quot;previouslyFormattedCitation&quot;:&quot;(41)&quot;},&quot;properties&quot;:{&quot;noteIndex&quot;:0},&quot;schema&quot;:&quot;https://github.com/citation-style-language/schema/raw/master/csl-citation.json&quot;}<span
style='mso-element:field-separator'></span></span><![endif]--><span
style='font-size:10.0pt;line-height:107%;font-family:"Times New Roman",serif;
mso-fareast-font-family:Calibri;mso-ansi-language:ES-CO'><span
style='mso-no-proof:yes'>(41)</span></span><!--[if supportFields]><span
style='font-size:10.0pt;line-height:107%;font-family:"Times New Roman",serif;
mso-fareast-font-family:Calibri;mso-ansi-language:ES-CO'><span
style='mso-element:field-end'></span></span><![endif]--><span style='font-size:
10.0pt;line-height:107%;font-family:"Times New Roman",serif;mso-fareast-font-family:
Calibri;mso-ansi-language:ES-CO'>. La RDD se obtuvo de guías locales de
consenso sobre terapia antimicrobiana empírica. Se encontró que las PDDs
correspondieron en 36% a la definición de DDDs y en 58% a la definición de
RDDs. En pacientes con disfunción renal (aclaramiento de creatinina &lt;50mL/min)
la correspondencia de DDDs y RDDs con PDDs fue 36 y 42% respectivamente. En
comparación con PDDs, el uso de DDDs como medida de consumo de antibióticos
tiende a sobrestimar el mismo en 32%, mientras el uso de RDDs tiende a generar
una subestimación del consumo en 9% </span><!--[if supportFields]><span
style='font-size:10.0pt;line-height:107%;font-family:"Times New Roman",serif;
mso-fareast-font-family:Calibri;mso-ansi-language:ES-CO'><span
style='mso-element:field-begin;mso-field-lock:yes'></span>ADDIN CSL_CITATION
{&quot;citationItems&quot;:[{&quot;id&quot;:&quot;ITEM-1&quot;,&quot;itemData&quot;:{&quot;DOI&quot;:&quot;10.1007/s15010-008-8138-4&quot;,&quot;ISBN&quot;:&quot;0300-8126&quot;,&quot;ISSN&quot;:&quot;03008126&quot;,&quot;PMID&quot;:&quot;19277464&quot;,&quot;abstract&quot;:&quot;BACKGROUND:
Hospital antibiotic use is usually measured by calculating the volume as the
number of daily doses defined by the World Health Organization/Anatomical
Therapeutic Chemical (WHO/ATC) index (DDDs) divided by a denominator indicating
clinical activity, such as the number of occupied bed days. Previous studies
have found discrepancies between DDDs, daily doses as recommended in practice
guidelines (recommended daily doses, RDDs), and truly prescribed daily doses
(PDDs). Very few studies have quantified these discrepancies. METHODS: A point
prevalence survey was carried out in defined acute care service areas of a
large German state university hospital. Of the 941 adult inpatients present on
the day of the survey for whom adequate information was available, 267 (28%)
had 471 prescriptions for antimicrobial drugs on that specific day. A check for
any additional antimicrobial drug prescriptions for these 267 patients during
the six days immediately preceding the survey day yielded a total of 2,304
PDDs, of which 1,754 were antibacterial agents. The latter antibacterial drug
PDDs constituted the basis for analysis. The proportion of PDDs different from
RDDs and from DDDs was evaluated, and the deviations were calculated. RDD dose
definitions corresponded to the local practice guideline recommendations of
antibiotic therapy for adult hospitalized patients with normal renal
function.\\n\\nRESULTS: Of the 1,754 PDDs, 625 were matching DDD dose
definitions (36%), and 1,024 (58%) were matching RDD dose definitions (p &lt;
0.01). Corresponding values for patients with impaired renal function
(creatinine clearance &lt; 50 ml/min) were 36% and 42%, respectively. Large DDD
discrepancies (&lt; 50% of prescribed doses matching DDD definitions) were
noted for beta-lactams and macrolides, while large RDD discrepancies were
observed for aminoglycosides. Compared with PDDs, the use of DDDs as the
measurement of hospital antibiotic use overestimated antibiotic use volumes by
32%, while the use of RDD led to a slight underestimation (-9%).CONCLUSION: The
use of DDDs as currently defined by WHO/ATC for measuring hospital antibiotic
consumption may be associated with a substantial overestimation of antibiotic
use density, while using practice guideline-derived RDDs may yield more valid
antibiotic exposure estimates that would be helpful in cross-sectional and
longitudinal analyses of antibiotic
consumption.&quot;,&quot;author&quot;:[{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;With&quot;,&quot;given&quot;:&quot;K.&quot;,&quot;non-dropping-particle&quot;:&quot;De&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Bestehorn&quot;,&quot;given&quot;:&quot;H.&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Steib-Bauert&quot;,&quot;given&quot;:&quot;M.&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;V.&quot;,&quot;family&quot;:&quot;Kern&quot;,&quot;given&quot;:&quot;W.&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;}],&quot;container-title&quot;:&quot;Infection&quot;,&quot;id&quot;:&quot;ITEM-1&quot;,&quot;issue&quot;:&quot;4&quot;,&quot;issued&quot;:{&quot;date-parts&quot;:[[&quot;2009&quot;]]},&quot;page&quot;:&quot;349-352&quot;,&quot;title&quot;:&quot;Comparison
of defined versus recommended versus prescribed daily doses for measuring
hospital antibiotic consumption&quot;,&quot;type&quot;:&quot;article-journal&quot;,&quot;volume&quot;:&quot;37&quot;},&quot;uris&quot;:[&quot;http://www.mendeley.com/documents/?uuid=57fcb398-1a6f-40d5-aaa1-0babbf0b8893&quot;]}],&quot;mendeley&quot;:{&quot;formattedCitation&quot;:&quot;(41)&quot;,&quot;plainTextFormattedCitation&quot;:&quot;(41)&quot;,&quot;previouslyFormattedCitation&quot;:&quot;(41)&quot;},&quot;properties&quot;:{&quot;noteIndex&quot;:0},&quot;schema&quot;:&quot;https://github.com/citation-style-language/schema/raw/master/csl-citation.json&quot;}<span
style='mso-element:field-separator'></span></span><![endif]--><span
style='font-size:10.0pt;line-height:107%;font-family:"Times New Roman",serif;
mso-fareast-font-family:Calibri;mso-ansi-language:ES-CO'><span
style='mso-no-proof:yes'>(41)</span></span><!--[if supportFields]><span
style='font-size:10.0pt;line-height:107%;font-family:"Times New Roman",serif;
mso-fareast-font-family:Calibri;mso-ansi-language:ES-CO'><span
style='mso-element:field-end'></span></span><![endif]--><span style='font-size:
10.0pt;line-height:107%;font-family:"Times New Roman",serif;mso-fareast-font-family:
Calibri;mso-ansi-language:ES-CO'>. <o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0mm;margin-bottom:.0001pt;text-align:
justify;text-indent:11.35pt'><span style='font-size:10.0pt;line-height:107%;
font-family:"Times New Roman",serif;mso-fareast-font-family:Calibri;mso-ansi-language:
ES-CO'><o:p>&nbsp;</o:p></span></p>

<p class=MsoNormal style='margin-bottom:0mm;margin-bottom:.0001pt;text-align:
justify;text-indent:11.35pt'><span style='font-size:10.0pt;line-height:107%;
font-family:"Times New Roman",serif;mso-fareast-font-family:Calibri;mso-ansi-language:
ES-CO'>En otro hospital de 1228 camas se hizo un estudio para determinar las
discrepancias entre PDD y DDD en diferentes servicios de la institución </span><!--[if supportFields]><span
style='font-size:10.0pt;line-height:107%;font-family:"Times New Roman",serif;
mso-fareast-font-family:Calibri;mso-ansi-language:ES-CO'><span
style='mso-element:field-begin;mso-field-lock:yes'></span>ADDIN CSL_CITATION
{&quot;citationItems&quot;:[{&quot;id&quot;:&quot;ITEM-1&quot;,&quot;itemData&quot;:{&quot;DOI&quot;:&quot;10.1111/j.1365-2125.2006.02605.x&quot;,&quot;ISBN&quot;:&quot;0306-5251&quot;,&quot;ISSN&quot;:&quot;03065251&quot;,&quot;PMID&quot;:&quot;16669851&quot;,&quot;abstract&quot;:&quot;AIMS:
The defined daily doses (DDD) defined by the WHO are widely used as an indicator
to measure antibiotic use in the hospital setting. However, discrepancies exist
between countries in terms of antibiotic dosage. The aim of the present study
was to compare, for each antibacterial agent available at our university
hospital, the prescribed daily doses (PDD) with the DDD.\\n\\nMETHODS: Data
were extracted from the pharmacy computer system. Antibiotic use was expressed
in DDD per 1000 patient days. We also calculated the ratio of number of
DDD:number of treatment-days and estimated the average PDD for each antibiotic
and route of administration.\\n\\nRESULTS: The average PDD did not correspond
to the DDD for many classes of antibiotics. If fluoroquinolones and
cephalosporins were prescribed at a dosage close to the DDD, other antimicrobial
classes such as penicillins, aminoglycosides or macrolides were not. Overall,
the number of DDD overestimated the number of treatment days by 40%. For the
most consumed antibiotic at our hospital, i.e. oral amoxicillin-clavulanic
acid, the PDD was three times the DDD.\\n\\nCONCLUSIONS: Our study shows that,
except for the fluoroquinolones and the cephalosporins, the number of DDD did
not correctly reflect the number of antibiotic treatment days at our hospital.
This does not invalidate the systematic approach of the WHO and hospitals
should use the DDDs to make national and international comparisons of their
antibiotic use. However, each hospital should define and validate its own
indicators to describe the local exposures to antibiotics and to study the relationship
with
resistance.&quot;,&quot;author&quot;:[{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Muller&quot;,&quot;given&quot;:&quot;Arno&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Monnet&quot;,&quot;given&quot;:&quot;Dominique
L.&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Talon&quot;,&quot;given&quot;:&quot;Daniel&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Hénon&quot;,&quot;given&quot;:&quot;Thierry&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Bertrand&quot;,&quot;given&quot;:&quot;Xavier&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;}],&quot;container-title&quot;:&quot;British
Journal of Clinical
Pharmacology&quot;,&quot;id&quot;:&quot;ITEM-1&quot;,&quot;issue&quot;:&quot;5&quot;,&quot;issued&quot;:{&quot;date-parts&quot;:[[&quot;2006&quot;]]},&quot;page&quot;:&quot;585-591&quot;,&quot;title&quot;:&quot;Discrepancies
between prescribed daily doses and WHO defined daily doses of antibacterials at
a university
hospital&quot;,&quot;type&quot;:&quot;article-journal&quot;,&quot;volume&quot;:&quot;61&quot;},&quot;uris&quot;:[&quot;http://www.mendeley.com/documents/?uuid=77e84106-dcfd-46ca-aeee-f819c2ebf883&quot;]}],&quot;mendeley&quot;:{&quot;formattedCitation&quot;:&quot;(54)&quot;,&quot;plainTextFormattedCitation&quot;:&quot;(54)&quot;,&quot;previouslyFormattedCitation&quot;:&quot;(54)&quot;},&quot;properties&quot;:{&quot;noteIndex&quot;:0},&quot;schema&quot;:&quot;https://github.com/citation-style-language/schema/raw/master/csl-citation.json&quot;}<span
style='mso-element:field-separator'></span></span><![endif]--><span
style='font-size:10.0pt;line-height:107%;font-family:"Times New Roman",serif;
mso-fareast-font-family:Calibri;mso-ansi-language:ES-CO'><span
style='mso-no-proof:yes'>(54)</span></span><!--[if supportFields]><span
style='font-size:10.0pt;line-height:107%;font-family:"Times New Roman",serif;
mso-fareast-font-family:Calibri;mso-ansi-language:ES-CO'><span
style='mso-element:field-end'></span></span><![endif]--><span style='font-size:
10.0pt;line-height:107%;font-family:"Times New Roman",serif;mso-fareast-font-family:
Calibri;mso-ansi-language:ES-CO'>. El promedio de consumo en el hospital fue
718.5 DDDs/1000PD. Este consumo fue mayor en la UCI, intermedio en medicina
general y menor en servicios quirúrgicos. En la mayoría de los medicamentos
estudiados la PDD era mayor a la recomendación DDD. Por esta razón, con
excepción del grupo de fluoroquinolonas y cefalosporinas, al usar el sistema
DDD se sobrestimaba el consumo de antibióticos en 40% </span><!--[if supportFields]><span
style='font-size:10.0pt;line-height:107%;font-family:"Times New Roman",serif;
mso-fareast-font-family:Calibri;mso-ansi-language:ES-CO'><span
style='mso-element:field-begin;mso-field-lock:yes'></span>ADDIN CSL_CITATION
{&quot;citationItems&quot;:[{&quot;id&quot;:&quot;ITEM-1&quot;,&quot;itemData&quot;:{&quot;DOI&quot;:&quot;10.1111/j.1365-2125.2006.02605.x&quot;,&quot;ISBN&quot;:&quot;0306-5251&quot;,&quot;ISSN&quot;:&quot;03065251&quot;,&quot;PMID&quot;:&quot;16669851&quot;,&quot;abstract&quot;:&quot;AIMS:
The defined daily doses (DDD) defined by the WHO are widely used as an
indicator to measure antibiotic use in the hospital setting. However,
discrepancies exist between countries in terms of antibiotic dosage. The aim of
the present study was to compare, for each antibacterial agent available at our
university hospital, the prescribed daily doses (PDD) with the
DDD.\\n\\nMETHODS: Data were extracted from the pharmacy computer system.
Antibiotic use was expressed in DDD per 1000 patient days. We also calculated
the ratio of number of DDD:number of treatment-days and estimated the average
PDD for each antibiotic and route of administration.\\n\\nRESULTS: The average
PDD did not correspond to the DDD for many classes of antibiotics. If
fluoroquinolones and cephalosporins were prescribed at a dosage close to the
DDD, other antimicrobial classes such as penicillins, aminoglycosides or
macrolides were not. Overall, the number of DDD overestimated the number of
treatment days by 40%. For the most consumed antibiotic at our hospital, i.e.
oral amoxicillin-clavulanic acid, the PDD was three times the
DDD.\\n\\nCONCLUSIONS: Our study shows that, except for the fluoroquinolones
and the cephalosporins, the number of DDD did not correctly reflect the number
of antibiotic treatment days at our hospital. This does not invalidate the
systematic approach of the WHO and hospitals should use the DDDs to make
national and international comparisons of their antibiotic use. However, each
hospital should define and validate its own indicators to describe the local
exposures to antibiotics and to study the relationship with
resistance.&quot;,&quot;author&quot;:[{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Muller&quot;,&quot;given&quot;:&quot;Arno&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Monnet&quot;,&quot;given&quot;:&quot;Dominique
L.&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Talon&quot;,&quot;given&quot;:&quot;Daniel&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Hénon&quot;,&quot;given&quot;:&quot;Thierry&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Bertrand&quot;,&quot;given&quot;:&quot;Xavier&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;}],&quot;container-title&quot;:&quot;British
Journal of Clinical
Pharmacology&quot;,&quot;id&quot;:&quot;ITEM-1&quot;,&quot;issue&quot;:&quot;5&quot;,&quot;issued&quot;:{&quot;date-parts&quot;:[[&quot;2006&quot;]]},&quot;page&quot;:&quot;585-591&quot;,&quot;title&quot;:&quot;Discrepancies
between prescribed daily doses and WHO defined daily doses of antibacterials at
a university
hospital&quot;,&quot;type&quot;:&quot;article-journal&quot;,&quot;volume&quot;:&quot;61&quot;},&quot;uris&quot;:[&quot;http://www.mendeley.com/documents/?uuid=77e84106-dcfd-46ca-aeee-f819c2ebf883&quot;]}],&quot;mendeley&quot;:{&quot;formattedCitation&quot;:&quot;(54)&quot;,&quot;plainTextFormattedCitation&quot;:&quot;(54)&quot;,&quot;previouslyFormattedCitation&quot;:&quot;(54)&quot;},&quot;properties&quot;:{&quot;noteIndex&quot;:0},&quot;schema&quot;:&quot;https://github.com/citation-style-language/schema/raw/master/csl-citation.json&quot;}<span
style='mso-element:field-separator'></span></span><![endif]--><span
style='font-size:10.0pt;line-height:107%;font-family:"Times New Roman",serif;
mso-fareast-font-family:Calibri;mso-ansi-language:ES-CO'><span
style='mso-no-proof:yes'>(54)</span></span><!--[if supportFields]><span
style='font-size:10.0pt;line-height:107%;font-family:"Times New Roman",serif;
mso-fareast-font-family:Calibri;mso-ansi-language:ES-CO'><span
style='mso-element:field-end'></span></span><![endif]--><span style='font-size:
10.0pt;line-height:107%;font-family:"Times New Roman",serif;mso-fareast-font-family:
Calibri;mso-ansi-language:ES-CO'>. <o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0mm;margin-bottom:.0001pt;text-align:
justify;text-indent:11.35pt'><span style='font-size:10.0pt;line-height:107%;
font-family:"Times New Roman",serif;mso-fareast-font-family:Calibri;mso-ansi-language:
ES-CO'><o:p>&nbsp;</o:p></span></p>

<p class=MsoNormal style='margin-bottom:0mm;margin-bottom:.0001pt;text-align:
justify;text-indent:11.35pt'><span lang=ES style='font-size:10.0pt;line-height:
107%;font-family:"Times New Roman",serif;mso-fareast-font-family:Calibri;
mso-ansi-language:ES'>Existe correlación entre el consumo medido por DDDs y
DOTs en la mayoría de las circunstancias </span><!--[if supportFields]><span
lang=ES style='font-size:10.0pt;line-height:107%;font-family:"Times New Roman",serif;
mso-fareast-font-family:Calibri;mso-ansi-language:ES'><span style='mso-element:
field-begin;mso-field-lock:yes'></span>ADDIN CSL_CITATION {&quot;citationItems&quot;:[{&quot;id&quot;:&quot;ITEM-1&quot;,&quot;itemData&quot;:{&quot;DOI&quot;:&quot;10.1586/eri.11.153&quot;,&quot;ISBN&quot;:&quot;1744-8336;
1478-7210&quot;,&quot;ISSN&quot;:&quot;1478-7210&quot;,&quot;PMID&quot;:&quot;22149615&quot;,&quot;abstract&quot;:&quot;The
judicious use of antibiotics is an important strategy to preserving efficacy in
the treatment of infectious diseases. Infectious disease practitioners are
poised to provide patient-specific recommendations for appropriate agents and
to optimize dosage and duration of therapy. Antimicrobial stewardship programs
(involving pharmacists, physicians and other healthcare providers) are
increasing in number as antibiotic resistance increases with a
disproportionately small number of new agents being developed. Two strategies
for antimicrobial stewardship are currently endorsed by national organizations
and include preauthorization/formulary restriction and prospective audit with
feedback. As it is important for programs to choose appropriate clinical and
financial outcomes goals in order to assure sustainability, we review these
strategies and discuss the impact of each on clinical outcomes and
costs.&quot;,&quot;author&quot;:[{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Griffith&quot;,&quot;given&quot;:&quot;Milena&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Postelnick&quot;,&quot;given&quot;:&quot;Michael&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Scheetz&quot;,&quot;given&quot;:&quot;Marc&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;}],&quot;container-title&quot;:&quot;Expert
Review of Anti-infective
Therapy&quot;,&quot;id&quot;:&quot;ITEM-1&quot;,&quot;issue&quot;:&quot;1&quot;,&quot;issued&quot;:{&quot;date-parts&quot;:[[&quot;2012&quot;]]},&quot;page&quot;:&quot;63-73&quot;,&quot;title&quot;:&quot;Antimicrobial
stewardship programs: methods of operation and suggested
outcomes&quot;,&quot;type&quot;:&quot;article-journal&quot;,&quot;volume&quot;:&quot;10&quot;},&quot;uris&quot;:[&quot;http://www.mendeley.com/documents/?uuid=9b006cd5-7f69-441a-b300-b3e6fae44d0e&quot;]}],&quot;mendeley&quot;:{&quot;formattedCitation&quot;:&quot;(45)&quot;,&quot;plainTextFormattedCitation&quot;:&quot;(45)&quot;,&quot;previouslyFormattedCitation&quot;:&quot;(45)&quot;},&quot;properties&quot;:{&quot;noteIndex&quot;:0},&quot;schema&quot;:&quot;https://github.com/citation-style-language/schema/raw/master/csl-citation.json&quot;}<span
style='mso-element:field-separator'></span></span><![endif]--><span lang=ES
style='font-size:10.0pt;line-height:107%;font-family:"Times New Roman",serif;
mso-fareast-font-family:Calibri;mso-ansi-language:ES'><span style='mso-no-proof:
yes'>(45)</span></span><!--[if supportFields]><span lang=ES style='font-size:
10.0pt;line-height:107%;font-family:"Times New Roman",serif;mso-fareast-font-family:
Calibri;mso-ansi-language:ES'><span style='mso-element:field-end'></span></span><![endif]--><span
lang=ES style='font-size:10.0pt;line-height:107%;font-family:"Times New Roman",serif;
mso-fareast-font-family:Calibri;mso-ansi-language:ES'>. Existen desviaciones
cuando la DDD difiere de la dosis prescrita, que tienden a que haya
sobrestimación en el consumo medido por DDDs comparados a DOTs </span><!--[if supportFields]><span
lang=ES style='font-size:10.0pt;line-height:107%;font-family:"Times New Roman",serif;
mso-fareast-font-family:Calibri;mso-ansi-language:ES'><span style='mso-element:
field-begin;mso-field-lock:yes'></span>ADDIN CSL_CITATION
{&quot;citationItems&quot;:[{&quot;id&quot;:&quot;ITEM-1&quot;,&quot;itemData&quot;:{&quot;DOI&quot;:&quot;10.1086/511640&quot;,&quot;ISBN&quot;:&quot;1058-4838\\r1537-6591&quot;,&quot;ISSN&quot;:&quot;1537-6591&quot;,&quot;PMID&quot;:&quot;17278056&quot;,&quot;abstract&quot;:&quot;BACKGROUND
Hospitals are advised to measure antibiotic use and monitor its relationship to
resistance. The World Health Organization's recommended metric is the defined
daily dose (DDD). An alternative measure is the number of days of therapy
(DOT). The purpose of this study was to contrast these measures. METHODS We
measured the use of 50 antibacterial drugs that were administered to adults who
were discharged from 130 US hospitals during 1 August 2002-31 July 2003.
RESULTS Of 1,795,504 patients, 1,074,174 received at least 1 dose of an
antibacterial drug (59.8%). The mean (+/- standard deviation) of total
antibacterial drug use measured by the number of DDDs per 1000 patient-days and
the number of DOTs per 1000 patient-days were not significantly different
(792+/-147 and 776+/-120, respectively; P=.137), although the correlation was
poor (r=0.603). For some individual drugs, such as levofloxacin and linezolid,
there was no significant difference between DDDs per 1000 patient-days and DOTs
per 1000 patient-days, because the administered daily dosage was nearly
equivalent to the DDD. When the administered dosage exceeded the DDD, such as
for ampicillin-sulbactam and cefepime, estimates of use based on DDDs per 1000
patient-days significantly exceeded those based on DOTs per 1000 patient-days
(P&lt;.001). When the administered dosage was less than the DDD, such as for
piperacillin-tazobactam and ceftriaxone, estimates of use based on DDDs per 1000
patient-days were significantly lower than those based on DOTs per 1000
patient-days (P&lt;.001). CONCLUSION The measurement of aggregate hospital
antibiotic use by DDDs per 1000 patient-days and DOTs per 1000 patient-days is
discordant for many frequently used antibacterial drugs, because the
administered dose is dissimilar from the DDD recommended by the World Health
Organization. DDD methods are useful for benchmarking purposes but cannot be
used to make inferences about the number of DOTs or relative use for many
antibacterial
drugs.&quot;,&quot;author&quot;:[{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Polk&quot;,&quot;given&quot;:&quot;Ronald
E&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Fox&quot;,&quot;given&quot;:&quot;Christina&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Mahoney&quot;,&quot;given&quot;:&quot;Anne&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Letcavage&quot;,&quot;given&quot;:&quot;Jim&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;MacDougall&quot;,&quot;given&quot;:&quot;Conan&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;}],&quot;container-title&quot;:&quot;Clinical
infectious
diseases&quot;,&quot;id&quot;:&quot;ITEM-1&quot;,&quot;issue&quot;:&quot;5&quot;,&quot;issued&quot;:{&quot;date-parts&quot;:[[&quot;2007&quot;]]},&quot;title&quot;:&quot;Measurement
of adult antibacterial drug use in 130 US hospitals: comparison of defined
daily dose and days of
therapy.&quot;,&quot;type&quot;:&quot;article-journal&quot;,&quot;volume&quot;:&quot;44&quot;},&quot;uris&quot;:[&quot;http://www.mendeley.com/documents/?uuid=2b357782-9c87-4d84-9324-10626d3be6a4&quot;,&quot;http://www.mendeley.com/documents/?uuid=1359fbb5-3bdc-40aa-bb18-aa566cf6fa0c&quot;]},{&quot;id&quot;:&quot;ITEM-2&quot;,&quot;itemData&quot;:{&quot;DOI&quot;:&quot;10.1023/B:PHAR.0000018595.78732.1c&quot;,&quot;ISBN&quot;:&quot;0928-1231&quot;,&quot;ISSN&quot;:&quot;09281231&quot;,&quot;PMID&quot;:&quot;15085943&quot;,&quot;abstract&quot;:&quot;BACKGROUND:
For several years now, the French national recommendations have been trying to
set up a surveillance system in hospitals to link data on antibiotic resistance
and data on the use of antibiotics, particularly for certain
'micro-organism/antibiotic' pairs. The indicators recommended in the lastest
newsletter of the Direction Générale de la Santé (French Public Health
Department) for monitoring the consumption of antibiotics were the number of
days of treatment or the number of defined daily doses (DDD), both (in)directly
related to the number of days of hospitalisation and/or the number of patients
hospitalised.OBJECTIVE: The aim of this study was to compare the actual number
of days of treatment, which is an observed indicator, with two indicators
calculated on the basis of the DDD and the DPD (daily prescribed dose), both in
terms of feasibility of collection and the relevance of the information
generated. MATERIALS AND METHODS: For several hospital care units, the 'length
of exposure' to a given antibiotic was determined by four different indicators:
two actual observed indicators [the patient's medical file (reference) and the
named-patient based, computerised dispensing system from the central pharmacy]
and two derived calculated indicators [obtained by dividing the number of grams
prescribed by the DDD or by the DPD]. RESULTS: The average incidence density of
antibiotic treatment (length of exposure per 1000 days of hospitalisation)
obtained by the calculated indicators was higher than that obtained with the
observed reference (+52% for the DDD and +33% for the DPD) but lower than that
obtained with the second observed indicator (computerised system) (-10%). The
differences were large and random (high variability depending on the hospital
department, the antibiotic and the administration route; variations in both
directions: actual length of treatment longer or shorter than the calculated
length of treatment). CONCLUSION: The question which indicator should be chosen
is inconclusive for the evaluation of the selection pressure exerted by an
antibiotic. The two indicators proposed in the newsletter (observed indicator
and calculated indicator) seem to be complementary for use in a regional or
national network to monitor resistance and consumption of antibiotics. Each
hospital should validate the indicators and define for itself which indicator
is most appropriate for estimating the actual length of antibiotic exposure.
This may imply
diff…&quot;,&quot;author&quot;:[{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Mandy&quot;,&quot;given&quot;:&quot;Bruno&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Koutny&quot;,&quot;given&quot;:&quot;Estelle&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Cornette&quot;,&quot;given&quot;:&quot;Christian&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Woronoff-Lemsi&quot;,&quot;given&quot;:&quot;Marie
Christine&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Talon&quot;,&quot;given&quot;:&quot;Daniel&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;}],&quot;container-title&quot;:&quot;Pharmacy
World and
Science&quot;,&quot;id&quot;:&quot;ITEM-2&quot;,&quot;issue&quot;:&quot;2&quot;,&quot;issued&quot;:{&quot;date-parts&quot;:[[&quot;2004&quot;]]},&quot;page&quot;:&quot;90-95&quot;,&quot;title&quot;:&quot;Methodological
validation of monitoring indicators of antibiotics use in
hospitals&quot;,&quot;type&quot;:&quot;article-journal&quot;,&quot;volume&quot;:&quot;26&quot;},&quot;uris&quot;:[&quot;http://www.mendeley.com/documents/?uuid=3e97ffab-bc6e-4997-bc6f-23f6a502face&quot;]}],&quot;mendeley&quot;:{&quot;formattedCitation&quot;:&quot;(40,55)&quot;,&quot;plainTextFormattedCitation&quot;:&quot;(40,55)&quot;,&quot;previouslyFormattedCitation&quot;:&quot;(40,55)&quot;},&quot;properties&quot;:{&quot;noteIndex&quot;:0},&quot;schema&quot;:&quot;https://github.com/citation-style-language/schema/raw/master/csl-citation.json&quot;}<span
style='mso-element:field-separator'></span></span><![endif]--><span lang=ES
style='font-size:10.0pt;line-height:107%;font-family:"Times New Roman",serif;
mso-fareast-font-family:Calibri;mso-ansi-language:ES'><span style='mso-no-proof:
yes'>(40,55)</span></span><!--[if supportFields]><span lang=ES
style='font-size:10.0pt;line-height:107%;font-family:"Times New Roman",serif;
mso-fareast-font-family:Calibri;mso-ansi-language:ES'><span style='mso-element:
field-end'></span></span><![endif]--><span lang=ES style='font-size:10.0pt;
line-height:107%;font-family:"Times New Roman",serif;mso-fareast-font-family:
Calibri;mso-ansi-language:ES'>. </span><span style='font-size:10.0pt;
line-height:107%;font-family:"Times New Roman",serif;mso-fareast-font-family:
Calibri;mso-ansi-language:ES-CO'>En un hospital de adultos se llevó a cabo un
estudio comparando el consumo medido por DDDs y PDDs versus el consumo medido
por DOTs obtenidos en registros de administración </span><!--[if supportFields]><span
style='font-size:10.0pt;line-height:107%;font-family:"Times New Roman",serif;
mso-fareast-font-family:Calibri;mso-ansi-language:ES-CO'><span
style='mso-element:field-begin;mso-field-lock:yes'></span>ADDIN CSL_CITATION
{&quot;citationItems&quot;:[{&quot;id&quot;:&quot;ITEM-1&quot;,&quot;itemData&quot;:{&quot;DOI&quot;:&quot;10.1023/B:PHAR.0000018595.78732.1c&quot;,&quot;ISBN&quot;:&quot;0928-1231&quot;,&quot;ISSN&quot;:&quot;09281231&quot;,&quot;PMID&quot;:&quot;15085943&quot;,&quot;abstract&quot;:&quot;BACKGROUND:
For several years now, the French national recommendations have been trying to
set up a surveillance system in hospitals to link data on antibiotic resistance
and data on the use of antibiotics, particularly for certain
'micro-organism/antibiotic' pairs. The indicators recommended in the lastest
newsletter of the Direction Générale de la Santé (French Public Health
Department) for monitoring the consumption of antibiotics were the number of
days of treatment or the number of defined daily doses (DDD), both (in)directly
related to the number of days of hospitalisation and/or the number of patients
hospitalised.OBJECTIVE: The aim of this study was to compare the actual number
of days of treatment, which is an observed indicator, with two indicators
calculated on the basis of the DDD and the DPD (daily prescribed dose), both in
terms of feasibility of collection and the relevance of the information
generated. MATERIALS AND METHODS: For several hospital care units, the 'length
of exposure' to a given antibiotic was determined by four different indicators:
two actual observed indicators [the patient's medical file (reference) and the
named-patient based, computerised dispensing system from the central pharmacy]
and two derived calculated indicators [obtained by dividing the number of grams
prescribed by the DDD or by the DPD]. RESULTS: The average incidence density of
antibiotic treatment (length of exposure per 1000 days of hospitalisation)
obtained by the calculated indicators was higher than that obtained with the
observed reference (+52% for the DDD and +33% for the DPD) but lower than that
obtained with the second observed indicator (computerised system) (-10%). The
differences were large and random (high variability depending on the hospital
department, the antibiotic and the administration route; variations in both
directions: actual length of treatment longer or shorter than the calculated
length of treatment). CONCLUSION: The question which indicator should be chosen
is inconclusive for the evaluation of the selection pressure exerted by an
antibiotic. The two indicators proposed in the newsletter (observed indicator
and calculated indicator) seem to be complementary for use in a regional or
national network to monitor resistance and consumption of antibiotics. Each
hospital should validate the indicators and define for itself which indicator
is most appropriate for estimating the actual length of antibiotic exposure.
This may imply
diff…&quot;,&quot;author&quot;:[{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Mandy&quot;,&quot;given&quot;:&quot;Bruno&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Koutny&quot;,&quot;given&quot;:&quot;Estelle&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Cornette&quot;,&quot;given&quot;:&quot;Christian&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Woronoff-Lemsi&quot;,&quot;given&quot;:&quot;Marie
Christine&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Talon&quot;,&quot;given&quot;:&quot;Daniel&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;}],&quot;container-title&quot;:&quot;Pharmacy
World and
Science&quot;,&quot;id&quot;:&quot;ITEM-1&quot;,&quot;issue&quot;:&quot;2&quot;,&quot;issued&quot;:{&quot;date-parts&quot;:[[&quot;2004&quot;]]},&quot;page&quot;:&quot;90-95&quot;,&quot;title&quot;:&quot;Methodological
validation of monitoring indicators of antibiotics use in
hospitals&quot;,&quot;type&quot;:&quot;article-journal&quot;,&quot;volume&quot;:&quot;26&quot;},&quot;uris&quot;:[&quot;http://www.mendeley.com/documents/?uuid=3e97ffab-bc6e-4997-bc6f-23f6a502face&quot;]}],&quot;mendeley&quot;:{&quot;formattedCitation&quot;:&quot;(40)&quot;,&quot;plainTextFormattedCitation&quot;:&quot;(40)&quot;,&quot;previouslyFormattedCitation&quot;:&quot;(40)&quot;},&quot;properties&quot;:{&quot;noteIndex&quot;:0},&quot;schema&quot;:&quot;https://github.com/citation-style-language/schema/raw/master/csl-citation.json&quot;}<span
style='mso-element:field-separator'></span></span><![endif]--><span
style='font-size:10.0pt;line-height:107%;font-family:"Times New Roman",serif;
mso-fareast-font-family:Calibri;mso-ansi-language:ES-CO'><span
style='mso-no-proof:yes'>(40)</span></span><!--[if supportFields]><span
style='font-size:10.0pt;line-height:107%;font-family:"Times New Roman",serif;
mso-fareast-font-family:Calibri;mso-ansi-language:ES-CO'><span
style='mso-element:field-end'></span></span><![endif]--><span style='font-size:
10.0pt;line-height:107%;font-family:"Times New Roman",serif;mso-fareast-font-family:
Calibri;mso-ansi-language:ES-CO'>. Se encontraron variaciones aleatorias que
eran dependientes del tipo de antibiótico, forma de administración y unidad de
estudio. El valor promedio general de días de tratamiento fue 340 DOTs/1000PD.
La cantidad de días de tratamiento fue sobreestimada cuando se utilizaron DDDs
y PDDs (52.3% y 33.5%, respectivamente) </span><!--[if supportFields]><span
style='font-size:10.0pt;line-height:107%;font-family:"Times New Roman",serif;
mso-fareast-font-family:Calibri;mso-ansi-language:ES-CO'><span
style='mso-element:field-begin;mso-field-lock:yes'></span>ADDIN CSL_CITATION
{&quot;citationItems&quot;:[{&quot;id&quot;:&quot;ITEM-1&quot;,&quot;itemData&quot;:{&quot;DOI&quot;:&quot;10.1023/B:PHAR.0000018595.78732.1c&quot;,&quot;ISBN&quot;:&quot;0928-1231&quot;,&quot;ISSN&quot;:&quot;09281231&quot;,&quot;PMID&quot;:&quot;15085943&quot;,&quot;abstract&quot;:&quot;BACKGROUND:
For several years now, the French national recommendations have been trying to
set up a surveillance system in hospitals to link data on antibiotic resistance
and data on the use of antibiotics, particularly for certain
'micro-organism/antibiotic' pairs. The indicators recommended in the lastest
newsletter of the Direction Générale de la Santé (French Public Health
Department) for monitoring the consumption of antibiotics were the number of
days of treatment or the number of defined daily doses (DDD), both (in)directly
related to the number of days of hospitalisation and/or the number of patients
hospitalised.OBJECTIVE: The aim of this study was to compare the actual number
of days of treatment, which is an observed indicator, with two indicators
calculated on the basis of the DDD and the DPD (daily prescribed dose), both in
terms of feasibility of collection and the relevance of the information
generated. MATERIALS AND METHODS: For several hospital care units, the 'length
of exposure' to a given antibiotic was determined by four different indicators:
two actual observed indicators [the patient's medical file (reference) and the
named-patient based, computerised dispensing system from the central pharmacy]
and two derived calculated indicators [obtained by dividing the number of grams
prescribed by the DDD or by the DPD]. RESULTS: The average incidence density of
antibiotic treatment (length of exposure per 1000 days of hospitalisation)
obtained by the calculated indicators was higher than that obtained with the
observed reference (+52% for the DDD and +33% for the DPD) but lower than that
obtained with the second observed indicator (computerised system) (-10%). The
differences were large and random (high variability depending on the hospital
department, the antibiotic and the administration route; variations in both
directions: actual length of treatment longer or shorter than the calculated
length of treatment). CONCLUSION: The question which indicator should be chosen
is inconclusive for the evaluation of the selection pressure exerted by an
antibiotic. The two indicators proposed in the newsletter (observed indicator
and calculated indicator) seem to be complementary for use in a regional or
national network to monitor resistance and consumption of antibiotics. Each
hospital should validate the indicators and define for itself which indicator
is most appropriate for estimating the actual length of antibiotic exposure.
This may imply diff…&quot;,&quot;author&quot;:[{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Mandy&quot;,&quot;given&quot;:&quot;Bruno&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Koutny&quot;,&quot;given&quot;:&quot;Estelle&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Cornette&quot;,&quot;given&quot;:&quot;Christian&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Woronoff-Lemsi&quot;,&quot;given&quot;:&quot;Marie
Christine&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Talon&quot;,&quot;given&quot;:&quot;Daniel&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;}],&quot;container-title&quot;:&quot;Pharmacy
World and Science&quot;,&quot;id&quot;:&quot;ITEM-1&quot;,&quot;issue&quot;:&quot;2&quot;,&quot;issued&quot;:{&quot;date-parts&quot;:[[&quot;2004&quot;]]},&quot;page&quot;:&quot;90-95&quot;,&quot;title&quot;:&quot;Methodological
validation of monitoring indicators of antibiotics use in
hospitals&quot;,&quot;type&quot;:&quot;article-journal&quot;,&quot;volume&quot;:&quot;26&quot;},&quot;uris&quot;:[&quot;http://www.mendeley.com/documents/?uuid=3e97ffab-bc6e-4997-bc6f-23f6a502face&quot;]}],&quot;mendeley&quot;:{&quot;formattedCitation&quot;:&quot;(40)&quot;,&quot;plainTextFormattedCitation&quot;:&quot;(40)&quot;,&quot;previouslyFormattedCitation&quot;:&quot;(40)&quot;},&quot;properties&quot;:{&quot;noteIndex&quot;:0},&quot;schema&quot;:&quot;https://github.com/citation-style-language/schema/raw/master/csl-citation.json&quot;}<span
style='mso-element:field-separator'></span></span><![endif]--><span
style='font-size:10.0pt;line-height:107%;font-family:"Times New Roman",serif;
mso-fareast-font-family:Calibri;mso-ansi-language:ES-CO'><span
style='mso-no-proof:yes'>(40)</span></span><!--[if supportFields]><span
style='font-size:10.0pt;line-height:107%;font-family:"Times New Roman",serif;
mso-fareast-font-family:Calibri;mso-ansi-language:ES-CO'><span
style='mso-element:field-end'></span></span><![endif]--><span style='font-size:
10.0pt;line-height:107%;font-family:"Times New Roman",serif;mso-fareast-font-family:
Calibri;mso-ansi-language:ES-CO'>.<o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0mm;margin-bottom:.0001pt;text-align:
justify;text-indent:11.35pt'><span style='font-size:10.0pt;line-height:107%;
font-family:"Times New Roman",serif;mso-fareast-font-family:Calibri;mso-ansi-language:
ES-CO'><o:p>&nbsp;</o:p></span></p>

<p class=MsoNormal style='margin-bottom:0mm;margin-bottom:.0001pt;text-align:
justify;text-indent:11.35pt'><span style='font-size:10.0pt;line-height:107%;
font-family:"Times New Roman",serif;mso-fareast-font-family:Calibri;mso-ansi-language:
ES-CO'>La diferencia entre la DDD y la dosis utilizada realmente en la práctica
clínica puede constituir una limitación al generar inexactitud en la medición
del consumo. Un estudio analizó el consumo de antibacterianos en 130 hospitales
durante un año para conocer las diferencias entre DDDs y DOTs </span><!--[if supportFields]><span
style='font-size:10.0pt;line-height:107%;font-family:"Times New Roman",serif;
mso-fareast-font-family:Calibri;mso-ansi-language:ES-CO'><span
style='mso-element:field-begin;mso-field-lock:yes'></span>ADDIN CSL_CITATION
{&quot;citationItems&quot;:[{&quot;id&quot;:&quot;ITEM-1&quot;,&quot;itemData&quot;:{&quot;DOI&quot;:&quot;10.1086/511640&quot;,&quot;ISBN&quot;:&quot;1058-4838\\r1537-6591&quot;,&quot;ISSN&quot;:&quot;1537-6591&quot;,&quot;PMID&quot;:&quot;17278056&quot;,&quot;abstract&quot;:&quot;BACKGROUND
Hospitals are advised to measure antibiotic use and monitor its relationship to
resistance. The World Health Organization's recommended metric is the defined
daily dose (DDD). An alternative measure is the number of days of therapy
(DOT). The purpose of this study was to contrast these measures. METHODS We
measured the use of 50 antibacterial drugs that were administered to adults who
were discharged from 130 US hospitals during 1 August 2002-31 July 2003.
RESULTS Of 1,795,504 patients, 1,074,174 received at least 1 dose of an
antibacterial drug (59.8%). The mean (+/- standard deviation) of total
antibacterial drug use measured by the number of DDDs per 1000 patient-days and
the number of DOTs per 1000 patient-days were not significantly different
(792+/-147 and 776+/-120, respectively; P=.137), although the correlation was
poor (r=0.603). For some individual drugs, such as levofloxacin and linezolid,
there was no significant difference between DDDs per 1000 patient-days and DOTs
per 1000 patient-days, because the administered daily dosage was nearly
equivalent to the DDD. When the administered dosage exceeded the DDD, such as
for ampicillin-sulbactam and cefepime, estimates of use based on DDDs per 1000
patient-days significantly exceeded those based on DOTs per 1000 patient-days
(P&lt;.001). When the administered dosage was less than the DDD, such as for
piperacillin-tazobactam and ceftriaxone, estimates of use based on DDDs per
1000 patient-days were significantly lower than those based on DOTs per 1000
patient-days (P&lt;.001). CONCLUSION The measurement of aggregate hospital
antibiotic use by DDDs per 1000 patient-days and DOTs per 1000 patient-days is
discordant for many frequently used antibacterial drugs, because the
administered dose is dissimilar from the DDD recommended by the World Health
Organization. DDD methods are useful for benchmarking purposes but cannot be
used to make inferences about the number of DOTs or relative use for many
antibacterial
drugs.&quot;,&quot;author&quot;:[{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Polk&quot;,&quot;given&quot;:&quot;Ronald
E&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Fox&quot;,&quot;given&quot;:&quot;Christina&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Mahoney&quot;,&quot;given&quot;:&quot;Anne&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Letcavage&quot;,&quot;given&quot;:&quot;Jim&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;MacDougall&quot;,&quot;given&quot;:&quot;Conan&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;}],&quot;container-title&quot;:&quot;Clinical
infectious
diseases&quot;,&quot;id&quot;:&quot;ITEM-1&quot;,&quot;issue&quot;:&quot;5&quot;,&quot;issued&quot;:{&quot;date-parts&quot;:[[&quot;2007&quot;]]},&quot;title&quot;:&quot;Measurement
of adult antibacterial drug use in 130 US hospitals: comparison of defined
daily dose and days of therapy.&quot;,&quot;type&quot;:&quot;article-journal&quot;,&quot;volume&quot;:&quot;44&quot;},&quot;uris&quot;:[&quot;http://www.mendeley.com/documents/?uuid=1359fbb5-3bdc-40aa-bb18-aa566cf6fa0c&quot;,&quot;http://www.mendeley.com/documents/?uuid=2b357782-9c87-4d84-9324-10626d3be6a4&quot;]}],&quot;mendeley&quot;:{&quot;formattedCitation&quot;:&quot;(55)&quot;,&quot;plainTextFormattedCitation&quot;:&quot;(55)&quot;,&quot;previouslyFormattedCitation&quot;:&quot;(55)&quot;},&quot;properties&quot;:{&quot;noteIndex&quot;:0},&quot;schema&quot;:&quot;https://github.com/citation-style-language/schema/raw/master/csl-citation.json&quot;}<span
style='mso-element:field-separator'></span></span><![endif]--><span
style='font-size:10.0pt;line-height:107%;font-family:"Times New Roman",serif;
mso-fareast-font-family:Calibri;mso-ansi-language:ES-CO'><span
style='mso-no-proof:yes'>(55)</span></span><!--[if supportFields]><span
style='font-size:10.0pt;line-height:107%;font-family:"Times New Roman",serif;
mso-fareast-font-family:Calibri;mso-ansi-language:ES-CO'><span
style='mso-element:field-end'></span></span><![endif]--><span style='font-size:
10.0pt;line-height:107%;font-family:"Times New Roman",serif;mso-fareast-font-family:
Calibri;mso-ansi-language:ES-CO'>.<span style='color:#4F6228'> </span>Los
antimicrobianos se agruparon de acuerdo a si el consumo era sobrestimado
(ampicilina + sulbactam), subestimado (ceftriaxona) o no difería (levofloxacina
IV) con el uso de DDDs en vez de DOTs. El consumo de ampicilina-sulbactam
medido por DDDs (88.7 DDDs/1000PD) fue mayor al consumo medido a través de DOTs
(22.1 DOTs/1000 PD). En este caso la dosis media administrada de 8.1 ± 1.8g es
mayor a la DDD de la OMS correspondiente a 2g. El consumo de ceftriaxona medido
a través de DDDs (44.9 DDDs/1000 PD) fue menor que el consumo medido por DOTs
(62.9 DOTs/1000 PD). Porque la dosis promedio administrada de ceftriaxona de
1.1 ± 0.21g es menor a la recomendación de la OMS de 2g. Para levofloxacina IV
la cantidad de DDDs (71.6 DDDs/1000PD) no fue diferente a la cantidad de DOTs
(70.9 DOTs /1000PD), presentándose correlación aceptable entre ambas medidas.
La dosis media observada fue 0.5 ± 0.1g/día similar a la DDD de la OMS
correspondiente a 0.5g.<o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0mm;margin-bottom:.0001pt;text-align:
justify;text-indent:11.35pt'><span style='font-size:10.0pt;line-height:107%;
font-family:"Times New Roman",serif;mso-fareast-font-family:Calibri;mso-ansi-language:
ES-CO'><o:p>&nbsp;</o:p></span></p>

<p class=MsoNormal style='margin-bottom:0mm;margin-bottom:.0001pt;text-align:
justify;text-indent:11.35pt'><span style='font-size:10.0pt;line-height:107%;
font-family:"Times New Roman",serif;mso-fareast-font-family:Calibri;mso-ansi-language:
ES-CO'>Un estudio en un hospital académico comparó DDDs frente a DOTs evaluando
las tendencias de consumo durante tres años </span><!--[if supportFields]><span
style='font-size:10.0pt;line-height:107%;font-family:"Times New Roman",serif;
mso-fareast-font-family:Calibri;mso-ansi-language:ES-CO'><span
style='mso-element:field-begin;mso-field-lock:yes'></span>ADDIN CSL_CITATION
{&quot;citationItems&quot;:[{&quot;id&quot;:&quot;ITEM-1&quot;,&quot;itemData&quot;:{&quot;DOI&quot;:&quot;10.2146/ajhp050140&quot;,&quot;ISSN&quot;:&quot;10792082&quot;,&quot;PMID&quot;:&quot;16239421&quot;,&quot;author&quot;:[{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Shetka&quot;,&quot;given&quot;:&quot;Mike&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Pastor&quot;,&quot;given&quot;:&quot;John&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Phelps&quot;,&quot;given&quot;:&quot;Pamela&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;}],&quot;container-title&quot;:&quot;American
Journal of Health-System
Pharmacy&quot;,&quot;id&quot;:&quot;ITEM-1&quot;,&quot;issue&quot;:&quot;21&quot;,&quot;issued&quot;:{&quot;date-parts&quot;:[[&quot;2005&quot;]]},&quot;page&quot;:&quot;2288-2292&quot;,&quot;title&quot;:&quot;Evaluation
of the defined daily dose method for estimating antiinfective use in a
university
hospital&quot;,&quot;type&quot;:&quot;article-journal&quot;,&quot;volume&quot;:&quot;62&quot;},&quot;uris&quot;:[&quot;http://www.mendeley.com/documents/?uuid=6604dbb3-3080-4daf-b7ee-3ff6b172d1a8&quot;]}],&quot;mendeley&quot;:{&quot;formattedCitation&quot;:&quot;(56)&quot;,&quot;plainTextFormattedCitation&quot;:&quot;(56)&quot;,&quot;previouslyFormattedCitation&quot;:&quot;(56)&quot;},&quot;properties&quot;:{&quot;noteIndex&quot;:0},&quot;schema&quot;:&quot;https://github.com/citation-style-language/schema/raw/master/csl-citation.json&quot;}<span
style='mso-element:field-separator'></span></span><![endif]--><span
style='font-size:10.0pt;line-height:107%;font-family:"Times New Roman",serif;
mso-fareast-font-family:Calibri;mso-ansi-language:ES-CO'><span
style='mso-no-proof:yes'>(56)</span></span><!--[if supportFields]><span
style='font-size:10.0pt;line-height:107%;font-family:"Times New Roman",serif;
mso-fareast-font-family:Calibri;mso-ansi-language:ES-CO'><span
style='mso-element:field-end'></span></span><![endif]--><span style='font-size:
10.0pt;line-height:107%;font-family:"Times New Roman",serif;mso-fareast-font-family:
Calibri;mso-ansi-language:ES-CO'>. El método de referencia para medición de
consumo fue días de terapias obtenidos de los registros de dispensación de la
farmacia. El consumo de los antinfecciosos estudiados en este hospital era
subestimado con el uso de DDDs respecto a DOTs en la mayoría de los casos. La
subestimación fue alta con vancomicina (40.8 y 63.0% para formas intravenosa y
oral) e imipenem (28.9%), moderada para ceftazidima (18.2%) y gatifloxacino
oral (18.7%), baja para voriconazol (13.1%) y ciprofloxacina oral (10.1%). Al
contrario, se presentó sobrestimación con ciprofloxacina IV&nbsp;(28.2%) y
voriconazol IV (24.3%). En general las magnitud de consumo de antibióticos se
mantuvo pese al cambio en la unidad de medición </span><!--[if supportFields]><span
style='font-size:10.0pt;line-height:107%;font-family:"Times New Roman",serif;
mso-fareast-font-family:Calibri;mso-ansi-language:ES-CO'><span
style='mso-element:field-begin;mso-field-lock:yes'></span>ADDIN CSL_CITATION
{&quot;citationItems&quot;:[{&quot;id&quot;:&quot;ITEM-1&quot;,&quot;itemData&quot;:{&quot;DOI&quot;:&quot;10.2146/ajhp050140&quot;,&quot;ISSN&quot;:&quot;10792082&quot;,&quot;PMID&quot;:&quot;16239421&quot;,&quot;author&quot;:[{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Shetka&quot;,&quot;given&quot;:&quot;Mike&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Pastor&quot;,&quot;given&quot;:&quot;John&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Phelps&quot;,&quot;given&quot;:&quot;Pamela&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;}],&quot;container-title&quot;:&quot;American
Journal of Health-System
Pharmacy&quot;,&quot;id&quot;:&quot;ITEM-1&quot;,&quot;issue&quot;:&quot;21&quot;,&quot;issued&quot;:{&quot;date-parts&quot;:[[&quot;2005&quot;]]},&quot;page&quot;:&quot;2288-2292&quot;,&quot;title&quot;:&quot;Evaluation
of the defined daily dose method for estimating antiinfective use in a
university hospital&quot;,&quot;type&quot;:&quot;article-journal&quot;,&quot;volume&quot;:&quot;62&quot;},&quot;uris&quot;:[&quot;http://www.mendeley.com/documents/?uuid=6604dbb3-3080-4daf-b7ee-3ff6b172d1a8&quot;]}],&quot;mendeley&quot;:{&quot;formattedCitation&quot;:&quot;(56)&quot;,&quot;plainTextFormattedCitation&quot;:&quot;(56)&quot;,&quot;previouslyFormattedCitation&quot;:&quot;(56)&quot;},&quot;properties&quot;:{&quot;noteIndex&quot;:0},&quot;schema&quot;:&quot;https://github.com/citation-style-language/schema/raw/master/csl-citation.json&quot;}<span
style='mso-element:field-separator'></span></span><![endif]--><span
style='font-size:10.0pt;line-height:107%;font-family:"Times New Roman",serif;
mso-fareast-font-family:Calibri;mso-ansi-language:ES-CO'><span
style='mso-no-proof:yes'>(56)</span></span><!--[if supportFields]><span
style='font-size:10.0pt;line-height:107%;font-family:"Times New Roman",serif;
mso-fareast-font-family:Calibri;mso-ansi-language:ES-CO'><span
style='mso-element:field-end'></span></span><![endif]--><span style='font-size:
10.0pt;line-height:107%;font-family:"Times New Roman",serif;mso-fareast-font-family:
Calibri;mso-ansi-language:ES-CO'>. Un estudio en un hospital materno-infantil
describió el consumo de antifúngicos por medio de DDDs y DOTs </span><!--[if supportFields]><span
style='font-size:10.0pt;line-height:107%;font-family:"Times New Roman",serif;
mso-fareast-font-family:Calibri;mso-ansi-language:ES-CO'><span
style='mso-element:field-begin;mso-field-lock:yes'></span>ADDIN CSL_CITATION
{&quot;citationItems&quot;:[{&quot;id&quot;:&quot;ITEM-1&quot;,&quot;itemData&quot;:{&quot;DOI&quot;:&quot;10.5863/1551-6776-19.3.196&quot;,&quot;ISBN&quot;:&quot;1551-6776
(Print)
1551-6776&quot;,&quot;ISSN&quot;:&quot;1551-6776&quot;,&quot;PMID&quot;:&quot;25309150&quot;,&quot;abstract&quot;:&quot;OBJECTIVES:
The objective was to describe antifungal drug use by using the number of
defined daily doses (DDD)/1000 patient-days per antifungal, the number of days
of therapy (DOT)/1000 patient-days per anti-fungal, and the mean dose in
mg/kg/day per antifungal during a 10-year period. METHODS: Retrospective,
cross-sectional, descriptive study, in a mother-child university hospital
center, with 400 pediatric beds and 100 obstetrics-gynecology beds. All
inpatients who received 1 of the 7 autho-rized antifungals on the institution's
local formulary in 2000-2001, 2005-2006, or 2010-2011 were included.
Prescriptions for emergency department and outpatient clinics were excluded.
The data were extracted from the patients' computerized medication profiles
linked to patient admission, discharge, and transfer data. The DDD, DOT, and
the mean dose in mg/kg/day were calculated for each antifungal and overall.
RESULTS: There was a 2.97-fold increase in the overall number of DDD/1000
patient-days, from 14.8 in 2000-2001 to 37.5 in 2005-2006 and 43.9 in
2010-2011. There was a 2.97-fold increase in the overall number of DOT/1000
patient-days, from 22.8 in 2000-2001 to 50.3 in 2005-2006 and 67.8 in
2010-2011. CONCLUSIONS: It can be difficult to compare the use of antifungal
drugs among institutions, owing to numerous factors, but it gives an idea about
the consumption outside the studied center. Moreover, these ratios help to
evaluate the use of antifungals within a same institution. These data could be
correlated among others, with resistance patterns, in order to improve our
daily practice concerning antifungal prescription.&quot;,&quot;author&quot;:[{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Guillot&quot;,&quot;given&quot;:&quot;Justine&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Lebel&quot;,&quot;given&quot;:&quot;Denis&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Roy&quot;,&quot;given&quot;:&quot;Hélène&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Ovetchkine&quot;,&quot;given&quot;:&quot;Philippe&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Bussières&quot;,&quot;given&quot;:&quot;Jean-François&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;}],&quot;container-title&quot;:&quot;J
Pediatr Pharmacol Ther&quot;,&quot;id&quot;:&quot;ITEM-1&quot;,&quot;issue&quot;:&quot;3&quot;,&quot;issued&quot;:{&quot;date-parts&quot;:[[&quot;2014&quot;]]},&quot;page&quot;:&quot;196-201&quot;,&quot;title&quot;:&quot;Usefulness
of Defined Daily Dose and Days of Therapy in Pediatrics and
Obstetrics-Gynecology: A Comparative Analysis of Antifungal Drugs (2000-2001,
2005-2006, and
2010-2011)&quot;,&quot;type&quot;:&quot;article-journal&quot;,&quot;volume&quot;:&quot;19&quot;},&quot;uris&quot;:[&quot;http://www.mendeley.com/documents/?uuid=b507cdb0-9239-4125-ab1f-1f8d71bea2f7&quot;,&quot;http://www.mendeley.com/documents/?uuid=7de478cc-d0f5-4dee-a2a0-227d7d0b611f&quot;]}],&quot;mendeley&quot;:{&quot;formattedCitation&quot;:&quot;(57)&quot;,&quot;plainTextFormattedCitation&quot;:&quot;(57)&quot;,&quot;previouslyFormattedCitation&quot;:&quot;(57)&quot;},&quot;properties&quot;:{&quot;noteIndex&quot;:0},&quot;schema&quot;:&quot;https://github.com/citation-style-language/schema/raw/master/csl-citation.json&quot;}<span
style='mso-element:field-separator'></span></span><![endif]--><span
style='font-size:10.0pt;line-height:107%;font-family:"Times New Roman",serif;
mso-fareast-font-family:Calibri;mso-ansi-language:ES-CO'><span
style='mso-no-proof:yes'>(57)</span></span><!--[if supportFields]><span
style='font-size:10.0pt;line-height:107%;font-family:"Times New Roman",serif;
mso-fareast-font-family:Calibri;mso-ansi-language:ES-CO'><span
style='mso-element:field-end'></span></span><![endif]--><span style='font-size:
10.0pt;line-height:107%;font-family:"Times New Roman",serif;mso-fareast-font-family:
Calibri;mso-ansi-language:ES-CO'>. En un periodo discontinuo de tres años se
encontró alta correlación entre las medidas de consumo (r=0.995-0.998), sin
embargo los autores opinan que DOTs es una medida más relevante en pediatría </span><!--[if supportFields]><span
style='font-size:10.0pt;line-height:107%;font-family:"Times New Roman",serif;
mso-fareast-font-family:Calibri;mso-ansi-language:ES-CO'><span
style='mso-element:field-begin;mso-field-lock:yes'></span>ADDIN CSL_CITATION
{&quot;citationItems&quot;:[{&quot;id&quot;:&quot;ITEM-1&quot;,&quot;itemData&quot;:{&quot;DOI&quot;:&quot;10.5863/1551-6776-19.3.196&quot;,&quot;ISBN&quot;:&quot;1551-6776
(Print) 1551-6776&quot;,&quot;ISSN&quot;:&quot;1551-6776&quot;,&quot;PMID&quot;:&quot;25309150&quot;,&quot;abstract&quot;:&quot;OBJECTIVES:
The objective was to describe antifungal drug use by using the number of
defined daily doses (DDD)/1000 patient-days per antifungal, the number of days
of therapy (DOT)/1000 patient-days per anti-fungal, and the mean dose in
mg/kg/day per antifungal during a 10-year period. METHODS: Retrospective, cross-sectional,
descriptive study, in a mother-child university hospital center, with 400
pediatric beds and 100 obstetrics-gynecology beds. All inpatients who received
1 of the 7 autho-rized antifungals on the institution's local formulary in
2000-2001, 2005-2006, or 2010-2011 were included. Prescriptions for emergency
department and outpatient clinics were excluded. The data were extracted from
the patients' computerized medication profiles linked to patient admission,
discharge, and transfer data. The DDD, DOT, and the mean dose in mg/kg/day were
calculated for each antifungal and overall. RESULTS: There was a 2.97-fold
increase in the overall number of DDD/1000 patient-days, from 14.8 in 2000-2001
to 37.5 in 2005-2006 and 43.9 in 2010-2011. There was a 2.97-fold increase in
the overall number of DOT/1000 patient-days, from 22.8 in 2000-2001 to 50.3 in
2005-2006 and 67.8 in 2010-2011. CONCLUSIONS: It can be difficult to compare
the use of antifungal drugs among institutions, owing to numerous factors, but it
gives an idea about the consumption outside the studied center. Moreover, these
ratios help to evaluate the use of antifungals within a same institution. These
data could be correlated among others, with resistance patterns, in order to
improve our daily practice concerning antifungal
prescription.&quot;,&quot;author&quot;:[{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Guillot&quot;,&quot;given&quot;:&quot;Justine&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Lebel&quot;,&quot;given&quot;:&quot;Denis&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Roy&quot;,&quot;given&quot;:&quot;Hélène&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Ovetchkine&quot;,&quot;given&quot;:&quot;Philippe&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Bussières&quot;,&quot;given&quot;:&quot;Jean-François&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;}],&quot;container-title&quot;:&quot;J
Pediatr Pharmacol
Ther&quot;,&quot;id&quot;:&quot;ITEM-1&quot;,&quot;issue&quot;:&quot;3&quot;,&quot;issued&quot;:{&quot;date-parts&quot;:[[&quot;2014&quot;]]},&quot;page&quot;:&quot;196-201&quot;,&quot;title&quot;:&quot;Usefulness
of Defined Daily Dose and Days of Therapy in Pediatrics and
Obstetrics-Gynecology: A Comparative Analysis of Antifungal Drugs (2000-2001,
2005-2006, and 2010-2011)&quot;,&quot;type&quot;:&quot;article-journal&quot;,&quot;volume&quot;:&quot;19&quot;},&quot;uris&quot;:[&quot;http://www.mendeley.com/documents/?uuid=7de478cc-d0f5-4dee-a2a0-227d7d0b611f&quot;,&quot;http://www.mendeley.com/documents/?uuid=b507cdb0-9239-4125-ab1f-1f8d71bea2f7&quot;]}],&quot;mendeley&quot;:{&quot;formattedCitation&quot;:&quot;(57)&quot;,&quot;plainTextFormattedCitation&quot;:&quot;(57)&quot;,&quot;previouslyFormattedCitation&quot;:&quot;(57)&quot;},&quot;properties&quot;:{&quot;noteIndex&quot;:0},&quot;schema&quot;:&quot;https://github.com/citation-style-language/schema/raw/master/csl-citation.json&quot;}<span
style='mso-element:field-separator'></span></span><![endif]--><span
style='font-size:10.0pt;line-height:107%;font-family:"Times New Roman",serif;
mso-fareast-font-family:Calibri;mso-ansi-language:ES-CO'><span
style='mso-no-proof:yes'>(57)</span></span><!--[if supportFields]><span
style='font-size:10.0pt;line-height:107%;font-family:"Times New Roman",serif;
mso-fareast-font-family:Calibri;mso-ansi-language:ES-CO'><span
style='mso-element:field-end'></span></span><![endif]--><span style='font-size:
10.0pt;line-height:107%;font-family:"Times New Roman",serif;mso-fareast-font-family:
Calibri;mso-ansi-language:ES-CO'>.<o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0mm;margin-bottom:.0001pt;text-align:
justify;text-indent:11.35pt'><span style='font-size:10.0pt;line-height:107%;
font-family:"Times New Roman",serif;mso-fareast-font-family:Calibri;mso-ansi-language:
ES-CO'><o:p>&nbsp;</o:p></span></p>

<p class=MsoNormal style='margin-bottom:0mm;margin-bottom:.0001pt;text-align:
justify;text-indent:11.35pt'><span lang=ES style='font-size:10.0pt;line-height:
107%;font-family:"Times New Roman",serif;mso-fareast-font-family:Calibri;
mso-ansi-language:ES'>El consumo a través de DDDs puede verse influenciado por
cambios en la composición del formulario de la institución. Un estudio </span><!--[if supportFields]><span
lang=ES style='font-size:10.0pt;line-height:107%;font-family:"Times New Roman",serif;
mso-fareast-font-family:Calibri;mso-ansi-language:ES'><span style='mso-element:
field-begin;mso-field-lock:yes'></span>ADDIN CSL_CITATION
{&quot;citationItems&quot;:[{&quot;id&quot;:&quot;ITEM-1&quot;,&quot;itemData&quot;:{&quot;DOI&quot;:&quot;10.1007/s15010-006-5085-9&quot;,&quot;ISSN&quot;:&quot;03008126&quot;,&quot;PMID&quot;:&quot;16703299&quot;,&quot;abstract&quot;:&quot;BACKGROUND:
Hospital antibiotic use can be measured by calculating daily doses as defined
by the WHO/ATC index (DDD) divided by the number of patient or occupied bed
days. We wondered whether changes in antibiotic use density over time at a
university hospital using this data format are similar in order of magnitude
when compared with a different, alternative dose definition and the number of
admissions rather than the number of patient days as denominator. METHODS: Data
obtained from the hospital pharmacy for the medical and surgical services of a
1,000-bed university hospital for the period 1992 through 2003 were expressed
both in daily doses per 100 patient days and daily doses per admission. A PDD
dose definition (prescribed daily doses), defining doses that reflect the
usually prescribed dose in adult hospitalized patients with normal renal
function was compared with the WHO/ATC 2001 DDD dose definitions. The percent
changes using the different data formats between two 3-year averages (1992-1994
and 2001-2003) were calculated. RESULTS AND CONCLUSION: The DDD/100 patient
days data format overestimated antibiotic use density changes in this hospital
both in medicine (81% vs 48%) as well as in surgery (69% vs 39%) when compared
with PDD/100 patient days. Due to changes in the number of admissions and
length of stay over the years, the percent change between the two periods
expressed in doses per 100 patient days in addition differed substantially from
that estimated by using the DDD per admission or PDD per admission data format.
Studies evaluating the evolution of hospital antibiotic use need to address the
limitations and adequacy of the different data
formats.&quot;,&quot;author&quot;:[{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;With&quot;,&quot;given&quot;:&quot;K.&quot;,&quot;non-dropping-particle&quot;:&quot;De&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Maier&quot;,&quot;given&quot;:&quot;L.&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Steib-Bauert&quot;,&quot;given&quot;:&quot;M.&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Kern&quot;,&quot;given&quot;:&quot;P.&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;V.&quot;,&quot;family&quot;:&quot;Kern&quot;,&quot;given&quot;:&quot;W.&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;}],&quot;container-title&quot;:&quot;Infection&quot;,&quot;id&quot;:&quot;ITEM-1&quot;,&quot;issue&quot;:&quot;2&quot;,&quot;issued&quot;:{&quot;date-parts&quot;:[[&quot;2006&quot;]]},&quot;page&quot;:&quot;91-94&quot;,&quot;title&quot;:&quot;Trends
in antibiotic use at a University Hospital: Defined or prescribed daily doses?
Patient days or admissions as denominator?&quot;,&quot;type&quot;:&quot;article-journal&quot;,&quot;volume&quot;:&quot;34&quot;},&quot;uris&quot;:[&quot;http://www.mendeley.com/documents/?uuid=d0a23bba-8474-405e-bf30-f999ad11ce60&quot;]}],&quot;mendeley&quot;:{&quot;formattedCitation&quot;:&quot;(53)&quot;,&quot;plainTextFormattedCitation&quot;:&quot;(53)&quot;,&quot;previouslyFormattedCitation&quot;:&quot;(53)&quot;},&quot;properties&quot;:{&quot;noteIndex&quot;:0},&quot;schema&quot;:&quot;https://github.com/citation-style-language/schema/raw/master/csl-citation.json&quot;}<span
style='mso-element:field-separator'></span></span><![endif]--><span lang=ES
style='font-size:10.0pt;line-height:107%;font-family:"Times New Roman",serif;
mso-fareast-font-family:Calibri;mso-ansi-language:ES'><span style='mso-no-proof:
yes'>(53)</span></span><!--[if supportFields]><span lang=ES style='font-size:
10.0pt;line-height:107%;font-family:"Times New Roman",serif;mso-fareast-font-family:
Calibri;mso-ansi-language:ES'><span style='mso-element:field-end'></span></span><![endif]--><span
lang=ES style='font-size:10.0pt;line-height:107%;font-family:"Times New Roman",serif;
mso-fareast-font-family:Calibri;mso-ansi-language:ES'> encontró que el consumo
de antimicrobianos en un hospital entre 1999 a 2000, se vio afectado por el
cambio de ofloxacina a levofloxacina. La DDD para levofloxacina era 250mg
mientras la PDD era 500mg, esta situación generó sobrestimación del consumo.
Este efecto no es observado con la utilización de DOTs o PDDs </span><!--[if supportFields]><span
lang=ES style='font-size:10.0pt;line-height:107%;font-family:"Times New Roman",serif;
mso-fareast-font-family:Calibri;mso-ansi-language:ES'><span style='mso-element:
field-begin;mso-field-lock:yes'></span>ADDIN CSL_CITATION
{&quot;citationItems&quot;:[{&quot;id&quot;:&quot;ITEM-1&quot;,&quot;itemData&quot;:{&quot;DOI&quot;:&quot;10.1007/s15010-006-5085-9&quot;,&quot;ISSN&quot;:&quot;03008126&quot;,&quot;PMID&quot;:&quot;16703299&quot;,&quot;abstract&quot;:&quot;BACKGROUND:
Hospital antibiotic use can be measured by calculating daily doses as defined
by the WHO/ATC index (DDD) divided by the number of patient or occupied bed
days. We wondered whether changes in antibiotic use density over time at a
university hospital using this data format are similar in order of magnitude
when compared with a different, alternative dose definition and the number of
admissions rather than the number of patient days as denominator. METHODS: Data
obtained from the hospital pharmacy for the medical and surgical services of a
1,000-bed university hospital for the period 1992 through 2003 were expressed
both in daily doses per 100 patient days and daily doses per admission. A PDD
dose definition (prescribed daily doses), defining doses that reflect the
usually prescribed dose in adult hospitalized patients with normal renal
function was compared with the WHO/ATC 2001 DDD dose definitions. The percent
changes using the different data formats between two 3-year averages (1992-1994
and 2001-2003) were calculated. RESULTS AND CONCLUSION: The DDD/100 patient
days data format overestimated antibiotic use density changes in this hospital
both in medicine (81% vs 48%) as well as in surgery (69% vs 39%) when compared
with PDD/100 patient days. Due to changes in the number of admissions and
length of stay over the years, the percent change between the two periods
expressed in doses per 100 patient days in addition differed substantially from
that estimated by using the DDD per admission or PDD per admission data format.
Studies evaluating the evolution of hospital antibiotic use need to address the
limitations and adequacy of the different data
formats.&quot;,&quot;author&quot;:[{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;With&quot;,&quot;given&quot;:&quot;K.&quot;,&quot;non-dropping-particle&quot;:&quot;De&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Maier&quot;,&quot;given&quot;:&quot;L.&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Steib-Bauert&quot;,&quot;given&quot;:&quot;M.&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Kern&quot;,&quot;given&quot;:&quot;P.&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;V.&quot;,&quot;family&quot;:&quot;Kern&quot;,&quot;given&quot;:&quot;W.&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;}],&quot;container-title&quot;:&quot;Infection&quot;,&quot;id&quot;:&quot;ITEM-1&quot;,&quot;issue&quot;:&quot;2&quot;,&quot;issued&quot;:{&quot;date-parts&quot;:[[&quot;2006&quot;]]},&quot;page&quot;:&quot;91-94&quot;,&quot;title&quot;:&quot;Trends
in antibiotic use at a University Hospital: Defined or prescribed daily doses?
Patient days or admissions as
denominator?&quot;,&quot;type&quot;:&quot;article-journal&quot;,&quot;volume&quot;:&quot;34&quot;},&quot;uris&quot;:[&quot;http://www.mendeley.com/documents/?uuid=d0a23bba-8474-405e-bf30-f999ad11ce60&quot;]}],&quot;mendeley&quot;:{&quot;formattedCitation&quot;:&quot;(53)&quot;,&quot;plainTextFormattedCitation&quot;:&quot;(53)&quot;,&quot;previouslyFormattedCitation&quot;:&quot;(53)&quot;},&quot;properties&quot;:{&quot;noteIndex&quot;:0},&quot;schema&quot;:&quot;https://github.com/citation-style-language/schema/raw/master/csl-citation.json&quot;}<span
style='mso-element:field-separator'></span></span><![endif]--><span lang=ES
style='font-size:10.0pt;line-height:107%;font-family:"Times New Roman",serif;
mso-fareast-font-family:Calibri;mso-ansi-language:ES'><span style='mso-no-proof:
yes'>(53)</span></span><!--[if supportFields]><span lang=ES style='font-size:
10.0pt;line-height:107%;font-family:"Times New Roman",serif;mso-fareast-font-family:
Calibri;mso-ansi-language:ES'><span style='mso-element:field-end'></span></span><![endif]--><span
lang=ES style='font-size:10.0pt;line-height:107%;font-family:"Times New Roman",serif;
mso-fareast-font-family:Calibri;mso-ansi-language:ES'>. <o:p></o:p></span></p>

<p class=MsoNormal style='margin-top:10.0pt;margin-right:0mm;margin-bottom:
6.0pt;margin-left:0mm'><i style='mso-bidi-font-style:normal'><span
style='mso-bidi-font-size:9.0pt;line-height:107%;mso-bidi-font-family:"Times New Roman";
mso-ansi-language:ES-CO'>7.2 Comparación entre denominadores<o:p></o:p></span></i></p>

<p class=MsoNormal style='margin-bottom:0mm;margin-bottom:.0001pt;text-align:
justify;text-indent:11.35pt'><span lang=ES style='font-size:10.0pt;line-height:
107%;font-family:"Times New Roman",serif;mso-fareast-font-family:Calibri;
mso-ansi-language:ES'>Un estudio comparó el consumo de antibióticos medido en
DDDs por 100 PD vs DDDs por FCEs encontrando una buena correlación (r=0.74)
entre los dos indicadores </span><!--[if supportFields]><span lang=ES
style='font-size:10.0pt;line-height:107%;font-family:"Times New Roman",serif;
mso-fareast-font-family:Calibri;mso-ansi-language:ES'><span style='mso-element:
field-begin;mso-field-lock:yes'></span>ADDIN CSL_CITATION
{&quot;citationItems&quot;:[{&quot;id&quot;:&quot;ITEM-1&quot;,&quot;itemData&quot;:{&quot;DOI&quot;:&quot;10.1093/jac/dkh362&quot;,&quot;ISSN&quot;:&quot;03057453&quot;,&quot;PMID&quot;:&quot;15269192&quot;,&quot;abstract&quot;:&quot;OBJECTIVES:
To compare the recognized defined daily dose per 100 bed-days (DDD/100
bed-days) measure with the defined daily dose per finished consultant episode
(DDD/FCE) in a group of hospitals with a variety of medicines management
strategies. To compare antibiotic usage using the above indicators in hospitals
with and without electronic prescribing systems.\\n\\nMETHODS: Twelve hospitals
were used in the study. Nine hospitals were selected and split into three
cohorts (three high-scoring, three medium-scoring and three low-scoring) by
their 2001 medicines management self-assessment scores (MMAS). An additional
cohort of three electronic prescribing hospitals was included for comparison.
MMAS were compared to antibiotic management scores (AMS) developed from a
questionnaire relating specifically to control of antibiotics. FCEs and
occupied bed-days were obtained from published statistics and statistical
analyses of the DDD/100 bed-days and DDD/FCE were carried out using
SPSS.\\n\\nRESULTS: The DDD/100 bed-days varied from 81.33 to 189.37 whilst the
DDD/FCE varied from 2.88 to 7.43. The two indicators showed a high degree of
correlation with r=0.74. MMAS were from 9 to 22 (possible range 0-23) and the
AMS from 2 to 13 (possible range 0-22). The two scores showed a high degree of
correlation with r=0.74. No correlation was established between either
indicator and either score.\\n\\nCONCLUSIONS: The WHO indicator for medicines
utilization, DDD/100 bed-days, exhibited the same level of conformity as that
exhibited from the use of the DDD/FCE indicating that the DDD/FCE is a useful
additional indicator for identifying hospitals which require further study. The
MMAS can be assumed to be an accurate guide to antibiotic medicines management
controls. No relationship has been found between a high degree of medicines
management control and the quantity of antibiotic
prescribed.&quot;,&quot;author&quot;:[{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Curtis&quot;,&quot;given&quot;:&quot;Chris&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Marriott&quot;,&quot;given&quot;:&quot;John&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Langley&quot;,&quot;given&quot;:&quot;Chris&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;}],&quot;container-title&quot;:&quot;Journal
of Antimicrobial
Chemotherapy&quot;,&quot;id&quot;:&quot;ITEM-1&quot;,&quot;issue&quot;:&quot;2&quot;,&quot;issued&quot;:{&quot;date-parts&quot;:[[&quot;2004&quot;]]},&quot;page&quot;:&quot;529-533&quot;,&quot;title&quot;:&quot;Development
of a prescribing indicator for objective quantification of antibiotic usage in
secondary care&quot;,&quot;type&quot;:&quot;article-journal&quot;,&quot;volume&quot;:&quot;54&quot;},&quot;uris&quot;:[&quot;http://www.mendeley.com/documents/?uuid=56ade435-5272-484d-a755-449440685d4b&quot;]}],&quot;mendeley&quot;:{&quot;formattedCitation&quot;:&quot;(14)&quot;,&quot;plainTextFormattedCitation&quot;:&quot;(14)&quot;,&quot;previouslyFormattedCitation&quot;:&quot;(14)&quot;},&quot;properties&quot;:{&quot;noteIndex&quot;:0},&quot;schema&quot;:&quot;https://github.com/citation-style-language/schema/raw/master/csl-citation.json&quot;}<span
style='mso-element:field-separator'></span></span><![endif]--><span lang=ES
style='font-size:10.0pt;line-height:107%;font-family:"Times New Roman",serif;
mso-fareast-font-family:Calibri;mso-ansi-language:ES'><span style='mso-no-proof:
yes'>(14)</span></span><!--[if supportFields]><span lang=ES style='font-size:
10.0pt;line-height:107%;font-family:"Times New Roman",serif;mso-fareast-font-family:
Calibri;mso-ansi-language:ES'><span style='mso-element:field-end'></span></span><![endif]--><span
lang=ES style='font-size:10.0pt;line-height:107%;font-family:"Times New Roman",serif;
mso-fareast-font-family:Calibri;mso-ansi-language:ES'>. Un mejor manejo de
antimicrobianos por parte de una institución no se relaciona con un mejor
comportamiento en el consumo frente a aquellos que tienen un peor manejo. El
indicador de consumo DDDs/FCEs puede servir como medida complementaria al
indicador DDDs/100 PD </span><!--[if supportFields]><span lang=ES
style='font-size:10.0pt;line-height:107%;font-family:"Times New Roman",serif;
mso-fareast-font-family:Calibri;mso-ansi-language:ES'><span style='mso-element:
field-begin;mso-field-lock:yes'></span>ADDIN CSL_CITATION
{&quot;citationItems&quot;:[{&quot;id&quot;:&quot;ITEM-1&quot;,&quot;itemData&quot;:{&quot;DOI&quot;:&quot;10.1093/jac/dkh362&quot;,&quot;ISSN&quot;:&quot;03057453&quot;,&quot;PMID&quot;:&quot;15269192&quot;,&quot;abstract&quot;:&quot;OBJECTIVES:
To compare the recognized defined daily dose per 100 bed-days (DDD/100
bed-days) measure with the defined daily dose per finished consultant episode
(DDD/FCE) in a group of hospitals with a variety of medicines management
strategies. To compare antibiotic usage using the above indicators in hospitals
with and without electronic prescribing systems.\\n\\nMETHODS: Twelve hospitals
were used in the study. Nine hospitals were selected and split into three
cohorts (three high-scoring, three medium-scoring and three low-scoring) by
their 2001 medicines management self-assessment scores (MMAS). An additional
cohort of three electronic prescribing hospitals was included for comparison.
MMAS were compared to antibiotic management scores (AMS) developed from a
questionnaire relating specifically to control of antibiotics. FCEs and
occupied bed-days were obtained from published statistics and statistical
analyses of the DDD/100 bed-days and DDD/FCE were carried out using
SPSS.\\n\\nRESULTS: The DDD/100 bed-days varied from 81.33 to 189.37 whilst the
DDD/FCE varied from 2.88 to 7.43. The two indicators showed a high degree of
correlation with r=0.74. MMAS were from 9 to 22 (possible range 0-23) and the
AMS from 2 to 13 (possible range 0-22). The two scores showed a high degree of
correlation with r=0.74. No correlation was established between either
indicator and either score.\\n\\nCONCLUSIONS: The WHO indicator for medicines
utilization, DDD/100 bed-days, exhibited the same level of conformity as that
exhibited from the use of the DDD/FCE indicating that the DDD/FCE is a useful
additional indicator for identifying hospitals which require further study. The
MMAS can be assumed to be an accurate guide to antibiotic medicines management
controls. No relationship has been found between a high degree of medicines
management control and the quantity of antibiotic
prescribed.&quot;,&quot;author&quot;:[{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Curtis&quot;,&quot;given&quot;:&quot;Chris&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Marriott&quot;,&quot;given&quot;:&quot;John&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Langley&quot;,&quot;given&quot;:&quot;Chris&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;}],&quot;container-title&quot;:&quot;Journal
of Antimicrobial
Chemotherapy&quot;,&quot;id&quot;:&quot;ITEM-1&quot;,&quot;issue&quot;:&quot;2&quot;,&quot;issued&quot;:{&quot;date-parts&quot;:[[&quot;2004&quot;]]},&quot;page&quot;:&quot;529-533&quot;,&quot;title&quot;:&quot;Development
of a prescribing indicator for objective quantification of antibiotic usage in
secondary care&quot;,&quot;type&quot;:&quot;article-journal&quot;,&quot;volume&quot;:&quot;54&quot;},&quot;uris&quot;:[&quot;http://www.mendeley.com/documents/?uuid=56ade435-5272-484d-a755-449440685d4b&quot;]}],&quot;mendeley&quot;:{&quot;formattedCitation&quot;:&quot;(14)&quot;,&quot;plainTextFormattedCitation&quot;:&quot;(14)&quot;,&quot;previouslyFormattedCitation&quot;:&quot;(14)&quot;},&quot;properties&quot;:{&quot;noteIndex&quot;:0},&quot;schema&quot;:&quot;https://github.com/citation-style-language/schema/raw/master/csl-citation.json&quot;}<span
style='mso-element:field-separator'></span></span><![endif]--><span lang=ES
style='font-size:10.0pt;line-height:107%;font-family:"Times New Roman",serif;
mso-fareast-font-family:Calibri;mso-ansi-language:ES'><span style='mso-no-proof:
yes'>(14)</span></span><!--[if supportFields]><span lang=ES style='font-size:
10.0pt;line-height:107%;font-family:"Times New Roman",serif;mso-fareast-font-family:
Calibri;mso-ansi-language:ES'><span style='mso-element:field-end'></span></span><![endif]--><span
lang=ES style='font-size:10.0pt;line-height:107%;font-family:"Times New Roman",serif;
mso-fareast-font-family:Calibri;mso-ansi-language:ES'>. El FCE está mejor
relacionado a las tasas de exposición a antibióticos que el número de pacientes
día, por ser una medición de los episodios de cuidado individual </span><!--[if supportFields]><span
lang=ES style='font-size:10.0pt;line-height:107%;font-family:"Times New Roman",serif;
mso-fareast-font-family:Calibri;mso-ansi-language:ES'><span style='mso-element:
field-begin;mso-field-lock:yes'></span>ADDIN CSL_CITATION
{&quot;citationItems&quot;:[{&quot;id&quot;:&quot;ITEM-1&quot;,&quot;itemData&quot;:{&quot;DOI&quot;:&quot;10.1093/jac/dkh362&quot;,&quot;ISSN&quot;:&quot;03057453&quot;,&quot;PMID&quot;:&quot;15269192&quot;,&quot;abstract&quot;:&quot;OBJECTIVES:
To compare the recognized defined daily dose per 100 bed-days (DDD/100
bed-days) measure with the defined daily dose per finished consultant episode
(DDD/FCE) in a group of hospitals with a variety of medicines management
strategies. To compare antibiotic usage using the above indicators in hospitals
with and without electronic prescribing systems.\\n\\nMETHODS: Twelve hospitals
were used in the study. Nine hospitals were selected and split into three
cohorts (three high-scoring, three medium-scoring and three low-scoring) by
their 2001 medicines management self-assessment scores (MMAS). An additional
cohort of three electronic prescribing hospitals was included for comparison.
MMAS were compared to antibiotic management scores (AMS) developed from a
questionnaire relating specifically to control of antibiotics. FCEs and
occupied bed-days were obtained from published statistics and statistical
analyses of the DDD/100 bed-days and DDD/FCE were carried out using
SPSS.\\n\\nRESULTS: The DDD/100 bed-days varied from 81.33 to 189.37 whilst the
DDD/FCE varied from 2.88 to 7.43. The two indicators showed a high degree of
correlation with r=0.74. MMAS were from 9 to 22 (possible range 0-23) and the
AMS from 2 to 13 (possible range 0-22). The two scores showed a high degree of
correlation with r=0.74. No correlation was established between either
indicator and either score.\\n\\nCONCLUSIONS: The WHO indicator for medicines
utilization, DDD/100 bed-days, exhibited the same level of conformity as that
exhibited from the use of the DDD/FCE indicating that the DDD/FCE is a useful
additional indicator for identifying hospitals which require further study. The
MMAS can be assumed to be an accurate guide to antibiotic medicines management
controls. No relationship has been found between a high degree of medicines
management control and the quantity of antibiotic
prescribed.&quot;,&quot;author&quot;:[{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Curtis&quot;,&quot;given&quot;:&quot;Chris&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Marriott&quot;,&quot;given&quot;:&quot;John&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Langley&quot;,&quot;given&quot;:&quot;Chris&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;}],&quot;container-title&quot;:&quot;Journal
of Antimicrobial
Chemotherapy&quot;,&quot;id&quot;:&quot;ITEM-1&quot;,&quot;issue&quot;:&quot;2&quot;,&quot;issued&quot;:{&quot;date-parts&quot;:[[&quot;2004&quot;]]},&quot;page&quot;:&quot;529-533&quot;,&quot;title&quot;:&quot;Development
of a prescribing indicator for objective quantification of antibiotic usage in
secondary
care&quot;,&quot;type&quot;:&quot;article-journal&quot;,&quot;volume&quot;:&quot;54&quot;},&quot;uris&quot;:[&quot;http://www.mendeley.com/documents/?uuid=56ade435-5272-484d-a755-449440685d4b&quot;]}],&quot;mendeley&quot;:{&quot;formattedCitation&quot;:&quot;(14)&quot;,&quot;plainTextFormattedCitation&quot;:&quot;(14)&quot;,&quot;previouslyFormattedCitation&quot;:&quot;(14)&quot;},&quot;properties&quot;:{&quot;noteIndex&quot;:0},&quot;schema&quot;:&quot;https://github.com/citation-style-language/schema/raw/master/csl-citation.json&quot;}<span
style='mso-element:field-separator'></span></span><![endif]--><span lang=ES
style='font-size:10.0pt;line-height:107%;font-family:"Times New Roman",serif;
mso-fareast-font-family:Calibri;mso-ansi-language:ES'><span style='mso-no-proof:
yes'>(14)</span></span><!--[if supportFields]><span lang=ES style='font-size:
10.0pt;line-height:107%;font-family:"Times New Roman",serif;mso-fareast-font-family:
Calibri;mso-ansi-language:ES'><span style='mso-element:field-end'></span></span><![endif]--><span
lang=ES style='font-size:10.0pt;line-height:107%;font-family:"Times New Roman",serif;
mso-fareast-font-family:Calibri;mso-ansi-language:ES'>.<o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0mm;margin-bottom:.0001pt;text-align:
justify;text-indent:11.35pt'><span lang=ES style='font-size:10.0pt;line-height:
107%;font-family:"Times New Roman",serif;mso-fareast-font-family:Calibri;
mso-ansi-language:ES'><o:p>&nbsp;</o:p></span></p>

<p class=MsoNormal style='margin-bottom:0mm;margin-bottom:.0001pt;text-align:
justify;text-indent:11.35pt'><span lang=ES style='font-size:10.0pt;line-height:
107%;font-family:"Times New Roman",serif;mso-fareast-font-family:Calibri;
mso-ansi-language:ES'>En otro estudio se hizo la recolección de datos de
consumo </span><!--[if supportFields]><span lang=ES style='font-size:10.0pt;
line-height:107%;font-family:"Times New Roman",serif;mso-fareast-font-family:
Calibri;mso-ansi-language:ES'><span style='mso-element:field-begin;mso-field-lock:
yes'></span>ADDIN CSL_CITATION {&quot;citationItems&quot;:[{&quot;id&quot;:&quot;ITEM-1&quot;,&quot;itemData&quot;:{&quot;DOI&quot;:&quot;10.1007/s15010-006-5085-9&quot;,&quot;ISSN&quot;:&quot;03008126&quot;,&quot;PMID&quot;:&quot;16703299&quot;,&quot;abstract&quot;:&quot;BACKGROUND:
Hospital antibiotic use can be measured by calculating daily doses as defined
by the WHO/ATC index (DDD) divided by the number of patient or occupied bed
days. We wondered whether changes in antibiotic use density over time at a
university hospital using this data format are similar in order of magnitude
when compared with a different, alternative dose definition and the number of
admissions rather than the number of patient days as denominator. METHODS: Data
obtained from the hospital pharmacy for the medical and surgical services of a
1,000-bed university hospital for the period 1992 through 2003 were expressed
both in daily doses per 100 patient days and daily doses per admission. A PDD
dose definition (prescribed daily doses), defining doses that reflect the
usually prescribed dose in adult hospitalized patients with normal renal
function was compared with the WHO/ATC 2001 DDD dose definitions. The percent
changes using the different data formats between two 3-year averages (1992-1994
and 2001-2003) were calculated. RESULTS AND CONCLUSION: The DDD/100 patient
days data format overestimated antibiotic use density changes in this hospital
both in medicine (81% vs 48%) as well as in surgery (69% vs 39%) when compared
with PDD/100 patient days. Due to changes in the number of admissions and
length of stay over the years, the percent change between the two periods
expressed in doses per 100 patient days in addition differed substantially from
that estimated by using the DDD per admission or PDD per admission data format.
Studies evaluating the evolution of hospital antibiotic use need to address the
limitations and adequacy of the different data
formats.&quot;,&quot;author&quot;:[{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;With&quot;,&quot;given&quot;:&quot;K.&quot;,&quot;non-dropping-particle&quot;:&quot;De&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Maier&quot;,&quot;given&quot;:&quot;L.&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Steib-Bauert&quot;,&quot;given&quot;:&quot;M.&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Kern&quot;,&quot;given&quot;:&quot;P.&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;V.&quot;,&quot;family&quot;:&quot;Kern&quot;,&quot;given&quot;:&quot;W.&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;}],&quot;container-title&quot;:&quot;Infection&quot;,&quot;id&quot;:&quot;ITEM-1&quot;,&quot;issue&quot;:&quot;2&quot;,&quot;issued&quot;:{&quot;date-parts&quot;:[[&quot;2006&quot;]]},&quot;page&quot;:&quot;91-94&quot;,&quot;title&quot;:&quot;Trends
in antibiotic use at a University Hospital: Defined or prescribed daily doses?
Patient days or admissions as
denominator?&quot;,&quot;type&quot;:&quot;article-journal&quot;,&quot;volume&quot;:&quot;34&quot;},&quot;uris&quot;:[&quot;http://www.mendeley.com/documents/?uuid=d0a23bba-8474-405e-bf30-f999ad11ce60&quot;]}],&quot;mendeley&quot;:{&quot;formattedCitation&quot;:&quot;(53)&quot;,&quot;plainTextFormattedCitation&quot;:&quot;(53)&quot;,&quot;previouslyFormattedCitation&quot;:&quot;(53)&quot;},&quot;properties&quot;:{&quot;noteIndex&quot;:0},&quot;schema&quot;:&quot;https://github.com/citation-style-language/schema/raw/master/csl-citation.json&quot;}<span
style='mso-element:field-separator'></span></span><![endif]--><span lang=ES
style='font-size:10.0pt;line-height:107%;font-family:"Times New Roman",serif;
mso-fareast-font-family:Calibri;mso-ansi-language:ES'><span style='mso-no-proof:
yes'>(53)</span></span><!--[if supportFields]><span lang=ES style='font-size:
10.0pt;line-height:107%;font-family:"Times New Roman",serif;mso-fareast-font-family:
Calibri;mso-ansi-language:ES'><span style='mso-element:field-end'></span></span><![endif]--><span
lang=ES style='font-size:10.0pt;line-height:107%;font-family:"Times New Roman",serif;
mso-fareast-font-family:Calibri;mso-ansi-language:ES'> cambiando el denominador
de 100 PD por número de admisiones. De esta manera el cambio en el consumo
durante el periodo 1992-1994 a 2001-2003 en PDDs por número de admisiones es
+22% y +50% (para medicina interna y cirugía respectivamente). El cambio de
consumo tiene un menor valor debido a que a través de los años, se daba un
incremento en el número de admisiones junto a una disminución de la duración de
estancia, que era mayor en el servicio de medicina interna </span><!--[if supportFields]><span
lang=ES style='font-size:10.0pt;line-height:107%;font-family:"Times New Roman",serif;
mso-fareast-font-family:Calibri;mso-ansi-language:ES'><span style='mso-element:
field-begin;mso-field-lock:yes'></span>ADDIN CSL_CITATION
{&quot;citationItems&quot;:[{&quot;id&quot;:&quot;ITEM-1&quot;,&quot;itemData&quot;:{&quot;DOI&quot;:&quot;10.1007/s15010-006-5085-9&quot;,&quot;ISSN&quot;:&quot;03008126&quot;,&quot;PMID&quot;:&quot;16703299&quot;,&quot;abstract&quot;:&quot;BACKGROUND:
Hospital antibiotic use can be measured by calculating daily doses as defined
by the WHO/ATC index (DDD) divided by the number of patient or occupied bed
days. We wondered whether changes in antibiotic use density over time at a
university hospital using this data format are similar in order of magnitude
when compared with a different, alternative dose definition and the number of
admissions rather than the number of patient days as denominator. METHODS: Data
obtained from the hospital pharmacy for the medical and surgical services of a
1,000-bed university hospital for the period 1992 through 2003 were expressed
both in daily doses per 100 patient days and daily doses per admission. A PDD dose
definition (prescribed daily doses), defining doses that reflect the usually
prescribed dose in adult hospitalized patients with normal renal function was
compared with the WHO/ATC 2001 DDD dose definitions. The percent changes using
the different data formats between two 3-year averages (1992-1994 and
2001-2003) were calculated. RESULTS AND CONCLUSION: The DDD/100 patient days
data format overestimated antibiotic use density changes in this hospital both
in medicine (81% vs 48%) as well as in surgery (69% vs 39%) when compared with
PDD/100 patient days. Due to changes in the number of admissions and length of
stay over the years, the percent change between the two periods expressed in
doses per 100 patient days in addition differed substantially from that
estimated by using the DDD per admission or PDD per admission data format.
Studies evaluating the evolution of hospital antibiotic use need to address the
limitations and adequacy of the different data
formats.&quot;,&quot;author&quot;:[{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;With&quot;,&quot;given&quot;:&quot;K.&quot;,&quot;non-dropping-particle&quot;:&quot;De&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Maier&quot;,&quot;given&quot;:&quot;L.&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Steib-Bauert&quot;,&quot;given&quot;:&quot;M.&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Kern&quot;,&quot;given&quot;:&quot;P.&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;V.&quot;,&quot;family&quot;:&quot;Kern&quot;,&quot;given&quot;:&quot;W.&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;}],&quot;container-title&quot;:&quot;Infection&quot;,&quot;id&quot;:&quot;ITEM-1&quot;,&quot;issue&quot;:&quot;2&quot;,&quot;issued&quot;:{&quot;date-parts&quot;:[[&quot;2006&quot;]]},&quot;page&quot;:&quot;91-94&quot;,&quot;title&quot;:&quot;Trends
in antibiotic use at a University Hospital: Defined or prescribed daily doses?
Patient days or admissions as
denominator?&quot;,&quot;type&quot;:&quot;article-journal&quot;,&quot;volume&quot;:&quot;34&quot;},&quot;uris&quot;:[&quot;http://www.mendeley.com/documents/?uuid=d0a23bba-8474-405e-bf30-f999ad11ce60&quot;]}],&quot;mendeley&quot;:{&quot;formattedCitation&quot;:&quot;(53)&quot;,&quot;plainTextFormattedCitation&quot;:&quot;(53)&quot;,&quot;previouslyFormattedCitation&quot;:&quot;(53)&quot;},&quot;properties&quot;:{&quot;noteIndex&quot;:0},&quot;schema&quot;:&quot;https://github.com/citation-style-language/schema/raw/master/csl-citation.json&quot;}<span
style='mso-element:field-separator'></span></span><![endif]--><span lang=ES
style='font-size:10.0pt;line-height:107%;font-family:"Times New Roman",serif;
mso-fareast-font-family:Calibri;mso-ansi-language:ES'><span style='mso-no-proof:
yes'>(53)</span></span><!--[if supportFields]><span lang=ES style='font-size:
10.0pt;line-height:107%;font-family:"Times New Roman",serif;mso-fareast-font-family:
Calibri;mso-ansi-language:ES'><span style='mso-element:field-end'></span></span><![endif]--><span
lang=ES style='font-size:10.0pt;line-height:107%;font-family:"Times New Roman",serif;
mso-fareast-font-family:Calibri;mso-ansi-language:ES'>. El número de admisiones
se ve afectado por LOS en comparación al número de camas ocupados.<o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0mm;margin-bottom:.0001pt;text-align:
justify;text-indent:11.35pt'><span lang=ES style='font-size:10.0pt;line-height:
107%;font-family:"Times New Roman",serif;mso-fareast-font-family:Calibri;
mso-ansi-language:ES'><o:p>&nbsp;</o:p></span></p>

<p class=MsoNormal style='margin-bottom:0mm;margin-bottom:.0001pt;text-align:
justify;text-indent:11.35pt'><span style='font-size:10.0pt;line-height:107%;
font-family:"Times New Roman",serif;mso-fareast-font-family:Calibri;mso-ansi-language:
ES-CO'>Existen factores dependientes de la metodología de medición que pueden
hacer cambiar los resultados de consumo obtenidos limitando la comparabilidad
de los resultados entre instituciones </span><!--[if supportFields]><span
style='font-size:10.0pt;line-height:107%;font-family:"Times New Roman",serif;
mso-fareast-font-family:Calibri;mso-ansi-language:ES-CO'><span
style='mso-element:field-begin;mso-field-lock:yes'></span>ADDIN CSL_CITATION
{&quot;citationItems&quot;:[{&quot;id&quot;:&quot;ITEM-1&quot;,&quot;itemData&quot;:{&quot;DOI&quot;:&quot;10.1007/s15010-008-7462-z&quot;,&quot;ISBN&quot;:&quot;03008126&quot;,&quot;ISSN&quot;:&quot;03008126&quot;,&quot;PMID&quot;:&quot;19011740&quot;,&quot;abstract&quot;:&quot;Reports
on antibiotic use often lack complete definitions of the units of measurement,
hampering the comparison of data between hospitals or hospital units. To
compare methods of measures of in-hospital antimicrobial use, we determined
aggregate in-hospital consumption data at a tertiary care university hospital
using variations of nominators and denominators. Means of defined daily doses
(DDD) of individual antimicrobials per 100 bed-days and per 100 admissions at
each hospital and intensive care unit (ICU) were calculated. Furthermore, a
literature review was performed for benchmarking purposes. Antibiotic use in
different hospital units ranged from 0.105 to 323.37 DDD/100 bed-days and from
4.23 to 6737.92 DDD/100 admissions, respectively. Including the day of
discharge in the denominator 'bed-days' underestimated antibiotic use in
various hospital wards by up to 27.7 DDD/100 bed-days (26.0%). Equating
'numbers of patients admitted to the hospital' and 'numbers of admissions' on a
hospital level resulted in a difference of 192.6 DDD/100 admissions (64%)
because patients transferred between hospital units accounted for multiple
admissions. Likewise, reporting antimicrobial (Anatomical Therapeutic Chemical
[ATC] group 'J') instead of antibiotic (ATC group 'J01') use led to a
difference of 16.5 DDD/100 bed-days (19.3%). The literature review revealed
underreporting of complete definitions of antibiotic use measurements. Data on
in-hospital antimicrobial use vary widely not only due to different antibiotic
policies at different institutions but also due to different methods of
measures. Adherence to the standard of reporting the methods of measurement is
warranted for benchmarking and promotion of rational antimicrobial
use.&quot;,&quot;author&quot;:[{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Kuster&quot;,&quot;given&quot;:&quot;S.
P.&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Ruef&quot;,&quot;given&quot;:&quot;C.&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Ledergerber&quot;,&quot;given&quot;:&quot;B.&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Hintermann&quot;,&quot;given&quot;:&quot;A.&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Deplazes&quot;,&quot;given&quot;:&quot;C.&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Neuber&quot;,&quot;given&quot;:&quot;L.&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Weber&quot;,&quot;given&quot;:&quot;R.&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;}],&quot;container-title&quot;:&quot;Infection&quot;,&quot;id&quot;:&quot;ITEM-1&quot;,&quot;issue&quot;:&quot;6&quot;,&quot;issued&quot;:{&quot;date-parts&quot;:[[&quot;2008&quot;]]},&quot;page&quot;:&quot;549-559&quot;,&quot;title&quot;:&quot;Quantitative
antibiotic use in hospitals: Comparison of measurements, literature review, and
recommendations for a standard of
reporting&quot;,&quot;type&quot;:&quot;article-journal&quot;,&quot;volume&quot;:&quot;36&quot;},&quot;uris&quot;:[&quot;http://www.mendeley.com/documents/?uuid=09d6d835-3880-4f79-83b5-6e020c660ddc&quot;]}],&quot;mendeley&quot;:{&quot;formattedCitation&quot;:&quot;(15)&quot;,&quot;plainTextFormattedCitation&quot;:&quot;(15)&quot;,&quot;previouslyFormattedCitation&quot;:&quot;(15)&quot;},&quot;properties&quot;:{&quot;noteIndex&quot;:0},&quot;schema&quot;:&quot;https://github.com/citation-style-language/schema/raw/master/csl-citation.json&quot;}<span
style='mso-element:field-separator'></span></span><![endif]--><span
style='font-size:10.0pt;line-height:107%;font-family:"Times New Roman",serif;
mso-fareast-font-family:Calibri;mso-ansi-language:ES-CO'><span
style='mso-no-proof:yes'>(15)</span></span><!--[if supportFields]><span
style='font-size:10.0pt;line-height:107%;font-family:"Times New Roman",serif;
mso-fareast-font-family:Calibri;mso-ansi-language:ES-CO'><span
style='mso-element:field-end'></span></span><![endif]--><span style='font-size:
10.0pt;line-height:107%;font-family:"Times New Roman",serif;mso-fareast-font-family:
Calibri;mso-ansi-language:ES-CO'>. En un estudio se encontraron discrepancias
de hasta 26% en el indicador de DDD/100 PD dependiendo sí los días de admisión
y egreso son contados como uno o dos, se sugiere contarlos como un solo día. El
consumo promedio de antibacterianos fue de 69.2 DDDs/100 PD equivalente a 300.3
DDDs/100 admisiones </span><!--[if supportFields]><span style='font-size:10.0pt;
line-height:107%;font-family:"Times New Roman",serif;mso-fareast-font-family:
Calibri;mso-ansi-language:ES-CO'><span style='mso-element:field-begin;
mso-field-lock:yes'></span>ADDIN CSL_CITATION
{&quot;citationItems&quot;:[{&quot;id&quot;:&quot;ITEM-1&quot;,&quot;itemData&quot;:{&quot;DOI&quot;:&quot;10.1007/s15010-008-7462-z&quot;,&quot;ISBN&quot;:&quot;03008126&quot;,&quot;ISSN&quot;:&quot;03008126&quot;,&quot;PMID&quot;:&quot;19011740&quot;,&quot;abstract&quot;:&quot;Reports
on antibiotic use often lack complete definitions of the units of measurement,
hampering the comparison of data between hospitals or hospital units. To
compare methods of measures of in-hospital antimicrobial use, we determined
aggregate in-hospital consumption data at a tertiary care university hospital
using variations of nominators and denominators. Means of defined daily doses
(DDD) of individual antimicrobials per 100 bed-days and per 100 admissions at
each hospital and intensive care unit (ICU) were calculated. Furthermore, a
literature review was performed for benchmarking purposes. Antibiotic use in
different hospital units ranged from 0.105 to 323.37 DDD/100 bed-days and from
4.23 to 6737.92 DDD/100 admissions, respectively. Including the day of
discharge in the denominator 'bed-days' underestimated antibiotic use in
various hospital wards by up to 27.7 DDD/100 bed-days (26.0%). Equating
'numbers of patients admitted to the hospital' and 'numbers of admissions' on a
hospital level resulted in a difference of 192.6 DDD/100 admissions (64%)
because patients transferred between hospital units accounted for multiple
admissions. Likewise, reporting antimicrobial (Anatomical Therapeutic Chemical
[ATC] group 'J') instead of antibiotic (ATC group 'J01') use led to a
difference of 16.5 DDD/100 bed-days (19.3%). The literature review revealed
underreporting of complete definitions of antibiotic use measurements. Data on
in-hospital antimicrobial use vary widely not only due to different antibiotic
policies at different institutions but also due to different methods of
measures. Adherence to the standard of reporting the methods of measurement is
warranted for benchmarking and promotion of rational antimicrobial
use.&quot;,&quot;author&quot;:[{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Kuster&quot;,&quot;given&quot;:&quot;S.
P.&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Ruef&quot;,&quot;given&quot;:&quot;C.&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Ledergerber&quot;,&quot;given&quot;:&quot;B.&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Hintermann&quot;,&quot;given&quot;:&quot;A.&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Deplazes&quot;,&quot;given&quot;:&quot;C.&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Neuber&quot;,&quot;given&quot;:&quot;L.&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Weber&quot;,&quot;given&quot;:&quot;R.&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;}],&quot;container-title&quot;:&quot;Infection&quot;,&quot;id&quot;:&quot;ITEM-1&quot;,&quot;issue&quot;:&quot;6&quot;,&quot;issued&quot;:{&quot;date-parts&quot;:[[&quot;2008&quot;]]},&quot;page&quot;:&quot;549-559&quot;,&quot;title&quot;:&quot;Quantitative
antibiotic use in hospitals: Comparison of measurements, literature review, and
recommendations for a standard of
reporting&quot;,&quot;type&quot;:&quot;article-journal&quot;,&quot;volume&quot;:&quot;36&quot;},&quot;uris&quot;:[&quot;http://www.mendeley.com/documents/?uuid=09d6d835-3880-4f79-83b5-6e020c660ddc&quot;]}],&quot;mendeley&quot;:{&quot;formattedCitation&quot;:&quot;(15)&quot;,&quot;plainTextFormattedCitation&quot;:&quot;(15)&quot;,&quot;previouslyFormattedCitation&quot;:&quot;(15)&quot;},&quot;properties&quot;:{&quot;noteIndex&quot;:0},&quot;schema&quot;:&quot;https://github.com/citation-style-language/schema/raw/master/csl-citation.json&quot;}<span
style='mso-element:field-separator'></span></span><![endif]--><span
style='font-size:10.0pt;line-height:107%;font-family:"Times New Roman",serif;
mso-fareast-font-family:Calibri;mso-ansi-language:ES-CO'><span
style='mso-no-proof:yes'>(15)</span></span><!--[if supportFields]><span
style='font-size:10.0pt;line-height:107%;font-family:"Times New Roman",serif;
mso-fareast-font-family:Calibri;mso-ansi-language:ES-CO'><span
style='mso-element:field-end'></span></span><![endif]--><span style='font-size:
10.0pt;line-height:107%;font-family:"Times New Roman",serif;mso-fareast-font-family:
Calibri;mso-ansi-language:ES-CO'>. La tendencia en el consumo de antibióticos
sobre el tiempo se vio alterada por la versión del índice ATC/DDD utilizada. Se
observó una reducción del consumo total del 20.6% (69.15 vs 87.09 DDD/100 PD)
debido a la utilización de la versión 2007 vs 2002. El cambio en la definición
de dosis para amoxicilina-clavulanato (antibiótico frecuentemente utilizado)
explica la variación </span><!--[if supportFields]><span style='font-size:10.0pt;
line-height:107%;font-family:"Times New Roman",serif;mso-fareast-font-family:
Calibri;mso-ansi-language:ES-CO'><span style='mso-element:field-begin;
mso-field-lock:yes'></span>ADDIN CSL_CITATION
{&quot;citationItems&quot;:[{&quot;id&quot;:&quot;ITEM-1&quot;,&quot;itemData&quot;:{&quot;DOI&quot;:&quot;10.1007/s15010-008-7462-z&quot;,&quot;ISBN&quot;:&quot;03008126&quot;,&quot;ISSN&quot;:&quot;03008126&quot;,&quot;PMID&quot;:&quot;19011740&quot;,&quot;abstract&quot;:&quot;Reports
on antibiotic use often lack complete definitions of the units of measurement,
hampering the comparison of data between hospitals or hospital units. To
compare methods of measures of in-hospital antimicrobial use, we determined
aggregate in-hospital consumption data at a tertiary care university hospital
using variations of nominators and denominators. Means of defined daily doses
(DDD) of individual antimicrobials per 100 bed-days and per 100 admissions at
each hospital and intensive care unit (ICU) were calculated. Furthermore, a
literature review was performed for benchmarking purposes. Antibiotic use in
different hospital units ranged from 0.105 to 323.37 DDD/100 bed-days and from
4.23 to 6737.92 DDD/100 admissions, respectively. Including the day of
discharge in the denominator 'bed-days' underestimated antibiotic use in
various hospital wards by up to 27.7 DDD/100 bed-days (26.0%). Equating
'numbers of patients admitted to the hospital' and 'numbers of admissions' on a
hospital level resulted in a difference of 192.6 DDD/100 admissions (64%)
because patients transferred between hospital units accounted for multiple
admissions. Likewise, reporting antimicrobial (Anatomical Therapeutic Chemical
[ATC] group 'J') instead of antibiotic (ATC group 'J01') use led to a
difference of 16.5 DDD/100 bed-days (19.3%). The literature review revealed
underreporting of complete definitions of antibiotic use measurements. Data on
in-hospital antimicrobial use vary widely not only due to different antibiotic
policies at different institutions but also due to different methods of
measures. Adherence to the standard of reporting the methods of measurement is
warranted for benchmarking and promotion of rational antimicrobial
use.&quot;,&quot;author&quot;:[{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Kuster&quot;,&quot;given&quot;:&quot;S.
P.&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Ruef&quot;,&quot;given&quot;:&quot;C.&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Ledergerber&quot;,&quot;given&quot;:&quot;B.&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Hintermann&quot;,&quot;given&quot;:&quot;A.&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Deplazes&quot;,&quot;given&quot;:&quot;C.&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Neuber&quot;,&quot;given&quot;:&quot;L.&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Weber&quot;,&quot;given&quot;:&quot;R.&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;}],&quot;container-title&quot;:&quot;Infection&quot;,&quot;id&quot;:&quot;ITEM-1&quot;,&quot;issue&quot;:&quot;6&quot;,&quot;issued&quot;:{&quot;date-parts&quot;:[[&quot;2008&quot;]]},&quot;page&quot;:&quot;549-559&quot;,&quot;title&quot;:&quot;Quantitative
antibiotic use in hospitals: Comparison of measurements, literature review, and
recommendations for a standard of
reporting&quot;,&quot;type&quot;:&quot;article-journal&quot;,&quot;volume&quot;:&quot;36&quot;},&quot;uris&quot;:[&quot;http://www.mendeley.com/documents/?uuid=09d6d835-3880-4f79-83b5-6e020c660ddc&quot;]}],&quot;mendeley&quot;:{&quot;formattedCitation&quot;:&quot;(15)&quot;,&quot;plainTextFormattedCitation&quot;:&quot;(15)&quot;,&quot;previouslyFormattedCitation&quot;:&quot;(15)&quot;},&quot;properties&quot;:{&quot;noteIndex&quot;:0},&quot;schema&quot;:&quot;https://github.com/citation-style-language/schema/raw/master/csl-citation.json&quot;}<span
style='mso-element:field-separator'></span></span><![endif]--><span
style='font-size:10.0pt;line-height:107%;font-family:"Times New Roman",serif;
mso-fareast-font-family:Calibri;mso-ansi-language:ES-CO'><span
style='mso-no-proof:yes'>(15)</span></span><!--[if supportFields]><span
style='font-size:10.0pt;line-height:107%;font-family:"Times New Roman",serif;
mso-fareast-font-family:Calibri;mso-ansi-language:ES-CO'><span
style='mso-element:field-end'></span></span><![endif]--><span style='font-size:
10.0pt;line-height:107%;font-family:"Times New Roman",serif;mso-fareast-font-family:
Calibri;mso-ansi-language:ES-CO'>.<o:p></o:p></span></p>

<p class=IOPH1><span style='mso-ansi-language:ES-CO'>8. Consumo de antibióticos
en falla renal<o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0mm;margin-bottom:.0001pt;text-align:
justify;text-indent:11.35pt'><span style='font-size:10.0pt;line-height:107%;
font-family:"Times New Roman",serif;mso-fareast-font-family:Calibri;mso-ansi-language:
ES-CO'>La necesidad de ajuste de dosis de antibióticos en pacientes con falla
renal constituye un factor que dificulta la medición del consumo de
antibióticos en este grupo de pacientes. Un estudio evaluó la influencia de la
falla renal en la medición de consumo a través de DDDs y DOTs, en vancomicina,
levofloxacina y ceftriaxona </span><!--[if supportFields]><span
style='font-size:10.0pt;line-height:107%;font-family:"Times New Roman",serif;
mso-fareast-font-family:Calibri;mso-ansi-language:ES-CO'><span
style='mso-element:field-begin;mso-field-lock:yes'></span>ADDIN CSL_CITATION
{&quot;citationItems&quot;:[{&quot;id&quot;:&quot;ITEM-1&quot;,&quot;itemData&quot;:{&quot;DOI&quot;:&quot;10.1086/344753&quot;,&quot;ISSN&quot;:&quot;1537-6591&quot;,&quot;PMID&quot;:&quot;12471568&quot;,&quot;abstract&quot;:&quot;The
defined daily dose, a popular measurement of antimicrobial use, may
underestimate the use of antimicrobials that are dose-adjusted in patients with
renal insufficiency. To evaluate the effect of renal dysfunction on these
measures, we performed a retrospective cohort study that involved patients
receiving ceftriaxone, levofloxacin, or vancomycin, with use of defined daily
doses and 2 methods based on therapy duration--stop-start days (i.e., entire
therapy duration) and transaction days (i.e., unique therapeutic days). The
vancomycin use rate for patients with renal insufficiency was 36% lower than
that of patients with normal renal function for defined daily doses, and it was
23% lower for transaction days; for levofloxacin, there was a 27% rate
reduction for the defined daily dose. No significant reduction was noted when
the stop-start day method was used. Compared with the defined daily dose
method, measures of therapy duration are less affected by renal function and
may improve comparisons between populations.&quot;,&quot;author&quot;:[{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Zagorski&quot;,&quot;given&quot;:&quot;B
M&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Trick&quot;,&quot;given&quot;:&quot;W
E&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Schwartz&quot;,&quot;given&quot;:&quot;D
N&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Wisniewski&quot;,&quot;given&quot;:&quot;M
F&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Hershow&quot;,&quot;given&quot;:&quot;R
C&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Fridkin&quot;,&quot;given&quot;:&quot;S
K&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Weinstein&quot;,&quot;given&quot;:&quot;R
a&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;}],&quot;container-title&quot;:&quot;Clinical
Infectious Diseases&quot;,&quot;id&quot;:&quot;ITEM-1&quot;,&quot;issue&quot;:&quot;12&quot;,&quot;issued&quot;:{&quot;date-parts&quot;:[[&quot;2002&quot;]]},&quot;page&quot;:&quot;1491-7&quot;,&quot;title&quot;:&quot;The
effect of renal dysfunction on antimicrobial use
measurements.&quot;,&quot;type&quot;:&quot;article-journal&quot;,&quot;volume&quot;:&quot;35&quot;},&quot;uris&quot;:[&quot;http://www.mendeley.com/documents/?uuid=f92142ad-ac18-4df9-b187-e43988032dfb&quot;]}],&quot;mendeley&quot;:{&quot;formattedCitation&quot;:&quot;(43)&quot;,&quot;plainTextFormattedCitation&quot;:&quot;(43)&quot;,&quot;previouslyFormattedCitation&quot;:&quot;(43)&quot;},&quot;properties&quot;:{&quot;noteIndex&quot;:0},&quot;schema&quot;:&quot;https://github.com/citation-style-language/schema/raw/master/csl-citation.json&quot;}<span
style='mso-element:field-separator'></span></span><![endif]--><span
style='font-size:10.0pt;line-height:107%;font-family:"Times New Roman",serif;
mso-fareast-font-family:Calibri;mso-ansi-language:ES-CO'><span
style='mso-no-proof:yes'>(43)</span></span><!--[if supportFields]><span
style='font-size:10.0pt;line-height:107%;font-family:"Times New Roman",serif;
mso-fareast-font-family:Calibri;mso-ansi-language:ES-CO'><span
style='mso-element:field-end'></span></span><![endif]--><span style='font-size:
10.0pt;line-height:107%;font-family:"Times New Roman",serif;mso-fareast-font-family:
Calibri;mso-ansi-language:ES-CO'>. La tasa de consumo en DDDs tiende a ser
subestimada en pacientes con insuficiencia renal. En pacientes con vancomicina
(31.8 vs 49.3 DDDs/100 PD) y levofloxacina (57.8 vs 79.3 DDDs/100 PD) el
consumo en DDDs es menor en pacientes con falla renal, FR que, en pacientes con
función renal normal, FRN respectivamente. En el caso de ceftriaxona no se
encontraron diferencias en consumo (86.8 vs 88.7 DDDs/100 PD) en pacientes con
FR y FRN </span><!--[if supportFields]><span style='font-size:10.0pt;
line-height:107%;font-family:"Times New Roman",serif;mso-fareast-font-family:
Calibri;mso-ansi-language:ES-CO'><span style='mso-element:field-begin;
mso-field-lock:yes'></span>ADDIN CSL_CITATION
{&quot;citationItems&quot;:[{&quot;id&quot;:&quot;ITEM-1&quot;,&quot;itemData&quot;:{&quot;DOI&quot;:&quot;10.1086/344753&quot;,&quot;ISSN&quot;:&quot;1537-6591&quot;,&quot;PMID&quot;:&quot;12471568&quot;,&quot;abstract&quot;:&quot;The
defined daily dose, a popular measurement of antimicrobial use, may
underestimate the use of antimicrobials that are dose-adjusted in patients with
renal insufficiency. To evaluate the effect of renal dysfunction on these
measures, we performed a retrospective cohort study that involved patients
receiving ceftriaxone, levofloxacin, or vancomycin, with use of defined daily
doses and 2 methods based on therapy duration--stop-start days (i.e., entire
therapy duration) and transaction days (i.e., unique therapeutic days). The
vancomycin use rate for patients with renal insufficiency was 36% lower than
that of patients with normal renal function for defined daily doses, and it was
23% lower for transaction days; for levofloxacin, there was a 27% rate
reduction for the defined daily dose. No significant reduction was noted when
the stop-start day method was used. Compared with the defined daily dose
method, measures of therapy duration are less affected by renal function and
may improve comparisons between
populations.&quot;,&quot;author&quot;:[{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Zagorski&quot;,&quot;given&quot;:&quot;B
M&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Trick&quot;,&quot;given&quot;:&quot;W
E&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Schwartz&quot;,&quot;given&quot;:&quot;D
N&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Wisniewski&quot;,&quot;given&quot;:&quot;M
F&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Hershow&quot;,&quot;given&quot;:&quot;R
C&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Fridkin&quot;,&quot;given&quot;:&quot;S
K&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Weinstein&quot;,&quot;given&quot;:&quot;R
a&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;}],&quot;container-title&quot;:&quot;Clinical
Infectious
Diseases&quot;,&quot;id&quot;:&quot;ITEM-1&quot;,&quot;issue&quot;:&quot;12&quot;,&quot;issued&quot;:{&quot;date-parts&quot;:[[&quot;2002&quot;]]},&quot;page&quot;:&quot;1491-7&quot;,&quot;title&quot;:&quot;The
effect of renal dysfunction on antimicrobial use
measurements.&quot;,&quot;type&quot;:&quot;article-journal&quot;,&quot;volume&quot;:&quot;35&quot;},&quot;uris&quot;:[&quot;http://www.mendeley.com/documents/?uuid=f92142ad-ac18-4df9-b187-e43988032dfb&quot;]}],&quot;mendeley&quot;:{&quot;formattedCitation&quot;:&quot;(43)&quot;,&quot;plainTextFormattedCitation&quot;:&quot;(43)&quot;,&quot;previouslyFormattedCitation&quot;:&quot;(43)&quot;},&quot;properties&quot;:{&quot;noteIndex&quot;:0},&quot;schema&quot;:&quot;https://github.com/citation-style-language/schema/raw/master/csl-citation.json&quot;}<span
style='mso-element:field-separator'></span></span><![endif]--><span
style='font-size:10.0pt;line-height:107%;font-family:"Times New Roman",serif;
mso-fareast-font-family:Calibri;mso-ansi-language:ES-CO'><span
style='mso-no-proof:yes'>(43)</span></span><!--[if supportFields]><span
style='font-size:10.0pt;line-height:107%;font-family:"Times New Roman",serif;
mso-fareast-font-family:Calibri;mso-ansi-language:ES-CO'><span
style='mso-element:field-end'></span></span><![endif]--><span style='font-size:
10.0pt;line-height:107%;font-family:"Times New Roman",serif;mso-fareast-font-family:
Calibri;mso-ansi-language:ES-CO'>. <o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0mm;margin-bottom:.0001pt;text-align:
justify;text-indent:11.35pt'><span style='font-size:10.0pt;line-height:107%;
font-family:"Times New Roman",serif;mso-fareast-font-family:Calibri;mso-ansi-language:
ES-CO'><o:p>&nbsp;</o:p></span></p>

<p class=MsoNormal style='margin-bottom:0mm;margin-bottom:.0001pt;text-align:
justify;text-indent:11.35pt'><span style='font-size:10.0pt;line-height:107%;
font-family:"Times New Roman",serif;mso-fareast-font-family:Calibri;mso-ansi-language:
ES-CO'>Las medidas de consumo que evalúan la duración de tratamiento son menos
afectadas por variaciones en la función renal </span><!--[if supportFields]><span
style='font-size:10.0pt;line-height:107%;font-family:"Times New Roman",serif;
mso-fareast-font-family:Calibri;mso-ansi-language:ES-CO'><span
style='mso-element:field-begin;mso-field-lock:yes'></span>ADDIN CSL_CITATION {&quot;citationItems&quot;:[{&quot;id&quot;:&quot;ITEM-1&quot;,&quot;itemData&quot;:{&quot;DOI&quot;:&quot;10.1086/344753&quot;,&quot;ISSN&quot;:&quot;1537-6591&quot;,&quot;PMID&quot;:&quot;12471568&quot;,&quot;abstract&quot;:&quot;The
defined daily dose, a popular measurement of antimicrobial use, may
underestimate the use of antimicrobials that are dose-adjusted in patients with
renal insufficiency. To evaluate the effect of renal dysfunction on these
measures, we performed a retrospective cohort study that involved patients
receiving ceftriaxone, levofloxacin, or vancomycin, with use of defined daily
doses and 2 methods based on therapy duration--stop-start days (i.e., entire
therapy duration) and transaction days (i.e., unique therapeutic days). The
vancomycin use rate for patients with renal insufficiency was 36% lower than
that of patients with normal renal function for defined daily doses, and it was
23% lower for transaction days; for levofloxacin, there was a 27% rate
reduction for the defined daily dose. No significant reduction was noted when
the stop-start day method was used. Compared with the defined daily dose
method, measures of therapy duration are less affected by renal function and
may improve comparisons between
populations.&quot;,&quot;author&quot;:[{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Zagorski&quot;,&quot;given&quot;:&quot;B
M&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Trick&quot;,&quot;given&quot;:&quot;W
E&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Schwartz&quot;,&quot;given&quot;:&quot;D
N&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Wisniewski&quot;,&quot;given&quot;:&quot;M
F&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Hershow&quot;,&quot;given&quot;:&quot;R
C&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Fridkin&quot;,&quot;given&quot;:&quot;S
K&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Weinstein&quot;,&quot;given&quot;:&quot;R
a&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;}],&quot;container-title&quot;:&quot;Clinical
Infectious Diseases&quot;,&quot;id&quot;:&quot;ITEM-1&quot;,&quot;issue&quot;:&quot;12&quot;,&quot;issued&quot;:{&quot;date-parts&quot;:[[&quot;2002&quot;]]},&quot;page&quot;:&quot;1491-7&quot;,&quot;title&quot;:&quot;The
effect of renal dysfunction on antimicrobial use
measurements.&quot;,&quot;type&quot;:&quot;article-journal&quot;,&quot;volume&quot;:&quot;35&quot;},&quot;uris&quot;:[&quot;http://www.mendeley.com/documents/?uuid=f92142ad-ac18-4df9-b187-e43988032dfb&quot;]}],&quot;mendeley&quot;:{&quot;formattedCitation&quot;:&quot;(43)&quot;,&quot;plainTextFormattedCitation&quot;:&quot;(43)&quot;,&quot;previouslyFormattedCitation&quot;:&quot;(43)&quot;},&quot;properties&quot;:{&quot;noteIndex&quot;:0},&quot;schema&quot;:&quot;https://github.com/citation-style-language/schema/raw/master/csl-citation.json&quot;}<span
style='mso-element:field-separator'></span></span><![endif]--><span
style='font-size:10.0pt;line-height:107%;font-family:"Times New Roman",serif;
mso-fareast-font-family:Calibri;mso-ansi-language:ES-CO'><span
style='mso-no-proof:yes'>(43)</span></span><!--[if supportFields]><span
style='font-size:10.0pt;line-height:107%;font-family:"Times New Roman",serif;
mso-fareast-font-family:Calibri;mso-ansi-language:ES-CO'><span
style='mso-element:field-end'></span></span><![endif]--><span style='font-size:
10.0pt;line-height:107%;font-family:"Times New Roman",serif;mso-fareast-font-family:
Calibri;mso-ansi-language:ES-CO'>. El consumo de levofloxacina (51.7 vs 57.0
DOTs/100 PD) y ceftriaxona (51.1 vs 54.1 DOTs/100 PD), es similar en pacientes
con FR y FRN </span><!--[if supportFields]><span style='font-size:10.0pt;
line-height:107%;font-family:"Times New Roman",serif;mso-fareast-font-family:
Calibri;mso-ansi-language:ES-CO'><span style='mso-element:field-begin;
mso-field-lock:yes'></span>ADDIN CSL_CITATION
{&quot;citationItems&quot;:[{&quot;id&quot;:&quot;ITEM-1&quot;,&quot;itemData&quot;:{&quot;DOI&quot;:&quot;10.1086/344753&quot;,&quot;ISSN&quot;:&quot;1537-6591&quot;,&quot;PMID&quot;:&quot;12471568&quot;,&quot;abstract&quot;:&quot;The
defined daily dose, a popular measurement of antimicrobial use, may
underestimate the use of antimicrobials that are dose-adjusted in patients with
renal insufficiency. To evaluate the effect of renal dysfunction on these
measures, we performed a retrospective cohort study that involved patients
receiving ceftriaxone, levofloxacin, or vancomycin, with use of defined daily
doses and 2 methods based on therapy duration--stop-start days (i.e., entire
therapy duration) and transaction days (i.e., unique therapeutic days). The
vancomycin use rate for patients with renal insufficiency was 36% lower than
that of patients with normal renal function for defined daily doses, and it was
23% lower for transaction days; for levofloxacin, there was a 27% rate
reduction for the defined daily dose. No significant reduction was noted when
the stop-start day method was used. Compared with the defined daily dose
method, measures of therapy duration are less affected by renal function and
may improve comparisons between
populations.&quot;,&quot;author&quot;:[{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Zagorski&quot;,&quot;given&quot;:&quot;B
M&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Trick&quot;,&quot;given&quot;:&quot;W
E&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Schwartz&quot;,&quot;given&quot;:&quot;D
N&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Wisniewski&quot;,&quot;given&quot;:&quot;M
F&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Hershow&quot;,&quot;given&quot;:&quot;R
C&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Fridkin&quot;,&quot;given&quot;:&quot;S
K&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Weinstein&quot;,&quot;given&quot;:&quot;R
a&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;}],&quot;container-title&quot;:&quot;Clinical
Infectious Diseases&quot;,&quot;id&quot;:&quot;ITEM-1&quot;,&quot;issue&quot;:&quot;12&quot;,&quot;issued&quot;:{&quot;date-parts&quot;:[[&quot;2002&quot;]]},&quot;page&quot;:&quot;1491-7&quot;,&quot;title&quot;:&quot;The
effect of renal dysfunction on antimicrobial use
measurements.&quot;,&quot;type&quot;:&quot;article-journal&quot;,&quot;volume&quot;:&quot;35&quot;},&quot;uris&quot;:[&quot;http://www.mendeley.com/documents/?uuid=f92142ad-ac18-4df9-b187-e43988032dfb&quot;]}],&quot;mendeley&quot;:{&quot;formattedCitation&quot;:&quot;(43)&quot;,&quot;plainTextFormattedCitation&quot;:&quot;(43)&quot;,&quot;previouslyFormattedCitation&quot;:&quot;(43)&quot;},&quot;properties&quot;:{&quot;noteIndex&quot;:0},&quot;schema&quot;:&quot;https://github.com/citation-style-language/schema/raw/master/csl-citation.json&quot;}<span
style='mso-element:field-separator'></span></span><![endif]--><span
style='font-size:10.0pt;line-height:107%;font-family:"Times New Roman",serif;
mso-fareast-font-family:Calibri;mso-ansi-language:ES-CO'><span
style='mso-no-proof:yes'>(43)</span></span><!--[if supportFields]><span
style='font-size:10.0pt;line-height:107%;font-family:"Times New Roman",serif;
mso-fareast-font-family:Calibri;mso-ansi-language:ES-CO'><span
style='mso-element:field-end'></span></span><![endif]--><span style='font-size:
10.0pt;line-height:107%;font-family:"Times New Roman",serif;mso-fareast-font-family:
Calibri;mso-ansi-language:ES-CO'>. Sin embargo el consumo de vancomicina para
pacientes con FR (34.8 DOTs/100 PD) es diferente al consumo en aquellos con FRN
(45.2 DOTs/100 PD) </span><!--[if supportFields]><span style='font-size:10.0pt;
line-height:107%;font-family:"Times New Roman",serif;mso-fareast-font-family:
Calibri;mso-ansi-language:ES-CO'><span style='mso-element:field-begin;
mso-field-lock:yes'></span>ADDIN CSL_CITATION
{&quot;citationItems&quot;:[{&quot;id&quot;:&quot;ITEM-1&quot;,&quot;itemData&quot;:{&quot;DOI&quot;:&quot;10.1086/344753&quot;,&quot;ISSN&quot;:&quot;1537-6591&quot;,&quot;PMID&quot;:&quot;12471568&quot;,&quot;abstract&quot;:&quot;The
defined daily dose, a popular measurement of antimicrobial use, may underestimate
the use of antimicrobials that are dose-adjusted in patients with renal
insufficiency. To evaluate the effect of renal dysfunction on these measures,
we performed a retrospective cohort study that involved patients receiving
ceftriaxone, levofloxacin, or vancomycin, with use of defined daily doses and 2
methods based on therapy duration--stop-start days (i.e., entire therapy
duration) and transaction days (i.e., unique therapeutic days). The vancomycin
use rate for patients with renal insufficiency was 36% lower than that of
patients with normal renal function for defined daily doses, and it was 23%
lower for transaction days; for levofloxacin, there was a 27% rate reduction
for the defined daily dose. No significant reduction was noted when the stop-start
day method was used. Compared with the defined daily dose method, measures of
therapy duration are less affected by renal function and may improve
comparisons between
populations.&quot;,&quot;author&quot;:[{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Zagorski&quot;,&quot;given&quot;:&quot;B
M&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Trick&quot;,&quot;given&quot;:&quot;W
E&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Schwartz&quot;,&quot;given&quot;:&quot;D
N&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Wisniewski&quot;,&quot;given&quot;:&quot;M
F&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Hershow&quot;,&quot;given&quot;:&quot;R
C&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Fridkin&quot;,&quot;given&quot;:&quot;S
K&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Weinstein&quot;,&quot;given&quot;:&quot;R
a&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;}],&quot;container-title&quot;:&quot;Clinical
Infectious
Diseases&quot;,&quot;id&quot;:&quot;ITEM-1&quot;,&quot;issue&quot;:&quot;12&quot;,&quot;issued&quot;:{&quot;date-parts&quot;:[[&quot;2002&quot;]]},&quot;page&quot;:&quot;1491-7&quot;,&quot;title&quot;:&quot;The
effect of renal dysfunction on antimicrobial use
measurements.&quot;,&quot;type&quot;:&quot;article-journal&quot;,&quot;volume&quot;:&quot;35&quot;},&quot;uris&quot;:[&quot;http://www.mendeley.com/documents/?uuid=f92142ad-ac18-4df9-b187-e43988032dfb&quot;]}],&quot;mendeley&quot;:{&quot;formattedCitation&quot;:&quot;(43)&quot;,&quot;plainTextFormattedCitation&quot;:&quot;(43)&quot;,&quot;previouslyFormattedCitation&quot;:&quot;(43)&quot;},&quot;properties&quot;:{&quot;noteIndex&quot;:0},&quot;schema&quot;:&quot;https://github.com/citation-style-language/schema/raw/master/csl-citation.json&quot;}<span
style='mso-element:field-separator'></span></span><![endif]--><span
style='font-size:10.0pt;line-height:107%;font-family:"Times New Roman",serif;
mso-fareast-font-family:Calibri;mso-ansi-language:ES-CO'><span
style='mso-no-proof:yes'>(43)</span></span><!--[if supportFields]><span
style='font-size:10.0pt;line-height:107%;font-family:"Times New Roman",serif;
mso-fareast-font-family:Calibri;mso-ansi-language:ES-CO'><span
style='mso-element:field-end'></span></span><![endif]--><span style='font-size:
10.0pt;line-height:107%;font-family:"Times New Roman",serif;mso-fareast-font-family:
Calibri;mso-ansi-language:ES-CO'>.<o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0mm;margin-bottom:.0001pt;text-align:
justify;text-indent:11.35pt'><span style='font-size:10.0pt;line-height:107%;
font-family:"Times New Roman",serif;mso-fareast-font-family:Calibri;mso-ansi-language:
ES-CO'><o:p>&nbsp;</o:p></span></p>

<p class=MsoNormal style='margin-bottom:0mm;margin-bottom:.0001pt;text-align:
justify;text-indent:11.35pt'><span style='font-size:10.0pt;line-height:107%;
font-family:"Times New Roman",serif;mso-fareast-font-family:Calibri;mso-ansi-language:
ES-CO'>Los pacientes con requerimiento de diálisis requieren intervalos de
dosificación mayores a un día de acuerdo al tipo de medicamento. En estos
pacientes la definición de DOTs como conteo de días en los cuales se administró
el antibiótico al paciente podría no reflejar la verdadera exposición al
fármaco </span><!--[if supportFields]><span style='font-size:10.0pt;line-height:
107%;font-family:"Times New Roman",serif;mso-fareast-font-family:Calibri;
mso-ansi-language:ES-CO'><span style='mso-element:field-begin;mso-field-lock:
yes'></span>ADDIN CSL_CITATION
{&quot;citationItems&quot;:[{&quot;id&quot;:&quot;ITEM-1&quot;,&quot;itemData&quot;:{&quot;DOI&quot;:&quot;10.1086/664770&quot;,&quot;ISSN&quot;:&quot;0899-823X&quot;,&quot;PMID&quot;:&quot;22418642&quot;,&quot;abstract&quot;:&quot;Days
of therapy (DOTs) are an important measure to quantify antimicrobial use but
may not reflect patients' true antimicrobial exposure. Three methods of
calculating DOTs were compared to determine whether including “exposure days,”
when antimicrobials are given less frequently than daily due to renal
dysfunction, makes a
difference.&quot;,&quot;author&quot;:[{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Kubin&quot;,&quot;given&quot;:&quot;Christine
J.&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Jia&quot;,&quot;given&quot;:&quot;Haomiao&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Alba&quot;,&quot;given&quot;:&quot;Luis
R.&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Furuya&quot;,&quot;given&quot;:&quot;E.
Yoko&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;}],&quot;container-title&quot;:&quot;Infection
Control and Hospital
Epidemiology&quot;,&quot;id&quot;:&quot;ITEM-1&quot;,&quot;issue&quot;:&quot;04&quot;,&quot;issued&quot;:{&quot;date-parts&quot;:[[&quot;2012&quot;]]},&quot;page&quot;:&quot;421-423&quot;,&quot;title&quot;:&quot;Lack
of Significant Variability among Different Methods for Calculating
Antimicrobial Days of
Therapy&quot;,&quot;type&quot;:&quot;article-journal&quot;,&quot;volume&quot;:&quot;33&quot;},&quot;uris&quot;:[&quot;http://www.mendeley.com/documents/?uuid=7def0dc7-828d-4184-99f6-5e05ccbc84f5&quot;]}],&quot;mendeley&quot;:{&quot;formattedCitation&quot;:&quot;(58)&quot;,&quot;plainTextFormattedCitation&quot;:&quot;(58)&quot;,&quot;previouslyFormattedCitation&quot;:&quot;(58)&quot;},&quot;properties&quot;:{&quot;noteIndex&quot;:0},&quot;schema&quot;:&quot;https://github.com/citation-style-language/schema/raw/master/csl-citation.json&quot;}<span
style='mso-element:field-separator'></span></span><![endif]--><span
style='font-size:10.0pt;line-height:107%;font-family:"Times New Roman",serif;
mso-fareast-font-family:Calibri;mso-ansi-language:ES-CO'><span
style='mso-no-proof:yes'>(58)</span></span><!--[if supportFields]><span
style='font-size:10.0pt;line-height:107%;font-family:"Times New Roman",serif;
mso-fareast-font-family:Calibri;mso-ansi-language:ES-CO'><span
style='mso-element:field-end'></span></span><![endif]--><span style='font-size:
10.0pt;line-height:107%;font-family:"Times New Roman",serif;mso-fareast-font-family:
Calibri;mso-ansi-language:ES-CO'>. Debido a que el individuo mantiene una
concentración en sangre efectiva todos los días pese a que no recibe la dosis
diariamente. Los días en los cuales no se recibe la dosis pueden ser
considerados como días de exposición (ExDs). Estos días se pueden incluir en la
determinación de DOTs para evaluar la exposición a antimicrobianos de manera
precisa. Un estudio encontró que en la mayoría de poblaciones no existen
diferencias en el consumo de DOTs al incluir ExDs en su cálculo. Lo anterior
puede no ser exacto en subpoblaciones con una proporción alta de individuos con
falla renal </span><!--[if supportFields]><span style='font-size:10.0pt;
line-height:107%;font-family:"Times New Roman",serif;mso-fareast-font-family:
Calibri;mso-ansi-language:ES-CO'><span style='mso-element:field-begin;
mso-field-lock:yes'></span>ADDIN CSL_CITATION {&quot;citationItems&quot;:[{&quot;id&quot;:&quot;ITEM-1&quot;,&quot;itemData&quot;:{&quot;DOI&quot;:&quot;10.1086/664770&quot;,&quot;ISSN&quot;:&quot;0899-823X&quot;,&quot;PMID&quot;:&quot;22418642&quot;,&quot;abstract&quot;:&quot;Days
of therapy (DOTs) are an important measure to quantify antimicrobial use but
may not reflect patients' true antimicrobial exposure. Three methods of
calculating DOTs were compared to determine whether including “exposure days,”
when antimicrobials are given less frequently than daily due to renal
dysfunction, makes a
difference.&quot;,&quot;author&quot;:[{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Kubin&quot;,&quot;given&quot;:&quot;Christine
J.&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Jia&quot;,&quot;given&quot;:&quot;Haomiao&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Alba&quot;,&quot;given&quot;:&quot;Luis
R.&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Furuya&quot;,&quot;given&quot;:&quot;E.
Yoko&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;}],&quot;container-title&quot;:&quot;Infection
Control and Hospital
Epidemiology&quot;,&quot;id&quot;:&quot;ITEM-1&quot;,&quot;issue&quot;:&quot;04&quot;,&quot;issued&quot;:{&quot;date-parts&quot;:[[&quot;2012&quot;]]},&quot;page&quot;:&quot;421-423&quot;,&quot;title&quot;:&quot;Lack
of Significant Variability among Different Methods for Calculating
Antimicrobial Days of Therapy&quot;,&quot;type&quot;:&quot;article-journal&quot;,&quot;volume&quot;:&quot;33&quot;},&quot;uris&quot;:[&quot;http://www.mendeley.com/documents/?uuid=7def0dc7-828d-4184-99f6-5e05ccbc84f5&quot;]}],&quot;mendeley&quot;:{&quot;formattedCitation&quot;:&quot;(58)&quot;,&quot;plainTextFormattedCitation&quot;:&quot;(58)&quot;,&quot;previouslyFormattedCitation&quot;:&quot;(58)&quot;},&quot;properties&quot;:{&quot;noteIndex&quot;:0},&quot;schema&quot;:&quot;https://github.com/citation-style-language/schema/raw/master/csl-citation.json&quot;}<span
style='mso-element:field-separator'></span></span><![endif]--><span
style='font-size:10.0pt;line-height:107%;font-family:"Times New Roman",serif;
mso-fareast-font-family:Calibri;mso-ansi-language:ES-CO'><span
style='mso-no-proof:yes'>(58)</span></span><!--[if supportFields]><span
style='font-size:10.0pt;line-height:107%;font-family:"Times New Roman",serif;
mso-fareast-font-family:Calibri;mso-ansi-language:ES-CO'><span
style='mso-element:field-end'></span></span><![endif]--><span style='font-size:
10.0pt;line-height:107%;font-family:"Times New Roman",serif;mso-fareast-font-family:
Calibri;mso-ansi-language:ES-CO'>.<o:p></o:p></span></p>

<p class=IOPH1><span style='mso-ansi-language:ES-CO'>9. Consumo de antibióticos
en pediatría<o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0mm;margin-bottom:.0001pt;text-align:
justify;text-indent:11.35pt'><span style='font-size:10.0pt;line-height:107%;
font-family:"Times New Roman",serif;mso-fareast-font-family:Calibri;mso-ansi-language:
ES-CO'>No ha sido posible establecer de manera definitiva, una medida de
consumo de antimicrobianos óptima para la población pediátrica. Una revisión
sistemática en la que se incluyeron 79 estudios que cumplieron con criterios de
inclusión, no pudo identificar una medida de consumo superior a otras en
población pediátrica. Lo anterior, en razón de la poca información disponible y
la gran heterogeneidad de la misma </span><!--[if supportFields]><span
style='font-size:10.0pt;line-height:107%;font-family:"Times New Roman",serif;
mso-fareast-font-family:Calibri;mso-ansi-language:ES-CO'><span
style='mso-element:field-begin;mso-field-lock:yes'></span>ADDIN CSL_CITATION
{&quot;citationItems&quot;:[{&quot;id&quot;:&quot;ITEM-1&quot;,&quot;itemData&quot;:{&quot;DOI&quot;:&quot;10.1093/jac/dku003&quot;,&quot;ISBN&quot;:&quot;1460-2091
(Electronic)\r0305-7453
(Linking)&quot;,&quot;ISSN&quot;:&quot;14602091&quot;,&quot;PMID&quot;:&quot;24481320&quot;,&quot;abstract&quot;:&quot;Objectives
The optimal measure to use for surveillance of antimicrobial usage in hospital
settings, especially when including paediatric populations, is unknown. This
systematic review of literature aims to list, define and compare existing
measures of antimicrobial use that have been applied in settings that included
paediatric inpatients, to complement surveillance of resistance.\\nMethods We
identified cohort studies and repeated point-prevalence studies presenting data
on antimicrobial use in populations of inpatients or validations/comparisons of
antimicrobial measures through a systematic search of literature using MEDLINE,
EMBASE, CINAHL and LILACS (1975–2011) and citation tracking. Study populations
needed to include hospitalized paediatric patients. Two reviewers independently
extracted data on study characteristics and results.\\nResults Overall, 3878
records were screened and 79 studies met selection criteria. Twenty-six
distinct measures were found, the most frequently used being defined daily
doses (DDD)/patient-days and exposed patients/patients. Only two studies
compared different measures quantitatively, showing (i) a positive correlation
between proportion of exposed patients and antimicrobial-days/patient-days and
(ii) a strong correlation between doses/patient-days and
agent-days/patient-days (r = 0.98), with doses/patient-days correlating more
with resistance rates (r = 0.80 versus 0.55).\\nConclusions The measure of
antimicrobial use that best predicts antimicrobial resistance prevalence and
rates, for surveillance purposes, has still not been identified; additional
evidence on this topic is a
necessity.&quot;,&quot;author&quot;:[{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Fortin&quot;,&quot;given&quot;:&quot;??&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Fontela&quot;,&quot;given&quot;:&quot;P.
S.&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Manges&quot;,&quot;given&quot;:&quot;A.
R.&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Platt&quot;,&quot;given&quot;:&quot;R.
W.&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Buckeridge&quot;,&quot;given&quot;:&quot;D.
L.&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Quach&quot;,&quot;given&quot;:&quot;C.&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;}],&quot;container-title&quot;:&quot;Journal
of Antimicrobial
Chemotherapy&quot;,&quot;id&quot;:&quot;ITEM-1&quot;,&quot;issue&quot;:&quot;6&quot;,&quot;issued&quot;:{&quot;date-parts&quot;:[[&quot;2014&quot;]]},&quot;page&quot;:&quot;1447-1456&quot;,&quot;title&quot;:&quot;Measuring
antimicrobial use in hospitalized patients: A systematic review of available
measures applicable to paediatrics&quot;,&quot;type&quot;:&quot;article-journal&quot;,&quot;volume&quot;:&quot;69&quot;},&quot;uris&quot;:[&quot;http://www.mendeley.com/documents/?uuid=78f22e19-8fdc-4837-af8a-62643303c1b8&quot;]}],&quot;mendeley&quot;:{&quot;formattedCitation&quot;:&quot;(33)&quot;,&quot;plainTextFormattedCitation&quot;:&quot;(33)&quot;,&quot;previouslyFormattedCitation&quot;:&quot;(33)&quot;},&quot;properties&quot;:{&quot;noteIndex&quot;:0},&quot;schema&quot;:&quot;https://github.com/citation-style-language/schema/raw/master/csl-citation.json&quot;}<span
style='mso-element:field-separator'></span></span><![endif]--><span
style='font-size:10.0pt;line-height:107%;font-family:"Times New Roman",serif;
mso-fareast-font-family:Calibri;mso-ansi-language:ES-CO'><span
style='mso-no-proof:yes'>(33)</span></span><!--[if supportFields]><span
style='font-size:10.0pt;line-height:107%;font-family:"Times New Roman",serif;
mso-fareast-font-family:Calibri;mso-ansi-language:ES-CO'><span
style='mso-element:field-end'></span></span><![endif]--><span style='font-size:
10.0pt;line-height:107%;font-family:"Times New Roman",serif;mso-fareast-font-family:
Calibri;mso-ansi-language:ES-CO'>.<o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0mm;margin-bottom:.0001pt;text-align:
justify;text-indent:11.35pt'><span style='font-size:10.0pt;line-height:107%;
font-family:"Times New Roman",serif;mso-fareast-font-family:Calibri;mso-ansi-language:
ES-CO'><o:p>&nbsp;</o:p></span></p>

<p class=MsoNormal style='margin-bottom:0mm;margin-bottom:.0001pt;text-align:
justify;text-indent:11.35pt'><span style='font-size:10.0pt;line-height:107%;
font-family:"Times New Roman",serif;mso-fareast-font-family:Calibri;mso-ansi-language:
ES-CO'>En hospitales pediátricos la medición de consumo de antibióticos permite
conocer blancos importantes para intervenciones dentro de un ASP. Los
resultados de un estudio con 42 hospitales pediátricos sugieren que implementar
estrategias para optimizar el manejo de neumonía no complicada, antibióticos en
pacientes sometidos a apendicetomía, pacientes con fibrosis quística y
profilaxis quirúrgica, puede tener impacto en la reducción del consumo de
antibióticos </span><!--[if supportFields]><span style='font-size:10.0pt;
line-height:107%;font-family:"Times New Roman",serif;mso-fareast-font-family:
Calibri;mso-ansi-language:ES-CO'><span style='mso-element:field-begin;
mso-field-lock:yes'></span>ADDIN CSL_CITATION {&quot;citationItems&quot;:[{&quot;id&quot;:&quot;ITEM-1&quot;,&quot;itemData&quot;:{&quot;DOI&quot;:&quot;10.1086/673982&quot;,&quot;ISBN&quot;:&quot;1559-6834;
0899-823X&quot;,&quot;ISSN&quot;:&quot;0899-823X&quot;,&quot;PMID&quot;:&quot;24225609&quot;,&quot;abstract&quot;:&quot;OBJECTIVE:
Antimicrobial stewardship programs (ASPs) are recommended to optimize
antimicrobial use for hospitalized patients. Although mechanisms for the
implementation of ASPs have been described, data-driven approaches to
prioritize specific conditions and antimicrobials for intervention have not
been established. We aimed to develop a strategy for identifying high-impact
targets for antimicrobial stewardship efforts. DESIGn: Retrospective
cross-sectional study.\\n\\nSETTING AND PATIENTS: Children admitted to 32
freestanding children's hospitals in the United States in 2010.\\n\\nMETHODS:
We identified the conditions with the largest proportional contribution to the
total days of antibiotic therapy prescribed to all hospitalized children. For
the 4 highest-using conditions, we examined variability between hospitals in
antibiotic selection patterns for use of either first- or second-line therapies
depending on the condition. Antibiotic use was determined using standardized
probability of exposure to selected agents and standardized days of therapy per
1,000 patient-days, adjusting for patient demographics and severity of
illness.\\n\\nRESULTS: In 2010, 524,364 children received 2,082,929 days of
antibiotic therapy. Surgical patients received 43% of all antibiotics. The 4
highest-using conditions-pneumonia, appendicitis, cystic fibrosis, and skin and
soft-tissue infection-represent 1% of all conditions yet accounted for more
than 10% of all antibiotic use. Wide variability in antibiotic use occurred for
3 of these 4 conditions.\\n\\nCONCLUSIONS: Antibiotic use in children's
hospitals varied broadly across institutions when examining diagnoses
individually and adjusting for severity of illness. Identifying conditions with
both frequent and variable antimicrobial use informs the prioritization of
high-impact targets for future antimicrobial stewardship interventions.&quot;,&quot;author&quot;:[{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Gerber&quot;,&quot;given&quot;:&quot;Jeffrey
S.&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Kronman&quot;,&quot;given&quot;:&quot;Matthew
P.&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Ross&quot;,&quot;given&quot;:&quot;Rachael
K.&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Hersh&quot;,&quot;given&quot;:&quot;Adam
L.&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Newland&quot;,&quot;given&quot;:&quot;Jason
G.&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Metjian&quot;,&quot;given&quot;:&quot;Talene
A.&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Zaoutis&quot;,&quot;given&quot;:&quot;Theoklis
E.&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;}],&quot;container-title&quot;:&quot;Infection
Control and Hospital Epidemiology&quot;,&quot;id&quot;:&quot;ITEM-1&quot;,&quot;issue&quot;:&quot;12&quot;,&quot;issued&quot;:{&quot;date-parts&quot;:[[&quot;2013&quot;]]},&quot;page&quot;:&quot;1252-1258&quot;,&quot;title&quot;:&quot;Identifying
Targets for Antimicrobial Stewardship in Children's
Hospitals&quot;,&quot;type&quot;:&quot;article-journal&quot;,&quot;volume&quot;:&quot;34&quot;},&quot;uris&quot;:[&quot;http://www.mendeley.com/documents/?uuid=663df377-b354-4d74-8734-d3005cc2c3a3&quot;]}],&quot;mendeley&quot;:{&quot;formattedCitation&quot;:&quot;(16)&quot;,&quot;plainTextFormattedCitation&quot;:&quot;(16)&quot;,&quot;previouslyFormattedCitation&quot;:&quot;(16)&quot;},&quot;properties&quot;:{&quot;noteIndex&quot;:0},&quot;schema&quot;:&quot;https://github.com/citation-style-language/schema/raw/master/csl-citation.json&quot;}<span
style='mso-element:field-separator'></span></span><![endif]--><span
style='font-size:10.0pt;line-height:107%;font-family:"Times New Roman",serif;
mso-fareast-font-family:Calibri;mso-ansi-language:ES-CO'><span
style='mso-no-proof:yes'>(16)</span></span><!--[if supportFields]><span
style='font-size:10.0pt;line-height:107%;font-family:"Times New Roman",serif;
mso-fareast-font-family:Calibri;mso-ansi-language:ES-CO'><span
style='mso-element:field-end'></span></span><![endif]--><span style='font-size:
10.0pt;line-height:107%;font-family:"Times New Roman",serif;mso-fareast-font-family:
Calibri;mso-ansi-language:ES-CO'>. El consumo promedio de antimicrobianos fue
de 698 DOTs/1000 PD. Los pacientes quirúrgicos recibieron en promedio un número
mayor de LOTs que los no quirúrgicos, pese a que se recomienda una duración de
24 horas para antibióticos peri-operativos. La utilización de antibióticos en
neumonía, fibrosis quística, apendicetomía e infecciones de piel/tejidos
blandos represento &gt;10% del consumo total entre 316 grupos diagnósticos
estudiados. La variabilidad fue evaluada para el consumo de antibióticos en:
manejo de neumonía no complicada, terapia anti-MRSA en fibrosis quística e infecciones
de piel sin aislamientos de MRSA y antipseudomónicos en candidatos a
apendicetomía. La proporción de pacientes que recibían antibióticos de primera
línea para neumonía no complicada fue 1-80%, mientras el consumo estuvo en un
rango de 298-977 DOTs/1000 PD. La proporción de pacientes que recibían
antipseudomónicos para apendicetomía varió de 1 a &gt; 94%. Esta variación fue
alta con el uso de agentes anti-MRSA en pacientes con infecciones y fibrosis
quística sin aislamientos de MRSA siendo la proporción de uso de 1-60%. La
variación en la utilización de agentes anti-MRSA en pacientes con infecciones
de piel y tejidos blandos sin aislamientos de MRSA fue baja. La variabilidad no
explicable en la atención en salud es utilizada para identificar prioridades en
estudios de efectividad comparativa y mejoramiento de la calidad. <o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0mm;margin-bottom:.0001pt;text-align:
justify;text-indent:11.35pt'><span style='font-size:10.0pt;line-height:107%;
font-family:"Times New Roman",serif;mso-fareast-font-family:Calibri;mso-ansi-language:
ES-CO'><o:p>&nbsp;</o:p></span></p>

<p class=MsoNormal style='margin-bottom:0mm;margin-bottom:.0001pt;text-align:
justify;text-indent:11.35pt'><span style='font-size:10.0pt;line-height:107%;
font-family:"Times New Roman",serif;mso-fareast-font-family:Calibri;mso-ansi-language:
ES-CO'>En las comparaciones interinstitucionales se puede encontrar gran
variabilidad en el consumo de antimicrobianos. En un estudio que agrupaba a 40
hospitales pediátricos se encontró gran diversidad de valores de consumo pese a
normalización por complejidad en la atención </span><!--[if supportFields]><span
style='font-size:10.0pt;line-height:107%;font-family:"Times New Roman",serif;
mso-fareast-font-family:Calibri;mso-ansi-language:ES-CO'><span
style='mso-element:field-begin;mso-field-lock:yes'></span>ADDIN CSL_CITATION
{&quot;citationItems&quot;:[{&quot;id&quot;:&quot;ITEM-1&quot;,&quot;itemData&quot;:{&quot;DOI&quot;:&quot;10.1542/peds.2010-1275&quot;,&quot;ISBN&quot;:&quot;1098-4275
(Electronic)\\n0031-4005 (Linking)&quot;,&quot;ISSN&quot;:&quot;1098-4275&quot;,&quot;PMID&quot;:&quot;21078728&quot;,&quot;abstract&quot;:&quot;BACKGROUND:
Variation in medical practice has identified opportunities for quality
improvement in patient care. The degree of variation in the use of antibiotics
in children's hospitals is unknown. METHODS: We conducted a retrospective
cohort study of 556,692 consecutive pediatric inpatient discharges from 40
freestanding children's hospitals between January 1, 2008, and December 31,
2008. We used the Pediatric Health Information System to acquire data on
antibiotic use and clinical diagnoses. RESULTS: Overall, 60% of the children
received at least 1 antibiotic agent during their hospitalization, including
&gt;90% of patients who had surgery, underwent central venous catheter
placement, had prolonged ventilation, or remained in the hospital for &gt;14
days. Even after adjustment for both hospital- and patient-level demographic
and clinical characteristics, antibiotic use varied substantially across
hospitals, including both the proportion of children exposed to antibiotics
(38%-72%) and the number of days children received antibiotics (368-601
antibiotic-days per 1000 patient-days). In general, hospitals that used more
antibiotics also used a higher proportion of broad-spectrum antibiotics.
CONCLUSIONS: Children's hospitals vary substantially in their use of
antibiotics to a degree unexplained by patient- or hospital-level factors
typically associated with the need for antibiotic therapy, which reveals an
opportunity to improve the use of these
drugs.&quot;,&quot;author&quot;:[{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Gerber&quot;,&quot;given&quot;:&quot;Jeffrey
S&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Newland&quot;,&quot;given&quot;:&quot;Jason
G&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Coffin&quot;,&quot;given&quot;:&quot;Susan
E&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Hall&quot;,&quot;given&quot;:&quot;Matt&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Thurm&quot;,&quot;given&quot;:&quot;Cary&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Prasad&quot;,&quot;given&quot;:&quot;Priya
A&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Feudtner&quot;,&quot;given&quot;:&quot;Chris&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Zaoutis&quot;,&quot;given&quot;:&quot;Theoklis
E&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;}],&quot;container-title&quot;:&quot;Pediatrics&quot;,&quot;id&quot;:&quot;ITEM-1&quot;,&quot;issue&quot;:&quot;6&quot;,&quot;issued&quot;:{&quot;date-parts&quot;:[[&quot;2010&quot;]]},&quot;page&quot;:&quot;1067-73&quot;,&quot;title&quot;:&quot;Variability
in antibiotic use at children's
hospitals.&quot;,&quot;type&quot;:&quot;article-journal&quot;,&quot;volume&quot;:&quot;126&quot;},&quot;uris&quot;:[&quot;http://www.mendeley.com/documents/?uuid=268844bf-9476-4442-b8ad-b75d241c3f4b&quot;,&quot;http://www.mendeley.com/documents/?uuid=d5dbf4b4-573b-4cce-88bb-6f5436253412&quot;]}],&quot;mendeley&quot;:{&quot;formattedCitation&quot;:&quot;(59)&quot;,&quot;plainTextFormattedCitation&quot;:&quot;(59)&quot;,&quot;previouslyFormattedCitation&quot;:&quot;(59)&quot;},&quot;properties&quot;:{&quot;noteIndex&quot;:0},&quot;schema&quot;:&quot;https://github.com/citation-style-language/schema/raw/master/csl-citation.json&quot;}<span
style='mso-element:field-separator'></span></span><![endif]--><span
style='font-size:10.0pt;line-height:107%;font-family:"Times New Roman",serif;
mso-fareast-font-family:Calibri;mso-ansi-language:ES-CO'><span
style='mso-no-proof:yes'>(59)</span></span><!--[if supportFields]><span
style='font-size:10.0pt;line-height:107%;font-family:"Times New Roman",serif;
mso-fareast-font-family:Calibri;mso-ansi-language:ES-CO'><span
style='mso-element:field-end'></span></span><![endif]--><span style='font-size:
10.0pt;line-height:107%;font-family:"Times New Roman",serif;mso-fareast-font-family:
Calibri;mso-ansi-language:ES-CO'>. En instituciones en el cuartil superior del
consumo había una probabilidad +27% de que los pacientes recibieran
antibióticos respecto a instituciones en el cuartil inferior. El consumo de
antibióticos promedio fue 468 DOTs/1000 PD con un 38-72% de la población
recibiendo ≥1 antibiótico durante la hospitalización. En este estudio se
encontró una relación proporcional entre el porcentaje de pacientes que recibía
un antibiótico y el valor de consumo en DOTs </span><!--[if supportFields]><span
style='font-size:10.0pt;line-height:107%;font-family:"Times New Roman",serif;
mso-fareast-font-family:Calibri;mso-ansi-language:ES-CO'><span
style='mso-element:field-begin;mso-field-lock:yes'></span>ADDIN CSL_CITATION
{&quot;citationItems&quot;:[{&quot;id&quot;:&quot;ITEM-1&quot;,&quot;itemData&quot;:{&quot;DOI&quot;:&quot;10.1542/peds.2010-1275&quot;,&quot;ISBN&quot;:&quot;1098-4275
(Electronic)\\n0031-4005
(Linking)&quot;,&quot;ISSN&quot;:&quot;1098-4275&quot;,&quot;PMID&quot;:&quot;21078728&quot;,&quot;abstract&quot;:&quot;BACKGROUND:
Variation in medical practice has identified opportunities for quality
improvement in patient care. The degree of variation in the use of antibiotics
in children's hospitals is unknown. METHODS: We conducted a retrospective
cohort study of 556,692 consecutive pediatric inpatient discharges from 40
freestanding children's hospitals between January 1, 2008, and December 31,
2008. We used the Pediatric Health Information System to acquire data on
antibiotic use and clinical diagnoses. RESULTS: Overall, 60% of the children
received at least 1 antibiotic agent during their hospitalization, including
&gt;90% of patients who had surgery, underwent central venous catheter
placement, had prolonged ventilation, or remained in the hospital for &gt;14
days. Even after adjustment for both hospital- and patient-level demographic
and clinical characteristics, antibiotic use varied substantially across
hospitals, including both the proportion of children exposed to antibiotics
(38%-72%) and the number of days children received antibiotics (368-601
antibiotic-days per 1000 patient-days). In general, hospitals that used more
antibiotics also used a higher proportion of broad-spectrum antibiotics.
CONCLUSIONS: Children's hospitals vary substantially in their use of
antibiotics to a degree unexplained by patient- or hospital-level factors
typically associated with the need for antibiotic therapy, which reveals an
opportunity to improve the use of these
drugs.&quot;,&quot;author&quot;:[{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Gerber&quot;,&quot;given&quot;:&quot;Jeffrey
S&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Newland&quot;,&quot;given&quot;:&quot;Jason
G&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Coffin&quot;,&quot;given&quot;:&quot;Susan
E&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Hall&quot;,&quot;given&quot;:&quot;Matt&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Thurm&quot;,&quot;given&quot;:&quot;Cary&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Prasad&quot;,&quot;given&quot;:&quot;Priya
A&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Feudtner&quot;,&quot;given&quot;:&quot;Chris&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Zaoutis&quot;,&quot;given&quot;:&quot;Theoklis
E&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;}],&quot;container-title&quot;:&quot;Pediatrics&quot;,&quot;id&quot;:&quot;ITEM-1&quot;,&quot;issue&quot;:&quot;6&quot;,&quot;issued&quot;:{&quot;date-parts&quot;:[[&quot;2010&quot;]]},&quot;page&quot;:&quot;1067-73&quot;,&quot;title&quot;:&quot;Variability
in antibiotic use at children's
hospitals.&quot;,&quot;type&quot;:&quot;article-journal&quot;,&quot;volume&quot;:&quot;126&quot;},&quot;uris&quot;:[&quot;http://www.mendeley.com/documents/?uuid=d5dbf4b4-573b-4cce-88bb-6f5436253412&quot;,&quot;http://www.mendeley.com/documents/?uuid=268844bf-9476-4442-b8ad-b75d241c3f4b&quot;]}],&quot;mendeley&quot;:{&quot;formattedCitation&quot;:&quot;(59)&quot;,&quot;plainTextFormattedCitation&quot;:&quot;(59)&quot;,&quot;previouslyFormattedCitation&quot;:&quot;(59)&quot;},&quot;properties&quot;:{&quot;noteIndex&quot;:0},&quot;schema&quot;:&quot;https://github.com/citation-style-language/schema/raw/master/csl-citation.json&quot;}<span
style='mso-element:field-separator'></span></span><![endif]--><span
style='font-size:10.0pt;line-height:107%;font-family:"Times New Roman",serif;
mso-fareast-font-family:Calibri;mso-ansi-language:ES-CO'><span
style='mso-no-proof:yes'>(59)</span></span><!--[if supportFields]><span
style='font-size:10.0pt;line-height:107%;font-family:"Times New Roman",serif;
mso-fareast-font-family:Calibri;mso-ansi-language:ES-CO'><span
style='mso-element:field-end'></span></span><![endif]--><span style='font-size:
10.0pt;line-height:107%;font-family:"Times New Roman",serif;mso-fareast-font-family:
Calibri;mso-ansi-language:ES-CO'>. En los hospitales con mayor número de DOTs
se observaron más pacientes con terapia prolongada y mayor consumo de
antibióticos de amplio-espectro. Otros factores asociados a un mayor consumo de
antimicrobianos eran realización de procedimientos quirúrgicos, presencia de
diagnósticos de infección asociados y complejidad en el cuidado </span><!--[if supportFields]><span
style='font-size:10.0pt;line-height:107%;font-family:"Times New Roman",serif;
mso-fareast-font-family:Calibri;mso-ansi-language:ES-CO'><span
style='mso-element:field-begin;mso-field-lock:yes'></span>ADDIN CSL_CITATION
{&quot;citationItems&quot;:[{&quot;id&quot;:&quot;ITEM-1&quot;,&quot;itemData&quot;:{&quot;DOI&quot;:&quot;10.1542/peds.2010-1275&quot;,&quot;ISBN&quot;:&quot;1098-4275
(Electronic)\\n0031-4005
(Linking)&quot;,&quot;ISSN&quot;:&quot;1098-4275&quot;,&quot;PMID&quot;:&quot;21078728&quot;,&quot;abstract&quot;:&quot;BACKGROUND:
Variation in medical practice has identified opportunities for quality
improvement in patient care. The degree of variation in the use of antibiotics
in children's hospitals is unknown. METHODS: We conducted a retrospective
cohort study of 556,692 consecutive pediatric inpatient discharges from 40
freestanding children's hospitals between January 1, 2008, and December 31,
2008. We used the Pediatric Health Information System to acquire data on
antibiotic use and clinical diagnoses. RESULTS: Overall, 60% of the children
received at least 1 antibiotic agent during their hospitalization, including
&gt;90% of patients who had surgery, underwent central venous catheter
placement, had prolonged ventilation, or remained in the hospital for &gt;14
days. Even after adjustment for both hospital- and patient-level demographic
and clinical characteristics, antibiotic use varied substantially across
hospitals, including both the proportion of children exposed to antibiotics
(38%-72%) and the number of days children received antibiotics (368-601
antibiotic-days per 1000 patient-days). In general, hospitals that used more
antibiotics also used a higher proportion of broad-spectrum antibiotics.
CONCLUSIONS: Children's hospitals vary substantially in their use of
antibiotics to a degree unexplained by patient- or hospital-level factors
typically associated with the need for antibiotic therapy, which reveals an
opportunity to improve the use of these
drugs.&quot;,&quot;author&quot;:[{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Gerber&quot;,&quot;given&quot;:&quot;Jeffrey
S&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Newland&quot;,&quot;given&quot;:&quot;Jason
G&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Coffin&quot;,&quot;given&quot;:&quot;Susan
E&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Hall&quot;,&quot;given&quot;:&quot;Matt&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Thurm&quot;,&quot;given&quot;:&quot;Cary&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Prasad&quot;,&quot;given&quot;:&quot;Priya
A&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Feudtner&quot;,&quot;given&quot;:&quot;Chris&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Zaoutis&quot;,&quot;given&quot;:&quot;Theoklis
E&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;}],&quot;container-title&quot;:&quot;Pediatrics&quot;,&quot;id&quot;:&quot;ITEM-1&quot;,&quot;issue&quot;:&quot;6&quot;,&quot;issued&quot;:{&quot;date-parts&quot;:[[&quot;2010&quot;]]},&quot;page&quot;:&quot;1067-73&quot;,&quot;title&quot;:&quot;Variability
in antibiotic use at children's
hospitals.&quot;,&quot;type&quot;:&quot;article-journal&quot;,&quot;volume&quot;:&quot;126&quot;},&quot;uris&quot;:[&quot;http://www.mendeley.com/documents/?uuid=d5dbf4b4-573b-4cce-88bb-6f5436253412&quot;,&quot;http://www.mendeley.com/documents/?uuid=268844bf-9476-4442-b8ad-b75d241c3f4b&quot;]}],&quot;mendeley&quot;:{&quot;formattedCitation&quot;:&quot;(59)&quot;,&quot;plainTextFormattedCitation&quot;:&quot;(59)&quot;,&quot;previouslyFormattedCitation&quot;:&quot;(59)&quot;},&quot;properties&quot;:{&quot;noteIndex&quot;:0},&quot;schema&quot;:&quot;https://github.com/citation-style-language/schema/raw/master/csl-citation.json&quot;}<span
style='mso-element:field-separator'></span></span><![endif]--><span
style='font-size:10.0pt;line-height:107%;font-family:"Times New Roman",serif;
mso-fareast-font-family:Calibri;mso-ansi-language:ES-CO'><span
style='mso-no-proof:yes'>(59)</span></span><!--[if supportFields]><span
style='font-size:10.0pt;line-height:107%;font-family:"Times New Roman",serif;
mso-fareast-font-family:Calibri;mso-ansi-language:ES-CO'><span
style='mso-element:field-end'></span></span><![endif]--><span style='font-size:
10.0pt;line-height:107%;font-family:"Times New Roman",serif;mso-fareast-font-family:
Calibri;mso-ansi-language:ES-CO'>. <o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0mm;margin-bottom:.0001pt;text-align:
justify;text-indent:11.35pt'><span style='font-size:10.0pt;line-height:107%;
font-family:"Times New Roman",serif;mso-fareast-font-family:Calibri;mso-ansi-language:
ES-CO'><o:p>&nbsp;</o:p></span></p>

<p class=MsoNormal style='margin-bottom:0mm;margin-bottom:.0001pt;text-align:
justify;text-indent:11.35pt'><span style='font-size:10.0pt;line-height:107%;
font-family:"Times New Roman",serif;mso-fareast-font-family:Calibri;mso-ansi-language:
ES-CO'>Un estudio realizado con una base de datos de prescripciones en 20
hospitales pediátricos reveló la tendencia en consumo de antibióticos </span><!--[if supportFields]><span
style='font-size:10.0pt;line-height:107%;font-family:"Times New Roman",serif;
mso-fareast-font-family:Calibri;mso-ansi-language:ES-CO'><span
style='mso-element:field-begin;mso-field-lock:yes'></span>ADDIN CSL_CITATION
{&quot;citationItems&quot;:[{&quot;id&quot;:&quot;ITEM-1&quot;,&quot;itemData&quot;:{&quot;DOI&quot;:&quot;doi:10.1086/600400&quot;,&quot;ISBN&quot;:&quot;1559-6834&quot;,&quot;ISSN&quot;:&quot;1559-6834&quot;,&quot;PMID&quot;:&quot;19419328&quot;,&quot;abstract&quot;:&quot;Trends
in pediatric antibacterial use were examined in 20 academic health centers
during the period 2002-2007. There was a significant increase in the use of
linezolid (P &lt; .001) and of macrolides (P = .001) and a significant decrease
in the use of aminoglycosides (P &lt; .001) and of first-generation cephalosporins
(P &lt;
.001).&quot;,&quot;author&quot;:[{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Pakyz&quot;,&quot;given&quot;:&quot;Amy
L&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Gurgle&quot;,&quot;given&quot;:&quot;Holly
E&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Ibrahim&quot;,&quot;given&quot;:&quot;Omar
M&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Oinonen&quot;,&quot;given&quot;:&quot;Michael
J&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Polk&quot;,&quot;given&quot;:&quot;Ronald
E&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;}],&quot;container-title&quot;:&quot;Infection
Control &amp; Hospital
Epidemiology&quot;,&quot;id&quot;:&quot;ITEM-1&quot;,&quot;issue&quot;:&quot;06&quot;,&quot;issued&quot;:{&quot;date-parts&quot;:[[&quot;2009&quot;]]},&quot;page&quot;:&quot;600-603&quot;,&quot;title&quot;:&quot;Trends
in Antibacterial Use in Hospitalized Pediatric Patients in United States
Academic Health
Centers&quot;,&quot;type&quot;:&quot;article-journal&quot;,&quot;volume&quot;:&quot;30&quot;},&quot;uris&quot;:[&quot;http://www.mendeley.com/documents/?uuid=4995d8d7-eeae-48f3-8b38-e76b921e1b72&quot;,&quot;http://www.mendeley.com/documents/?uuid=5cc16bd6-9ea1-419a-81df-cec2244e218f&quot;]}],&quot;mendeley&quot;:{&quot;formattedCitation&quot;:&quot;(60)&quot;,&quot;plainTextFormattedCitation&quot;:&quot;(60)&quot;,&quot;previouslyFormattedCitation&quot;:&quot;(60)&quot;},&quot;properties&quot;:{&quot;noteIndex&quot;:0},&quot;schema&quot;:&quot;https://github.com/citation-style-language/schema/raw/master/csl-citation.json&quot;}<span
style='mso-element:field-separator'></span></span><![endif]--><span
style='font-size:10.0pt;line-height:107%;font-family:"Times New Roman",serif;
mso-fareast-font-family:Calibri;mso-ansi-language:ES-CO'><span
style='mso-no-proof:yes'>(60)</span></span><!--[if supportFields]><span
style='font-size:10.0pt;line-height:107%;font-family:"Times New Roman",serif;
mso-fareast-font-family:Calibri;mso-ansi-language:ES-CO'><span
style='mso-element:field-end'></span></span><![endif]--><span style='font-size:
10.0pt;line-height:107%;font-family:"Times New Roman",serif;mso-fareast-font-family:
Calibri;mso-ansi-language:ES-CO'>. El consumo de antibióticos promedio para
hospitales estuvo entre 539-557 DOTs/1000 PD durante los años 2002 a 2007. No
se observa diferencia en el consumo a lo largo de los años de acuerdo al test
ANOVA. La proporción media de pacientes que recibieron terapia con antibióticos
fue 21-45%. En el periodo de estudio los antibióticos más utilizados, en orden
descendente, fueron penicilinas lábiles a β-lactamasa, aminoglucósidos,
cefalosporinas de 3era o 4ta generación, glucopéptidos y cefalosporinas de 1era
generación. Se presentó un incremento en la utilización de oxazolidionas y
macrólidos, con disminución del consumo de cefalosporinas de primera generación
y aminoglucósidos </span><!--[if supportFields]><span style='font-size:10.0pt;
line-height:107%;font-family:"Times New Roman",serif;mso-fareast-font-family:
Calibri;mso-ansi-language:ES-CO'><span style='mso-element:field-begin;
mso-field-lock:yes'></span>ADDIN CSL_CITATION
{&quot;citationItems&quot;:[{&quot;id&quot;:&quot;ITEM-1&quot;,&quot;itemData&quot;:{&quot;DOI&quot;:&quot;doi:10.1086/600400&quot;,&quot;ISBN&quot;:&quot;1559-6834&quot;,&quot;ISSN&quot;:&quot;1559-6834&quot;,&quot;PMID&quot;:&quot;19419328&quot;,&quot;abstract&quot;:&quot;Trends
in pediatric antibacterial use were examined in 20 academic health centers
during the period 2002-2007. There was a significant increase in the use of
linezolid (P &lt; .001) and of macrolides (P = .001) and a significant decrease
in the use of aminoglycosides (P &lt; .001) and of first-generation
cephalosporins (P &lt;
.001).&quot;,&quot;author&quot;:[{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Pakyz&quot;,&quot;given&quot;:&quot;Amy
L&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Gurgle&quot;,&quot;given&quot;:&quot;Holly
E&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Ibrahim&quot;,&quot;given&quot;:&quot;Omar
M&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Oinonen&quot;,&quot;given&quot;:&quot;Michael
J&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Polk&quot;,&quot;given&quot;:&quot;Ronald
E&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;}],&quot;container-title&quot;:&quot;Infection
Control &amp; Hospital
Epidemiology&quot;,&quot;id&quot;:&quot;ITEM-1&quot;,&quot;issue&quot;:&quot;06&quot;,&quot;issued&quot;:{&quot;date-parts&quot;:[[&quot;2009&quot;]]},&quot;page&quot;:&quot;600-603&quot;,&quot;title&quot;:&quot;Trends
in Antibacterial Use in Hospitalized Pediatric Patients in United States
Academic Health
Centers&quot;,&quot;type&quot;:&quot;article-journal&quot;,&quot;volume&quot;:&quot;30&quot;},&quot;uris&quot;:[&quot;http://www.mendeley.com/documents/?uuid=5cc16bd6-9ea1-419a-81df-cec2244e218f&quot;,&quot;http://www.mendeley.com/documents/?uuid=4995d8d7-eeae-48f3-8b38-e76b921e1b72&quot;]}],&quot;mendeley&quot;:{&quot;formattedCitation&quot;:&quot;(60)&quot;,&quot;plainTextFormattedCitation&quot;:&quot;(60)&quot;,&quot;previouslyFormattedCitation&quot;:&quot;(60)&quot;},&quot;properties&quot;:{&quot;noteIndex&quot;:0},&quot;schema&quot;:&quot;https://github.com/citation-style-language/schema/raw/master/csl-citation.json&quot;}<span
style='mso-element:field-separator'></span></span><![endif]--><span
style='font-size:10.0pt;line-height:107%;font-family:"Times New Roman",serif;
mso-fareast-font-family:Calibri;mso-ansi-language:ES-CO'><span
style='mso-no-proof:yes'>(60)</span></span><!--[if supportFields]><span
style='font-size:10.0pt;line-height:107%;font-family:"Times New Roman",serif;
mso-fareast-font-family:Calibri;mso-ansi-language:ES-CO'><span
style='mso-element:field-end'></span></span><![endif]--><span style='font-size:
10.0pt;line-height:107%;font-family:"Times New Roman",serif;mso-fareast-font-family:
Calibri;mso-ansi-language:ES-CO'>. <o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0mm;margin-bottom:.0001pt;text-align:
justify;text-indent:11.35pt'><span style='font-size:10.0pt;line-height:107%;
font-family:"Times New Roman",serif;mso-fareast-font-family:Calibri;mso-ansi-language:
ES-CO'><o:p>&nbsp;</o:p></span></p>

<p class=MsoNormal style='margin-bottom:0mm;margin-bottom:.0001pt;text-align:
justify;text-indent:11.35pt;tab-stops:81.75pt'><span style='font-size:10.0pt;
line-height:107%;font-family:"Times New Roman",serif;mso-fareast-font-family:
Calibri;mso-ansi-language:ES-CO'>El consumo de antimicrobianos por parte de
unidades críticas es mayor que el promedio general en pacientes pediátricos con
excepción de unidades críticas neonatales. Un estudio realizado por medio de
encuestas en 31 hospitales pediátricos, encontró una alta tasa de utilización
en pacientes en unidades de cuidado intensivo neonatales y pediátricas </span><!--[if supportFields]><span
style='font-size:10.0pt;line-height:107%;font-family:"Times New Roman",serif;
mso-fareast-font-family:Calibri;mso-ansi-language:ES-CO'><span
style='mso-element:field-begin;mso-field-lock:yes'></span>ADDIN CSL_CITATION
{&quot;citationItems&quot;:[{&quot;id&quot;:&quot;ITEM-1&quot;,&quot;itemData&quot;:{&quot;DOI&quot;:&quot;10.1097/01.inf.0000178064.55193.1c&quot;,&quot;ISBN&quot;:&quot;0891-3668&quot;,&quot;ISSN&quot;:&quot;0891-3668&quot;,&quot;PMID&quot;:&quot;16148841&quot;,&quot;abstract&quot;:&quot;OBJECTIVE:Antimicrobial
use contributes to the development of emergence and dissemination of
antimicrobial-resistant bacteria among intensive care unit (ICU) patients.
There are few published data on antimicrobial use in neonatal (NICU) and
pediatric ICU (PICU) patients.METHODS:Personnel at 31 Pediatric Prevention
Network hospitals participated in point prevalence surveys on August 4, 1999
(summer) and February 8, 2000 (winter). Data collected for all NICU and PICU
inpatients included demographics, antimicrobials and indications for use and
therapeutic interventions.RESULTS:Data were reported for 2647 patients in 29
NICUs (827 patients in summer; 753 in winter) and 35 PICUs (512 patients in
summer; 555 in winter). PICU patients were more likely than NICU patients to be
receiving antimicrobials on the survey date [758 of 1070 (70.8%) versus 684 of
1582 (43.2%), P &amp;lt; 0.0001]. NICU patients were receiving a higher median
number of antimicrobials (2 versus 1, P &amp;lt; 0.0001). The most common
agents among NICU patients were gentamicin, ampicillin and vancomycin; the most
common agents among PICU patients were cefazolin, vancomycin and cefotaxime.
Use of aminoglycosides, aminopenicillins and topical antibacterials was
significantly more common in NICU patients; first, second and third generation
cephalosporins, extended spectrum penicillins, sulfonamides, fluoroquinolones,
antianaerobic agents, systemic antifungals and systemic antivirals were more
common in PICU patients.CONCLUSIONS:This is the first U.S. national multicenter
description of antimicrobial use in NICUs and PICUs and demonstrates the high
prevalence of antimicrobial use among these patients. Assessment strategies
targeting antimicrobial use in pediatrics are
needed.&quot;,&quot;author&quot;:[{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Grohskopf&quot;,&quot;given&quot;:&quot;Lisa
A.&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Huskins&quot;,&quot;given&quot;:&quot;W
Charles&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Sinkowitz-Cochran&quot;,&quot;given&quot;:&quot;Ronda
L.&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Levine&quot;,&quot;given&quot;:&quot;Gail
L.&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Goldmann&quot;,&quot;given&quot;:&quot;Donald
A.&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Jarvis&quot;,&quot;given&quot;:&quot;William
R.&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;}],&quot;container-title&quot;:&quot;The
Pediatric Infectious Disease
Journal&quot;,&quot;id&quot;:&quot;ITEM-1&quot;,&quot;issue&quot;:&quot;9&quot;,&quot;issued&quot;:{&quot;date-parts&quot;:[[&quot;2005&quot;]]},&quot;page&quot;:&quot;766-773&quot;,&quot;title&quot;:&quot;Use
of Antimicrobial Agents in United States Neonatal and Pediatric Intensive Care
Patients&quot;,&quot;type&quot;:&quot;article-journal&quot;,&quot;volume&quot;:&quot;24&quot;},&quot;uris&quot;:[&quot;http://www.mendeley.com/documents/?uuid=dcd7dbd6-9309-471d-b0fa-bf33cd31088a&quot;]}],&quot;mendeley&quot;:{&quot;formattedCitation&quot;:&quot;(61)&quot;,&quot;plainTextFormattedCitation&quot;:&quot;(61)&quot;,&quot;previouslyFormattedCitation&quot;:&quot;(61)&quot;},&quot;properties&quot;:{&quot;noteIndex&quot;:0},&quot;schema&quot;:&quot;https://github.com/citation-style-language/schema/raw/master/csl-citation.json&quot;}<span
style='mso-element:field-separator'></span></span><![endif]--><span
style='font-size:10.0pt;line-height:107%;font-family:"Times New Roman",serif;
mso-fareast-font-family:Calibri;mso-ansi-language:ES-CO'><span
style='mso-no-proof:yes'>(61)</span></span><!--[if supportFields]><span
style='font-size:10.0pt;line-height:107%;font-family:"Times New Roman",serif;
mso-fareast-font-family:Calibri;mso-ansi-language:ES-CO'><span
style='mso-element:field-end'></span></span><![endif]--><span style='font-size:
10.0pt;line-height:107%;font-family:"Times New Roman",serif;mso-fareast-font-family:
Calibri;mso-ansi-language:ES-CO'>. Hasta 70.8% de los pacientes se encontraban
recibiendo antibióticos comparado con 43.2% en unidades neonatales durante la
encuesta. Los pacientes de UCIN recibían en promedio un número más alto de
antibióticos que aquellos en UCIP. Los agentes más usados en UCIN son
gentamicina, ampicilina y vancomicina, a diferencia de la UCIP donde se
utilizan más cefalosporinas de 1era y 3era generación junto a vancomicina </span><!--[if supportFields]><span
style='font-size:10.0pt;line-height:107%;font-family:"Times New Roman",serif;
mso-fareast-font-family:Calibri;mso-ansi-language:ES-CO'><span
style='mso-element:field-begin;mso-field-lock:yes'></span>ADDIN CSL_CITATION
{&quot;citationItems&quot;:[{&quot;id&quot;:&quot;ITEM-1&quot;,&quot;itemData&quot;:{&quot;DOI&quot;:&quot;10.1097/01.inf.0000178064.55193.1c&quot;,&quot;ISBN&quot;:&quot;0891-3668&quot;,&quot;ISSN&quot;:&quot;0891-3668&quot;,&quot;PMID&quot;:&quot;16148841&quot;,&quot;abstract&quot;:&quot;OBJECTIVE:Antimicrobial
use contributes to the development of emergence and dissemination of
antimicrobial-resistant bacteria among intensive care unit (ICU) patients.
There are few published data on antimicrobial use in neonatal (NICU) and
pediatric ICU (PICU) patients.METHODS:Personnel at 31 Pediatric Prevention
Network hospitals participated in point prevalence surveys on August 4, 1999
(summer) and February 8, 2000 (winter). Data collected for all NICU and PICU
inpatients included demographics, antimicrobials and indications for use and
therapeutic interventions.RESULTS:Data were reported for 2647 patients in 29
NICUs (827 patients in summer; 753 in winter) and 35 PICUs (512 patients in
summer; 555 in winter). PICU patients were more likely than NICU patients to be
receiving antimicrobials on the survey date [758 of 1070 (70.8%) versus 684 of
1582 (43.2%), P &amp;lt; 0.0001]. NICU patients were receiving a higher median
number of antimicrobials (2 versus 1, P &amp;lt; 0.0001). The most common
agents among NICU patients were gentamicin, ampicillin and vancomycin; the most
common agents among PICU patients were cefazolin, vancomycin and cefotaxime.
Use of aminoglycosides, aminopenicillins and topical antibacterials was
significantly more common in NICU patients; first, second and third generation
cephalosporins, extended spectrum penicillins, sulfonamides, fluoroquinolones,
antianaerobic agents, systemic antifungals and systemic antivirals were more
common in PICU patients.CONCLUSIONS:This is the first U.S. national multicenter
description of antimicrobial use in NICUs and PICUs and demonstrates the high
prevalence of antimicrobial use among these patients. Assessment strategies
targeting antimicrobial use in pediatrics are
needed.&quot;,&quot;author&quot;:[{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Grohskopf&quot;,&quot;given&quot;:&quot;Lisa
A.&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Huskins&quot;,&quot;given&quot;:&quot;W
Charles&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Sinkowitz-Cochran&quot;,&quot;given&quot;:&quot;Ronda
L.&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Levine&quot;,&quot;given&quot;:&quot;Gail
L.&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Goldmann&quot;,&quot;given&quot;:&quot;Donald
A.&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Jarvis&quot;,&quot;given&quot;:&quot;William
R.&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;}],&quot;container-title&quot;:&quot;The
Pediatric Infectious Disease Journal&quot;,&quot;id&quot;:&quot;ITEM-1&quot;,&quot;issue&quot;:&quot;9&quot;,&quot;issued&quot;:{&quot;date-parts&quot;:[[&quot;2005&quot;]]},&quot;page&quot;:&quot;766-773&quot;,&quot;title&quot;:&quot;Use
of Antimicrobial Agents in United States Neonatal and Pediatric Intensive Care
Patients&quot;,&quot;type&quot;:&quot;article-journal&quot;,&quot;volume&quot;:&quot;24&quot;},&quot;uris&quot;:[&quot;http://www.mendeley.com/documents/?uuid=dcd7dbd6-9309-471d-b0fa-bf33cd31088a&quot;]}],&quot;mendeley&quot;:{&quot;formattedCitation&quot;:&quot;(61)&quot;,&quot;plainTextFormattedCitation&quot;:&quot;(61)&quot;,&quot;previouslyFormattedCitation&quot;:&quot;(61)&quot;},&quot;properties&quot;:{&quot;noteIndex&quot;:0},&quot;schema&quot;:&quot;https://github.com/citation-style-language/schema/raw/master/csl-citation.json&quot;}<span
style='mso-element:field-separator'></span></span><![endif]--><span
style='font-size:10.0pt;line-height:107%;font-family:"Times New Roman",serif;
mso-fareast-font-family:Calibri;mso-ansi-language:ES-CO'><span
style='mso-no-proof:yes'>(61)</span></span><!--[if supportFields]><span
style='font-size:10.0pt;line-height:107%;font-family:"Times New Roman",serif;
mso-fareast-font-family:Calibri;mso-ansi-language:ES-CO'><span
style='mso-element:field-end'></span></span><![endif]--><span style='font-size:
10.0pt;line-height:107%;font-family:"Times New Roman",serif;mso-fareast-font-family:
Calibri;mso-ansi-language:ES-CO'>. <o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0mm;margin-bottom:.0001pt;text-align:
justify;text-indent:11.35pt'><span style='font-size:10.0pt;line-height:107%;
font-family:"Times New Roman",serif;mso-fareast-font-family:Calibri;mso-ansi-language:
ES-CO'><o:p>&nbsp;</o:p></span></p>

<p class=MsoNormal style='margin-bottom:0mm;margin-bottom:.0001pt;text-align:
justify;text-indent:11.35pt'><span style='font-size:10.0pt;line-height:107%;
font-family:"Times New Roman",serif;mso-fareast-font-family:Calibri;mso-ansi-language:
ES-CO'>En una UCIN se realizó un estudio del consumo y patrones de prescripción
de antibióticos para identificar escenarios en los cuales se debían aplicar
intervenciones </span><!--[if supportFields]><span style='font-size:10.0pt;
line-height:107%;font-family:"Times New Roman",serif;mso-fareast-font-family:
Calibri;mso-ansi-language:ES-CO'><span style='mso-element:field-begin;
mso-field-lock:yes'></span>ADDIN CSL_CITATION
{&quot;citationItems&quot;:[{&quot;id&quot;:&quot;ITEM-1&quot;,&quot;itemData&quot;:{&quot;DOI&quot;:&quot;10.1097/INF.0000000000000542&quot;,&quot;ISBN&quot;:&quot;0000000000000&quot;,&quot;ISSN&quot;:&quot;ISSN
0891-3668&quot;,&quot;PMID&quot;:&quot;25191849&quot;,&quot;abstract&quot;:&quot;Background:
Prolonged or unnecessary antibiotic use is associated with adverse outcomes in
neonates. Our objectives were to quantify all antibiotic use in a Level-III
neonatal intensive care unit and to identify scenarios where their use could be
reduced. Methods: Surveillance and evaluation of all antibiotic use provided to
every infant admitted to a Level-III neonatal intensive care unit from 10/3/11
to 11/30/12 was performed. Types of antibiotics, reasons for their initiation,
discontinuation and duration, as well as clinical, laboratory and outcome data
were recorded. Antibiotic use was quantified by days of therapy (DOT) per 1000
patient-days (PD). Results: A total of 1607 infants were included. The total
antibiotic use was 9165 DOT (343.2 DOT/1000 PD; 5.7 DOT/infant). Seventy-two
percent of infants received 1 (43%) or more (29%) courses of antibiotics.
Gentamicin (46%), ampicillin (39%) and oxacillin (8%) were the most frequently
used agents. Ninety-four percent of antibiotic use (323 DOT/1000 PD) was
empiric therapy for suspected infection. Sixty-three percent (216.2 DOT/1000
PD) was discontinued at approximately 48 hours when cultures were sterile (68%
&gt;48 hours, 32% ≤48 hours). Twenty-six percent of all antibiotic use (89.4
DOT/1000 PD) was therapy for ≥5 days despite sterile cultures; pneumonia (16%)
and \&quot;culture-negative\&quot; sepsis (8%) were the major contributors.
Five percent (17.4 DOT/1000 PD) of antibiotic use was for culture-proven
sepsis, 5% (16.6 DOT/1000 PD) was penicillin prophylaxis for group B
Streptococcus and 1% (3.5 DOT/1000 PD) was preprocedural prophylaxis.
Conclusions: Narrow-spectrum therapy accounted for &gt;92% of antibiotic use
and would not be monitored by most stewardship programs. Only 5% of antibiotic
usage was due to culture-proven infection. Pneumonia and
\&quot;culture-negative\&quot; sepsis were frequent reasons for prolonged
therapy; further study of these conditions may allow reduction in treatment
duration. Copyright © 2014 Wolters Kluwer Health, Inc. All rights
reserved.&quot;,&quot;author&quot;:[{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Cantey&quot;,&quot;given&quot;:&quot;J
B&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Wozniak&quot;,&quot;given&quot;:&quot;P
S&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Sánchez&quot;,&quot;given&quot;:&quot;P
J&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;}],&quot;container-title&quot;:&quot;Pediatric
Infectious Disease Journal&quot;,&quot;id&quot;:&quot;ITEM-1&quot;,&quot;issue&quot;:&quot;3&quot;,&quot;issued&quot;:{&quot;date-parts&quot;:[[&quot;2015&quot;]]},&quot;page&quot;:&quot;267-272&quot;,&quot;title&quot;:&quot;Prospective
surveillance of antibiotic use in the neonatal intensive care unit: Results
from the SCOUT
study&quot;,&quot;type&quot;:&quot;article-journal&quot;,&quot;volume&quot;:&quot;34&quot;},&quot;uris&quot;:[&quot;http://www.mendeley.com/documents/?uuid=a3f9ccf6-ba41-4ca6-bc93-a453392ab88a&quot;,&quot;http://www.mendeley.com/documents/?uuid=40672200-7bcd-4526-a5be-b38b68f0bbdd&quot;]}],&quot;mendeley&quot;:{&quot;formattedCitation&quot;:&quot;(62)&quot;,&quot;plainTextFormattedCitation&quot;:&quot;(62)&quot;,&quot;previouslyFormattedCitation&quot;:&quot;(62)&quot;},&quot;properties&quot;:{&quot;noteIndex&quot;:0},&quot;schema&quot;:&quot;https://github.com/citation-style-language/schema/raw/master/csl-citation.json&quot;}<span
style='mso-element:field-separator'></span></span><![endif]--><span
style='font-size:10.0pt;line-height:107%;font-family:"Times New Roman",serif;
mso-fareast-font-family:Calibri;mso-ansi-language:ES-CO'><span
style='mso-no-proof:yes'>(62)</span></span><!--[if supportFields]><span
style='font-size:10.0pt;line-height:107%;font-family:"Times New Roman",serif;
mso-fareast-font-family:Calibri;mso-ansi-language:ES-CO'><span
style='mso-element:field-end'></span></span><![endif]--><span style='font-size:
10.0pt;line-height:107%;font-family:"Times New Roman",serif;mso-fareast-font-family:
Calibri;mso-ansi-language:ES-CO'>. Se encontró un consumo de 343.2 DOTs/1000 PD
(equivalente a 195.3 LOTs/1000 PD). Los diagnósticos que se asociaron a un
mayor número de DOTs fueron neumonía, sepsis con cultivos negativos y
enterocolitis necrosante. Los diagnósticos anteriores se consideran objetivos
para el diseño de intervenciones dentro de un ASP </span><!--[if supportFields]><span
style='font-size:10.0pt;line-height:107%;font-family:"Times New Roman",serif;
mso-fareast-font-family:Calibri;mso-ansi-language:ES-CO'><span
style='mso-element:field-begin;mso-field-lock:yes'></span>ADDIN CSL_CITATION
{&quot;citationItems&quot;:[{&quot;id&quot;:&quot;ITEM-1&quot;,&quot;itemData&quot;:{&quot;DOI&quot;:&quot;10.1097/INF.0000000000000542&quot;,&quot;ISBN&quot;:&quot;0000000000000&quot;,&quot;ISSN&quot;:&quot;ISSN
0891-3668&quot;,&quot;PMID&quot;:&quot;25191849&quot;,&quot;abstract&quot;:&quot;Background:
Prolonged or unnecessary antibiotic use is associated with adverse outcomes in
neonates. Our objectives were to quantify all antibiotic use in a Level-III
neonatal intensive care unit and to identify scenarios where their use could be
reduced. Methods: Surveillance and evaluation of all antibiotic use provided to
every infant admitted to a Level-III neonatal intensive care unit from 10/3/11
to 11/30/12 was performed. Types of antibiotics, reasons for their initiation,
discontinuation and duration, as well as clinical, laboratory and outcome data
were recorded. Antibiotic use was quantified by days of therapy (DOT) per 1000
patient-days (PD). Results: A total of 1607 infants were included. The total
antibiotic use was 9165 DOT (343.2 DOT/1000 PD; 5.7 DOT/infant). Seventy-two
percent of infants received 1 (43%) or more (29%) courses of antibiotics.
Gentamicin (46%), ampicillin (39%) and oxacillin (8%) were the most frequently
used agents. Ninety-four percent of antibiotic use (323 DOT/1000 PD) was
empiric therapy for suspected infection. Sixty-three percent (216.2 DOT/1000
PD) was discontinued at approximately 48 hours when cultures were sterile (68%
&gt;48 hours, 32% ≤48 hours). Twenty-six percent of all antibiotic use (89.4
DOT/1000 PD) was therapy for ≥5 days despite sterile cultures; pneumonia (16%)
and \&quot;culture-negative\&quot; sepsis (8%) were the major contributors.
Five percent (17.4 DOT/1000 PD) of antibiotic use was for culture-proven
sepsis, 5% (16.6 DOT/1000 PD) was penicillin prophylaxis for group B
Streptococcus and 1% (3.5 DOT/1000 PD) was preprocedural prophylaxis.
Conclusions: Narrow-spectrum therapy accounted for &gt;92% of antibiotic use
and would not be monitored by most stewardship programs. Only 5% of antibiotic
usage was due to culture-proven infection. Pneumonia and
\&quot;culture-negative\&quot; sepsis were frequent reasons for prolonged
therapy; further study of these conditions may allow reduction in treatment
duration. Copyright © 2014 Wolters Kluwer Health, Inc. All rights
reserved.&quot;,&quot;author&quot;:[{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Cantey&quot;,&quot;given&quot;:&quot;J
B&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Wozniak&quot;,&quot;given&quot;:&quot;P
S&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Sánchez&quot;,&quot;given&quot;:&quot;P
J&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;}],&quot;container-title&quot;:&quot;Pediatric
Infectious Disease
Journal&quot;,&quot;id&quot;:&quot;ITEM-1&quot;,&quot;issue&quot;:&quot;3&quot;,&quot;issued&quot;:{&quot;date-parts&quot;:[[&quot;2015&quot;]]},&quot;page&quot;:&quot;267-272&quot;,&quot;title&quot;:&quot;Prospective
surveillance of antibiotic use in the neonatal intensive care unit: Results
from the SCOUT
study&quot;,&quot;type&quot;:&quot;article-journal&quot;,&quot;volume&quot;:&quot;34&quot;},&quot;uris&quot;:[&quot;http://www.mendeley.com/documents/?uuid=40672200-7bcd-4526-a5be-b38b68f0bbdd&quot;,&quot;http://www.mendeley.com/documents/?uuid=a3f9ccf6-ba41-4ca6-bc93-a453392ab88a&quot;]}],&quot;mendeley&quot;:{&quot;formattedCitation&quot;:&quot;(62)&quot;,&quot;plainTextFormattedCitation&quot;:&quot;(62)&quot;,&quot;previouslyFormattedCitation&quot;:&quot;(62)&quot;},&quot;properties&quot;:{&quot;noteIndex&quot;:0},&quot;schema&quot;:&quot;https://github.com/citation-style-language/schema/raw/master/csl-citation.json&quot;}<span
style='mso-element:field-separator'></span></span><![endif]--><span
style='font-size:10.0pt;line-height:107%;font-family:"Times New Roman",serif;
mso-fareast-font-family:Calibri;mso-ansi-language:ES-CO'><span
style='mso-no-proof:yes'>(62)</span></span><!--[if supportFields]><span
style='font-size:10.0pt;line-height:107%;font-family:"Times New Roman",serif;
mso-fareast-font-family:Calibri;mso-ansi-language:ES-CO'><span
style='mso-element:field-end'></span></span><![endif]--><span style='font-size:
10.0pt;line-height:107%;font-family:"Times New Roman",serif;mso-fareast-font-family:
Calibri;mso-ansi-language:ES-CO'>. Un estudio con antifúngicos en un hospital
materno-infantil no encontró diferencias importantes entre la utilización de
DDDs y DOTs para la medición de consumo </span><!--[if supportFields]><span
style='font-size:10.0pt;line-height:107%;font-family:"Times New Roman",serif;
mso-fareast-font-family:Calibri;mso-ansi-language:ES-CO'><span
style='mso-element:field-begin;mso-field-lock:yes'></span>ADDIN CSL_CITATION
{&quot;citationItems&quot;:[{&quot;id&quot;:&quot;ITEM-1&quot;,&quot;itemData&quot;:{&quot;DOI&quot;:&quot;10.5863/1551-6776-19.3.196&quot;,&quot;ISBN&quot;:&quot;1551-6776
(Print) 1551-6776&quot;,&quot;ISSN&quot;:&quot;1551-6776&quot;,&quot;PMID&quot;:&quot;25309150&quot;,&quot;abstract&quot;:&quot;OBJECTIVES:
The objective was to describe antifungal drug use by using the number of
defined daily doses (DDD)/1000 patient-days per antifungal, the number of days
of therapy (DOT)/1000 patient-days per anti-fungal, and the mean dose in
mg/kg/day per antifungal during a 10-year period. METHODS: Retrospective,
cross-sectional, descriptive study, in a mother-child university hospital
center, with 400 pediatric beds and 100 obstetrics-gynecology beds. All
inpatients who received 1 of the 7 autho-rized antifungals on the institution's
local formulary in 2000-2001, 2005-2006, or 2010-2011 were included.
Prescriptions for emergency department and outpatient clinics were excluded.
The data were extracted from the patients' computerized medication profiles
linked to patient admission, discharge, and transfer data. The DDD, DOT, and
the mean dose in mg/kg/day were calculated for each antifungal and overall.
RESULTS: There was a 2.97-fold increase in the overall number of DDD/1000
patient-days, from 14.8 in 2000-2001 to 37.5 in 2005-2006 and 43.9 in
2010-2011. There was a 2.97-fold increase in the overall number of DOT/1000
patient-days, from 22.8 in 2000-2001 to 50.3 in 2005-2006 and 67.8 in
2010-2011. CONCLUSIONS: It can be difficult to compare the use of antifungal
drugs among institutions, owing to numerous factors, but it gives an idea about
the consumption outside the studied center. Moreover, these ratios help to
evaluate the use of antifungals within a same institution. These data could be
correlated among others, with resistance patterns, in order to improve our
daily practice concerning antifungal
prescription.&quot;,&quot;author&quot;:[{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Guillot&quot;,&quot;given&quot;:&quot;Justine&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Lebel&quot;,&quot;given&quot;:&quot;Denis&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Roy&quot;,&quot;given&quot;:&quot;Hélène&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Ovetchkine&quot;,&quot;given&quot;:&quot;Philippe&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Bussières&quot;,&quot;given&quot;:&quot;Jean-François&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;}],&quot;container-title&quot;:&quot;J
Pediatr Pharmacol Ther&quot;,&quot;id&quot;:&quot;ITEM-1&quot;,&quot;issue&quot;:&quot;3&quot;,&quot;issued&quot;:{&quot;date-parts&quot;:[[&quot;2014&quot;]]},&quot;page&quot;:&quot;196-201&quot;,&quot;title&quot;:&quot;Usefulness
of Defined Daily Dose and Days of Therapy in Pediatrics and Obstetrics-Gynecology:
A Comparative Analysis of Antifungal Drugs (2000-2001, 2005-2006, and
2010-2011)&quot;,&quot;type&quot;:&quot;article-journal&quot;,&quot;volume&quot;:&quot;19&quot;},&quot;uris&quot;:[&quot;http://www.mendeley.com/documents/?uuid=7de478cc-d0f5-4dee-a2a0-227d7d0b611f&quot;,&quot;http://www.mendeley.com/documents/?uuid=b507cdb0-9239-4125-ab1f-1f8d71bea2f7&quot;]}],&quot;mendeley&quot;:{&quot;formattedCitation&quot;:&quot;(57)&quot;,&quot;plainTextFormattedCitation&quot;:&quot;(57)&quot;,&quot;previouslyFormattedCitation&quot;:&quot;(57)&quot;},&quot;properties&quot;:{&quot;noteIndex&quot;:0},&quot;schema&quot;:&quot;https://github.com/citation-style-language/schema/raw/master/csl-citation.json&quot;}<span
style='mso-element:field-separator'></span></span><![endif]--><span
style='font-size:10.0pt;line-height:107%;font-family:"Times New Roman",serif;
mso-fareast-font-family:Calibri;mso-ansi-language:ES-CO'><span
style='mso-no-proof:yes'>(57)</span></span><!--[if supportFields]><span
style='font-size:10.0pt;line-height:107%;font-family:"Times New Roman",serif;
mso-fareast-font-family:Calibri;mso-ansi-language:ES-CO'><span
style='mso-element:field-end'></span></span><![endif]--><span style='font-size:
10.0pt;line-height:107%;font-family:"Times New Roman",serif;mso-fareast-font-family:
Calibri;mso-ansi-language:ES-CO'>.<o:p></o:p></span></p>

<p class=IOPH1><span style='mso-ansi-language:ES-CO'>10. Fuentes de Datos de
Consumo<o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0mm;margin-bottom:.0001pt;text-align:
justify;text-indent:11.35pt'><span style='font-size:10.0pt;line-height:107%;
font-family:"Times New Roman",serif;mso-fareast-font-family:Calibri;color:black;
mso-ansi-language:ES-CO'>Es recomendable la utilización de datos de consumo
basados en los registros de administración de medicamentos llevados por el
personal de enfermería. Los datos provenientes de registros de prescripción o
dispensación tienden a sobrestimar el consumo y por tal son menos precisos </span><!--[if supportFields]><span
style='font-size:10.0pt;line-height:107%;font-family:"Times New Roman",serif;
mso-fareast-font-family:Calibri;color:black;mso-ansi-language:ES-CO'><span
style='mso-element:field-begin;mso-field-lock:yes'></span>ADDIN CSL_CITATION
{&quot;citationItems&quot;:[{&quot;id&quot;:&quot;ITEM-1&quot;,&quot;itemData&quot;:{&quot;DOI&quot;:&quot;10.1086/659760&quot;,&quot;ISBN&quot;:&quot;0899-823X&quot;,&quot;ISSN&quot;:&quot;0899-823X&quot;,&quot;PMID&quot;:&quot;21515978&quot;,&quot;abstract&quot;:&quot;OBJECTIVE:
To outline methods for deriving and validating intensive care unit (ICU)
antimicrobial utilization (AU) measures from computerized data and to describe
programming problems that emerged.\\n\\nDESIGN: Retrospective evaluation of
computerized pharmacy and administrative data.\\n\\nSETTING: ICUs from 4
academic medical centers over 36 months.\\n\\nINTERVENTIONS: Investigators
separately developed and validated programming code to report AU measures in
selected ICUs. Use of antibacterial and antifungal drugs for systemic
administration was categorized and expressed as antimicrobial-days (each day
that each antimicrobial drug was given to each patient) and patient-days
receiving antimicrobials (each day that any antimicrobial drug was given to
each patient). Monthly rates were compiled and analyzed centrally, with ICU
patient-days as the denominator. Results were validated against data collected
from manual review of medical records. Frequent discussion among investigators
aided identification and correction of programming problems.\\n\\nRESULTS: AU
data were successfully programmed though a reiterative process of computer code
revision. After identifying and resolving major programming errors, comparison
of computerized patient-level data with data collected by manual review of
medical records revealed discrepancies in antimicrobial-days and patient-days
receiving antimicrobials that ranged from less than 1% to 17.7%. The hospital
from which numerator data were derived from electronic records of medication
administration had the least discrepant results.\\n\\nCONCLUSIONS: Computerized
AU measures can be derived feasibly, but threats to validity must be sought out
and corrected. The magnitude of discrepancies between computerized AU data and
a gold standard based on manual review of medical records varies, with
electronic records of medication administration providing maximal
accuracy.&quot;,&quot;author&quot;:[{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Schwartz&quot;,&quot;given&quot;:&quot;David
N.&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Evans&quot;,&quot;given&quot;:&quot;R.
Scott&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Camins&quot;,&quot;given&quot;:&quot;Bernard
C.&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Khan&quot;,&quot;given&quot;:&quot;Yosef
M.&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Lloyd&quot;,&quot;given&quot;:&quot;James
F.&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Shehab&quot;,&quot;given&quot;:&quot;Nadine&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Stevenson&quot;,&quot;given&quot;:&quot;Kurt&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;}],&quot;container-title&quot;:&quot;Infection
Control and Hospital
Epidemiology&quot;,&quot;id&quot;:&quot;ITEM-1&quot;,&quot;issue&quot;:&quot;05&quot;,&quot;issued&quot;:{&quot;date-parts&quot;:[[&quot;2011&quot;]]},&quot;page&quot;:&quot;472-480&quot;,&quot;title&quot;:&quot;Deriving
Measures of Intensive Care Unit Antimicrobial Use from Computerized Pharmacy
Data: Methods, Validation, and Overcoming
Barriers&quot;,&quot;type&quot;:&quot;article-journal&quot;,&quot;volume&quot;:&quot;32&quot;},&quot;uris&quot;:[&quot;http://www.mendeley.com/documents/?uuid=b93a587b-a878-4657-a6c2-10fad159a795&quot;]}],&quot;mendeley&quot;:{&quot;formattedCitation&quot;:&quot;(63)&quot;,&quot;plainTextFormattedCitation&quot;:&quot;(63)&quot;,&quot;previouslyFormattedCitation&quot;:&quot;(63)&quot;},&quot;properties&quot;:{&quot;noteIndex&quot;:0},&quot;schema&quot;:&quot;https://github.com/citation-style-language/schema/raw/master/csl-citation.json&quot;}<span
style='mso-element:field-separator'></span></span><![endif]--><span
style='font-size:10.0pt;line-height:107%;font-family:"Times New Roman",serif;
mso-fareast-font-family:Calibri;color:black;mso-ansi-language:ES-CO'><span
style='mso-no-proof:yes'>(63)</span></span><!--[if supportFields]><span
style='font-size:10.0pt;line-height:107%;font-family:"Times New Roman",serif;
mso-fareast-font-family:Calibri;color:black;mso-ansi-language:ES-CO'><span
style='mso-element:field-end'></span></span><![endif]--><span style='font-size:
10.0pt;line-height:107%;font-family:"Times New Roman",serif;mso-fareast-font-family:
Calibri;color:black;mso-ansi-language:ES-CO'>. Este comportamiento es normal y
refleja variaciones interinstitucionales en la eficiencia y coordinación entre
procedimientos de prescripción, dispensación y administración de medicamentos.
La obtención de datos de consumo a través de revisión manual de registros de
administración es propensa a errores e intensiva en el consumo de recursos
materiales y de personal. Se deben programar herramientas informáticos que
permitan automatización del proceso </span><!--[if supportFields]><span
style='font-size:10.0pt;line-height:107%;font-family:"Times New Roman",serif;
mso-fareast-font-family:Calibri;color:black;mso-ansi-language:ES-CO'><span
style='mso-element:field-begin;mso-field-lock:yes'></span>ADDIN CSL_CITATION
{&quot;citationItems&quot;:[{&quot;id&quot;:&quot;ITEM-1&quot;,&quot;itemData&quot;:{&quot;DOI&quot;:&quot;10.1086/659760&quot;,&quot;ISBN&quot;:&quot;0899-823X&quot;,&quot;ISSN&quot;:&quot;0899-823X&quot;,&quot;PMID&quot;:&quot;21515978&quot;,&quot;abstract&quot;:&quot;OBJECTIVE:
To outline methods for deriving and validating intensive care unit (ICU)
antimicrobial utilization (AU) measures from computerized data and to describe
programming problems that emerged.\\n\\nDESIGN: Retrospective evaluation of
computerized pharmacy and administrative data.\\n\\nSETTING: ICUs from 4
academic medical centers over 36 months.\\n\\nINTERVENTIONS: Investigators
separately developed and validated programming code to report AU measures in
selected ICUs. Use of antibacterial and antifungal drugs for systemic
administration was categorized and expressed as antimicrobial-days (each day
that each antimicrobial drug was given to each patient) and patient-days
receiving antimicrobials (each day that any antimicrobial drug was given to
each patient). Monthly rates were compiled and analyzed centrally, with ICU
patient-days as the denominator. Results were validated against data collected
from manual review of medical records. Frequent discussion among investigators
aided identification and correction of programming problems.\\n\\nRESULTS: AU
data were successfully programmed though a reiterative process of computer code
revision. After identifying and resolving major programming errors, comparison
of computerized patient-level data with data collected by manual review of
medical records revealed discrepancies in antimicrobial-days and patient-days
receiving antimicrobials that ranged from less than 1% to 17.7%. The hospital
from which numerator data were derived from electronic records of medication
administration had the least discrepant results.\\n\\nCONCLUSIONS: Computerized
AU measures can be derived feasibly, but threats to validity must be sought out
and corrected. The magnitude of discrepancies between computerized AU data and
a gold standard based on manual review of medical records varies, with
electronic records of medication administration providing maximal accuracy.&quot;,&quot;author&quot;:[{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Schwartz&quot;,&quot;given&quot;:&quot;David
N.&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Evans&quot;,&quot;given&quot;:&quot;R.
Scott&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Camins&quot;,&quot;given&quot;:&quot;Bernard
C.&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Khan&quot;,&quot;given&quot;:&quot;Yosef
M.&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Lloyd&quot;,&quot;given&quot;:&quot;James
F.&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Shehab&quot;,&quot;given&quot;:&quot;Nadine&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Stevenson&quot;,&quot;given&quot;:&quot;Kurt&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;}],&quot;container-title&quot;:&quot;Infection
Control and Hospital Epidemiology&quot;,&quot;id&quot;:&quot;ITEM-1&quot;,&quot;issue&quot;:&quot;05&quot;,&quot;issued&quot;:{&quot;date-parts&quot;:[[&quot;2011&quot;]]},&quot;page&quot;:&quot;472-480&quot;,&quot;title&quot;:&quot;Deriving
Measures of Intensive Care Unit Antimicrobial Use from Computerized Pharmacy
Data: Methods, Validation, and Overcoming
Barriers&quot;,&quot;type&quot;:&quot;article-journal&quot;,&quot;volume&quot;:&quot;32&quot;},&quot;uris&quot;:[&quot;http://www.mendeley.com/documents/?uuid=b93a587b-a878-4657-a6c2-10fad159a795&quot;]}],&quot;mendeley&quot;:{&quot;formattedCitation&quot;:&quot;(63)&quot;,&quot;plainTextFormattedCitation&quot;:&quot;(63)&quot;,&quot;previouslyFormattedCitation&quot;:&quot;(63)&quot;},&quot;properties&quot;:{&quot;noteIndex&quot;:0},&quot;schema&quot;:&quot;https://github.com/citation-style-language/schema/raw/master/csl-citation.json&quot;}<span
style='mso-element:field-separator'></span></span><![endif]--><span
style='font-size:10.0pt;line-height:107%;font-family:"Times New Roman",serif;
mso-fareast-font-family:Calibri;color:black;mso-ansi-language:ES-CO'><span
style='mso-no-proof:yes'>(63)</span></span><!--[if supportFields]><span
style='font-size:10.0pt;line-height:107%;font-family:"Times New Roman",serif;
mso-fareast-font-family:Calibri;color:black;mso-ansi-language:ES-CO'><span
style='mso-element:field-end'></span></span><![endif]--><span style='font-size:
10.0pt;line-height:107%;font-family:"Times New Roman",serif;mso-fareast-font-family:
Calibri;color:black;mso-ansi-language:ES-CO'>. <o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0mm;margin-bottom:.0001pt;text-align:
justify'><span style='font-size:10.0pt;line-height:107%;font-family:"Times New Roman",serif;
mso-fareast-font-family:Calibri;color:black;mso-ansi-language:ES-CO'><o:p>&nbsp;</o:p></span></p>

<p class=MsoNormal style='margin-bottom:0mm;margin-bottom:.0001pt;text-align:
justify;text-indent:11.35pt'><span style='font-size:10.0pt;line-height:107%;
font-family:"Times New Roman",serif;mso-fareast-font-family:Calibri;color:black;
mso-ansi-language:ES-CO'>Un estudio en 4 UCI de adultos comparó los datos de
consumo de antimicrobianos obtenidos por medio de herramientas informáticas de
fuentes de prescripción, dispensación y administración de medicamentos </span><!--[if supportFields]><span
style='font-size:10.0pt;line-height:107%;font-family:"Times New Roman",serif;
mso-fareast-font-family:Calibri;color:black;mso-ansi-language:ES-CO'><span
style='mso-element:field-begin;mso-field-lock:yes'></span>ADDIN CSL_CITATION
{&quot;citationItems&quot;:[{&quot;id&quot;:&quot;ITEM-1&quot;,&quot;itemData&quot;:{&quot;DOI&quot;:&quot;10.1086/659760&quot;,&quot;ISBN&quot;:&quot;0899-823X&quot;,&quot;ISSN&quot;:&quot;0899-823X&quot;,&quot;PMID&quot;:&quot;21515978&quot;,&quot;abstract&quot;:&quot;OBJECTIVE:
To outline methods for deriving and validating intensive care unit (ICU)
antimicrobial utilization (AU) measures from computerized data and to describe
programming problems that emerged.\\n\\nDESIGN: Retrospective evaluation of
computerized pharmacy and administrative data.\\n\\nSETTING: ICUs from 4
academic medical centers over 36 months.\\n\\nINTERVENTIONS: Investigators
separately developed and validated programming code to report AU measures in
selected ICUs. Use of antibacterial and antifungal drugs for systemic
administration was categorized and expressed as antimicrobial-days (each day
that each antimicrobial drug was given to each patient) and patient-days
receiving antimicrobials (each day that any antimicrobial drug was given to
each patient). Monthly rates were compiled and analyzed centrally, with ICU
patient-days as the denominator. Results were validated against data collected
from manual review of medical records. Frequent discussion among investigators
aided identification and correction of programming problems.\\n\\nRESULTS: AU
data were successfully programmed though a reiterative process of computer code
revision. After identifying and resolving major programming errors, comparison
of computerized patient-level data with data collected by manual review of
medical records revealed discrepancies in antimicrobial-days and patient-days
receiving antimicrobials that ranged from less than 1% to 17.7%. The hospital
from which numerator data were derived from electronic records of medication
administration had the least discrepant results.\\n\\nCONCLUSIONS: Computerized
AU measures can be derived feasibly, but threats to validity must be sought out
and corrected. The magnitude of discrepancies between computerized AU data and
a gold standard based on manual review of medical records varies, with
electronic records of medication administration providing maximal
accuracy.&quot;,&quot;author&quot;:[{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Schwartz&quot;,&quot;given&quot;:&quot;David
N.&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Evans&quot;,&quot;given&quot;:&quot;R.
Scott&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Camins&quot;,&quot;given&quot;:&quot;Bernard
C.&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Khan&quot;,&quot;given&quot;:&quot;Yosef
M.&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Lloyd&quot;,&quot;given&quot;:&quot;James
F.&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Shehab&quot;,&quot;given&quot;:&quot;Nadine&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Stevenson&quot;,&quot;given&quot;:&quot;Kurt&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;}],&quot;container-title&quot;:&quot;Infection
Control and Hospital
Epidemiology&quot;,&quot;id&quot;:&quot;ITEM-1&quot;,&quot;issue&quot;:&quot;05&quot;,&quot;issued&quot;:{&quot;date-parts&quot;:[[&quot;2011&quot;]]},&quot;page&quot;:&quot;472-480&quot;,&quot;title&quot;:&quot;Deriving
Measures of Intensive Care Unit Antimicrobial Use from Computerized Pharmacy
Data: Methods, Validation, and Overcoming
Barriers&quot;,&quot;type&quot;:&quot;article-journal&quot;,&quot;volume&quot;:&quot;32&quot;},&quot;uris&quot;:[&quot;http://www.mendeley.com/documents/?uuid=b93a587b-a878-4657-a6c2-10fad159a795&quot;]}],&quot;mendeley&quot;:{&quot;formattedCitation&quot;:&quot;(63)&quot;,&quot;plainTextFormattedCitation&quot;:&quot;(63)&quot;,&quot;previouslyFormattedCitation&quot;:&quot;(63)&quot;},&quot;properties&quot;:{&quot;noteIndex&quot;:0},&quot;schema&quot;:&quot;https://github.com/citation-style-language/schema/raw/master/csl-citation.json&quot;}<span
style='mso-element:field-separator'></span></span><![endif]--><span
style='font-size:10.0pt;line-height:107%;font-family:"Times New Roman",serif;
mso-fareast-font-family:Calibri;color:black;mso-ansi-language:ES-CO'><span
style='mso-no-proof:yes'>(63)</span></span><!--[if supportFields]><span
style='font-size:10.0pt;line-height:107%;font-family:"Times New Roman",serif;
mso-fareast-font-family:Calibri;color:black;mso-ansi-language:ES-CO'><span
style='mso-element:field-end'></span></span><![endif]--><span style='font-size:
10.0pt;line-height:107%;font-family:"Times New Roman",serif;mso-fareast-font-family:
Calibri;color:black;mso-ansi-language:ES-CO'>. Se compararon los resultados
frente a un patrón de oro consistente en la revisión retrospectiva de los
registros de administración manuales en una muestra representativa. Cuando se
utilizaron datos de dispensación de medicamentos de la farmacia, se presentó
una sobrestimación del consumo del 17.7% en DOTs y 14.5% en LOTs. Con los datos
de un sistema de prescripción informatizada (CPOE, computer provider order
entry) se obtuvo un nivel de sobrestimación intermedio 6.8-10.7% en DOTs y
2.3-5.7% en LOTs. Los datos provenientes de registros de administración de
medicamentos electrónicos (eMAR, electronic Medication Administration Records)
no presentaron mayor desviación del método de referencia (&lt;1%) </span><!--[if supportFields]><span
style='font-size:10.0pt;line-height:107%;font-family:"Times New Roman",serif;
mso-fareast-font-family:Calibri;color:black;mso-ansi-language:ES-CO'><span
style='mso-element:field-begin;mso-field-lock:yes'></span>ADDIN CSL_CITATION
{&quot;citationItems&quot;:[{&quot;id&quot;:&quot;ITEM-1&quot;,&quot;itemData&quot;:{&quot;DOI&quot;:&quot;10.1086/659760&quot;,&quot;ISBN&quot;:&quot;0899-823X&quot;,&quot;ISSN&quot;:&quot;0899-823X&quot;,&quot;PMID&quot;:&quot;21515978&quot;,&quot;abstract&quot;:&quot;OBJECTIVE:
To outline methods for deriving and validating intensive care unit (ICU)
antimicrobial utilization (AU) measures from computerized data and to describe
programming problems that emerged.\\n\\nDESIGN: Retrospective evaluation of
computerized pharmacy and administrative data.\\n\\nSETTING: ICUs from 4
academic medical centers over 36 months.\\n\\nINTERVENTIONS: Investigators
separately developed and validated programming code to report AU measures in
selected ICUs. Use of antibacterial and antifungal drugs for systemic
administration was categorized and expressed as antimicrobial-days (each day
that each antimicrobial drug was given to each patient) and patient-days
receiving antimicrobials (each day that any antimicrobial drug was given to
each patient). Monthly rates were compiled and analyzed centrally, with ICU
patient-days as the denominator. Results were validated against data collected
from manual review of medical records. Frequent discussion among investigators
aided identification and correction of programming problems.\\n\\nRESULTS: AU
data were successfully programmed though a reiterative process of computer code
revision. After identifying and resolving major programming errors, comparison
of computerized patient-level data with data collected by manual review of
medical records revealed discrepancies in antimicrobial-days and patient-days
receiving antimicrobials that ranged from less than 1% to 17.7%. The hospital
from which numerator data were derived from electronic records of medication
administration had the least discrepant results.\\n\\nCONCLUSIONS: Computerized
AU measures can be derived feasibly, but threats to validity must be sought out
and corrected. The magnitude of discrepancies between computerized AU data and
a gold standard based on manual review of medical records varies, with
electronic records of medication administration providing maximal
accuracy.&quot;,&quot;author&quot;:[{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Schwartz&quot;,&quot;given&quot;:&quot;David
N.&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Evans&quot;,&quot;given&quot;:&quot;R.
Scott&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Camins&quot;,&quot;given&quot;:&quot;Bernard
C.&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Khan&quot;,&quot;given&quot;:&quot;Yosef
M.&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Lloyd&quot;,&quot;given&quot;:&quot;James
F.&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Shehab&quot;,&quot;given&quot;:&quot;Nadine&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;},{&quot;dropping-particle&quot;:&quot;&quot;,&quot;family&quot;:&quot;Stevenson&quot;,&quot;given&quot;:&quot;Kurt&quot;,&quot;non-dropping-particle&quot;:&quot;&quot;,&quot;parse-names&quot;:false,&quot;suffix&quot;:&quot;&quot;}],&quot;container-title&quot;:&quot;Infection
Control and Hospital
Epidemiology&quot;,&quot;id&quot;:&quot;ITEM-1&quot;,&quot;issue&quot;:&quot;05&quot;,&quot;issued&quot;:{&quot;date-parts&quot;:[[&quot;2011&quot;]]},&quot;page&quot;:&quot;472-480&quot;,&quot;title&quot;:&quot;Deriving
Measures of Intensive Care Unit Antimicrobial Use from Computerized Pharmacy Data:
Methods, Validation, and Overcoming
Barriers&quot;,&quot;type&quot;:&quot;article-journal&quot;,&quot;volume&quot;:&quot;32&quot;},&quot;uris&quot;:[&quot;http://www.mendeley.com/documents/?uuid=b93a587b-a878-4657-a6c2-10fad159a795&quot;]}],&quot;mendeley&quot;:{&quot;formattedCitation&quot;:&quot;(63)&quot;,&quot;plainTextFormattedCitation&quot;:&quot;(63)&quot;,&quot;previouslyFormattedCitation&quot;:&quot;(63)&quot;},&quot;properties&quot;:{&quot;noteIndex&quot;:0},&quot;schema&quot;:&quot;https://github.com/citation-style-language/schema/raw/master/csl-citation.json&quot;}<span
style='mso-element:field-separator'></span></span><![endif]--><span
style='font-size:10.0pt;line-height:107%;font-family:"Times New Roman",serif;
mso-fareast-font-family:Calibri;color:black;mso-ansi-language:ES-CO'><span
style='mso-no-proof:yes'>(63)</span></span><!--[if supportFields]><span
style='font-size:10.0pt;line-height:107%;font-family:"Times New Roman",serif;
mso-fareast-font-family:Calibri;color:black;mso-ansi-language:ES-CO'><span
style='mso-element:field-end'></span></span><![endif]--><span style='font-size:
10.0pt;line-height:107%;font-family:"Times New Roman",serif;mso-fareast-font-family:
Calibri;color:black;mso-ansi-language:ES-CO'>.<o:p></o:p></span></p>

<p class=IOPH1><span style='mso-ansi-language:ES-CO'>11. Conclusiones<o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0mm;margin-bottom:.0001pt;text-align:
justify;text-indent:11.35pt'><span style='font-size:10.0pt;line-height:107%;
font-family:"Times New Roman",serif;mso-fareast-font-family:Calibri;color:black;
mso-ansi-language:ES-CO'>Se encuentra en la literatura una gran diversidad de
indicadores de medición de consumo de antimicrobianos. Cada indicador cuenta
con una serie de ventajas y desventajas, pero en un sentido general no parece
haber uno superior a otro en su capacidad de discriminar el consumo. Por otra
parte, en situaciones específicas como en pacientes pediátricos, los
indicadores de duración parecen ser mejores. Por tal, se recomienda hacer un
cambio en los indicadores en la institución para poder tener un mejor control
sobre este parámetro.<o:p></o:p></span></p>

<p class=IOPH1><span lang=EN-US style='mso-ansi-language:EN-US;mso-no-proof:
yes'>Referencias<o:p></o:p></span></p>

<p class=MsoNormal style='margin-top:0mm;margin-right:0mm;margin-bottom:0mm;
margin-left:14.2pt;margin-bottom:.0001pt;text-align:justify;text-indent:-14.2pt;
mso-pagination:none;mso-layout-grid-align:none;text-autospace:none'><!--[if supportFields]><span
lang=EN-US style='mso-ansi-language:EN-US'><span style='mso-element:field-begin;
mso-field-lock:yes'></span>ADDIN Mendeley Bibliography CSL_BIBLIOGRAPHY <span
style='mso-element:field-separator'></span></span><![endif]--><span lang=EN-GB
style='font-size:9.0pt;mso-bidi-font-size:12.0pt;line-height:107%;font-family:
"Times New Roman",serif;mso-no-proof:yes'>1. <span style='mso-tab-count:1'>  </span>Michael
CA, Dominey-Howes D, Labbate M. The Antimicrobial Resistance Crisis: Causes,
Consequences, and Management. Front Public Heal. 2014;2(September):145. <o:p></o:p></span></p>

<p class=MsoNormal style='margin-top:0mm;margin-right:0mm;margin-bottom:0mm;
margin-left:14.2pt;margin-bottom:.0001pt;text-align:justify;text-indent:-14.2pt;
mso-pagination:none;mso-layout-grid-align:none;text-autospace:none'><span
lang=EN-GB style='font-size:9.0pt;mso-bidi-font-size:12.0pt;line-height:107%;
font-family:"Times New Roman",serif;mso-no-proof:yes'>2. <span
style='mso-tab-count:1'>  </span>World Economic Forum (WEF). Global Risks Report
2013 Eighth Edition. World Economic Forum. 2013. 80 p. <o:p></o:p></span></p>

<p class=MsoNormal style='margin-top:0mm;margin-right:0mm;margin-bottom:0mm;
margin-left:14.2pt;margin-bottom:.0001pt;text-align:justify;text-indent:-14.2pt;
mso-pagination:none;mso-layout-grid-align:none;text-autospace:none'><span
lang=EN-GB style='font-size:9.0pt;mso-bidi-font-size:12.0pt;line-height:107%;
font-family:"Times New Roman",serif;mso-no-proof:yes'>3. <span
style='mso-tab-count:1'>  </span>Shlaes DM. Role of Antimicrobial Stewardship
in Prevention and Control of Antibiotic Resistance. Curr Infect Dis Rep.
1999;1(4):334-7. <o:p></o:p></span></p>

<p class=MsoNormal style='margin-top:0mm;margin-right:0mm;margin-bottom:0mm;
margin-left:14.2pt;margin-bottom:.0001pt;text-align:justify;text-indent:-14.2pt;
mso-pagination:none;mso-layout-grid-align:none;text-autospace:none'><span
lang=EN-GB style='font-size:9.0pt;mso-bidi-font-size:12.0pt;line-height:107%;
font-family:"Times New Roman",serif;mso-no-proof:yes'>4. <span
style='mso-tab-count:1'>  </span>Jones RN. Resistance patterns among nosocomial
pathogens: Trends over the past few years. Chest. 2001;119(2 SUPPL.):397S-404S.
<o:p></o:p></span></p>

<p class=MsoNormal style='margin-top:0mm;margin-right:0mm;margin-bottom:0mm;
margin-left:14.2pt;margin-bottom:.0001pt;text-align:justify;text-indent:-14.2pt;
mso-pagination:none;mso-layout-grid-align:none;text-autospace:none'><span
lang=EN-GB style='font-size:9.0pt;mso-bidi-font-size:12.0pt;line-height:107%;
font-family:"Times New Roman",serif;mso-no-proof:yes'>5. <span
style='mso-tab-count:1'>  </span>McGowan J, Gerding D. Does antibiotic
restriction prevent resistance? New Horiz. 1996;4(3):370-6. <o:p></o:p></span></p>

<p class=MsoNormal style='margin-top:0mm;margin-right:0mm;margin-bottom:0mm;
margin-left:14.2pt;margin-bottom:.0001pt;text-align:justify;text-indent:-14.2pt;
mso-pagination:none;mso-layout-grid-align:none;text-autospace:none'><span
lang=EN-GB style='font-size:9.0pt;mso-bidi-font-size:12.0pt;line-height:107%;
font-family:"Times New Roman",serif;mso-no-proof:yes'>6. <span
style='mso-tab-count:1'>  </span>Shlaes DM, Gerding DN, John JF, Craig WA,
Bornstein DL, Duncan RA, et&nbsp;al. Society for Healthcare Epidemiology of
America and Infectious Diseases Society of America Joint Committee on the
Prevention of Antimicrobial Resistance: Guidelines for the prevention of
antimicrobial resistance in hospitals. Clin Infect Dis. 1997;25(3):584-99. <o:p></o:p></span></p>

<p class=MsoNormal style='margin-top:0mm;margin-right:0mm;margin-bottom:0mm;
margin-left:14.2pt;margin-bottom:.0001pt;text-align:justify;text-indent:-14.2pt;
mso-pagination:none;mso-layout-grid-align:none;text-autospace:none'><span
lang=EN-GB style='font-size:9.0pt;mso-bidi-font-size:12.0pt;line-height:107%;
font-family:"Times New Roman",serif;mso-no-proof:yes'>7. <span
style='mso-tab-count:1'>  </span>Dellit TH, Owens RC, MacGowan JE, Hooton TM,
Gerding DN, Weinstein RA, et&nbsp;al. Infectious Diseases Society of America
and Society for Healthcare Epidemiology of America Guidelines for developing an
institutional program to enhance antimicrobial stewardship. Clin Infect Dis.
2007;44(1):159-77. <o:p></o:p></span></p>

<p class=MsoNormal style='margin-top:0mm;margin-right:0mm;margin-bottom:0mm;
margin-left:14.2pt;margin-bottom:.0001pt;text-align:justify;text-indent:-14.2pt;
mso-pagination:none;mso-layout-grid-align:none;text-autospace:none'><span
lang=EN-GB style='font-size:9.0pt;mso-bidi-font-size:12.0pt;line-height:107%;
font-family:"Times New Roman",serif;mso-no-proof:yes'>8. <span
style='mso-tab-count:1'>  </span>Barlam TF, Cosgrove SE, Abbo LM, Macdougall C,
Schuetz AN, Septimus EJ, et&nbsp;al. Executive summary: Implementing an
antibiotic stewardship program: Guidelines by the infectious diseases society
of America and the society for healthcare epidemiology of America. Clin Infect
Dis. 2016;62(10):1197-202. <o:p></o:p></span></p>

<p class=MsoNormal style='margin-top:0mm;margin-right:0mm;margin-bottom:0mm;
margin-left:14.2pt;margin-bottom:.0001pt;text-align:justify;text-indent:-14.2pt;
mso-pagination:none;mso-layout-grid-align:none;text-autospace:none'><span
style='font-size:9.0pt;mso-bidi-font-size:12.0pt;line-height:107%;font-family:
"Times New Roman",serif;mso-ansi-language:ES-CO;mso-no-proof:yes'>9. <span
style='mso-tab-count:1'>  </span>Rodríguez-Baño J, Paño-Pardo JR, Alvarez-Rocha
L, Asensio Á, Calbo E, Cercenado E, et&nbsp;al. Programas de optimización de
uso de antimicrobianos (PROA) en hospitales españoles: documento de consenso
GEIH-SEIMC, SEFH y SEMPSPH. </span><span lang=EN-GB style='font-size:9.0pt;
mso-bidi-font-size:12.0pt;line-height:107%;font-family:"Times New Roman",serif;
mso-no-proof:yes'>Farm Hosp. 2012;36(1). <o:p></o:p></span></p>

<p class=MsoNormal style='margin-top:0mm;margin-right:0mm;margin-bottom:0mm;
margin-left:14.2pt;margin-bottom:.0001pt;text-align:justify;text-indent:-14.2pt;
mso-pagination:none;mso-layout-grid-align:none;text-autospace:none'><span
lang=EN-GB style='font-size:9.0pt;mso-bidi-font-size:12.0pt;line-height:107%;
font-family:"Times New Roman",serif;mso-no-proof:yes'>10. <span
style='mso-tab-count:1'> </span>Dik J-WH, Hendrix R, Poelman R, Niesters HG,
Postma MJ, Sinha B, et&nbsp;al. Measuring the impact of antimicrobial
stewardship programs. Expert Rev Anti Infect Ther. 2016;14(6):569-75. <o:p></o:p></span></p>

<p class=MsoNormal style='margin-top:0mm;margin-right:0mm;margin-bottom:0mm;
margin-left:14.2pt;margin-bottom:.0001pt;text-align:justify;text-indent:-14.2pt;
mso-pagination:none;mso-layout-grid-align:none;text-autospace:none'><span
lang=EN-GB style='font-size:9.0pt;mso-bidi-font-size:12.0pt;line-height:107%;
font-family:"Times New Roman",serif;mso-no-proof:yes'>11. <span
style='mso-tab-count:1'> </span>Donabedian A. The quality of care. How can it
be assessed? JAMA. 1997;260(12):1743-8. <o:p></o:p></span></p>

<p class=MsoNormal style='margin-top:0mm;margin-right:0mm;margin-bottom:0mm;
margin-left:14.2pt;margin-bottom:.0001pt;text-align:justify;text-indent:-14.2pt;
mso-pagination:none;mso-layout-grid-align:none;text-autospace:none'><span
lang=EN-GB style='font-size:9.0pt;mso-bidi-font-size:12.0pt;line-height:107%;
font-family:"Times New Roman",serif;mso-no-proof:yes'>12. <span
style='mso-tab-count:1'> </span>Ibrahim OM, Polk RE. Antimicrobial use metrics
and benchmarking to improve stewardship outcomes: Methodology, opportunities,
and challenges. Infect Dis Clin North Am. 2014;28(2):195-214. <o:p></o:p></span></p>

<p class=MsoNormal style='margin-top:0mm;margin-right:0mm;margin-bottom:0mm;
margin-left:14.2pt;margin-bottom:.0001pt;text-align:justify;text-indent:-14.2pt;
mso-pagination:none;mso-layout-grid-align:none;text-autospace:none'><span
lang=EN-GB style='font-size:9.0pt;mso-bidi-font-size:12.0pt;line-height:107%;
font-family:"Times New Roman",serif;mso-no-proof:yes'>13. <span
style='mso-tab-count:1'> </span>Jacob JT, Gaynes R. Emerging trends in
antibiotic use in US hospitals: quality, quantification and stewardship. Expert
Rev Anti Infect Ther. 2010;8(8):893-902. <o:p></o:p></span></p>

<p class=MsoNormal style='margin-top:0mm;margin-right:0mm;margin-bottom:0mm;
margin-left:14.2pt;margin-bottom:.0001pt;text-align:justify;text-indent:-14.2pt;
mso-pagination:none;mso-layout-grid-align:none;text-autospace:none'><span
lang=EN-GB style='font-size:9.0pt;mso-bidi-font-size:12.0pt;line-height:107%;
font-family:"Times New Roman",serif;mso-no-proof:yes'>14. <span
style='mso-tab-count:1'> </span>Curtis C, Marriott J, Langley C. Development of
a prescribing indicator for objective quantification of antibiotic usage in
secondary care. J Antimicrob Chemother. 2004;54(2):529-33. <o:p></o:p></span></p>

<p class=MsoNormal style='margin-top:0mm;margin-right:0mm;margin-bottom:0mm;
margin-left:14.2pt;margin-bottom:.0001pt;text-align:justify;text-indent:-14.2pt;
mso-pagination:none;mso-layout-grid-align:none;text-autospace:none'><span
lang=EN-GB style='font-size:9.0pt;mso-bidi-font-size:12.0pt;line-height:107%;
font-family:"Times New Roman",serif;mso-no-proof:yes'>15. <span
style='mso-tab-count:1'> </span>Kuster SP, Ruef C, Ledergerber B, Hintermann A,
Deplazes C, Neuber L, et&nbsp;al. Quantitative antibiotic use in hospitals:
Comparison of measurements, literature review, and recommendations for a
standard of reporting. Infection. 2008;36(6):549-59. <o:p></o:p></span></p>

<p class=MsoNormal style='margin-top:0mm;margin-right:0mm;margin-bottom:0mm;
margin-left:14.2pt;margin-bottom:.0001pt;text-align:justify;text-indent:-14.2pt;
mso-pagination:none;mso-layout-grid-align:none;text-autospace:none'><span
lang=EN-GB style='font-size:9.0pt;mso-bidi-font-size:12.0pt;line-height:107%;
font-family:"Times New Roman",serif;mso-no-proof:yes'>16. <span
style='mso-tab-count:1'> </span>Gerber JS, Kronman MP, Ross RK, Hersh AL,
Newland JG, Metjian TA, et&nbsp;al. Identifying Targets for Antimicrobial
Stewardship in Children’s Hospitals. Infect Control Hosp Epidemiol.
2013;34(12):1252-8. <o:p></o:p></span></p>

<p class=MsoNormal style='margin-top:0mm;margin-right:0mm;margin-bottom:0mm;
margin-left:14.2pt;margin-bottom:.0001pt;text-align:justify;text-indent:-14.2pt;
mso-pagination:none;mso-layout-grid-align:none;text-autospace:none'><span
lang=EN-GB style='font-size:9.0pt;mso-bidi-font-size:12.0pt;line-height:107%;
font-family:"Times New Roman",serif;mso-no-proof:yes'>17. <span
style='mso-tab-count:1'> </span>Stevens V, Dumyati G, Fine LS, Fisher SG, Van
Wijngaarden E. Cumulative antibiotic exposures over time and the risk of
clostridium difficile infection. Clin Infect Dis. 2011;53(1):42-8. <o:p></o:p></span></p>

<p class=MsoNormal style='margin-top:0mm;margin-right:0mm;margin-bottom:0mm;
margin-left:14.2pt;margin-bottom:.0001pt;text-align:justify;text-indent:-14.2pt;
mso-pagination:none;mso-layout-grid-align:none;text-autospace:none'><span
lang=EN-GB style='font-size:9.0pt;mso-bidi-font-size:12.0pt;line-height:107%;
font-family:"Times New Roman",serif;mso-no-proof:yes'>18. <span
style='mso-tab-count:1'> </span>Paterson DL. «Collateral Damage» from
Cephalosporin or Quinolone Antibiotic Therapy. Clin Infect Dis.
2004;38(Supplement 4):S341-5. <o:p></o:p></span></p>

<p class=MsoNormal style='margin-top:0mm;margin-right:0mm;margin-bottom:0mm;
margin-left:14.2pt;margin-bottom:.0001pt;text-align:justify;text-indent:-14.2pt;
mso-pagination:none;mso-layout-grid-align:none;text-autospace:none'><span
lang=EN-GB style='font-size:9.0pt;mso-bidi-font-size:12.0pt;line-height:107%;
font-family:"Times New Roman",serif;mso-no-proof:yes'>19. <span
style='mso-tab-count:1'> </span>Harbarth S, Harris AD, Carmeli Y, Samore MH.
Parallel Analysis of Individual and Aggregated Data on Antibiotic Exposure and
Resistance in Gram-Negative Bacilli. Clin Infect Dis. 2001;33:1462-168. <o:p></o:p></span></p>

<p class=MsoNormal style='margin-top:0mm;margin-right:0mm;margin-bottom:0mm;
margin-left:14.2pt;margin-bottom:.0001pt;text-align:justify;text-indent:-14.2pt;
mso-pagination:none;mso-layout-grid-align:none;text-autospace:none'><span
lang=EN-GB style='font-size:9.0pt;mso-bidi-font-size:12.0pt;line-height:107%;
font-family:"Times New Roman",serif;mso-no-proof:yes'>20. <span
style='mso-tab-count:1'> </span>Kern W V., Steib-Bauert M, de With K, Reuter S,
Bertz H, Frank U, et&nbsp;al. Fluoroquinolone consumption and resistance in
haematology-oncology patients: Ecological analysis in two university hospitals
1999-2002. J Antimicrob Chemother. 2005;55(1):57-60. <o:p></o:p></span></p>

<p class=MsoNormal style='margin-top:0mm;margin-right:0mm;margin-bottom:0mm;
margin-left:14.2pt;margin-bottom:.0001pt;text-align:justify;text-indent:-14.2pt;
mso-pagination:none;mso-layout-grid-align:none;text-autospace:none'><span
lang=EN-GB style='font-size:9.0pt;mso-bidi-font-size:12.0pt;line-height:107%;
font-family:"Times New Roman",serif;mso-no-proof:yes'>21. <span
style='mso-tab-count:1'> </span>Price J, Cheek E, Lippett S. Impact of an
intervention to control Clostridium difficile infection on hospital and
community-onset disease; an interrupted time series analysis. Clin Microbiol
Infect. 2010;16(8):1297-302. <o:p></o:p></span></p>

<p class=MsoNormal style='margin-top:0mm;margin-right:0mm;margin-bottom:0mm;
margin-left:14.2pt;margin-bottom:.0001pt;text-align:justify;text-indent:-14.2pt;
mso-pagination:none;mso-layout-grid-align:none;text-autospace:none'><span
lang=EN-GB style='font-size:9.0pt;mso-bidi-font-size:12.0pt;line-height:107%;
font-family:"Times New Roman",serif;mso-no-proof:yes'>22. <span
style='mso-tab-count:1'> </span>Sarma JB, Marshall B, Cleeve V, Tate D, Oswald
T, Woolfrey S. Effects of fluoroquinolone restriction (from 2007 to 2012) on
Clostridium difficile infections: Interrupted time-series analysis. J Hosp
Infect. 2015;91(1):74-80. <o:p></o:p></span></p>

<p class=MsoNormal style='margin-top:0mm;margin-right:0mm;margin-bottom:0mm;
margin-left:14.2pt;margin-bottom:.0001pt;text-align:justify;text-indent:-14.2pt;
mso-pagination:none;mso-layout-grid-align:none;text-autospace:none'><span
lang=EN-GB style='font-size:9.0pt;mso-bidi-font-size:12.0pt;line-height:107%;
font-family:"Times New Roman",serif;mso-no-proof:yes'>23. <span
style='mso-tab-count:1'> </span>Ostrowsky B, Ruiz R, Brown S, Chung P,
Koppelman E, van Deusen Lukas C, et&nbsp;al. Lessons Learned from Implementing <i>Clostridium
difficile</i> –Focused Antibiotic Stewardship Interventions. Infect Control
Hosp Epidemiol. 2014;35(S3):S86-95. <o:p></o:p></span></p>

<p class=MsoNormal style='margin-top:0mm;margin-right:0mm;margin-bottom:0mm;
margin-left:14.2pt;margin-bottom:.0001pt;text-align:justify;text-indent:-14.2pt;
mso-pagination:none;mso-layout-grid-align:none;text-autospace:none'><span
lang=EN-GB style='font-size:9.0pt;mso-bidi-font-size:12.0pt;line-height:107%;
font-family:"Times New Roman",serif;mso-no-proof:yes'>24. <span
style='mso-tab-count:1'> </span>Joseph NM, Bhanupriya B, Shewade DG, Harish BN.
Relationship between antimicrobial consumption and the incidence of
antimicrobial resistance in Escherichia coli and Klebsiella pneumoniae
isolates. J Clin Diagnostic Res. 2015;9(2):DC08-DC12. <o:p></o:p></span></p>

<p class=MsoNormal style='margin-top:0mm;margin-right:0mm;margin-bottom:0mm;
margin-left:14.2pt;margin-bottom:.0001pt;text-align:justify;text-indent:-14.2pt;
mso-pagination:none;mso-layout-grid-align:none;text-autospace:none'><span
lang=EN-GB style='font-size:9.0pt;mso-bidi-font-size:12.0pt;line-height:107%;
font-family:"Times New Roman",serif;mso-no-proof:yes'>25. <span
style='mso-tab-count:1'> </span>Sedláková MH, Urbánek K, Vojtová V, Suchánková
H, Imwensi P, Kolář M. Antibiotic consumption and its influence on the
resistance in Enterobacteriaceae. BMC Res Notes. 2014;7:454. <o:p></o:p></span></p>

<p class=MsoNormal style='margin-top:0mm;margin-right:0mm;margin-bottom:0mm;
margin-left:14.2pt;margin-bottom:.0001pt;text-align:justify;text-indent:-14.2pt;
mso-pagination:none;mso-layout-grid-align:none;text-autospace:none'><span
lang=EN-GB style='font-size:9.0pt;mso-bidi-font-size:12.0pt;line-height:107%;
font-family:"Times New Roman",serif;mso-no-proof:yes'>26. <span
style='mso-tab-count:1'> </span>Westh H, Zinn CS, Rosdahl VT. An international
multicenter study of antimicrobial consumption and resistance in Staphylococcus
aureus isolates from 15 hospitals in 14 countries. Microb Drug Resist.
2004;10(1076-6294 (Print)):169-76. <o:p></o:p></span></p>

<p class=MsoNormal style='margin-top:0mm;margin-right:0mm;margin-bottom:0mm;
margin-left:14.2pt;margin-bottom:.0001pt;text-align:justify;text-indent:-14.2pt;
mso-pagination:none;mso-layout-grid-align:none;text-autospace:none'><span
lang=EN-GB style='font-size:9.0pt;mso-bidi-font-size:12.0pt;line-height:107%;
font-family:"Times New Roman",serif;mso-no-proof:yes'>27. <span
style='mso-tab-count:1'> </span>Hoffmann C, Khadem T, Schweighardt A, Brown J.
New thoughts on the «forgotten» aspect of Antimicrobial stewardship: Adverse
event reporting. Pharmacotherapy. 2015;35(1):59-63. <o:p></o:p></span></p>

<p class=MsoNormal style='margin-top:0mm;margin-right:0mm;margin-bottom:0mm;
margin-left:14.2pt;margin-bottom:.0001pt;text-align:justify;text-indent:-14.2pt;
mso-pagination:none;mso-layout-grid-align:none;text-autospace:none'><span
lang=EN-GB style='font-size:9.0pt;mso-bidi-font-size:12.0pt;line-height:107%;
font-family:"Times New Roman",serif;mso-no-proof:yes'>28. <span
style='mso-tab-count:1'> </span>Hamad A, Cavell G, Wade P, Hinton J, Whittlesea
C. Risk of medication safety incidents with antibiotic use measured by defined
daily doses. Int J Clin Pharm. 2013;35(5):772-9. <o:p></o:p></span></p>

<p class=MsoNormal style='margin-top:0mm;margin-right:0mm;margin-bottom:0mm;
margin-left:14.2pt;margin-bottom:.0001pt;text-align:justify;text-indent:-14.2pt;
mso-pagination:none;mso-layout-grid-align:none;text-autospace:none'><span
lang=EN-GB style='font-size:9.0pt;mso-bidi-font-size:12.0pt;line-height:107%;
font-family:"Times New Roman",serif;mso-no-proof:yes'>29. <span
style='mso-tab-count:1'> </span>Berrington A. Antimicrobial prescribing in
hospitals: Be careful what you measure. J Antimicrob Chemother.
2009;65(1):163-8. <o:p></o:p></span></p>

<p class=MsoNormal style='margin-top:0mm;margin-right:0mm;margin-bottom:0mm;
margin-left:14.2pt;margin-bottom:.0001pt;text-align:justify;text-indent:-14.2pt;
mso-pagination:none;mso-layout-grid-align:none;text-autospace:none'><span
lang=EN-GB style='font-size:9.0pt;mso-bidi-font-size:12.0pt;line-height:107%;
font-family:"Times New Roman",serif;mso-no-proof:yes'>30. <span
style='mso-tab-count:1'> </span>Morris AM. Antimicrobial Stewardship Programs:
Appropriate Measures and Metrics to Study their Impact. Curr Treat Options
Infect Dis. 2014;6(2):101-12. <o:p></o:p></span></p>

<p class=MsoNormal style='margin-top:0mm;margin-right:0mm;margin-bottom:0mm;
margin-left:14.2pt;margin-bottom:.0001pt;text-align:justify;text-indent:-14.2pt;
mso-pagination:none;mso-layout-grid-align:none;text-autospace:none'><span
lang=EN-GB style='font-size:9.0pt;mso-bidi-font-size:12.0pt;line-height:107%;
font-family:"Times New Roman",serif;mso-no-proof:yes'>31. <span
style='mso-tab-count:1'> </span>Hutchinson JM, Patrick DM, Marra F, Ng H, Bowie
WR, Heule L, et&nbsp;al. Measurement of antibiotic consumption: A practical
guide to the use of the Anatomical Thgerapeutic Chemical classification and
Definied Daily Dose system methodology in Canada. Can J Infect Dis.
2004;15(1):29-35. <o:p></o:p></span></p>

<p class=MsoNormal style='margin-top:0mm;margin-right:0mm;margin-bottom:0mm;
margin-left:14.2pt;margin-bottom:.0001pt;text-align:justify;text-indent:-14.2pt;
mso-pagination:none;mso-layout-grid-align:none;text-autospace:none'><span
lang=EN-GB style='font-size:9.0pt;mso-bidi-font-size:12.0pt;line-height:107%;
font-family:"Times New Roman",serif;mso-no-proof:yes'>32. <span
style='mso-tab-count:1'> </span>World Health Organization. Introduction to Drug
Utilization Research. Oslo: World Health Organization; 2003. 1-84 p. <o:p></o:p></span></p>

<p class=MsoNormal style='margin-top:0mm;margin-right:0mm;margin-bottom:0mm;
margin-left:14.2pt;margin-bottom:.0001pt;text-align:justify;text-indent:-14.2pt;
mso-pagination:none;mso-layout-grid-align:none;text-autospace:none'><span
lang=EN-GB style='font-size:9.0pt;mso-bidi-font-size:12.0pt;line-height:107%;
font-family:"Times New Roman",serif;mso-no-proof:yes'>33. <span
style='mso-tab-count:1'> </span>Fortin ??, Fontela PS, Manges AR, Platt RW,
Buckeridge DL, Quach C. Measuring antimicrobial use in hospitalized patients: A
systematic review of available measures applicable to paediatrics. J Antimicrob
Chemother. 2014;69(6):1447-56. <o:p></o:p></span></p>

<p class=MsoNormal style='margin-top:0mm;margin-right:0mm;margin-bottom:0mm;
margin-left:14.2pt;margin-bottom:.0001pt;text-align:justify;text-indent:-14.2pt;
mso-pagination:none;mso-layout-grid-align:none;text-autospace:none'><span
lang=EN-GB style='font-size:9.0pt;mso-bidi-font-size:12.0pt;line-height:107%;
font-family:"Times New Roman",serif;mso-no-proof:yes'>34. <span
style='mso-tab-count:1'> </span>Curtis CE. Indicators for the monitoring of
antibiotic use. J Infect Prev. 2010;11(4):124-6. <o:p></o:p></span></p>

<p class=MsoNormal style='margin-top:0mm;margin-right:0mm;margin-bottom:0mm;
margin-left:14.2pt;margin-bottom:.0001pt;text-align:justify;text-indent:-14.2pt;
mso-pagination:none;mso-layout-grid-align:none;text-autospace:none'><span
lang=EN-GB style='font-size:9.0pt;mso-bidi-font-size:12.0pt;line-height:107%;
font-family:"Times New Roman",serif;mso-no-proof:yes'>35. <span
style='mso-tab-count:1'> </span>WHO Collaborating Centre for Drug Statistics
Methodology. Guidelines for ATC classification and DDD assignment 2016. 19th
editi. Vol. 1. Oslo; 2015. 1-292 p. <o:p></o:p></span></p>

<p class=MsoNormal style='margin-top:0mm;margin-right:0mm;margin-bottom:0mm;
margin-left:14.2pt;margin-bottom:.0001pt;text-align:justify;text-indent:-14.2pt;
mso-pagination:none;mso-layout-grid-align:none;text-autospace:none'><span
lang=EN-GB style='font-size:9.0pt;mso-bidi-font-size:12.0pt;line-height:107%;
font-family:"Times New Roman",serif;mso-no-proof:yes'>36. <span
style='mso-tab-count:1'> </span>Monnet DL. Measuring Antimicrobial Use: The Way
Forward. Clin Infect Dis. 2007;44(5):671-3. <o:p></o:p></span></p>

<p class=MsoNormal style='margin-top:0mm;margin-right:0mm;margin-bottom:0mm;
margin-left:14.2pt;margin-bottom:.0001pt;text-align:justify;text-indent:-14.2pt;
mso-pagination:none;mso-layout-grid-align:none;text-autospace:none'><span
lang=EN-GB style='font-size:9.0pt;mso-bidi-font-size:12.0pt;line-height:107%;
font-family:"Times New Roman",serif;mso-no-proof:yes'>37. <span
style='mso-tab-count:1'> </span>Joseph PD, Craig JC, Caldwell PHY. Clinical
trials in children. Br J Clin Pharmacol. 2015;79(3):357-69. <o:p></o:p></span></p>

<p class=MsoNormal style='margin-top:0mm;margin-right:0mm;margin-bottom:0mm;
margin-left:14.2pt;margin-bottom:.0001pt;text-align:justify;text-indent:-14.2pt;
mso-pagination:none;mso-layout-grid-align:none;text-autospace:none'><span
lang=EN-GB style='font-size:9.0pt;mso-bidi-font-size:12.0pt;line-height:107%;
font-family:"Times New Roman",serif;mso-no-proof:yes'>38. <span
style='mso-tab-count:1'> </span>Liem TBY, Heerdink ER, Egberts ACG, Rademaker
CMA. Quantifying antibiotic use in paediatrics: A proposal for neonatal DDDs.
Eur J Clin Microbiol Infect Dis. 2010;29(10):1301-3. <o:p></o:p></span></p>

<p class=MsoNormal style='margin-top:0mm;margin-right:0mm;margin-bottom:0mm;
margin-left:14.2pt;margin-bottom:.0001pt;text-align:justify;text-indent:-14.2pt;
mso-pagination:none;mso-layout-grid-align:none;text-autospace:none'><span
lang=EN-GB style='font-size:9.0pt;mso-bidi-font-size:12.0pt;line-height:107%;
font-family:"Times New Roman",serif;mso-no-proof:yes'>39. <span
style='mso-tab-count:1'> </span>AstraZeneca. Merrem Highlights of Prescribing
Information. 2016;1-24. <o:p></o:p></span></p>

<p class=MsoNormal style='margin-top:0mm;margin-right:0mm;margin-bottom:0mm;
margin-left:14.2pt;margin-bottom:.0001pt;text-align:justify;text-indent:-14.2pt;
mso-pagination:none;mso-layout-grid-align:none;text-autospace:none'><span
lang=EN-GB style='font-size:9.0pt;mso-bidi-font-size:12.0pt;line-height:107%;
font-family:"Times New Roman",serif;mso-no-proof:yes'>40. <span
style='mso-tab-count:1'> </span>Mandy B, Koutny E, Cornette C, Woronoff-Lemsi
MC, Talon D. Methodological validation of monitoring indicators of antibiotics
use in hospitals. Pharm World Sci. 2004;26(2):90-5. <o:p></o:p></span></p>

<p class=MsoNormal style='margin-top:0mm;margin-right:0mm;margin-bottom:0mm;
margin-left:14.2pt;margin-bottom:.0001pt;text-align:justify;text-indent:-14.2pt;
mso-pagination:none;mso-layout-grid-align:none;text-autospace:none'><span
lang=EN-GB style='font-size:9.0pt;mso-bidi-font-size:12.0pt;line-height:107%;
font-family:"Times New Roman",serif;mso-no-proof:yes'>41. <span
style='mso-tab-count:1'> </span>De With K, Bestehorn H, Steib-Bauert M, Kern W
V. Comparison of defined versus recommended versus prescribed daily doses for
measuring hospital antibiotic consumption. Infection. 2009;37(4):349-52. <o:p></o:p></span></p>

<p class=MsoNormal style='margin-top:0mm;margin-right:0mm;margin-bottom:0mm;
margin-left:14.2pt;margin-bottom:.0001pt;text-align:justify;text-indent:-14.2pt;
mso-pagination:none;mso-layout-grid-align:none;text-autospace:none'><span
lang=EN-GB style='font-size:9.0pt;mso-bidi-font-size:12.0pt;line-height:107%;
font-family:"Times New Roman",serif;mso-no-proof:yes'>42. <span
style='mso-tab-count:1'> </span>Polk RE, Hohmann SF, Medvedev S, Ibrahim O.
Benchmarking risk-adjusted adult antibacterial drug use in 70 US academic
medical center hospitals. Clin Infect Dis. 2011;53(11):1100-10. <o:p></o:p></span></p>

<p class=MsoNormal style='margin-top:0mm;margin-right:0mm;margin-bottom:0mm;
margin-left:14.2pt;margin-bottom:.0001pt;text-align:justify;text-indent:-14.2pt;
mso-pagination:none;mso-layout-grid-align:none;text-autospace:none'><span
lang=EN-GB style='font-size:9.0pt;mso-bidi-font-size:12.0pt;line-height:107%;
font-family:"Times New Roman",serif;mso-no-proof:yes'>43. <span
style='mso-tab-count:1'> </span>Zagorski BM, Trick WE, Schwartz DN, Wisniewski
MF, Hershow RC, Fridkin SK, et&nbsp;al. The effect of renal dysfunction on
antimicrobial use measurements. Clin Infect Dis. 2002;35(12):1491-7. <o:p></o:p></span></p>

<p class=MsoNormal style='margin-top:0mm;margin-right:0mm;margin-bottom:0mm;
margin-left:14.2pt;margin-bottom:.0001pt;text-align:justify;text-indent:-14.2pt;
mso-pagination:none;mso-layout-grid-align:none;text-autospace:none'><span
lang=EN-GB style='font-size:9.0pt;mso-bidi-font-size:12.0pt;line-height:107%;
font-family:"Times New Roman",serif;mso-no-proof:yes'>44. <span
style='mso-tab-count:1'> </span>Schechner V, Temkin E, Harbarth S, Carmeli Y,
Schwaber MJ. Epidemiological interpretation of studies examining the effect of
antibiotic usage on resistance. Clin Microbiol Rev. 2013;26(2):289-307. <o:p></o:p></span></p>

<p class=MsoNormal style='margin-top:0mm;margin-right:0mm;margin-bottom:0mm;
margin-left:14.2pt;margin-bottom:.0001pt;text-align:justify;text-indent:-14.2pt;
mso-pagination:none;mso-layout-grid-align:none;text-autospace:none'><span
lang=EN-GB style='font-size:9.0pt;mso-bidi-font-size:12.0pt;line-height:107%;
font-family:"Times New Roman",serif;mso-no-proof:yes'>45. <span
style='mso-tab-count:1'> </span>Griffith M, Postelnick M, Scheetz M.
Antimicrobial stewardship programs: methods of operation and suggested
outcomes. Expert Rev Anti Infect Ther. 2012;10(1):63-73. <o:p></o:p></span></p>

<p class=MsoNormal style='margin-top:0mm;margin-right:0mm;margin-bottom:0mm;
margin-left:14.2pt;margin-bottom:.0001pt;text-align:justify;text-indent:-14.2pt;
mso-pagination:none;mso-layout-grid-align:none;text-autospace:none'><span
lang=EN-GB style='font-size:9.0pt;mso-bidi-font-size:12.0pt;line-height:107%;
font-family:"Times New Roman",serif;mso-no-proof:yes'>46. <span
style='mso-tab-count:1'> </span>Klevens RM, Edwards JR, Richards CL, Horan TC,
Gaynes RP, Pollock DA, et&nbsp;al. Estimating Health Care-Associated Infections
and Deaths in U.S. Hospitals, 2002. </span><span style='font-size:9.0pt;
mso-bidi-font-size:12.0pt;line-height:107%;font-family:"Times New Roman",serif;
mso-ansi-language:ES-CO;mso-no-proof:yes'>Public Health Rep. 2007;122(2):160-6.
<o:p></o:p></span></p>

<p class=MsoNormal style='margin-top:0mm;margin-right:0mm;margin-bottom:0mm;
margin-left:14.2pt;margin-bottom:.0001pt;text-align:justify;text-indent:-14.2pt;
mso-pagination:none;mso-layout-grid-align:none;text-autospace:none'><span
style='font-size:9.0pt;mso-bidi-font-size:12.0pt;line-height:107%;font-family:
"Times New Roman",serif;mso-ansi-language:ES-CO;mso-no-proof:yes'>47. <span
style='mso-tab-count:1'> </span>Retamal M. Autogestión hospitalaria en cifras.
Rev Chil Salud Pública. </span><span lang=EN-GB style='font-size:9.0pt;
mso-bidi-font-size:12.0pt;line-height:107%;font-family:"Times New Roman",serif;
mso-no-proof:yes'>2009;13(3):169-74. <o:p></o:p></span></p>

<p class=MsoNormal style='margin-top:0mm;margin-right:0mm;margin-bottom:0mm;
margin-left:14.2pt;margin-bottom:.0001pt;text-align:justify;text-indent:-14.2pt;
mso-pagination:none;mso-layout-grid-align:none;text-autospace:none'><span
lang=EN-GB style='font-size:9.0pt;mso-bidi-font-size:12.0pt;line-height:107%;
font-family:"Times New Roman",serif;mso-no-proof:yes'>48. <span
style='mso-tab-count:1'> </span>Filius PMG, Liem TBY, van der Linden PD,
Janknegt R, Natsch S, Vulto AG, et&nbsp;al. An additional measure for
quantifying antibiotic use in hospitals. J Antimicrob Chemother.
2005;55(5):805-8. <o:p></o:p></span></p>

<p class=MsoNormal style='margin-top:0mm;margin-right:0mm;margin-bottom:0mm;
margin-left:14.2pt;margin-bottom:.0001pt;text-align:justify;text-indent:-14.2pt;
mso-pagination:none;mso-layout-grid-align:none;text-autospace:none'><span
lang=EN-GB style='font-size:9.0pt;mso-bidi-font-size:12.0pt;line-height:107%;
font-family:"Times New Roman",serif;mso-no-proof:yes'>49. <span
style='mso-tab-count:1'> </span>Fitzpatrick RW, Edwards CMC. Evaluation of a
tool to benchmark hospital antibiotic prescribing in the United Kingdom. Pharm
World Sci. 2008;30(1):73-8. <o:p></o:p></span></p>

<p class=MsoNormal style='margin-top:0mm;margin-right:0mm;margin-bottom:0mm;
margin-left:14.2pt;margin-bottom:.0001pt;text-align:justify;text-indent:-14.2pt;
mso-pagination:none;mso-layout-grid-align:none;text-autospace:none'><span
lang=EN-GB style='font-size:9.0pt;mso-bidi-font-size:12.0pt;line-height:107%;
font-family:"Times New Roman",serif;mso-no-proof:yes'>50. <span
style='mso-tab-count:1'> </span>Lambert MF, Masters GA, Brent SL. Can mass
media campaigns change antimicrobial prescribing? A regional evaluation study.
J Antimicrob Chemother. 2007;59(3):537-43. <o:p></o:p></span></p>

<p class=MsoNormal style='margin-top:0mm;margin-right:0mm;margin-bottom:0mm;
margin-left:14.2pt;margin-bottom:.0001pt;text-align:justify;text-indent:-14.2pt;
mso-pagination:none;mso-layout-grid-align:none;text-autospace:none'><span
lang=EN-GB style='font-size:9.0pt;mso-bidi-font-size:12.0pt;line-height:107%;
font-family:"Times New Roman",serif;mso-no-proof:yes'>51. <span
style='mso-tab-count:1'> </span>Wang KY, Seed P, Schofield P, Ibrahim S,
Ashworth M. Which practices are high antibiotic prescribers? A cross-sectional
analysis. Br J Gen Pract. 2009;59(567):724-7. <o:p></o:p></span></p>

<p class=MsoNormal style='margin-top:0mm;margin-right:0mm;margin-bottom:0mm;
margin-left:14.2pt;margin-bottom:.0001pt;text-align:justify;text-indent:-14.2pt;
mso-pagination:none;mso-layout-grid-align:none;text-autospace:none'><span
lang=EN-GB style='font-size:9.0pt;mso-bidi-font-size:12.0pt;line-height:107%;
font-family:"Times New Roman",serif;mso-no-proof:yes'>52. <span
style='mso-tab-count:1'> </span>Lloyd DC, Harris CM, Roberts DJ. Specific
therapeutic group age-sex related prescribing units (STAR-PUs): weightings for
analysing general practices’ prescribing in England. Br Med J.
1995;311(7011):991-4. <o:p></o:p></span></p>

<p class=MsoNormal style='margin-top:0mm;margin-right:0mm;margin-bottom:0mm;
margin-left:14.2pt;margin-bottom:.0001pt;text-align:justify;text-indent:-14.2pt;
mso-pagination:none;mso-layout-grid-align:none;text-autospace:none'><span
lang=EN-GB style='font-size:9.0pt;mso-bidi-font-size:12.0pt;line-height:107%;
font-family:"Times New Roman",serif;mso-no-proof:yes'>53. <span
style='mso-tab-count:1'> </span>De With K, Maier L, Steib-Bauert M, Kern P,
Kern W V. Trends in antibiotic use at a University Hospital: Defined or
prescribed daily doses? Patient days or admissions as denominator? Infection.
2006;34(2):91-4. <o:p></o:p></span></p>

<p class=MsoNormal style='margin-top:0mm;margin-right:0mm;margin-bottom:0mm;
margin-left:14.2pt;margin-bottom:.0001pt;text-align:justify;text-indent:-14.2pt;
mso-pagination:none;mso-layout-grid-align:none;text-autospace:none'><span
lang=EN-GB style='font-size:9.0pt;mso-bidi-font-size:12.0pt;line-height:107%;
font-family:"Times New Roman",serif;mso-no-proof:yes'>54. <span
style='mso-tab-count:1'> </span>Muller A, Monnet DL, Talon D, Hénon T, Bertrand
X. Discrepancies between prescribed daily doses and WHO defined daily doses of
antibacterials at a university hospital. Br J Clin Pharmacol.
2006;61(5):585-91. <o:p></o:p></span></p>

<p class=MsoNormal style='margin-top:0mm;margin-right:0mm;margin-bottom:0mm;
margin-left:14.2pt;margin-bottom:.0001pt;text-align:justify;text-indent:-14.2pt;
mso-pagination:none;mso-layout-grid-align:none;text-autospace:none'><span
lang=EN-GB style='font-size:9.0pt;mso-bidi-font-size:12.0pt;line-height:107%;
font-family:"Times New Roman",serif;mso-no-proof:yes'>55. <span
style='mso-tab-count:1'> </span>Polk RE, Fox C, Mahoney A, Letcavage J,
MacDougall C. Measurement of adult antibacterial drug use in 130 US hospitals:
comparison of defined daily dose and days of therapy. Clin Infect Dis.
2007;44(5). <o:p></o:p></span></p>

<p class=MsoNormal style='margin-top:0mm;margin-right:0mm;margin-bottom:0mm;
margin-left:14.2pt;margin-bottom:.0001pt;text-align:justify;text-indent:-14.2pt;
mso-pagination:none;mso-layout-grid-align:none;text-autospace:none'><span
lang=EN-GB style='font-size:9.0pt;mso-bidi-font-size:12.0pt;line-height:107%;
font-family:"Times New Roman",serif;mso-no-proof:yes'>56. <span
style='mso-tab-count:1'> </span>Shetka M, Pastor J, Phelps P. Evaluation of the
defined daily dose method for estimating antiinfective use in a university
hospital. Am J Heal Pharm. 2005;62(21):2288-92. <o:p></o:p></span></p>

<p class=MsoNormal style='margin-top:0mm;margin-right:0mm;margin-bottom:0mm;
margin-left:14.2pt;margin-bottom:.0001pt;text-align:justify;text-indent:-14.2pt;
mso-pagination:none;mso-layout-grid-align:none;text-autospace:none'><span
lang=EN-GB style='font-size:9.0pt;mso-bidi-font-size:12.0pt;line-height:107%;
font-family:"Times New Roman",serif;mso-no-proof:yes'>57. <span
style='mso-tab-count:1'> </span>Guillot J, Lebel D, Roy H, Ovetchkine P,
Bussières J-F. Usefulness of Defined Daily Dose and Days of Therapy in
Pediatrics and Obstetrics-Gynecology: A Comparative Analysis of Antifungal
Drugs (2000-2001, 2005-2006, and 2010-2011). J Pediatr Pharmacol Ther.
2014;19(3):196-201. <o:p></o:p></span></p>

<p class=MsoNormal style='margin-top:0mm;margin-right:0mm;margin-bottom:0mm;
margin-left:14.2pt;margin-bottom:.0001pt;text-align:justify;text-indent:-14.2pt;
mso-pagination:none;mso-layout-grid-align:none;text-autospace:none'><span
lang=EN-GB style='font-size:9.0pt;mso-bidi-font-size:12.0pt;line-height:107%;
font-family:"Times New Roman",serif;mso-no-proof:yes'>58. <span
style='mso-tab-count:1'> </span>Kubin CJ, Jia H, Alba LR, Furuya EY. Lack of
Significant Variability among Different Methods for Calculating Antimicrobial
Days of Therapy. Infect Control Hosp Epidemiol. 2012;33(04):421-3. <o:p></o:p></span></p>

<p class=MsoNormal style='margin-top:0mm;margin-right:0mm;margin-bottom:0mm;
margin-left:14.2pt;margin-bottom:.0001pt;text-align:justify;text-indent:-14.2pt;
mso-pagination:none;mso-layout-grid-align:none;text-autospace:none'><span
lang=EN-GB style='font-size:9.0pt;mso-bidi-font-size:12.0pt;line-height:107%;
font-family:"Times New Roman",serif;mso-no-proof:yes'>59. <span
style='mso-tab-count:1'> </span>Gerber JS, Newland JG, Coffin SE, Hall M, Thurm
C, Prasad PA, et&nbsp;al. Variability in antibiotic use at children’s
hospitals. Pediatrics. 2010;126(6):1067-73. <o:p></o:p></span></p>

<p class=MsoNormal style='margin-top:0mm;margin-right:0mm;margin-bottom:0mm;
margin-left:14.2pt;margin-bottom:.0001pt;text-align:justify;text-indent:-14.2pt;
mso-pagination:none;mso-layout-grid-align:none;text-autospace:none'><span
lang=EN-GB style='font-size:9.0pt;mso-bidi-font-size:12.0pt;line-height:107%;
font-family:"Times New Roman",serif;mso-no-proof:yes'>60. <span
style='mso-tab-count:1'> </span>Pakyz AL, Gurgle HE, Ibrahim OM, Oinonen MJ,
Polk RE. Trends in Antibacterial Use in Hospitalized Pediatric Patients in
United States Academic Health Centers. Infect Control Hosp Epidemiol.
2009;30(06):600-3. <o:p></o:p></span></p>

<p class=MsoNormal style='margin-top:0mm;margin-right:0mm;margin-bottom:0mm;
margin-left:14.2pt;margin-bottom:.0001pt;text-align:justify;text-indent:-14.2pt;
mso-pagination:none;mso-layout-grid-align:none;text-autospace:none'><span
lang=EN-GB style='font-size:9.0pt;mso-bidi-font-size:12.0pt;line-height:107%;
font-family:"Times New Roman",serif;mso-no-proof:yes'>61. <span
style='mso-tab-count:1'> </span>Grohskopf LA, Huskins WC, Sinkowitz-Cochran RL,
Levine GL, Goldmann DA, Jarvis WR. Use of Antimicrobial Agents in United States
Neonatal and Pediatric Intensive Care Patients. Pediatr Infect Dis J.
2005;24(9):766-73. <o:p></o:p></span></p>

<p class=MsoNormal style='margin-top:0mm;margin-right:0mm;margin-bottom:0mm;
margin-left:14.2pt;margin-bottom:.0001pt;text-align:justify;text-indent:-14.2pt;
mso-pagination:none;mso-layout-grid-align:none;text-autospace:none'><span
lang=EN-GB style='font-size:9.0pt;mso-bidi-font-size:12.0pt;line-height:107%;
font-family:"Times New Roman",serif;mso-no-proof:yes'>62. <span
style='mso-tab-count:1'> </span>Cantey JB, Wozniak PS, Sánchez PJ. Prospective
surveillance of antibiotic use in the neonatal intensive care unit: Results
from the SCOUT study. Pediatr Infect Dis J. 2015;34(3):267-72. <o:p></o:p></span></p>

<p class=MsoNormal style='margin-top:0mm;margin-right:0mm;margin-bottom:0mm;
margin-left:14.2pt;margin-bottom:.0001pt;text-align:justify;text-indent:-14.2pt;
mso-pagination:none;mso-layout-grid-align:none;text-autospace:none'><span
lang=EN-GB style='font-size:9.0pt;mso-bidi-font-size:12.0pt;line-height:107%;
font-family:"Times New Roman",serif;mso-no-proof:yes'>63. <span
style='mso-tab-count:1'> </span>Schwartz DN, Evans RS, Camins BC, Khan YM,
Lloyd JF, Shehab N, et&nbsp;al. Deriving Measures of Intensive Care Unit
Antimicrobial Use from Computerized Pharmacy Data: Methods, Validation, and
Overcoming Barriers. Infect Control Hosp Epidemiol. 2011;32(05):472-80. </span><span
lang=EN-GB style='font-size:9.0pt;mso-bidi-font-size:11.0pt;line-height:107%;
font-family:"Times New Roman",serif;mso-no-proof:yes'><o:p></o:p></span></p>

<p class=IOPRefs0 style='text-align:justify;mso-list:none;tab-stops:36.0pt'><!--[if supportFields]><span
lang=EN-US style='mso-ansi-language:EN-US'><span style='mso-element:field-end'></span></span><![endif]--><span
lang=EN-US style='mso-ansi-language:EN-US'><o:p></o:p></span></p>

</div>

<span lang=EN-US style='font-size:9.0pt;mso-bidi-font-size:11.0pt;line-height:
107%;font-family:"Times New Roman",serif;mso-fareast-font-family:Calibri;
mso-fareast-theme-font:minor-latin;mso-bidi-theme-font:minor-bidi;mso-ansi-language:
EN-US;mso-fareast-language:EN-US;mso-bidi-language:AR-SA;mso-no-proof:yes'><br
clear=all style='page-break-before:auto;mso-break-type:section-break'>
</span>

<div class=WordSection3>

<p class=IOPRefs0 style='margin-left:0mm;text-indent:0mm;mso-list:none;
tab-stops:36.0pt'><span lang=EN-US style='mso-ansi-language:EN-US'><o:p>&nbsp;</o:p></span></p>

<p class=IOPRefs0 style='margin-left:0mm;text-indent:0mm;mso-list:none;
tab-stops:36.0pt'><span lang=EN-US style='mso-ansi-language:EN-US'><o:p>&nbsp;</o:p></span></p>

<p class=IOPRefs0 style='margin-left:0mm;text-indent:0mm;mso-list:none;
tab-stops:36.0pt'><span lang=EN-US style='mso-ansi-language:EN-US'><o:p>&nbsp;</o:p></span></p>

</div>

<span lang=EN-US style='font-size:9.0pt;mso-bidi-font-size:11.0pt;line-height:
107%;font-family:"Times New Roman",serif;mso-fareast-font-family:Calibri;
mso-fareast-theme-font:minor-latin;mso-bidi-theme-font:minor-bidi;mso-ansi-language:
EN-US;mso-fareast-language:EN-US;mso-bidi-language:AR-SA;mso-no-proof:yes'><br
clear=all style='page-break-before:auto;mso-break-type:section-break'>
</span>

<div class=WordSection4>

<p class=IOPRefs0 style='margin-left:0mm;text-indent:0mm;mso-list:none;
tab-stops:36.0pt'><span lang=EN-US style='mso-ansi-language:EN-US'><o:p>&nbsp;</o:p></span></p>

</div>

</body>

</html>
